{"id": 1042097, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "e7ee4a44-f967-470e-867c-2faab3a61918", "title": null, "text": "【0】页码:284\n 227. Bigger JT, Jr., Mandel WJ. Effect of lidocaine on the electrophysiological properties of ventricular muscle and purkinje fibers. J Clin Invest .\n\n【1】1970;49:63–77.\n\n【2】228. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A.\n\n【3】Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med . 2002;346:884–890.\n\n【4】229. Wilson FC, Harpur J, Watson T, Morrow JI. Adult survivors of severe cerebral hypoxia–case series survey and comparative analysis. Neuro Rehabilitation . 2003;18:291–298.\n\n【5】230.\n\n【6】Thomson PD, Melmon KL, Richardson JA, Cohn K, Steinbrunn W, Cudihee R, Rowland M. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med .\n\n【7】1973;78:499–508.\n\n【8】231.\n\n【9】Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A, Horowitz M, Nashed A, Yablonski M.  Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting.\n\n【10】Resuscitation . 2001;49:245–249.\n\n【11】232. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation.\n\n【12】Emerg Med J . 2002;19:57–62.\n\n【13】233.\n\n【14】Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM.\n\n【15】Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet. 1997;350:1272–1276.\n\n【16】234. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff- Parkinson-White and atrioventricular nodal reentry. Ann Pharmacother .\n\n【17】1997;31:1227–1243.\n\n【18】235. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraventricular tachycardias in children, part 2: atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharmacother . 1997;31:1347–1359.\n\n【19】236. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y.  Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol .\n\n【20】2010;3:134–140.\n\n【21】237. Vukmir RB, Katz L.  Sodium bicarbonate improves outcome in prolonged prehospital cardiac arrest. Am J Emerg Med . 2006;24:156–161.\n\n【22】238. Lokesh L, Kumar P, Murki S, Narang A. A randomized controlled trial of sodium bicarbonate in neonatal resuscitation-effect on immediate outcome. Resuscitation. 2004;60:219–223.\n\n【23】239. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI.\n\n【24】Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med . 1986;315:153–156.\n\n【25】240. Steedman DJ, Robertson CE. Acid-base changes in arterial and central venous blood during cardiopulmonary resuscitation. Arch Emerg Med .\n\n【26】1992;9:169–176.\n\n【27】241.\n\n【28】Wayne MA, Delbridge TR, Ornato JP, Swor RA, Blackwell T. Concepts and application of prehospital ventilation. Prehosp Emerg Care. 2001; 5:73–78.\n\n【29】242. Mattar JA, Weil MH, Shubin H, Stein L. Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. Am J Med . 1974; 56 : 162–168.\n\n【30】243. Aufderheide TP, Martin DR, Olson DW, Aprahamian C, Woo JW, Hendley GE, Hargarten KM, Thompson B. Prehospital bicarbonate use in cardiac arrest: a 3-year experience. Am J Emerg Med . 1992;10:4–7.\n\n【31】244.\n\n【32】Bishop RL, Weisfeldt ML.  Sodium bicarbonate administration during cardiac arrest. Effect on arterial pH PCO2, and osmolality. JAMA .\n\n【33】1976;235:506–509.\n\n【34】245. Mann K, Berg RA, Nadkarni V.  Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series. Resuscitation . 2002;52: 149–156.\n\n【35】246. Matok I, Vardi A, Augarten A, Efrati O, Leibovitch L, Rubinshtein M, Paret G. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series. Crit Care Med . 2007;35: 1161–1164.\n\n【36】247. Gil- Anton J, Lopez- Herce J, Morteruel E, Carrillo A, Rodriguez- Nunez A. Pediatric cardiac arrest refractory to advanced life support: is there a role for terlipressin? Pediatr Crit Care Med . 2010;11:139–141.\n\n【37】248. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med . 1996;124:1061–1064.\n\n【38】Lee CC, Kim GW, Kim SH, Crupi RS.  Cases of aminophylline and 249.\n\n【39】vasopressin use after failed prehospital resuscitation of cardiac arrest.\n\n【40】Prehosp Emerg Care . 2001;5:304–307.\n\n【41】 250. Duncan JM, Meaney P, Simpson P, Berg RA, Nadkarni V, Schexnayder S. Vasopressin for in-hospital pediatric cardiac arrest: results from the American Heart Association National Registry of Cardiopulmonary Resuscitation. Pediatr Crit Care Med . 2009;10:191–195.\n\n【42】251. Callaway CW, Hostler D, Doshi AA, Pinchalk M, Roth RN, Lubin J, Newman DH, Kelly LJ.  Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest. Am J Cardiol. 2006; 98:1316–1321.\n\n【43】252. Gueugniaud PY, David JS, Chanzy E, Hubert H, Dubien PY, Mauriaucourt P, Braganca C, Billeres X, Clotteau-Lambert MP, Fuster P, Thiercelin D, Debaty G, Ricard-Hibon A, Roux P, Espesson C, Querellou E, Ducros L, Ecollan P, Halbout L, Savary D, Guillaumee F, Maupoint R, Capelle P, Bracq C, Dreyfus P, Nouguier P, Gache A, Meurisse C, Boulanger B, Lae C, Metzger J, Raphael V, Beruben A, Wenzel V, Guinhouya C, Vilhelm C, Marret E. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med . 2008;359:21–30.\n\n【44】253. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 1997;349:535–537.\n\n【45】254. Mukoyama T, Kinoshita K, Nagao K, Tanjoh K. Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation . 2009;80:755–761.\n\n【46】255. Stiell IG, Hebert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, Dreyer JF, Clement C, Battram E, Watpool I, Mason S, Klassen T, Weitzman BN.  Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358:105–109.\n\n【47】256. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med . 2004;350:105–113.\n\n【48】257. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med . 2004;350:1722–1730.\n\n【49】258. Rodriguez Nunez A, Garcia C, Lopez-Herce Cid J. [Is high-dose epinephrine justified in cardiorespiratory arrest in children?]. An Pediatr (Barc) . 2005;62:113–116.\n\n【50】259. Patterson MD, Boenning DA, Klein BL, Fuchs S, Smith KM, Hegenbarth MA, Carlson DW, Krug SE, Harris EM.  The use of high-dose epinephrine for patients with out-of-hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatr Emerg Care. 2005 ; 21:227–237.\n\n【51】260. Dieckmann RA, Vardis R.  High- dose epinephrine in pediatric out- ofhospital cardiopulmonary arrest. Pediatrics . 1995;95:901–913.\n\n【52】261.\n\n【53】Carpenter TC, Stenmark KR. High-dose epinephrine is not superior to standard-dose epinephrine in pediatric in-hospital cardiopulmonary arrest. Pediatrics . 1997;99:403–408.\n\n【54】262. Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S.\n\n【55】Characteristics and outcome among children suffering from out of hospital cardiac arrest in Sweden. Resuscitation. 2005;64:37–40.\n\n【56】263. Safranek DJ, Eisenberg MS, Larsen MP. The epidemiology of cardiac arrest in young adults. Ann Emerg Med . 1992;21:1102–1106.\n\n【57】264. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP.  Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med . 1993;22:1652–1658.\n\n【58】265. Atkins DL, Sirna S, Kieso R, Charbonnier F, Kerber RE.  Pediatric defibrillation: importance of paddle size in determining transthoracic impedance. Pediatrics. 1988;82:914–918.\n\n【59】266. Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved by using \"adult\" electrode paddles. Pediatrics . 1994;94:90–93.\n\n【60】267. Samson RA, Atkins DL, Kerber RE.  Optimal size of self-adhesive preapplied electrode pads in pediatric defibrillation. Am J Cardiol .\n\n【61】1995;75:544–545.\n\n【62】268. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M.  External and internal biphasic direct current shock doses for pediatric ventricular fibrillation and pulseless ventricular tachycardia. Pediatr Crit Care Med .\n\n【63】2010. In press.\n\n【64】269. Berg MD, Samson RA, Meyer RJ, Clark LL, Valenzuela TD, Berg RA.\n\n【65】Pediatric defibrillation doses often fail to terminate prolonged out-ofhospital ventricular fibrillation in children. Resuscitation . 2005;67: 63–67.\n\n【66】270. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, Dominguez P, Carrillo A, Bellon JM.  Pediatric defibrillation after cardiac arrest: initial response and outcome. Crit Care. 2006;10:R113.\n\n【67】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "227. Bigger JT, Jr., Mandel WJ. Effect of lidocaine on the electrophysiolog-", "bbox": [61.0, 85.0, 375.0, 96.0]}, {"text": "ical properties of ventricular muscle and purkinje fibers. J Clin Invest .", "bbox": [84.0, 98.0, 375.0, 109.0]}, {"text": "1970;49:63–77.", "bbox": [84.0, 109.0, 148.0, 120.0]}, {"text": "228. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A.", "bbox": [61.0, 122.0, 375.0, 134.0]}, {"text": "Amiodarone as compared with lidocaine for shock-resistant ventricular", "bbox": [84.0, 134.0, 375.0, 146.0]}, {"text": "fibrillation. N Engl J Med . 2002;346:884–890.", "bbox": [84.0, 147.0, 278.0, 158.0]}, {"text": "229. Wilson FC, Harpur J, Watson T, Morrow JI. Adult survivors of severe", "bbox": [61.0, 158.0, 376.0, 171.0]}, {"text": "cerebral hypoxia–case series survey and comparative analysis. Neuro", "bbox": [83.0, 171.0, 375.0, 183.0]}, {"text": "Rehabilitation . 2003;18:291–298.", "bbox": [84.0, 183.0, 221.0, 194.0]}, {"text": "230.", "bbox": [61.0, 195.0, 82.0, 207.0]}, {"text": "Thomson PD, Melmon KL, Richardson JA, Cohn K, Steinbrunn W,", "bbox": [81.0, 195.0, 375.0, 207.0]}, {"text": "Cudihee R, Rowland M. Lidocaine pharmacokinetics in advanced heart", "bbox": [83.0, 207.0, 377.0, 219.0]}, {"text": "failure, liver disease, and renal failure in humans. Ann Intern Med .", "bbox": [84.0, 220.0, 375.0, 232.0]}, {"text": "1973;78:499–508.", "bbox": [84.0, 234.0, 159.0, 244.0]}, {"text": "231.", "bbox": [61.0, 244.0, 80.0, 255.0]}, {"text": "Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A,", "bbox": [82.0, 244.0, 376.0, 256.0]}, {"text": "Horowitz M, Nashed A, Yablonski M.  Magnesium sulfate in the", "bbox": [83.0, 257.0, 376.0, 269.0]}, {"text": "treatment of refractory ventricular fibrillation in the prehospital setting.", "bbox": [83.0, 269.0, 375.0, 281.0]}, {"text": "Resuscitation . 2001;49:245–249.", "bbox": [84.0, 282.0, 217.0, 294.0]}, {"text": "232. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the", "bbox": [61.0, 293.0, 375.0, 305.0]}, {"text": "efficacy of magnesium sulphate for refractory ventricular fibrillation.", "bbox": [83.0, 307.0, 375.0, 318.0]}, {"text": "Emerg Med J . 2002;19:57–62.", "bbox": [84.0, 318.0, 210.0, 329.0]}, {"text": "233.", "bbox": [61.0, 330.0, 82.0, 341.0]}, {"text": "Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM.", "bbox": [81.0, 330.0, 375.0, 342.0]}, {"text": "Randomised trial of magnesium in in-hospital cardiac arrest. Duke", "bbox": [84.0, 342.0, 376.0, 354.0]}, {"text": "Internal Medicine Housestaff. Lancet. 1997;350:1272–1276.", "bbox": [84.0, 355.0, 332.0, 367.0]}, {"text": "234. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of", "bbox": [61.0, 367.0, 376.0, 379.0]}, {"text": "supraventricular tachycardias in children. Part 1: Wolff-", "bbox": [84.0, 380.0, 375.0, 391.0]}, {"text": "Parkinson-White and atrioventricular nodal reentry. Ann Pharmacother .", "bbox": [84.0, 391.0, 375.0, 403.0]}, {"text": "1997;31:1227–1243.", "bbox": [84.0, 404.0, 168.0, 415.0]}, {"text": "235. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of", "bbox": [61.0, 416.0, 376.0, 428.0]}, {"text": "supraventricular tachycardias in children, part 2: atrial flutter, atrial", "bbox": [84.0, 428.0, 376.0, 441.0]}, {"text": "fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharma-", "bbox": [83.0, 441.0, 375.0, 453.0]}, {"text": "cother . 1997;31:1347–1359.", "bbox": [83.0, 453.0, 200.0, 464.0]}, {"text": "236. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y.  Amiodarone", "bbox": [61.0, 465.0, 375.0, 477.0]}, {"text": "versus procainamide for the acute treatment of recurrent supraventricu-", "bbox": [84.0, 477.0, 375.0, 489.0]}, {"text": "lar tachycardia in pediatric patients. Circ Arrhythm Electrophysiol .", "bbox": [84.0, 490.0, 375.0, 502.0]}, {"text": "2010;3:134–140.", "bbox": [84.0, 501.0, 154.0, 513.0]}, {"text": "237. Vukmir RB, Katz L.  Sodium bicarbonate improves outcome in pro-", "bbox": [61.0, 514.0, 375.0, 528.0]}, {"text": "longed prehospital cardiac arrest. Am J Emerg Med . 2006;24:156–161.", "bbox": [84.0, 527.0, 375.0, 538.0]}, {"text": "238. Lokesh L, Kumar P, Murki S, Narang A. A randomized controlled trial", "bbox": [61.0, 539.0, 376.0, 552.0]}, {"text": "of sodium bicarbonate in neonatal resuscitation-effect on immediate", "bbox": [83.0, 551.0, 375.0, 562.0]}, {"text": "outcome. Resuscitation. 2004;60:219–223.", "bbox": [84.0, 564.0, 261.0, 575.0]}, {"text": "239. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI.", "bbox": [61.0, 575.0, 375.0, 587.0]}, {"text": "Difference in acid-base state between venous and arterial blood during", "bbox": [83.0, 588.0, 375.0, 600.0]}, {"text": "cardiopulmonary resuscitation. N Engl J Med . 1986;315:153–156.", "bbox": [83.0, 600.0, 355.0, 611.0]}, {"text": "240. Steedman DJ, Robertson CE. Acid-base changes in arterial and central", "bbox": [61.0, 612.0, 376.0, 625.0]}, {"text": "venous blood during cardiopulmonary resuscitation. Arch Emerg Med .", "bbox": [84.0, 624.0, 375.0, 635.0]}, {"text": "1992;9:169–176.", "bbox": [84.0, 637.0, 155.0, 649.0]}, {"text": "241.", "bbox": [61.0, 649.0, 82.0, 659.0]}, {"text": "Wayne MA, Delbridge TR, Ornato JP, Swor RA, Blackwell T. Concepts", "bbox": [81.0, 649.0, 376.0, 660.0]}, {"text": "and application of prehospital ventilation. Prehosp Emerg Care. 2001;", "bbox": [84.0, 662.0, 375.0, 673.0]}, {"text": "5:73–78.", "bbox": [84.0, 674.0, 121.0, 684.0]}, {"text": "242. Mattar JA, Weil MH, Shubin H, Stein L. Cardiac arrest in the critically", "bbox": [61.0, 685.0, 375.0, 697.0]}, {"text": "ill. II. Hyperosmolal states following cardiac arrest. Am J Med . 1974;", "bbox": [84.0, 697.0, 376.0, 709.0]}, {"text": "56 : 162–168.", "bbox": [84.0, 710.0, 135.0, 722.0]}, {"text": "243. Aufderheide TP, Martin DR, Olson DW, Aprahamian C, Woo JW,", "bbox": [61.0, 722.0, 375.0, 734.0]}, {"text": "Hendley GE, Hargarten KM, Thompson B. Prehospital bicarbonate use", "bbox": [84.0, 735.0, 375.0, 747.0]}, {"text": "in cardiac arrest: a 3-year experience. Am J Emerg Med . 1992;10:4–7.", "bbox": [83.0, 747.0, 375.0, 758.0]}, {"text": "244.", "bbox": [61.0, 758.0, 82.0, 769.0]}, {"text": "Bishop RL, Weisfeldt ML.  Sodium bicarbonate administration during", "bbox": [81.0, 759.0, 375.0, 770.0]}, {"text": "cardiac arrest. Effect on arterial pH PCO2, and osmolality. JAMA .", "bbox": [84.0, 771.0, 375.0, 783.0]}, {"text": "1976;235:506–509.", "bbox": [84.0, 783.0, 164.0, 795.0]}, {"text": "245. Mann K, Berg RA, Nadkarni V.  Beneficial effects of vasopressin in", "bbox": [61.0, 795.0, 376.0, 807.0]}, {"text": "prolonged pediatric cardiac arrest: a case series. Resuscitation . 2002;52:", "bbox": [84.0, 808.0, 375.0, 820.0]}, {"text": "149–156.", "bbox": [84.0, 819.0, 124.0, 832.0]}, {"text": "246. Matok I, Vardi A, Augarten A, Efrati O, Leibovitch L, Rubinshtein M,", "bbox": [61.0, 832.0, 375.0, 844.0]}, {"text": "Paret G. Beneficial effects of terlipressin in prolonged pediatric cardio-", "bbox": [83.0, 845.0, 374.0, 856.0]}, {"text": "pulmonary resuscitation: a case series. Crit Care Med . 2007;35:", "bbox": [84.0, 857.0, 375.0, 869.0]}, {"text": "1161–1164.", "bbox": [84.0, 870.0, 134.0, 880.0]}, {"text": "247. Gil- Anton J, Lopez- Herce J, Morteruel E, Carrillo A, Rodriguez- Nunez", "bbox": [61.0, 881.0, 376.0, 893.0]}, {"text": "A. Pediatric cardiac arrest refractory to advanced life support: is there a", "bbox": [84.0, 895.0, 376.0, 905.0]}, {"text": "role for terlipressin? Pediatr Crit Care Med . 2010;11:139–141.", "bbox": [83.0, 906.0, 345.0, 917.0]}, {"text": "248. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM,", "bbox": [61.0, 918.0, 375.0, 931.0]}, {"text": "Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann", "bbox": [84.0, 930.0, 376.0, 942.0]}, {"text": "Intern Med . 1996;124:1061–1064.", "bbox": [83.0, 943.0, 225.0, 955.0]}, {"text": "Lee CC, Kim GW, Kim SH, Crupi RS.  Cases of aminophylline and", "bbox": [81.0, 954.0, 376.0, 966.0]}, {"text": "249.", "bbox": [61.0, 955.0, 82.0, 965.0]}, {"text": "vasopressin use after failed prehospital resuscitation of cardiac arrest.", "bbox": [85.0, 968.0, 375.0, 979.0]}, {"text": "Prehosp Emerg Care . 2001;5:304–307.", "bbox": [84.0, 979.0, 247.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "250. Duncan JM, Meaney P, Simpson P, Berg RA, Nadkarni V, Schexnayder", "bbox": [404.0, 85.0, 720.0, 98.0]}, {"text": "S. Vasopressin for in-hospital pediatric cardiac arrest: results from the", "bbox": [427.0, 98.0, 720.0, 109.0]}, {"text": "American Heart Association National Registry of Cardiopulmonary", "bbox": [428.0, 111.0, 720.0, 122.0]}, {"text": "Resuscitation. Pediatr Crit Care Med . 2009;10:191–195.", "bbox": [427.0, 122.0, 661.0, 134.0]}, {"text": "251. Callaway CW, Hostler D, Doshi AA, Pinchalk M, Roth RN, Lubin J,", "bbox": [404.0, 135.0, 720.0, 147.0]}, {"text": "Newman DH, Kelly LJ.  Usefulness of vasopressin administered with", "bbox": [427.0, 147.0, 720.0, 159.0]}, {"text": "epinephrine during out-of-hospital cardiac arrest. Am J Cardiol. 2006;", "bbox": [428.0, 160.0, 720.0, 172.0]}, {"text": "98:1316–1321.", "bbox": [427.0, 172.0, 491.0, 183.0]}, {"text": "252. Gueugniaud PY, David JS, Chanzy E, Hubert H, Dubien PY, Mauri-", "bbox": [404.0, 185.0, 719.0, 196.0]}, {"text": "aucourt P, Braganca C, Billeres X, Clotteau-Lambert MP, Fuster P,", "bbox": [427.0, 197.0, 720.0, 209.0]}, {"text": "Thiercelin D, Debaty G, Ricard-Hibon A, Roux P, Espesson C, Que-", "bbox": [428.0, 209.0, 718.0, 221.0]}, {"text": "rellou E, Ducros L, Ecollan P, Halbout L, Savary D, Guillaumee F,", "bbox": [427.0, 221.0, 720.0, 234.0]}, {"text": "Maupoint R, Capelle P, Bracq C, Dreyfus P, Nouguier P, Gache A,", "bbox": [427.0, 234.0, 720.0, 246.0]}, {"text": "Meurisse C, Boulanger B, Lae C, Metzger J, Raphael V, Beruben A,", "bbox": [427.0, 247.0, 720.0, 259.0]}, {"text": "Wenzel V, Guinhouya C, Vilhelm C, Marret E. Vasopressin and epi-", "bbox": [427.0, 259.0, 719.0, 271.0]}, {"text": "nephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl", "bbox": [428.0, 272.0, 720.0, 283.0]}, {"text": "J Med . 2008;359:21–30.", "bbox": [427.0, 284.0, 530.0, 295.0]}, {"text": "253. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie", "bbox": [404.0, 296.0, 720.0, 308.0]}, {"text": "KG. Randomised comparison of epinephrine and vasopressin in patients", "bbox": [427.0, 309.0, 720.0, 321.0]}, {"text": "with out-of-hospital ventricular fibrillation. Lancet. 1997;349:535–537.", "bbox": [428.0, 321.0, 719.0, 333.0]}, {"text": "254. Mukoyama T, Kinoshita K, Nagao K, Tanjoh K. Reduced effectiveness", "bbox": [404.0, 334.0, 720.0, 346.0]}, {"text": "of vasopressin in repeated doses for patients undergoing prolonged", "bbox": [427.0, 346.0, 720.0, 357.0]}, {"text": "cardiopulmonary resuscitation. Resuscitation . 2009;80:755–761.", "bbox": [427.0, 359.0, 690.0, 370.0]}, {"text": "255. Stiell IG, Hebert PC, Wells GA, Vandemheen KL, Tang AS, Higginson", "bbox": [404.0, 371.0, 720.0, 383.0]}, {"text": "LA, Dreyer JF, Clement C, Battram E, Watpool I, Mason S, Klassen T,", "bbox": [427.0, 384.0, 720.0, 395.0]}, {"text": "Weitzman BN.  Vasopressin versus epinephrine for inhospital cardiac", "bbox": [428.0, 396.0, 720.0, 408.0]}, {"text": "arrest: a randomised controlled trial. Lancet. 2001;358:105–109.", "bbox": [427.0, 408.0, 692.0, 420.0]}, {"text": "256. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner", "bbox": [405.0, 421.0, 720.0, 433.0]}, {"text": "KH. A comparison of vasopressin and epinephrine for out-of-hospital", "bbox": [427.0, 433.0, 721.0, 445.0]}, {"text": "cardiopulmonary resuscitation. N Engl J Med . 2004;350:105–113.", "bbox": [428.0, 446.0, 699.0, 457.0]}, {"text": "257. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A com-", "bbox": [404.0, 458.0, 719.0, 470.0]}, {"text": "parison of high-dose and standard-dose epinephrine in children with", "bbox": [427.0, 471.0, 720.0, 482.0]}, {"text": "cardiac arrest. N Engl J Med . 2004;350:1722–1730.", "bbox": [427.0, 483.0, 641.0, 495.0]}, {"text": "258. Rodriguez Nunez A, Garcia C, Lopez-Herce Cid J. [Is high-dose epi-", "bbox": [404.0, 495.0, 719.0, 507.0]}, {"text": "nephrine justified in cardiorespiratory arrest in children?]. An Pediatr", "bbox": [428.0, 508.0, 720.0, 520.0]}, {"text": "(Barc) . 2005;62:113–116.", "bbox": [427.0, 520.0, 536.0, 531.0]}, {"text": "259. Patterson MD, Boenning DA, Klein BL, Fuchs S, Smith KM,", "bbox": [404.0, 533.0, 719.0, 545.0]}, {"text": "Hegenbarth MA, Carlson DW, Krug SE, Harris EM.  The use of", "bbox": [427.0, 544.0, 720.0, 556.0]}, {"text": "high-dose epinephrine for patients with out-of-hospital cardiopulmonary", "bbox": [427.0, 557.0, 718.0, 569.0]}, {"text": "arrest refractory to prehospital interventions. Pediatr Emerg Care. 2005 ;", "bbox": [427.0, 571.0, 720.0, 580.0]}, {"text": "21:227–237.", "bbox": [427.0, 582.0, 480.0, 594.0]}, {"text": "260. Dieckmann RA, Vardis R.  High- dose epinephrine in pediatric out- of-", "bbox": [405.0, 595.0, 719.0, 607.0]}, {"text": "hospital cardiopulmonary arrest. Pediatrics . 1995;95:901–913.", "bbox": [427.0, 607.0, 685.0, 618.0]}, {"text": "261.", "bbox": [405.0, 620.0, 425.0, 630.0]}, {"text": "Carpenter TC, Stenmark KR. High-dose epinephrine is not superior to", "bbox": [425.0, 620.0, 721.0, 631.0]}, {"text": "standard-dose epinephrine in pediatric in-hospital cardiopulmonary", "bbox": [427.0, 632.0, 719.0, 642.0]}, {"text": "arrest. Pediatrics . 1997;99:403–408.", "bbox": [427.0, 644.0, 577.0, 656.0]}, {"text": "262. Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S.", "bbox": [405.0, 656.0, 719.0, 669.0]}, {"text": "Characteristics and outcome among children suffering from out of", "bbox": [427.0, 669.0, 720.0, 681.0]}, {"text": "hospital cardiac arrest in Sweden. Resuscitation. 2005;64:37–40.", "bbox": [427.0, 682.0, 696.0, 694.0]}, {"text": "263. Safranek DJ, Eisenberg MS, Larsen MP. The epidemiology of cardiac", "bbox": [404.0, 694.0, 720.0, 705.0]}, {"text": "arrest in young adults. Ann Emerg Med . 1992;21:1102–1106.", "bbox": [428.0, 707.0, 680.0, 718.0]}, {"text": "264. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP.  Predicting", "bbox": [404.0, 719.0, 720.0, 730.0]}, {"text": "survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg", "bbox": [428.0, 731.0, 720.0, 743.0]}, {"text": "Med . 1993;22:1652–1658.", "bbox": [427.0, 743.0, 536.0, 755.0]}, {"text": "265. Atkins DL, Sirna S, Kieso R, Charbonnier F, Kerber RE.  Pediatric", "bbox": [404.0, 756.0, 719.0, 768.0]}, {"text": "defibrillation: importance of paddle size in determining transthoracic", "bbox": [427.0, 768.0, 720.0, 781.0]}, {"text": "impedance. Pediatrics. 1988;82:914–918.", "bbox": [427.0, 781.0, 599.0, 792.0]}, {"text": "266. Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved", "bbox": [405.0, 794.0, 720.0, 805.0]}, {"text": "by using \"adult\" electrode paddles. Pediatrics . 1994;94:90–93.", "bbox": [427.0, 805.0, 688.0, 816.0]}, {"text": "267. Samson RA, Atkins DL, Kerber RE.  Optimal size of self-adhesive", "bbox": [404.0, 818.0, 720.0, 829.0]}, {"text": "preapplied electrode pads in pediatric defibrillation. Am J Cardiol .", "bbox": [428.0, 830.0, 720.0, 843.0]}, {"text": "1995;75:544–545.", "bbox": [428.0, 843.0, 503.0, 854.0]}, {"text": "268. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M.  External and", "bbox": [404.0, 856.0, 720.0, 868.0]}, {"text": "internal biphasic direct current shock doses for pediatric ventricular", "bbox": [427.0, 868.0, 720.0, 879.0]}, {"text": "fibrillation and pulseless ventricular tachycardia. Pediatr Crit Care Med .", "bbox": [427.0, 881.0, 718.0, 892.0]}, {"text": "2010. In press.", "bbox": [427.0, 892.0, 490.0, 903.0]}, {"text": "269. Berg MD, Samson RA, Meyer RJ, Clark LL, Valenzuela TD, Berg RA.", "bbox": [404.0, 904.0, 719.0, 916.0]}, {"text": "Pediatric defibrillation doses often fail to terminate prolonged out-of-", "bbox": [427.0, 917.0, 719.0, 929.0]}, {"text": "hospital ventricular fibrillation in children. Resuscitation . 2005;67:", "bbox": [427.0, 930.0, 719.0, 941.0]}, {"text": "63–67.", "bbox": [427.0, 943.0, 459.0, 953.0]}, {"text": "270. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, Dominguez P, Carrillo", "bbox": [404.0, 954.0, 720.0, 966.0]}, {"text": "A, Bellon JM.  Pediatric defibrillation after cardiac arrest: initial", "bbox": [427.0, 968.0, 720.0, 979.0]}, {"text": "response and outcome. Crit Care. 2006;10:R113.", "bbox": [427.0, 979.0, 631.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 284}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#67#全篇为参考文献"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:40:00"}
{"id": 1042096, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "2a8265a3-dcc2-46d6-bc18-84fc71485ecb", "title": null, "text": "【0】页码:137\n the far end of the tube, and placing your lips around the spacer's mouthpiece at the opposite end. First, depress the MDI canister to release the medicine into the spacer, and then a moment later inhale deeply and steadily before holding your breath for 10 seconds or more. Some rigid spacers, such as the Aerochamber® family of products, whistle if you breathe in too fast.\n\n【1】Learn to inhale so that the spacer remains silent.\n\n【2】Remember to wash any new plastic spacer with mild dishwashing soap and warm water before you first use it. Make certain to rinse it and allow it to air-dry. Do not rub it dry. Plastic spacers are such that they have an electrostatic field that draws some of the MDI's particles toward the inside of the spacer's walls. Cleaning the spacer may reduce the electrostatic charge and cause it to dissipate. Most doctors agree that if you have a plastic spacer that you use regularly, you should take it apart according to the manufacturer's directions, and wash it gently in dishwashing soap and warm water every 2 to 4 weeks. As of this writing, there is one commercially available non-electrostatic spacer on the North American market. The Pari Respiratory Equipment Company's Vortex® is a novel spacer made of aluminum. Because it is not made of plastic, and therefore non-electrostatic, it improves the consistency of the MDI medication delivery; no medicine particles are attracted to the spacer walls, and more particles remain available for inhalation. Another convenient advantage to the aluminum spacer is that it can be washed in a dishwasher!\n\n【3】## 69. What Is A Nebulizer?\n\n【4】\n A nebulizer is a machine that runs off electrical current or batteries. Some people use the term \"breathing machine\" interchangeably with the term \"nebulizer.\" A", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "the far end of the tube, and placing your lips around", "bbox": [150.0, 69.0, 507.0, 87.0]}, {"text": "the spacer's mouthpiece at the opposite end. First,", "bbox": [149.0, 88.0, 507.0, 107.0]}, {"text": "depress the MDI canister to release the medicine into", "bbox": [149.0, 109.0, 507.0, 127.0]}, {"text": "the spacer, and then a moment later inhale deeply and", "bbox": [149.0, 128.0, 507.0, 147.0]}, {"text": "steadily before holding your breath for 10 seconds or", "bbox": [150.0, 149.0, 507.0, 167.0]}, {"text": "more. Some rigid spacers, such as the Aerochamber®", "bbox": [150.0, 169.0, 507.0, 187.0]}, {"text": "family of products, whistle if you breathe in too fast.", "bbox": [150.0, 189.0, 506.0, 207.0]}, {"text": "Learn to inhale so that the spacer remains silent.", "bbox": [150.0, 209.0, 506.0, 227.0]}, {"text": "Remember to wash any new plastic spacer with mild", "bbox": [150.0, 228.0, 508.0, 246.0]}, {"text": "dishwashing soap and warm water before you first use", "bbox": [149.0, 249.0, 507.0, 267.0]}, {"text": "it. Make certain to rinse it and allow it to air-dry. Do", "bbox": [149.0, 269.0, 507.0, 287.0]}, {"text": "not rub it dry. Plastic spacers are such that they have", "bbox": [150.0, 288.0, 507.0, 307.0]}, {"text": "an electrostatic field that draws some of the MDI's", "bbox": [150.0, 308.0, 508.0, 326.0]}, {"text": "particles toward the inside of the spacer's walls. Clean-", "bbox": [150.0, 329.0, 506.0, 347.0]}, {"text": "ing the spacer may reduce the electrostatic charge and", "bbox": [149.0, 349.0, 507.0, 367.0]}, {"text": "cause it to dissipate. Most doctors agree that if you", "bbox": [149.0, 369.0, 507.0, 387.0]}, {"text": "have a plastic spacer that you use regularly, you should", "bbox": [149.0, 388.0, 507.0, 407.0]}, {"text": "take it apart according to the manufacturer's direc-", "bbox": [150.0, 408.0, 506.0, 427.0]}, {"text": "tions, and wash it gently in dishwashing soap and", "bbox": [149.0, 429.0, 508.0, 447.0]}, {"text": "warm water every 2 to 4 weeks. As of this writing,", "bbox": [150.0, 449.0, 507.0, 466.0]}, {"text": "there is one commercially available non-electrostatic", "bbox": [149.0, 468.0, 508.0, 487.0]}, {"text": "spacer on the North American market. The Pari Res-", "bbox": [150.0, 488.0, 506.0, 507.0]}, {"text": "piratory Equipment Company's Vortex® is a novel", "bbox": [149.0, 509.0, 507.0, 527.0]}, {"text": "spacer made of aluminum. Because it is not made of", "bbox": [149.0, 529.0, 509.0, 547.0]}, {"text": "plastic, and therefore non-electrostatic, it improves the", "bbox": [149.0, 549.0, 507.0, 567.0]}, {"text": "consistency of the MDI medication delivery; no medi-", "bbox": [149.0, 568.0, 506.0, 587.0]}, {"text": "cine particles are attracted to the spacer walls, and", "bbox": [149.0, 588.0, 507.0, 607.0]}, {"text": "more particles remain available for inhalation. Another", "bbox": [150.0, 609.0, 507.0, 627.0]}, {"text": "convenient advantage to the aluminum spacer is that it", "bbox": [150.0, 629.0, 508.0, 647.0]}, {"text": "can be washed in a dishwasher!", "bbox": [150.0, 648.0, 354.0, 667.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "69. What is a nebulizer?", "bbox": [150.0, 700.0, 367.0, 724.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "A nebulizer is a machine that runs off electrical current", "bbox": [150.0, 727.0, 507.0, 747.0]}, {"text": "or batteries. Some people use the term \"breathing", "bbox": [149.0, 748.0, 507.0, 767.0]}, {"text": "machine\" interchangeably with the term \"nebulizer.\" A", "bbox": [150.0, 768.0, 508.0, 787.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 137}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 00:15:26"}
{"id": 1042095, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "b72cb13c-0973-4cc9-b3c3-d9660b0da865", "title": null, "text": "【0】页码:24\n# Colorful Pebbles And Darwin’S Dictum Science Is An Exquisite Blend Of Data And Theory   By Michael Shermer\n\n【1】\n Writing to a friend on September 18, 1861, Charles Darwin reflected on how far the science of geology had come since he first took it up seriously during his fiveyear voyage on the HMS Beagle :\n\n【2】 About thirty years ago there was much talk that geologists ought only to observe and not theorise; and I well remember some one saying that at this rate a man might as well go into a gravel-pit and count the pebbles and describe the colours. How odd it is that anyone should not see that all observation must be for or against some view if it is to be of any service!\n\n【3】 For my money, this is one of the deepest single statements ever made on the nature of science itself, particularly in the understated denouement. If scientific observations are to be of any use, they must be tested against a theory, hypothesis or model. The facts never just speak for themselves. They must be interpreted through the colored lens- The facts never es of ideas: percepts need concepts.\n\n【4】just speak When Louis and Mary Leakey went for themselves.\n\n【5】to Africa in search of our hominid an- They must be cestors, they did so not because of any interpreted existing data but because of Darwin's theory of human descent and his arguthrough ideas.\n\n【6】ment that we are obviously closely related to the great apes. Because the great apes live in Africa, it is there that the fossil remains of our forebears would most likely be found. In other words, the Leakeys went to Africa because of a concept, not a percept. The data followed and confirmed this theory, the very opposite of how we usually think science works. Science is an exquisite blend of data and theory, facts and hypotheses, observations and views. We can no more expunge ourselves of biases and preferences than we can find a truly objective, Archimedean perspective—a god's-eye view—of the human condition. We are, after all, humans, not gods.\n\n【7】In the first half of the 20th century, philosophers and\n\n【8】 historians of science (who were mostly scientists doing philosophy and history on the side) presented science as a progressive march toward a complete understanding of Reality—an asymptotic curve to Truth. It was only a matter of time before physics (and eventually even the social sciences) would round out their equations to the sixth decimal place. Later, professional philosophers and historians took over and, in a paroxysm of postmodern deconstruction, proffered a view of science as a relativistic game played by European white males who, in a reductionistic frenzy of hermeneutical hegemony, were hell-bent on suppressing the masses beneath the thumb of dialectical scientism and technocracy. (Yes, some of them actually talk like that, and one really did call Newton's Principia a \"rape manual.\") Thankfully, intellectual trends, like social movements, have a tendency to push both ends to the middle, and these two extremist views of science are now largely passé. Physics is nowhere near explaining everything to six decimal places, and as for the social sciences, in the words of a friend from New Jersey, \"fuhgeddaboudit.\" Yet science does progress, and some views really are superior to others, regardless of the color, gender or country of origin of the scientist holding that view. Although scientific data are \"theory laden,\" as philosophers like to say, science is truly different from art, music, religion and other forms of human expression in that it has a self-correcting mechanism built into it. If you don't catch the flaws in your theory, the slant in your bias or the distortion in your preferences, someone else will. The history of science is littered with the debris of downed theories.\n\n【9】Future columns will explore these borderlands of science where theory and data intersect. Let us continue to bear in mind Darwin's dictum: all observation must be for or against some view to be of any service.\n\n【10】 Michael Shermer, founding publisher of Skeptic magazine , is author of The Borderlands of Science.\n\n【11】 IOTOGRAPH BY BRAD HINES", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Colorful Pebbles and Darwin’s Dictum", "bbox": [46.0, 224.0, 721.0, 272.0]}, {"text": "Science is an exquisite blend of data and theory   By MICHAEL SHERMER", "bbox": [46.0, 276.0, 532.0, 296.0]}], "type": "Title", "position": 3}, {"raw_context": [{"text": "Writing to a friend on September 18, 1861, Charles Dar-", "bbox": [132.0, 342.0, 419.0, 357.0]}, {"text": "win reflected on how far the science of geology had", "bbox": [133.0, 359.0, 419.0, 374.0]}, {"text": "come since he first took it up seriously during his five-", "bbox": [132.0, 374.0, 418.0, 389.0]}, {"text": "year voyage on the HMS Beagle :", "bbox": [133.0, 392.0, 308.0, 405.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "About thirty years ago there was much talk that", "bbox": [170.0, 415.0, 401.0, 429.0]}, {"text": "geologists ought only to observe and not theorise; and", "bbox": [150.0, 431.0, 401.0, 445.0]}, {"text": "I well remember some one saying that at this rate a", "bbox": [150.0, 447.0, 401.0, 461.0]}, {"text": "man might as well go into a gravel-pit and count the", "bbox": [151.0, 464.0, 401.0, 477.0]}, {"text": "pebbles and describe the colours. How odd it is that", "bbox": [150.0, 479.0, 401.0, 493.0]}, {"text": "anyone should not see that all observation must be for", "bbox": [150.0, 495.0, 401.0, 509.0]}, {"text": "or against some view if it is to be of any service!", "bbox": [151.0, 511.0, 376.0, 525.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "For my money, this is one of the deepest single", "bbox": [151.0, 534.0, 419.0, 549.0]}, {"text": "statements ever made on the nature of science itself,", "bbox": [132.0, 551.0, 418.0, 565.0]}, {"text": "particularly in the understated denouement. If scientif-", "bbox": [132.0, 567.0, 417.0, 581.0]}, {"text": "ic observations are to be of any use, they must be test-", "bbox": [131.0, 583.0, 418.0, 597.0]}, {"text": "ed against a theory, hypothesis or model. The facts nev-", "bbox": [131.0, 599.0, 418.0, 614.0]}, {"text": "er just speak for themselves. They must", "bbox": [211.0, 615.0, 419.0, 629.0]}, {"text": "be interpreted through the colored lens-", "bbox": [212.0, 632.0, 419.0, 645.0]}, {"text": "The facts never", "bbox": [78.0, 635.0, 201.0, 653.0]}, {"text": "es of ideas: percepts need concepts.", "bbox": [212.0, 647.0, 403.0, 662.0]}, {"text": "just speak", "bbox": [115.0, 657.0, 200.0, 672.0]}, {"text": "When Louis and Mary Leakey went", "bbox": [232.0, 663.0, 419.0, 677.0]}, {"text": "for themselves.", "bbox": [74.0, 674.0, 198.0, 690.0]}, {"text": "to Africa in search of our hominid an-", "bbox": [212.0, 679.0, 418.0, 694.0]}, {"text": "They must be", "bbox": [92.0, 693.0, 199.0, 708.0]}, {"text": "cestors, they did so not because of any", "bbox": [211.0, 695.0, 419.0, 709.0]}, {"text": "interpreted", "bbox": [108.0, 712.0, 200.0, 727.0]}, {"text": "existing data but because of Darwin's", "bbox": [212.0, 712.0, 419.0, 724.0]}, {"text": "theory of human descent and his argu-", "bbox": [212.0, 727.0, 419.0, 742.0]}, {"text": "through ideas.", "bbox": [84.0, 731.0, 198.0, 747.0]}, {"text": "ment that we are obviously closely re-", "bbox": [213.0, 743.0, 418.0, 757.0]}, {"text": "lated to the great apes. Because the", "bbox": [213.0, 759.0, 419.0, 773.0]}, {"text": "great apes live in Africa, it is there that the fossil re-", "bbox": [131.0, 775.0, 418.0, 789.0]}, {"text": "mains of our forebears would most likely be found. In", "bbox": [131.0, 791.0, 420.0, 805.0]}, {"text": "other words, the Leakeys went to Africa because of a", "bbox": [131.0, 807.0, 419.0, 821.0]}, {"text": "concept, not a percept. The data followed and con-", "bbox": [131.0, 823.0, 418.0, 837.0]}, {"text": "firmed this theory, the very opposite of how we usual-", "bbox": [132.0, 839.0, 419.0, 853.0]}, {"text": "ly think science works. Science is an exquisite blend of", "bbox": [131.0, 855.0, 419.0, 869.0]}, {"text": "data and theory, facts and hypotheses, observations", "bbox": [131.0, 871.0, 420.0, 885.0]}, {"text": "and views. We can no more expunge ourselves of bi-", "bbox": [132.0, 887.0, 419.0, 902.0]}, {"text": "ases and preferences than we can find a truly objective,", "bbox": [133.0, 903.0, 419.0, 917.0]}, {"text": "Archimedean perspective—a god's-eye view—of the hu-", "bbox": [133.0, 919.0, 417.0, 933.0]}, {"text": "man condition. We are, after all, humans, not gods.", "bbox": [132.0, 935.0, 408.0, 950.0]}, {"text": "In the first half of the 20th century, philosophers and", "bbox": [151.0, 952.0, 420.0, 965.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "historians of science (who were mostly scientists doing", "bbox": [430.0, 343.0, 719.0, 356.0]}, {"text": "philosophy and history on the side) presented science as", "bbox": [431.0, 359.0, 719.0, 374.0]}, {"text": "a progressive march toward a complete understanding", "bbox": [431.0, 374.0, 718.0, 389.0]}, {"text": "of Reality—an asymptotic curve to Truth. It was only", "bbox": [431.0, 392.0, 718.0, 405.0]}, {"text": "a matter of time before physics (and eventually even the", "bbox": [431.0, 406.0, 718.0, 421.0]}, {"text": "social sciences) would round out their equations to the", "bbox": [431.0, 423.0, 719.0, 437.0]}, {"text": "sixth decimal place. Later, professional philosophers", "bbox": [431.0, 439.0, 719.0, 453.0]}, {"text": "and historians took over and, in a paroxysm of post-", "bbox": [431.0, 454.0, 718.0, 469.0]}, {"text": "modern deconstruction, proffered a view of science as", "bbox": [431.0, 471.0, 719.0, 485.0]}, {"text": "a relativistic game played by European white males", "bbox": [431.0, 487.0, 719.0, 501.0]}, {"text": "who, in a reductionistic frenzy of hermeneutical hege-", "bbox": [432.0, 503.0, 718.0, 517.0]}, {"text": "mony, were hell-bent on suppressing the masses be-", "bbox": [432.0, 519.0, 718.0, 534.0]}, {"text": "neath the thumb of dialectical scientism and technoc-", "bbox": [431.0, 535.0, 718.0, 549.0]}, {"text": "racy. (Yes, some of them actually talk like that, and one", "bbox": [431.0, 551.0, 718.0, 565.0]}, {"text": "really did call Newton's Principia a \"rape manual.\")", "bbox": [432.0, 567.0, 710.0, 581.0]}, {"text": "Thankfully, intellectual trends, like social move-", "bbox": [451.0, 583.0, 718.0, 597.0]}, {"text": "ments, have a tendency to push both ends to the mid-", "bbox": [431.0, 599.0, 718.0, 614.0]}, {"text": "dle, and these two extremist views of science are now", "bbox": [431.0, 615.0, 718.0, 629.0]}, {"text": "largely passé. Physics is nowhere near explaining every-", "bbox": [431.0, 632.0, 718.0, 645.0]}, {"text": "thing to six decimal places, and as for the social sci-", "bbox": [431.0, 647.0, 718.0, 662.0]}, {"text": "ences, in the words of a friend from New Jersey,", "bbox": [431.0, 663.0, 719.0, 677.0]}, {"text": "\"fuhgeddaboudit.\" Yet science does progress, and some", "bbox": [432.0, 678.0, 718.0, 694.0]}, {"text": "views really are superior to others, regardless of the col-", "bbox": [432.0, 695.0, 718.0, 710.0]}, {"text": "or, gender or country of origin of the scientist holding", "bbox": [431.0, 712.0, 719.0, 725.0]}, {"text": "that view. Although scientific data are \"theory laden,\"", "bbox": [431.0, 727.0, 717.0, 742.0]}, {"text": "as philosophers like to say, science is truly different", "bbox": [432.0, 743.0, 719.0, 757.0]}, {"text": "from art, music, religion and other forms of human ex-", "bbox": [432.0, 759.0, 718.0, 773.0]}, {"text": "pression in that it has a self-correcting mechanism built", "bbox": [432.0, 775.0, 718.0, 789.0]}, {"text": "into it. If you don't catch the flaws in your theory, the", "bbox": [432.0, 791.0, 718.0, 805.0]}, {"text": "slant in your bias or the distortion in your preferences,", "bbox": [432.0, 807.0, 718.0, 821.0]}, {"text": "someone else will. The history of science is littered with", "bbox": [431.0, 823.0, 719.0, 837.0]}, {"text": "the debris of downed theories.", "bbox": [431.0, 839.0, 592.0, 853.0]}, {"text": "Future columns will explore these borderlands of sci-", "bbox": [450.0, 854.0, 718.0, 869.0]}, {"text": "ence where theory and data intersect. Let us continue to", "bbox": [430.0, 871.0, 718.0, 885.0]}, {"text": "bear in mind Darwin's dictum: all observation must be", "bbox": [432.0, 887.0, 718.0, 901.0]}, {"text": "for or against some view to be of any service.", "bbox": [432.0, 903.0, 666.0, 917.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Michael Shermer, founding publisher of Skeptic", "bbox": [432.0, 935.0, 688.0, 950.0]}, {"text": "magazine , is author of The Borderlands of Science.", "bbox": [431.0, 951.0, 703.0, 965.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "IOTOGRAPH BY BRAD HINES", "bbox": [746.0, 863.0, 760.0, 955.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 24}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#4#6#为同段\n多余换行#7#8#为同段\n缺少换行#8#*# Thankfully, intellectual trends这里开始应与前文分行", "type3": "无关文本#4#4#just speak         for themselves. 左侧内容插入正文\n无关文本#5#5#They must be      through ideas左侧内容插入正文", "type4": "", "type6": "信息有用性#0#0#Colorful Pebbles And Darwin’S Dictum Science Is An Exquisite Blend Of Data And Theory By Michael Shermer无用内容\n信息有用性#10#11#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:11:41"}
{"id": 1042094, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "2dc73cb3-fc72-453e-ae1d-afaa762ac8bf", "title": null, "text": "【0】页码:338\n The Essix* \"C+\" can be used for dental intrusion.\n\n【1】7.\n\n【2】8.\n\n【3】Articular stabilizer.\n\n【4】9.\n\n【5】We can add acrylic to the Essix® type \"A\", like a bite plane, for example.\n\n【6】Slight movements (2 mm to 3 mm) like rotations, tip 10.\n\n【7】and torque can be done with both retainers. In order\n Figs. 121 and 122. Section the guard in the rebound space, place buttons and elastics to close the space.\n\n【8】 to correct slight rebounds we can place a resin button on the affected tooth (2 mm to 3 mm in diameter and 1 mm to 3 mm in height), and we can open a window on the Essix® (on the opposite side) to allow movement.\n\n【9】In order to accelerate this movement, we must do some stripping on the tooth we want to move. (18,31,32,33)\n Figs. 125 and 126. Rebound corrections in a canine and a lower central incisor.\n Figs. 123 and 124. Rebound correction in an upper lateral incisor.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "The Essix* \"C+\" can be used for dental intrusion.", "bbox": [100.0, 82.0, 368.0, 105.0]}, {"text": "7.", "bbox": [74.0, 86.0, 89.0, 102.0]}, {"text": "8.", "bbox": [74.0, 103.0, 89.0, 118.0]}, {"text": "Articular stabilizer.", "bbox": [101.0, 102.0, 209.0, 118.0]}, {"text": "9.", "bbox": [74.0, 120.0, 89.0, 136.0]}, {"text": "We can add acrylic to the Essix® type \"A\", like a bite", "bbox": [101.0, 120.0, 391.0, 138.0]}, {"text": "plane, for example.", "bbox": [101.0, 138.0, 208.0, 154.0]}, {"text": "Slight movements (2 mm to 3 mm) like rotations, tip", "bbox": [99.0, 153.0, 391.0, 172.0]}, {"text": "10.", "bbox": [74.0, 155.0, 97.0, 171.0]}, {"text": "and torque can be done with both retainers. In order", "bbox": [100.0, 172.0, 391.0, 189.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Figs. 121 and 122. Section the guard in the rebound space, place buttons", "bbox": [74.0, 662.0, 389.0, 678.0]}, {"text": "and elastics to close the space.", "bbox": [74.0, 676.0, 208.0, 691.0]}], "type": "Caption", "position": 3}, {"raw_context": [{"text": "to correct slight rebounds we can place a resin button", "bbox": [437.0, 84.0, 726.0, 102.0]}, {"text": "on the affected tooth (2 mm to 3 mm in diameter and", "bbox": [437.0, 102.0, 726.0, 118.0]}, {"text": "1 mm to 3 mm in height), and we can open a window", "bbox": [437.0, 119.0, 726.0, 138.0]}, {"text": "on the Essix® (on the opposite side) to allow movement.", "bbox": [437.0, 137.0, 725.0, 153.0]}, {"text": "In order to accelerate this movement, we must do some", "bbox": [437.0, 154.0, 726.0, 172.0]}, {"text": "stripping on the tooth we want to move. (18,31,32,33)", "bbox": [437.0, 172.0, 695.0, 187.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Figs. 125 and 126. Rebound corrections in a canine", "bbox": [410.0, 662.0, 639.0, 677.0]}, {"text": "and a lower central incisor.", "bbox": [411.0, 677.0, 531.0, 691.0]}], "type": "Caption", "position": 6}, {"raw_context": [{"text": "Figs. 123 and 124. Rebound correction in an upper lateral incisor.", "bbox": [256.0, 962.0, 544.0, 977.0]}], "type": "Caption", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 338}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#0#0#Essix*应该是Essix®", "type2": "多余换行#1#5#1段序号7.应该联接0段The Essix* “C+” can...的内容。2段的序号8.应该联接3段Articular stabilizer.的内容。4段的序号9.应该联接5段We can add acrylic to...的内容\n序号格式不一致#6#6#Slight movements (2 mm to 3 mm) like rotations, tip 10.  序号应该在前面\n多余换行#7#7#and torque can be done...与上面6段联接\n多余换行#8#8# to correct slight rebounds...与上面7段... retainers. In order联接", "type3": "无关文本#9#9#(18,31,32,33)", "type4": null, "type5": null, "type6": "有用性#7#7#Figs. 121 and 122. Section the guard in the rebound space, place buttons and elastics to close the space.图片描述\n有用性#9#0#Figs. 125 and 126. Rebound corrections in a canine and a lower central incisor.\nFigs. 123 and 124. Rebound correction in an upper lateral incisor.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 01:14:02"}
{"id": 1042093, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "44a526e1-060a-43d7-b6c0-99c92ddc2b0a", "title": null, "text": "【0】页码:155\n\n【1】## Recommendations\n\n【2】\n Keep this movement until the teeth are aligned.\n\n【3】l.\n\n【4】2.\n\n【5】Anchor the molars to avoid undesired tip.\n\n【6】3.\n\n【7】In case of TMJ alterations, immediately remove the arch wire.\n\n【8】## Posterior Bite Block\n\n【9】\n One of the functions of bite blocks is the intrusion of the posterior segment which provokes a mandibular autorota¬ tion that successfully closes open bites. Among orthodontic movements, intrusion is one of the most violent and painful, due to the compression of the apical nerves and blood vessels upon alveolar bone. (9)\n\n【10】 These blocks can be place in the upper and lower dental arches, and they can be fixed or removable. We generally make them with acrylic and they must not cover the pos¬ terior braces. The ideal period for placement is around 9 -12 years of age, when the second permanent molar has not completed its eruption; this does not mean that it can not be used after this age, but it is the period in which can obtain the best results.\n\n【11】 In case there are no fixed appliances, we can extend the acrylic to the buccal aspects of bicuspids and molars; it can be combined with a rapid maxillary expander (RME). It must be used 24 hours a day for 6 to 8 months. (10.11)\n Fig. 31. Lower bite block.\n Fig. 32. Upper bite block.\n Fig. 33. Bite block with a Hyrax.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Recommendations", "bbox": [61.0, 90.0, 191.0, 107.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "Keep this movement until the teeth are aligned.", "bbox": [88.0, 124.0, 350.0, 141.0]}, {"text": "l.", "bbox": [61.0, 125.0, 75.0, 140.0]}, {"text": "2.", "bbox": [60.0, 142.0, 74.0, 158.0]}, {"text": "Anchor the molars to avoid undesired tip.", "bbox": [88.0, 142.0, 320.0, 159.0]}, {"text": "3.", "bbox": [60.0, 160.0, 75.0, 175.0]}, {"text": "In case of TMJ alterations, immediately remove the", "bbox": [88.0, 160.0, 375.0, 175.0]}, {"text": "arch wire.", "bbox": [88.0, 176.0, 144.0, 193.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Posterior bite block", "bbox": [61.0, 243.0, 211.0, 262.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "One of the functions of bite blocks is the intrusion of the", "bbox": [61.0, 297.0, 375.0, 314.0]}, {"text": "posterior segment which provokes a mandibular autorota¬", "bbox": [61.0, 315.0, 373.0, 332.0]}, {"text": "tion that successfully closes open bites. Among orthodon-", "bbox": [61.0, 333.0, 373.0, 349.0]}, {"text": "tic movements, intrusion is one of the most violent and", "bbox": [61.0, 350.0, 375.0, 365.0]}, {"text": "painful, due to the compression of the apical nerves and", "bbox": [61.0, 366.0, 375.0, 383.0]}, {"text": "blood vessels upon alveolar bone. (9)", "bbox": [61.0, 382.0, 254.0, 399.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "These blocks can be place in the upper and lower dental", "bbox": [61.0, 413.0, 375.0, 431.0]}, {"text": "arches, and they can be fixed or removable. We generally", "bbox": [61.0, 431.0, 374.0, 448.0]}, {"text": "make them with acrylic and they must not cover the pos¬", "bbox": [61.0, 449.0, 373.0, 465.0]}, {"text": "terior braces. The ideal period for placement is around 9", "bbox": [61.0, 466.0, 375.0, 481.0]}, {"text": "-12 years of age, when the second permanent molar has", "bbox": [61.0, 482.0, 375.0, 499.0]}, {"text": "not completed its eruption; this does not mean that it can", "bbox": [61.0, 501.0, 375.0, 517.0]}, {"text": "not be used after this age, but it is the period in which can", "bbox": [61.0, 517.0, 375.0, 534.0]}, {"text": "obtain the best results.", "bbox": [60.0, 535.0, 188.0, 551.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "In case there are no fixed appliances, we can extend the", "bbox": [61.0, 567.0, 375.0, 583.0]}, {"text": "acrylic to the buccal aspects of bicuspids and molars; it can", "bbox": [60.0, 584.0, 375.0, 600.0]}, {"text": "be combined with a rapid maxillary expander (RME). It", "bbox": [61.0, 602.0, 375.0, 617.0]}, {"text": "must be used 24 hours a day for 6 to 8 months. (10.11)", "bbox": [61.0, 618.0, 342.0, 635.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Fig. 31. Lower bite block.", "bbox": [496.0, 362.0, 610.0, 376.0]}], "type": "Caption", "position": 8}, {"raw_context": [{"text": "Fig. 32. Upper bite block.", "bbox": [497.0, 685.0, 608.0, 700.0]}], "type": "Caption", "position": 11}, {"raw_context": [{"text": "Fig. 33. Bite block with a Hyrax.", "bbox": [482.0, 958.0, 625.0, 973.0]}], "type": "Caption", "position": 13}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 155}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "序号格式不一致#3#3#l.应该是1.\n标点错误#10#10# pos¬应该去掉¬\n", "type3": "无关文本#9#9# (9)\n无关文本#11#11# (10.11)", "type4": "栏目混乱#2#7#序号和内容分离，上下颠倒。3段应该是2段Anchor the molars...的序号，4段2.应该是5段Anchor the molars to ...的序号", "type5": null, "type6": "有用性#11#11#Fig. 31. Lower bite block.\nFig. 32. Upper bite block.Fig. 33. Bite block with a Hyrax.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:28:25"}
{"id": 1042092, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "8e2c2ed5-27ea-4133-959a-6d8403bdbed6", "title": null, "text": "【0】页码:71\n 196. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L, Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. Ann Emerg Med .\n\n【1】2010;55:249–257.\n\n【2】197. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB.  Public use of automated external defibrillators. N Engl J Med . 2002;347:1242–1247.\n\n【3】198. Fries M, Tang W, Chang YT, Wang J, Castillo C, Weil MH. Microvascular blood flow during cardiopulmonary resuscitation is predictive of outcome. Resuscitation . 2006;71:248–253.\n\n【4】199. Stiell IG, Callaway C, Davis D, Terndrup T, Powell J, Cook A, Kudenchuk PJ, Daya M, Kerber R, Idris A, Morrison LJ, Aufderheide T.\n\n【5】Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 2: rationale and methodology for \"Analyze Later vs.\n\n【6】Analyze Early\" protocol. Resuscitation. 2008;78:186–195.\n\n【7】200. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ, Grantham H.  Defibrillation or cardiopulmonary resuscitation first for patients with out-of-hospital cardiac arrests found by paramedics to be in ventricular fibrillation? A randomised control trial. Resuscitation. 2008 ; 79:424–431.\n\n【8】201.\n\n【9】Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas .\n\n【10】2005;17:39–45.\n\n【11】202. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen PA. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. JAMA . 2003;289:1389–1395.\n\n【12】203.\n\n【13】Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin M, Hallstrom AP.  Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.\n\n【14】JAMA . 1999;281:1182–1188.\n\n【15】204. Handley AJ. Recovery Position. Resuscitation . 1993;26:93–95.\n\n【16】205. Turner S, Turner I, Chapman D, Howard P, Champion P, Hatfield J, James A, Marshall S, Barber S. A comparative study of the 1992 and 1997 recovery positions for use in the UK. Resuscitation. 1998;39: 153–160.\n\n【17】206.\n\n【18】Gunn BD, Eizenberg N, Silberstein M, McMeeken JM, Tully EA, Stillman BC, Brown DJ, Gutteridge GA. How should an unconscious person with a suspected neck injury be positioned? Prehospital Disaster Med . 1995;10:239–244.\n\n【19】207. Blake WE, Stillman BC, Eizenberg N, Briggs C, McMeeken JM.  The position of the spine in the recovery position–an experimental comparison between the lateral recovery position and the modified HAINES position. Resuscitation. 2002;53:289–297.\n\n【20】WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown 208.\n\n【21】TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel- Smoller S, Wong ND, Wylie-Rosett J. Committee obotAHAS, Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics–2010 Update: A Report From the American Heart Association. Circulation.\n\n【22】2010;121:e46–e215.\n\n【23】209. Chiriboga D, Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: a communitywide perspective. Circulation . 1994;89: 998–1003.\n\n【24】210. Anderson JL, Karagounis LA, Califf RM. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol . 1996; 78:1–8.\n\n【25】211. Raitt MH, Maynard C, Wagner GS, Cerqueira MD, Selvester RH, Weaver WD. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. Circulation . 1996;93:48–53.\n\n【26】212. Douglas PS, Ginsburg GS.  The evaluation of chest pain in women.\n\n【27】N Engl J Med . 1996;334:1311–1315.\n\n【28】213. Solomon CG, Lee TH, Cook EF, Weisberg MC, Brand DA, Rouan GW, Goldman L.  Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. Am J Cardiol. 1989;63: 772–776.\n\n【29】214. Peberdy MA, Ornato JP. Coronary artery disease in women. Heart Dis Stroke . 1992;1:315–319.\n\n【30】 215. Body R, Carley S, Wibberley C, McDowell G, Ferguson J, Mackway-Jones K. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation . 2010;81: 281–286.\n\n【31】216. Goodacre SW, Angelini K, Arnold J, Revill S, Morris F.  Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain. QJM . 2003;96:893–898.\n\n【32】217. Goodacre S, Locker T, Morris F, Campbell S. How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? Acad Emerg Med . 2002;9:203–208.\n\n【33】218. Everts B, Karlson BW, Wahrborg P, Hedner T, Herlitz J. Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. Heart Lung .\n\n【34】1996;25:430–437.\n\n【35】219. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction.\n\n【36】Circulation . 2003;108:2619–2623.\n\n【37】220. Panju AA, BR Hemmelgarn, GG Guyatt, DL Simel. Is this patient having a myocardial infarction? JAMA . 1998;280:1256–1263.\n\n【38】221. Mant J, McManus RJ, Oakes RA, Delaney BC, Barton PM, Deeks JJ, Hammersley L, Davies RC, Davies MK, Hobbs FD. Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. Health Technol Assess . 2004;8:iii,1–158.\n\n【39】222. Berger JP, Buclin T, Haller E, Van Melle G, Yersin B.  Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain. J Intern Med .\n\n【40】1990;227:165–172.\n\n【41】223. Jonsbu J, Rollag A, Aase O, Lippestad CT, Arnesen KE, Erikssen J, Koss A.  Rapid and correct diagnosis of myocardial infarction: standardized case history and clinical examination provide important information for correct referral to monitored beds. J Intern Med . 1991;229: 143–149.\n\n【42】224. Hargarten KM, Aprahamian C, Stueven H, Olson DW, Aufderheide TP, Mateer JR.  Limitations of prehospital predictors of acute myocardial infarction and unstable angina. Ann Emerg Med . 1987;16:1325–1329.\n\n【43】225. Herlitz J, Hansson E, Ringvall E, Starke M, Karlson BW, Waagstein L.\n\n【44】Predicting a life-threatening disease and death among ambulancetransported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome. Am J Emerg Med . 2002;20:588–594.\n\n【45】226. Lee TH, Pearson SD, Johnson PA, Garcia TB, Weisberg MC, Guadagnoli E, Cook EF, Goldman L. Failure of information as an intervention to modify clinical management. A time-series trial in patients with acute chest pain. Ann Intern Med . 1995;122:434–437.\n\n【46】227. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, Bushnell AC, Chandra-Strobos N. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med .\n\n【47】2003;139:979–986.\n\n【48】228. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, Walshon J, Terranova G, Gottlieb L, Goldstein-Wayne B, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol . 1987;60:219–224.\n\n【49】229. Freimark D, Matetzky S, Leor J, Boyko V, Barbash IM, Behar S, Hod H.  Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis.\n\n【50】Am J Cardiol . 2002;89:381–385.\n\n【51】230. Barbash IM, Freimark D, Gottlieb S, Hod H, Hasin Y, Battler A, Crystal E, Matetzky S, Boyko V, Mandelzweig L, Behar S, Leor J. Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration. Cardiology . 2002;98:141–147.\n\n【52】231. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349–360.\n\n【53】232. Casaccia M, Bertello F, De Bernardi A, Sicuro M, Scacciatella P.\n\n【54】Prehospital management of acute myocardial infarct in an experimental metropolitan system of medical emergencies [in Italian]. G Ital Cardiol .\n\n【55】1996;26:657–672.\n\n【56】233. Quan D, LoVecchio F, Clark B, Gallagher JV III. Prehospital use of aspirin rarely is associated with adverse events. Prehosp Disaster Med.\n\n【57】2004;19:362–365.\n\n【58】234. Verheugt FW, van der Laarse A, Funke-Kupper AJ, Sterkman LG, Galema TW, Roos JP.  Effects of early intervention with low-dose\n\n【59】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "196. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh", "bbox": [61.0, 85.0, 376.0, 97.0]}, {"text": "S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L,", "bbox": [83.0, 98.0, 374.0, 109.0]}, {"text": "Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital", "bbox": [83.0, 109.0, 376.0, 121.0]}, {"text": "cardiac arrest: role of the Utstein data elements. Ann Emerg Med .", "bbox": [83.0, 122.0, 375.0, 133.0]}, {"text": "2010;55:249–257.", "bbox": [84.0, 133.0, 159.0, 145.0]}, {"text": "197. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB.  Public use of", "bbox": [61.0, 145.0, 375.0, 158.0]}, {"text": "automated external defibrillators. N Engl J Med . 2002;347:1242–1247.", "bbox": [84.0, 157.0, 375.0, 169.0]}, {"text": "198. Fries M, Tang W, Chang YT, Wang J, Castillo C, Weil MH. Micro-", "bbox": [61.0, 169.0, 375.0, 182.0]}, {"text": "vascular blood flow during cardiopulmonary resuscitation is predictive", "bbox": [84.0, 182.0, 376.0, 194.0]}, {"text": "of outcome. Resuscitation . 2006;71:248–253.", "bbox": [83.0, 195.0, 271.0, 207.0]}, {"text": "199. Stiell IG, Callaway C, Davis D, Terndrup T, Powell J, Cook A,", "bbox": [61.0, 207.0, 375.0, 218.0]}, {"text": "Kudenchuk PJ, Daya M, Kerber R, Idris A, Morrison LJ, Aufderheide T.", "bbox": [83.0, 219.0, 375.0, 231.0]}, {"text": "Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial", "bbox": [84.0, 230.0, 376.0, 242.0]}, {"text": "methods part 2: rationale and methodology for \"Analyze Later vs.", "bbox": [84.0, 243.0, 375.0, 254.0]}, {"text": "Analyze Early\" protocol. Resuscitation. 2008;78:186–195.", "bbox": [84.0, 254.0, 324.0, 267.0]}, {"text": "200. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ,", "bbox": [61.0, 266.0, 375.0, 279.0]}, {"text": "Grantham H.  Defibrillation or cardiopulmonary resuscitation first for", "bbox": [83.0, 279.0, 375.0, 290.0]}, {"text": "patients with out-of-hospital cardiac arrests found by paramedics to be in", "bbox": [83.0, 290.0, 376.0, 301.0]}, {"text": "ventricular fibrillation? A randomised control trial. Resuscitation. 2008 ;", "bbox": [84.0, 303.0, 375.0, 314.0]}, {"text": "79:424–431.", "bbox": [84.0, 315.0, 139.0, 326.0]}, {"text": "201.", "bbox": [61.0, 327.0, 81.0, 339.0]}, {"text": "Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in", "bbox": [81.0, 327.0, 376.0, 340.0]}, {"text": "out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas .", "bbox": [83.0, 340.0, 375.0, 351.0]}, {"text": "2005;17:39–45.", "bbox": [84.0, 352.0, 150.0, 363.0]}, {"text": "202. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen", "bbox": [61.0, 363.0, 376.0, 375.0]}, {"text": "PA. Delaying defibrillation to give basic cardiopulmonary resuscitation", "bbox": [83.0, 376.0, 376.0, 388.0]}, {"text": "to patients with out-of-hospital ventricular fibrillation: a randomized", "bbox": [83.0, 388.0, 376.0, 399.0]}, {"text": "trial. JAMA . 2003;289:1389–1395.", "bbox": [83.0, 400.0, 227.0, 411.0]}, {"text": "203.", "bbox": [61.0, 411.0, 80.0, 422.0]}, {"text": "Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin", "bbox": [81.0, 411.0, 376.0, 423.0]}, {"text": "M, Hallstrom AP.  Influence of cardiopulmonary resuscitation prior to", "bbox": [83.0, 424.0, 376.0, 435.0]}, {"text": "defibrillation in patients with out-of-hospital ventricular fibrillation.", "bbox": [83.0, 435.0, 375.0, 448.0]}, {"text": "JAMA . 1999;281:1182–1188.", "bbox": [84.0, 448.0, 204.0, 459.0]}, {"text": "204. Handley AJ. Recovery Position. Resuscitation . 1993;26:93–95.", "bbox": [61.0, 460.0, 341.0, 472.0]}, {"text": "205. Turner S, Turner I, Chapman D, Howard P, Champion P, Hatfield J,", "bbox": [61.0, 474.0, 376.0, 484.0]}, {"text": "James A, Marshall S, Barber S. A comparative study of the 1992 and", "bbox": [84.0, 484.0, 376.0, 496.0]}, {"text": "1997 recovery positions for use in the UK. Resuscitation. 1998;39:", "bbox": [84.0, 497.0, 376.0, 508.0]}, {"text": "153–160.", "bbox": [84.0, 508.0, 123.0, 520.0]}, {"text": "206.", "bbox": [61.0, 520.0, 82.0, 531.0]}, {"text": "Gunn BD, Eizenberg N, Silberstein M, McMeeken JM, Tully EA,", "bbox": [80.0, 520.0, 375.0, 532.0]}, {"text": "Stillman BC, Brown DJ, Gutteridge GA. How should an unconscious", "bbox": [84.0, 533.0, 375.0, 544.0]}, {"text": "person with a suspected neck injury be positioned? Prehospital Disaster", "bbox": [84.0, 544.0, 376.0, 557.0]}, {"text": "Med . 1995;10:239–244.", "bbox": [84.0, 557.0, 183.0, 568.0]}, {"text": "207. Blake WE, Stillman BC, Eizenberg N, Briggs C, McMeeken JM.  The", "bbox": [61.0, 567.0, 376.0, 581.0]}, {"text": "position of the spine in the recovery position–an experimental com-", "bbox": [83.0, 582.0, 375.0, 593.0]}, {"text": "parison between the lateral recovery position and the modified HAINES", "bbox": [83.0, 593.0, 375.0, 604.0]}, {"text": "position. Resuscitation. 2002;53:289–297.", "bbox": [84.0, 606.0, 258.0, 615.0]}, {"text": "WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown", "bbox": [81.0, 616.0, 376.0, 629.0]}, {"text": "208.", "bbox": [61.0, 617.0, 81.0, 628.0]}, {"text": "TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K,", "bbox": [84.0, 630.0, 375.0, 642.0]}, {"text": "Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard", "bbox": [83.0, 642.0, 376.0, 653.0]}, {"text": "V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott", "bbox": [84.0, 654.0, 376.0, 666.0]}, {"text": "MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL,", "bbox": [83.0, 665.0, 375.0, 677.0]}, {"text": "Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-", "bbox": [83.0, 677.0, 375.0, 689.0]}, {"text": "Smoller S, Wong ND, Wylie-Rosett J. Committee obotAHAS, Stroke", "bbox": [84.0, 689.0, 375.0, 702.0]}, {"text": "Statistics Subcommittee. Heart Disease and Stroke Statistics–2010", "bbox": [84.0, 702.0, 376.0, 712.0]}, {"text": "Update: A Report From the American Heart Association. Circulation.", "bbox": [83.0, 714.0, 375.0, 725.0]}, {"text": "2010;121:e46–e215.", "bbox": [84.0, 725.0, 169.0, 736.0]}, {"text": "209. Chiriboga D, Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal", "bbox": [61.0, 736.0, 376.0, 749.0]}, {"text": "trends (1975 through 1990) in the incidence and case-fatality rates of", "bbox": [83.0, 749.0, 376.0, 761.0]}, {"text": "primary ventricular fibrillation complicating acute myocardial", "bbox": [83.0, 762.0, 376.0, 774.0]}, {"text": "infarction: a communitywide perspective. Circulation . 1994;89:", "bbox": [83.0, 774.0, 375.0, 786.0]}, {"text": "998–1003.", "bbox": [83.0, 787.0, 129.0, 797.0]}, {"text": "210. Anderson JL, Karagounis LA, Califf RM. Metaanalysis of five reported", "bbox": [61.0, 798.0, 376.0, 809.0]}, {"text": "studies on the relation of early coronary patency grades with mortality", "bbox": [83.0, 811.0, 375.0, 823.0]}, {"text": "and outcomes after acute myocardial infarction. Am J Cardiol . 1996;", "bbox": [84.0, 823.0, 375.0, 834.0]}, {"text": "78:1–8.", "bbox": [84.0, 836.0, 117.0, 846.0]}, {"text": "211. Raitt MH, Maynard C, Wagner GS, Cerqueira MD, Selvester RH,", "bbox": [61.0, 846.0, 375.0, 858.0]}, {"text": "Weaver WD. Relation between symptom duration before thrombolytic", "bbox": [84.0, 859.0, 375.0, 871.0]}, {"text": "therapy and final myocardial infarct size. Circulation . 1996;93:48–53.", "bbox": [84.0, 870.0, 374.0, 883.0]}, {"text": "212. Douglas PS, Ginsburg GS.  The evaluation of chest pain in women.", "bbox": [61.0, 882.0, 375.0, 894.0]}, {"text": "N Engl J Med . 1996;334:1311–1315.", "bbox": [83.0, 895.0, 237.0, 906.0]}, {"text": "213. Solomon CG, Lee TH, Cook EF, Weisberg MC, Brand DA, Rouan GW,", "bbox": [61.0, 906.0, 375.0, 919.0]}, {"text": "Goldman L.  Comparison of clinical presentation of acute myocardial", "bbox": [83.0, 919.0, 376.0, 930.0]}, {"text": "infarction in patients older than 65 years of age to younger patients: the", "bbox": [83.0, 929.0, 375.0, 945.0]}, {"text": "Multicenter Chest Pain Study experience. Am J Cardiol. 1989;63:", "bbox": [84.0, 943.0, 375.0, 956.0]}, {"text": "772–776.", "bbox": [84.0, 956.0, 124.0, 966.0]}, {"text": "214. Peberdy MA, Ornato JP. Coronary artery disease in women. Heart Dis", "bbox": [61.0, 967.0, 376.0, 981.0]}, {"text": "Stroke . 1992;1:315–319.", "bbox": [84.0, 979.0, 185.0, 991.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "215. Body R, Carley S, Wibberley C, McDowell G, Ferguson J,", "bbox": [404.0, 85.0, 720.0, 98.0]}, {"text": "Mackway-Jones K. The value of symptoms and signs in the emergent", "bbox": [427.0, 98.0, 720.0, 109.0]}, {"text": "diagnosis of acute coronary syndromes. Resuscitation . 2010;81:", "bbox": [427.0, 109.0, 720.0, 120.0]}, {"text": "281–286.", "bbox": [427.0, 122.0, 467.0, 133.0]}, {"text": "216. Goodacre SW, Angelini K, Arnold J, Revill S, Morris F.  Clinical", "bbox": [404.0, 134.0, 720.0, 147.0]}, {"text": "predictors of acute coronary syndromes in patients with undifferentiated", "bbox": [427.0, 147.0, 720.0, 159.0]}, {"text": "chest pain. QJM . 2003;96:893–898.", "bbox": [427.0, 159.0, 577.0, 169.0]}, {"text": "217. Goodacre S, Locker T, Morris F, Campbell S. How useful are clinical", "bbox": [404.0, 171.0, 720.0, 183.0]}, {"text": "features in the diagnosis of acute, undifferentiated chest pain? Acad", "bbox": [427.0, 184.0, 720.0, 196.0]}, {"text": "Emerg Med . 2002;9:203–208.", "bbox": [428.0, 195.0, 549.0, 207.0]}, {"text": "218. Everts B, Karlson BW, Wahrborg P, Hedner T, Herlitz J. Localization of", "bbox": [404.0, 207.0, 721.0, 220.0]}, {"text": "pain in suspected acute myocardial infarction in relation to final", "bbox": [427.0, 220.0, 720.0, 232.0]}, {"text": "diagnosis, age and sex, and site and type of infarction. Heart Lung .", "bbox": [428.0, 234.0, 719.0, 245.0]}, {"text": "1996;25:430–437.", "bbox": [428.0, 245.0, 505.0, 255.0]}, {"text": "219. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin", "bbox": [404.0, 255.0, 720.0, 268.0]}, {"text": "BJ. Women's early warning symptoms of acute myocardial infarction.", "bbox": [427.0, 269.0, 719.0, 281.0]}, {"text": "Circulation . 2003;108:2619–2623.", "bbox": [427.0, 282.0, 570.0, 294.0]}, {"text": "220. Panju AA, BR Hemmelgarn, GG Guyatt, DL Simel. Is this patient", "bbox": [404.0, 293.0, 720.0, 305.0]}, {"text": "having a myocardial infarction? JAMA . 1998;280:1256–1263.", "bbox": [427.0, 306.0, 683.0, 318.0]}, {"text": "221. Mant J, McManus RJ, Oakes RA, Delaney BC, Barton PM, Deeks JJ,", "bbox": [404.0, 318.0, 720.0, 329.0]}, {"text": "Hammersley L, Davies RC, Davies MK, Hobbs FD. Systematic review", "bbox": [427.0, 331.0, 720.0, 342.0]}, {"text": "and modelling of the investigation of acute and chronic chest pain", "bbox": [427.0, 342.0, 720.0, 354.0]}, {"text": "presenting in primary care. Health Technol Assess . 2004;8:iii,1–158.", "bbox": [428.0, 355.0, 712.0, 367.0]}, {"text": "222. Berger JP, Buclin T, Haller E, Van Melle G, Yersin B.  Right arm", "bbox": [404.0, 367.0, 720.0, 379.0]}, {"text": "involvement and pain extension can help to differentiate coronary", "bbox": [427.0, 380.0, 719.0, 392.0]}, {"text": "diseases from chest pain of other origin: a prospective emergency ward", "bbox": [427.0, 391.0, 720.0, 403.0]}, {"text": "study of 278 consecutive patients admitted for chest pain. J Intern Med .", "bbox": [428.0, 404.0, 719.0, 415.0]}, {"text": "1990;227:165–172.", "bbox": [427.0, 415.0, 507.0, 427.0]}, {"text": "223. Jonsbu J, Rollag A, Aase O, Lippestad CT, Arnesen KE, Erikssen J,", "bbox": [404.0, 428.0, 720.0, 441.0]}, {"text": "Koss A.  Rapid and correct diagnosis of myocardial infarction: stan-", "bbox": [427.0, 441.0, 719.0, 452.0]}, {"text": "dardized case history and clinical examination provide important infor-", "bbox": [427.0, 453.0, 718.0, 464.0]}, {"text": "mation for correct referral to monitored beds. J Intern Med . 1991;229:", "bbox": [427.0, 465.0, 719.0, 477.0]}, {"text": "143–149.", "bbox": [428.0, 478.0, 468.0, 488.0]}, {"text": "224. Hargarten KM, Aprahamian C, Stueven H, Olson DW, Aufderheide TP,", "bbox": [404.0, 488.0, 719.0, 502.0]}, {"text": "Mateer JR.  Limitations of prehospital predictors of acute myocardial", "bbox": [427.0, 501.0, 720.0, 514.0]}, {"text": "infarction and unstable angina. Ann Emerg Med . 1987;16:1325–1329.", "bbox": [427.0, 515.0, 716.0, 527.0]}, {"text": "225. Herlitz J, Hansson E, Ringvall E, Starke M, Karlson BW, Waagstein L.", "bbox": [404.0, 526.0, 719.0, 538.0]}, {"text": "Predicting a life-threatening disease and death among ambulance-", "bbox": [427.0, 539.0, 719.0, 551.0]}, {"text": "transported patients with chest pain or other symptoms raising suspicion", "bbox": [427.0, 551.0, 720.0, 562.0]}, {"text": "of an acute coronary syndrome. Am J Emerg Med . 2002;20:588–594.", "bbox": [427.0, 563.0, 716.0, 575.0]}, {"text": "226. Lee TH, Pearson SD, Johnson PA, Garcia TB, Weisberg MC, Guad-", "bbox": [404.0, 575.0, 719.0, 587.0]}, {"text": "agnoli E, Cook EF, Goldman L. Failure of information as an intervention", "bbox": [427.0, 587.0, 720.0, 601.0]}, {"text": "to modify clinical management. A time-series trial in patients with acute", "bbox": [427.0, 600.0, 720.0, 611.0]}, {"text": "chest pain. Ann Intern Med . 1995;122:434–437.", "bbox": [428.0, 613.0, 625.0, 623.0]}, {"text": "227. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Fried-", "bbox": [404.0, 624.0, 719.0, 635.0]}, {"text": "lander T, Bushnell AC, Chandra-Strobos N. Chest pain relief by nitro-", "bbox": [427.0, 637.0, 719.0, 649.0]}, {"text": "glycerin does not predict active coronary artery disease. Ann Intern Med .", "bbox": [427.0, 649.0, 719.0, 660.0]}, {"text": "2003;139:979–986.", "bbox": [428.0, 662.0, 508.0, 673.0]}, {"text": "228. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasi-", "bbox": [404.0, 673.0, 719.0, 685.0]}, {"text": "ulewicz C, Walshon J, Terranova G, Gottlieb L, Goldstein-Wayne B, et", "bbox": [427.0, 686.0, 720.0, 697.0]}, {"text": "al. Clinical characteristics and natural history of patients with acute", "bbox": [427.0, 697.0, 720.0, 709.0]}, {"text": "myocardial infarction sent home from the emergency room. Am J", "bbox": [427.0, 710.0, 720.0, 722.0]}, {"text": "Cardiol . 1987;60:219–224.", "bbox": [427.0, 722.0, 541.0, 733.0]}, {"text": "229. Freimark D, Matetzky S, Leor J, Boyko V, Barbash IM, Behar S, Hod", "bbox": [404.0, 735.0, 721.0, 747.0]}, {"text": "H.  Timing of aspirin administration as a determinant of survival of", "bbox": [427.0, 746.0, 720.0, 757.0]}, {"text": "patients with acute myocardial infarction treated with thrombolysis.", "bbox": [427.0, 759.0, 718.0, 770.0]}, {"text": "Am J Cardiol . 2002;89:381–385.", "bbox": [427.0, 771.0, 564.0, 782.0]}, {"text": "230. Barbash IM, Freimark D, Gottlieb S, Hod H, Hasin Y, Battler A, Crystal", "bbox": [404.0, 783.0, 720.0, 796.0]}, {"text": "E, Matetzky S, Boyko V, Mandelzweig L, Behar S, Leor J. Outcome of", "bbox": [427.0, 796.0, 720.0, 808.0]}, {"text": "myocardial infarction in patients treated with aspirin is enhanced by", "bbox": [427.0, 808.0, 719.0, 820.0]}, {"text": "pre-hospital administration. Cardiology . 2002;98:141–147.", "bbox": [428.0, 821.0, 668.0, 831.0]}, {"text": "231. Randomised trial of intravenous streptokinase, oral aspirin, both, or", "bbox": [404.0, 832.0, 720.0, 844.0]}, {"text": "neither among 17,187 cases of suspected acute myocardial infarction:", "bbox": [427.0, 844.0, 720.0, 856.0]}, {"text": "ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collab-", "bbox": [427.0, 856.0, 718.0, 869.0]}, {"text": "orative Group. Lancet. 1988;2:349–360.", "bbox": [427.0, 870.0, 595.0, 881.0]}, {"text": "232. Casaccia M, Bertello F, De Bernardi A, Sicuro M, Scacciatella P.", "bbox": [404.0, 882.0, 719.0, 893.0]}, {"text": "Prehospital management of acute myocardial infarct in an experimental", "bbox": [427.0, 894.0, 720.0, 906.0]}, {"text": "metropolitan system of medical emergencies [in Italian]. G Ital Cardiol .", "bbox": [427.0, 905.0, 719.0, 917.0]}, {"text": "1996;26:657–672.", "bbox": [428.0, 918.0, 503.0, 930.0]}, {"text": "233. Quan D, LoVecchio F, Clark B, Gallagher JV III. Prehospital use of", "bbox": [404.0, 930.0, 720.0, 942.0]}, {"text": "aspirin rarely is associated with adverse events. Prehosp Disaster Med.", "bbox": [427.0, 943.0, 719.0, 955.0]}, {"text": "2004;19:362–365.", "bbox": [428.0, 955.0, 503.0, 966.0]}, {"text": "234. Verheugt FW, van der Laarse A, Funke-Kupper AJ, Sterkman LG,", "bbox": [404.0, 967.0, 719.0, 979.0]}, {"text": "Galema TW, Roos JP.  Effects of early intervention with low-dose", "bbox": [427.0, 979.0, 720.0, 991.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1001.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 71}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#59#参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:36:57"}
{"id": 1042091, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "1ccef463-e8c2-42b0-aea0-7833bacfca90", "title": null, "text": "【0】页码:48\n tify key considerations for directed efforts of improvement (see Table 2).\n\n【1】 Change The process of simply measuring and benchmarking care can positively influence outcome. 48 However, ongoing review and interpretation are necessary to identify areas for improvement. Local data may suggest the need to increase bystander CPR response rates, improve CPR performance, or shorten the time to defibrillation. Useful strategies might include programs targeting citizen awareness, education and training for citizens and professionals, and various technologic solutions. These programs need to be continually re-evaluated to ensure that potential areas for improvement are fully addressed.\n\n【2】## Important Lessons From Cpr And Summary The 2010 Aha Guidelines For Cpr And Ecc Mark The 50 Th\n\n【3】\n anniversary of modern CPR. There is general agreement that the 1960 Meeting of the Maryland Medical Society in Ocean City, MD, formally introduced the combination of chest compressions and rescue breathing. 49 Two years later (1962) direct-current, monophasic waveform defibrillation was described. 50 In 1966, the American Heart Association developed the first CPR guidelines. 51 Over the past 50 years, these modern-era basic life support fundamentals of early recognition and activation, early CPR, and early\n\n【4】 defibrillation have saved hundreds of thousands of lives around the world. These lives stand as a testament to the importance of resuscitation research and clinical translation. They give us cause to celebrate this 50 th anniversary of CPR.\n\n【5】And yet we still have a long road to travel if we are to fulfill the potential offered by the Chain of Survival. There is a striking disparity in survival across systems of care for cardiac arrest. Survival disparities that were present a generation ago appear to persist. 3.8.52 Although future discoveries will offer opportunities to improve survival, we currently possess the knowledge and tools—represented by the Chain of Survival—to address many of these care gaps.\n\n【6】The challenge is one of real-world translation across\n\n【7】 diverse systems. Since the 2005 AHA Guidelines for CPR and ECC , many instructive and encouraging examples have been published, describing ways in which that translation can be accomplished. Each system, whether in the hospital or in the community, must assess its performance and implement a strategy for improving care in cases of cardiac arrest. That strategy should support the building blocks of resuscitation: the BLS links of immediate recognition and emergency activation, early CPR, and rapid defibrillation. If we accept this imperative to act, we can achieve the full potential offered by the Chain of Survival and, in turn, improve public health.\n\n【8】## Disclosures\n\n【9】 Guidelines Part 4: Overview of CPR Writing Group Disclosures\n\n【10】 Guidelines Part 4: Overview of CPR Writing Group Disclosures Writing Other Research Speakers' Consultant/ Group Ownership Member Employment Research Grant Bureau/Honoraria Advisory Board Other Support Interest Andrew H.\n\n【11】Emergency Health None None None None None None Travers Services Nova Scotia- Provincial Medical Director Thomas D.\n\n【12】University of *In the past, I have received modest grants from Philips Inc \"We recently *1 participate None None None Washington: Physician, and PhysioControl to evaluate changes in resuscitation completed an as part of a Real Associate Professor of protocols. These investigations did not support evaluation of AED training DSMB in a Medicine; Emergency proprietary equipment. I am an investigator in the study for which trial sponsored Medical Services Resuscitation Outcomes Consortium so participate in studies Philips and by Philips Inc Division - Public Health evaluating dynamic CPR feedback available in a Philips PhysioControl to evaluate Seattle & King defibrillator and the impedance threshold device which is provided quantitative VF County–Program developed and owned by a private company. These studies equipment. I did waveform Medical Director are funded primarily by the NIH and I receive no support not directly algorithm to from private industry related to these research activities. I receive any guide care. I participate in a trial of chest compression alone versus chest receive no equipment as compression plus ventilation supported in part by the Laerdal part of the financial Foundation. Collectively I receive < 5% of my salary from support as part.\n\n【13】research activity.\n\n【14】these research activities.\n\n【15】of the DSMB.\n\n【16】↑AHA. Ultra-Brief CPR Video Study, PL.\n\n【17】Bentley J.\n\n【18】Arizona Department of None None None None None *Medtronic Foundation. Arizona Statewide Resuscitation Bobrow Health Services–Medical System of Care, 2010–2015, Pl.\n\n【19】Director, Bureau of EMS and Trauma System; Maricopa Medical Center-Clin.\n\n【20】Associate. Professor, Emergency Medicine Department (Continued)\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "tify key considerations for directed efforts of improvement", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "(see Table 2).", "bbox": [60.0, 100.0, 137.0, 113.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Change", "bbox": [60.0, 126.0, 104.0, 139.0]}, {"text": "The process of simply measuring and benchmarking care", "bbox": [60.0, 139.0, 376.0, 154.0]}, {"text": "can positively influence outcome. 48 However, ongoing", "bbox": [60.0, 153.0, 375.0, 168.0]}, {"text": "review and interpretation are necessary to identify areas", "bbox": [60.0, 170.0, 375.0, 184.0]}, {"text": "for improvement. Local data may suggest the need to", "bbox": [60.0, 185.0, 376.0, 200.0]}, {"text": "increase bystander CPR response rates, improve CPR", "bbox": [60.0, 201.0, 375.0, 214.0]}, {"text": "performance, or shorten the time to defibrillation. Useful", "bbox": [60.0, 216.0, 376.0, 231.0]}, {"text": "strategies might include programs targeting citizen aware-", "bbox": [60.0, 232.0, 375.0, 246.0]}, {"text": "ness, education and training for citizens and professionals,", "bbox": [60.0, 247.0, 375.0, 261.0]}, {"text": "and various technologic solutions. These programs need to", "bbox": [60.0, 263.0, 376.0, 277.0]}, {"text": "be continually re-evaluated to ensure that potential areas", "bbox": [60.0, 278.0, 376.0, 292.0]}, {"text": "for improvement are fully addressed.", "bbox": [60.0, 294.0, 263.0, 308.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Important Lessons from CPR and Summary", "bbox": [66.0, 323.0, 369.0, 338.0]}, {"text": "The 2010 AHA Guidelines for CPR and ECC mark the 50 th", "bbox": [61.0, 340.0, 375.0, 353.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "anniversary of modern CPR. There is general agreement", "bbox": [60.0, 354.0, 376.0, 370.0]}, {"text": "that the 1960 Meeting of the Maryland Medical Society in", "bbox": [60.0, 370.0, 377.0, 384.0]}, {"text": "Ocean City, MD, formally introduced the combination of", "bbox": [60.0, 386.0, 376.0, 400.0]}, {"text": "chest compressions and rescue breathing. 49 Two years later", "bbox": [60.0, 401.0, 376.0, 415.0]}, {"text": "(1962) direct-current, monophasic waveform defibrillation", "bbox": [60.0, 417.0, 376.0, 431.0]}, {"text": "was described. 50 In 1966, the American Heart Association", "bbox": [60.0, 432.0, 376.0, 447.0]}, {"text": "developed the first CPR guidelines. 51 Over the past 50", "bbox": [60.0, 448.0, 376.0, 461.0]}, {"text": "years, these modern-era basic life support fundamentals of", "bbox": [60.0, 463.0, 376.0, 478.0]}, {"text": "early recognition and activation, early CPR, and early", "bbox": [60.0, 479.0, 375.0, 493.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "defibrillation have saved hundreds of thousands of lives", "bbox": [403.0, 84.0, 720.0, 98.0]}, {"text": "around the world. These lives stand as a testament to the", "bbox": [404.0, 100.0, 720.0, 113.0]}, {"text": "importance of resuscitation research and clinical transla-", "bbox": [403.0, 114.0, 718.0, 128.0]}, {"text": "tion. They give us cause to celebrate this 50 th anniversary", "bbox": [403.0, 129.0, 719.0, 144.0]}, {"text": "of CPR.", "bbox": [403.0, 146.0, 451.0, 159.0]}, {"text": "And yet we still have a long road to travel if we are to", "bbox": [417.0, 160.0, 721.0, 174.0]}, {"text": "fulfill the potential offered by the Chain of Survival. There", "bbox": [404.0, 175.0, 720.0, 189.0]}, {"text": "is a striking disparity in survival across systems of care for", "bbox": [403.0, 191.0, 720.0, 204.0]}, {"text": "cardiac arrest. Survival disparities that were present a", "bbox": [403.0, 206.0, 720.0, 220.0]}, {"text": "generation ago appear to persist. 3.8.52 Although future", "bbox": [404.0, 221.0, 720.0, 234.0]}, {"text": "discoveries will offer opportunities to improve survival,", "bbox": [403.0, 236.0, 720.0, 250.0]}, {"text": "we currently possess the knowledge and tools—represent-", "bbox": [403.0, 251.0, 719.0, 266.0]}, {"text": "ed by the Chain of Survival—to address many of these care", "bbox": [403.0, 267.0, 720.0, 281.0]}, {"text": "gaps.", "bbox": [404.0, 283.0, 433.0, 295.0]}, {"text": "The challenge is one of real-world translation across", "bbox": [417.0, 296.0, 720.0, 311.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "diverse systems. Since the 2005 AHA Guidelines for CPR", "bbox": [403.0, 312.0, 720.0, 326.0]}, {"text": "and ECC , many instructive and encouraging examples", "bbox": [403.0, 327.0, 720.0, 341.0]}, {"text": "have been published, describing ways in which that trans-", "bbox": [403.0, 342.0, 718.0, 356.0]}, {"text": "lation can be accomplished. Each system, whether in the", "bbox": [403.0, 358.0, 720.0, 371.0]}, {"text": "hospital or in the community, must assess its performance", "bbox": [403.0, 373.0, 720.0, 388.0]}, {"text": "and implement a strategy for improving care in cases of", "bbox": [403.0, 388.0, 720.0, 402.0]}, {"text": "cardiac arrest. That strategy should support the building", "bbox": [403.0, 403.0, 720.0, 417.0]}, {"text": "blocks of resuscitation: the BLS links of immediate rec-", "bbox": [403.0, 418.0, 718.0, 433.0]}, {"text": "ognition and emergency activation, early CPR, and rapid", "bbox": [403.0, 434.0, 720.0, 448.0]}, {"text": "defibrillation. If we accept this imperative to act, we can", "bbox": [403.0, 448.0, 720.0, 462.0]}, {"text": "achieve the full potential offered by the Chain of Survival", "bbox": [403.0, 464.0, 720.0, 478.0]}, {"text": "and, in turn, improve public health.", "bbox": [403.0, 480.0, 601.0, 493.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Disclosures", "bbox": [351.0, 544.0, 428.0, 559.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Guidelines Part 4: Overview of CPR Writing Group Disclosures", "bbox": [60.0, 570.0, 364.0, 586.0]}], "type": "Caption", "position": 10}, {"raw_context": [{"text": "Guidelines Part 4: Overview of CPR Writing Group Disclosures", "bbox": [60.0, 570.0, 364.0, 586.0]}, {"text": "Writing", "bbox": [61.0, 594.0, 86.0, 605.0]}, {"text": "Other Research", "bbox": [421.0, 606.0, 472.0, 617.0]}, {"text": "Speakers'", "bbox": [500.0, 606.0, 533.0, 617.0]}, {"text": "Consultant/", "bbox": [609.0, 606.0, 648.0, 617.0]}, {"text": "Group", "bbox": [61.0, 607.0, 84.0, 617.0]}, {"text": "Ownership", "bbox": [556.0, 607.0, 589.0, 617.0]}, {"text": "Member", "bbox": [61.0, 618.0, 89.0, 629.0]}, {"text": "Employment", "bbox": [132.0, 617.0, 175.0, 629.0]}, {"text": "Research Grant", "bbox": [278.0, 617.0, 331.0, 629.0]}, {"text": "Bureau/Honoraria", "bbox": [488.0, 617.0, 544.0, 628.0]}, {"text": "Advisory Board", "bbox": [604.0, 618.0, 653.0, 629.0]}, {"text": "Other", "bbox": [683.0, 618.0, 702.0, 628.0]}, {"text": "Support", "bbox": [432.0, 619.0, 460.0, 628.0]}, {"text": "Interest", "bbox": [559.0, 619.0, 586.0, 628.0]}, {"text": "Andrew H.", "bbox": [61.0, 634.0, 97.0, 647.0]}, {"text": "Emergency Health", "bbox": [122.0, 635.0, 185.0, 646.0]}, {"text": "None", "bbox": [295.0, 635.0, 315.0, 646.0]}, {"text": "None", "bbox": [507.0, 635.0, 525.0, 645.0]}, {"text": "None", "bbox": [562.0, 635.0, 582.0, 645.0]}, {"text": "None", "bbox": [618.0, 635.0, 638.0, 645.0]}, {"text": "None", "bbox": [683.0, 635.0, 703.0, 646.0]}, {"text": "None", "bbox": [437.0, 636.0, 456.0, 644.0]}, {"text": "Travers", "bbox": [61.0, 648.0, 88.0, 658.0]}, {"text": "Services Nova Scotia-", "bbox": [119.0, 648.0, 188.0, 658.0]}, {"text": "Provincial Medical", "bbox": [122.0, 659.0, 184.0, 670.0]}, {"text": "Director", "bbox": [139.0, 672.0, 167.0, 681.0]}, {"text": "Thomas D.", "bbox": [61.0, 686.0, 97.0, 697.0]}, {"text": "University of", "bbox": [131.0, 686.0, 176.0, 697.0]}, {"text": "*In the past, I have received modest grants from Philips Inc", "bbox": [206.0, 686.0, 404.0, 697.0]}, {"text": "\"We recently", "bbox": [425.0, 686.0, 468.0, 697.0]}, {"text": "*1 participate", "bbox": [672.0, 686.0, 715.0, 697.0]}, {"text": "None", "bbox": [507.0, 687.0, 525.0, 697.0]}, {"text": "None", "bbox": [563.0, 687.0, 583.0, 697.0]}, {"text": "None", "bbox": [618.0, 687.0, 638.0, 697.0]}, {"text": "Washington: Physician,", "bbox": [115.0, 697.0, 191.0, 709.0]}, {"text": "and PhysioControl to evaluate changes in resuscitation", "bbox": [213.0, 697.0, 397.0, 709.0]}, {"text": "completed an", "bbox": [424.0, 698.0, 471.0, 709.0]}, {"text": "as part of a", "bbox": [672.0, 698.0, 715.0, 709.0]}, {"text": "Real", "bbox": [61.0, 699.0, 76.0, 708.0]}, {"text": "Associate Professor of", "bbox": [116.0, 710.0, 193.0, 721.0]}, {"text": "protocols. These investigations did not support evaluation of", "bbox": [204.0, 710.0, 406.0, 722.0]}, {"text": "AED training", "bbox": [425.0, 710.0, 469.0, 722.0]}, {"text": "DSMB in a", "bbox": [674.0, 710.0, 714.0, 722.0]}, {"text": "Medicine; Emergency", "bbox": [117.0, 722.0, 190.0, 733.0]}, {"text": "proprietary equipment. I am an investigator in the", "bbox": [221.0, 722.0, 390.0, 733.0]}, {"text": "study for which", "bbox": [421.0, 722.0, 473.0, 733.0]}, {"text": "trial sponsored", "bbox": [668.0, 722.0, 718.0, 733.0]}, {"text": "Medical Services", "bbox": [123.0, 735.0, 184.0, 745.0]}, {"text": "Resuscitation Outcomes Consortium so participate in studies", "bbox": [204.0, 735.0, 406.0, 745.0]}, {"text": "Philips and", "bbox": [426.0, 735.0, 468.0, 746.0]}, {"text": "by Philips Inc", "bbox": [669.0, 735.0, 716.0, 746.0]}, {"text": "Division - Public Health", "bbox": [114.0, 746.0, 193.0, 757.0]}, {"text": "evaluating dynamic CPR feedback available in a Philips", "bbox": [211.0, 746.0, 398.0, 757.0]}, {"text": "PhysioControl", "bbox": [425.0, 746.0, 469.0, 757.0]}, {"text": "to evaluate", "bbox": [672.0, 746.0, 713.0, 757.0]}, {"text": "Seattle & King", "bbox": [128.0, 758.0, 180.0, 769.0]}, {"text": "defibrillator and the impedance threshold device which is", "bbox": [209.0, 758.0, 401.0, 768.0]}, {"text": "provided", "bbox": [430.0, 759.0, 464.0, 768.0]}, {"text": "quantitative VF", "bbox": [670.0, 759.0, 717.0, 768.0]}, {"text": "County–Program", "bbox": [126.0, 769.0, 182.0, 781.0]}, {"text": "developed and owned by a private company. These studies", "bbox": [206.0, 769.0, 404.0, 782.0]}, {"text": "equipment. I did", "bbox": [420.0, 770.0, 474.0, 781.0]}, {"text": "waveform", "bbox": [674.0, 770.0, 711.0, 781.0]}, {"text": "Medical Director", "bbox": [126.0, 782.0, 182.0, 793.0]}, {"text": "are funded primarily by the NIH and I receive no support", "bbox": [209.0, 782.0, 401.0, 793.0]}, {"text": "not directly", "bbox": [427.0, 783.0, 466.0, 791.0]}, {"text": "algorithm to", "bbox": [672.0, 783.0, 715.0, 793.0]}, {"text": "from private industry related to these research activities. I", "bbox": [207.0, 794.0, 403.0, 805.0]}, {"text": "receive any", "bbox": [427.0, 795.0, 467.0, 805.0]}, {"text": "guide care. I", "bbox": [672.0, 795.0, 716.0, 805.0]}, {"text": "participate in a trial of chest compression alone versus chest", "bbox": [203.0, 805.0, 407.0, 816.0]}, {"text": "receive no", "bbox": [674.0, 806.0, 712.0, 816.0]}, {"text": "equipment as", "bbox": [424.0, 807.0, 471.0, 816.0]}, {"text": "compression plus ventilation supported in part by the Laerdal", "bbox": [204.0, 818.0, 406.0, 829.0]}, {"text": "part of the", "bbox": [428.0, 818.0, 466.0, 829.0]}, {"text": "financial", "bbox": [677.0, 818.0, 709.0, 829.0]}, {"text": "Foundation. Collectively I receive < 5% of my salary from", "bbox": [207.0, 829.0, 402.0, 841.0]}, {"text": "support as part.", "bbox": [667.0, 829.0, 718.0, 841.0]}, {"text": "research activity.", "bbox": [419.0, 830.0, 474.0, 841.0]}, {"text": "these research activities.", "bbox": [261.0, 843.0, 347.0, 853.0]}, {"text": "of the DSMB.", "bbox": [669.0, 843.0, 715.0, 853.0]}, {"text": "↑AHA. Ultra-Brief CPR Video Study, PL.", "bbox": [241.0, 853.0, 368.0, 865.0]}, {"text": "Bentley J.", "bbox": [61.0, 854.0, 94.0, 865.0]}, {"text": "Arizona Department of", "bbox": [116.0, 854.0, 191.0, 865.0]}, {"text": "None", "bbox": [437.0, 854.0, 456.0, 864.0]}, {"text": "None", "bbox": [507.0, 854.0, 526.0, 864.0]}, {"text": "None", "bbox": [563.0, 854.0, 583.0, 864.0]}, {"text": "None", "bbox": [619.0, 854.0, 638.0, 864.0]}, {"text": "None", "bbox": [682.0, 854.0, 703.0, 864.0]}, {"text": "*Medtronic Foundation. Arizona Statewide Resuscitation", "bbox": [213.0, 866.0, 397.0, 876.0]}, {"text": "Bobrow", "bbox": [61.0, 867.0, 89.0, 876.0]}, {"text": "Health", "bbox": [141.0, 867.0, 165.0, 876.0]}, {"text": "Services–Medical", "bbox": [124.0, 877.0, 183.0, 889.0]}, {"text": "System of Care, 2010–2015, Pl.", "bbox": [250.0, 878.0, 358.0, 890.0]}, {"text": "Director, Bureau of", "bbox": [121.0, 890.0, 186.0, 901.0]}, {"text": "EMS and Trauma", "bbox": [123.0, 902.0, 183.0, 913.0]}, {"text": "System; Maricopa", "bbox": [122.0, 913.0, 185.0, 924.0]}, {"text": "Medical Center-Clin.", "bbox": [119.0, 926.0, 187.0, 937.0]}, {"text": "Associate. Professor,", "bbox": [118.0, 937.0, 187.0, 949.0]}, {"text": "Emergency Medicine", "bbox": [118.0, 950.0, 188.0, 962.0]}, {"text": "Department", "bbox": [133.0, 963.0, 174.0, 973.0]}, {"text": "(Continued)", "bbox": [680.0, 973.0, 720.0, 983.0]}], "type": "Table", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 48}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#1#1#Change 标题应该单独一行\n缺少换行#2#2#The 2010 Aha Guidelines For Cpr And Ecc Mark The 50 Th 文章内容应该和标题分开\n多余换行#3#3#anniversary of modern CPR. There is general...与上面2段缺少换行的内容联接\n多余换行#4#4#defibrillation have saved hundreds ...与上面3段联接\n多余换行#7#7# diverse systems. Since the 2005...与上面6段联接", "type3": null, "type4": null, "type5": null, "type6": "有用性#8#20#表格的内容，但是内容杂乱没有顺序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:04:01"}
{"id": 1042090, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "6df87b6f-021d-40f6-ac95-7f5fc2b3aec9", "title": null, "text": "【0】页码:58\n A out your arms, with fingers interlocked but palms now facing out.\n\n【1】Exhale to bring your arms back to your chest.\n\n【2】 in step 2, but this time extending your arms up at an angle of 45 degrees.\n\n【3】Inhale on extension, and exhale on return.\n\n【4】 C repeat steps 1 and 2, but this time extending your arms up and lengthening your spine. Exhaling, return to the start position. Do each stretch at least five times.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "A out your arms, with", "bbox": [42.0, 567.0, 133.0, 577.0]}, {"text": "fingers interlocked but", "bbox": [36.0, 579.0, 133.0, 590.0]}, {"text": "palms now facing out.", "bbox": [36.0, 591.0, 131.0, 602.0]}, {"text": "Exhale to bring your arms", "bbox": [36.0, 603.0, 144.0, 614.0]}, {"text": "back to your chest.", "bbox": [36.0, 615.0, 119.0, 626.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "in step 2, but this time", "bbox": [175.0, 567.0, 272.0, 578.0]}, {"text": "extending your arms up at", "bbox": [161.0, 579.0, 275.0, 590.0]}, {"text": "an angle of 45 degrees.", "bbox": [161.0, 591.0, 264.0, 602.0]}, {"text": "Inhale on extension, and", "bbox": [161.0, 603.0, 267.0, 614.0]}, {"text": "exhale on return.", "bbox": [161.0, 615.0, 234.0, 626.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "C repeat steps 1 and 2, but this", "bbox": [298.0, 567.0, 429.0, 578.0]}, {"text": "time extending your arms up and", "bbox": [288.0, 579.0, 429.0, 590.0]}, {"text": "lengthening your spine. Exhaling,", "bbox": [288.0, 591.0, 430.0, 602.0]}, {"text": "return to the start position. Do", "bbox": [288.0, 603.0, 415.0, 614.0]}, {"text": "each stretch at least five times.", "bbox": [288.0, 615.0, 419.0, 626.0]}], "type": "Text", "position": 4}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/101 Essential Tips Yoga (Dorling Kindersley (DK)) (Z-Library).pdf", "page_num": 58}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type3": "无关文本#0#0#A \n无关文本#4#4#C  ", "type4": "语义不完整#0#0#out your arms, 前面缺少内容\n语义不完整#2#2#in step 2,前面缺少内容\n语义不完整#4#4#repeat steps 1 and 2, 前面缺少内容", "type6": "信息不完整#0#0#文章前面内容缺失不完整"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:16:21"}
{"id": 1042089, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "60b19135-daed-41db-b72b-e120c7ad5093", "title": null, "text": "【0】页码:50\n sisoubeig pue swozdw/s\n\n【1】 cussed in Question 28). Other useful tests include blood tests and X-ray studies. Additional, more specialized studies may be indicated. An example of a specialized study is skin-prick testing for suspected allergy.\n\n【2】Blood tests are useful in getting an overall picture of a person's health, as well as in excluding other diagnoses.\n\n【3】Assessment of immune function and allergies, for example, can be performed in part via blood testing.\n\n【4】X-ray studies include conventional chest X-rays, as well as three-dimensional chest CT (computed tomography) scans. Chest X-rays and CT scans provide information about the anatomy or structure of the lungs and larger breathing passages. In quiescent, controlled asthma, the chest X-ray should be entirely normal. The same is true of the chest CT scan. During an exacerbation, however, the lungs' appearance on an X-ray may suggest what radiologists call \"hyperinflation,\" and the CT might reveal \"air-trapping.\" Both findings reflect the uneven lung filling and emptying when breathing occurs through inflamed, constricted air tubes.\n\n【5】 MRI (magnetic resonance imaging) scanning and PET (positron emission tomography) scanning, while useful in other types of lung diseases, are not required in asthma. The same is true of nuclear medicine scans, such as ventilation-perfusion scans, and gallium scans.\n\n【6】## 28. What Are Pulmonary Function Tests (Pfts), Spirometry, And Peak Expiratory Flow (Pef) Measurements?\n\n【7】\n Pulmonary function tests (PFTs)—as the name implies—are tests designed to measure lung function (Table 10). PFTs were originally used as research tools, available only in specialized academic hospital centers.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "sisoubeig pue swozdw/s", "bbox": [544.0, 88.0, 570.0, 257.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "cussed in Question 28). Other useful tests include", "bbox": [69.0, 66.0, 426.0, 86.0]}, {"text": "blood tests and X-ray studies. Additional, more special-", "bbox": [69.0, 87.0, 425.0, 106.0]}, {"text": "ized studies may be indicated. An example of a special-", "bbox": [69.0, 106.0, 425.0, 128.0]}, {"text": "ized study is skin-prick testing for suspected allergy.", "bbox": [69.0, 128.0, 426.0, 146.0]}, {"text": "Blood tests are useful in getting an overall picture of a", "bbox": [70.0, 147.0, 427.0, 167.0]}, {"text": "person's health, as well as in excluding other diagnoses.", "bbox": [69.0, 167.0, 426.0, 186.0]}, {"text": "Assessment of immune function and allergies, for", "bbox": [69.0, 187.0, 427.0, 206.0]}, {"text": "example, can be performed in part via blood testing.", "bbox": [69.0, 208.0, 426.0, 226.0]}, {"text": "X-ray studies include conventional chest X-rays, as well", "bbox": [69.0, 227.0, 428.0, 246.0]}, {"text": "as three-dimensional chest CT (computed tomogra-", "bbox": [69.0, 247.0, 425.0, 267.0]}, {"text": "phy) scans. Chest X-rays and CT scans provide infor-", "bbox": [69.0, 267.0, 425.0, 287.0]}, {"text": "mation about the anatomy or structure of the lungs and", "bbox": [69.0, 288.0, 428.0, 307.0]}, {"text": "larger breathing passages. In quiescent, controlled", "bbox": [69.0, 308.0, 428.0, 327.0]}, {"text": "asthma, the chest X-ray should be entirely normal. The", "bbox": [69.0, 328.0, 427.0, 347.0]}, {"text": "same is true of the chest CT scan. During an exacerba-", "bbox": [70.0, 348.0, 425.0, 368.0]}, {"text": "tion, however, the lungs' appearance on an X-ray may", "bbox": [70.0, 368.0, 427.0, 388.0]}, {"text": "suggest what radiologists call \"hyperinflation,\" and the", "bbox": [70.0, 388.0, 427.0, 408.0]}, {"text": "CT might reveal \"air-trapping.\" Both findings reflect", "bbox": [69.0, 408.0, 428.0, 428.0]}, {"text": "the uneven lung filling and emptying when breathing", "bbox": [69.0, 429.0, 427.0, 447.0]}, {"text": "occurs through inflamed, constricted air tubes.", "bbox": [69.0, 448.0, 370.0, 468.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "MRI (magnetic resonance imaging) scanning and", "bbox": [69.0, 488.0, 427.0, 507.0]}, {"text": "PET (positron emission tomography) scanning, while", "bbox": [70.0, 509.0, 427.0, 527.0]}, {"text": "useful in other types of lung diseases, are not required", "bbox": [69.0, 528.0, 427.0, 547.0]}, {"text": "in asthma. The same is true of nuclear medicine scans,", "bbox": [69.0, 548.0, 427.0, 568.0]}, {"text": "such as ventilation-perfusion scans, and gallium scans.", "bbox": [70.0, 568.0, 423.0, 588.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "28. What are pulmonary function tests", "bbox": [72.0, 612.0, 406.0, 633.0]}, {"text": "(PFTs), spirometry, and peak expiratory", "bbox": [71.0, 635.0, 425.0, 659.0]}, {"text": "flow (PEF) measurements?", "bbox": [70.0, 660.0, 313.0, 684.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Pulmonary function tests (PFTs)—as the name", "bbox": [69.0, 685.0, 426.0, 708.0]}, {"text": "implies—are tests designed to measure lung function", "bbox": [69.0, 708.0, 427.0, 727.0]}, {"text": "(Table 10). PFTs were originally used as research tools,", "bbox": [69.0, 728.0, 427.0, 748.0]}, {"text": "available only in specialized academic hospital centers.", "bbox": [70.0, 748.0, 426.0, 768.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 50}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#0#0#sisoubeig pue swozdw/s\n无关文本#7#7#(Table 10)", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:05:07"}
{"id": 1042088, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "b62b1ebc-f3b7-4d38-a03e-96939d771629", "title": null, "text": "【0】页码:116\n p10 pus wəN :suoitesib9M smq1sA\n\n【1】 defined period of time, after which the patent is said to expire. When a medicine is new on the market, and its manufacturer is the only producer of that medicine, only one form of the drug is available to the consumer. As time goes by, the patent protection expires, and other companies may choose to produce the generic form of the medicine. In most cases, the generic form of a medication sold in the United States is pharmacologically equivalent to the brand formulation. Most generic medicine sold in the United States is generally less costly than the brand-name medicine, and is of good quality.\n\n【2】In the state of New York, for example, where I practice pulmonary medicine, the pharmacist will dispense a generic formulation of the medication I prescribe for my patient unless I specifically write \"DAW\" (for \"dispense as written\") on the prescription. Similarly, your physician will, in most circumstances, approve that a prescription medicine be filled with a generic formulation rather than with a specific brand.\n\n【3】 It is easy to become confused by the fact that a medicine will have different names. I usually ask my patients to bring all their medicines with them to my office so that I can make sure they understand what medicines they should take and how to take them. I frequently come across a patient who thinks that he or she is taking \"a lot of medicine,\" only to discover that the \"two different inhalers\" are \"different\" only to the extent that two different manufacturers are producing the same medicine. If a patient is using inhaled Proventil® along with inhaled Ventolin®, they are really only using one type of drug: the trade form of albuterol sulfate.\n\n【4】Remember that the generic name of a medicine refers to the drug itself, whereas the trade name refers to a specific company's product and brand. Aspirin is a", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "p10 pus wəN :suoitesib9M smq1sA", "bbox": [549.0, 63.0, 570.0, 286.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "defined period of time, after which the patent is said to", "bbox": [69.0, 69.0, 427.0, 87.0]}, {"text": "expire. When a medicine is new on the market, and its", "bbox": [69.0, 89.0, 428.0, 108.0]}, {"text": "manufacturer is the only producer of that medicine, only", "bbox": [70.0, 109.0, 427.0, 128.0]}, {"text": "one form of the drug is available to the consumer. As", "bbox": [69.0, 129.0, 428.0, 147.0]}, {"text": "time goes by, the patent protection expires, and other", "bbox": [70.0, 149.0, 427.0, 167.0]}, {"text": "companies may choose to produce the generic form of", "bbox": [69.0, 169.0, 429.0, 187.0]}, {"text": "the medicine. In most cases, the generic form of a med-", "bbox": [70.0, 189.0, 425.0, 208.0]}, {"text": "ication sold in the United States is pharmacologically", "bbox": [69.0, 209.0, 427.0, 228.0]}, {"text": "equivalent to the brand formulation. Most generic med-", "bbox": [69.0, 228.0, 426.0, 248.0]}, {"text": "icine sold in the United States is generally less costly", "bbox": [69.0, 249.0, 427.0, 267.0]}, {"text": "than the brand-name medicine, and is of good quality.", "bbox": [70.0, 269.0, 427.0, 287.0]}, {"text": "In the state of New York, for example, where I practice", "bbox": [70.0, 289.0, 427.0, 308.0]}, {"text": "pulmonary medicine, the pharmacist will dispense a", "bbox": [69.0, 308.0, 427.0, 327.0]}, {"text": "generic formulation of the medication I prescribe for my", "bbox": [69.0, 329.0, 427.0, 347.0]}, {"text": "patient unless I specifically write \"DAW\" (for \"dispense", "bbox": [69.0, 349.0, 427.0, 367.0]}, {"text": "as written\") on the prescription. Similarly, your physi-", "bbox": [69.0, 369.0, 426.0, 388.0]}, {"text": "cian will, in most circumstances, approve that a pre-", "bbox": [69.0, 389.0, 426.0, 408.0]}, {"text": "scription medicine be filled with a generic formulation", "bbox": [69.0, 408.0, 427.0, 428.0]}, {"text": "rather than with a specific brand.", "bbox": [69.0, 429.0, 282.0, 447.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "It is easy to become confused by the fact that a medi-", "bbox": [69.0, 469.0, 425.0, 487.0]}, {"text": "cine will have different names. I usually ask my patients", "bbox": [69.0, 487.0, 427.0, 508.0]}, {"text": "to bring all their medicines with them to my office so", "bbox": [70.0, 509.0, 427.0, 527.0]}, {"text": "that I can make sure they understand what medicines", "bbox": [70.0, 529.0, 427.0, 547.0]}, {"text": "they should take and how to take them. I frequently", "bbox": [70.0, 549.0, 427.0, 568.0]}, {"text": "come across a patient who thinks that he or she is tak-", "bbox": [69.0, 568.0, 425.0, 588.0]}, {"text": "ing \"a lot of medicine,\" only to discover that the \"two", "bbox": [69.0, 588.0, 427.0, 608.0]}, {"text": "different inhalers\" are \"different\" only to the extent that", "bbox": [69.0, 607.0, 427.0, 629.0]}, {"text": "two different manufacturers are producing the same", "bbox": [70.0, 629.0, 427.0, 648.0]}, {"text": "medicine. If a patient is using inhaled Proventil® along", "bbox": [70.0, 649.0, 427.0, 668.0]}, {"text": "with inhaled Ventolin®, they are really only using one", "bbox": [69.0, 668.0, 427.0, 688.0]}, {"text": "type of drug: the trade form of albuterol sulfate.", "bbox": [70.0, 689.0, 426.0, 707.0]}, {"text": "Remember that the generic name of a medicine refers", "bbox": [70.0, 709.0, 427.0, 727.0]}, {"text": "to the drug itself, whereas the trade name refers to a", "bbox": [70.0, 729.0, 427.0, 748.0]}, {"text": "specific company's product and brand. Aspirin is a", "bbox": [69.0, 749.0, 427.0, 768.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 116}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#0#p10 pus wəN :suoitesib9M smq1sA无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:38:23"}
{"id": 1042087, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "73e4213c-fdc8-475d-aea5-f27c069bb04a", "title": null, "text": "【0】页码:160\n əlytsəti] ydileəH A :emq1sA\n\n【1】 culator,\" or \"BMI computation\" to navigate among the different sites, and learn how you compare!\n\n【2】## 77. Is Caffeine Good For People With Asthma?\n\n【3】\n Caffeine is a naturally occurring compound. The German analytical chemist Friedrich Ferdinand Runge (1795-1867) discovered caffeine in 1819, apparently at the urging of Gœthe, who had encouraged Runge to study and analyze coffee. We now know that caffeine is naturally present in foods such as coffee beans, tea leaves, cacao beans (used to make chocolate), kola nuts, guarana, and maté. Caffeine is also frequently added to beverage products, such as carbonated soft drinks and drinks marketed as \"energy drinks.\" It is also available in pill form, either alone (NoDoze®, Vivarin®), or as an additive, to aspirin for example, as in Anacin® and Excedrin®.\n\n【4】 Research studies of the effect of caffeine in humans confirm that caffeine is a bronchodilator. It improves pulmonary function, and although it is a weak bronchodilator, it clearly has beneficial effects on direct measurements of lung function, such as the vital capacity, the FEV 1 , and expiratory flows (discussed in Question 28). Studies of the human metabolism of caffeine reveal that ingested caffeine is metabolized by the body and transformed into three separate compounds. Caffeine metabolites are paraxanthine, theobromine, and theophylline. Theophylline is a well-known bronchodilator, used in pill form for decades in the treatment of several lung ailments, including asthma, chronic obstructive bronchitis, and emphysema. The effects of orally administered caffeine are maximal at", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "əlytsəti] ydileəH A :emq1sA", "bbox": [545.0, 84.0, 570.0, 270.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "culator,\" or \"BMI computation\" to navigate among the", "bbox": [69.0, 67.0, 426.0, 89.0]}, {"text": "different sites, and learn how you compare!", "bbox": [69.0, 88.0, 336.0, 107.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "77. Is caffeine good for people with", "bbox": [71.0, 133.0, 372.0, 158.0]}, {"text": "asthma?", "bbox": [70.0, 159.0, 147.0, 181.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Caffeine is a naturally occurring compound. The Ger-", "bbox": [69.0, 186.0, 425.0, 205.0]}, {"text": "man analytical chemist Friedrich Ferdinand Runge", "bbox": [70.0, 206.0, 427.0, 226.0]}, {"text": "(1795-1867) discovered caffeine in 1819, apparently at", "bbox": [69.0, 226.0, 428.0, 245.0]}, {"text": "the urging of Gœthe, who had encouraged Runge to", "bbox": [69.0, 246.0, 427.0, 265.0]}, {"text": "study and analyze coffee. We now know that caffeine", "bbox": [69.0, 267.0, 427.0, 285.0]}, {"text": "is naturally present in foods such as coffee beans, tea", "bbox": [69.0, 286.0, 427.0, 306.0]}, {"text": "leaves, cacao beans (used to make chocolate), kola", "bbox": [69.0, 306.0, 428.0, 326.0]}, {"text": "nuts, guarana, and maté. Caffeine is also frequently", "bbox": [70.0, 326.0, 427.0, 346.0]}, {"text": "added to beverage products, such as carbonated soft", "bbox": [70.0, 347.0, 428.0, 365.0]}, {"text": "drinks and drinks marketed as \"energy drinks.\" It is", "bbox": [69.0, 366.0, 427.0, 385.0]}, {"text": "also available in pill form, either alone (NoDoze®,", "bbox": [69.0, 386.0, 426.0, 406.0]}, {"text": "Vivarin®), or as an additive, to aspirin for example, as", "bbox": [70.0, 406.0, 427.0, 426.0]}, {"text": "in Anacin® and Excedrin®.", "bbox": [69.0, 426.0, 249.0, 446.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Research studies of the effect of caffeine in humans", "bbox": [70.0, 468.0, 427.0, 487.0]}, {"text": "confirm that caffeine is a bronchodilator. It improves", "bbox": [70.0, 488.0, 427.0, 507.0]}, {"text": "pulmonary function, and although it is a weak bron-", "bbox": [70.0, 509.0, 426.0, 527.0]}, {"text": "chodilator, it clearly has beneficial effects on direct", "bbox": [69.0, 528.0, 428.0, 547.0]}, {"text": "measurements of lung function, such as the vital capac-", "bbox": [70.0, 548.0, 426.0, 567.0]}, {"text": "ity, the FEV 1 , and expiratory flows (discussed in Ques-", "bbox": [69.0, 569.0, 425.0, 587.0]}, {"text": "tion 28). Studies of the human metabolism of caffeine", "bbox": [69.0, 588.0, 427.0, 607.0]}, {"text": "reveal that ingested caffeine is metabolized by the body", "bbox": [70.0, 609.0, 427.0, 627.0]}, {"text": "and transformed into three separate compounds. Caf-", "bbox": [70.0, 628.0, 426.0, 647.0]}, {"text": "feine metabolites are paraxanthine, theobromine, and", "bbox": [69.0, 648.0, 427.0, 668.0]}, {"text": "theophylline. Theophylline is a well-known bron-", "bbox": [70.0, 668.0, 426.0, 687.0]}, {"text": "chodilator, used in pill form for decades in the treat-", "bbox": [69.0, 688.0, 426.0, 707.0]}, {"text": "ment of several lung ailments, including asthma,", "bbox": [70.0, 709.0, 427.0, 727.0]}, {"text": "chronic obstructive bronchitis, and emphysema. The", "bbox": [69.0, 728.0, 427.0, 748.0]}, {"text": "effects of orally administered caffeine are maximal at", "bbox": [69.0, 748.0, 427.0, 768.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 160}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#0#0#əlytsəti] ydileəH A :emq1sA", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:09:35"}
{"id": 1042086, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "61b341ea-2a4b-4a5c-b55a-5a3492ae2f9e", "title": null, "text": "【0】页码:1\n T.C.\n\n【1】DOKUZ EYLÜL ÜNİVERSİTESİ EDEBİYAT FAKÜLTESİ DILBILIM\n\n【2】 HAYALET UZUV\n\n【3】 ONURHAN DEMIR 2011287008", "tags": {}, "lang": "None", "attr": {"raw_info": [{"raw_context": [{"text": "T.C.", "bbox": [377.0, 89.0, 416.0, 115.0]}, {"text": "DOKUZ EYLÜL ÜNİVERSİTESİ", "bbox": [274.0, 116.0, 519.0, 143.0]}, {"text": "EDEBİYAT FAKÜLTESİ", "bbox": [302.0, 145.0, 491.0, 171.0]}, {"text": "DILBILIM", "bbox": [353.0, 173.0, 440.0, 198.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "HAYALET UZUV", "bbox": [306.0, 366.0, 486.0, 397.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "ONURHAN DEMIR", "bbox": [321.0, 568.0, 472.0, 594.0]}, {"text": "2011287008", "bbox": [351.0, 596.0, 441.0, 622.0]}], "type": "Text", "position": 2}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/HAYALET UZUV (ONURHAN DEMİR) (Z-Library).pdf", "page_num": 1}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#3#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:20:53"}
{"id": 1042085, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "fbfec72c-b074-4093-bf7b-aabc1d8b2fee", "title": null, "text": "【0】页码:62\n \n\n【1】 A\n\n【2】 \n\n【3】 42\n\n【4】 y William W. Ha official\n\n【5】 profession\n\n【6】 17. III\n\n【7】 10. 10.\n\n【8】A\n\n【9】 . 25\n\n【10】 CLUSTER OF PCs at the Oak Ridge National Laboratory in Tennessee has been dubbed the Stone SouperComputer.  .\n\n【11】 Copyright 2001 Se\n\n【12】 ientific American, Inc.\n\n【13】 i", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "", "bbox": [746.0, 2.0, 764.0, 13.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "A", "bbox": [772.0, 31.0, 779.0, 41.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "", "bbox": [737.0, 29.0, 759.0, 38.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "42", "bbox": [360.0, 176.0, 384.0, 191.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "y William W. Ha", "bbox": [441.0, 255.0, 595.0, 286.0]}, {"text": "official", "bbox": [586.0, 300.0, 629.0, 313.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "profession", "bbox": [696.0, 190.0, 718.0, 256.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "17. III", "bbox": [733.0, 186.0, 769.0, 256.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "10. 10.", "bbox": [689.0, 418.0, 724.0, 431.0]}, {"text": "A", "bbox": [683.0, 448.0, 713.0, 459.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": ". 25", "bbox": [500.0, 509.0, 533.0, 531.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "CLUSTER OF PCs at the ", "bbox": [44.0, 909.0, 157.0, 927.0]}, {"text": "Oak Ridge National ", "bbox": [44.0, 924.0, 139.0, 942.0]}, {"text": "Laboratory in Tennessee", "bbox": [44.0, 939.0, 164.0, 956.0]}, {"text": "has been dubbed the", "bbox": [44.0, 953.0, 146.0, 970.0]}, {"text": "Stone SouperComputer.  .", "bbox": [44.0, 969.0, 165.0, 984.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Copyright 2001 Se", "bbox": [286.0, 990.0, 383.0, 1005.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "ientific American, Inc.", "bbox": [385.0, 989.0, 491.0, 1006.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "i", "bbox": [606.0, 1023.0, 614.0, 1031.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 62}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#1#13#图片封面内的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:39:11"}
{"id": 1042084, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "de719146-5294-4e86-a096-6c01acbd63e3", "title": null, "text": "【0】页码:216\n\n【1】## Maternal Cardiac Arrest Not Immediately Reversed By Bls And Acls\n\n【2】\n Emergency Cesarean Section in Cardiac Arrest Resuscitation team leaders should activate the protocol for an emergency cesarean delivery as soon as cardiac arrest is identified in a pregnant woman with an obviously gravid uterus. By the time the physician is ready to deliver the baby, standard ACLS should be underway and immediately reversible causes of cardiac arrest should be ruled out. When the gravid uterus is large enough to cause maternal hemodynamic changes due to aortocaval compression, emergency cesarean section should be considered, regardless of fetal viability.\n\n【3】## What Defines A Gravid Uterus With The Potential To Cause Aortocaval Compression?\n\n【4】\n A study found that maternal aortocaval compression can occur for singleton pregnancies at ≥ 20 weeks of gestational age. 156 However, the exact gestational age at which aortocaval compression occurs is not consistent, especially with multiplegestation pregnancies or intrauterine growth retardation, and gestational age and number of fetuses may not always be known in the emergency situation. Fundal height is often used to estimate gestational age. In a singleton gestation, by 20 weeks fundal height is approximately at the level of the umbilicus 157 ; however the fundus may reach the umbilicus between 15 and 19 weeks of gestation. 158 Fundal height may also be skewed by other factors such as abdominal distention 157 and increased body mass index; therefore fundal height may be a poor predictor of gestational age.\n\n【5】One review of emergency cesarean sections in maternal cardiac arrest before the third trimester concluded that if the fundus extends above the level of the umbilicus, aortocaval compression can occur, and emergency cesarean section should be performed regardless of gestational age. 158 Two cases of maternal cardiac arrest in early pregnancy of 13 to 15 weeks were reported in which the mother was resuscitated without an emergency cesarean section being performed and the pregnancy continued to successful delivery of a live infant at term. 159,160 Not every pregnant woman in cardiac arrest is a candidate for an emergency cesarean section; the decision depends on whether or not the gravid uterus is thought to interfere with maternal hemodynamics.\n\n【6】## Why Perform An Emergency Cesarean Section In Cardiac Arrest?\n\n【7】\n Several case reports of emergency cesarean section in maternal cardiac arrest indicate a return of spontaneous circulation or improvement in maternal hemodynamic status only after the uterus has been emptied. 94 – 96 , 143 , 149 , 161 – 166 In a case series of 38 cases of perimortem cesarean section, 12 of 20 women for whom maternal outcome was recorded had return of spontaneous circulation immediately after delivery. No cases of worsened maternal status after cesarean section were reported. 166 The critical point to remember is that both mother and infant may die if the provider cannot restore blood flow to the mother's heart. 94\n\n【8】## The Importance Of Timing With Emergency\n\n【9】\n## Cesarean Section\n\n【10】\n The 5-minute window that providers have to determine if cardiac arrest can be reversed by BLS and ACLS was first\n\n【11】 described in 1986 and has been perpetuated in specialty guidelines. 143,166 The rescue team is not required to wait 5 minutes before initiating emergency hysterotomy, and there are circumstances that support an earlier start. 157 For instance, in an obvious nonsurvivable injury, 166, 167–169 when the maternal prognosis is grave and resuscitative efforts appear futile, moving straight to an emergency cesarean section may be appropriate, especially if the fetus is viable.\n\n【12】Many reports document long intervals between an urgent decision for hysterotomy and actual delivery of the infant, far exceeding the obstetric guideline of 30 minutes for patients not in arrest. 170 , 171 Very few cases of perimortem cesarean section fall within the recommended 5-minute period. 94 , 166 Survival of the mother has been reported with perimortem cesarean section performed up to 15 minutes after the onset of maternal cardiac arrest. 94 , 172 – 174 If emergency cesarean section cannot be performed by the 5-minute mark, it may be advisable to prepare to evacuate the uterus while the resuscitation continues. (Class IIb, LOE C).\n\n【13】At > 24 to 25 weeks of gestation, the best survival rate for the\n\n【14】 infant occurs when the infant is delivered no more than 5 minutes after the mother's heart stops beating. 175–178 Typically this requires that the provider begin the hysterotomy about 4 minutes after cardiac arrest. At gestational ages ≥ 30 weeks, infant survival has been seen even when delivery occurred after 5 minutes from onset of maternal cardiac arrest. 166 In a recent retrospective cohort series, neonatal survival was documented when delivery occurred within 30 minutes after onset of maternal cardiac arrest. 94 When there is an obvious gravid uterus, the emergency\n\n【15】 cesarean section team should be activated at the onset of maternal cardiac arrest (Class I, LOE B). Emergency cesarean section may be considered at 4 minutes after onset of maternal cardiac arrest if there is no return of spontaneous circulation (Class IIb, LOE C).\n\n【16】## Institutional Preparation For Maternal Cardiac Arrest\n\n【17】\n Experts and organizations have emphasized the importance of preparation. 143. 179 Providers at medical centers must review whether performance of an emergency hysterotomy is feasible, and if so, they must identify the best means of accomplishing this procedure rapidly. Team planning should be done in collaboration with the obstetric, neonatal, emergency, anesthesiology, intensive care, and cardiac arrest services (Class I, LOE C).\n\n【18】## Post–Cardiac Arrest Care\n\n【19】\n One case report showed that post–cardiac arrest hypothermia can be used safely and effectively in early pregnancy without emergency cesarean section (with fetal heart monitoring), with favorable maternal and fetal outcome after a term delivery. 159 No cases in the literature have reported the use of therapeutic hypothermia with perimortem cesarean section. Therapeutic hypothermia may be considered on an individual basis after cardiac arrest in a comatose pregnant patient based on current recommendations for the nonpregnant patient (Class IIb, LOE C). During therapeutic hypothermia of the pregnant patient, it is recommended that the fetus be continuously monitored for\n\n【20】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Maternal Cardiac Arrest Not Immediately", "bbox": [60.0, 84.0, 323.0, 100.0]}, {"text": "Reversed by BLS and ACLS", "bbox": [60.0, 100.0, 238.0, 114.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Emergency Cesarean Section in Cardiac Arrest", "bbox": [60.0, 121.0, 317.0, 134.0]}, {"text": "Resuscitation team leaders should activate the protocol for an", "bbox": [60.0, 136.0, 376.0, 149.0]}, {"text": "emergency cesarean delivery as soon as cardiac arrest is identi-", "bbox": [60.0, 151.0, 375.0, 165.0]}, {"text": "fied in a pregnant woman with an obviously gravid uterus. By", "bbox": [60.0, 167.0, 375.0, 180.0]}, {"text": "the time the physician is ready to deliver the baby, standard", "bbox": [60.0, 181.0, 376.0, 196.0]}, {"text": "ACLS should be underway and immediately reversible causes of", "bbox": [60.0, 198.0, 376.0, 211.0]}, {"text": "cardiac arrest should be ruled out. When the gravid uterus is", "bbox": [60.0, 213.0, 376.0, 227.0]}, {"text": "large enough to cause maternal hemodynamic changes due to", "bbox": [60.0, 229.0, 376.0, 242.0]}, {"text": "aortocaval compression, emergency cesarean section should be", "bbox": [60.0, 244.0, 376.0, 257.0]}, {"text": "considered, regardless of fetal viability.", "bbox": [60.0, 260.0, 257.0, 273.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "What Defines a Gravid Uterus With the Potential to", "bbox": [60.0, 283.0, 342.0, 298.0]}, {"text": "Cause Aortocaval Compression?", "bbox": [61.0, 301.0, 236.0, 313.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "A study found that maternal aortocaval compression can occur", "bbox": [60.0, 314.0, 375.0, 326.0]}, {"text": "for singleton pregnancies at ≥ 20 weeks of gestational age. 156", "bbox": [60.0, 329.0, 375.0, 342.0]}, {"text": "However, the exact gestational age at which aortocaval com-", "bbox": [60.0, 344.0, 375.0, 357.0]}, {"text": "pression occurs is not consistent, especially with multiple-", "bbox": [60.0, 359.0, 375.0, 374.0]}, {"text": "gestation pregnancies or intrauterine growth retardation, and", "bbox": [60.0, 375.0, 376.0, 388.0]}, {"text": "gestational age and number of fetuses may not always be known", "bbox": [60.0, 390.0, 376.0, 404.0]}, {"text": "in the emergency situation. Fundal height is often used to", "bbox": [60.0, 406.0, 377.0, 420.0]}, {"text": "estimate gestational age. In a singleton gestation, by 20 weeks", "bbox": [60.0, 421.0, 376.0, 435.0]}, {"text": "fundal height is approximately at the level of the umbilicus 157 ;", "bbox": [60.0, 437.0, 375.0, 450.0]}, {"text": "however the fundus may reach the umbilicus between 15 and 19", "bbox": [60.0, 452.0, 376.0, 466.0]}, {"text": "weeks of gestation. 158 Fundal height may also be skewed by", "bbox": [60.0, 468.0, 375.0, 481.0]}, {"text": "other factors such as abdominal distention 157 and increased body", "bbox": [60.0, 483.0, 375.0, 496.0]}, {"text": "mass index; therefore fundal height may be a poor predictor of", "bbox": [60.0, 498.0, 376.0, 513.0]}, {"text": "gestational age.", "bbox": [60.0, 515.0, 139.0, 528.0]}, {"text": "One review of emergency cesarean sections in maternal", "bbox": [72.0, 529.0, 376.0, 544.0]}, {"text": "cardiac arrest before the third trimester concluded that if the", "bbox": [60.0, 546.0, 375.0, 559.0]}, {"text": "fundus extends above the level of the umbilicus, aortocaval", "bbox": [60.0, 561.0, 376.0, 575.0]}, {"text": "compression can occur, and emergency cesarean section should", "bbox": [60.0, 576.0, 376.0, 590.0]}, {"text": "be performed regardless of gestational age. 158", "bbox": [60.0, 592.0, 289.0, 606.0]}, {"text": "Two cases of maternal cardiac arrest in early pregnancy of 13", "bbox": [73.0, 608.0, 377.0, 622.0]}, {"text": "to 15 weeks were reported in which the mother was resuscitated", "bbox": [60.0, 622.0, 377.0, 636.0]}, {"text": "without an emergency cesarean section being performed and the", "bbox": [60.0, 638.0, 375.0, 652.0]}, {"text": "pregnancy continued to successful delivery of a live infant at", "bbox": [60.0, 654.0, 376.0, 667.0]}, {"text": "term. 159,160 Not every pregnant woman in cardiac arrest is a", "bbox": [60.0, 668.0, 377.0, 684.0]}, {"text": "candidate for an emergency cesarean section; the decision", "bbox": [60.0, 685.0, 376.0, 698.0]}, {"text": "depends on whether or not the gravid uterus is thought to", "bbox": [60.0, 700.0, 377.0, 715.0]}, {"text": "interfere with maternal hemodynamics.", "bbox": [60.0, 716.0, 255.0, 729.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Why Perform an Emergency Cesarean Section in", "bbox": [60.0, 741.0, 328.0, 756.0]}, {"text": "Cardiac Arrest?", "bbox": [61.0, 756.0, 148.0, 769.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Several case reports of emergency cesarean section in maternal", "bbox": [60.0, 769.0, 376.0, 783.0]}, {"text": "cardiac arrest indicate a return of spontaneous circulation or", "bbox": [60.0, 784.0, 375.0, 798.0]}, {"text": "improvement in maternal hemodynamic status only after the", "bbox": [60.0, 800.0, 376.0, 814.0]}, {"text": "uterus has been emptied. 94 – 96 , 143 , 149 , 161 – 166 In a case series of 38", "bbox": [60.0, 815.0, 376.0, 829.0]}, {"text": "cases of perimortem cesarean section, 12 of 20 women for", "bbox": [60.0, 831.0, 375.0, 845.0]}, {"text": "whom maternal outcome was recorded had return of spontane-", "bbox": [60.0, 847.0, 375.0, 861.0]}, {"text": "ous circulation immediately after delivery. No cases of worsened", "bbox": [60.0, 863.0, 376.0, 876.0]}, {"text": "maternal status after cesarean section were reported. 166 The", "bbox": [60.0, 877.0, 376.0, 891.0]}, {"text": "critical point to remember is that both mother and infant may die", "bbox": [60.0, 893.0, 376.0, 907.0]}, {"text": "if the provider cannot restore blood flow to the mother's heart. 94", "bbox": [60.0, 909.0, 375.0, 923.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "The Importance of Timing With Emergency", "bbox": [60.0, 934.0, 297.0, 949.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Cesarean Section", "bbox": [61.0, 950.0, 156.0, 962.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "The 5-minute window that providers have to determine if", "bbox": [60.0, 962.0, 377.0, 976.0]}, {"text": "cardiac arrest can be reversed by BLS and ACLS was first", "bbox": [60.0, 977.0, 377.0, 991.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "described in 1986 and has been perpetuated in specialty guide-", "bbox": [403.0, 84.0, 718.0, 99.0]}, {"text": "lines. 143,166 The rescue team is not required to wait 5 minutes", "bbox": [403.0, 99.0, 720.0, 115.0]}, {"text": "before initiating emergency hysterotomy, and there are cir-", "bbox": [403.0, 115.0, 719.0, 130.0]}, {"text": "cumstances that support an earlier start. 157 For instance, in an", "bbox": [403.0, 131.0, 720.0, 145.0]}, {"text": "obvious nonsurvivable injury, 166, 167–169 when the maternal", "bbox": [403.0, 146.0, 720.0, 160.0]}, {"text": "prognosis is grave and resuscitative efforts appear futile,", "bbox": [404.0, 162.0, 720.0, 176.0]}, {"text": "moving straight to an emergency cesarean section may be", "bbox": [403.0, 178.0, 720.0, 191.0]}, {"text": "appropriate, especially if the fetus is viable.", "bbox": [403.0, 193.0, 633.0, 207.0]}, {"text": "Many reports document long intervals between an urgent", "bbox": [416.0, 208.0, 721.0, 222.0]}, {"text": "decision for hysterotomy and actual delivery of the infant, far", "bbox": [403.0, 224.0, 720.0, 238.0]}, {"text": "exceeding the obstetric guideline of 30 minutes for patients not", "bbox": [403.0, 240.0, 720.0, 253.0]}, {"text": "in arrest. 170 , 171 Very few cases of perimortem cesarean section", "bbox": [403.0, 253.0, 720.0, 269.0]}, {"text": "fall within the recommended 5-minute period. 94 , 166 Survival of", "bbox": [404.0, 270.0, 720.0, 284.0]}, {"text": "the mother has been reported with perimortem cesarean section", "bbox": [403.0, 286.0, 721.0, 300.0]}, {"text": "performed up to 15 minutes after the onset of maternal cardiac", "bbox": [404.0, 301.0, 720.0, 315.0]}, {"text": "arrest. 94 , 172 – 174 If emergency cesarean section cannot be per-", "bbox": [403.0, 316.0, 719.0, 331.0]}, {"text": "formed by the 5-minute mark, it may be advisable to prepare to", "bbox": [403.0, 332.0, 721.0, 346.0]}, {"text": "evacuate the uterus while the resuscitation continues. (Class IIb,", "bbox": [403.0, 348.0, 720.0, 361.0]}, {"text": "LOE C).", "bbox": [403.0, 362.0, 449.0, 377.0]}, {"text": "At > 24 to 25 weeks of gestation, the best survival rate for the", "bbox": [416.0, 379.0, 720.0, 392.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "infant occurs when the infant is delivered no more than 5", "bbox": [403.0, 394.0, 720.0, 408.0]}, {"text": "minutes after the mother's heart stops beating. 175–178 Typically", "bbox": [403.0, 410.0, 720.0, 423.0]}, {"text": "this requires that the provider begin the hysterotomy about 4", "bbox": [403.0, 425.0, 720.0, 439.0]}, {"text": "minutes after cardiac arrest. At gestational ages ≥ 30 weeks,", "bbox": [404.0, 441.0, 720.0, 455.0]}, {"text": "infant survival has been seen even when delivery occurred after", "bbox": [403.0, 455.0, 720.0, 469.0]}, {"text": "5 minutes from onset of maternal cardiac arrest. 166 In a recent", "bbox": [404.0, 471.0, 720.0, 485.0]}, {"text": "retrospective cohort series, neonatal survival was documented", "bbox": [403.0, 487.0, 720.0, 500.0]}, {"text": "when delivery occurred within 30 minutes after onset of mater-", "bbox": [404.0, 502.0, 719.0, 516.0]}, {"text": "nal cardiac arrest. 94", "bbox": [404.0, 518.0, 502.0, 531.0]}, {"text": "When there is an obvious gravid uterus, the emergency", "bbox": [417.0, 533.0, 720.0, 548.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "cesarean section team should be activated at the onset of", "bbox": [403.0, 548.0, 720.0, 562.0]}, {"text": "maternal cardiac arrest (Class I, LOE B). Emergency cesarean", "bbox": [403.0, 564.0, 720.0, 578.0]}, {"text": "section may be considered at 4 minutes after onset of maternal", "bbox": [404.0, 580.0, 720.0, 594.0]}, {"text": "cardiac arrest if there is no return of spontaneous circulation", "bbox": [403.0, 595.0, 720.0, 609.0]}, {"text": "(Class IIb, LOE C).", "bbox": [403.0, 610.0, 505.0, 624.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Institutional Preparation for Maternal", "bbox": [404.0, 640.0, 642.0, 655.0]}, {"text": "Cardiac Arrest", "bbox": [403.0, 655.0, 499.0, 669.0]}], "type": "Section-header", "position": 15}, {"raw_context": [{"text": "Experts and organizations have emphasized the importance", "bbox": [403.0, 670.0, 720.0, 684.0]}, {"text": "of preparation. 143. 179 Providers at medical centers must", "bbox": [403.0, 685.0, 721.0, 699.0]}, {"text": "review whether performance of an emergency hysterotomy", "bbox": [403.0, 701.0, 720.0, 716.0]}, {"text": "is feasible, and if so, they must identify the best means of", "bbox": [403.0, 716.0, 720.0, 730.0]}, {"text": "accomplishing this procedure rapidly. Team planning", "bbox": [404.0, 732.0, 720.0, 746.0]}, {"text": "should be done in collaboration with the obstetric, neona-", "bbox": [404.0, 748.0, 719.0, 762.0]}, {"text": "tal, emergency, anesthesiology, intensive care, and cardiac", "bbox": [403.0, 763.0, 720.0, 777.0]}, {"text": "arrest services (Class I, LOE C).", "bbox": [404.0, 779.0, 584.0, 792.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Post–Cardiac Arrest Care", "bbox": [404.0, 807.0, 566.0, 821.0]}], "type": "Section-header", "position": 17}, {"raw_context": [{"text": "One case report showed that post–cardiac arrest hypothermia", "bbox": [403.0, 823.0, 720.0, 836.0]}, {"text": "can be used safely and effectively in early pregnancy without", "bbox": [403.0, 838.0, 720.0, 852.0]}, {"text": "emergency cesarean section (with fetal heart monitoring), with", "bbox": [403.0, 854.0, 720.0, 868.0]}, {"text": "favorable maternal and fetal outcome after a term delivery. 159 No", "bbox": [404.0, 870.0, 720.0, 883.0]}, {"text": "cases in the literature have reported the use of therapeutic", "bbox": [403.0, 884.0, 720.0, 899.0]}, {"text": "hypothermia with perimortem cesarean section. Therapeutic", "bbox": [403.0, 901.0, 720.0, 914.0]}, {"text": "hypothermia may be considered on an individual basis after", "bbox": [403.0, 916.0, 720.0, 930.0]}, {"text": "cardiac arrest in a comatose pregnant patient based on current", "bbox": [403.0, 931.0, 720.0, 945.0]}, {"text": "recommendations for the nonpregnant patient (Class IIb, LOE", "bbox": [403.0, 946.0, 720.0, 961.0]}, {"text": "C). During therapeutic hypothermia of the pregnant patient, it is", "bbox": [403.0, 962.0, 720.0, 976.0]}, {"text": "recommended that the fetus be continuously monitored for", "bbox": [403.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 19}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 216}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#5#5Two cases of maternal cardiac 这里开始应与前面换行\n多余换行#8#9#为同段\n多余换行#10#11#为同段内容\n多余换行#13#14#为同段内容", "type3": "无关文本#0#19#全文存在多处无关数字", "type4": "栏目混乱#14#15#14的When there is an obvious gravid uterus, the emergency应在15开头", "type5": null, "type6": "信息有用性#20#20#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:01:02"}
{"id": 1042083, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "71225b3c-194a-42f1-89a0-42201cdbfa54", "title": null, "text": "【0】页码:69\n During Bell's palsy, the eyebrow may droop, and the upper eyelid may not close completely. Similarly, the lower eyelid may sag. This exposes your eye to the environment making it more susceptible to damage, discomfort and visual impairment. The main aim of eye surgery is to reduce discomfort. The surgery is also very effective in preserving vision.\n\n【1】 As with any surgical procedure, there are certain risks associated with eye surgery. Remember, there are various other treatments, surgeries and therapies that are helpful for people suffering from Bell's palsy. You can discuss possible options with your doctor before making a final decision.\n\n【2】 I've come across many people who live a very happy life even though they decided against having any surgical corrections. It really depends on what makes you happy as a person. If you can live with the fact that you have a droopy eye, then more power to you. However, if you don't want to deal with a droopy eye for life, you may choose to go under the knife.\n\n【3】## Upper Eyelid Surgery\n\n【4】\n This surgery helps the upper lid cover more of the cornea and patients can close over 75% of their eye. Usually, it involves the surgical implantation of gold eyelid weights. The weights help the eyelid close with the help of gravity.\n\n【5】 Gold eyelid weights can be implanted in an outpatient procedure. You can go back home the very same day. Once gold weights are attached to the eyelid, you can close the eyelid immediately. Minor bruising and swelling of the area is quite common, but it goes away in a few weeks.\n\n【6】 There can be a slight bump on the eyelid where the weights are implanted. A qualified surgeon may place the gold implants in a place where they remain hidden. The reason gold weights are used is that the metal does not irritate a patient's skin. Gold weights are also safe to be used during an MRI.\n\n【7】 The risk of upper eyelid surgery is that it can be difficult to control the position of the upper lid. If the eyelid still remains high, a repeat surgery may be required. Sometimes the weight may be too heavy, which will be seen as a bulky mass through the upper eyelid. The use of heavy weights can also blur your vision.\n\n【8】## Lower Eyelid Surgery\n\n【9】\n Surgical correction of the lower eyelid is done to reduce watering and allow the", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "During Bell's palsy, the eyebrow may droop, and the upper eyelid may not close", "bbox": [93.0, 96.0, 723.0, 116.0]}, {"text": "completely. Similarly, the lower eyelid may sag. This exposes your eye to the", "bbox": [93.0, 118.0, 722.0, 138.0]}, {"text": "environment making it more susceptible to damage, discomfort and visual", "bbox": [93.0, 141.0, 724.0, 161.0]}, {"text": "impairment. The main aim of eye surgery is to reduce discomfort. The surgery is", "bbox": [93.0, 163.0, 724.0, 183.0]}, {"text": "also very effective in preserving vision.", "bbox": [93.0, 186.0, 402.0, 205.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "As with any surgical procedure, there are certain risks associated with eye", "bbox": [93.0, 220.0, 723.0, 239.0]}, {"text": "surgery. Remember, there are various other treatments, surgeries and therapies", "bbox": [93.0, 242.0, 724.0, 261.0]}, {"text": "that are helpful for people suffering from Bell's palsy. You can discuss possible", "bbox": [93.0, 264.0, 722.0, 283.0]}, {"text": "options with your doctor before making a final decision.", "bbox": [93.0, 286.0, 531.0, 305.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "I've come across many people who live a very happy life even though they", "bbox": [93.0, 322.0, 722.0, 341.0]}, {"text": "decided against having any surgical corrections. It really depends on what makes", "bbox": [93.0, 344.0, 722.0, 363.0]}, {"text": "you happy as a person. If you can live with the fact that you have a droopy eye,", "bbox": [93.0, 366.0, 723.0, 385.0]}, {"text": "then more power to you. However, if you don't want to deal with a droopy eye", "bbox": [93.0, 388.0, 723.0, 407.0]}, {"text": "for life, you may choose to go under the knife.", "bbox": [93.0, 410.0, 455.0, 429.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Upper Eyelid Surgery", "bbox": [93.0, 450.0, 277.0, 471.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "This surgery helps the upper lid cover more of the cornea and patients can close", "bbox": [93.0, 488.0, 722.0, 508.0]}, {"text": "over 75% of their eye. Usually, it involves the surgical implantation of gold", "bbox": [93.0, 511.0, 724.0, 530.0]}, {"text": "eyelid weights. The weights help the eyelid close with the help of gravity.", "bbox": [93.0, 533.0, 666.0, 552.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Gold eyelid weights can be implanted in an outpatient procedure. You can go", "bbox": [93.0, 567.0, 722.0, 586.0]}, {"text": "back home the very same day. Once gold weights are attached to the eyelid, you", "bbox": [93.0, 590.0, 724.0, 608.0]}, {"text": "can close the eyelid immediately. Minor bruising and swelling of the area is", "bbox": [93.0, 612.0, 724.0, 631.0]}, {"text": "quite common, but it goes away in a few weeks.", "bbox": [93.0, 634.0, 467.0, 653.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "There can be a slight bump on the eyelid where the weights are implanted. A", "bbox": [93.0, 667.0, 724.0, 687.0]}, {"text": "qualified surgeon may place the gold implants in a place where they remain", "bbox": [93.0, 690.0, 724.0, 710.0]}, {"text": "hidden. The reason gold weights are used is that the metal does not irritate a", "bbox": [93.0, 712.0, 725.0, 732.0]}, {"text": "patient's skin. Gold weights are also safe to be used during an MRI.", "bbox": [93.0, 735.0, 620.0, 754.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The risk of upper eyelid surgery is that it can be difficult to control the position", "bbox": [93.0, 770.0, 724.0, 789.0]}, {"text": "of the upper lid. If the eyelid still remains high, a repeat surgery may be", "bbox": [93.0, 792.0, 722.0, 811.0]}, {"text": "required. Sometimes the weight may be too heavy, which will be seen as a bulky", "bbox": [93.0, 814.0, 722.0, 833.0]}, {"text": "mass through the upper eyelid. The use of heavy weights can also blur your", "bbox": [93.0, 836.0, 722.0, 855.0]}, {"text": "vision.", "bbox": [93.0, 858.0, 150.0, 878.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Lower Eyelid Surgery", "bbox": [93.0, 899.0, 278.0, 919.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Surgical correction of the lower eyelid is done to reduce watering and allow the", "bbox": [93.0, 936.0, 722.0, 956.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 69}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 00:02:14"}
{"id": 1042082, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "e729d981-c458-4fea-bc30-c33d4ce6db13", "title": null, "text": "【0】页码:175\n to include in that particular year's influenza vaccine. A different influenza vaccine is thus developed and produced each year. The influenza vaccine available each fall in the United States is directed against three (3) specific influenza strains that health authorities believe will cause most of the serious illness for that year's fall and winter influenza season. The vaccine you receive in the fall of 2005, for example, can be expected to protect you from the common disease-causing strains of influenza circulating in the United States during the winter of 2005 and 2006.\n\n【1】 Two different types of influenza vaccines are available for prevention of influenza in the United States: the inactivated influenza vaccine, and the live, attenuated influenza vaccine (LAIV) (Table 31). The first is an\n\n【2】## Table 31\n\n【3】 Comparison of Available Influenza Vaccines\n\n【4】## Inactivated Influenza Vaccine\n\n【5】\n## Live, Attenuated Influenza Vaccine\n\n【6】\n • The vaccine is a \"shot,\" given by\n\n【7】 injection into muscle.\n\n【8】 • The vaccine has been used for many\n\n【9】 years.\n\n【10】 • The vaccine contains an inactivated\n\n【11】 (\"killed\") form of influenza virus.\n\n【12】 • The vaccine is updated every year.\n\n【13】 .\n\n【14】 The vaccine is best taken in October\n\n【15】 or November each fall. Vaccination is\n required yearly.\n\n【16】 .\n\n【17】 Protection begins about 14 days after\n\n【18】 vaccination.\n\n【19】 .\n\n【20】 Protection lasts about 1 year.\n\n【21】 Side effects, if any, are usually mild:\n\n【22】 .\n\n【23】 soreness at the injection site is the\n most common. Fever and aches can occur. Call your doctor if you think you are experiencing a more serious side effect.\n\n【24】 • The vaccine is sprayed into the nos-\n trils.\n\n【25】 • The vaccine was licensed in the U.S.\n\n【26】 in 2003 for use in healthy children and\n\n【27】 adults from 5 to 49 years of age.\n\n【28】 • The vaccine contains a live, attenuated\n\n【29】 (\"weakened\") form of influenza virus.\n • The vaccine is not presently recommended for pregnant women, and for people with underlying medical diseases. It is not presently recommended for persons with asthma.\n • The vaccine is updated each year.\n\n【30】October or November is the best time for vaccination. It should be repeated yearly.\n\n【31】 • Side effects, if any, are usually mild\n\n【32】 and may include: runny nose, conges-\n\n【33】 tion, cough, mild fever, aches, fatigue,\n\n【34】 throat soreness, and in children,\n\n【35】 abdominal pain, vomiting or diarrhea.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "to include in that particular year's influenza vaccine. A", "bbox": [150.0, 69.0, 507.0, 87.0]}, {"text": "different influenza vaccine is thus developed and pro-", "bbox": [149.0, 88.0, 505.0, 107.0]}, {"text": "duced each year. The influenza vaccine available each", "bbox": [149.0, 108.0, 507.0, 129.0]}, {"text": "fall in the United States is directed against three (3)", "bbox": [149.0, 129.0, 507.0, 148.0]}, {"text": "specific influenza strains that health authorities believe", "bbox": [149.0, 149.0, 506.0, 167.0]}, {"text": "will cause most of the serious illness for that year's fall", "bbox": [149.0, 169.0, 507.0, 187.0]}, {"text": "and winter influenza season. The vaccine you receive in", "bbox": [150.0, 189.0, 506.0, 208.0]}, {"text": "the fall of 2005, for example, can be expected to protect", "bbox": [149.0, 209.0, 507.0, 228.0]}, {"text": "you from the common disease-causing strains of", "bbox": [150.0, 230.0, 509.0, 247.0]}, {"text": "influenza circulating in the United States during the", "bbox": [149.0, 249.0, 506.0, 267.0]}, {"text": "winter of 2005 and 2006.", "bbox": [150.0, 268.0, 313.0, 287.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Two different types of influenza vaccines are available", "bbox": [150.0, 307.0, 506.0, 324.0]}, {"text": "for prevention of influenza in the United States: the", "bbox": [149.0, 326.0, 506.0, 344.0]}, {"text": "inactivated influenza vaccine, and the live, attenuated", "bbox": [149.0, 346.0, 507.0, 365.0]}, {"text": "influenza vaccine (LAIV) (Table 31). The first is an", "bbox": [149.0, 365.0, 507.0, 385.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Table 31", "bbox": [70.0, 405.0, 114.0, 420.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Comparison of Available Influenza Vaccines", "bbox": [120.0, 403.0, 325.0, 421.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "Inactivated Influenza Vaccine", "bbox": [73.0, 432.0, 215.0, 447.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Live, Attenuated Influenza Vaccine", "bbox": [299.0, 432.0, 465.0, 447.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "• The vaccine is a \"shot,\" given by", "bbox": [73.0, 466.0, 244.0, 481.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "injection into muscle.", "bbox": [86.0, 481.0, 192.0, 494.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "• The vaccine has been used for many", "bbox": [74.0, 497.0, 263.0, 512.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "years.", "bbox": [86.0, 512.0, 116.0, 524.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "• The vaccine contains an inactivated", "bbox": [74.0, 528.0, 261.0, 543.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "(\"killed\") form of influenza virus.", "bbox": [86.0, 542.0, 248.0, 555.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "• The vaccine is updated every year.", "bbox": [74.0, 558.0, 252.0, 573.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": ".", "bbox": [74.0, 578.0, 84.0, 587.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "The vaccine is best taken in October", "bbox": [84.0, 576.0, 265.0, 589.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "or November each fall. Vaccination is", "bbox": [86.0, 590.0, 270.0, 604.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "required yearly.", "bbox": [86.0, 604.0, 163.0, 616.0]}], "type": "Footnote", "position": 17}, {"raw_context": [{"text": ".", "bbox": [74.0, 622.0, 82.0, 632.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Protection begins about 14 days after", "bbox": [84.0, 620.0, 267.0, 634.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "vaccination.", "bbox": [86.0, 635.0, 145.0, 647.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": ".", "bbox": [74.0, 652.0, 85.0, 662.0]}], "type": "Text", "position": 21}, {"raw_context": [{"text": "Protection lasts about 1 year.", "bbox": [84.0, 650.0, 227.0, 665.0]}], "type": "Text", "position": 22}, {"raw_context": [{"text": "Side effects, if any, are usually mild:", "bbox": [84.0, 668.0, 261.0, 682.0]}], "type": "Text", "position": 23}, {"raw_context": [{"text": ".", "bbox": [75.0, 670.0, 82.0, 680.0]}], "type": "Text", "position": 24}, {"raw_context": [{"text": "soreness at the injection site is the", "bbox": [86.0, 682.0, 253.0, 696.0]}], "type": "Text", "position": 25}, {"raw_context": [{"text": "most common. Fever and aches can", "bbox": [86.0, 695.0, 261.0, 709.0]}, {"text": "occur. Call your doctor if you think", "bbox": [85.0, 709.0, 260.0, 722.0]}, {"text": "you are experiencing a more serious", "bbox": [86.0, 722.0, 260.0, 735.0]}, {"text": "side effect.", "bbox": [86.0, 735.0, 140.0, 748.0]}], "type": "Footnote", "position": 26}, {"raw_context": [{"text": "• The vaccine is sprayed into the nos-", "bbox": [299.0, 467.0, 485.0, 482.0]}], "type": "Text", "position": 27}, {"raw_context": [{"text": "trils.", "bbox": [311.0, 481.0, 336.0, 494.0]}], "type": "List-item", "position": 28}, {"raw_context": [{"text": "• The vaccine was licensed in the U.S.", "bbox": [300.0, 497.0, 490.0, 512.0]}], "type": "Text", "position": 29}, {"raw_context": [{"text": "in 2003 for use in healthy children and", "bbox": [311.0, 512.0, 502.0, 525.0]}], "type": "Text", "position": 30}, {"raw_context": [{"text": "adults from 5 to 49 years of age.", "bbox": [311.0, 526.0, 467.0, 538.0]}], "type": "Text", "position": 31}, {"raw_context": [{"text": "• The vaccine contains a live, attenuated", "bbox": [300.0, 542.0, 501.0, 555.0]}], "type": "Text", "position": 32}, {"raw_context": [{"text": "(\"weakened\") form of influenza virus.", "bbox": [311.0, 556.0, 493.0, 570.0]}], "type": "Text", "position": 33}, {"raw_context": [{"text": "• The vaccine is not presently recom-", "bbox": [300.0, 573.0, 485.0, 586.0]}, {"text": "mended for pregnant women, and for", "bbox": [311.0, 587.0, 495.0, 600.0]}, {"text": "people with underlying medical dis-", "bbox": [311.0, 601.0, 487.0, 612.0]}, {"text": "eases. It is not presently recommended", "bbox": [311.0, 613.0, 501.0, 626.0]}, {"text": "for persons with asthma.", "bbox": [311.0, 627.0, 433.0, 639.0]}], "type": "Footnote", "position": 34}, {"raw_context": [{"text": "• The vaccine is updated each year.", "bbox": [300.0, 643.0, 474.0, 658.0]}, {"text": "October or November is the best time", "bbox": [309.0, 660.0, 497.0, 673.0]}, {"text": "for vaccination. It should be repeated", "bbox": [311.0, 674.0, 494.0, 687.0]}, {"text": "yearly.", "bbox": [311.0, 689.0, 346.0, 702.0]}], "type": "Footnote", "position": 35}, {"raw_context": [{"text": "• Side effects, if any, are usually mild", "bbox": [300.0, 704.0, 484.0, 719.0]}], "type": "Text", "position": 36}, {"raw_context": [{"text": "and may include: runny nose, conges-", "bbox": [311.0, 719.0, 494.0, 732.0]}], "type": "Text", "position": 37}, {"raw_context": [{"text": "tion, cough, mild fever, aches, fatigue,", "bbox": [311.0, 732.0, 497.0, 745.0]}], "type": "Text", "position": 38}, {"raw_context": [{"text": "throat soreness, and in children,", "bbox": [311.0, 745.0, 468.0, 758.0]}], "type": "Text", "position": 39}, {"raw_context": [{"text": "abdominal pain, vomiting or diarrhea.", "bbox": [311.0, 758.0, 496.0, 771.0]}], "type": "Text", "position": 40}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 175}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#7#7# injection into muscle.联接上面的6段\n多余换行#9#9#  years.联接上面的8段\n多余换行#11#11#  (“killed”) form of influenza virus.联接上面的10段\n多余换行#15#15#  (“killed”) form of influenza virus.联接上面的14段.required yearly.联接Vaccination is\n多余换行#18#18#  vaccination.联接上面的17段\n多余换行#23#23#  soreness at the injection...联接上面的21段，most common. Fever and aches can occur. ..联接 soreness at the injection site is the\n多余换行#24#24#  trils.联接上面的...sprayed into the nos-\n多余换行#26#27# in 2003 for use in healthy... adults from 5 to 49...联接上面的25段\n多余换行#29#29#  (“weakened”) form of influenza virus.联接上面的28段\n多余换行#32#35# • Side effects, if any,... vomiting or diarrhea.是一段内容", "type3": null, "type4": null, "type5": null, "type6": "准确性#5#5#Live, Attenuated Influenza Vaccine应该是下面24段前的标题"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 00:19:13"}
{"id": 1042081, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "ef4543d1-c85e-4035-8583-fe0d1b2bc36a", "title": null, "text": "【0】页码:251\n American College of Emergency Physicians 162 is available online (www.aap.org/advocacy/EIFTemp09.pdf).\n\n【1】## Advanced Directives\n\n【2】\n If a decision to limit or withhold resuscitative efforts is made, the physician must write an order clearly detailing the limits of any attempted resuscitation. A separate order must be written for the out-of-hospital setting. Regulations regarding out-of-hospital DNAR or AND directives vary from state to state.\n\n【3】When a child with a chronic or potentially lifethreatening condition is discharged from the hospital, parents, school nurses, and home healthcare providers should be informed about the reason for hospitalization, a summary of the hospital course, and how to recognize signs of deterioration. They should receive specific instructions about CPR and whom to contact. 161\n\n【4】## Ventilation With A Tracheostomy Or Stoma\n\n【5】\n Everyone involved with the care of a child with a tracheostomy (parents, school nurses, and home healthcare providers) should know how to assess patency of the airway, clear the airway, change the tracheostomy tube, and perform CPR using the artificial airway.\n\n【6】Use the tracheostomy tube for ventilation and verify adequacy of airway and ventilation by watching for chest expansion. If the tracheostomy tube does not allow effective ventilation even after suctioning, replace it. If you are still unable to achieve chest rise, remove the tracheostomy tube and attempt alternative ventilation methods, such as mouth-to-stoma ventilation or bag-mask ventilation through the nose and mouth (while you or someone else occludes the tracheal stoma).\n\n【7】## Trauma\n\n【8】\n The principles of BLS resuscitation for the injured child are the same as those for the ill child, but some aspects require emphasis.\n\n【9】The following are important aspects of resuscitation of pediatric victims of trauma:\n • Anticipate airway obstruction by dental fragments, blood, or other debris. Use a suction device if necessary.\n\n【10】• Stop all external bleeding with direct pressure.\n\n【11】• When the mechanism of injury is compatible with spinal injury, minimize motion of the cervical spine and movement of the head and neck.\n\n【12】• Professional rescuers should open and maintain the airway with a jaw thrust and try not to tilt the head. If a jaw thrust\n\n【13】 does not open the airway, use a head tilt–chin lift, because a patent airway is necessary. If there are 2 rescuers, 1 can manually restrict cervical spine motion while the other rescuer opens the airway.\n\n【14】To limit spine motion, secure at least the thighs, pelvis, and shoulders to the immobilization board. Because of the disproportionately large size of the head in infants and young children, optimal positioning may require recessing the occiput 163 or elevating the torso to avoid undesirable backboard-induced cervical flexion. 163,164 • If possible, transport children with potential for serious trauma to a trauma center with pediatric expertise.\n\n【15】## Drowning\n\n【16】\n Outcome after drowning is determined by the duration of submersion, the water temperature, and how promptly and effectively CPR is provided. 1,16,165 Neurologically intact survival has been reported after prolonged submersion in icy waters. 166 . 167 Start resuscitation by safely removing the victim from the water as rapidly as possible. If you have special training, start rescue breathing while the victim is still in the water168 if doing so will not delay removing the victim from the water. Do not attempt chest compressions in the water.\n\n【17】After removing the victim from the water start CPR if\n\n【18】 the victim is unresponsive and is not breathing. If you are alone, continue with 5 cycles (about 2 minutes) of compressions and ventilations before activating the emergency response system and getting an AED. If 2 rescuers are present, send the second rescuer to activate the emergency response system immediately and get the AED while you continue CPR.\n\n【19】## The Quality Of Bls\n\n【20】\n Immediate CPR can improve survival from cardiac arrest in children, but not enough children receive high-quality CPR.  We must increase the number of laypersons who learn, remember, and perform CPR, and must improve the quality of CPR provided by lay rescuers and healthcare providers alike.\n\n【21】Healthcare systems that deliver CPR should implement processes of performance improvement. These include monitoring the time required for recognition and activation of the emergency response system, the quality of CPR delivered at the scene of cardiac arrest, other process-ofcare measures (eg, initial rhythm, bystander CPR, and response intervals), and patient outcome up to hospital discharge (see Part 4: \"Overview of CPR\"). This evidence should be used to optimize the quality of CPR delivered.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "American College of Emergency Physicians 162 is available", "bbox": [60.0, 85.0, 376.0, 98.0]}, {"text": "online (www.aap.org/advocacy/EIFTemp09.pdf).", "bbox": [60.0, 100.0, 327.0, 113.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Advanced Directives", "bbox": [60.0, 133.0, 172.0, 147.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "If a decision to limit or withhold resuscitative efforts is", "bbox": [60.0, 147.0, 377.0, 161.0]}, {"text": "made, the physician must write an order clearly detailing", "bbox": [60.0, 162.0, 376.0, 176.0]}, {"text": "the limits of any attempted resuscitation. A separate order", "bbox": [60.0, 178.0, 376.0, 191.0]}, {"text": "must be written for the out-of-hospital setting. Regulations", "bbox": [60.0, 193.0, 377.0, 207.0]}, {"text": "regarding out-of-hospital DNAR or AND directives vary", "bbox": [60.0, 208.0, 375.0, 222.0]}, {"text": "from state to state.", "bbox": [60.0, 224.0, 163.0, 238.0]}, {"text": "When a child with a chronic or potentially life-", "bbox": [73.0, 240.0, 375.0, 254.0]}, {"text": "threatening condition is discharged from the hospital,", "bbox": [60.0, 254.0, 376.0, 269.0]}, {"text": "parents, school nurses, and home healthcare providers", "bbox": [60.0, 271.0, 377.0, 284.0]}, {"text": "should be informed about the reason for hospitalization,", "bbox": [60.0, 286.0, 377.0, 301.0]}, {"text": "a summary of the hospital course, and how to recognize", "bbox": [60.0, 301.0, 376.0, 315.0]}, {"text": "signs of deterioration. They should receive specific in-", "bbox": [60.0, 317.0, 375.0, 331.0]}, {"text": "structions about CPR and whom to contact. 161", "bbox": [60.0, 333.0, 313.0, 347.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Ventilation With a Tracheostomy or Stoma", "bbox": [60.0, 364.0, 293.0, 378.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Everyone involved with the care of a child with a trache-", "bbox": [60.0, 380.0, 375.0, 393.0]}, {"text": "ostomy (parents, school nurses, and home healthcare", "bbox": [60.0, 394.0, 376.0, 408.0]}, {"text": "providers) should know how to assess patency of the", "bbox": [60.0, 410.0, 376.0, 424.0]}, {"text": "airway, clear the airway, change the tracheostomy tube,", "bbox": [60.0, 425.0, 376.0, 440.0]}, {"text": "and perform CPR using the artificial airway.", "bbox": [60.0, 441.0, 306.0, 455.0]}, {"text": "Use the tracheostomy tube for ventilation and verify", "bbox": [72.0, 456.0, 376.0, 471.0]}, {"text": "adequacy of airway and ventilation by watching for chest", "bbox": [60.0, 472.0, 377.0, 486.0]}, {"text": "expansion. If the tracheostomy tube does not allow effec-", "bbox": [60.0, 488.0, 375.0, 501.0]}, {"text": "tive ventilation even after suctioning, replace it. If you are", "bbox": [60.0, 503.0, 377.0, 517.0]}, {"text": "still unable to achieve chest rise, remove the tracheostomy", "bbox": [60.0, 518.0, 376.0, 532.0]}, {"text": "tube and attempt alternative ventilation methods, such as", "bbox": [60.0, 534.0, 377.0, 548.0]}, {"text": "mouth-to-stoma ventilation or bag-mask ventilation", "bbox": [60.0, 549.0, 377.0, 562.0]}, {"text": "through the nose and mouth (while you or someone else", "bbox": [60.0, 564.0, 377.0, 579.0]}, {"text": "occludes the tracheal stoma).", "bbox": [60.0, 581.0, 220.0, 594.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Trauma", "bbox": [60.0, 613.0, 106.0, 627.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "The principles of BLS resuscitation for the injured child", "bbox": [60.0, 627.0, 377.0, 642.0]}, {"text": "are the same as those for the ill child, but some aspects", "bbox": [60.0, 642.0, 377.0, 656.0]}, {"text": "require emphasis.", "bbox": [60.0, 658.0, 158.0, 672.0]}, {"text": "The following are important aspects of resuscitation of", "bbox": [74.0, 673.0, 377.0, 688.0]}, {"text": "pediatric victims of trauma:", "bbox": [60.0, 689.0, 215.0, 703.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "• Anticipate airway obstruction by dental fragments, blood,", "bbox": [60.0, 715.0, 375.0, 729.0]}, {"text": "or other debris. Use a suction device if necessary.", "bbox": [71.0, 730.0, 336.0, 744.0]}, {"text": "• Stop all external bleeding with direct pressure.", "bbox": [60.0, 746.0, 317.0, 760.0]}, {"text": "• When the mechanism of injury is compatible with spinal", "bbox": [60.0, 762.0, 377.0, 775.0]}, {"text": "injury, minimize motion of the cervical spine and move-", "bbox": [72.0, 776.0, 375.0, 790.0]}, {"text": "ment of the head and neck.", "bbox": [71.0, 793.0, 215.0, 806.0]}, {"text": "• Professional rescuers should open and maintain the airway", "bbox": [60.0, 808.0, 376.0, 822.0]}, {"text": "with a jaw thrust and try not to tilt the head. If a jaw thrust", "bbox": [72.0, 823.0, 376.0, 837.0]}], "type": "List-item", "position": 10}, {"raw_context": [{"text": "does not open the airway, use a head tilt–chin lift, because", "bbox": [416.0, 84.0, 720.0, 99.0]}, {"text": "a patent airway is necessary. If there are 2 rescuers, 1 can", "bbox": [415.0, 100.0, 721.0, 113.0]}, {"text": "manually restrict cervical spine motion while the other", "bbox": [416.0, 115.0, 721.0, 129.0]}, {"text": "rescuer opens the airway.", "bbox": [416.0, 130.0, 552.0, 144.0]}, {"text": "To limit spine motion, secure at least the thighs, pelvis, and", "bbox": [414.0, 145.0, 720.0, 159.0]}, {"text": "shoulders to the immobilization board. Because of the", "bbox": [416.0, 160.0, 720.0, 174.0]}, {"text": "disproportionately large size of the head in infants and", "bbox": [416.0, 175.0, 720.0, 189.0]}, {"text": "young children, optimal positioning may require recessing", "bbox": [416.0, 191.0, 720.0, 204.0]}, {"text": "the occiput 163 or elevating the torso to avoid undesirable", "bbox": [416.0, 206.0, 720.0, 220.0]}, {"text": "backboard-induced cervical flexion. 163,164", "bbox": [416.0, 220.0, 633.0, 235.0]}, {"text": "• If possible, transport children with potential for serious", "bbox": [404.0, 236.0, 721.0, 250.0]}, {"text": "trauma to a trauma center with pediatric expertise.", "bbox": [416.0, 251.0, 681.0, 266.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Drowning", "bbox": [403.0, 284.0, 460.0, 298.0]}], "type": "Section-header", "position": 12}, {"raw_context": [{"text": "Outcome after drowning is determined by the duration of", "bbox": [403.0, 297.0, 721.0, 312.0]}, {"text": "submersion, the water temperature, and how promptly and", "bbox": [403.0, 314.0, 721.0, 327.0]}, {"text": "effectively CPR is provided. 1,16,165 Neurologically intact", "bbox": [403.0, 327.0, 721.0, 342.0]}, {"text": "survival has been reported after prolonged submersion in", "bbox": [403.0, 344.0, 722.0, 357.0]}, {"text": "icy waters. 166 . 167 Start resuscitation by safely removing the", "bbox": [403.0, 357.0, 720.0, 375.0]}, {"text": "victim from the water as rapidly as possible. If you have", "bbox": [403.0, 373.0, 720.0, 390.0]}, {"text": "special training, start rescue breathing while the victim is", "bbox": [403.0, 389.0, 721.0, 403.0]}, {"text": "still in the water168 if doing so will not delay removing the", "bbox": [403.0, 404.0, 720.0, 419.0]}, {"text": "victim from the water. Do not attempt chest compressions", "bbox": [403.0, 421.0, 721.0, 434.0]}, {"text": "in the water.", "bbox": [403.0, 435.0, 476.0, 448.0]}, {"text": "After removing the victim from the water start CPR if", "bbox": [417.0, 449.0, 722.0, 464.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "the victim is unresponsive and is not breathing. If you are", "bbox": [404.0, 466.0, 720.0, 479.0]}, {"text": "alone, continue with 5 cycles (about 2 minutes) of com-", "bbox": [403.0, 481.0, 720.0, 495.0]}, {"text": "pressions and ventilations before activating the emergency", "bbox": [403.0, 496.0, 720.0, 510.0]}, {"text": "response system and getting an AED. If 2 rescuers are", "bbox": [403.0, 511.0, 721.0, 524.0]}, {"text": "present, send the second rescuer to activate the emergency", "bbox": [403.0, 526.0, 720.0, 541.0]}, {"text": "response system immediately and get the AED while you", "bbox": [403.0, 542.0, 721.0, 555.0]}, {"text": "continue CPR.", "bbox": [403.0, 557.0, 485.0, 571.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "The Quality of BLS", "bbox": [494.0, 594.0, 630.0, 608.0]}], "type": "Section-header", "position": 15}, {"raw_context": [{"text": "Immediate CPR can improve survival from cardiac arrest", "bbox": [404.0, 609.0, 721.0, 624.0]}, {"text": "in children, but not enough children receive high-quality", "bbox": [403.0, 626.0, 720.0, 639.0]}, {"text": "CPR.  We must increase the number of laypersons who", "bbox": [403.0, 641.0, 721.0, 655.0]}, {"text": "learn, remember, and perform CPR, and must improve the", "bbox": [403.0, 655.0, 720.0, 669.0]}, {"text": "quality of CPR provided by lay rescuers and healthcare", "bbox": [403.0, 671.0, 721.0, 685.0]}, {"text": "providers alike.", "bbox": [403.0, 686.0, 492.0, 700.0]}, {"text": "Healthcare systems that deliver CPR should implement", "bbox": [416.0, 701.0, 721.0, 715.0]}, {"text": "processes of performance improvement. These include", "bbox": [404.0, 716.0, 720.0, 730.0]}, {"text": "monitoring the time required for recognition and activation", "bbox": [403.0, 731.0, 721.0, 746.0]}, {"text": "of the emergency response system, the quality of CPR", "bbox": [403.0, 748.0, 720.0, 761.0]}, {"text": "delivered at the scene of cardiac arrest, other process-of-", "bbox": [403.0, 762.0, 720.0, 776.0]}, {"text": "care measures (eg, initial rhythm, bystander CPR, and", "bbox": [403.0, 777.0, 721.0, 791.0]}, {"text": "response intervals), and patient outcome up to hospital", "bbox": [403.0, 793.0, 720.0, 806.0]}, {"text": "discharge (see Part 4: \"Overview of CPR\"). This evidence", "bbox": [403.0, 808.0, 720.0, 823.0]}, {"text": "should be used to optimize the quality of CPR delivered.", "bbox": [403.0, 823.0, 718.0, 837.0]}], "type": "Text", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 251}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#12#13#Professional rescuers到opens the airway.是一句话\n缺少换行#14#14# If possible, transport children另起一行\n多余换行#17#18#After removing the到while you continue CPR.是一句话", "type3": "无关文本#3#3#类似whom to contact. 161出现在句末的无关数字引用\n无关文本#14#14#类似 recessing the occiput 163出现在句中或者cervical flexion. 163,164句末的无关数字引用\n无关文本#16#16#类似 submersion in icy waters. 166 . 167出现在句中或者effectively CPR is provided. 1,16,165 句末的无关数字引用", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:40:01"}
{"id": 1042080, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "bf75129e-13d8-4c6e-8d28-9205bd64bd70", "title": null, "text": "【0】页码:15\n\n【1】 Guidelines Part 1: Executive Summary: Writing Group Disclosures, Continued Writing Broup Other Research Consultant/Advisory Dwnership Research Grant Speakers' Bureau/Honoraria Interest Member Employment Support Board Other Mary Ann Virginia Commonwealth University-Professor of Internal None None None Nane Modicine and Emergency Modicine Peberdy \"NIH Grant –Co-PI-Antimicrobial Dosing in Jeffrey M.\n\n【2】Well Cornell Medical College-Professor of Pediatrics None None None None Nane Periman the NH Pann State Horshey Medical Center– Professor of Elizabeth Nane None None None None Nane Sinz Anesthesiology and Neurosurpery \"Associate Science Editor for AHA.\n\n【3】Emergency Health Services NS-Provincial Medical Director Andrew H.\n\n【4】None Nane None None None Nane Travers Marc D.\n\n【5】University of Arizona/University Physician's Heatthcare Nane None None None None Nane (UPH)– Asso. Prof. Clinical Pediatrics Attending Intensivist, Barg Podiatric Critical Care Modicine John E. Billi University of Michigan Modical School -Professor None None None Nane None Nane Brian Eigel American Heart Association–Director of Science, ECC None Nane None None None Nane Proprams Robert W.\n\n【6】University of Pittsburgh–MD ↑ NIH sponsored research on the effect of None None None None \"Occasional expert cyclopentenone prostaglandins upon witness in medical Hickey post-ischemic brain maipractice cases (1–2 times/yr) Children's Hospital Anesthesia Foundation: Not-for-profit Monica E.\n\n【7】Nane None None None None Nane Kleinman foundation– Seniar Associate in Critical Care Medicine Tufts Medical Center Academic Medical Mark S.\n\n【8】Nane None None None None Nane Link Institution-Attending Physician Laurie J.\n\n【9】St. Michael Hospital, clinician None None None None Nane Nane Marrisan Robert E.\n\n【10】University of Virginia Health System–Professor and Chair of None None None None Nane Nane 0 Cannon Emergency Modicine Michael Self-employed; Emergency Physician None None None None None Nane Shuster Clinan W.\n\n【11】University of Pittsburgh School of Modicine; Associate 1NHLBI-Resuscitation Dutcomes Consortium *Loan of coding None 1 Cainventor on None Nane Callavay Professor equipment from patents related to UPMC Health System; Physician Medivance, Inc., timing of a manufacturer deforilator.\n\n【12】of hypothernia Patents licensed to devices Medtronic ERS, by the University of Pitsburgh.\n\n【13】*Own stock in Apple Computer Inc.\n\n【14】University of Pennsylvania Assistant Professor of Neurology ↑ NH RO1-migraine imaging research \"Multiple CME talks at different Brett None None None *Docasionally serves as expert winess for Cucchiara institutions medicologal cases Jeffrey D.\n\n【15】Brody School of Medicine at East Carolina University– Nane None None None None \"Carrantly involved as Assistant Professor expert witness on two Ferpress pending cases. Fors to date total less than $10,000 over previous.\n\n【16】12 months Thomas D.\n\n【17】University of Washington-Associate Professor 1 Medtronic Foundation to develop 1 Philips Medical None None None Nane Rea community approaches to improve and resuscitation. Monies to the institution.\n\n【18】PhysioControl ¶Laerdal Foundation to evaluate optimal provided approaches for bystander CPR. Monios to oquipment to the institution.\n\n【19】support research.\n\n【20】*Philips Medical Inc.\n\n【21】Equipment went PhysioControl Inc: to the institution (Continued)\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Guidelines Part 1: Executive Summary: Writing Group Disclosures, Continued", "bbox": [59.0, 81.0, 438.0, 100.0]}, {"text": "Writing", "bbox": [60.0, 107.0, 81.0, 116.0]}, {"text": "Broup", "bbox": [60.0, 118.0, 79.0, 131.0]}, {"text": "Other Research", "bbox": [390.0, 119.0, 430.0, 130.0]}, {"text": "Consultant/Advisory", "bbox": [594.0, 119.0, 644.0, 128.0]}, {"text": "Dwnership", "bbox": [544.0, 120.0, 572.0, 130.0]}, {"text": "Research Grant", "bbox": [299.0, 130.0, 341.0, 141.0]}, {"text": "Speakers' Bureau/Honoraria", "bbox": [447.0, 130.0, 520.0, 141.0]}, {"text": "Interest", "bbox": [546.0, 130.0, 568.0, 141.0]}, {"text": "Member", "bbox": [60.0, 131.0, 83.0, 141.0]}, {"text": "Employment", "bbox": [161.0, 131.0, 196.0, 141.0]}, {"text": "Support", "bbox": [399.0, 131.0, 422.0, 141.0]}, {"text": "Board", "bbox": [611.0, 131.0, 629.0, 141.0]}, {"text": "Other", "bbox": [681.0, 131.0, 698.0, 141.0]}, {"text": "Mary Ann", "bbox": [60.0, 147.0, 86.0, 158.0]}, {"text": "Virginia Commonwealth University-Professor of Internal", "bbox": [107.0, 147.0, 247.0, 158.0]}, {"text": "None", "bbox": [402.0, 147.0, 416.0, 158.0]}, {"text": "None", "bbox": [476.0, 147.0, 489.0, 156.0]}, {"text": "None", "bbox": [549.0, 147.0, 563.0, 158.0]}, {"text": "Nane", "bbox": [682.0, 147.0, 696.0, 158.0]}, {"text": "Modicine and Emergency Modicine", "bbox": [131.0, 158.0, 224.0, 169.0]}, {"text": "Peberdy", "bbox": [60.0, 160.0, 84.0, 168.0]}, {"text": "\"NIH Grant –Co-PI-Antimicrobial Dosing in", "bbox": [266.0, 173.0, 375.0, 183.0]}, {"text": "Jeffrey M.", "bbox": [61.0, 174.0, 87.0, 183.0]}, {"text": "Well Cornell Medical College-Professor of Pediatrics", "bbox": [110.0, 174.0, 246.0, 183.0]}, {"text": "None", "bbox": [401.0, 174.0, 418.0, 183.0]}, {"text": "None", "bbox": [475.0, 174.0, 492.0, 183.0]}, {"text": "None", "bbox": [548.0, 174.0, 564.0, 183.0]}, {"text": "None", "bbox": [611.0, 174.0, 627.0, 183.0]}, {"text": "Nane", "bbox": [681.0, 174.0, 697.0, 182.0]}, {"text": "Periman", "bbox": [60.0, 186.0, 84.0, 196.0]}, {"text": "the NH", "bbox": [310.0, 186.0, 331.0, 197.0]}, {"text": "Pann State Horshey Medical Center– Professor of", "bbox": [113.0, 199.0, 243.0, 211.0]}, {"text": "Elizabeth", "bbox": [60.0, 200.0, 85.0, 210.0]}, {"text": "Nane", "bbox": [312.0, 200.0, 328.0, 210.0]}, {"text": "None", "bbox": [401.0, 200.0, 418.0, 211.0]}, {"text": "None", "bbox": [475.0, 200.0, 492.0, 211.0]}, {"text": "None", "bbox": [549.0, 200.0, 565.0, 211.0]}, {"text": "None", "bbox": [611.0, 200.0, 627.0, 211.0]}, {"text": "Nane", "bbox": [681.0, 200.0, 698.0, 211.0]}, {"text": "Sinz", "bbox": [60.0, 213.0, 75.0, 220.0]}, {"text": "Anesthesiology and Neurosurpery", "bbox": [133.0, 212.0, 221.0, 220.0]}, {"text": "\"Associate Science Editor for AHA.", "bbox": [133.0, 223.0, 222.0, 234.0]}, {"text": "Emergency Health Services NS-Provincial Medical Director", "bbox": [102.0, 238.0, 253.0, 249.0]}, {"text": "Andrew H.", "bbox": [60.0, 239.0, 89.0, 249.0]}, {"text": "None", "bbox": [401.0, 239.0, 418.0, 248.0]}, {"text": "Nane", "bbox": [311.0, 240.0, 328.0, 248.0]}, {"text": "None", "bbox": [475.0, 240.0, 492.0, 248.0]}, {"text": "None", "bbox": [548.0, 240.0, 564.0, 248.0]}, {"text": "None", "bbox": [611.0, 240.0, 627.0, 248.0]}, {"text": "Nane", "bbox": [681.0, 240.0, 697.0, 248.0]}, {"text": "Travers", "bbox": [60.0, 251.0, 81.0, 261.0]}, {"text": "Marc D.", "bbox": [60.0, 265.0, 82.0, 276.0]}, {"text": "University of Arizona/University Physician's Heatthcare", "bbox": [107.0, 265.0, 248.0, 277.0]}, {"text": "Nane", "bbox": [312.0, 266.0, 328.0, 276.0]}, {"text": "None", "bbox": [401.0, 266.0, 418.0, 277.0]}, {"text": "None", "bbox": [475.0, 266.0, 492.0, 277.0]}, {"text": "None", "bbox": [549.0, 266.0, 565.0, 277.0]}, {"text": "None", "bbox": [611.0, 266.0, 627.0, 277.0]}, {"text": "Nane", "bbox": [681.0, 266.0, 697.0, 277.0]}, {"text": "(UPH)– Asso. Prof. Clinical Pediatrics Attending Intensivist,", "bbox": [103.0, 278.0, 251.0, 287.0]}, {"text": "Barg", "bbox": [60.0, 279.0, 76.0, 287.0]}, {"text": "Podiatric Critical Care Modicine", "bbox": [135.0, 289.0, 219.0, 301.0]}, {"text": "John E. Billi", "bbox": [61.0, 303.0, 94.0, 314.0]}, {"text": "University of Michigan Modical School -Professor", "bbox": [113.0, 303.0, 241.0, 315.0]}, {"text": "None", "bbox": [475.0, 303.0, 492.0, 314.0]}, {"text": "None", "bbox": [549.0, 303.0, 564.0, 314.0]}, {"text": "None", "bbox": [611.0, 303.0, 627.0, 314.0]}, {"text": "Nane", "bbox": [312.0, 304.0, 328.0, 314.0]}, {"text": "None", "bbox": [401.0, 304.0, 418.0, 314.0]}, {"text": "Nane", "bbox": [681.0, 304.0, 698.0, 314.0]}, {"text": "Brian Eigel", "bbox": [60.0, 318.0, 90.0, 329.0]}, {"text": "American Heart Association–Director of Science, ECC", "bbox": [109.0, 318.0, 247.0, 329.0]}, {"text": "None", "bbox": [401.0, 318.0, 418.0, 329.0]}, {"text": "Nane", "bbox": [312.0, 319.0, 328.0, 329.0]}, {"text": "None", "bbox": [475.0, 319.0, 492.0, 329.0]}, {"text": "None", "bbox": [549.0, 319.0, 564.0, 329.0]}, {"text": "None", "bbox": [611.0, 319.0, 627.0, 329.0]}, {"text": "Nane", "bbox": [681.0, 319.0, 697.0, 329.0]}, {"text": "Proprams", "bbox": [163.0, 331.0, 193.0, 341.0]}, {"text": "Robert W.", "bbox": [60.0, 345.0, 87.0, 357.0]}, {"text": "University of Pittsburgh–MD", "bbox": [141.0, 345.0, 215.0, 357.0]}, {"text": "↑ NIH sponsored research on the effect of", "bbox": [267.0, 345.0, 375.0, 357.0]}, {"text": "None", "bbox": [401.0, 346.0, 418.0, 357.0]}, {"text": "None", "bbox": [475.0, 346.0, 492.0, 357.0]}, {"text": "None", "bbox": [549.0, 346.0, 565.0, 357.0]}, {"text": "None", "bbox": [611.0, 346.0, 627.0, 357.0]}, {"text": "\"Occasional expert", "bbox": [664.0, 346.0, 714.0, 357.0]}, {"text": "cyclopentenone prostaglandins upon", "bbox": [273.0, 358.0, 367.0, 367.0]}, {"text": "witness in medical", "bbox": [664.0, 358.0, 715.0, 367.0]}, {"text": "Hickey", "bbox": [60.0, 359.0, 81.0, 367.0]}, {"text": "post-ischemic brain", "bbox": [294.0, 369.0, 345.0, 381.0]}, {"text": "maipractice cases", "bbox": [665.0, 369.0, 711.0, 381.0]}, {"text": "(1–2 times/yr)", "bbox": [669.0, 382.0, 707.0, 391.0]}, {"text": "Children's Hospital Anesthesia Foundation: Not-for-profit", "bbox": [105.0, 394.0, 250.0, 406.0]}, {"text": "Monica E.", "bbox": [60.0, 396.0, 87.0, 406.0]}, {"text": "Nane", "bbox": [312.0, 396.0, 328.0, 405.0]}, {"text": "None", "bbox": [401.0, 396.0, 418.0, 405.0]}, {"text": "None", "bbox": [475.0, 396.0, 492.0, 405.0]}, {"text": "None", "bbox": [548.0, 396.0, 564.0, 405.0]}, {"text": "None", "bbox": [611.0, 396.0, 627.0, 405.0]}, {"text": "Nane", "bbox": [681.0, 396.0, 696.0, 405.0]}, {"text": "Kleinman", "bbox": [60.0, 408.0, 86.0, 419.0]}, {"text": "foundation– Seniar Associate in Critical Care Medicine", "bbox": [107.0, 408.0, 248.0, 419.0]}, {"text": "Tufts Medical Center Academic Medical", "bbox": [126.0, 421.0, 229.0, 434.0]}, {"text": "Mark S.", "bbox": [60.0, 422.0, 82.0, 434.0]}, {"text": "Nane", "bbox": [312.0, 423.0, 328.0, 434.0]}, {"text": "None", "bbox": [401.0, 422.0, 418.0, 434.0]}, {"text": "None", "bbox": [475.0, 422.0, 492.0, 434.0]}, {"text": "None", "bbox": [549.0, 422.0, 565.0, 434.0]}, {"text": "None", "bbox": [611.0, 422.0, 627.0, 434.0]}, {"text": "Nane", "bbox": [681.0, 422.0, 698.0, 434.0]}, {"text": "Link", "bbox": [60.0, 435.0, 74.0, 445.0]}, {"text": "Institution-Attending Physician", "bbox": [138.0, 435.0, 217.0, 444.0]}, {"text": "Laurie J.", "bbox": [60.0, 449.0, 85.0, 461.0]}, {"text": "St. Michael Hospital, clinician", "bbox": [139.0, 449.0, 217.0, 461.0]}, {"text": "None", "bbox": [401.0, 449.0, 417.0, 461.0]}, {"text": "None", "bbox": [475.0, 449.0, 491.0, 461.0]}, {"text": "None", "bbox": [549.0, 449.0, 564.0, 461.0]}, {"text": "None", "bbox": [611.0, 449.0, 627.0, 461.0]}, {"text": "Nane", "bbox": [312.0, 450.0, 328.0, 461.0]}, {"text": "Nane", "bbox": [681.0, 450.0, 697.0, 461.0]}, {"text": "Marrisan", "bbox": [60.0, 462.0, 84.0, 471.0]}, {"text": "Robert E.", "bbox": [60.0, 475.0, 85.0, 486.0]}, {"text": "University of Virginia Health System–Professor and Chair of", "bbox": [101.0, 475.0, 255.0, 486.0]}, {"text": "None", "bbox": [401.0, 476.0, 418.0, 485.0]}, {"text": "None", "bbox": [475.0, 476.0, 492.0, 485.0]}, {"text": "None", "bbox": [548.0, 476.0, 564.0, 485.0]}, {"text": "None", "bbox": [611.0, 476.0, 627.0, 485.0]}, {"text": "Nane", "bbox": [681.0, 476.0, 697.0, 485.0]}, {"text": "Nane", "bbox": [312.0, 477.0, 328.0, 485.0]}, {"text": "0 Cannon", "bbox": [60.0, 488.0, 85.0, 499.0]}, {"text": "Emergency Modicine", "bbox": [149.0, 488.0, 206.0, 499.0]}, {"text": "Michael", "bbox": [60.0, 502.0, 83.0, 514.0]}, {"text": "Self-employed; Emergency Physician", "bbox": [130.0, 502.0, 225.0, 514.0]}, {"text": "None", "bbox": [312.0, 503.0, 328.0, 514.0]}, {"text": "None", "bbox": [401.0, 503.0, 419.0, 514.0]}, {"text": "None", "bbox": [475.0, 502.0, 492.0, 514.0]}, {"text": "None", "bbox": [548.0, 503.0, 565.0, 514.0]}, {"text": "None", "bbox": [611.0, 502.0, 627.0, 514.0]}, {"text": "Nane", "bbox": [681.0, 503.0, 698.0, 514.0]}, {"text": "Shuster", "bbox": [60.0, 515.0, 82.0, 524.0]}, {"text": "Clinan W.", "bbox": [60.0, 529.0, 86.0, 541.0]}, {"text": "University of Pittsburgh School of Modicine; Associate", "bbox": [107.0, 529.0, 248.0, 541.0]}, {"text": "1NHLBI-Resuscitation Dutcomes Consortium", "bbox": [263.0, 529.0, 378.0, 541.0]}, {"text": "*Loan of coding", "bbox": [388.0, 529.0, 432.0, 541.0]}, {"text": "None", "bbox": [475.0, 529.0, 491.0, 541.0]}, {"text": "1 Cainventor on", "bbox": [538.0, 529.0, 575.0, 541.0]}, {"text": "None", "bbox": [611.0, 529.0, 627.0, 541.0]}, {"text": "Nane", "bbox": [681.0, 530.0, 697.0, 541.0]}, {"text": "Callavay", "bbox": [60.0, 542.0, 84.0, 551.0]}, {"text": "Professor", "bbox": [163.0, 542.0, 191.0, 551.0]}, {"text": "equipment from", "bbox": [388.0, 542.0, 431.0, 551.0]}, {"text": "patents related to", "bbox": [534.0, 542.0, 577.0, 552.0]}, {"text": "UPMC Health System; Physician", "bbox": [135.0, 554.0, 219.0, 565.0]}, {"text": "Medivance, Inc.,", "bbox": [388.0, 554.0, 430.0, 565.0]}, {"text": "timing of", "bbox": [544.0, 554.0, 570.0, 565.0]}, {"text": "a manufacturer", "bbox": [388.0, 566.0, 430.0, 576.0]}, {"text": "deforilator.", "bbox": [540.0, 566.0, 572.0, 576.0]}, {"text": "of hypothernia", "bbox": [389.0, 578.0, 429.0, 588.0]}, {"text": "Patents licensed to", "bbox": [534.0, 578.0, 579.0, 587.0]}, {"text": "devices", "bbox": [398.0, 589.0, 421.0, 601.0]}, {"text": "Medtronic ERS, by", "bbox": [534.0, 589.0, 579.0, 601.0]}, {"text": "the University of", "bbox": [536.0, 602.0, 577.0, 610.0]}, {"text": "Pitsburgh.", "bbox": [542.0, 614.0, 570.0, 624.0]}, {"text": "*Own stock in", "bbox": [539.0, 626.0, 575.0, 635.0]}, {"text": "Apple Computer", "bbox": [536.0, 638.0, 575.0, 648.0]}, {"text": "Inc.", "bbox": [549.0, 651.0, 562.0, 659.0]}, {"text": "University of Pennsylvania Assistant Professor of Neurology", "bbox": [102.0, 663.0, 256.0, 674.0]}, {"text": "↑ NH RO1-migraine imaging research", "bbox": [271.0, 663.0, 370.0, 674.0]}, {"text": "\"Multiple CME talks at different", "bbox": [443.0, 662.0, 526.0, 674.0]}, {"text": "Brett", "bbox": [60.0, 664.0, 77.0, 673.0]}, {"text": "None", "bbox": [401.0, 664.0, 418.0, 673.0]}, {"text": "None", "bbox": [548.0, 664.0, 564.0, 673.0]}, {"text": "None", "bbox": [611.0, 664.0, 627.0, 673.0]}, {"text": "*Docasionally serves", "bbox": [662.0, 664.0, 716.0, 673.0]}, {"text": "as expert winess for", "bbox": [661.0, 675.0, 718.0, 687.0]}, {"text": "Cucchiara", "bbox": [60.0, 676.0, 86.0, 687.0]}, {"text": "institutions", "bbox": [469.0, 676.0, 496.0, 684.0]}, {"text": "medicologal cases", "bbox": [664.0, 689.0, 713.0, 697.0]}, {"text": "Jeffrey D.", "bbox": [61.0, 703.0, 87.0, 712.0]}, {"text": "Brody School of Medicine at East Carolina University–", "bbox": [107.0, 702.0, 246.0, 713.0]}, {"text": "Nane", "bbox": [312.0, 703.0, 328.0, 711.0]}, {"text": "None", "bbox": [401.0, 703.0, 418.0, 712.0]}, {"text": "None", "bbox": [474.0, 703.0, 492.0, 712.0]}, {"text": "None", "bbox": [548.0, 703.0, 564.0, 712.0]}, {"text": "None", "bbox": [611.0, 703.0, 627.0, 712.0]}, {"text": "\"Carrantly involved as", "bbox": [661.0, 702.0, 718.0, 711.0]}, {"text": "Assistant Professor", "bbox": [151.0, 714.0, 202.0, 725.0]}, {"text": "expert witness on two", "bbox": [659.0, 714.0, 718.0, 726.0]}, {"text": "Ferpress", "bbox": [60.0, 715.0, 85.0, 726.0]}, {"text": "pending cases. Fors", "bbox": [661.0, 728.0, 716.0, 736.0]}, {"text": "to date total less than", "bbox": [659.0, 738.0, 718.0, 749.0]}, {"text": "$10,000 over previous.", "bbox": [659.0, 750.0, 718.0, 761.0]}, {"text": "12 months", "bbox": [674.0, 762.0, 705.0, 774.0]}, {"text": "Thomas D.", "bbox": [60.0, 776.0, 90.0, 788.0]}, {"text": "University of Washington-Associate Professor", "bbox": [119.0, 776.0, 235.0, 788.0]}, {"text": "1 Medtronic Foundation to develop", "bbox": [276.0, 776.0, 365.0, 788.0]}, {"text": "1 Philips Medical", "bbox": [388.0, 776.0, 432.0, 788.0]}, {"text": "None", "bbox": [475.0, 776.0, 492.0, 788.0]}, {"text": "None", "bbox": [548.0, 776.0, 565.0, 788.0]}, {"text": "None", "bbox": [611.0, 776.0, 627.0, 788.0]}, {"text": "Nane", "bbox": [681.0, 776.0, 698.0, 788.0]}, {"text": "Rea", "bbox": [60.0, 789.0, 73.0, 798.0]}, {"text": "community approaches to improve", "bbox": [274.0, 789.0, 365.0, 799.0]}, {"text": "and", "bbox": [403.0, 790.0, 417.0, 798.0]}, {"text": "resuscitation. Monies to the institution.", "bbox": [269.0, 801.0, 369.0, 811.0]}, {"text": "PhysioControl", "bbox": [391.0, 801.0, 428.0, 811.0]}, {"text": "¶Laerdal Foundation to evaluate optimal", "bbox": [268.0, 812.0, 373.0, 823.0]}, {"text": "provided", "bbox": [397.0, 813.0, 423.0, 823.0]}, {"text": "approaches for bystander CPR. Monios to", "bbox": [266.0, 825.0, 375.0, 836.0]}, {"text": "oquipment to", "bbox": [391.0, 825.0, 429.0, 836.0]}, {"text": "the institution.", "bbox": [300.0, 836.0, 339.0, 848.0]}, {"text": "support research.", "bbox": [388.0, 836.0, 432.0, 848.0]}, {"text": "*Philips Medical Inc.", "bbox": [295.0, 849.0, 346.0, 857.0]}, {"text": "Equipment went", "bbox": [388.0, 849.0, 432.0, 857.0]}, {"text": "PhysioControl Inc:", "bbox": [297.0, 860.0, 343.0, 871.0]}, {"text": "to the institution", "bbox": [388.0, 860.0, 430.0, 871.0]}, {"text": "(Continued)", "bbox": [689.0, 875.0, 719.0, 886.0]}], "type": "Table", "position": 2}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 15}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": null, "type3": null, "type4": null, "type6": "有用性#1#21#表格的内容，但是内容互相穿插，没有语序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 00:23:14"}
{"id": 1042079, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "a2c9c1cc-5a97-42ea-b7de-1dd3646c6c5f", "title": null, "text": "【0】页码:88\n s\t916113 1101116911 :\t6111112A\n\n【1】 asthma. The medicine is designed to be taken daily, around the clock, to keep the inflammation controlled and quiescent. It is a preventive medicine. You should use it as prescribed, especially if you have no symptoms. The fact that you have no symptoms means that the medicine is working perfectly! Continue taking it!\n\n【2】If you stop your medicine because you \"feel fine,\" you may not \"feel fine\" for long. Instead of stopping medicine on your own, contact your asthma doctor for advice. The fact that you feel healthy certainly indicates that your treatment has been effective. It may also be a hint that now that your asthma symptoms have responded to treatment, you may ready to \"step down\" that particular treatment.\n\n【3】 What about my patient who suffered daily symptoms from Thanksgiving until Easter? After her first visit several years ago, and the prescription of two different inhalers, she was no longer symptomatic in the cold weather. Together we learned that her asthma requires only infrequent doses of inhaled, short acting β 2 agonist bronchodilator therapy in the spring and summer for control. In the late fall and through the winter, she needs to take additional medicine daily. She begins using the inhalers as soon as the weather cools and before she develops the cold air induced cough and breathlessness. Now that she has control over her asthma, she has more choices of how to get to work! She also decided to get a small dog (which she'd always wanted) and proudly walks the pup before and after work, in all kinds of nasty weather!", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "s\t916113 1101116911 :\t6111112A", "bbox": [547.0, 76.0, 569.0, 273.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "asthma. The medicine is designed to be taken daily,", "bbox": [70.0, 69.0, 426.0, 87.0]}, {"text": "around the clock, to keep the inflammation controlled", "bbox": [69.0, 89.0, 427.0, 107.0]}, {"text": "and quiescent. It is a preventive medicine. You should", "bbox": [69.0, 108.0, 427.0, 126.0]}, {"text": "use it as prescribed, especially if you have no symp-", "bbox": [69.0, 128.0, 426.0, 147.0]}, {"text": "toms. The fact that you have no symptoms means that", "bbox": [70.0, 149.0, 427.0, 167.0]}, {"text": "the medicine is working perfectly! Continue taking it!", "bbox": [69.0, 169.0, 427.0, 187.0]}, {"text": "If you stop your medicine because you \"feel fine,\" you", "bbox": [69.0, 189.0, 427.0, 207.0]}, {"text": "may not \"feel fine\" for long. Instead of stopping medi-", "bbox": [69.0, 208.0, 426.0, 227.0]}, {"text": "cine on your own, contact your asthma doctor for", "bbox": [69.0, 228.0, 427.0, 246.0]}, {"text": "advice. The fact that you feel healthy certainly indi-", "bbox": [69.0, 249.0, 426.0, 267.0]}, {"text": "cates that your treatment has been effective. It may", "bbox": [69.0, 268.0, 426.0, 287.0]}, {"text": "also be a hint that now that your asthma symptoms", "bbox": [69.0, 289.0, 427.0, 307.0]}, {"text": "have responded to treatment, you may ready to \"step", "bbox": [69.0, 308.0, 427.0, 327.0]}, {"text": "down\" that particular treatment.", "bbox": [70.0, 329.0, 281.0, 347.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "What about my patient who suffered daily symp-", "bbox": [70.0, 373.0, 425.0, 390.0]}, {"text": "toms from Thanksgiving until Easter? After her first", "bbox": [70.0, 393.0, 427.0, 411.0]}, {"text": "visit several years ago, and the prescription of two", "bbox": [69.0, 413.0, 427.0, 431.0]}, {"text": "different inhalers, she was no longer symptomatic in", "bbox": [69.0, 433.0, 428.0, 451.0]}, {"text": "the cold weather. Together we learned that her", "bbox": [69.0, 452.0, 427.0, 471.0]}, {"text": "asthma requires only infrequent doses of inhaled,", "bbox": [69.0, 473.0, 427.0, 491.0]}, {"text": "short acting β 2 agonist bronchodilator therapy in the", "bbox": [69.0, 493.0, 427.0, 511.0]}, {"text": "spring and summer for control. In the late fall and", "bbox": [69.0, 512.0, 427.0, 531.0]}, {"text": "through the winter, she needs to take additional", "bbox": [69.0, 532.0, 427.0, 551.0]}, {"text": "medicine daily. She begins using the inhalers as soon", "bbox": [69.0, 552.0, 428.0, 571.0]}, {"text": "as the weather cools and before she develops the", "bbox": [69.0, 573.0, 427.0, 591.0]}, {"text": "cold air induced cough and breathlessness. Now that", "bbox": [69.0, 593.0, 427.0, 611.0]}, {"text": "she has control over her asthma, she has more", "bbox": [69.0, 613.0, 427.0, 631.0]}, {"text": "choices of how to get to work! She also decided to", "bbox": [69.0, 632.0, 427.0, 651.0]}, {"text": "get a small dog (which she'd always wanted) and", "bbox": [69.0, 653.0, 427.0, 671.0]}, {"text": "proudly walks the pup before and after work, in all", "bbox": [69.0, 673.0, 427.0, 691.0]}, {"text": "kinds of nasty weather!", "bbox": [70.0, 694.0, 228.0, 711.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 88}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#0#s\t916113 1101116911 :\t6111112A无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:51:43"}
{"id": 1042078, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "062674fe-1faa-444e-a6f1-644ecb9dd64d", "title": null, "text": "【0】页码:223\n\n【1】## Carbon Monoxide\n\n【2】\n## Hyperbaric Oxygen\n\n【3】\n## Part 12.8: Cardiac Arrest Associated With Trauma\n\n【4】\n## Bls Modifications\n\n【5】\n## Cyanide\n\n【6】\n## Acls Modifications\n\n【7】\n Patients in cardiac arrest 383 – 385 or those presenting with cardiovascular instability 383–389 caused by known or suspected cyanide poisoning should receive cyanide-antidote therapy with a cyanide scavenger (either IV hydroxocobalamin or a nitrate such as IV sodium nitrite and/or inhaled amyl nitrite), followed as soon as possible by IV sodium thiosulfate. 387 ,390 ,391 Both hydroxocobalamin 383 – 389 and sodium nitrite 387 , 390 , 391 serve to rapidly and effectively bind cyanide in the serum and reverse the effects of cyanide toxicity. Because nitrites induce methemoglobin formation 390 and can cause hypotension, 392 hydroxocobalamin has a safety advantage, particularly in children and victims of smoke inhalation who might also have carbon monoxide poisoning. A detailed comparison of these measures has been recently published. 393 Sodium thiosulfate serves as a metabolic cofactor, enhancing the detoxification of cyanide to thiocyanate.\n\n【8】Thiosulfate administration enhances the effectiveness of cyanide scavengers in animal experimentation 394 – 397 and has been used successfully in humans with both hydroxocobalamin 383 , 389 and sodium nitrite. 387 , 390 , 391 Sodium thiosulfate is associated with vomiting but has no other significant toxicity. 398 Therefore, based on the best evidence available, a treatment regimen of 100% oxygen and hydroxocobalamin, with or without sodium thiosulfate, is recommended (Class I, LOE B).\n\n【9】 Apart from complications from deliberate drug abuse, carbon monoxide is the leading cause of unintentional poisoning death in the United States. 369 In addition to reducing the ability of hemoglobin to deliver oxygen, carbon monoxide causes direct cellular damage to the brain and myocardium. 370 Survivors of carbon monoxide poisoning are at risk for lasting neurological injury. 370 Several studies have suggested that very few patients who develop cardiac arrest from carbon monoxide poisoning survive to hospital discharge, regardless of treatment administered following return of spontaneous circulation. 371 – 373 Routine care of patients in cardiac arrest and severe cardiotoxicity from carbon monoxide poisoning should comply with standard BLS and ACLS recommendations.\n\n【10】 Two studies suggest that neurological outcomes were improved in patients with carbon monoxide toxicity of all severity (excluding \"moribund\" patients) 374 and mild to moderate severity (excluding loss of consciousness and cardiac instability) 375 who received hyperbaric oxygen therapy for carbon monoxide poisoning. Other studies found no difference in neurologically intact survival. 376 , 377 A systematic review 378 . 379 and a recent evidence-based clinical policy review 380 concluded that, based on the available evidence, improvement in neurologically intact survival following treatment for carbon monoxide poisoning with hyperbaric oxygen is possible but unproven.\n\n【11】Hyperbaric oxygen therapy is associated with a low incidence of severe side effects. Because hyperbaric oxygen therapy appears to confer little risk, 380 the available data suggest that hyperbaric oxygen therapy may be helpful in treatment of acute carbon monoxide poisoning in patients with severe toxicity (Class IIb, LOE C).\n\n【12】Patients with carbon monoxide poisoning who develop a cardiac injury have an increased risk of cardiovascular and all-cause mortality for at least 7 years after the event, even if hyperbaric oxygen is administered. 381 , 382 Although data about effective interventions in this population are lacking, it is reasonable to advise enhanced follow-up for these patients.\n\n【13】On the basis of this conflicting evidence, the routine transfer of patients to a hyperbaric treatment facility following resuscitation from severe cardiovascular toxicity should be carefully considered, weighing the risk of transport against the possible improvement in neurologically intact survival.\n\n【14】 BLS and ACLS for the trauma patient are fundamentally the same as that for the patient with primary cardiac arrest, with focus on support of airway, breathing, and circulation. In addition, reversible causes of cardiac arrest need to considered. While CPR in the pulseless trauma patient has overall been considered futile, several reversible causes of cardiac arrest in the context of trauma are correctible and their prompt treatment could be life-saving. These include hypoxia, hypovolemia, diminished cardiac output secondary to pneumothorax or pericardial tamponade, and hypothermia.\n\n【15】 When multisystem trauma is present or trauma involves the head and neck, the cervical spine must be stabilized. A jaw thrust should be used instead of a head tilt–chin lift to establish a patent airway. If breathing is inadequate and the patient's face is bloody, ventilation should be provided with a barrier device, a pocket mask, or a bag-mask device while maintaining cervical spine stabilization. Stop any visible hemorrhage using direct compression and appropriate dressings. If the patient is completely unresponsive despite rescue breathing, provide standard CPR and defibrillation as indicated.\n\n【16】 Cyanide is a surprisingly common chemical. In addition to industrial sources, cyanide can be found in jewelry cleaners, electroplating solutions, and as a metabolic product of the putative antitumor drug amygdalin (laetrile). Cyanide is a major component of fire smoke, and cyanide poisoning must be considered in victims of smoke inhalation who have hypotension, central nervous system depression, metabolic acidosis, or soot in the nares or respiratory secretions. 383 Cyanide poisoning causes rapid cardiovascular collapse, which manifests as hypotension, lactic acidosis, central apnea, and seizures.\n\n【17】 After initiation of BLS care, if bag-mask ventilation is inadequate, an advanced airway should be inserted while maintaining cervical spine stabilization. If insertion of an advanced airway is not possible and ventilation remains\n\n【18】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Carbon Monoxide", "bbox": [60.0, 85.0, 174.0, 99.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Hyperbaric Oxygen", "bbox": [60.0, 327.0, 167.0, 343.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Part 12.8: Cardiac Arrest Associated", "bbox": [437.0, 507.0, 687.0, 524.0]}, {"text": "With Trauma", "bbox": [514.0, 525.0, 610.0, 540.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "BLS Modifications", "bbox": [404.0, 712.0, 522.0, 726.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Cyanide", "bbox": [60.0, 805.0, 114.0, 820.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "ACLS Modifications", "bbox": [404.0, 915.0, 532.0, 929.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Patients in cardiac arrest 383 – 385 or those presenting with", "bbox": [416.0, 82.0, 720.0, 99.0]}, {"text": "cardiovascular instability 383–389 caused by known or sus-", "bbox": [403.0, 97.0, 719.0, 113.0]}, {"text": "pected cyanide poisoning should receive cyanide-antidote", "bbox": [403.0, 114.0, 720.0, 130.0]}, {"text": "therapy with a cyanide scavenger (either IV hydroxocobal-", "bbox": [403.0, 132.0, 719.0, 145.0]}, {"text": "amin or a nitrate such as IV sodium nitrite and/or inhaled", "bbox": [404.0, 147.0, 721.0, 161.0]}, {"text": "amyl nitrite), followed as soon as possible by IV sodium", "bbox": [404.0, 163.0, 721.0, 176.0]}, {"text": "thiosulfate. 387 ,390 ,391", "bbox": [403.0, 179.0, 506.0, 192.0]}, {"text": "Both hydroxocobalamin 383 – 389 and sodium nitrite 387 , 390 , 391", "bbox": [416.0, 192.0, 720.0, 207.0]}, {"text": "serve to rapidly and effectively bind cyanide in the serum and", "bbox": [404.0, 208.0, 721.0, 224.0]}, {"text": "reverse the effects of cyanide toxicity. Because nitrites induce", "bbox": [403.0, 225.0, 720.0, 239.0]}, {"text": "methemoglobin formation 390 and can cause hypotension, 392", "bbox": [403.0, 240.0, 720.0, 255.0]}, {"text": "hydroxocobalamin has a safety advantage, particularly in", "bbox": [403.0, 257.0, 721.0, 270.0]}, {"text": "children and victims of smoke inhalation who might also", "bbox": [403.0, 272.0, 721.0, 287.0]}, {"text": "have carbon monoxide poisoning. A detailed comparison of", "bbox": [403.0, 288.0, 721.0, 301.0]}, {"text": "these measures has been recently published. 393", "bbox": [403.0, 303.0, 648.0, 318.0]}, {"text": "Sodium thiosulfate serves as a metabolic cofactor, en-", "bbox": [417.0, 320.0, 719.0, 333.0]}, {"text": "hancing the detoxification of cyanide to thiocyanate.", "bbox": [403.0, 335.0, 719.0, 349.0]}, {"text": "Thiosulfate administration enhances the effectiveness of", "bbox": [404.0, 351.0, 721.0, 364.0]}, {"text": "cyanide scavengers in animal experimentation 394 – 397 and", "bbox": [403.0, 367.0, 721.0, 380.0]}, {"text": "has been used successfully in humans with both hydroxo-", "bbox": [403.0, 382.0, 719.0, 396.0]}, {"text": "cobalamin 383 , 389 and sodium nitrite. 387 , 390 , 391 Sodium thiosul-", "bbox": [403.0, 397.0, 720.0, 412.0]}, {"text": "fate is associated with vomiting but has no other significant", "bbox": [404.0, 414.0, 721.0, 427.0]}, {"text": "toxicity. 398 Therefore, based on the best evidence available, a", "bbox": [403.0, 428.0, 721.0, 443.0]}, {"text": "treatment regimen of 100% oxygen and hydroxocobalamin,", "bbox": [403.0, 445.0, 720.0, 458.0]}, {"text": "with or without sodium thiosulfate, is recommended (Class I,", "bbox": [403.0, 460.0, 720.0, 475.0]}, {"text": "LOE B).", "bbox": [403.0, 476.0, 453.0, 490.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Apart from complications from deliberate drug abuse, carbon", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "monoxide is the leading cause of unintentional poisoning", "bbox": [60.0, 115.0, 376.0, 130.0]}, {"text": "death in the United States. 369 In addition to reducing the", "bbox": [60.0, 131.0, 375.0, 145.0]}, {"text": "ability of hemoglobin to deliver oxygen, carbon monoxide", "bbox": [60.0, 147.0, 376.0, 161.0]}, {"text": "causes direct cellular damage to the brain and myocardium. 370", "bbox": [60.0, 163.0, 376.0, 176.0]}, {"text": "Survivors of carbon monoxide poisoning are at risk for", "bbox": [60.0, 178.0, 377.0, 193.0]}, {"text": "lasting neurological injury. 370", "bbox": [60.0, 194.0, 215.0, 207.0]}, {"text": "Several studies have suggested that very few patients who", "bbox": [72.0, 209.0, 377.0, 224.0]}, {"text": "develop cardiac arrest from carbon monoxide poisoning", "bbox": [60.0, 225.0, 376.0, 239.0]}, {"text": "survive to hospital discharge, regardless of treatment admin-", "bbox": [60.0, 240.0, 375.0, 254.0]}, {"text": "istered following return of spontaneous circulation. 371 – 373", "bbox": [60.0, 255.0, 375.0, 270.0]}, {"text": "Routine care of patients in cardiac arrest and severe cardio-", "bbox": [60.0, 271.0, 375.0, 285.0]}, {"text": "toxicity from carbon monoxide poisoning should comply", "bbox": [60.0, 287.0, 375.0, 301.0]}, {"text": "with standard BLS and ACLS recommendations.", "bbox": [60.0, 302.0, 317.0, 316.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Two studies suggest that neurological outcomes were im-", "bbox": [61.0, 341.0, 375.0, 355.0]}, {"text": "proved in patients with carbon monoxide toxicity of all", "bbox": [60.0, 357.0, 376.0, 371.0]}, {"text": "severity (excluding \"moribund\" patients) 374 and mild to", "bbox": [60.0, 372.0, 376.0, 387.0]}, {"text": "moderate severity (excluding loss of consciousness and car-", "bbox": [60.0, 388.0, 375.0, 402.0]}, {"text": "diac instability) 375 who received hyperbaric oxygen therapy", "bbox": [60.0, 403.0, 375.0, 419.0]}, {"text": "for carbon monoxide poisoning. Other studies found no", "bbox": [60.0, 419.0, 377.0, 434.0]}, {"text": "difference in neurologically intact survival. 376 , 377 A system-", "bbox": [60.0, 435.0, 375.0, 448.0]}, {"text": "atic review 378 . 379 and a recent evidence-based clinical policy", "bbox": [60.0, 449.0, 375.0, 464.0]}, {"text": "review 380 concluded that, based on the available evidence,", "bbox": [60.0, 466.0, 376.0, 480.0]}, {"text": "improvement in neurologically intact survival following", "bbox": [60.0, 481.0, 376.0, 495.0]}, {"text": "treatment for carbon monoxide poisoning with hyperbaric", "bbox": [60.0, 497.0, 376.0, 511.0]}, {"text": "oxygen is possible but unproven.", "bbox": [60.0, 513.0, 234.0, 527.0]}, {"text": "Hyperbaric oxygen therapy is associated with a low inci-", "bbox": [72.0, 528.0, 375.0, 542.0]}, {"text": "dence of severe side effects. Because hyperbaric oxygen", "bbox": [60.0, 543.0, 376.0, 558.0]}, {"text": "therapy appears to confer little risk, 380 the available data", "bbox": [60.0, 560.0, 376.0, 573.0]}, {"text": "suggest that hyperbaric oxygen therapy may be helpful in", "bbox": [60.0, 575.0, 377.0, 589.0]}, {"text": "treatment of acute carbon monoxide poisoning in patients", "bbox": [60.0, 591.0, 375.0, 604.0]}, {"text": "with severe toxicity (Class IIb, LOE C).", "bbox": [60.0, 606.0, 273.0, 621.0]}, {"text": "Patients with carbon monoxide poisoning who develop a", "bbox": [72.0, 622.0, 377.0, 635.0]}, {"text": "cardiac injury have an increased risk of cardiovascular and", "bbox": [60.0, 637.0, 377.0, 651.0]}, {"text": "all-cause mortality for at least 7 years after the event, even if", "bbox": [60.0, 653.0, 377.0, 667.0]}, {"text": "hyperbaric oxygen is administered. 381 , 382 Although data about", "bbox": [60.0, 669.0, 376.0, 682.0]}, {"text": "effective interventions in this population are lacking, it is", "bbox": [60.0, 684.0, 376.0, 697.0]}, {"text": "reasonable to advise enhanced follow-up for these patients.", "bbox": [60.0, 699.0, 371.0, 713.0]}, {"text": "On the basis of this conflicting evidence, the routine", "bbox": [72.0, 716.0, 375.0, 729.0]}, {"text": "transfer of patients to a hyperbaric treatment facility follow-", "bbox": [60.0, 730.0, 375.0, 744.0]}, {"text": "ing resuscitation from severe cardiovascular toxicity should", "bbox": [60.0, 747.0, 376.0, 760.0]}, {"text": "be carefully considered, weighing the risk of transport against", "bbox": [60.0, 762.0, 376.0, 776.0]}, {"text": "the possible improvement in neurologically intact survival.", "bbox": [60.0, 777.0, 369.0, 791.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "BLS and ACLS for the trauma patient are fundamentally the", "bbox": [404.0, 542.0, 720.0, 555.0]}, {"text": "same as that for the patient with primary cardiac arrest, with", "bbox": [403.0, 557.0, 721.0, 572.0]}, {"text": "focus on support of airway, breathing, and circulation. In", "bbox": [404.0, 573.0, 721.0, 587.0]}, {"text": "addition, reversible causes of cardiac arrest need to consid-", "bbox": [403.0, 588.0, 719.0, 602.0]}, {"text": "ered. While CPR in the pulseless trauma patient has overall", "bbox": [403.0, 604.0, 720.0, 618.0]}, {"text": "been considered futile, several reversible causes of cardiac", "bbox": [403.0, 620.0, 720.0, 634.0]}, {"text": "arrest in the context of trauma are correctible and their prompt", "bbox": [404.0, 635.0, 721.0, 649.0]}, {"text": "treatment could be life-saving. These include hypoxia, hypo-", "bbox": [403.0, 651.0, 719.0, 665.0]}, {"text": "volemia, diminished cardiac output secondary to pneumotho-", "bbox": [404.0, 667.0, 719.0, 681.0]}, {"text": "rax or pericardial tamponade, and hypothermia.", "bbox": [403.0, 682.0, 653.0, 696.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "When multisystem trauma is present or trauma involves", "bbox": [404.0, 728.0, 720.0, 742.0]}, {"text": "the head and neck, the cervical spine must be stabilized. A", "bbox": [403.0, 744.0, 720.0, 757.0]}, {"text": "jaw thrust should be used instead of a head tilt–chin lift to", "bbox": [404.0, 759.0, 721.0, 774.0]}, {"text": "establish a patent airway. If breathing is inadequate and the", "bbox": [403.0, 776.0, 720.0, 789.0]}, {"text": "patient's face is bloody, ventilation should be provided", "bbox": [403.0, 790.0, 721.0, 805.0]}, {"text": "with a barrier device, a pocket mask, or a bag-mask device", "bbox": [403.0, 807.0, 720.0, 820.0]}, {"text": "while maintaining cervical spine stabilization. Stop any", "bbox": [403.0, 822.0, 720.0, 836.0]}, {"text": "visible hemorrhage using direct compression and appropriate", "bbox": [404.0, 838.0, 720.0, 851.0]}, {"text": "dressings. If the patient is completely unresponsive despite", "bbox": [403.0, 853.0, 720.0, 868.0]}, {"text": "rescue breathing, provide standard CPR and defibrillation as", "bbox": [403.0, 870.0, 720.0, 883.0]}, {"text": "indicated.", "bbox": [403.0, 884.0, 458.0, 899.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Cyanide is a surprisingly common chemical. In addition to", "bbox": [59.0, 821.0, 376.0, 836.0]}, {"text": "industrial sources, cyanide can be found in jewelry cleaners,", "bbox": [60.0, 837.0, 375.0, 851.0]}, {"text": "electroplating solutions, and as a metabolic product of the", "bbox": [60.0, 853.0, 376.0, 867.0]}, {"text": "putative antitumor drug amygdalin (laetrile). Cyanide is a", "bbox": [60.0, 869.0, 376.0, 883.0]}, {"text": "major component of fire smoke, and cyanide poisoning must", "bbox": [60.0, 884.0, 377.0, 898.0]}, {"text": "be considered in victims of smoke inhalation who have", "bbox": [60.0, 900.0, 376.0, 914.0]}, {"text": "hypotension, central nervous system depression, metabolic", "bbox": [60.0, 915.0, 376.0, 929.0]}, {"text": "acidosis, or soot in the nares or respiratory secretions. 383", "bbox": [60.0, 931.0, 376.0, 944.0]}, {"text": "Cyanide poisoning causes rapid cardiovascular collapse,", "bbox": [60.0, 946.0, 376.0, 960.0]}, {"text": "which manifests as hypotension, lactic acidosis, central ap-", "bbox": [60.0, 962.0, 375.0, 976.0]}, {"text": "nea, and seizures.", "bbox": [60.0, 977.0, 154.0, 991.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "After initiation of BLS care, if bag-mask ventilation is", "bbox": [404.0, 930.0, 722.0, 944.0]}, {"text": "inadequate, an advanced airway should be inserted while", "bbox": [403.0, 946.0, 720.0, 959.0]}, {"text": "maintaining cervical spine stabilization. If insertion of an", "bbox": [403.0, 961.0, 720.0, 976.0]}, {"text": "advanced airway is not possible and ventilation remains", "bbox": [404.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 223}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#7#7#Both hydroxocobalamin另起一行\n缺少换行#8#8#Sodium thiosulfate serves as另起一行\n缺少换行#9#9#Several studies have另起一行", "type3": "无关文本#7#17#instability 383–389出现在句中或者句末的无关数字引用多次出现，应用全文\n无关文本#18#18#Downloaded fromhttp://circ.ahajournals.org/ by guest on September 4, 2011页脚内容", "type4": "栏目混乱#0#18#小标题与正文内容分开，且正文内容存在穿插出现的情况", "type6": ""}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 19:17:03"}
{"id": 1042077, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "19d16811-aa22-4c53-bfdc-2a64db2ce180", "title": null, "text": "【0】页码:300\n The anchorage of choice in the lower dental arch is the lingual arch. When it dislodges, the bands tend to impinge deep in the mucosa, the same thing happens with the lin¬ gual bar. This impingment causes pain to the patient. (4.15)\n Fig. 75. Lingual arch decementation.\n Figs. 73 and 74. Traumatic ulcer caused by the transpalatine arch.\n Fig. 76. Loop invagination.\n\n【1】## Recommendations\n\n【2】\n 1.\n\n【3】 2.\n\n【4】 3.\n\n【5】 4.\n\n【6】 5.\n\n【7】 Remove the anchorage immediately and place a mini¬ mal anchorage during the healing process.\n\n【8】Suspend canine or anterior segment retraction.\n\n【9】Use a topical analgesic and antiseptic in the lesion zone combined with a mouth wash with Monohydrate Sodium Perborate, Chlorhexedine or a Iodine based broad spectrum microbicide (Iodinepolividone).\n\n【10】Adjust as best as possible the new anchorage appliance to the mandibular anatomy.\n\n【11】Contour and cement the bands correctly.\n\n【12】 One of the most popular appliances for upper molar distalization is the Pendulum or the Pendex. These appli¬ ances are very effective for this dental movement, but we", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "The anchorage of choice in the lower dental arch is the", "bbox": [78.0, 416.0, 393.0, 433.0]}, {"text": "lingual arch. When it dislodges, the bands tend to impinge", "bbox": [78.0, 434.0, 393.0, 451.0]}, {"text": "deep in the mucosa, the same thing happens with the lin¬", "bbox": [78.0, 452.0, 393.0, 467.0]}, {"text": "gual bar. This impingment causes pain to the patient. (4.15)", "bbox": [78.0, 468.0, 390.0, 485.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Fig. 75. Lingual arch decementation.", "bbox": [155.0, 948.0, 317.0, 963.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "Figs. 73 and 74. Traumatic ulcer caused by the transpalatine arch.", "bbox": [415.0, 337.0, 702.0, 353.0]}], "type": "Caption", "position": 6}, {"raw_context": [{"text": "Fig. 76. Loop invagination.", "bbox": [511.0, 653.0, 631.0, 668.0]}], "type": "Caption", "position": 8}, {"raw_context": [{"text": "Recommendations", "bbox": [416.0, 693.0, 546.0, 710.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "1.", "bbox": [416.0, 729.0, 430.0, 745.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "2.", "bbox": [415.0, 763.0, 430.0, 779.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "3.", "bbox": [415.0, 781.0, 430.0, 797.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "4.", "bbox": [415.0, 850.0, 430.0, 866.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "5.", "bbox": [416.0, 885.0, 430.0, 901.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Remove the anchorage immediately and place a mini¬", "bbox": [441.0, 728.0, 729.0, 744.0]}, {"text": "mal anchorage during the healing process.", "bbox": [441.0, 745.0, 674.0, 762.0]}, {"text": "Suspend canine or anterior segment retraction.", "bbox": [441.0, 763.0, 704.0, 779.0]}, {"text": "Use a topical analgesic and antiseptic in the lesion", "bbox": [441.0, 779.0, 731.0, 796.0]}, {"text": "zone combined with a mouth wash with Monohydrate", "bbox": [442.0, 797.0, 730.0, 814.0]}, {"text": "Sodium Perborate, Chlorhexedine or a Iodine based", "bbox": [442.0, 815.0, 731.0, 831.0]}, {"text": "broad spectrum microbicide (Iodinepolividone).", "bbox": [442.0, 831.0, 704.0, 848.0]}, {"text": "Adjust as best as possible the new anchorage appliance", "bbox": [441.0, 849.0, 731.0, 866.0]}, {"text": "to the mandibular anatomy.", "bbox": [442.0, 867.0, 596.0, 883.0]}, {"text": "Contour and cement the bands correctly.", "bbox": [441.0, 884.0, 669.0, 901.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "One of the most popular appliances for upper molar", "bbox": [416.0, 918.0, 731.0, 934.0]}, {"text": "distalization is the Pendulum or the Pendex. These appli¬", "bbox": [416.0, 935.0, 729.0, 952.0]}, {"text": "ances are very effective for this dental movement, but we", "bbox": [416.0, 953.0, 731.0, 969.0]}], "type": "Text", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 300}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "标点错误#0#0#lin¬ gual应该去掉¬\n多余换行#2#11#2段1.对应7段 Remove the anchorage immediately...3段 2.对应8段Suspend canine or anterior...依次往下", "type3": "无关文本#0#0# (4.15)", "type4": null, "type5": null, "type6": "有用性#0#0#Fig. 75. Lingual arch decementation.....Fig. 76. Loop invagination.图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:36:32"}
{"id": 1042076, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "e74b7fcb-a6b9-4b09-bb01-98dde0041d41", "title": null, "text": "【0】页码:127\n ventricular tachyarrhythmias, infusing 1.5 mg/kg of sotalol over ¶ 5 minutes was found to be relatively safe and effective, causing hypotension in only 2 patients, both of whom responded to IV fluid. 421 Package insert recommends slow infusion, but the literature supports more rapid infusion of 1.5 mg/kg over 5 minutes or less. Sotalol should be avoided in patients with a prolonged QT interval.\n\n【1】Amiodarone is also effective in preventing recurrent monomorphic VT or treating refractory ventricular arrhythmias 286 . 422 – 424 in patients with coronary artery disease and poor ventricular function. It is given 150 mg IV over 10 minutes; dosing should be repeated as needed to a maximum dose of 2.2 g IV per 24 hours. Higher doses (300 mg) were associated with an increased frequency of hypotension, although some reports 422,424 attributed the hypotension to the vasoactive solvents that are not present in a new form of the drug recently approved for use in the US.\n\n【2】By comparison, lidocaine is less effective in terminating VT than procainamide, sotalol, and amiodarone, 286 , 419 , 420 and when given to patients with or without a history of MI with spontaneous sustained stable VT in the hospital setting. 413,425,426 Lidocaine has been reported to variably terminate VT when administered intramuscularly to patients with AMI and VT in the out-of-hospital setting. 427,428 Thus, while occasionally effective, lidocaine should be considered second-line antiarrhythmic therapy for monomorphic VT. Lidocaine can be administered at a dose of 1 to 1.5 mg/kg IV bolus. Maintenance infusion is 1 to 4 mg/min (30 to 50 mcg/kg per minute).\n\n【3】## Irregular Tachycardias\n\n【4】\n## Atrial Fibrillation And Flutter\n\n【5】\n Evaluation An irregular narrow-complex or wide-complex tachycardia is most likely atrial fibrillation (with or without aberrant conduction) with an uncontrolled ventricular response. Other diagnostic possibilities include MAT or sinus rhythm/tachycardia with frequent atrial premature beats. When there is doubt about the rhythm diagnosis and the patient is stable, a 12-lead ECG with expert consultation is recommended.\n\n【6】 Therapy General management of atrial fibrillation should focus on control of the rapid ventricular rate (rate control), conversion of hemodynamically unstable atrial fibrillation to sinus rhythm (rhythm control), or both. Patients with an atrial fibrillation duration of > 48 hours are at increased risk for cardioembolic events, although shorter durations of atrial fibrillation do not exclude the possibility of such events. Electric or pharmacologic cardioversion (conversion to normal sinus rhythm) should not be attempted in these patients unless the patient is unstable. An alternative strategy is to perform cardioversion following anticoagulation with heparin and performance of transesophageal echocardiography to ensure the absence of a left atrial thrombus; see the ACC/AHA Guidelines for Management of Patients with Atrial Fibrillation. 429\n\n【7】 Rate Control Patients who are hemodynamically unstable should receive prompt electric cardioversion. More stable patients require\n\n【8】 ventricular rate control as directed by patient symptoms and hemodynamics. IV b -blockers and nondihydropyridine calcium channel blockers such as diltiazem 430 – 433 are the drugs of choice for acute rate control in most individuals with atrial fibrillation and rapid ventricular response (Class IIa, LOE A). Digoxin 434 – 436 and amiodarone 437 . 438 may be used for rate control in patients with congestive heart failure; however, the potential risk of conversion to sinus rhythm with amiodarone should be considered before treating with this agent.\n\n【9】A wide-complex irregular rhythm should be considered preexcited atrial fibrillation. Expert consultation is advised. Avoid AV nodal blocking agents such as adenosine, calcium channel blockers, digoxin, and possibly β -blockers in patients with pre-excitation atrial fibrillation because these drugs may cause a paradoxical increase in the ventricular response. Typically, patients with pre-excited atrial fibrillation present with very rapid heart rates and require emergent electric cardioversion.\n\n【10】When electric cardioversion is not feasible or effective, or atrial fibrillation is recurrent, use of rhythm control agents (discussed below) may be useful for both rate control and stabilization of the rhythm.\n\n【11】 Rhythm Control A variety of agents have been shown to be effective in terminating atrial fibrillation (pharmacologic or chemical cardioversion), although success between them varies and not all are available as parenteral formulations. Expert consultation is recommended.\n\n【12】## Polymorphic (Irregular) Vt\n\n【13】\n Polymorphic (irregular) VT requires immediate defibrillation with the same strategy used for VF.\n\n【14】Pharmacologic treatment to prevent recurrent polymorphic VT should be directed by the underlying cause of VT and the presence or absence of a long QT interval during sinus rhythm.\n\n【15】If a long QT interval is observed during sinus rhythm (ie, the VT is torsades de pointes), the first step is to stop medications known to prolong the QT interval. Correct electrolyte imbalance and other acute precipitants (eg, drug overdose or poisoning: see Part 12.7: \"Cardiac Arrest Associated With Toxic Ingestions\").\n\n【16】Although magnesium is commonly used to treat torsades de pointes VT (polymorphic VT associated with long QT interval), it is supported by only 2 observational studies 107 . 170 that showed effectiveness in patients with prolonged QT interval. One adult case series 439 showed that isoproterenol or ventricular pacing can be effective in terminating torsades de pointes associated with bradycardia and drug-induced QT prolongation. Polymorphic VT associated with familial long QT syndrome may be treated with IV magnesium, pacing, and/or β -blockers; isoproterenol should be avoided. Polymorphic VT associated with acquired long QT syndrome may be treated with IV magnesium. The addition of pacing or IV isoproterenol may be considered when polymorphic VT is accompanied by bradycardia or appears to be precipitated by pauses in rhythm.\n\n【17】In the absence of a prolonged QT interval, the most common cause of polymorphic VT is myocardial ischemia. In this situation IV amiodarone and b -blockers may reduce the frequency of arrhythmia recurrence (Class Ilb, LOE C). Myocar-\n\n【18】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "ventricular tachyarrhythmias, infusing 1.5 mg/kg of sotalol over", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "¶ 5 minutes was found to be relatively safe and effective,", "bbox": [60.0, 100.0, 375.0, 113.0]}, {"text": "causing hypotension in only 2 patients, both of whom responded", "bbox": [60.0, 115.0, 377.0, 130.0]}, {"text": "to IV fluid. 421 Package insert recommends slow infusion, but the", "bbox": [60.0, 131.0, 375.0, 145.0]}, {"text": "literature supports more rapid infusion of 1.5 mg/kg over 5", "bbox": [60.0, 147.0, 376.0, 160.0]}, {"text": "minutes or less. Sotalol should be avoided in patients with a", "bbox": [60.0, 162.0, 377.0, 176.0]}, {"text": "prolonged QT interval.", "bbox": [60.0, 178.0, 176.0, 191.0]}, {"text": "Amiodarone is also effective in preventing recurrent", "bbox": [74.0, 194.0, 377.0, 207.0]}, {"text": "monomorphic VT or treating refractory ventricular", "bbox": [60.0, 208.0, 375.0, 223.0]}, {"text": "arrhythmias 286 . 422 – 424 in patients with coronary artery disease", "bbox": [60.0, 222.0, 376.0, 238.0]}, {"text": "and poor ventricular function. It is given 150 mg IV over 10", "bbox": [60.0, 239.0, 377.0, 253.0]}, {"text": "minutes; dosing should be repeated as needed to a maximum", "bbox": [60.0, 254.0, 377.0, 269.0]}, {"text": "dose of 2.2 g IV per 24 hours. Higher doses (300 mg) were", "bbox": [60.0, 270.0, 375.0, 284.0]}, {"text": "associated with an increased frequency of hypotension, al-", "bbox": [60.0, 286.0, 375.0, 300.0]}, {"text": "though some reports 422,424 attributed the hypotension to the", "bbox": [60.0, 301.0, 376.0, 315.0]}, {"text": "vasoactive solvents that are not present in a new form of the", "bbox": [60.0, 316.0, 376.0, 330.0]}, {"text": "drug recently approved for use in the US.", "bbox": [60.0, 332.0, 279.0, 346.0]}, {"text": "By comparison, lidocaine is less effective in terminating VT", "bbox": [73.0, 348.0, 375.0, 361.0]}, {"text": "than procainamide, sotalol, and amiodarone, 286 , 419 , 420 and when", "bbox": [60.0, 362.0, 377.0, 377.0]}, {"text": "given to patients with or without a history of MI with sponta-", "bbox": [60.0, 378.0, 375.0, 392.0]}, {"text": "neous sustained stable VT in the hospital setting. 413,425,426 Lido-", "bbox": [60.0, 394.0, 375.0, 408.0]}, {"text": "caine has been reported to variably terminate VT when admin-", "bbox": [60.0, 409.0, 375.0, 423.0]}, {"text": "istered intramuscularly to patients with AMI and VT in the", "bbox": [60.0, 425.0, 376.0, 439.0]}, {"text": "out-of-hospital setting. 427,428 Thus, while occasionally effective,", "bbox": [60.0, 440.0, 375.0, 455.0]}, {"text": "lidocaine should be considered second-line antiarrhythmic ther-", "bbox": [60.0, 455.0, 375.0, 470.0]}, {"text": "apy for monomorphic VT. Lidocaine can be administered at a", "bbox": [60.0, 470.0, 377.0, 487.0]}, {"text": "dose of 1 to 1.5 mg/kg IV bolus. Maintenance infusion is 1 to 4", "bbox": [60.0, 487.0, 376.0, 501.0]}, {"text": "mg/min (30 to 50 mcg/kg per minute).", "bbox": [60.0, 502.0, 255.0, 516.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Irregular Tachycardias", "bbox": [60.0, 531.0, 206.0, 547.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Atrial Fibrillation and Flutter", "bbox": [60.0, 553.0, 223.0, 568.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Evaluation", "bbox": [60.0, 576.0, 120.0, 589.0]}, {"text": "An irregular narrow-complex or wide-complex tachycardia is", "bbox": [60.0, 589.0, 377.0, 604.0]}, {"text": "most likely atrial fibrillation (with or without aberrant conduc-", "bbox": [60.0, 605.0, 375.0, 619.0]}, {"text": "tion) with an uncontrolled ventricular response. Other diagnostic", "bbox": [60.0, 621.0, 375.0, 635.0]}, {"text": "possibilities include MAT or sinus rhythm/tachycardia with", "bbox": [60.0, 636.0, 376.0, 649.0]}, {"text": "frequent atrial premature beats. When there is doubt about the", "bbox": [60.0, 651.0, 375.0, 666.0]}, {"text": "rhythm diagnosis and the patient is stable, a 12-lead ECG with", "bbox": [60.0, 668.0, 376.0, 681.0]}, {"text": "expert consultation is recommended.", "bbox": [60.0, 682.0, 245.0, 696.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Therapy", "bbox": [61.0, 709.0, 107.0, 722.0]}, {"text": "General management of atrial fibrillation should focus on", "bbox": [60.0, 721.0, 376.0, 736.0]}, {"text": "control of the rapid ventricular rate (rate control), conversion of", "bbox": [60.0, 737.0, 376.0, 750.0]}, {"text": "hemodynamically unstable atrial fibrillation to sinus rhythm", "bbox": [60.0, 752.0, 377.0, 767.0]}, {"text": "(rhythm control), or both. Patients with an atrial fibrillation", "bbox": [60.0, 769.0, 376.0, 782.0]}, {"text": "duration of > 48 hours are at increased risk for cardioembolic", "bbox": [60.0, 783.0, 375.0, 797.0]}, {"text": "events, although shorter durations of atrial fibrillation do not", "bbox": [60.0, 800.0, 376.0, 813.0]}, {"text": "exclude the possibility of such events. Electric or pharmacologic", "bbox": [60.0, 815.0, 376.0, 829.0]}, {"text": "cardioversion (conversion to normal sinus rhythm) should not be", "bbox": [60.0, 830.0, 376.0, 844.0]}, {"text": "attempted in these patients unless the patient is unstable. An", "bbox": [60.0, 845.0, 377.0, 859.0]}, {"text": "alternative strategy is to perform cardioversion following anti-", "bbox": [60.0, 861.0, 375.0, 875.0]}, {"text": "coagulation with heparin and performance of transesophageal", "bbox": [60.0, 876.0, 376.0, 890.0]}, {"text": "echocardiography to ensure the absence of a left atrial thrombus;", "bbox": [60.0, 891.0, 376.0, 906.0]}, {"text": "see the ACC/AHA Guidelines for Management of Patients with", "bbox": [60.0, 908.0, 376.0, 921.0]}, {"text": "Atrial Fibrillation. 429", "bbox": [60.0, 923.0, 165.0, 936.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Rate Control", "bbox": [60.0, 948.0, 131.0, 962.0]}, {"text": "Patients who are hemodynamically unstable should receive", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "prompt electric cardioversion. More stable patients require", "bbox": [60.0, 977.0, 376.0, 991.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "ventricular rate control as directed by patient symptoms", "bbox": [403.0, 84.0, 720.0, 99.0]}, {"text": "and hemodynamics. IV b -blockers and nondihydropyri-", "bbox": [403.0, 100.0, 720.0, 113.0]}, {"text": "dine calcium channel blockers such as diltiazem 430 – 433 are", "bbox": [403.0, 115.0, 720.0, 129.0]}, {"text": "the drugs of choice for acute rate control in most individ-", "bbox": [403.0, 132.0, 719.0, 144.0]}, {"text": "uals with atrial fibrillation and rapid ventricular response", "bbox": [403.0, 146.0, 720.0, 160.0]}, {"text": "(Class IIa, LOE A). Digoxin 434 – 436 and amiodarone 437 . 438", "bbox": [403.0, 160.0, 720.0, 175.0]}, {"text": "may be used for rate control in patients with congestive", "bbox": [403.0, 177.0, 721.0, 190.0]}, {"text": "heart failure; however, the potential risk of conversion to", "bbox": [403.0, 192.0, 721.0, 207.0]}, {"text": "sinus rhythm with amiodarone should be considered before", "bbox": [403.0, 208.0, 720.0, 221.0]}, {"text": "treating with this agent.", "bbox": [403.0, 223.0, 536.0, 237.0]}, {"text": "A wide-complex irregular rhythm should be considered pre-", "bbox": [417.0, 238.0, 719.0, 253.0]}, {"text": "excited atrial fibrillation. Expert consultation is advised. Avoid", "bbox": [403.0, 254.0, 720.0, 267.0]}, {"text": "AV nodal blocking agents such as adenosine, calcium channel", "bbox": [404.0, 269.0, 720.0, 283.0]}, {"text": "blockers, digoxin, and possibly β -blockers in patients with", "bbox": [403.0, 285.0, 720.0, 298.0]}, {"text": "pre-excitation atrial fibrillation because these drugs may cause a", "bbox": [404.0, 300.0, 721.0, 314.0]}, {"text": "paradoxical increase in the ventricular response. Typically,", "bbox": [403.0, 316.0, 720.0, 329.0]}, {"text": "patients with pre-excited atrial fibrillation present with very", "bbox": [403.0, 330.0, 720.0, 344.0]}, {"text": "rapid heart rates and require emergent electric cardioversion.", "bbox": [403.0, 347.0, 719.0, 361.0]}, {"text": "When electric cardioversion is not feasible or effective, or atrial", "bbox": [404.0, 361.0, 720.0, 374.0]}, {"text": "fibrillation is recurrent, use of rhythm control agents (discussed", "bbox": [404.0, 376.0, 720.0, 391.0]}, {"text": "below) may be useful for both rate control and stabilization of", "bbox": [403.0, 393.0, 720.0, 406.0]}, {"text": "the rhythm.", "bbox": [403.0, 408.0, 464.0, 421.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Rhythm Control", "bbox": [404.0, 433.0, 491.0, 447.0]}, {"text": "A variety of agents have been shown to be effective in", "bbox": [404.0, 446.0, 721.0, 461.0]}, {"text": "terminating atrial fibrillation (pharmacologic or chemical", "bbox": [403.0, 462.0, 720.0, 475.0]}, {"text": "cardioversion), although success between them varies and not", "bbox": [403.0, 477.0, 721.0, 491.0]}, {"text": "all are available as parenteral formulations. Expert consulta-", "bbox": [403.0, 493.0, 718.0, 507.0]}, {"text": "tion is recommended.", "bbox": [403.0, 508.0, 518.0, 522.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Polymorphic (Irregular) VT", "bbox": [404.0, 531.0, 556.0, 548.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Polymorphic (irregular) VT requires immediate defibrillation", "bbox": [403.0, 547.0, 721.0, 560.0]}, {"text": "with the same strategy used for VF.", "bbox": [403.0, 562.0, 594.0, 576.0]}, {"text": "Pharmacologic treatment to prevent recurrent polymorphic", "bbox": [416.0, 577.0, 720.0, 591.0]}, {"text": "VT should be directed by the underlying cause of VT and the", "bbox": [404.0, 593.0, 720.0, 607.0]}, {"text": "presence or absence of a long QT interval during sinus", "bbox": [403.0, 609.0, 720.0, 622.0]}, {"text": "rhythm.", "bbox": [403.0, 623.0, 447.0, 637.0]}, {"text": "If a long QT interval is observed during sinus rhythm (ie, the", "bbox": [416.0, 638.0, 720.0, 653.0]}, {"text": "VT is torsades de pointes), the first step is to stop medications", "bbox": [404.0, 654.0, 720.0, 668.0]}, {"text": "known to prolong the QT interval. Correct electrolyte imbalance", "bbox": [403.0, 669.0, 720.0, 683.0]}, {"text": "and other acute precipitants (eg, drug overdose or poisoning: see", "bbox": [404.0, 685.0, 720.0, 698.0]}, {"text": "Part 12.7: \"Cardiac Arrest Associated With Toxic Ingestions\").", "bbox": [404.0, 700.0, 720.0, 715.0]}, {"text": "Although magnesium is commonly used to treat torsades de", "bbox": [404.0, 716.0, 720.0, 729.0]}, {"text": "pointes VT (polymorphic VT associated with long QT interval),", "bbox": [404.0, 731.0, 720.0, 745.0]}, {"text": "it is supported by only 2 observational studies 107 . 170 that showed", "bbox": [403.0, 747.0, 720.0, 761.0]}, {"text": "effectiveness in patients with prolonged QT interval. One adult", "bbox": [403.0, 762.0, 721.0, 776.0]}, {"text": "case series 439 showed that isoproterenol or ventricular pacing can", "bbox": [403.0, 776.0, 720.0, 791.0]}, {"text": "be effective in terminating torsades de pointes associated with", "bbox": [403.0, 793.0, 720.0, 806.0]}, {"text": "bradycardia and drug-induced QT prolongation. Polymorphic", "bbox": [403.0, 808.0, 720.0, 823.0]}, {"text": "VT associated with familial long QT syndrome may be treated", "bbox": [404.0, 823.0, 720.0, 837.0]}, {"text": "with IV magnesium, pacing, and/or β -blockers; isoproterenol", "bbox": [404.0, 838.0, 720.0, 852.0]}, {"text": "should be avoided. Polymorphic VT associated with acquired", "bbox": [403.0, 855.0, 720.0, 868.0]}, {"text": "long QT syndrome may be treated with IV magnesium. The", "bbox": [404.0, 870.0, 720.0, 883.0]}, {"text": "addition of pacing or IV isoproterenol may be considered when", "bbox": [404.0, 885.0, 720.0, 899.0]}, {"text": "polymorphic VT is accompanied by bradycardia or appears to be", "bbox": [403.0, 901.0, 720.0, 914.0]}, {"text": "precipitated by pauses in rhythm.", "bbox": [403.0, 916.0, 572.0, 930.0]}, {"text": "In the absence of a prolonged QT interval, the most common", "bbox": [417.0, 931.0, 720.0, 945.0]}, {"text": "cause of polymorphic VT is myocardial ischemia. In this", "bbox": [403.0, 946.0, 720.0, 961.0]}, {"text": "situation IV amiodarone and b -blockers may reduce the fre-", "bbox": [403.0, 962.0, 718.0, 976.0]}, {"text": "quency of arrhythmia recurrence (Class Ilb, LOE C). Myocar-", "bbox": [403.0, 977.0, 718.0, 991.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 13}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 127}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#5#5#Evaluation应与后面分行\n缺少换行#6#6# Therapy应与后面分行\n缺少换行#7#7# Rate Control应与后面分行\n多余换行#7#8#为同段内容\n缺少换行#11#11# Rhythm Control应与后面分开", "type3": "无关文本#0#17#多处存在无关数字", "type6": "信息有用性#18#18#无关内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:36:22"}
{"id": 1042075, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "fe07082a-7e76-44a1-b437-e0a0c4d5e745", "title": null, "text": "【0】页码:299\n\n【1】## Disclosures\n\n【2】 Guidelines Part 15: Neonatal Resuscitation Writing Group Disclosures\n\n【3】 Guidelines Part 15: Neonatal Resuscitation Writing Group Disclosures Writing Group Ownership Member Employment Research Grant Other Research Support Speakers' Bureau/ Honoraria Interest Consultant/ Advisory Board Other University of Virginia–Professor None None None None John None None Kattwinkel of Pediatrics Well Comell-Professor of Jeffrey M.\n\n【4】† NH-NH- Improving antimicrobial None None None None None Periman Pediatrics prescribing practices in the NICU University of Alberta – Associate Khalid Aziz None None None None None None Professor of Pediatrics Mayo Clinic–physician Christopher None None None None None None Colby Karen University of Virginia Health None None None None None None Fairchild System–Associate Professor of Pediatrics Univ. Hosp of Cleveland-Crit None None None None None John None Care Coordinator of Ped Resp.\n\n【5】Gallapher Care Mary Fran Vanderbilt University School of Nane None None None None None Hazinski Nursing—Professor; AHA ECC Product Development-Senior Science Editor †Significant AHA compensation to write, edit and review documents such as the 2010 AHA Guidelines for CPR and ECO Stanford University–Associate † Laerdal Foundation: The Laerdal \"I have received <: 10 honoraria \"Laerdal Medical Advanced Louis P.\n\n【6】None None \"I provide medical in amounts of $500 or less from Medical Simulation Both of consultation to the logal Foundation (not company) provided a grant to the Center for speaking at various academic these companies reimburse profession for which I am Advanced Pediatric and Perinatal meetings in the past 24 months; reimbursed directly.\n\n【7】me directly.\n\n【8】Education at Packard Children's none of these meetings were Hospital at Stanford during the conducted by for-profit entities.\n\n【9】academic years 2006–07, 2007–08, 2008–09; I develop simulation-based training programs and conduct research at CAPE. This support was provided directly to my institution.\n\n【10】Praveen PEDIATRIC FACULTY None None None None None None Kumar FOUNDATION- ATTENDING NEONATOLOGIST Dartmouth College- Ped.\n\n【11】None None None None None George None Little Professor; Dartmouth Hitchcock.\n\n【12】Medfont. Center Neonatologist St Christopher's Pediatric Jane E.\n\n【13】None None None None * reviewed records of cases None McGovan Associate/ involving neonatal Tenet Healthcare–Attending resuscitation on one or two neonatologist; medical drector; occasions over the past 5 NICU years.\n\n【14】\"As co-editor for Textbook of Neonatal Resuscitation 6th edition, to be published by the AAP, being paid a total of $4000 over 3 years by the AAP.\n\n【15】Univ.Health Assoc,Nurse Barbara Nane None None None None None Nightengale Practitioner Mildred M.\n\n【16】Univ of Texas Med School \"Expert for Current expert None None \"Signed as consultant for None None Ramirez Houston-Physiolan Cytokine Pharmasciences, Inc.\n\n【17】case of triplets and preterm for a lecture in Mexico City.\n\n【18】delivery. Money to the Product Propress for central university &quote;09 rippening. $2,000 Money to Univ.\n\n【19】\"Vermont Oxford Neonatal Steven Brigham and Women's None None None *Aere $2000, consultation †Several Attorneys, serving Ringer Hospital–Chief, Newborn Network, $1000, comes to me Dey Pharamaceutical $1000 as expert witness in Medicine Consultation Forrest Medical malpractice cases Pharmaceuticals $1500 Grant Review Committee Wendy M.\n\n【20】American Academy of None None None None None None Pediatrics–Director, Life Support Simon Programs Gary M.\n\n【21】St. Joseph Mercy Hospital-Ann None †Received equipment on-igan None None None None Arbor Michigan–Attending (3 resuscitation mannequins, 2 Weiner asts of video recording Neonatologist equipment) from Laerdal Medical Corporation to be used to complete a research project evaluating educational methods for teaching neonatal resuscitation. The value of the on-loan equipment is approximately $35,000.\n\n【22】(Continued)\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Disclosures", "bbox": [351.0, 85.0, 429.0, 100.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Guidelines Part 15: Neonatal Resuscitation Writing Group Disclosures", "bbox": [60.0, 111.0, 401.0, 127.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "Guidelines Part 15: Neonatal Resuscitation Writing Group Disclosures", "bbox": [60.0, 111.0, 401.0, 127.0]}, {"text": "Writing", "bbox": [61.0, 136.0, 83.0, 144.0]}, {"text": "Group", "bbox": [61.0, 144.0, 81.0, 155.0]}, {"text": "Ownership", "bbox": [509.0, 144.0, 540.0, 154.0]}, {"text": "Member", "bbox": [60.0, 153.0, 85.0, 162.0]}, {"text": "Employment", "bbox": [131.0, 153.0, 169.0, 165.0]}, {"text": "Research Grant", "bbox": [229.0, 153.0, 276.0, 164.0]}, {"text": "Other Research Support", "bbox": [318.0, 153.0, 389.0, 165.0]}, {"text": "Speakers' Bureau/ Honoraria", "bbox": [411.0, 153.0, 494.0, 165.0]}, {"text": "Interest", "bbox": [512.0, 153.0, 538.0, 165.0]}, {"text": "Consultant/ Advisory Board", "bbox": [551.0, 153.0, 629.0, 165.0]}, {"text": "Other", "bbox": [669.0, 153.0, 687.0, 162.0]}, {"text": "University of Virginia–Professor", "bbox": [105.0, 167.0, 193.0, 180.0]}, {"text": "None", "bbox": [243.0, 169.0, 260.0, 178.0]}, {"text": "None", "bbox": [344.0, 169.0, 361.0, 178.0]}, {"text": "None", "bbox": [443.0, 169.0, 460.0, 178.0]}, {"text": "None", "bbox": [669.0, 169.0, 686.0, 178.0]}, {"text": "John", "bbox": [61.0, 170.0, 78.0, 178.0]}, {"text": "None", "bbox": [516.0, 170.0, 533.0, 178.0]}, {"text": "None", "bbox": [581.0, 170.0, 598.0, 178.0]}, {"text": "Kattwinkel", "bbox": [60.0, 178.0, 91.0, 187.0]}, {"text": "of Pediatrics", "bbox": [131.0, 178.0, 170.0, 188.0]}, {"text": "Well Comell-Professor of", "bbox": [113.0, 191.0, 187.0, 200.0]}, {"text": "Jeffrey M.", "bbox": [61.0, 192.0, 89.0, 200.0]}, {"text": "† NH-NH- Improving antimicrobial", "bbox": [204.0, 192.0, 301.0, 203.0]}, {"text": "None", "bbox": [343.0, 192.0, 361.0, 201.0]}, {"text": "None", "bbox": [443.0, 192.0, 461.0, 202.0]}, {"text": "None", "bbox": [516.0, 192.0, 533.0, 201.0]}, {"text": "None", "bbox": [581.0, 192.0, 598.0, 200.0]}, {"text": "None", "bbox": [669.0, 192.0, 687.0, 200.0]}, {"text": "Periman", "bbox": [60.0, 202.0, 85.0, 210.0]}, {"text": "Pediatrics", "bbox": [133.0, 202.0, 165.0, 210.0]}, {"text": "prescribing practices in the NICU", "bbox": [206.0, 202.0, 299.0, 211.0]}, {"text": "University of Alberta – Associate", "bbox": [104.0, 215.0, 193.0, 224.0]}, {"text": "Khalid Aziz", "bbox": [60.0, 216.0, 93.0, 224.0]}, {"text": "None", "bbox": [243.0, 216.0, 260.0, 224.0]}, {"text": "None", "bbox": [344.0, 216.0, 361.0, 224.0]}, {"text": "None", "bbox": [443.0, 216.0, 460.0, 225.0]}, {"text": "None", "bbox": [516.0, 216.0, 533.0, 225.0]}, {"text": "None", "bbox": [581.0, 216.0, 598.0, 225.0]}, {"text": "None", "bbox": [669.0, 216.0, 687.0, 224.0]}, {"text": "Professor of Pediatrics", "bbox": [117.0, 225.0, 182.0, 234.0]}, {"text": "Mayo Clinic–physician", "bbox": [118.0, 238.0, 182.0, 249.0]}, {"text": "Christopher", "bbox": [61.0, 239.0, 94.0, 249.0]}, {"text": "None", "bbox": [243.0, 239.0, 260.0, 248.0]}, {"text": "None", "bbox": [443.0, 239.0, 460.0, 248.0]}, {"text": "None", "bbox": [516.0, 239.0, 533.0, 248.0]}, {"text": "None", "bbox": [669.0, 239.0, 687.0, 248.0]}, {"text": "None", "bbox": [344.0, 240.0, 361.0, 248.0]}, {"text": "None", "bbox": [581.0, 240.0, 598.0, 248.0]}, {"text": "Colby", "bbox": [61.0, 248.0, 79.0, 259.0]}, {"text": "Karen", "bbox": [60.0, 261.0, 80.0, 272.0]}, {"text": "University of Virginia Health", "bbox": [109.0, 261.0, 190.0, 273.0]}, {"text": "None", "bbox": [243.0, 261.0, 261.0, 273.0]}, {"text": "None", "bbox": [443.0, 261.0, 460.0, 273.0]}, {"text": "None", "bbox": [516.0, 261.0, 533.0, 273.0]}, {"text": "None", "bbox": [581.0, 261.0, 598.0, 273.0]}, {"text": "None", "bbox": [669.0, 261.0, 687.0, 273.0]}, {"text": "None", "bbox": [344.0, 262.0, 361.0, 273.0]}, {"text": "Fairchild", "bbox": [60.0, 272.0, 86.0, 281.0]}, {"text": "System–Associate Professor of", "bbox": [107.0, 272.0, 193.0, 281.0]}, {"text": "Pediatrics", "bbox": [133.0, 282.0, 165.0, 290.0]}, {"text": "Univ. Hosp of Cleveland-Crit", "bbox": [109.0, 294.0, 191.0, 305.0]}, {"text": "None", "bbox": [243.0, 295.0, 260.0, 304.0]}, {"text": "None", "bbox": [443.0, 295.0, 460.0, 304.0]}, {"text": "None", "bbox": [516.0, 295.0, 533.0, 304.0]}, {"text": "None", "bbox": [581.0, 295.0, 598.0, 304.0]}, {"text": "None", "bbox": [669.0, 295.0, 687.0, 304.0]}, {"text": "John", "bbox": [61.0, 296.0, 78.0, 304.0]}, {"text": "None", "bbox": [344.0, 296.0, 362.0, 304.0]}, {"text": "Care Coordinator of Ped Resp.", "bbox": [107.0, 303.0, 191.0, 314.0]}, {"text": "Gallapher", "bbox": [61.0, 304.0, 88.0, 314.0]}, {"text": "Care", "bbox": [141.0, 314.0, 156.0, 323.0]}, {"text": "Mary Fran", "bbox": [61.0, 327.0, 91.0, 339.0]}, {"text": "Vanderbilt University School of", "bbox": [107.0, 327.0, 193.0, 339.0]}, {"text": "Nane", "bbox": [243.0, 328.0, 260.0, 338.0]}, {"text": "None", "bbox": [344.0, 328.0, 360.0, 337.0]}, {"text": "None", "bbox": [443.0, 327.0, 460.0, 337.0]}, {"text": "None", "bbox": [516.0, 328.0, 532.0, 337.0]}, {"text": "None", "bbox": [581.0, 328.0, 598.0, 337.0]}, {"text": "None", "bbox": [669.0, 328.0, 686.0, 337.0]}, {"text": "Hazinski", "bbox": [61.0, 338.0, 86.0, 346.0]}, {"text": "Nursing—Professor; AHA ECC", "bbox": [107.0, 338.0, 192.0, 346.0]}, {"text": "Product Development-Senior", "bbox": [109.0, 345.0, 187.0, 357.0]}, {"text": "Science Editor", "bbox": [128.0, 355.0, 171.0, 367.0]}, {"text": "†Significant AHA compensation", "bbox": [105.0, 365.0, 193.0, 374.0]}, {"text": "to write, edit and review", "bbox": [113.0, 373.0, 185.0, 385.0]}, {"text": "documents such as the 2010", "bbox": [108.0, 383.0, 191.0, 395.0]}, {"text": "AHA Guidelines for CPR and", "bbox": [109.0, 394.0, 190.0, 401.0]}, {"text": "ECO", "bbox": [141.0, 402.0, 154.0, 411.0]}, {"text": "Stanford University–Associate", "bbox": [107.0, 414.0, 193.0, 427.0]}, {"text": "† Laerdal Foundation: The Laerdal", "bbox": [204.0, 414.0, 300.0, 427.0]}, {"text": "\"I have received <: 10 honoraria", "bbox": [406.0, 414.0, 499.0, 427.0]}, {"text": "\"Laerdal Medical Advanced", "bbox": [551.0, 414.0, 629.0, 427.0]}, {"text": "Louis P.", "bbox": [61.0, 415.0, 85.0, 427.0]}, {"text": "None", "bbox": [344.0, 415.0, 362.0, 426.0]}, {"text": "None", "bbox": [516.0, 415.0, 534.0, 426.0]}, {"text": "\"I provide medical", "bbox": [652.0, 415.0, 705.0, 427.0]}, {"text": "in amounts of $500 or less from", "bbox": [405.0, 425.0, 498.0, 437.0]}, {"text": "Medical Simulation Both of", "bbox": [551.0, 425.0, 629.0, 436.0]}, {"text": "consultation to the logal", "bbox": [644.0, 425.0, 713.0, 437.0]}, {"text": "Foundation (not company)", "bbox": [215.0, 426.0, 289.0, 437.0]}, {"text": "provided a grant to the Center for", "bbox": [204.0, 435.0, 300.0, 444.0]}, {"text": "speaking at various academic", "bbox": [409.0, 435.0, 494.0, 444.0]}, {"text": "these companies reimburse", "bbox": [549.0, 435.0, 629.0, 443.0]}, {"text": "profession for which I am", "bbox": [641.0, 435.0, 715.0, 443.0]}, {"text": "Advanced Pediatric and Perinatal", "bbox": [206.0, 443.0, 298.0, 455.0]}, {"text": "meetings in the past 24 months;", "bbox": [406.0, 443.0, 497.0, 455.0]}, {"text": "reimbursed directly.", "bbox": [651.0, 444.0, 705.0, 454.0]}, {"text": "me directly.", "bbox": [573.0, 445.0, 605.0, 454.0]}, {"text": "Education at Packard Children's", "bbox": [206.0, 453.0, 297.0, 465.0]}, {"text": "none of these meetings were", "bbox": [409.0, 453.0, 495.0, 465.0]}, {"text": "Hospital at Stanford during the", "bbox": [208.0, 463.0, 297.0, 471.0]}, {"text": "conducted by for-profit entities.", "bbox": [406.0, 463.0, 495.0, 472.0]}, {"text": "academic years 2006–07,", "bbox": [213.0, 472.0, 289.0, 481.0]}, {"text": "2007–08, 2008–09; I develop", "bbox": [209.0, 481.0, 295.0, 493.0]}, {"text": "simulation-based training", "bbox": [216.0, 491.0, 289.0, 499.0]}, {"text": "programs and conduct research at", "bbox": [204.0, 501.0, 302.0, 510.0]}, {"text": "CAPE. This support was provided", "bbox": [204.0, 509.0, 299.0, 521.0]}, {"text": "directly to my institution.", "bbox": [216.0, 519.0, 287.0, 529.0]}, {"text": "Praveen", "bbox": [60.0, 533.0, 85.0, 542.0]}, {"text": "PEDIATRIC FACULTY", "bbox": [120.0, 532.0, 180.0, 542.0]}, {"text": "None", "bbox": [243.0, 533.0, 260.0, 542.0]}, {"text": "None", "bbox": [344.0, 533.0, 362.0, 542.0]}, {"text": "None", "bbox": [443.0, 533.0, 461.0, 543.0]}, {"text": "None", "bbox": [516.0, 533.0, 533.0, 543.0]}, {"text": "None", "bbox": [581.0, 533.0, 599.0, 543.0]}, {"text": "None", "bbox": [669.0, 533.0, 687.0, 543.0]}, {"text": "Kumar", "bbox": [61.0, 543.0, 81.0, 550.0]}, {"text": "FOUNDATION-", "bbox": [128.0, 543.0, 169.0, 551.0]}, {"text": "ATTENDING NEONATOLOGIST", "bbox": [107.0, 551.0, 191.0, 562.0]}, {"text": "Dartmouth College- Ped.", "bbox": [113.0, 565.0, 185.0, 576.0]}, {"text": "None", "bbox": [243.0, 566.0, 260.0, 575.0]}, {"text": "None", "bbox": [443.0, 566.0, 460.0, 575.0]}, {"text": "None", "bbox": [516.0, 566.0, 533.0, 575.0]}, {"text": "None", "bbox": [581.0, 566.0, 598.0, 575.0]}, {"text": "None", "bbox": [669.0, 566.0, 687.0, 575.0]}, {"text": "George", "bbox": [61.0, 567.0, 81.0, 575.0]}, {"text": "None", "bbox": [344.0, 567.0, 361.0, 575.0]}, {"text": "Little", "bbox": [61.0, 575.0, 76.0, 586.0]}, {"text": "Professor; Dartmouth Hitchcock.", "bbox": [105.0, 575.0, 194.0, 586.0]}, {"text": "Medfont. Center Neonatologist", "bbox": [106.0, 585.0, 193.0, 593.0]}, {"text": "St Christopher's Pediatric", "bbox": [113.0, 596.0, 185.0, 608.0]}, {"text": "Jane E.", "bbox": [61.0, 598.0, 83.0, 607.0]}, {"text": "None", "bbox": [243.0, 598.0, 260.0, 607.0]}, {"text": "None", "bbox": [443.0, 598.0, 460.0, 607.0]}, {"text": "None", "bbox": [516.0, 598.0, 533.0, 607.0]}, {"text": "None", "bbox": [581.0, 598.0, 598.0, 607.0]}, {"text": "* reviewed records of cases", "bbox": [638.0, 597.0, 718.0, 608.0]}, {"text": "None", "bbox": [344.0, 599.0, 361.0, 607.0]}, {"text": "McGovan", "bbox": [61.0, 609.0, 88.0, 616.0]}, {"text": "Associate/", "bbox": [133.0, 609.0, 165.0, 617.0]}, {"text": "involving neonatal", "bbox": [650.0, 609.0, 705.0, 618.0]}, {"text": "Tenet Healthcare–Attending", "bbox": [110.0, 616.0, 188.0, 628.0]}, {"text": "resuscitation on one or two", "bbox": [639.0, 616.0, 718.0, 629.0]}, {"text": "neonatologist; medical drector;", "bbox": [106.0, 627.0, 192.0, 635.0]}, {"text": "occasions over the past 5", "bbox": [640.0, 627.0, 716.0, 635.0]}, {"text": "NICU", "bbox": [141.0, 636.0, 158.0, 645.0]}, {"text": "years.", "bbox": [667.0, 637.0, 687.0, 645.0]}, {"text": "\"As co-editor for Textbook", "bbox": [640.0, 644.0, 716.0, 655.0]}, {"text": "of Neonatal Resuscitation", "bbox": [640.0, 655.0, 715.0, 662.0]}, {"text": "6th edition, to be published", "bbox": [638.0, 663.0, 718.0, 674.0]}, {"text": "by the AAP, being paid a", "bbox": [641.0, 671.0, 716.0, 685.0]}, {"text": "total of $4000 over 3 years", "bbox": [638.0, 682.0, 718.0, 691.0]}, {"text": "by the AAP.", "bbox": [660.0, 693.0, 694.0, 701.0]}, {"text": "Univ.Health Assoc,Nurse", "bbox": [115.0, 705.0, 185.0, 716.0]}, {"text": "Barbara", "bbox": [60.0, 707.0, 85.0, 715.0]}, {"text": "Nane", "bbox": [243.0, 707.0, 260.0, 715.0]}, {"text": "None", "bbox": [344.0, 707.0, 362.0, 715.0]}, {"text": "None", "bbox": [443.0, 707.0, 460.0, 715.0]}, {"text": "None", "bbox": [516.0, 707.0, 533.0, 715.0]}, {"text": "None", "bbox": [581.0, 707.0, 598.0, 715.0]}, {"text": "None", "bbox": [669.0, 707.0, 687.0, 715.0]}, {"text": "Nightengale", "bbox": [61.0, 715.0, 93.0, 726.0]}, {"text": "Practitioner", "bbox": [131.0, 715.0, 167.0, 725.0]}, {"text": "Mildred M.", "bbox": [60.0, 728.0, 92.0, 739.0]}, {"text": "Univ of Texas Med School", "bbox": [113.0, 728.0, 187.0, 740.0]}, {"text": "\"Expert for Current expert", "bbox": [641.0, 728.0, 716.0, 740.0]}, {"text": "None", "bbox": [243.0, 729.0, 261.0, 739.0]}, {"text": "None", "bbox": [344.0, 729.0, 362.0, 739.0]}, {"text": "\"Signed as consultant for", "bbox": [416.0, 729.0, 488.0, 740.0]}, {"text": "None", "bbox": [516.0, 729.0, 533.0, 739.0]}, {"text": "None", "bbox": [581.0, 729.0, 598.0, 739.0]}, {"text": "Ramirez", "bbox": [61.0, 738.0, 85.0, 746.0]}, {"text": "Houston-Physiolan", "bbox": [123.0, 738.0, 176.0, 746.0]}, {"text": "Cytokine Pharmasciences, Inc.", "bbox": [408.0, 738.0, 493.0, 747.0]}, {"text": "case of triplets and preterm", "bbox": [639.0, 738.0, 718.0, 748.0]}, {"text": "for a lecture in Mexico City.", "bbox": [411.0, 748.0, 492.0, 756.0]}, {"text": "delivery. Money to the", "bbox": [645.0, 749.0, 711.0, 756.0]}, {"text": "Product Propress for central", "bbox": [411.0, 756.0, 494.0, 768.0]}, {"text": "university &quote;09", "bbox": [648.0, 756.0, 709.0, 768.0]}, {"text": "rippening. $2,000 Money to Univ.", "bbox": [404.0, 766.0, 499.0, 777.0]}, {"text": "\"Vermont Oxford Neonatal", "bbox": [414.0, 779.0, 490.0, 789.0]}, {"text": "Steven", "bbox": [60.0, 780.0, 82.0, 790.0]}, {"text": "Brigham and Women's", "bbox": [116.0, 780.0, 183.0, 790.0]}, {"text": "None", "bbox": [243.0, 780.0, 260.0, 789.0]}, {"text": "None", "bbox": [343.0, 780.0, 361.0, 789.0]}, {"text": "None", "bbox": [516.0, 780.0, 534.0, 790.0]}, {"text": "*Aere $2000, consultation", "bbox": [551.0, 780.0, 629.0, 790.0]}, {"text": "†Several Attorneys, serving", "bbox": [640.0, 780.0, 718.0, 791.0]}, {"text": "Ringer", "bbox": [60.0, 790.0, 81.0, 798.0]}, {"text": "Hospital–Chief, Newborn", "bbox": [115.0, 790.0, 185.0, 798.0]}, {"text": "Network, $1000, comes to me", "bbox": [408.0, 790.0, 495.0, 798.0]}, {"text": "Dey Pharamaceutical $1000", "bbox": [549.0, 790.0, 629.0, 798.0]}, {"text": "as expert witness in", "bbox": [648.0, 790.0, 708.0, 798.0]}, {"text": "Medicine", "bbox": [135.0, 798.0, 163.0, 810.0]}, {"text": "Consultation Forrest", "bbox": [560.0, 799.0, 620.0, 809.0]}, {"text": "Medical malpractice cases", "bbox": [642.0, 799.0, 714.0, 809.0]}, {"text": "Pharmaceuticals $1500", "bbox": [555.0, 808.0, 625.0, 818.0]}, {"text": "Grant Review Committee", "bbox": [555.0, 818.0, 625.0, 826.0]}, {"text": "Wendy M.", "bbox": [60.0, 832.0, 89.0, 841.0]}, {"text": "American Academy of", "bbox": [117.0, 832.0, 182.0, 840.0]}, {"text": "None", "bbox": [243.0, 832.0, 260.0, 841.0]}, {"text": "None", "bbox": [344.0, 832.0, 361.0, 840.0]}, {"text": "None", "bbox": [443.0, 832.0, 460.0, 841.0]}, {"text": "None", "bbox": [516.0, 832.0, 533.0, 841.0]}, {"text": "None", "bbox": [581.0, 832.0, 598.0, 840.0]}, {"text": "None", "bbox": [669.0, 832.0, 687.0, 841.0]}, {"text": "Pediatrics–Director, Life Support", "bbox": [105.0, 841.0, 196.0, 851.0]}, {"text": "Simon", "bbox": [61.0, 843.0, 81.0, 849.0]}, {"text": "Programs", "bbox": [135.0, 850.0, 163.0, 861.0]}, {"text": "Gary M.", "bbox": [61.0, 863.0, 85.0, 875.0]}, {"text": "St. Joseph Mercy Hospital-Ann", "bbox": [105.0, 863.0, 193.0, 875.0]}, {"text": "None", "bbox": [243.0, 863.0, 261.0, 875.0]}, {"text": "†Received equipment on-igan", "bbox": [310.0, 863.0, 396.0, 875.0]}, {"text": "None", "bbox": [443.0, 863.0, 460.0, 875.0]}, {"text": "None", "bbox": [516.0, 863.0, 533.0, 875.0]}, {"text": "None", "bbox": [581.0, 863.0, 598.0, 875.0]}, {"text": "None", "bbox": [669.0, 864.0, 687.0, 875.0]}, {"text": "Arbor Michigan–Attending", "bbox": [113.0, 874.0, 187.0, 883.0]}, {"text": "(3 resuscitation mannequins, 2", "bbox": [308.0, 874.0, 397.0, 882.0]}, {"text": "Weiner", "bbox": [61.0, 875.0, 81.0, 882.0]}, {"text": "asts of video recording", "bbox": [319.0, 883.0, 386.0, 892.0]}, {"text": "Neonatologist", "bbox": [129.0, 884.0, 169.0, 892.0]}, {"text": "equipment) from Laerdal", "bbox": [318.0, 891.0, 387.0, 903.0]}, {"text": "Medical Corporation to be", "bbox": [315.0, 902.0, 391.0, 912.0]}, {"text": "used to complete a research", "bbox": [311.0, 912.0, 393.0, 920.0]}, {"text": "project evaluating educational", "bbox": [310.0, 919.0, 396.0, 931.0]}, {"text": "methods for teaching neonatal", "bbox": [310.0, 930.0, 397.0, 941.0]}, {"text": "resuscitation. The value of the", "bbox": [310.0, 940.0, 396.0, 948.0]}, {"text": "on-loan equipment is", "bbox": [321.0, 948.0, 384.0, 959.0]}, {"text": "approximately $35,000.", "bbox": [319.0, 957.0, 386.0, 969.0]}, {"text": "(Continued)", "bbox": [685.0, 971.0, 720.0, 983.0]}], "type": "Table", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 299}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#1#22#指南表格的内容，但是杂乱无章，没有语序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 00:25:53"}
{"id": 1042074, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "5f548b2d-ee66-48d2-b956-eed8f5aaf62c", "title": null, "text": "【0】页码:331\n 200. Murao M.  Studies on the treatment of hydrofluoric acid burn. Bull Osaka Med Coll . 1989;35:39–48.\n\n【1】Lorette JJ Jr, Wilkinson JA. Alkaline chemical burn to the face requiring 201.\n\n【2】full-thickness skin grafting. Ann Emerg Med . 1988;17:739–741.\n\n【3】202.\n\n【4】Leonard LG, Scheulen JJ, Munster AM.  Chemical burns: effect of prompt first aid. J Trauma . 1982;22:420–423.\n\n【5】203. Kompa S, Schareck B, Tympner J, Wustemeyer H, Schrage NF. Comparison of emergency eye-wash products in burned porcine eyes.\n\n【6】Graefes Arch Clin Exp Ophthalmol . 2002;240:308–313.\n\n【7】204. McCulley JP. Ocular hydrofluoric acid burns: animal model, mechanism of injury and therapy. Trans Am Ophthalmol Soc . 1990;88:649–684.\n\n【8】Hojer J, Personne M, Hulten P, Ludwigs U.  Topical treatments for 205.\n\n【9】hydrofluoric acid burns: a blind controlled experimental study. J Toxicol Clin Toxicol. 2002;40:861–866.\n\n【10】206. Herr RD, White GL Jr, Bernhisel K, Mamalis N, Swanson E. Clinical comparison of ocular irrigation fluids following chemical injury. Am J Emerg Med . 1991;9:228–231.\n\n【11】207. Ingram TA III. Response of the human eye to accidental exposure to sodium hypochlorite. J Endod . 1990;16:235–238.\n\n【12】Burns FR, Paterson CA. Prompt irrigation of chemical eye injuries may 208.\n\n【13】avert severe damage. Occup Health Saf. 1989;58:33–36.\n\n【14】209.\n\n【15】Kompa S, Redbrake C, Hilgers C, Wustemeyer H, Schrage N, Remky A.\n\n【16】Effect of different irrigating solutions on aqueous humour pH changes, intraocular pressure and histological findings after induced alkali burns.\n\n【17】Acta Ophthalmol Scand . 2005;83:467–470.\n\n【18】210. Spoler F, Frentz M, Forst M, Kurz H, Schrage NF.  Analysis of hydrofluoric acid penetration and decontamination of the eye by means of time-resolved optical coherence tomography. Burns . 2008;34: 549 – 555.\n\n【19】211. Rihawi S, Frentz M, Schrage NF. Emergency treatment of eye burns: which rinsing solution should we choose? Graefes Arch Clin Exp Ophthalmol. 2006;244:845–854.\n\n【20】212. Homan CS, Maitra SR, Lane BP, Geller ER. Effective treatment of acute alkali injury of the rat esophagus with early saline dilution therapy. Ann Emerg Med . 1993;22:178–182.\n\n【21】213. Homan CS, Maitra SR, Lane BP, Thode HC, Sable M.  Therapeutic effects of water and milk for acute alkali injury of the esophagus. Ann Emerg Med . 1994;24:14–20.\n\n【22】214. Homan CS, Maitra SR, Lane BP, Thode HC Jr, Davidson L. Histopathologic evaluation of the therapeutic efficacy of water and milk dilution for esophageal acid injury. Acad Emerg Med . 1995;2:587–591.\n\n【23】 215. Homan CS, Singer AJ, Henry MC, Thode HC Jr. Thermal effects of neutralization therapy and water dilution for acute alkali exposure in canines. Acad Emerg Med . 1997;4:27–32.\n\n【24】216. Homan CS, Singer AJ, Thomajan C, Henry MC, Thode HC Jr. Thermal characteristics of neutralization therapy and water dilution for strong acid ingestion: an in-vivo canine model. Acad Emerg Med . 1998;5: 286–292.\n\n【25】217. Spiller HA, Rodgers GC Jr. Evaluation of administration of activated charcoal in the home. Pediatrics. 2001;108:E100.\n\n【26】218. Lamminpaa A, Vilska J, Hoppu K.  Medical charcoal for a child's poisoning at home: availability and success of administration in Finland.\n\n【27】Hum Exp Toxicol. 1993;12:29–32.\n\n【28】Donoso A, Linares M, Leon J, Rojas G, Valverde C, Ramirez M, 219.\n\n【29】Oberpaur B.  Activated charcoal laryngitis in an intubated patient.\n\n【30】Pediatr Emerg Care . 2003;19:420–421.\n\n【31】220. Dorrington CL, Johnson DW, Brant R. The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med . 2003;41:370–377.\n\n【32】221. Givens T, Holloway M, Wason S.  Pulmonary aspiration of activated charcoal: a complication of its misuse in overdose management. Pediatr Emerg Care . 1992;8:137–140.\n\n【33】222. Scharman EJ, Cloonan HA, Durback-Morris LF. Home administration of charcoal: can mothers administer a therapeutic dose? J Emerg Med .\n\n【34】2001;21:357–361.\n\n【35】223. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med .\n\n【36】1985;14:562–567.\n\n【37】224. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW.\n\n【38】Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust . 1995;163:345–349.\n\n【39】225. Caravati EM. Unintentional acetaminophen ingestion in children and the potential for hepatotoxicity. J Toxicol Clin Toxicol . 2000;38:291–296.\n\n【40】226. Bond G.  Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics . 2003;112:1061–1064.\n\n【41】227. Kornberg AE, Dolgin J.  Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med . 1991;20:648–651.\n\n【42】228. Czajka PA, Russell SL. Nonemetic effects of ipecac syrup. Pediatrics .\n\n【43】1985;75:1101–1104.\n\n【44】## K Ey W Ords : Emergency  ■ Injury\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "200. Murao M.  Studies on the treatment of hydrofluoric acid burn. Bull", "bbox": [61.0, 85.0, 376.0, 97.0]}, {"text": "Osaka Med Coll . 1989;35:39–48.", "bbox": [83.0, 98.0, 224.0, 109.0]}, {"text": "Lorette JJ Jr, Wilkinson JA. Alkaline chemical burn to the face requiring", "bbox": [81.0, 108.0, 376.0, 121.0]}, {"text": "201.", "bbox": [61.0, 110.0, 81.0, 120.0]}, {"text": "full-thickness skin grafting. Ann Emerg Med . 1988;17:739–741.", "bbox": [84.0, 122.0, 349.0, 133.0]}, {"text": "202.", "bbox": [61.0, 133.0, 80.0, 144.0]}, {"text": "Leonard LG, Scheulen JJ, Munster AM.  Chemical burns: effect of", "bbox": [81.0, 133.0, 375.0, 145.0]}, {"text": "prompt first aid. J Trauma . 1982;22:420–423.", "bbox": [84.0, 144.0, 276.0, 155.0]}, {"text": "203. Kompa S, Schareck B, Tympner J, Wustemeyer H, Schrage NF. Com-", "bbox": [61.0, 157.0, 375.0, 169.0]}, {"text": "parison of emergency eye-wash products in burned porcine eyes.", "bbox": [83.0, 168.0, 375.0, 180.0]}, {"text": "Graefes Arch Clin Exp Ophthalmol . 2002;240:308–313.", "bbox": [84.0, 180.0, 315.0, 193.0]}, {"text": "204. McCulley JP. Ocular hydrofluoric acid burns: animal model, mechanism", "bbox": [61.0, 192.0, 375.0, 204.0]}, {"text": "of injury and therapy. Trans Am Ophthalmol Soc . 1990;88:649–684.", "bbox": [83.0, 206.0, 369.0, 216.0]}, {"text": "Hojer J, Personne M, Hulten P, Ludwigs U.  Topical treatments for", "bbox": [82.0, 216.0, 375.0, 228.0]}, {"text": "205.", "bbox": [61.0, 217.0, 79.0, 227.0]}, {"text": "hydrofluoric acid burns: a blind controlled experimental study. J Toxicol", "bbox": [83.0, 227.0, 375.0, 239.0]}, {"text": "Clin Toxicol. 2002;40:861–866.", "bbox": [83.0, 240.0, 215.0, 251.0]}, {"text": "206. Herr RD, White GL Jr, Bernhisel K, Mamalis N, Swanson E. Clinical", "bbox": [61.0, 251.0, 376.0, 263.0]}, {"text": "comparison of ocular irrigation fluids following chemical injury. Am J", "bbox": [83.0, 264.0, 376.0, 276.0]}, {"text": "Emerg Med . 1991;9:228–231.", "bbox": [84.0, 275.0, 207.0, 287.0]}, {"text": "207. Ingram TA III. Response of the human eye to accidental exposure to", "bbox": [61.0, 287.0, 377.0, 300.0]}, {"text": "sodium hypochlorite. J Endod . 1990;16:235–238.", "bbox": [87.0, 300.0, 287.0, 311.0]}, {"text": "Burns FR, Paterson CA. Prompt irrigation of chemical eye injuries may", "bbox": [81.0, 310.0, 375.0, 323.0]}, {"text": "208.", "bbox": [61.0, 312.0, 81.0, 321.0]}, {"text": "avert severe damage. Occup Health Saf. 1989;58:33–36.", "bbox": [84.0, 324.0, 315.0, 335.0]}, {"text": "209.", "bbox": [61.0, 335.0, 81.0, 346.0]}, {"text": "Kompa S, Redbrake C, Hilgers C, Wustemeyer H, Schrage N, Remky A.", "bbox": [81.0, 335.0, 375.0, 347.0]}, {"text": "Effect of different irrigating solutions on aqueous humour pH changes,", "bbox": [84.0, 345.0, 376.0, 360.0]}, {"text": "intraocular pressure and histological findings after induced alkali burns.", "bbox": [84.0, 359.0, 375.0, 370.0]}, {"text": "Acta Ophthalmol Scand . 2005;83:467–470.", "bbox": [83.0, 370.0, 262.0, 381.0]}, {"text": "210. Spoler F, Frentz M, Forst M, Kurz H, Schrage NF.  Analysis of", "bbox": [61.0, 382.0, 376.0, 394.0]}, {"text": "hydrofluoric acid penetration and decontamination of the eye by means", "bbox": [83.0, 394.0, 375.0, 406.0]}, {"text": "of time-resolved optical coherence tomography. Burns . 2008;34:", "bbox": [83.0, 408.0, 375.0, 419.0]}, {"text": "549 – 555.", "bbox": [84.0, 418.0, 122.0, 429.0]}, {"text": "211. Rihawi S, Frentz M, Schrage NF. Emergency treatment of eye burns:", "bbox": [61.0, 428.0, 375.0, 444.0]}, {"text": "which rinsing solution should we choose? Graefes Arch Clin Exp Oph-", "bbox": [84.0, 442.0, 374.0, 455.0]}, {"text": "thalmol. 2006;244:845–854.", "bbox": [84.0, 454.0, 201.0, 465.0]}, {"text": "212. Homan CS, Maitra SR, Lane BP, Geller ER. Effective treatment of acute", "bbox": [61.0, 465.0, 375.0, 477.0]}, {"text": "alkali injury of the rat esophagus with early saline dilution therapy. Ann", "bbox": [84.0, 477.0, 375.0, 489.0]}, {"text": "Emerg Med . 1993;22:178–182.", "bbox": [84.0, 490.0, 211.0, 500.0]}, {"text": "213. Homan CS, Maitra SR, Lane BP, Thode HC, Sable M.  Therapeutic", "bbox": [61.0, 501.0, 375.0, 513.0]}, {"text": "effects of water and milk for acute alkali injury of the esophagus. Ann", "bbox": [83.0, 514.0, 375.0, 526.0]}, {"text": "Emerg Med . 1994;24:14–20.", "bbox": [84.0, 526.0, 204.0, 537.0]}, {"text": "214. Homan CS, Maitra SR, Lane BP, Thode HC Jr, Davidson L. His-", "bbox": [61.0, 537.0, 375.0, 548.0]}, {"text": "topathologic evaluation of the therapeutic efficacy of water and milk", "bbox": [83.0, 550.0, 375.0, 562.0]}, {"text": "dilution for esophageal acid injury. Acad Emerg Med . 1995;2:587–591.", "bbox": [84.0, 561.0, 375.0, 573.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "215. Homan CS, Singer AJ, Henry MC, Thode HC Jr. Thermal effects of", "bbox": [404.0, 85.0, 721.0, 98.0]}, {"text": "neutralization therapy and water dilution for acute alkali exposure in", "bbox": [428.0, 98.0, 720.0, 109.0]}, {"text": "canines. Acad Emerg Med . 1997;4:27–32.", "bbox": [428.0, 109.0, 601.0, 120.0]}, {"text": "216. Homan CS, Singer AJ, Thomajan C, Henry MC, Thode HC Jr. Thermal", "bbox": [404.0, 121.0, 720.0, 133.0]}, {"text": "characteristics of neutralization therapy and water dilution for strong", "bbox": [427.0, 133.0, 720.0, 145.0]}, {"text": "acid ingestion: an in-vivo canine model. Acad Emerg Med . 1998;5:", "bbox": [427.0, 147.0, 720.0, 158.0]}, {"text": "286–292.", "bbox": [428.0, 158.0, 468.0, 169.0]}, {"text": "217. Spiller HA, Rodgers GC Jr. Evaluation of administration of activated", "bbox": [404.0, 171.0, 720.0, 182.0]}, {"text": "charcoal in the home. Pediatrics. 2001;108:E100.", "bbox": [427.0, 182.0, 632.0, 194.0]}, {"text": "218. Lamminpaa A, Vilska J, Hoppu K.  Medical charcoal for a child's", "bbox": [404.0, 195.0, 720.0, 206.0]}, {"text": "poisoning at home: availability and success of administration in Finland.", "bbox": [428.0, 207.0, 718.0, 218.0]}, {"text": "Hum Exp Toxicol. 1993;12:29–32.", "bbox": [427.0, 220.0, 571.0, 230.0]}, {"text": "Donoso A, Linares M, Leon J, Rojas G, Valverde C, Ramirez M,", "bbox": [424.0, 230.0, 720.0, 242.0]}, {"text": "219.", "bbox": [404.0, 231.0, 425.0, 241.0]}, {"text": "Oberpaur B.  Activated charcoal laryngitis in an intubated patient.", "bbox": [427.0, 243.0, 719.0, 255.0]}, {"text": "Pediatr Emerg Care . 2003;19:420–421.", "bbox": [427.0, 255.0, 594.0, 267.0]}, {"text": "220. Dorrington CL, Johnson DW, Brant R. The frequency of complications", "bbox": [404.0, 267.0, 720.0, 280.0]}, {"text": "associated with the use of multiple-dose activated charcoal. Ann Emerg", "bbox": [428.0, 280.0, 720.0, 291.0]}, {"text": "Med . 2003;41:370–377.", "bbox": [427.0, 292.0, 527.0, 302.0]}, {"text": "221. Givens T, Holloway M, Wason S.  Pulmonary aspiration of activated", "bbox": [404.0, 303.0, 720.0, 315.0]}, {"text": "charcoal: a complication of its misuse in overdose management. Pediatr", "bbox": [427.0, 316.0, 719.0, 327.0]}, {"text": "Emerg Care . 1992;8:137–140.", "bbox": [428.0, 327.0, 553.0, 339.0]}, {"text": "222. Scharman EJ, Cloonan HA, Durback-Morris LF. Home administration", "bbox": [404.0, 339.0, 720.0, 351.0]}, {"text": "of charcoal: can mothers administer a therapeutic dose? J Emerg Med .", "bbox": [428.0, 352.0, 718.0, 363.0]}, {"text": "2001;21:357–361.", "bbox": [427.0, 363.0, 502.0, 374.0]}, {"text": "223. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of", "bbox": [404.0, 376.0, 720.0, 388.0]}, {"text": "acutely poisoned patients without gastric emptying. Ann Emerg Med .", "bbox": [428.0, 388.0, 719.0, 401.0]}, {"text": "1985;14:562–567.", "bbox": [428.0, 401.0, 501.0, 412.0]}, {"text": "224. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW.", "bbox": [404.0, 412.0, 719.0, 424.0]}, {"text": "Gastric emptying in acute overdose: a prospective randomised con-", "bbox": [427.0, 425.0, 718.0, 436.0]}, {"text": "trolled trial. Med J Aust . 1995;163:345–349.", "bbox": [427.0, 436.0, 612.0, 448.0]}, {"text": "225. Caravati EM. Unintentional acetaminophen ingestion in children and the", "bbox": [405.0, 448.0, 720.0, 461.0]}, {"text": "potential for hepatotoxicity. J Toxicol Clin Toxicol . 2000;38:291–296.", "bbox": [428.0, 461.0, 717.0, 472.0]}, {"text": "226. Bond G.  Home syrup of ipecac use does not reduce emergency", "bbox": [405.0, 473.0, 719.0, 486.0]}, {"text": "department use or improve outcome. Pediatrics . 2003;112:1061–1064.", "bbox": [427.0, 485.0, 718.0, 496.0]}, {"text": "227. Kornberg AE, Dolgin J.  Pediatric ingestions: charcoal alone versus", "bbox": [404.0, 498.0, 720.0, 509.0]}, {"text": "ipecac and charcoal. Ann Emerg Med . 1991;20:648–651.", "bbox": [427.0, 509.0, 666.0, 521.0]}, {"text": "228. Czajka PA, Russell SL. Nonemetic effects of ipecac syrup. Pediatrics .", "bbox": [405.0, 521.0, 719.0, 534.0]}, {"text": "1985;75:1101–1104.", "bbox": [428.0, 534.0, 511.0, 545.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "K EY W ORDS : emergency  ■ injury", "bbox": [404.0, 561.0, 549.0, 573.0]}], "type": "Section-header", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 331}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#44#全篇参考文献"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:18:55"}
{"id": 1042073, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "f3c4335a-20d3-4077-8992-23baafbe1090", "title": null, "text": "【0】页码:333\n 6.\n\n【1】 We must cut the hard acetate gingivally, at the termi¬ nal level of the soft acetate (on the marked gingival line over the model). We then polish.\n 7.\n Place the Osamu retainer in the mouth.\n Figs. 97-100. Osamu out of the mouth. We can observe the double acetate in the retainer.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "6.", "bbox": [60.0, 362.0, 77.0, 379.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "We must cut the hard acetate gingivally, at the termi¬", "bbox": [86.0, 360.0, 375.0, 382.0]}, {"text": "nal level of the soft acetate (on the marked gingival", "bbox": [87.0, 378.0, 377.0, 397.0]}, {"text": "line over the model). We then polish.", "bbox": [87.0, 395.0, 296.0, 415.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "7.", "bbox": [60.0, 695.0, 78.0, 714.0]}], "type": "Caption", "position": 9}, {"raw_context": [{"text": "Place the Osamu retainer in the mouth.", "bbox": [87.0, 696.0, 308.0, 714.0]}], "type": "Caption", "position": 10}, {"raw_context": [{"text": "Figs. 97-100. Osamu out of the mouth. We can observe the double acetate in the retainer.", "bbox": [188.0, 958.0, 584.0, 977.0]}], "type": "Caption", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 333}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "", "type2": "标点错误#0#0#termi¬不需要这个标点", "type3": "", "type6": "有用性#1#1#Figs. 97-100. Osamu out of the mouth. We can observe the double acetate in the retainer.是对图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 19:04:04"}
{"id": 1042072, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "32a20606-eb15-4161-a371-b5acc14cdd26", "title": null, "text": "【0】页码:32\n 6. Trouble eating and drinking\n\n【1】 7. Changes in the amount of tears and saliva\n\n【2】 8. Headache\n\n【3】 9. Trouble speaking, causing slurred speech\n\n【4】 10. Earache. There is also hypersensitivity to sound in the affected ear\n\n【5】 11. Numbness of the mouth\n\n【6】 12. Strange taste sensations\n\n【7】## What If My Child Shows These Symptoms?\n\n【8】\n As mentioned earlier, seek medical attention immediately or call emergency when you notice the first symptoms.\n\n【9】 After a medical examination, the doctor may advise therapy or medication for your child. If a kid is facing difficulty closing their eyelid, the doctor may suggest appropriate eye drops.\n\n【10】 Children with Bell's palsy may also have difficulty speaking and trouble showing facial expressions. Make sure that the child is receiving sufficient care to cope with these issues. Look for specialist advice from related health professionals.\n\n【11】 Bell's palsy has an adverse impact on the child's confidence. Young sufferers experience low self-esteem, become introverted and avoid seeing people. You could invite your child's friends to your home. This will also help expand your child's social circle and give them more confidence to interact with others.\n\n【12】 You should remain very patient with your child who might become obsessed with his/her face, asking you repeatedly if their face shows any signs of improvement. It is vital that you explain to your child that they will most likely completely recover from Bell's palsy within a few months.\n\n【13】 Remember, be supportive and don’t let your child feel different. A child will not appreciate people feeling sorry for him/her as this will make them feel inferior.\n\n【14】 School going children have a difficult time coping with Bell's palsy since some children will pick on them and start teasing them about their condition. They could get bullied at school which can be a heartbreaking experience.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "6. Trouble eating and drinking", "bbox": [106.0, 97.0, 351.0, 117.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "7. Changes in the amount of tears and saliva", "bbox": [106.0, 131.0, 458.0, 153.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "8. Headache", "bbox": [106.0, 167.0, 213.0, 186.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "9. Trouble speaking, causing slurred speech", "bbox": [106.0, 202.0, 454.0, 221.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "10. Earache. There is also hypersensitivity to sound in the affected ear", "bbox": [98.0, 235.0, 648.0, 256.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "11. Numbness of the mouth", "bbox": [98.0, 272.0, 322.0, 291.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "12. Strange taste sensations", "bbox": [97.0, 308.0, 319.0, 326.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "What if My Child Shows These Symptoms?", "bbox": [95.0, 347.0, 454.0, 367.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "As mentioned earlier, seek medical attention immediately or call emergency", "bbox": [93.0, 381.0, 722.0, 401.0]}, {"text": "when you notice the first symptoms.", "bbox": [93.0, 404.0, 379.0, 423.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "After a medical examination, the doctor may advise therapy or medication for", "bbox": [93.0, 440.0, 723.0, 460.0]}, {"text": "your child. If a kid is facing difficulty closing their eyelid, the doctor may", "bbox": [93.0, 462.0, 721.0, 480.0]}, {"text": "suggest appropriate eye drops.", "bbox": [93.0, 484.0, 333.0, 503.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Children with Bell's palsy may also have difficulty speaking and trouble", "bbox": [93.0, 519.0, 723.0, 538.0]}, {"text": "showing facial expressions. Make sure that the child is receiving sufficient care", "bbox": [93.0, 541.0, 722.0, 560.0]}, {"text": "to cope with these issues. Look for specialist advice from related health", "bbox": [93.0, 563.0, 723.0, 582.0]}, {"text": "professionals.", "bbox": [93.0, 585.0, 204.0, 604.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Bell's palsy has an adverse impact on the child's confidence. Young sufferers", "bbox": [93.0, 619.0, 724.0, 639.0]}, {"text": "experience low self-esteem, become introverted and avoid seeing people. You", "bbox": [93.0, 642.0, 723.0, 661.0]}, {"text": "could invite your child's friends to your home. This will also help expand your", "bbox": [93.0, 664.0, 724.0, 683.0]}, {"text": "child's social circle and give them more confidence to interact with others.", "bbox": [93.0, 686.0, 673.0, 705.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "You should remain very patient with your child who might become obsessed", "bbox": [95.0, 720.0, 723.0, 740.0]}, {"text": "with his/her face, asking you repeatedly if their face shows any signs of", "bbox": [93.0, 743.0, 722.0, 763.0]}, {"text": "improvement. It is vital that you explain to your child that they will most likely", "bbox": [93.0, 765.0, 722.0, 784.0]}, {"text": "completely recover from Bell's palsy within a few months.", "bbox": [93.0, 787.0, 550.0, 806.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Remember, be supportive and don’t let your child feel different. A child will not", "bbox": [93.0, 821.0, 723.0, 841.0]}, {"text": "appreciate people feeling sorry for him/her as this will make them feel inferior.", "bbox": [93.0, 844.0, 706.0, 863.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "School going children have a difficult time coping with Bell's palsy since some", "bbox": [93.0, 879.0, 722.0, 898.0]}, {"text": "children will pick on them and start teasing them about their condition. They", "bbox": [93.0, 901.0, 721.0, 920.0]}, {"text": "could get bullied at school which can be a heartbreaking experience.", "bbox": [93.0, 923.0, 624.0, 942.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 32}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:20:38"}
{"id": 1042071, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "923e87d1-3553-466f-8291-8ce5ff39291a", "title": null, "text": "【0】页码:94\n series with concurrent controls 92 showed no benefit over conventional CPR for out-of-hospital witnessed cardiac arrest. Additional case series have reported variable success with the device. 93–98 One feasibility study reported successful deployment during diagnostic and interventional procedures. 99 There is insufficient evidence to support or refute the routine use of mechanical piston devices in the treatment of cardiac arrest. Mechanical piston devices may be considered for use by properly trained personnel in specific settings for the treatment of adult cardiac arrest in circumstances (eg, during diagnostic and interventional procedures) that make manual resuscitation difficult (Class IIb, LOE C). Rescuers should attempt to limit substantial interruptions in CPR during deployment. The device should be programmed to deliver high-quality CPR, ensuring an adequate compression depth of at least 2 inches (5 cm)—this may require conversion from a percent of chest depth, a rate of at least 100 compressions per minute, and a compression duration of approximately 50% of the cycle length.\n\n【1】## Load-Distributing Band Cpr Or Vest Cpr The Load-Distributing Band (Ldb) Is A Circumferential Chest\n\n【2】\n compression device composed of a pneumatically or electrically actuated constricting band and backboard. Case series have demonstrated improved hemodynamics, 100 ROSC, 101 , 102 and survival to hospital discharge with use of the LDB for cardiac arrest. 102 In a study using concurrent controls, 103 the use of LDB-CPR was associated with lower odds of 30-day survival (odds ratio 0.4). One multicenter prospective randomized controlled trial 104 , 104 λ comparing LDB-CPR (Autopulse device) to manual CPR for out-of-hospital cardiac arrest demonstrated no improvement in 4-hour survival and worse neurologic outcome when the device was used. These results raised concerns about possible harm with use of this device. Further studies are required to determine whether site-specific factors 105 and experience with deployment of the device106 could influence its efficacy.\n\n【3】The LDB may be considered for use by properly trained personnel in specific settings for the treatment of cardiac arrest (Class IIb, LOE B). However, there is insufficient evidence to support the routine use of the LDB in the treatment of cardiac arrest.\n\n【4】## Extracorporeal Techniques And Invasive Perfusion Devices\n\n【5】\n## Extracorporeal Cpr\n\n【6】\n For the purpose of these Guidelines, extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass are considered together as different forms of extracorporeal CPR (ECPR; an alternative term may be extracorporeal life support or ECLS) when either is used for resuscitation for cardiac arrest. Both are sophisticated\n\n【7】 techniques for circulating blood outside the body with or without extracorporeal oxygenation, with the goal of supporting the body's circulation in the absence of an adequately functioning cardiac pump. The initiation of ECPR and the management of a patient on ECPR require highly trained personnel and specialized equipment.\n\n【8】Although there are no data from randomized studies to support the routine use of ECPR, in case series and observational studies the use of ECPR for in-hospital 107 . 108 and out-of-hospital 109 – 111 cardiac arrest has been associated with improved survival when compared with conventional CPR in patients < 75 years old with potentially correctable conditions. However, supportive studies consisted of small numbers of patients, and some had unbalanced comparison groups with respect to age, witnessed arrest, bystander CPR, and the quality of conventional CPR.\n\n【9】There are no randomized studies that compare ECPR with conventional CPR for patients in cardiac arrest. However, data from several case series have demonstrated the feasibility and safety of ECPR in highly specialized centers. 108,110,111 Observational studies of adults in both the in-hospital 107 and out-of-hospital 109 settings have demonstrated an association between ECPR use and improved survival when compared with conventional CPR in patients with potentially correctable conditions. These studies had small numbers of patients, and some had unbalanced comparison groups with respect to age, witness status, bystander CPR, and the quality of conventional CPR. Please refer to the Pediatrics section for discussion and specific recommendations related to the pediatric population (See Part 14: \"Pediatric Advanced Life Support\").\n\n【10】There is insufficient evidence to recommend the routine\n\n【11】 use of ECPR for patients in cardiac arrest. However, in settings where ECPR is readily available, it may be considered when the time without blood flow is brief and the condition leading to the cardiac arrest is reversible (eg, accidental hypothermia drug intoxication) or amenable to heart transplantation (eg, myocarditis) or revascularization (eg, acute myocardial infarction) (Class IIb, LOE C).\n\n【12】## Summary\n\n【13】\n A variety of CPR techniques and devices may improve hemodynamics or short-term survival when used by welltrained providers in selected patients. All of these techniques and devices have the potential to delay chest compressions and defibrillation. In order to prevent delays and maximize efficiency, initial training, ongoing monitoring, and retraining programs should be offered to providers on a frequent and ongoing basis. To date, no adjunct has consistently been shown to be superior to standard conventional (manual) CPR for out-of-hospital basic life support, and no device other than a defibrillator has consistently improved long-term survival from out-of-hospital cardiac arrest.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "series with concurrent controls 92 showed no benefit over", "bbox": [60.0, 83.0, 377.0, 98.0]}, {"text": "conventional CPR for out-of-hospital witnessed cardiac", "bbox": [60.0, 100.0, 375.0, 113.0]}, {"text": "arrest. Additional case series have reported variable suc-", "bbox": [60.0, 115.0, 375.0, 128.0]}, {"text": "cess with the device. 93–98 One feasibility study reported", "bbox": [60.0, 129.0, 377.0, 144.0]}, {"text": "successful deployment during diagnostic and interven-", "bbox": [60.0, 146.0, 375.0, 160.0]}, {"text": "tional procedures. 99", "bbox": [60.0, 161.0, 169.0, 175.0]}, {"text": "There is insufficient evidence to support or refute the", "bbox": [73.0, 176.0, 376.0, 190.0]}, {"text": "routine use of mechanical piston devices in the treatment of", "bbox": [60.0, 192.0, 377.0, 206.0]}, {"text": "cardiac arrest. Mechanical piston devices may be considered", "bbox": [60.0, 207.0, 376.0, 221.0]}, {"text": "for use by properly trained personnel in specific settings for", "bbox": [60.0, 222.0, 376.0, 236.0]}, {"text": "the treatment of adult cardiac arrest in circumstances (eg,", "bbox": [60.0, 238.0, 376.0, 252.0]}, {"text": "during diagnostic and interventional procedures) that make", "bbox": [60.0, 254.0, 376.0, 267.0]}, {"text": "manual resuscitation difficult (Class IIb, LOE C). Rescuers", "bbox": [60.0, 268.0, 376.0, 282.0]}, {"text": "should attempt to limit substantial interruptions in CPR", "bbox": [60.0, 284.0, 376.0, 298.0]}, {"text": "during deployment. The device should be programmed to", "bbox": [60.0, 299.0, 377.0, 313.0]}, {"text": "deliver high-quality CPR, ensuring an adequate compression", "bbox": [60.0, 314.0, 377.0, 328.0]}, {"text": "depth of at least 2 inches (5 cm)—this may require conver-", "bbox": [60.0, 330.0, 375.0, 343.0]}, {"text": "sion from a percent of chest depth, a rate of at least 100", "bbox": [60.0, 345.0, 377.0, 360.0]}, {"text": "compressions per minute, and a compression duration of", "bbox": [60.0, 361.0, 377.0, 374.0]}, {"text": "approximately 50% of the cycle length.", "bbox": [60.0, 375.0, 268.0, 389.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Load-Distributing Band CPR or Vest CPR", "bbox": [60.0, 406.0, 290.0, 420.0]}, {"text": "The load-distributing band (LDB) is a circumferential chest", "bbox": [61.0, 421.0, 376.0, 433.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "compression device composed of a pneumatically or electri-", "bbox": [60.0, 435.0, 375.0, 449.0]}, {"text": "cally actuated constricting band and backboard. Case series", "bbox": [60.0, 450.0, 376.0, 464.0]}, {"text": "have demonstrated improved hemodynamics, 100 ROSC, 101 , 102", "bbox": [60.0, 466.0, 375.0, 479.0]}, {"text": "and survival to hospital discharge with use of the LDB for", "bbox": [60.0, 481.0, 376.0, 495.0]}, {"text": "cardiac arrest. 102 In a study using concurrent controls, 103 the", "bbox": [60.0, 496.0, 376.0, 510.0]}, {"text": "use of LDB-CPR was associated with lower odds of 30-day", "bbox": [60.0, 511.0, 375.0, 526.0]}, {"text": "survival (odds ratio 0.4). One multicenter prospective ran-", "bbox": [60.0, 526.0, 375.0, 542.0]}, {"text": "domized controlled trial 104 , 104 λ comparing LDB-CPR (Auto-", "bbox": [60.0, 542.0, 375.0, 556.0]}, {"text": "pulse device) to manual CPR for out-of-hospital cardiac", "bbox": [60.0, 557.0, 375.0, 572.0]}, {"text": "arrest demonstrated no improvement in 4-hour survival and", "bbox": [60.0, 573.0, 377.0, 587.0]}, {"text": "worse neurologic outcome when the device was used. These", "bbox": [60.0, 588.0, 376.0, 602.0]}, {"text": "results raised concerns about possible harm with use of this", "bbox": [60.0, 603.0, 376.0, 617.0]}, {"text": "device. Further studies are required to determine whether", "bbox": [60.0, 619.0, 376.0, 633.0]}, {"text": "site-specific factors 105 and experience with deployment of the", "bbox": [60.0, 634.0, 376.0, 649.0]}, {"text": "device106 could influence its efficacy.", "bbox": [60.0, 649.0, 256.0, 663.0]}, {"text": "The LDB may be considered for use by properly trained", "bbox": [73.0, 665.0, 377.0, 679.0]}, {"text": "personnel in specific settings for the treatment of cardiac", "bbox": [60.0, 681.0, 375.0, 695.0]}, {"text": "arrest (Class IIb, LOE B). However, there is insufficient", "bbox": [60.0, 696.0, 376.0, 709.0]}, {"text": "evidence to support the routine use of the LDB in the", "bbox": [60.0, 711.0, 376.0, 725.0]}, {"text": "treatment of cardiac arrest.", "bbox": [60.0, 727.0, 201.0, 740.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Extracorporeal Techniques and Invasive", "bbox": [60.0, 761.0, 311.0, 775.0]}, {"text": "Perfusion Devices", "bbox": [60.0, 776.0, 172.0, 790.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Extracorporeal CPR", "bbox": [60.0, 803.0, 172.0, 816.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "For the purpose of these Guidelines, extracorporeal mem-", "bbox": [60.0, 815.0, 375.0, 829.0]}, {"text": "brane oxygenation (ECMO) and cardiopulmonary bypass", "bbox": [60.0, 831.0, 376.0, 844.0]}, {"text": "are considered together as different forms of extracorpo-", "bbox": [60.0, 846.0, 375.0, 861.0]}, {"text": "real CPR (ECPR; an alternative term may be extracorpo-", "bbox": [60.0, 863.0, 375.0, 876.0]}, {"text": "real life support or ECLS) when either is used for", "bbox": [60.0, 877.0, 376.0, 891.0]}, {"text": "resuscitation for cardiac arrest. Both are sophisticated", "bbox": [60.0, 893.0, 377.0, 907.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "techniques for circulating blood outside the body with or", "bbox": [403.0, 84.0, 721.0, 99.0]}, {"text": "without extracorporeal oxygenation, with the goal of", "bbox": [403.0, 100.0, 721.0, 113.0]}, {"text": "supporting the body's circulation in the absence of an", "bbox": [404.0, 115.0, 721.0, 130.0]}, {"text": "adequately functioning cardiac pump. The initiation of", "bbox": [404.0, 131.0, 720.0, 145.0]}, {"text": "ECPR and the management of a patient on ECPR require", "bbox": [404.0, 147.0, 720.0, 160.0]}, {"text": "highly trained personnel and specialized equipment.", "bbox": [403.0, 162.0, 689.0, 176.0]}, {"text": "Although there are no data from randomized studies to", "bbox": [417.0, 177.0, 721.0, 191.0]}, {"text": "support the routine use of ECPR, in case series and observa-", "bbox": [404.0, 192.0, 719.0, 207.0]}, {"text": "tional studies the use of ECPR for in-hospital 107 . 108 and", "bbox": [403.0, 208.0, 720.0, 222.0]}, {"text": "out-of-hospital 109 – 111 cardiac arrest has been associated with", "bbox": [403.0, 222.0, 720.0, 239.0]}, {"text": "improved survival when compared with conventional CPR in", "bbox": [403.0, 239.0, 721.0, 253.0]}, {"text": "patients < 75 years old with potentially correctable condi-", "bbox": [403.0, 254.0, 719.0, 268.0]}, {"text": "tions. However, supportive studies consisted of small num-", "bbox": [403.0, 271.0, 719.0, 284.0]}, {"text": "bers of patients, and some had unbalanced comparison groups", "bbox": [403.0, 286.0, 720.0, 300.0]}, {"text": "with respect to age, witnessed arrest, bystander CPR, and the", "bbox": [404.0, 301.0, 720.0, 315.0]}, {"text": "quality of conventional CPR.", "bbox": [403.0, 316.0, 557.0, 330.0]}, {"text": "There are no randomized studies that compare ECPR with", "bbox": [417.0, 331.0, 721.0, 346.0]}, {"text": "conventional CPR for patients in cardiac arrest. However,", "bbox": [403.0, 348.0, 720.0, 361.0]}, {"text": "data from several case series have demonstrated the feasibil-", "bbox": [403.0, 362.0, 720.0, 376.0]}, {"text": "ity and safety of ECPR in highly specialized centers. 108,110,111", "bbox": [403.0, 378.0, 720.0, 392.0]}, {"text": "Observational studies of adults in both the in-hospital 107 and", "bbox": [403.0, 394.0, 721.0, 407.0]}, {"text": "out-of-hospital 109 settings have demonstrated an association", "bbox": [403.0, 408.0, 720.0, 424.0]}, {"text": "between ECPR use and improved survival when compared", "bbox": [403.0, 425.0, 720.0, 438.0]}, {"text": "with conventional CPR in patients with potentially correct-", "bbox": [404.0, 441.0, 720.0, 455.0]}, {"text": "able conditions. These studies had small numbers of patients,", "bbox": [403.0, 455.0, 720.0, 469.0]}, {"text": "and some had unbalanced comparison groups with respect to", "bbox": [404.0, 471.0, 721.0, 485.0]}, {"text": "age, witness status, bystander CPR, and the quality of", "bbox": [403.0, 487.0, 720.0, 500.0]}, {"text": "conventional CPR. Please refer to the Pediatrics section for", "bbox": [403.0, 501.0, 720.0, 515.0]}, {"text": "discussion and specific recommendations related to the pedi-", "bbox": [403.0, 517.0, 720.0, 531.0]}, {"text": "atric population (See Part 14: \"Pediatric Advanced Life", "bbox": [403.0, 532.0, 720.0, 546.0]}, {"text": "Support\").", "bbox": [404.0, 548.0, 460.0, 562.0]}, {"text": "There is insufficient evidence to recommend the routine", "bbox": [417.0, 563.0, 720.0, 577.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "use of ECPR for patients in cardiac arrest. However, in", "bbox": [403.0, 580.0, 721.0, 593.0]}, {"text": "settings where ECPR is readily available, it may be consid-", "bbox": [404.0, 595.0, 719.0, 609.0]}, {"text": "ered when the time without blood flow is brief and the", "bbox": [403.0, 609.0, 720.0, 624.0]}, {"text": "condition leading to the cardiac arrest is reversible (eg,", "bbox": [403.0, 626.0, 720.0, 639.0]}, {"text": "accidental hypothermia drug intoxication) or amenable to", "bbox": [404.0, 641.0, 721.0, 655.0]}, {"text": "heart transplantation (eg, myocarditis) or revascularization", "bbox": [403.0, 656.0, 720.0, 670.0]}, {"text": "(eg, acute myocardial infarction) (Class IIb, LOE C).", "bbox": [403.0, 671.0, 684.0, 685.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Summary", "bbox": [527.0, 708.0, 595.0, 722.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "A variety of CPR techniques and devices may improve", "bbox": [404.0, 722.0, 720.0, 736.0]}, {"text": "hemodynamics or short-term survival when used by well-", "bbox": [403.0, 738.0, 720.0, 752.0]}, {"text": "trained providers in selected patients. All of these techniques", "bbox": [403.0, 754.0, 720.0, 768.0]}, {"text": "and devices have the potential to delay chest compressions", "bbox": [403.0, 769.0, 720.0, 783.0]}, {"text": "and defibrillation. In order to prevent delays and maximize", "bbox": [404.0, 785.0, 720.0, 798.0]}, {"text": "efficiency, initial training, ongoing monitoring, and retraining", "bbox": [403.0, 800.0, 720.0, 814.0]}, {"text": "programs should be offered to providers on a frequent and", "bbox": [403.0, 816.0, 720.0, 829.0]}, {"text": "ongoing basis. To date, no adjunct has consistently been", "bbox": [403.0, 831.0, 720.0, 844.0]}, {"text": "shown to be superior to standard conventional (manual) CPR", "bbox": [403.0, 846.0, 720.0, 861.0]}, {"text": "for out-of-hospital basic life support, and no device other than", "bbox": [403.0, 863.0, 720.0, 876.0]}, {"text": "a defibrillator has consistently improved long-term survival", "bbox": [403.0, 877.0, 720.0, 891.0]}, {"text": "from out-of-hospital cardiac arrest.", "bbox": [404.0, 892.0, 586.0, 906.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 94}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#0#0#There is insufficient evidence...应该换行\n缺少换行#1#1# The Load-Distributing Band (Ldb)...应该换行\n多余换行#2#2#compression device composed of a...与上面1段缺少换行的内容联接\n多余换行#7#7# techniques for circulating blood ...与6段联接\n多余换行#11#11#use of ECPR for patients in...与10段联接", "type3": "无关文本#0#13#...concurrent controls 92 showed no...\n93–98 One feasibility study reported...像这样在.号开头和结尾或者文字中间出现的数字都是无关引用", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:15:45"}
{"id": 1042070, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "643ffc3f-63e9-4ecb-92c4-1f0daedc3b55", "title": null, "text": "【0】页码:2\n QuickStudy\n\n【1】 Images © Vincent Perez/pe U.S.$3.95 / CAN.$5.95 Layout: Rich Marino NOTE TO STUDENT: Use this comprehensive QuickStudy study guide in the\nsystem. This guide is not designed to take the place of classroom attandance.\n\n【2】All rights reserved. No part of this publication may be reproduced or transmitted in a\nform, or by any means, electronic or mechanical, induding photocopy, recording, information storage and retrieval system, without written pers\nsher. ©2004 BarCharts Inc.   0308 on from the\n\n【3】 Customer Hotline # 1.800.230.952", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "QuickStudy", "bbox": [357.0, 4.0, 453.0, 20.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Images © Vincent Perez/pe", "bbox": [118.0, 966.0, 218.0, 974.0]}, {"text": "U.S.$3.95 / CAN.$5.95", "bbox": [13.0, 968.0, 113.0, 980.0]}, {"text": "Layout: Rich Marino", "bbox": [117.0, 975.0, 197.0, 985.0]}, {"text": "\nNOTE TO STUDENT: Use this comprehensive QuickStudy study guide in the\nsystem. This guide is not designed to take the place of classroom attandance.", "bbox": [15.0, 982.0, 265.0, 1012.0]}, {"text": "All rights reserved. No part of this publication may be reproduced or transmitted in a\nform, or by any means, electronic or mechanical, induding photocopy, recording,", "bbox": [17.0, 1007.0, 256.0, 1028.0]}, {"text": "information storage and retrieval system, without written pers\nsher. ©2004 BarCharts Inc.   0308", "bbox": [33.0, 1026.0, 216.0, 1040.0]}, {"text": "on from the", "bbox": [231.0, 1026.0, 265.0, 1032.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Customer Hotline # 1.800.230.952", "bbox": [476.0, 980.0, 643.0, 992.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/BarCharts QuickStudy Dental Anatomy (Rich Marino) (Z-Library).pdf", "page_num": 2}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#3#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:02:34"}
{"id": 1042069, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "68230c36-a690-4ccd-8150-b034b9b8fc2a", "title": null, "text": "【0】页码:64\n from your doctor if you have any such disorders.\n\n【1】 Pregnant women should also seek the advice of their doctor before beginning acupuncture treatment. In general, acupuncture is highly effective during pregnancy because it reduces pain.\n\n【2】 People with pacemakers must avoid electro-acupuncture. Acupuncture has different variations, and it's not always about the insertion of needles. Some treatments require electrical stimulation. So for patients who have pacemakers, this could be bothersome or extremely harmful as it may disrupt the function of the device.\n\n【3】 If you have metal allergies, especially to stainless steel, acupuncture may not be a good option for you. Moreover, patients with unstable diabetes and immune disorders must seek expert advice before having acupuncture.\n\n【4】## Speech Therapy\n\n【5】\n Some people experience speech problems due to Bell's palsy. This is because the facial nerve has the responsibility of keeping facial muscles toned and is responsible for lip movements required for clear speech.  So because of the malfunction of the facial nerve in Bell's palsy, patients experience either partial or complete facial weakness.\n\n【6】 Those affected with Bell's palsy may find it hard to pronounce certain words correctly, especially those with the letters B and P. However, the trouble in talking typically depends on the severity of muscle weakness.\n\n【7】 Patients become reluctant to talk to other people and become very embarrassed due to their slurred speech. This is particularly awkward for school-going children who develop Bell’s palsy. Sadly, they can turn out to be an easy target for bullying and teasing at school.\n\n【8】 In addition, patients whose careers require talking to others or giving presentations have to deal with several challenges. Because of slurred speech, they may become self-conscious, which may affect the quality of their work.\n\n【9】This is typically true for professions such as acting, teaching, training or sales.\n\n【10】 As I've mentioned throughout the book, you should not worry. The majority of people affected with Bell's palsy show no signs of slurred speech once they recover completely. Here are some simple tips that are particularly significant in dealing with speech difficulties:", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "from your doctor if you have any such disorders.", "bbox": [93.0, 97.0, 473.0, 116.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Pregnant women should also seek the advice of their doctor before beginning", "bbox": [93.0, 131.0, 724.0, 151.0]}, {"text": "acupuncture treatment. In general, acupuncture is highly effective during", "bbox": [93.0, 154.0, 724.0, 173.0]}, {"text": "pregnancy because it reduces pain.", "bbox": [93.0, 176.0, 365.0, 195.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "People with pacemakers must avoid electro-acupuncture. Acupuncture has", "bbox": [93.0, 212.0, 722.0, 231.0]}, {"text": "different variations, and it's not always about the insertion of needles. Some", "bbox": [93.0, 234.0, 722.0, 253.0]}, {"text": "treatments require electrical stimulation. So for patients who have pacemakers,", "bbox": [93.0, 256.0, 722.0, 275.0]}, {"text": "this could be bothersome or extremely harmful as it may disrupt the function of", "bbox": [93.0, 278.0, 724.0, 297.0]}, {"text": "the device.", "bbox": [93.0, 300.0, 181.0, 319.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "If you have metal allergies, especially to stainless steel, acupuncture may not be", "bbox": [93.0, 333.0, 723.0, 353.0]}, {"text": "a good option for you. Moreover, patients with unstable diabetes and immune", "bbox": [93.0, 356.0, 722.0, 375.0]}, {"text": "disorders must seek expert advice before having acupuncture.", "bbox": [93.0, 378.0, 571.0, 397.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Speech Therapy", "bbox": [93.0, 419.0, 230.0, 440.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Some people experience speech problems due to Bell's palsy. This is because", "bbox": [93.0, 456.0, 722.0, 476.0]}, {"text": "the facial nerve has the responsibility of keeping facial muscles toned and is", "bbox": [93.0, 479.0, 723.0, 498.0]}, {"text": "responsible for lip movements required for clear speech.  So because of the", "bbox": [93.0, 501.0, 722.0, 520.0]}, {"text": "malfunction of the facial nerve in Bell's palsy, patients experience either partial", "bbox": [93.0, 523.0, 723.0, 543.0]}, {"text": "or complete facial weakness.", "bbox": [93.0, 546.0, 319.0, 564.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Those affected with Bell's palsy may find it hard to pronounce certain words", "bbox": [93.0, 579.0, 723.0, 600.0]}, {"text": "correctly, especially those with the letters B and P. However, the trouble in", "bbox": [93.0, 601.0, 723.0, 622.0]}, {"text": "talking typically depends on the severity of muscle weakness.", "bbox": [93.0, 623.0, 572.0, 643.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Patients become reluctant to talk to other people and become very embarrassed", "bbox": [93.0, 660.0, 723.0, 679.0]}, {"text": "due to their slurred speech. This is particularly awkward for school-going", "bbox": [93.0, 682.0, 724.0, 701.0]}, {"text": "children who develop Bell’s palsy. Sadly, they can turn out to be an easy target", "bbox": [93.0, 704.0, 724.0, 723.0]}, {"text": "for bullying and teasing at school.", "bbox": [93.0, 726.0, 360.0, 745.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "In addition, patients whose careers require talking to others or giving", "bbox": [93.0, 760.0, 723.0, 780.0]}, {"text": "presentations have to deal with several challenges. Because of slurred speech,", "bbox": [93.0, 783.0, 722.0, 802.0]}, {"text": "they may become self-conscious, which may affect the quality of their work.", "bbox": [93.0, 805.0, 722.0, 824.0]}, {"text": "This is typically true for professions such as acting, teaching, training or sales.", "bbox": [93.0, 827.0, 701.0, 846.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "As I've mentioned throughout the book, you should not worry. The majority of", "bbox": [93.0, 861.0, 723.0, 880.0]}, {"text": "people affected with Bell's palsy show no signs of slurred speech once they", "bbox": [93.0, 883.0, 722.0, 902.0]}, {"text": "recover completely. Here are some simple tips that are particularly significant in", "bbox": [93.0, 906.0, 723.0, 925.0]}, {"text": "dealing with speech difficulties:", "bbox": [93.0, 928.0, 344.0, 946.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 64}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:30:47"}
{"id": 1042068, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "0569f1b9-2000-4fba-8425-7f73e2d1dda3", "title": null, "text": "【0】页码:91\n# Puzzlingadventure\n\n【1】\n## No Tipping By Dennis E. Shasha As Archimedes Famously Observed, If You Put An\n\n【2】\n object on a lever arm, it will exert a twisting force around the lever's fulcrum. This twisting is called torque and is equal to the object's weight multiplied by its distance from the fulcrum (the angle of the lever also comes in, but that does not concern us here). If the object is to the left of the fulcrum, the direction of the torque is counterclockwise; if the object is to the right, the direction is clockwise. To compute the torque around a support, simply sum all the torques of the individual objects on the lever.\n\n【3】The challenge is to keep the lever balanced while adjusting the objects on it. First, let's try a warmup problem: Assume you have a straight, evenly weighted board, 20 meters long and weighing three kilograms. The middle of the board is the center of mass, and we will call that position 0. So the possible positions on the board range from –10 (the left end) to +10 (the right end). The board is supported at positions −1.5 and +1.5 by two equal fulcrums, both two meters tall and standing on a flat floor.\n\n【4】On the board are six packages, at positions – 8, – 4,\n\n【5】 − 3, 2, 5 and 8, having weights of 4, 10, 10, 4, 7 and 8 kilograms, respectively [ see illustration A below ].\n\n【6】Your job is to remove the packages one at a time in such a way that the board rests on both supports without tipping. The board would tip if the net torque around the left fulcrum (resulting from the weights of the packages and the board itself) were counterclockwise or if the net torque around the right fulcrum were clockwise. One answer (there are several) is at the right.\n\n【7】Now for a trickier problem. Assume there are 15 packages on the same board, with the positions and weights indicated in illustration B. Some of the packages are at the same distances from the center of the board but sit side by side. Find an order for removing the packages such that the board never tips. One answer (again, there are several) will appear in next month's column.\n\n【8】es\n\n【9】 Dennis E. Shasha, professor of computer science at the Courant Institute of New York University , creates and solves puzzles for a living .\n\n【10】 Web Solution For a peek at the answer to the second problem and at readers' other solutions, visit www.sciam.com\n\n【11】 Note to Sticklers: How can a 20-meter-long board weigh only three kilograms? Assume that it's made of a light titanium alloy.\n\n【12】 \"S fullenit brie E- neds 'S uarb '8- narb '8 16 agesped am uarn 'pnonisod is agenced ays avomatic testi-fi tweldely dn-musW of tewenA", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "PUZZLINGADVENTURE", "bbox": [48.0, 51.0, 470.0, 96.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "No Tipping", "bbox": [49.0, 218.0, 266.0, 274.0]}, {"text": "BY DENNIS E. SHASHA", "bbox": [261.0, 245.0, 410.0, 266.0]}, {"text": "As Archimedes famously observed, if you put an", "bbox": [47.0, 279.0, 316.0, 294.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "object on a lever arm, it will exert a twisting force", "bbox": [47.0, 295.0, 315.0, 309.0]}, {"text": "around the lever's fulcrum. This twisting is called", "bbox": [47.0, 311.0, 314.0, 325.0]}, {"text": "torque and is equal to the object's weight multiplied", "bbox": [47.0, 327.0, 315.0, 342.0]}, {"text": "by its distance from the fulcrum (the angle of the", "bbox": [47.0, 344.0, 315.0, 357.0]}, {"text": "lever also comes in, but that does not concern us", "bbox": [47.0, 359.0, 315.0, 374.0]}, {"text": "here). If the object is to the left of the fulcrum, the", "bbox": [47.0, 375.0, 315.0, 390.0]}, {"text": "direction of the torque is counterclockwise; if the", "bbox": [47.0, 392.0, 315.0, 405.0]}, {"text": "object is to the right, the direction is clockwise. To", "bbox": [47.0, 407.0, 315.0, 422.0]}, {"text": "compute the torque around a support, simply sum", "bbox": [47.0, 423.0, 315.0, 438.0]}, {"text": "all the torques of the individual objects on the lever.", "bbox": [47.0, 440.0, 313.0, 453.0]}, {"text": "The challenge is to keep the lever balanced while", "bbox": [66.0, 455.0, 315.0, 470.0]}, {"text": "adjusting the objects on it. First, let's try a warm-", "bbox": [47.0, 472.0, 313.0, 485.0]}, {"text": "up problem: Assume you have a straight, evenly", "bbox": [47.0, 488.0, 313.0, 501.0]}, {"text": "weighted board, 20 meters long and weighing three", "bbox": [47.0, 503.0, 314.0, 517.0]}, {"text": "kilograms. The middle of the board is the center of", "bbox": [47.0, 519.0, 314.0, 534.0]}, {"text": "mass, and we will call that position 0. So the possi-", "bbox": [47.0, 535.0, 313.0, 549.0]}, {"text": "ble positions on the board range from –10 (the left", "bbox": [47.0, 551.0, 314.0, 565.0]}, {"text": "end) to +10 (the right end). The board is supported", "bbox": [47.0, 567.0, 315.0, 582.0]}, {"text": "at positions −1.5 and +1.5 by two equal fulcrums,", "bbox": [47.0, 583.0, 314.0, 597.0]}, {"text": "both two meters tall and standing on a flat floor.", "bbox": [47.0, 599.0, 313.0, 614.0]}, {"text": "On the board are six packages, at positions – 8, – 4,", "bbox": [47.0, 615.0, 313.0, 630.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "− 3, 2, 5 and 8, having weights of 4, 10, 10, 4, 7 and", "bbox": [326.0, 279.0, 594.0, 294.0]}, {"text": "8 kilograms, respectively [ see illustration A below ].", "bbox": [327.0, 295.0, 594.0, 309.0]}, {"text": "Your job is to remove the packages one at a", "bbox": [347.0, 311.0, 594.0, 325.0]}, {"text": "time in such a way that the board rests on both sup-", "bbox": [327.0, 327.0, 594.0, 342.0]}, {"text": "ports without tipping. The board would tip if the", "bbox": [327.0, 344.0, 594.0, 357.0]}, {"text": "net torque around the left fulcrum (resulting from", "bbox": [326.0, 359.0, 594.0, 374.0]}, {"text": "the weights of the packages and the board itself)", "bbox": [326.0, 375.0, 594.0, 390.0]}, {"text": "were counterclockwise or if the net torque around", "bbox": [327.0, 392.0, 594.0, 405.0]}, {"text": "the right fulcrum were clockwise. One answer", "bbox": [326.0, 407.0, 594.0, 422.0]}, {"text": "(there are several) is at the right.", "bbox": [327.0, 423.0, 499.0, 438.0]}, {"text": "Now for a trickier problem. Assume there are", "bbox": [346.0, 440.0, 594.0, 453.0]}, {"text": "15 packages on the same board, with the positions", "bbox": [328.0, 455.0, 594.0, 470.0]}, {"text": "and weights indicated in illustration B. Some of the", "bbox": [327.0, 471.0, 594.0, 485.0]}, {"text": "packages are at the same distances from the center", "bbox": [327.0, 488.0, 594.0, 501.0]}, {"text": "of the board but sit side by side. Find an order for", "bbox": [327.0, 503.0, 594.0, 517.0]}, {"text": "removing the packages such that the board never", "bbox": [327.0, 519.0, 594.0, 534.0]}, {"text": "tips. One answer (again, there are several) will", "bbox": [326.0, 535.0, 594.0, 549.0]}, {"text": "appear in next month's column.", "bbox": [327.0, 551.0, 499.0, 565.0]}, {"text": "es", "bbox": [583.0, 554.0, 596.0, 565.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Dennis E. Shasha, professor of computer science", "bbox": [328.0, 583.0, 587.0, 597.0]}, {"text": "at the Courant Institute of New York University ,", "bbox": [327.0, 599.0, 588.0, 614.0]}, {"text": "creates and solves puzzles for a living .", "bbox": [327.0, 615.0, 529.0, 630.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Web Solution", "bbox": [664.0, 313.0, 713.0, 322.0]}, {"text": "For a peek at the", "bbox": [654.0, 327.0, 716.0, 338.0]}, {"text": "answer to the", "bbox": [664.0, 341.0, 716.0, 350.0]}, {"text": "second problem and", "bbox": [642.0, 353.0, 716.0, 364.0]}, {"text": "at readers' other", "bbox": [654.0, 367.0, 716.0, 377.0]}, {"text": "solutions, visit", "bbox": [659.0, 380.0, 716.0, 391.0]}, {"text": "www.sciam.com", "bbox": [655.0, 393.0, 716.0, 404.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Note to Sticklers:", "bbox": [651.0, 420.0, 715.0, 430.0]}, {"text": "How can a", "bbox": [676.0, 434.0, 716.0, 443.0]}, {"text": "20-meter-long board", "bbox": [639.0, 447.0, 717.0, 458.0]}, {"text": "weigh only three", "bbox": [654.0, 460.0, 716.0, 471.0]}, {"text": "kilograms? Assume", "bbox": [642.0, 473.0, 716.0, 484.0]}, {"text": "that it's made of a", "bbox": [648.0, 486.0, 716.0, 497.0]}, {"text": "light titanium alloy.", "bbox": [643.0, 500.0, 716.0, 511.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "\"S fullenit brie E- neds", "bbox": [638.0, 527.0, 716.0, 538.0]}, {"text": "'S uarb '8- narb '8 16", "bbox": [640.0, 540.0, 716.0, 552.0]}, {"text": "agesped am uarn 'p-", "bbox": [638.0, 553.0, 715.0, 564.0]}, {"text": "nonisod is agenced", "bbox": [642.0, 567.0, 717.0, 576.0]}, {"text": "ays avomatic testi-fi", "bbox": [654.0, 580.0, 717.0, 590.0]}, {"text": "tweldely", "bbox": [682.0, 594.0, 716.0, 602.0]}, {"text": "dn-musW of tewenA", "bbox": [642.0, 607.0, 717.0, 618.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 91}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#1#1#As Archimedes Famously另起一行\n多余换行#1#1# If You Put An接object on a lever arm是一句话\n多余换行#4#5#at positions – 8, – 4,接− 3, 2, 5 and 8,是一句话", "type3": "无关文本#8#8#es\n", "type4": null, "type5": null, "type6": "有用性#10#12#侧边栏目没用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:30:23"}
{"id": 1042067, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "0366ebc2-c472-419a-b545-22d899e51d9b", "title": null, "text": "【0】页码:53\n Fig. 15. 45* tip back bend.\n\n【1】 and roots of the molar and incisors will move once the wire becomes active.\n\n【2】 3.\n\n【3】 Use of intermaxillary elastics. These allow teeth from a dental arch to function as anchorage and produce a differential movement of the antagonist teeth; for example Class II, Class III or Delta elastics.\n\n【4】 Fig. 17. Once activated, the wire is going to produce intrusion of the incisors, and the roots of the molar will mesially incline making it more resistant to movement.\n\n【5】 2.\n\n【6】Torque force utilization. The use of pre-torque arch wires will increase the anchorage of the incisors against buccal force.\n Fig. 19. Class II elastics.\n Fig. 20. Class III elastics.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Fig. 15. 45* tip back bend.", "bbox": [169.0, 273.0, 285.0, 290.0]}], "type": "Caption", "position": 2}, {"raw_context": [{"text": "and roots of the molar and incisors will move once the wire becomes", "bbox": [71.0, 532.0, 385.0, 548.0]}, {"text": "active.", "bbox": [71.0, 546.0, 103.0, 560.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "3.", "bbox": [406.0, 408.0, 422.0, 425.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Use of intermaxillary elastics. These allow teeth from", "bbox": [432.0, 409.0, 722.0, 426.0]}, {"text": "a dental arch to function as anchorage and produce", "bbox": [432.0, 426.0, 723.0, 445.0]}, {"text": "a differential movement of the antagonist teeth; for", "bbox": [432.0, 444.0, 722.0, 461.0]}, {"text": "example Class II, Class III or Delta elastics.", "bbox": [432.0, 461.0, 673.0, 479.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Fig. 17. Once activated, the wire is going to produce intrusion of the", "bbox": [71.0, 809.0, 383.0, 828.0]}, {"text": "incisors, and the roots of the molar will mesially incline making it more", "bbox": [71.0, 823.0, 383.0, 842.0]}, {"text": "resistant to movement.", "bbox": [71.0, 838.0, 176.0, 852.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "2.", "bbox": [70.0, 920.0, 85.0, 939.0]}, {"text": "Torque force utilization. The use of pre-torque arch", "bbox": [96.0, 921.0, 385.0, 941.0]}, {"text": "wires will increase the anchorage of the incisors against", "bbox": [97.0, 939.0, 385.0, 959.0]}, {"text": "buccal force.", "bbox": [97.0, 957.0, 169.0, 974.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Fig. 19. Class II elastics.", "bbox": [524.0, 718.0, 631.0, 734.0]}], "type": "Caption", "position": 12}, {"raw_context": [{"text": "Fig. 20. Class III elastics.", "bbox": [510.0, 962.0, 621.0, 978.0]}], "type": "Caption", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 53}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#3#序号正文分开了\n多余换行#5#6#序号正文分开了", "type3": "无关文本#0#1#非正文内容\n无关文本#4#4#非正文内容\n无关文本#6#6#Fig. 19. Class II elastics.\nFig. 20. Class III elastics.非正文内容", "type4": "栏目混乱#2#6#正文顺序颠倒", "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 01:01:59"}
{"id": 1042066, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "4efd9d5b-771c-42d4-91ee-bf86864c5b27", "title": null, "text": "【0】页码:60\n Scale score of < 8, 139, 140 or both. 138, 139 For victims with suspected spinal injury, rescuers should initially use manual spinal motion restriction (eg, placing 1 hand on either side of the patient's head to hold it still) rather than immobilization devices (Class IIb, LOE C 141 , 142 ). Spinal immobilization devices may interfere with maintaining a patent airway, 143 . 144 but ultimately the use of such a device may be necessary to maintain spinal alignment during transport.\n\n【1】If healthcare providers suspect a cervical spine injury, they should open the airway using a jaw thrust without head extension (Class IIb, LOE C 133 ). Because maintaining a patent airway and providing adequate ventilation are priorities in CPR (Class I, LOE C), use the head tilt–chin lift maneuver if the jaw thrust does not adequately open the airway.\n\n【2】## Rescue Breathing (Box 3A, 4)\n\n【3】\n The 2010 AHA Guidelines for CPR and ECC make many of the same recommendations regarding rescue breathing as in 2005:\n • Deliver each rescue breath over 1 second (Class IIa, LOE C).\n\n【4】• Give a sufficient tidal volume to produce visible chest rise (Class IIa, LOE C). 55 • Use a compression to ventilation ratio of 30 chest compressions to 2 ventilations.\n\n【5】• When an advanced airway (ie, endotracheal tube, Combitube, or laryngeal mask airway [LMA]) is in place during 2-person CPR, give 1 breath every 6 to 8 seconds without attempting to synchronize breaths between compressions (this will result in delivery of 8 to 10 breaths/minute).\n\n【6】There should be no pause in chest compressions for delivery of ventilations (Class IIb, LOE C).\n\n【7】 Studies in anesthetized adults (with normal perfusion) suggest that a tidal volume of 8 to 10 mL/kg maintains normal oxygenation and elimination of CO 2 . During CPR, cardiac output is ≈ 25% to 33% of normal, so oxygen uptake from the lungs and CO 2 delivery to the lungs are also reduced. As a result, a low minute ventilation (lower than normal tidal volume and respiratory rate) can maintain effective oxygenation and ventilation. 55,110,111,119 For that reason during adult CPR tidal volumes of approximately 500 to 600 mL (6 to 7 mL/kg) should suffice (Class IIa, LOE B). 145–147 This is consistent with a tidal volume that produces visible chest rise.\n\n【8】Patients with airway obstruction or poor lung compliance may require high pressures to be properly ventilated (to make the chest visibly rise). A pressure-relief valve on a resuscitation bag-mask may prevent the delivery of a sufficient tidal volume in these patients. 148 Ensure that the bag-mask device allows you to bypass the pressure-relief valve and use high pressures, if necessary, to achieve visible chest expansion. 149 Excessive ventilation is unnecessary and can cause gastric inflation and its resultant complications, such as regurgitation and aspiration (Class III, LOE B 150 – 152 ). More important, excessive ventilation can be harmful because it increases intrathoracic pressure, decreases venous return to the heart, and diminishes cardiac output and survival. 152 In summary, rescuers should avoid excessive ventilation (too many breaths or too large a volume) during CPR (Class III, LOE B).\n\n【9】 During CPR the primary purpose of assisted ventilation is to maintain adequate oxygenation; the secondary purpose is to eliminate CO 2 . However, the optimal inspired oxygen concentration, tidal volume and respiratory rate to achieve those purposes are not known. As noted above, during the first minutes of sudden VF cardiac arrest, rescue breaths are not as important as chest compressions 29 , 108 , 153 because the oxygen content in the noncirculating arterial blood remains unchanged until CPR is started; the blood oxygen content then continues to be adequate during the first several minutes of CPR. In addition, attempts to open the airway and give rescue breaths (or to access and set up airway equipment) may delay the initiation of chest compressions. 154 These issues support the CAB approach of the 2010 AHA Guidelines for CPR and ECC (ie, starting with Chest Compressions prior to Airway and Breathing).\n\n【10】For victims of prolonged cardiac arrest both ventilations and compressions are important because over time oxygen in the blood is consumed and oxygen in the lungs is depleted (although the precise time course is unknown). Ventilations and compressions are also important for victims of asphyxial arrest, such as children and drowning victims, because they are hypoxemic at the time of cardiac arrest. 30,109\n\n【11】## Mouth-To-Mouth Rescue Breathing\n\n【12】\n Mouth-to-mouth rescue breathing provides oxygen and ventilation to the victim. 155 To provide mouth-to-mouth rescue breaths, open the victim's airway, pinch the victim's nose, and create an airtight mouth-to-mouth seal. Give 1 breath over 1 second, take a \"regular\" (not a deep) breath, and give a second rescue breath over 1 second (Class IIb, LOE C).\n\n【13】Taking a regular rather than a deep breath prevents the rescuer from getting dizzy or lightheaded and prevents overinflation of the victim's lungs. The most common cause of ventilation difficulty is an improperly opened airway, 57 so if the victim's chest does not rise with the first rescue breath, reposition the head by performing the head tilt–chin lift again and then give the second rescue breath.\n\n【14】If an adult victim with spontaneous circulation (ie, strong and easily palpable pulses) requires support of ventilation, the healthcare provider should give rescue breaths at a rate of about 1 breath every 5 to 6 seconds, or about 10 to 12 breaths per minute (Class IIb, LOE C). Each breath should be given over 1 second regardless of whether an advanced airway is in place. Each breath should cause visible chest rise.\n\n【15】## Mouth-To–Barrier Device Breathing\n\n【16】\n Some healthcare providers 114 – 116 and lay rescuers state that they may hesitate to give mouth-to-mouth rescue breathing and prefer to use a barrier device. The risk of disease transmission through mouth to mouth ventilation is very low, and it is reasonable to initiate rescue breathing with or without a barrier device. When using a barrier device the rescuer should not delay chest compressions while setting up the device.\n\n【17】 Mouth-to-Nose and Mouth-to-Stoma Ventilation Mouth-to-nose ventilation is recommended if ventilation through the victim's mouth is impossible (eg, the mouth is seriously injured), the mouth cannot be opened, the victim is in water, or a mouth-to-mouth seal is difficult to achieve\n\n【18】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Scale score of < 8, 139, 140 or both. 138, 139 For victims with", "bbox": [60.0, 83.0, 377.0, 98.0]}, {"text": "suspected spinal injury, rescuers should initially use manual", "bbox": [60.0, 100.0, 377.0, 113.0]}, {"text": "spinal motion restriction (eg, placing 1 hand on either side of", "bbox": [60.0, 115.0, 376.0, 129.0]}, {"text": "the patient's head to hold it still) rather than immobilization", "bbox": [60.0, 131.0, 376.0, 145.0]}, {"text": "devices (Class IIb, LOE C 141 , 142 ). Spinal immobilization", "bbox": [60.0, 146.0, 377.0, 160.0]}, {"text": "devices may interfere with maintaining a patent airway, 143 . 144", "bbox": [60.0, 160.0, 375.0, 175.0]}, {"text": "but ultimately the use of such a device may be necessary to", "bbox": [60.0, 177.0, 377.0, 191.0]}, {"text": "maintain spinal alignment during transport.", "bbox": [60.0, 193.0, 286.0, 207.0]}, {"text": "If healthcare providers suspect a cervical spine injury, they", "bbox": [73.0, 208.0, 375.0, 221.0]}, {"text": "should open the airway using a jaw thrust without head exten-", "bbox": [60.0, 223.0, 375.0, 238.0]}, {"text": "sion (Class IIb, LOE C 133 ). Because maintaining a patent airway", "bbox": [60.0, 239.0, 375.0, 253.0]}, {"text": "and providing adequate ventilation are priorities in CPR (Class I,", "bbox": [60.0, 253.0, 375.0, 269.0]}, {"text": "LOE C), use the head tilt–chin lift maneuver if the jaw thrust", "bbox": [60.0, 270.0, 376.0, 283.0]}, {"text": "does not adequately open the airway.", "bbox": [60.0, 286.0, 248.0, 300.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Rescue Breathing (Box 3A, 4)", "bbox": [60.0, 309.0, 225.0, 324.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "The 2010 AHA Guidelines for CPR and ECC make many of", "bbox": [61.0, 324.0, 376.0, 338.0]}, {"text": "the same recommendations regarding rescue breathing as in", "bbox": [60.0, 340.0, 376.0, 354.0]}, {"text": "2005:", "bbox": [60.0, 354.0, 93.0, 368.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "• Deliver each rescue breath over 1 second (Class IIa, LOE C).", "bbox": [60.0, 380.0, 375.0, 394.0]}, {"text": "• Give a sufficient tidal volume to produce visible chest rise", "bbox": [60.0, 396.0, 375.0, 410.0]}, {"text": "(Class IIa, LOE C). 55", "bbox": [70.0, 412.0, 185.0, 426.0]}, {"text": "• Use a compression to ventilation ratio of 30 chest com-", "bbox": [60.0, 427.0, 375.0, 441.0]}, {"text": "pressions to 2 ventilations.", "bbox": [72.0, 442.0, 211.0, 456.0]}, {"text": "• When an advanced airway (ie, endotracheal tube, Combi-", "bbox": [60.0, 457.0, 375.0, 473.0]}, {"text": "tube, or laryngeal mask airway [LMA]) is in place during", "bbox": [71.0, 474.0, 375.0, 488.0]}, {"text": "2-person CPR, give 1 breath every 6 to 8 seconds without", "bbox": [72.0, 489.0, 376.0, 502.0]}, {"text": "attempting to synchronize breaths between compressions", "bbox": [71.0, 504.0, 376.0, 518.0]}, {"text": "(this will result in delivery of 8 to 10 breaths/minute).", "bbox": [71.0, 519.0, 375.0, 534.0]}, {"text": "There should be no pause in chest compressions for", "bbox": [73.0, 535.0, 376.0, 548.0]}, {"text": "delivery of ventilations (Class IIb, LOE C).", "bbox": [71.0, 550.0, 301.0, 565.0]}], "type": "List-item", "position": 6}, {"raw_context": [{"text": "Studies in anesthetized adults (with normal perfusion)", "bbox": [73.0, 575.0, 377.0, 590.0]}, {"text": "suggest that a tidal volume of 8 to 10 mL/kg maintains", "bbox": [60.0, 592.0, 376.0, 606.0]}, {"text": "normal oxygenation and elimination of CO 2 . During CPR,", "bbox": [60.0, 608.0, 375.0, 622.0]}, {"text": "cardiac output is ≈ 25% to 33% of normal, so oxygen uptake", "bbox": [60.0, 622.0, 376.0, 636.0]}, {"text": "from the lungs and CO 2 delivery to the lungs are also", "bbox": [60.0, 638.0, 377.0, 652.0]}, {"text": "reduced. As a result, a low minute ventilation (lower than", "bbox": [60.0, 654.0, 376.0, 667.0]}, {"text": "normal tidal volume and respiratory rate) can maintain", "bbox": [60.0, 669.0, 377.0, 683.0]}, {"text": "effective oxygenation and ventilation. 55,110,111,119 For that", "bbox": [60.0, 684.0, 376.0, 698.0]}, {"text": "reason during adult CPR tidal volumes of approximately 500", "bbox": [60.0, 699.0, 376.0, 713.0]}, {"text": "to 600 mL (6 to 7 mL/kg) should suffice (Class IIa, LOE", "bbox": [60.0, 716.0, 376.0, 729.0]}, {"text": "B). 145–147 This is consistent with a tidal volume that produces", "bbox": [60.0, 730.0, 376.0, 744.0]}, {"text": "visible chest rise.", "bbox": [60.0, 746.0, 152.0, 760.0]}, {"text": "Patients with airway obstruction or poor lung compliance", "bbox": [72.0, 762.0, 376.0, 775.0]}, {"text": "may require high pressures to be properly ventilated (to make", "bbox": [60.0, 776.0, 376.0, 791.0]}, {"text": "the chest visibly rise). A pressure-relief valve on a resuscita-", "bbox": [60.0, 793.0, 375.0, 806.0]}, {"text": "tion bag-mask may prevent the delivery of a sufficient tidal", "bbox": [60.0, 808.0, 377.0, 823.0]}, {"text": "volume in these patients. 148 Ensure that the bag-mask device", "bbox": [60.0, 823.0, 376.0, 837.0]}, {"text": "allows you to bypass the pressure-relief valve and use high", "bbox": [60.0, 838.0, 376.0, 852.0]}, {"text": "pressures, if necessary, to achieve visible chest expansion. 149", "bbox": [60.0, 854.0, 376.0, 868.0]}, {"text": "Excessive ventilation is unnecessary and can cause gastric", "bbox": [72.0, 870.0, 376.0, 883.0]}, {"text": "inflation and its resultant complications, such as regurgitation", "bbox": [60.0, 884.0, 376.0, 899.0]}, {"text": "and aspiration (Class III, LOE B 150 – 152 ). More important,", "bbox": [60.0, 899.0, 376.0, 914.0]}, {"text": "excessive ventilation can be harmful because it increases", "bbox": [60.0, 915.0, 376.0, 930.0]}, {"text": "intrathoracic pressure, decreases venous return to the heart,", "bbox": [60.0, 931.0, 376.0, 945.0]}, {"text": "and diminishes cardiac output and survival. 152 In summary,", "bbox": [60.0, 947.0, 377.0, 960.0]}, {"text": "rescuers should avoid excessive ventilation (too many breaths", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "or too large a volume) during CPR (Class III, LOE B).", "bbox": [60.0, 977.0, 351.0, 991.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "During CPR the primary purpose of assisted ventilation is", "bbox": [416.0, 84.0, 721.0, 99.0]}, {"text": "to maintain adequate oxygenation; the secondary purpose is", "bbox": [404.0, 100.0, 721.0, 113.0]}, {"text": "to eliminate CO 2 . However, the optimal inspired oxygen", "bbox": [403.0, 115.0, 721.0, 130.0]}, {"text": "concentration, tidal volume and respiratory rate to achieve", "bbox": [403.0, 132.0, 720.0, 145.0]}, {"text": "those purposes are not known. As noted above, during the", "bbox": [403.0, 147.0, 720.0, 160.0]}, {"text": "first minutes of sudden VF cardiac arrest, rescue breaths are", "bbox": [404.0, 162.0, 720.0, 176.0]}, {"text": "not as important as chest compressions 29 , 108 , 153 because the", "bbox": [403.0, 177.0, 720.0, 191.0]}, {"text": "oxygen content in the noncirculating arterial blood remains", "bbox": [403.0, 194.0, 720.0, 207.0]}, {"text": "unchanged until CPR is started; the blood oxygen content", "bbox": [403.0, 208.0, 721.0, 222.0]}, {"text": "then continues to be adequate during the first several minutes", "bbox": [403.0, 224.0, 720.0, 239.0]}, {"text": "of CPR. In addition, attempts to open the airway and give", "bbox": [403.0, 240.0, 720.0, 253.0]}, {"text": "rescue breaths (or to access and set up airway equipment)", "bbox": [403.0, 255.0, 721.0, 269.0]}, {"text": "may delay the initiation of chest compressions. 154 These", "bbox": [403.0, 271.0, 720.0, 284.0]}, {"text": "issues support the CAB approach of the 2010 AHA Guide-", "bbox": [403.0, 286.0, 719.0, 301.0]}, {"text": "lines for CPR and ECC (ie, starting with Chest Compressions", "bbox": [404.0, 301.0, 720.0, 315.0]}, {"text": "prior to Airway and Breathing).", "bbox": [403.0, 317.0, 572.0, 331.0]}, {"text": "For victims of prolonged cardiac arrest both ventilations", "bbox": [416.0, 333.0, 720.0, 347.0]}, {"text": "and compressions are important because over time oxygen in", "bbox": [404.0, 348.0, 721.0, 362.0]}, {"text": "the blood is consumed and oxygen in the lungs is depleted", "bbox": [403.0, 364.0, 720.0, 378.0]}, {"text": "(although the precise time course is unknown). Ventilations", "bbox": [403.0, 379.0, 720.0, 393.0]}, {"text": "and compressions are also important for victims of asphyxial", "bbox": [404.0, 394.0, 720.0, 408.0]}, {"text": "arrest, such as children and drowning victims, because they", "bbox": [404.0, 410.0, 720.0, 423.0]}, {"text": "are hypoxemic at the time of cardiac arrest. 30,109", "bbox": [404.0, 426.0, 658.0, 440.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Mouth-to-Mouth Rescue Breathing", "bbox": [404.0, 450.0, 594.0, 465.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Mouth-to-mouth rescue breathing provides oxygen and ven-", "bbox": [404.0, 466.0, 719.0, 479.0]}, {"text": "tilation to the victim. 155 To provide mouth-to-mouth rescue", "bbox": [403.0, 481.0, 720.0, 495.0]}, {"text": "breaths, open the victim's airway, pinch the victim's nose,", "bbox": [403.0, 496.0, 720.0, 510.0]}, {"text": "and create an airtight mouth-to-mouth seal. Give 1 breath", "bbox": [403.0, 511.0, 721.0, 525.0]}, {"text": "over 1 second, take a \"regular\" (not a deep) breath, and give", "bbox": [403.0, 527.0, 720.0, 542.0]}, {"text": "a second rescue breath over 1 second (Class IIb, LOE C).", "bbox": [403.0, 542.0, 720.0, 556.0]}, {"text": "Taking a regular rather than a deep breath prevents the", "bbox": [404.0, 558.0, 720.0, 572.0]}, {"text": "rescuer from getting dizzy or lightheaded and prevents", "bbox": [403.0, 574.0, 720.0, 587.0]}, {"text": "overinflation of the victim's lungs. The most common cause", "bbox": [403.0, 588.0, 720.0, 603.0]}, {"text": "of ventilation difficulty is an improperly opened airway, 57 so", "bbox": [403.0, 605.0, 720.0, 618.0]}, {"text": "if the victim's chest does not rise with the first rescue breath,", "bbox": [403.0, 620.0, 720.0, 635.0]}, {"text": "reposition the head by performing the head tilt–chin lift again", "bbox": [403.0, 635.0, 720.0, 649.0]}, {"text": "and then give the second rescue breath.", "bbox": [404.0, 651.0, 612.0, 665.0]}, {"text": "If an adult victim with spontaneous circulation (ie, strong", "bbox": [416.0, 667.0, 720.0, 681.0]}, {"text": "and easily palpable pulses) requires support of ventilation, the", "bbox": [404.0, 682.0, 720.0, 696.0]}, {"text": "healthcare provider should give rescue breaths at a rate of", "bbox": [403.0, 698.0, 720.0, 712.0]}, {"text": "about 1 breath every 5 to 6 seconds, or about 10 to 12 breaths", "bbox": [404.0, 713.0, 720.0, 727.0]}, {"text": "per minute (Class IIb, LOE C). Each breath should be given", "bbox": [403.0, 728.0, 720.0, 742.0]}, {"text": "over 1 second regardless of whether an advanced airway is in", "bbox": [403.0, 744.0, 721.0, 757.0]}, {"text": "place. Each breath should cause visible chest rise.", "bbox": [404.0, 759.0, 666.0, 774.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Mouth-to–Barrier Device Breathing", "bbox": [404.0, 784.0, 597.0, 799.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Some healthcare providers 114 – 116 and lay rescuers state that they", "bbox": [404.0, 798.0, 720.0, 813.0]}, {"text": "may hesitate to give mouth-to-mouth rescue breathing and prefer", "bbox": [403.0, 814.0, 720.0, 828.0]}, {"text": "to use a barrier device. The risk of disease transmission through", "bbox": [403.0, 829.0, 721.0, 843.0]}, {"text": "mouth to mouth ventilation is very low, and it is reasonable to", "bbox": [404.0, 845.0, 721.0, 858.0]}, {"text": "initiate rescue breathing with or without a barrier device. When", "bbox": [403.0, 860.0, 720.0, 875.0]}, {"text": "using a barrier device the rescuer should not delay chest", "bbox": [404.0, 876.0, 720.0, 890.0]}, {"text": "compressions while setting up the device.", "bbox": [403.0, 891.0, 613.0, 906.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Mouth-to-Nose and Mouth-to-Stoma Ventilation", "bbox": [404.0, 916.0, 664.0, 930.0]}, {"text": "Mouth-to-nose ventilation is recommended if ventilation", "bbox": [404.0, 931.0, 721.0, 945.0]}, {"text": "through the victim's mouth is impossible (eg, the mouth is", "bbox": [403.0, 946.0, 721.0, 961.0]}, {"text": "seriously injured), the mouth cannot be opened, the victim is", "bbox": [404.0, 962.0, 720.0, 976.0]}, {"text": "in water, or a mouth-to-mouth seal is difficult to achieve", "bbox": [404.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 60}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#4#4# • Use a compression to ventilation...另起一行\n缺少换行#8#8#Excessive ventilation is unnecessary and...另起一行\n缺少换行#17#17#Mouth-to-nose ventilation is recommended if...标题和内容分开，另起一行", "type3": "无关文本#0#17# ...devices (Class IIb, LOE C 141 , 142 ).\n...a patent airway, 143 . 144...\nScale score of < 8, 139, 140 or both.像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#18#18#属于页脚的内容，和正文无关", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:52:53"}
{"id": 1042065, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "5818d776-004b-427a-844d-964219883d91", "title": null, "text": "【0】页码:179\n greater force, can affect the alveolar process. Many studies done in children with posterior cross bite have encountered a very high prevalence of finger sucking habits in these patients. The proportion of girls with posterior cross bite is slightly higher than boys with the same problem. This difference is attributed to the fact that girls have a higher frequency of finger sucking habit. (216)\n\n【1】 Another suction habit is pacifier habit. The prevalence of posterior cross bite in patients in the mixed dentition that have a suction habit is greater, and this habit has been catalogued as an important etiological factor in the development of this malocclusion.\n\n【2】 According to Larsson, posterior cross bite usually disap¬ pears spontaneously in the permanent dentition, due to the fact that the habit is interrupted before the eruption of the premolars and permanent canines. (16)\n\n【3】 Infantile deglutition: the typical deglutition pattern of a child before teeth erupt is characterized by the fact that the tongue is placed between the gingival pads and is projected forward. Deglutition is controlled by the contact of the lips, the tongue and the perioral muscles. 116 The persistence of infantile deglutition can be provoked by hypertrophic tonsils, mouth breathing or psychological sucking habit.\n\n【4】The tongue is interposed between the teeth to stabilize the mandible and to seal the oral cavity. The lack of tongue pressure and strong pressure of the buccinator muscles provoke a deficient transversal development of the maxi¬ lla, which is usually associated with an anterior open bite because the anterior teeth have not erupted yet. (2.16)\n\n【5】 Lingual interposition: the persistence of this habit ■ is similar to the one just described, but the action of the tongue is prolonged through time. The role of the tongue in the etiology of malocclusions is related with a series of variables, like position, pressure, volume and time. (16)\n\n【6】## 3.\n\n【7】Interferences And Occlusal Factors\n\n【8】\n The anatomic characteristics of teeth serve as a guide to establish a correct occlusion, so any type of alteration in teeth anatomy or in the eruption sequence can provoke the devel¬ opment of posterior cross bites. The most common cause of unilateral posterior cross bites is a functional deviation of the mandible, generally produced by occlusal interferences or premature contacts. The presence of occlusal interferences in the deciduous canines that are too long may be the cause\n\n【9】 of cross bites, because these teeth provoke a lateral deviation of the mandible during closure. (2.16)\n\n【10】## 4.\n\n【11】Trauma\n\n【12】\n Dental trauma in the deciduous dentition can displace the primary teeth or the buds of the permanent teeth, provoking an anomalous inclination of the upper teeth toward the palate and the apparition of a dental posterior cross bite. The same can occur if the trauma provokes the displacement of the permanent teeth.\n\n【13】 Other types of trauma can provoke mandibular or condyle fractures, that cause grave facial asymmetries in patients that are growing and the apparition of skeletal cross bites. 12 • 16 •\n\n【14】 A third group of trauma are the ones caused during birth with the manipulation of instruments.\n\n【15】## Other Causes 5.\n\n【16】\n Some other factors exist that in an indirect way can favor the presence of posterior cross bites. One of them is an¬ kyloglossia. A short lingual frenum maintains the tongue in a low position, favoring the apparition of maxillary compression. (16)\n\n【17】## Types Of Posterior Cross Bites\n\n【18】\n Posterior cross bites can be:\n\n【19】 o\n\n【20】 o\n\n【21】 o\n\n【22】 Bilateral, which affects both maxillary hemiarches.\n\n【23】Unilateral, affecting the right or the left hemiarch.\n\n【24】Of an isolated tooth. (16)\n\n【25】 The following classification was proposed by Moyers (1966), still being applied today. (2)\n\n【26】## 1.\n\n【27】Functional Cross Bite\n\n【28】\n These are produced when there is an occlusal inter¬ ■ ference that displaces the mandible to the left or the right during the last phase of closure.\n\n【29】They are unilateral cross bites.\n\n【30】II ■ There may be a chin deviation. (13) Lower dental midline deviation as a consequence of ■ the mandibular deviation. (2)", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "greater force, can affect the alveolar process. Many studies", "bbox": [72.0, 86.0, 385.0, 102.0]}, {"text": "done in children with posterior cross bite have encountered", "bbox": [72.0, 102.0, 385.0, 118.0]}, {"text": "a very high prevalence of finger sucking habits in these", "bbox": [72.0, 120.0, 385.0, 136.0]}, {"text": "patients. The proportion of girls with posterior cross bite", "bbox": [72.0, 138.0, 385.0, 153.0]}, {"text": "is slightly higher than boys with the same problem. This", "bbox": [71.0, 155.0, 385.0, 171.0]}, {"text": "difference is attributed to the fact that girls have a higher", "bbox": [72.0, 170.0, 384.0, 190.0]}, {"text": "frequency of finger sucking habit. (216)", "bbox": [72.0, 189.0, 274.0, 204.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Another suction habit is pacifier habit. The prevalence", "bbox": [72.0, 224.0, 385.0, 240.0]}, {"text": "of posterior cross bite in patients in the mixed dentition", "bbox": [70.0, 240.0, 385.0, 258.0]}, {"text": "that have a suction habit is greater, and this habit has", "bbox": [70.0, 259.0, 384.0, 275.0]}, {"text": "been catalogued as an important etiological factor in the", "bbox": [70.0, 274.0, 385.0, 293.0]}, {"text": "development of this malocclusion.", "bbox": [71.0, 293.0, 260.0, 309.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "According to Larsson, posterior cross bite usually disap¬", "bbox": [72.0, 328.0, 382.0, 344.0]}, {"text": "pears spontaneously in the permanent dentition, due to", "bbox": [71.0, 345.0, 385.0, 361.0]}, {"text": "the fact that the habit is interrupted before the eruption", "bbox": [70.0, 363.0, 384.0, 379.0]}, {"text": "of the premolars and permanent canines. (16)", "bbox": [70.0, 379.0, 309.0, 397.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Infantile deglutition: the typical deglutition pattern of a", "bbox": [70.0, 413.0, 384.0, 431.0]}, {"text": "child before teeth erupt is characterized by the fact that the", "bbox": [69.0, 432.0, 383.0, 448.0]}, {"text": "tongue is placed between the gingival pads and is projected", "bbox": [70.0, 448.0, 383.0, 467.0]}, {"text": "forward. Deglutition is controlled by the contact of the lips,", "bbox": [70.0, 466.0, 382.0, 483.0]}, {"text": "the tongue and the perioral muscles. 116 The persistence", "bbox": [69.0, 483.0, 383.0, 500.0]}, {"text": "of infantile deglutition can be provoked by hypertrophic", "bbox": [69.0, 501.0, 383.0, 517.0]}, {"text": "tonsils, mouth breathing or psychological sucking habit.", "bbox": [69.0, 519.0, 382.0, 534.0]}, {"text": "The tongue is interposed between the teeth to stabilize the", "bbox": [70.0, 536.0, 383.0, 552.0]}, {"text": "mandible and to seal the oral cavity. The lack of tongue", "bbox": [69.0, 552.0, 383.0, 570.0]}, {"text": "pressure and strong pressure of the buccinator muscles", "bbox": [69.0, 570.0, 383.0, 586.0]}, {"text": "provoke a deficient transversal development of the maxi¬", "bbox": [69.0, 586.0, 381.0, 605.0]}, {"text": "lla, which is usually associated with an anterior open bite", "bbox": [69.0, 604.0, 383.0, 622.0]}, {"text": "because the anterior teeth have not erupted yet. (2.16)", "bbox": [69.0, 621.0, 350.0, 640.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Lingual interposition: the persistence of this habit", "bbox": [95.0, 656.0, 383.0, 674.0]}, {"text": "■", "bbox": [69.0, 657.0, 81.0, 670.0]}, {"text": "is similar to the one just described, but the action of the", "bbox": [69.0, 674.0, 383.0, 690.0]}, {"text": "tongue is prolonged through time. The role of the tongue", "bbox": [69.0, 692.0, 382.0, 708.0]}, {"text": "in the etiology of malocclusions is related with a series of", "bbox": [69.0, 709.0, 382.0, 725.0]}, {"text": "variables, like position, pressure, volume and time. (16)", "bbox": [69.0, 727.0, 352.0, 743.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "3.", "bbox": [69.0, 795.0, 84.0, 809.0]}, {"text": "Interferences and occlusal factors", "bbox": [93.0, 795.0, 307.0, 811.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "The anatomic characteristics of teeth serve as a guide to es-", "bbox": [69.0, 830.0, 379.0, 847.0]}, {"text": "tablish a correct occlusion, so any type of alteration in teeth", "bbox": [68.0, 847.0, 381.0, 863.0]}, {"text": "anatomy or in the eruption sequence can provoke the devel¬", "bbox": [68.0, 865.0, 380.0, 881.0]}, {"text": "opment of posterior cross bites. The most common cause of", "bbox": [67.0, 881.0, 382.0, 899.0]}, {"text": "unilateral posterior cross bites is a functional deviation of the", "bbox": [67.0, 899.0, 381.0, 915.0]}, {"text": "mandible, generally produced by occlusal interferences or", "bbox": [67.0, 915.0, 381.0, 934.0]}, {"text": "premature contacts. The presence of occlusal interferences", "bbox": [67.0, 934.0, 381.0, 949.0]}, {"text": "in the deciduous canines that are too long may be the cause", "bbox": [67.0, 951.0, 381.0, 967.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "of cross bites, because these teeth provoke a lateral deviation", "bbox": [407.0, 87.0, 721.0, 103.0]}, {"text": "of the mandible during closure. (2.16)", "bbox": [407.0, 104.0, 595.0, 121.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "4.", "bbox": [408.0, 158.0, 423.0, 172.0]}, {"text": "Trauma", "bbox": [434.0, 157.0, 483.0, 172.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Dental trauma in the deciduous dentition can displace", "bbox": [407.0, 191.0, 721.0, 207.0]}, {"text": "the primary teeth or the buds of the permanent teeth,", "bbox": [406.0, 209.0, 721.0, 225.0]}, {"text": "provoking an anomalous inclination of the upper teeth", "bbox": [407.0, 226.0, 721.0, 242.0]}, {"text": "toward the palate and the apparition of a dental posterior", "bbox": [407.0, 244.0, 721.0, 260.0]}, {"text": "cross bite. The same can occur if the trauma provokes the", "bbox": [406.0, 262.0, 721.0, 277.0]}, {"text": "displacement of the permanent teeth.", "bbox": [406.0, 278.0, 614.0, 293.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Other types of trauma can provoke mandibular or condyle", "bbox": [406.0, 312.0, 721.0, 329.0]}, {"text": "fractures, that cause grave facial asymmetries in patients that", "bbox": [406.0, 330.0, 721.0, 346.0]}, {"text": "are growing and the apparition of skeletal cross bites. 12 • 16 •", "bbox": [406.0, 348.0, 710.0, 364.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "A third group of trauma are the ones caused during birth", "bbox": [406.0, 380.0, 721.0, 400.0]}, {"text": "with the manipulation of instruments.", "bbox": [406.0, 399.0, 617.0, 415.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Other causes", "bbox": [432.0, 450.0, 515.0, 466.0]}, {"text": "5.", "bbox": [405.0, 451.0, 421.0, 466.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "Some other factors exist that in an indirect way can favor", "bbox": [405.0, 486.0, 721.0, 502.0]}, {"text": "the presence of posterior cross bites. One of them is an¬", "bbox": [405.0, 502.0, 719.0, 521.0]}, {"text": "kyloglossia. A short lingual frenum maintains the tongue", "bbox": [405.0, 521.0, 721.0, 537.0]}, {"text": "in a low position, favoring the apparition of maxillary", "bbox": [405.0, 537.0, 720.0, 555.0]}, {"text": "compression. (16)", "bbox": [405.0, 554.0, 498.0, 570.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Types of posterior cross bites", "bbox": [406.0, 604.0, 625.0, 622.0]}], "type": "Section-header", "position": 15}, {"raw_context": [{"text": "Posterior cross bites can be:", "bbox": [405.0, 641.0, 559.0, 657.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "o", "bbox": [406.0, 678.0, 417.0, 690.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "o", "bbox": [405.0, 695.0, 417.0, 708.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "o", "bbox": [405.0, 713.0, 417.0, 726.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "Bilateral, which affects both maxillary hemiarches.", "bbox": [432.0, 675.0, 710.0, 694.0]}, {"text": "Unilateral, affecting the right or the left hemiarch.", "bbox": [432.0, 694.0, 707.0, 710.0]}, {"text": "Of an isolated tooth. (16)", "bbox": [431.0, 711.0, 559.0, 727.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "The following classification was proposed by Moyers", "bbox": [405.0, 744.0, 720.0, 763.0]}, {"text": "(1966), still being applied today. (2)", "bbox": [405.0, 763.0, 589.0, 779.0]}], "type": "Text", "position": 21}, {"raw_context": [{"text": "1.", "bbox": [404.0, 814.0, 420.0, 830.0]}, {"text": "Functional cross bite", "bbox": [430.0, 814.0, 562.0, 830.0]}], "type": "Section-header", "position": 22}, {"raw_context": [{"text": "These are produced when there is an occlusal inter¬", "bbox": [432.0, 849.0, 718.0, 866.0]}, {"text": "■", "bbox": [404.0, 851.0, 417.0, 863.0]}, {"text": "ference that displaces the mandible to the left or the right", "bbox": [404.0, 867.0, 720.0, 884.0]}, {"text": "during the last phase of closure.", "bbox": [403.0, 884.0, 580.0, 900.0]}, {"text": "They are unilateral cross bites.", "bbox": [432.0, 902.0, 598.0, 917.0]}, {"text": "II", "bbox": [404.0, 904.0, 416.0, 916.0]}, {"text": "■", "bbox": [403.0, 919.0, 416.0, 933.0]}, {"text": "There may be a chin deviation. (13)", "bbox": [431.0, 919.0, 614.0, 934.0]}, {"text": "Lower dental midline deviation as a consequence of", "bbox": [430.0, 936.0, 719.0, 952.0]}, {"text": "■", "bbox": [404.0, 937.0, 416.0, 949.0]}, {"text": "the mandibular deviation. (2)", "bbox": [403.0, 954.0, 557.0, 969.0]}], "type": "Text", "position": 23}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 179}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#7#7#Interferences And Occlusal Factors与上面6的序号联接\n标点错误#8#8#devel¬ 应该是去掉¬ \n多余换行#9#9#of cross bites, because these teeth...与上面8相连接\n多余换行#11#11#Trauma内容与上面序号分开\n序号格式不一致#15#15#Other Causes 5.序号与格式颠倒\n多余换行#19#24#序号标点与内容分开19对应22内容\n多余换行#27#27#Functional Cross Bite内容与上面序号分开\n序号格式不一致#28#28#occlusal inter¬■ ference that displaces  ■ 应该在句子开头\n标点错误#28#28#inter¬ 应该是inter-\n序号格式不一致#29#29#缺少开头■ \n序号格式不一致#30#30#consequence of ■ the mandibular   ■ 应该在句子开头\n缺少换行#30#30# Lower dental midline deviation ...应该另起一行", "type3": "无关文本#0#30#(216) 类似的（  ）数字引用过多\n无关文本#30#30#II ■ 里面的II "}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 19:15:02"}
{"id": 1042064, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "38f8c0a5-4922-4c42-a59c-89cb01228a1d", "title": null, "text": "【0】页码:169\n Although the diagnosis of ACS is important and will help to guide immediate therapy, the estimation of risk for major adverse cardiac events in the immediate, short-term, and long-term time frames helps the physician determine the urgency in completing the diagnostic workup not just for ACS but also for CAD. Many patients can be managed in the outpatient setting once it is determined that they are at very low risk for short-term (30 days) major adverse cardiac events.\n\n【1】 Braunwald Risk Stratification ACC/AHA Guidelines recommend that all patients be risk stratified for the selection of an initial management strategy and site of care. 3 A well-recognized approach is the one initially proposed and later refined by Braunwald and colleagues and published in ACC/AHA Guidelines on the Management of Patients With Unstable Angina and Non-ST Segment Elevation MI. 122–126 This approach is based on a combination of historical, clinical, laboratory, and ECG variables and answers two questions: what is the likelihood that signs and symptoms represent ACS secondary to obstructive CAD, and what is the likelihood of an adverse clinical outcome?\n\n【2】Table 2 127 is a modified version of Braunwald and col-\n\n【3】 leagues' approach updated over several publications. 124 , 126 , 128 Patients are initially risk-stratified according to the likelihood that symptoms are due to unstable CAD. Patients at intermediate or high risk for CAD are further classified by their risk of major adverse cardiac events. This second classification is useful for prospectively identifying patients at intermediate or high risk who can benefit from an invasive strategy and more aggressive pharmacology with antiplatelet and antithrombin agents. Other risk stratification schemes include the TIMI, GRACE, and PURSUIT risk scores developed for short- and longer-term risk assessment. 129–133 Stratification tools cannot be used to determine discharge from the ED.\n\n【4】 TIMI Risk Score The risk of major adverse cardiac events has been further studied and refined. Researchers who derived the important Thrombolysis in Myocardial Ischemia (TIMI) risk score used data from the TIMI-11B and ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events) trials for UA/NSTEMI 134 , 135 and from the In-TIME trial for STEMI. 136 The TIMI risk score comprises 7 independent prognostic variables (Table 3). These 7 variables were significantly associated with the occurrence within 14 days of at least one of the primary end points: death, new or recurrent MI, or need for urgent revascularization. The score is derived from complex multivariate logistic regression. It is useful to note that traditional cardiac risk factors are only weakly associated with major adverse cardiac events. Aspirin use was found to be one of the most powerful predictors. 134 It is possible that aspirin use identified a subgroup of patients at higher risk or on active but failed therapy for CAD.\n\n【5】The TIMI risk score was validated with 3 groups of patients, and 4 clinical trials showed a significant interaction between the TIMI risk score and outcome (Table 3). 136 – 139\n\n【6】 These findings confirm the value of the TIMI risk score as a guide to therapeutic decisions (Class IIa, LOE B).\n\n【7】## Indicators For Early Invasive Strategies\n\n【8】\n Risk stratification (Figure 1, Boxes 9, 13, 14, 15) helps the clinician identify patients with non–ST-elevation ACS who should be managed with an early invasive strategy versus a selectively invasive one. Early coronary angiography may allow the clinician to determine whether patients are appropriate candidates for revascularization with PCI or coronary artery bypass grafting (CABG).\n\n【9】The 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention contains the following recommendations related to the selection of early invasive PCI versus conservative strategies.\n 1. An early invasive PCI strategy is indicated for patients with non–ST-elevation ACS who have no serious comorbidity and who have coronary lesions amenable to PCI and an elevated risk for clinical events (Class I, LOE A). (See Table 4 and Section 3.3 of the ACC/AHA 2007 UA/NSTEMI Guidelines).\n\n【10】2. An early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) is indicated in non–ST-elevation ACS patients who have refractory angina or hemodynamic or electric instability (without serious comorbidities or contraindications to such procedures) (Class I, LOE B).\n\n【11】3. In initially stabilized patients, an initially conservative (ie, a selectively invasive) strategy may be considered as a treatment strategy for non–ST-elevation ACS patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events including those with abnormal troponin elevations (Class IIb, LOE B).\n\n【12】4. The decision to implement an initial conservative (versus initial invasive) strategy in these patients may be made by considering physician and patient preference (Class IIb, LOE C).\n\n【13】## Normal Or Nondiagnostic Ecg Changes (Figure 1, Boxes 13 Through 17)\n\n【14】\n The majority of patients with normal or nondiagnostic ECGs do not have ACS. Patients in this category with ACS are most often at low or intermediate risk. The physician's goal involves risk stratification (see above) to provide appropriate diagnostic or treatment strategies for an individual patient.\n\n【15】These strategies then target patients at increased risk for benefit while avoiding risk (eg, anticoagulation therapy and invasive cardiac catheterization) in patients with low or minimal risk.\n\n【16】 The Chest Pain Unit Model Chest pain observation protocols may be employed in a dedicated space (ie, a physical chest pain unit [CPU]) or throughout an ED/hospital (ie, virtual CPU). These chest pain observation protocols are a rapid system of patient assessment that should generally include a history and physical examination, a period of observation, serial electrocardiography, and serial measurement of serum cardiac markers. In selected patients, an evaluation for inducible myocardial ischemia or anatomic coronary disease after AMI is excluded\n\n【17】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Although the diagnosis of ACS is important and will help", "bbox": [73.0, 84.0, 376.0, 99.0]}, {"text": "to guide immediate therapy, the estimation of risk for major", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "adverse cardiac events in the immediate, short-term, and", "bbox": [60.0, 115.0, 377.0, 130.0]}, {"text": "long-term time frames helps the physician determine the", "bbox": [60.0, 132.0, 375.0, 145.0]}, {"text": "urgency in completing the diagnostic workup not just for", "bbox": [60.0, 147.0, 376.0, 161.0]}, {"text": "ACS but also for CAD. Many patients can be managed in the", "bbox": [60.0, 163.0, 375.0, 176.0]}, {"text": "outpatient setting once it is determined that they are at very", "bbox": [60.0, 178.0, 375.0, 193.0]}, {"text": "low risk for short-term (30 days) major adverse cardiac", "bbox": [60.0, 194.0, 375.0, 208.0]}, {"text": "events.", "bbox": [60.0, 209.0, 99.0, 224.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Braunwald Risk Stratification", "bbox": [60.0, 234.0, 217.0, 250.0]}, {"text": "ACC/AHA Guidelines recommend that all patients be risk", "bbox": [60.0, 249.0, 375.0, 263.0]}, {"text": "stratified for the selection of an initial management strategy", "bbox": [60.0, 265.0, 375.0, 279.0]}, {"text": "and site of care. 3 A well-recognized approach is the one", "bbox": [60.0, 281.0, 375.0, 294.0]}, {"text": "initially proposed and later refined by Braunwald and col-", "bbox": [60.0, 296.0, 375.0, 310.0]}, {"text": "leagues and published in ACC/AHA Guidelines on the", "bbox": [60.0, 312.0, 375.0, 326.0]}, {"text": "Management of Patients With Unstable Angina and Non-ST", "bbox": [60.0, 326.0, 375.0, 342.0]}, {"text": "Segment Elevation MI. 122–126 This approach is based on a", "bbox": [60.0, 341.0, 376.0, 357.0]}, {"text": "combination of historical, clinical, laboratory, and ECG", "bbox": [60.0, 358.0, 377.0, 373.0]}, {"text": "variables and answers two questions: what is the likelihood", "bbox": [60.0, 374.0, 377.0, 388.0]}, {"text": "that signs and symptoms represent ACS secondary to obstruc-", "bbox": [60.0, 390.0, 375.0, 404.0]}, {"text": "tive CAD, and what is the likelihood of an adverse clinical", "bbox": [60.0, 406.0, 377.0, 420.0]}, {"text": "outcome?", "bbox": [60.0, 421.0, 115.0, 435.0]}, {"text": "Table 2 127 is a modified version of Braunwald and col-", "bbox": [74.0, 436.0, 375.0, 452.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "leagues' approach updated over several publications. 124 , 126 , 128", "bbox": [60.0, 453.0, 376.0, 467.0]}, {"text": "Patients are initially risk-stratified according to the likelihood", "bbox": [60.0, 468.0, 377.0, 482.0]}, {"text": "that symptoms are due to unstable CAD. Patients at interme-", "bbox": [60.0, 484.0, 375.0, 498.0]}, {"text": "diate or high risk for CAD are further classified by their risk", "bbox": [60.0, 500.0, 376.0, 514.0]}, {"text": "of major adverse cardiac events. This second classification is", "bbox": [60.0, 515.0, 377.0, 529.0]}, {"text": "useful for prospectively identifying patients at intermediate or", "bbox": [60.0, 531.0, 376.0, 545.0]}, {"text": "high risk who can benefit from an invasive strategy and more", "bbox": [60.0, 547.0, 376.0, 561.0]}, {"text": "aggressive pharmacology with antiplatelet and antithrombin", "bbox": [60.0, 562.0, 376.0, 576.0]}, {"text": "agents. Other risk stratification schemes include the TIMI,", "bbox": [60.0, 578.0, 376.0, 592.0]}, {"text": "GRACE, and PURSUIT risk scores developed for short- and", "bbox": [60.0, 594.0, 376.0, 608.0]}, {"text": "longer-term risk assessment. 129–133 Stratification tools cannot", "bbox": [60.0, 609.0, 377.0, 622.0]}, {"text": "be used to determine discharge from the ED.", "bbox": [60.0, 623.0, 297.0, 638.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "TIMI Risk Score", "bbox": [60.0, 650.0, 149.0, 663.0]}, {"text": "The risk of major adverse cardiac events has been further", "bbox": [61.0, 664.0, 376.0, 678.0]}, {"text": "studied and refined. Researchers who derived the important", "bbox": [60.0, 680.0, 376.0, 694.0]}, {"text": "Thrombolysis in Myocardial Ischemia (TIMI) risk score used", "bbox": [60.0, 696.0, 376.0, 709.0]}, {"text": "data from the TIMI-11B and ESSENCE (Efficacy and Safety", "bbox": [60.0, 710.0, 375.0, 725.0]}, {"text": "of Subcutaneous Enoxaparin in Non–Q-Wave Coronary", "bbox": [60.0, 727.0, 375.0, 740.0]}, {"text": "Events) trials for UA/NSTEMI 134 , 135 and from the In-TIME", "bbox": [60.0, 741.0, 376.0, 756.0]}, {"text": "trial for STEMI. 136", "bbox": [60.0, 758.0, 161.0, 771.0]}, {"text": "The TIMI risk score comprises 7 independent prognostic", "bbox": [73.0, 773.0, 376.0, 788.0]}, {"text": "variables (Table 3). These 7 variables were significantly", "bbox": [60.0, 789.0, 375.0, 803.0]}, {"text": "associated with the occurrence within 14 days of at least one", "bbox": [60.0, 805.0, 375.0, 819.0]}, {"text": "of the primary end points: death, new or recurrent MI, or need", "bbox": [60.0, 821.0, 376.0, 834.0]}, {"text": "for urgent revascularization. The score is derived from", "bbox": [60.0, 836.0, 377.0, 850.0]}, {"text": "complex multivariate logistic regression. It is useful to note", "bbox": [60.0, 852.0, 376.0, 866.0]}, {"text": "that traditional cardiac risk factors are only weakly associated", "bbox": [60.0, 868.0, 377.0, 882.0]}, {"text": "with major adverse cardiac events. Aspirin use was found to", "bbox": [60.0, 883.0, 376.0, 896.0]}, {"text": "be one of the most powerful predictors. 134 It is possible that", "bbox": [60.0, 898.0, 377.0, 913.0]}, {"text": "aspirin use identified a subgroup of patients at higher risk or", "bbox": [60.0, 915.0, 376.0, 928.0]}, {"text": "on active but failed therapy for CAD.", "bbox": [60.0, 930.0, 258.0, 944.0]}, {"text": "The TIMI risk score was validated with 3 groups of", "bbox": [73.0, 944.0, 377.0, 961.0]}, {"text": "patients, and 4 clinical trials showed a significant interaction", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "between the TIMI risk score and outcome (Table 3). 136 – 139", "bbox": [60.0, 978.0, 376.0, 991.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "These findings confirm the value of the TIMI risk score as a", "bbox": [404.0, 84.0, 721.0, 99.0]}, {"text": "guide to therapeutic decisions (Class IIa, LOE B).", "bbox": [404.0, 100.0, 668.0, 113.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Indicators for Early Invasive Strategies", "bbox": [404.0, 128.0, 649.0, 144.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Risk stratification (Figure 1, Boxes 9, 13, 14, 15) helps the", "bbox": [403.0, 145.0, 720.0, 159.0]}, {"text": "clinician identify patients with non–ST-elevation ACS who", "bbox": [403.0, 160.0, 721.0, 174.0]}, {"text": "should be managed with an early invasive strategy versus a", "bbox": [403.0, 174.0, 721.0, 189.0]}, {"text": "selectively invasive one. Early coronary angiography may", "bbox": [404.0, 190.0, 720.0, 204.0]}, {"text": "allow the clinician to determine whether patients are appro-", "bbox": [403.0, 206.0, 719.0, 219.0]}, {"text": "priate candidates for revascularization with PCI or coronary", "bbox": [403.0, 220.0, 719.0, 234.0]}, {"text": "artery bypass grafting (CABG).", "bbox": [403.0, 236.0, 570.0, 249.0]}, {"text": "The 2007 Focused Update of the ACC/AHA/SCAI 2005", "bbox": [417.0, 251.0, 720.0, 266.0]}, {"text": "Guideline Update for Percutaneous Coronary Intervention", "bbox": [403.0, 267.0, 720.0, 281.0]}, {"text": "contains the following recommendations related to the selec-", "bbox": [403.0, 282.0, 718.0, 296.0]}, {"text": "tion of early invasive PCI versus conservative strategies.", "bbox": [403.0, 298.0, 702.0, 311.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "1. An early invasive PCI strategy is indicated for patients", "bbox": [417.0, 326.0, 720.0, 340.0]}, {"text": "with non–ST-elevation ACS who have no serious co-", "bbox": [433.0, 341.0, 719.0, 354.0]}, {"text": "morbidity and who have coronary lesions amenable to", "bbox": [433.0, 356.0, 721.0, 368.0]}, {"text": "PCI and an elevated risk for clinical events (Class I,", "bbox": [433.0, 369.0, 721.0, 381.0]}, {"text": "LOE A). (See Table 4 and Section 3.3 of the ACC/AHA", "bbox": [432.0, 382.0, 720.0, 397.0]}, {"text": "2007 UA/NSTEMI Guidelines).", "bbox": [434.0, 398.0, 601.0, 410.0]}, {"text": "2. An early invasive strategy (ie, diagnostic angiography", "bbox": [417.0, 411.0, 719.0, 425.0]}, {"text": "with intent to perform revascularization) is indicated in", "bbox": [432.0, 425.0, 720.0, 438.0]}, {"text": "non–ST-elevation ACS patients who have refractory", "bbox": [432.0, 439.0, 719.0, 453.0]}, {"text": "angina or hemodynamic or electric instability (without", "bbox": [432.0, 454.0, 720.0, 468.0]}, {"text": "serious comorbidities or contraindications to such pro-", "bbox": [432.0, 468.0, 719.0, 481.0]}, {"text": "cedures) (Class I, LOE B).", "bbox": [432.0, 482.0, 575.0, 495.0]}, {"text": "3. In initially stabilized patients, an initially conservative", "bbox": [417.0, 495.0, 720.0, 509.0]}, {"text": "(ie, a selectively invasive) strategy may be considered", "bbox": [432.0, 511.0, 720.0, 523.0]}, {"text": "as a treatment strategy for non–ST-elevation ACS", "bbox": [433.0, 526.0, 720.0, 537.0]}, {"text": "patients (without serious comorbidities or contraindica-", "bbox": [433.0, 539.0, 720.0, 551.0]}, {"text": "tions to such procedures) who have an elevated risk for", "bbox": [432.0, 553.0, 720.0, 565.0]}, {"text": "clinical events including those with abnormal troponin", "bbox": [432.0, 568.0, 720.0, 580.0]}, {"text": "elevations (Class IIb, LOE B).", "bbox": [433.0, 582.0, 593.0, 593.0]}, {"text": "4. The decision to implement an initial conservative (ver-", "bbox": [417.0, 594.0, 720.0, 608.0]}, {"text": "sus initial invasive) strategy in these patients may be", "bbox": [432.0, 609.0, 720.0, 622.0]}, {"text": "made by considering physician and patient preference", "bbox": [432.0, 622.0, 720.0, 635.0]}, {"text": "(Class IIb, LOE C).", "bbox": [432.0, 636.0, 538.0, 649.0]}], "type": "List-item", "position": 10}, {"raw_context": [{"text": "Normal or Nondiagnostic ECG Changes (Figure 1,", "bbox": [404.0, 662.0, 718.0, 677.0]}, {"text": "Boxes 13 Through 17)", "bbox": [404.0, 678.0, 542.0, 692.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "The majority of patients with normal or nondiagnostic ECGs", "bbox": [404.0, 693.0, 720.0, 708.0]}, {"text": "do not have ACS. Patients in this category with ACS are most", "bbox": [403.0, 709.0, 720.0, 722.0]}, {"text": "often at low or intermediate risk. The physician's goal", "bbox": [403.0, 724.0, 720.0, 737.0]}, {"text": "involves risk stratification (see above) to provide appropriate", "bbox": [403.0, 739.0, 720.0, 753.0]}, {"text": "diagnostic or treatment strategies for an individual patient.", "bbox": [403.0, 755.0, 719.0, 768.0]}, {"text": "These strategies then target patients at increased risk for", "bbox": [404.0, 769.0, 720.0, 784.0]}, {"text": "benefit while avoiding risk (eg, anticoagulation therapy and", "bbox": [403.0, 786.0, 720.0, 799.0]}, {"text": "invasive cardiac catheterization) in patients with low or", "bbox": [403.0, 801.0, 720.0, 815.0]}, {"text": "minimal risk.", "bbox": [404.0, 815.0, 475.0, 829.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "The Chest Pain Unit Model", "bbox": [404.0, 841.0, 557.0, 855.0]}, {"text": "Chest pain observation protocols may be employed in a", "bbox": [403.0, 854.0, 721.0, 869.0]}, {"text": "dedicated space (ie, a physical chest pain unit [CPU]) or", "bbox": [403.0, 870.0, 720.0, 883.0]}, {"text": "throughout an ED/hospital (ie, virtual CPU). These chest pain", "bbox": [403.0, 885.0, 721.0, 899.0]}, {"text": "observation protocols are a rapid system of patient assess-", "bbox": [403.0, 901.0, 719.0, 914.0]}, {"text": "ment that should generally include a history and physical", "bbox": [403.0, 916.0, 721.0, 930.0]}, {"text": "examination, a period of observation, serial electrocardiogra-", "bbox": [403.0, 932.0, 719.0, 945.0]}, {"text": "phy, and serial measurement of serum cardiac markers. In", "bbox": [403.0, 947.0, 721.0, 960.0]}, {"text": "selected patients, an evaluation for inducible myocardial", "bbox": [403.0, 962.0, 720.0, 976.0]}, {"text": "ischemia or anatomic coronary disease after AMI is excluded", "bbox": [404.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 169}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#1#1#ACC/AHA Guidelines这里开始应与前面分行\n多余换行#2#3#为同段\n缺少换行#4#4#The risk of major这里开始应与前面分行\n缺少换行#4#4#The TIMI risk score comprises 这里开始应与前面换行\n缺少换行#16#16#Chest pain observation这里开始应与前面换行", "type3": "无关文本#0#0#全文存在多处无关数字", "type4": null, "type5": null, "type6": "信息有用性#17#17#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:48:24"}
{"id": 1042063, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "52db90b3-1888-41f4-bb57-af3abf7d6afa", "title": null, "text": "【0】页码:1\n# Space Ice\n\n【1】\n ■\n# Machines That Build Themselves\n\n【2】\n ▪ CANNIBALS\n\n【3】 AUGUST 2001 www.sciam.com\n\n【4】 $4.95\n\n【5】 to Find Bombs", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "SPACE ICE ", "bbox": [62.0, 9.0, 176.0, 36.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "■", "bbox": [173.0, 14.0, 193.0, 30.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "MACHINES THAT BUILD THEMSELVES", "bbox": [192.0, 8.0, 577.0, 37.0]}], "type": "Title", "position": 2}, {"raw_context": [{"text": "▪ CANNIBALS", "bbox": [575.0, 8.0, 721.0, 37.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "AUGUST 2001", "bbox": [591.0, 49.0, 683.0, 69.0]}, {"text": "www.sciam.com", "bbox": [591.0, 68.0, 707.0, 88.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "$4.95", "bbox": [720.0, 50.0, 764.0, 69.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "to Find Bombs", "bbox": [615.0, 975.0, 757.0, 1002.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 1}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#5#封面内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:37:22"}
{"id": 1042062, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "5ff4f389-17df-4c38-84da-3e680a018d20", "title": null, "text": "【0】页码:275\n\n【1】## Advantages\n\n【2】\n i.\n\n【3】It is very versatile; it can be used in combination with practically every corrective appliance like braces, lingual arches, removable extra oral appliances, etc.\n\n【4】2.\n\n【5】When the appliance eliminates the excessive pressure of the lower lip, it allows a passive expansion of the lower dental arch and the correction of anteroinferior overcrowding.\n\n【6】3.\n\n【7】The lip bumper can be acrylic free.\n Figs. 60-62. Acrylic free lip bumper.\n\n【8】 4.\n\n【9】 5, 6, 7.\n\n【10】 It helps in the correction of atypical deglutition caused by lower lip interposition.\n\n【11】It serves as anchorage.\n\n【12】It annuls the action of the buccinators and the quadra¬ tus labii inferioris muscle.\n\n【13】Labial seal is restituted.\n\n【14】## Disadvantages\n\n【15】\n 1.\n\n【16】 Once the appliance is in place, the patient usually does not like how he or she looks.\n\n【17】 2.\n\n【18】If the appliance is removable, we depend upon patient cooperation.\n\n【19】3.\n\n【20】If the appliance is removable it can be lost.\n\n【21】4.\n\n【22】If the bands debond they can lacerate the oral mucosa.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Advantages", "bbox": [66.0, 82.0, 153.0, 100.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "i.", "bbox": [66.0, 116.0, 81.0, 133.0]}, {"text": "It is very versatile; it can be used in combination with", "bbox": [91.0, 116.0, 382.0, 134.0]}, {"text": "practically every corrective appliance like braces,", "bbox": [92.0, 134.0, 380.0, 151.0]}, {"text": "lingual arches, removable extra oral appliances, etc.", "bbox": [92.0, 150.0, 377.0, 168.0]}, {"text": "2.", "bbox": [66.0, 168.0, 80.0, 186.0]}, {"text": "When the appliance eliminates the excessive pressure", "bbox": [92.0, 169.0, 381.0, 187.0]}, {"text": "of the lower lip, it allows a passive expansion of the", "bbox": [92.0, 187.0, 381.0, 204.0]}, {"text": "lower dental arch and the correction of anteroinferior", "bbox": [92.0, 204.0, 380.0, 219.0]}, {"text": "overcrowding.", "bbox": [92.0, 221.0, 175.0, 237.0]}, {"text": "3.", "bbox": [66.0, 238.0, 81.0, 255.0]}, {"text": "The lip bumper can be acrylic free.", "bbox": [92.0, 238.0, 286.0, 255.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Figs. 60-62. Acrylic free lip bumper.", "bbox": [143.0, 698.0, 303.0, 714.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "4.", "bbox": [67.0, 775.0, 82.0, 792.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "5,", "bbox": [66.0, 811.0, 81.0, 829.0]}, {"text": "6,", "bbox": [66.0, 828.0, 81.0, 845.0]}, {"text": "7.", "bbox": [66.0, 861.0, 81.0, 879.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "It helps in the correction of atypical deglutition caused", "bbox": [93.0, 776.0, 382.0, 793.0]}, {"text": "by lower lip interposition.", "bbox": [93.0, 794.0, 238.0, 811.0]}, {"text": "It serves as anchorage.", "bbox": [93.0, 811.0, 220.0, 827.0]}, {"text": "It annuls the action of the buccinators and the quadra¬", "bbox": [93.0, 828.0, 381.0, 845.0]}, {"text": "tus labii inferioris muscle.", "bbox": [93.0, 845.0, 238.0, 862.0]}, {"text": "Labial seal is restituted.", "bbox": [93.0, 863.0, 224.0, 879.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Disadvantages", "bbox": [68.0, 897.0, 174.0, 916.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "1.", "bbox": [68.0, 933.0, 82.0, 949.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Once the appliance is in place, the patient usually does", "bbox": [93.0, 932.0, 383.0, 950.0]}, {"text": "not like how he or she looks.", "bbox": [93.0, 950.0, 255.0, 966.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "2.", "bbox": [402.0, 879.0, 418.0, 896.0]}, {"text": "If the appliance is removable, we depend upon patient", "bbox": [429.0, 879.0, 720.0, 897.0]}, {"text": "cooperation.", "bbox": [430.0, 898.0, 504.0, 913.0]}, {"text": "3.", "bbox": [404.0, 914.0, 418.0, 931.0]}, {"text": "If the appliance is removable it can be lost.", "bbox": [429.0, 914.0, 666.0, 932.0]}, {"text": "4.", "bbox": [404.0, 932.0, 418.0, 948.0]}, {"text": "If the bands debond they can lacerate the oral", "bbox": [429.0, 932.0, 719.0, 948.0]}, {"text": "mucosa.", "bbox": [430.0, 949.0, 485.0, 965.0]}], "type": "Text", "position": 13}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 275}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#2#2#i.应是1.", "type2": "多余换行#8#13#序号和内容分开 4.和 It helps in the correction of是一句话，以此类推\n", "type3": "", "type4": "", "type6": "有用性#7#7#Figs. 60-62. Acrylic free lip bumper.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:37:14"}
{"id": 1042061, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "cb2e8a85-5ca6-4dab-86d3-911db1979b3d", "title": null, "text": "【0】页码:196\n PFig. 73. Lower adhesion flat skidding surfaces and the anterior rotraction arch.\n Fig. 74. Extra oral view of the Tandem in the mouth.\n\n【1】## Advantages\n\n【2】\n 1.\n\n【3】 2.\n\n【4】 3.\n\n【5】 4.\n\n【6】 5.\n\n【7】 6.\n\n【8】 7.\n\n【9】 8.\n\n【10】 9.\n\n【11】 10.\n\n【12】 11.\n\n【13】 12.\n\n【14】 13.\n\n【15】 We do not require expensive materials to elaborate this appliance.\n\n【16】Easy to elaborate.\n\n【17】Much more esthetic than the face mask so we can expect more collaboration from the patient.\n\n【18】The appliance not only corrects the malocclusion but also has a positive effect upon the soft tissues. (15) The appliance produces consistent results in a brief time period. (15) It produces between 2 mm to 3 mm of protraction.\n\n【19】The Tandem is an effective tool for the correction of mild to moderate skeletal Class III malocclu¬ sions, with a retrusive maxilla and a hypodivergent growth pattern. (5) The use of the Tandem produces an increase of the lower third of the face; this is due to the downward movement of the maxilla and the downward and backward movement of the mandible.\n\n【20】It reduces the risk of a surgical procedure in the future.\n\n【21】In general, skeletal Class III patients have a concave profile, a depressed nasomaxillary region, lower lip protrusion and a prominent mandible. The maxillary protraction produced by the Tandem rectifies the facial profile and the position of the lower lip. (5) Clinically the anterior cross bites can correct in 3 to 4 months depending upon the severity of the malocclusion. (5) The maxilla can be placed forward between 2 mm to 4 mm in about 8 to 10 months of protraction, but the majority of orthopedic changes can be observed in the first 3 to 6 months of continuous treatment. (5) It is a very versatile appliance because it can be combined with fixed appliances during the maxillar protraction.\n Fig. 75. It allows the use of fixed appliances during the protraction of the maxilla.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "PFig. 73. Lower adhesion flat skidding surfaces and the anterior rotraction", "bbox": [82.0, 557.0, 395.0, 571.0]}, {"text": "arch.", "bbox": [84.0, 573.0, 106.0, 585.0]}], "type": "Caption", "position": 3}, {"raw_context": [{"text": "Fig. 74. Extra oral view of the Tandem in the mouth.", "bbox": [125.0, 962.0, 355.0, 975.0]}], "type": "Caption", "position": 5}, {"raw_context": [{"text": "Advantages", "bbox": [417.0, 89.0, 502.0, 104.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "1.", "bbox": [418.0, 126.0, 430.0, 140.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "2.", "bbox": [416.0, 159.0, 430.0, 174.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "3.", "bbox": [416.0, 176.0, 430.0, 191.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "4.", "bbox": [418.0, 212.0, 430.0, 226.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "5.", "bbox": [418.0, 247.0, 430.0, 261.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "6.", "bbox": [417.0, 281.0, 431.0, 295.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "7.", "bbox": [418.0, 298.0, 431.0, 312.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "8.", "bbox": [418.0, 368.0, 431.0, 382.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "9.", "bbox": [419.0, 437.0, 432.0, 451.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "10.", "bbox": [419.0, 453.0, 438.0, 468.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "11.", "bbox": [420.0, 541.0, 438.0, 554.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "12.", "bbox": [420.0, 592.0, 439.0, 607.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "13.", "bbox": [421.0, 662.0, 440.0, 675.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "We do not require expensive materials to elaborate", "bbox": [443.0, 123.0, 731.0, 139.0]}, {"text": "this appliance.", "bbox": [443.0, 142.0, 525.0, 157.0]}, {"text": "Easy to elaborate.", "bbox": [443.0, 158.0, 540.0, 174.0]}, {"text": "Much more esthetic than the face mask so we can", "bbox": [443.0, 176.0, 731.0, 189.0]}, {"text": "expect more collaboration from the patient.", "bbox": [443.0, 191.0, 684.0, 208.0]}, {"text": "The appliance not only corrects the malocclusion but", "bbox": [444.0, 209.0, 731.0, 226.0]}, {"text": "also has a positive effect upon the soft tissues. (15)", "bbox": [443.0, 228.0, 713.0, 242.0]}, {"text": "The appliance produces consistent results in a brief", "bbox": [444.0, 244.0, 732.0, 259.0]}, {"text": "time period. (15)", "bbox": [444.0, 263.0, 527.0, 278.0]}, {"text": "It produces between 2 mm to 3 mm of protraction.", "bbox": [443.0, 278.0, 726.0, 294.0]}, {"text": "The Tandem is an effective tool for the correction", "bbox": [444.0, 296.0, 732.0, 312.0]}, {"text": "of mild to moderate skeletal Class III malocclu¬", "bbox": [444.0, 314.0, 731.0, 328.0]}, {"text": "sions, with a retrusive maxilla and a hypodivergent", "bbox": [445.0, 330.0, 732.0, 347.0]}, {"text": "growth pattern. (5)", "bbox": [444.0, 349.0, 548.0, 364.0]}, {"text": "The use of the Tandem produces an increase of the", "bbox": [445.0, 365.0, 732.0, 380.0]}, {"text": "lower third of the face; this is due to the downward", "bbox": [444.0, 382.0, 732.0, 398.0]}, {"text": "movement of the maxilla and the downward and", "bbox": [445.0, 400.0, 732.0, 416.0]}, {"text": "backward movement of the mandible.", "bbox": [445.0, 417.0, 653.0, 433.0]}, {"text": "It reduces the risk of a surgical procedure in the future.", "bbox": [445.0, 435.0, 725.0, 450.0]}, {"text": "In general, skeletal Class III patients have a concave", "bbox": [444.0, 452.0, 732.0, 467.0]}, {"text": "profile, a depressed nasomaxillary region, lower lip", "bbox": [445.0, 470.0, 733.0, 484.0]}, {"text": "protrusion and a prominent mandible. The maxillary", "bbox": [445.0, 487.0, 732.0, 501.0]}, {"text": "protraction produced by the Tandem rectifies the", "bbox": [445.0, 505.0, 733.0, 518.0]}, {"text": "facial profile and the position of the lower lip. (5)", "bbox": [445.0, 521.0, 705.0, 537.0]}, {"text": "Clinically the anterior cross bites can correct in 3", "bbox": [444.0, 539.0, 733.0, 553.0]}, {"text": "to 4 months depending upon the severity of the", "bbox": [445.0, 555.0, 733.0, 571.0]}, {"text": "malocclusion. (5)", "bbox": [445.0, 573.0, 537.0, 589.0]}, {"text": "The maxilla can be placed forward between 2 mm", "bbox": [445.0, 590.0, 733.0, 604.0]}, {"text": "to 4 mm in about 8 to 10 months of protraction, but", "bbox": [445.0, 607.0, 733.0, 623.0]}, {"text": "the majority of orthopedic changes can be observed", "bbox": [445.0, 625.0, 733.0, 641.0]}, {"text": "in the first 3 to 6 months of continuous treatment. (5)", "bbox": [445.0, 641.0, 726.0, 657.0]}, {"text": "It is a very versatile appliance because it can be", "bbox": [445.0, 659.0, 734.0, 675.0]}, {"text": "combined with fixed appliances during the maxillar", "bbox": [445.0, 678.0, 733.0, 691.0]}, {"text": "protraction.", "bbox": [447.0, 695.0, 514.0, 710.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Fig. 75. It allows the use of fixed appliances during", "bbox": [422.0, 947.0, 644.0, 960.0]}, {"text": "the protraction of the maxilla.", "bbox": [422.0, 962.0, 554.0, 973.0]}], "type": "Caption", "position": 22}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 196}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#18#18#The appliance produces另起一行\n缺少换行#18#18#It produces between 2 mm另起一行\n缺少换行#19#19#The use of the Tandem另起一行\n缺少换行#21#21#Clinically the anterior cross另起一行\nThe maxilla can be placed另起一行\n It is a very versatile另起一行\n多余换行#2#21#序号与正文分离1.和We do not require expensive是一句话，以此类推\n标点错误#19#19#malocclu¬不需要这个标点", "type3": "无关文本#0#21#类似 the soft tissues. (15)出现在句号后面的无关数字引用多次出现，应用全文", "type4": null, "type5": null, "type6": "有用性#0#0#PFig. 73. Lower adhesion flat skidding surfaces and the anterior rotraction arch.\nFig. 74. Extra oral view of the Tandem in the mouth.对图片的描述\n有用性#21#21#Fig. 75. It allows the use of fixed appliances during the protraction of the maxilla.对图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-29 19:47:19"}
{"id": 1042060, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "4a13d536-6d52-4efb-918a-0fec43825e5e", "title": null, "text": "【0】页码:24\n Abraham Katz, one of the handful of rich philanthropists who have been his sole source of funding since he was cut off from all the normal channels five years ago.\n\n【1】\"We're down to our last $45,000,\" the 64-year-old Duesberg confides glumly as we stand in the dark courtyard of the villa. Katz, whose wife suffers from leukemia, is his final hope; if this grant doesn't come through, Duesberg will have to cut loose his two assistants, close his lab at Berkeley and move to Germany. That is where he was born to two doctors, where he worked through a Ph.D. in chemistry and where he says he still has an open invitation to teach at the University of Heidelberg.\n\n【2】Leaving the U.S., if it comes to that, would thus close the loop on a roller coaster of a career. Although his ascendance is clear enough, it is hard to say exactly when his fall from grace began.\n\n【3】Several weeks later as we talk in his small lab—one fifth the size of the facilities he once had—he hands me a paper he published in 1983. \"This is the one that started it all,\" he says.\n\n【4】The paper is not, as I expect, his now infamous 1988 article in Science provocatively entitled \"HIV Is Not the Cause of AIDS.\" Nor is it any of the several dozen articles and letters he published in peer-reviewed journals over the next 10 years arguing that the link between HIV and AIDS is a mirage, an artifact of sloppy epidemiology that has lumped together different diseases with disparate causes just because the sufferers have all been exposed to what he calls \"a harmless passenger virus.\" Although these dissenting theories of AIDS did not originate with Duesberg, he soon became their champion—and thus the target of derision for those who feared that disagreement among scientists could confuse the public and endanger 150 its health. When Mbeki, after consulting with Duesberg and other AIDS experts, told the International AIDS Conference last year that he felt \"we could not blame everything on a single virus,\" more than 5,000 scientists and physicians felt it necessary to sign the Durban Declaration, devoutly affirming their belief that HIV is the one true cause of AIDS.\n\n【5】Duesberg's arguments ultimately converted no more than a tiny minority of scientists to his view that \"the various AIDS diseases are brought on by the long-term consumption of recreational drugs and anti-HIV drugs, such as the DNA chain terminator AZT, which is prescribed to prevent or treat AIDS.\" Or, as he puts it more bluntly in Milan, in rich countries it is the toxicity of the very drugs that are prescribed to save HIV-infected people that kills them.\n\n【6】The hypothesis has never been tested directly, although Duesberg claims it could be done ethically by comparing 3,000 HIV- positive army recruits with 3,000 HIV-negative recruits matched for disease and drug use. And so his idea has died as most failed\n\n【7】 theories do, never fully disproved but convincingly rebutted—in this case by a 40-page treatise from the National Institute for Allergic and Immune Disease—and ultimately ignored by nearly everyone working in the field.\n\n【8】But Duesberg didn't even know AIDS existed in 1983, when he wrote the paper that he says first marked him as a troublemaker. The title seems innocuous: \"Retroviral Transforming Genes in Normal Cells?\" But in Duesberg papers the question mark often signals that he is about to yank on the loose threads of a popular theory. This time the theory concerned cancer.\n\n【9】He and others had shown that when certain retroviruses insinuate their genes into the cells of mice, the cells turn malignant.\n\n【10】Weinberg, Baltimore and others in the field speculated that perhaps similar genes, which they called \"proto-oncogenes,\" lie dormant in the human genome, like time bombs that turn on only if a random mutation flips some sort of genetic switch. This hypothesis spawned a cottage industry to search for oncogenes, so-called tumor suppressor genes and, most recently, cancer \"predisposition\" genes.\n\n【11】As two decades passed, human genes with sequences similar to the viral oncogenes were found, and support for this story of cancer's origin solidified. \"If you were to poll researchers,\n ROLLER-COASTER CAREER of Peter H. Duesberg is traced by the rate at which he has published research articles and the rate at which other scientists have cited his work.\n\n【12】 I'd guess 95 percent would say that the accumulation of mutations [to key genes] causes cancer,\" says Cristoph Lengauer, an oncologist at Johns Hopkins University.\n\n【13】But the story also grew steadily more complicated—and, to Duesberg, less convincing. Scientists expected to find some combination of oncogenes and tumor suppressor genes that are always mutated, at least in certain forms of cancer. They did not.\n\n【14】Instead the number of putative cancer genes has leaped into the dozens, experiments have shown that different cells in the same\n\n【15】 JOHNSON; SOURCE: INSTITUTE FOR SCIENTIFIC INFORMATION WEB OF SCIENCE", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Abraham Katz, one of the handful of rich philanthropists who", "bbox": [61.0, 134.0, 395.0, 149.0]}, {"text": "have been his sole source of funding since he was cut off from all", "bbox": [61.0, 151.0, 394.0, 165.0]}, {"text": "the normal channels five years ago.", "bbox": [60.0, 167.0, 245.0, 181.0]}, {"text": "\"We're down to our last $45,000,\" the 64-year-old Dues-", "bbox": [81.0, 182.0, 392.0, 197.0]}, {"text": "berg confides glumly as we stand in the dark courtyard of the vil-", "bbox": [61.0, 199.0, 393.0, 214.0]}, {"text": "la. Katz, whose wife suffers from leukemia, is his final hope; if", "bbox": [61.0, 215.0, 394.0, 229.0]}, {"text": "this grant doesn't come through, Duesberg will have to cut loose", "bbox": [60.0, 231.0, 394.0, 245.0]}, {"text": "his two assistants, close his lab at Berkeley and move to Ger-", "bbox": [61.0, 247.0, 393.0, 262.0]}, {"text": "many. That is where he was born to two doctors, where he", "bbox": [60.0, 264.0, 393.0, 277.0]}, {"text": "worked through a Ph.D. in chemistry and where he says he still", "bbox": [60.0, 279.0, 394.0, 294.0]}, {"text": "has an open invitation to teach at the University of Heidelberg.", "bbox": [61.0, 295.0, 391.0, 309.0]}, {"text": "Leaving the U.S., if it comes to that, would thus close the loop", "bbox": [80.0, 311.0, 393.0, 325.0]}, {"text": "on a roller coaster of a career. Although his ascendance is clear", "bbox": [60.0, 327.0, 393.0, 342.0]}, {"text": "enough, it is hard to say exactly when his fall from grace began.", "bbox": [60.0, 344.0, 393.0, 357.0]}, {"text": "Several weeks later as we talk in his small lab—one fifth the size", "bbox": [61.0, 359.0, 393.0, 374.0]}, {"text": "of the facilities he once had—he hands me a paper he published", "bbox": [60.0, 375.0, 393.0, 390.0]}, {"text": "in 1983. \"This is the one that started it all,\" he says.", "bbox": [60.0, 392.0, 335.0, 405.0]}, {"text": "The paper is not, as I expect, his now infamous 1988 article", "bbox": [80.0, 407.0, 393.0, 422.0]}, {"text": "in Science provocatively entitled \"HIV Is Not the Cause of", "bbox": [61.0, 423.0, 393.0, 438.0]}, {"text": "AIDS.\" Nor is it any of the several dozen articles and letters he", "bbox": [61.0, 439.0, 393.0, 453.0]}, {"text": "published in peer-reviewed journals over the next 10 years ar-", "bbox": [60.0, 455.0, 393.0, 470.0]}, {"text": "guing that the link between HIV and AIDS is a mirage, an arti-", "bbox": [60.0, 471.0, 393.0, 485.0]}, {"text": "fact of sloppy epidemiology that has lumped to-", "bbox": [61.0, 487.0, 312.0, 501.0]}, {"text": "gether different diseases with disparate causes", "bbox": [60.0, 503.0, 313.0, 517.0]}, {"text": "just because the sufferers have all been exposed", "bbox": [60.0, 519.0, 313.0, 534.0]}, {"text": "to what he calls \"a harmless passenger virus.\"", "bbox": [60.0, 535.0, 304.0, 549.0]}, {"text": "Although these dissenting theories of AIDS", "bbox": [81.0, 551.0, 313.0, 565.0]}, {"text": "did not originate with Duesberg, he soon became", "bbox": [61.0, 567.0, 313.0, 582.0]}, {"text": "their champion—and thus the target of derision", "bbox": [60.0, 583.0, 313.0, 597.0]}, {"text": "for those who feared that disagreement among", "bbox": [61.0, 599.0, 313.0, 614.0]}, {"text": "scientists could confuse the public and endanger", "bbox": [61.0, 615.0, 313.0, 629.0]}, {"text": "150", "bbox": [327.0, 615.0, 343.0, 626.0]}, {"text": "its health. When Mbeki, after consulting with", "bbox": [60.0, 632.0, 313.0, 645.0]}, {"text": "Duesberg and other AIDS experts, told the In-", "bbox": [61.0, 647.0, 313.0, 662.0]}, {"text": "ternational AIDS Conference last year that he felt", "bbox": [61.0, 663.0, 313.0, 677.0]}, {"text": "\"we could not blame everything on a single", "bbox": [61.0, 679.0, 313.0, 694.0]}, {"text": "virus,\" more than 5,000 scientists and physicians", "bbox": [61.0, 695.0, 313.0, 710.0]}, {"text": "felt it necessary to sign the Durban Declaration,", "bbox": [61.0, 712.0, 313.0, 725.0]}, {"text": "devoutly affirming their belief that HIV is the one", "bbox": [60.0, 727.0, 313.0, 742.0]}, {"text": "true cause of AIDS.", "bbox": [61.0, 743.0, 164.0, 757.0]}, {"text": "Duesberg's arguments ultimately converted", "bbox": [80.0, 759.0, 313.0, 773.0]}, {"text": "no more than a tiny minority of scientists to his", "bbox": [61.0, 775.0, 313.0, 790.0]}, {"text": "view that \"the various AIDS diseases are brought", "bbox": [61.0, 791.0, 313.0, 805.0]}, {"text": "on by the long-term consumption of recreation-", "bbox": [61.0, 808.0, 312.0, 821.0]}, {"text": "al drugs and anti-HIV drugs, such as the DNA chain termina-", "bbox": [61.0, 823.0, 393.0, 837.0]}, {"text": "tor AZT, which is prescribed to prevent or treat AIDS.\" Or, as", "bbox": [61.0, 839.0, 395.0, 854.0]}, {"text": "he puts it more bluntly in Milan, in rich countries it is the toxic-", "bbox": [61.0, 855.0, 392.0, 869.0]}, {"text": "ity of the very drugs that are prescribed to save HIV-infected peo-", "bbox": [60.0, 871.0, 391.0, 885.0]}, {"text": "ple that kills them.", "bbox": [61.0, 887.0, 162.0, 901.0]}, {"text": "The hypothesis has never been tested directly, although Dues-", "bbox": [81.0, 903.0, 393.0, 917.0]}, {"text": "berg claims it could be done ethically by comparing 3,000 HIV-", "bbox": [61.0, 919.0, 393.0, 933.0]}, {"text": "positive army recruits with 3,000 HIV-negative recruits matched", "bbox": [61.0, 935.0, 394.0, 950.0]}, {"text": "for disease and drug use. And so his idea has died as most failed", "bbox": [61.0, 952.0, 394.0, 965.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "theories do, never fully disproved but convincingly rebutted—in", "bbox": [404.0, 134.0, 738.0, 149.0]}, {"text": "this case by a 40-page treatise from the National Institute for Al-", "bbox": [404.0, 151.0, 737.0, 165.0]}, {"text": "lergic and Immune Disease—and ultimately ignored by nearly", "bbox": [405.0, 167.0, 737.0, 181.0]}, {"text": "everyone working in the field.", "bbox": [404.0, 183.0, 564.0, 197.0]}, {"text": "But Duesberg didn't even know AIDS existed in 1983, when", "bbox": [424.0, 199.0, 739.0, 213.0]}, {"text": "he wrote the paper that he says first marked him as a trouble-", "bbox": [405.0, 215.0, 737.0, 229.0]}, {"text": "maker. The title seems innocuous: \"Retroviral Transforming", "bbox": [404.0, 231.0, 739.0, 245.0]}, {"text": "Genes in Normal Cells?\" But in Duesberg papers the question", "bbox": [405.0, 247.0, 739.0, 262.0]}, {"text": "mark often signals that he is about to yank on the loose threads", "bbox": [405.0, 263.0, 739.0, 277.0]}, {"text": "of a popular theory. This time the theory concerned cancer.", "bbox": [404.0, 279.0, 719.0, 294.0]}, {"text": "He and others had shown that when certain retroviruses in-", "bbox": [424.0, 295.0, 737.0, 309.0]}, {"text": "sinuate their genes into the cells of mice, the cells turn malignant.", "bbox": [405.0, 311.0, 738.0, 325.0]}, {"text": "Weinberg, Baltimore and others in the field speculated that per-", "bbox": [406.0, 327.0, 737.0, 342.0]}, {"text": "haps similar genes, which they called \"proto-oncogenes,\" lie", "bbox": [405.0, 344.0, 738.0, 358.0]}, {"text": "dormant in the human genome, like time bombs that turn on", "bbox": [404.0, 359.0, 739.0, 374.0]}, {"text": "only if a random mutation flips some sort of genetic switch. This", "bbox": [404.0, 375.0, 739.0, 390.0]}, {"text": "hypothesis spawned a cottage industry to search for oncogenes,", "bbox": [405.0, 392.0, 739.0, 405.0]}, {"text": "so-called tumor suppressor genes and, most recently, cancer", "bbox": [404.0, 407.0, 737.0, 422.0]}, {"text": "\"predisposition\" genes.", "bbox": [406.0, 423.0, 531.0, 437.0]}, {"text": "As two decades passed, human genes with sequences simi-", "bbox": [424.0, 438.0, 737.0, 454.0]}, {"text": "lar to the viral oncogenes were found, and support for this sto-", "bbox": [405.0, 455.0, 737.0, 470.0]}, {"text": "ry of cancer's origin solidified. \"If you were to poll researchers,", "bbox": [404.0, 471.0, 737.0, 485.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "ROLLER-COASTER CAREER of Peter H. Duesberg is traced by the rate at which he has published", "bbox": [326.0, 768.0, 728.0, 781.0]}, {"text": "research articles and the rate at which other scientists have cited his work.", "bbox": [325.0, 781.0, 637.0, 794.0]}], "type": "Caption", "position": 3}, {"raw_context": [{"text": "I'd guess 95 percent would say that the accumulation of muta-", "bbox": [404.0, 823.0, 737.0, 837.0]}, {"text": "tions [to key genes] causes cancer,\" says Cristoph Lengauer, an", "bbox": [404.0, 839.0, 739.0, 854.0]}, {"text": "oncologist at Johns Hopkins University.", "bbox": [405.0, 855.0, 618.0, 869.0]}, {"text": "But the story also grew steadily more complicated—and, to", "bbox": [424.0, 871.0, 739.0, 885.0]}, {"text": "Duesberg, less convincing. Scientists expected to find some com-", "bbox": [406.0, 887.0, 737.0, 902.0]}, {"text": "bination of oncogenes and tumor suppressor genes that are al-", "bbox": [405.0, 903.0, 737.0, 917.0]}, {"text": "ways mutated, at least in certain forms of cancer. They did not.", "bbox": [405.0, 919.0, 738.0, 933.0]}, {"text": "Instead the number of putative cancer genes has leaped into the", "bbox": [405.0, 935.0, 738.0, 950.0]}, {"text": "dozens, experiments have shown that different cells in the same", "bbox": [404.0, 952.0, 738.0, 965.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "JOHNSON; SOURCE: INSTITUTE FOR SCIENTIFIC INFORMATION WEB OF SCIENCE", "bbox": [18.0, 659.0, 33.0, 935.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 24}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#4#4#Although these dissenting另起一行\n多余换行#6#7#The hypothesis has到working in the field.是一句话\n多余换行#11#12#As two decades passed到Johns Hopkins University.是一句话", "type3": "", "type6": "有用性#11#11#ROLLER-COASTER CAREER到have cited his work.是对图表的描述\n有用性#15#15#JOHNSON; SOURCE: INSTITUTE FOR SCIENTIFIC INFORMATION WEB OF SCIENCE侧边栏目内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 19:15:51"}
{"id": 1042059, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "7db6edf3-8ca3-45ac-a9a2-b49083cbb097", "title": null, "text": "【0】页码:204\n uə.pliq) pue emqtsA :>iqoT lei>əds\n\n【1】 highly effective measure in allergy treatment. Some allergens, such as dust mites or molds, are so ubiquitous that it can be nearly impossible to completely remove them from the home environment. Others, such as pet dander, are far easier to address. If you remove the family pet from your home, and you are then able to rid your home of any pet allergen left behind, your child will likely have a significant lessening in allergy and asthma symptoms, as well as decreased medication requirements.\n\n【2】 If you are not willing to relocate your pet for the health benefits it will provide your child, then you should at minimum reduce the child's exposure to pet allergen. You should make sure that the allergic child's bedroom remains off limits to the pet and that the bedroom is kept as allergen-free as possible. An allergist can provide you with specific recommendations depending on what type of pet you have and the layout of your home.\n\n【3】## 99. How Can I Make Sure That My Child’S School Staff Can Cope With His Or Her Asthma? What About Summer Camp Staff?\n\n【4】\n The best way to make sure that your child's school or camp is in a position to cope with your child's asthma is to teach your child about asthma and to establish good communication with the school and camp administration. Even though asthma is a very common condition throughout childhood and adolescence, it is still a good idea to make sure that school and camp staff know that your child carries a diagnosis of asthma. Several measures are helpful to ensure that your child's asthma remains well-controlled at school or camp. Familiarize yourself with the school or camp", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "uə.pliq) pue emqtsA :>iqoT lei>əds", "bbox": [545.0, 60.0, 569.0, 287.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "highly effective measure in allergy treatment. Some", "bbox": [69.0, 68.0, 426.0, 89.0]}, {"text": "allergens, such as dust mites or molds, are so ubiqui-", "bbox": [69.0, 89.0, 425.0, 108.0]}, {"text": "tous that it can be nearly impossible to completely", "bbox": [70.0, 109.0, 426.0, 128.0]}, {"text": "remove them from the home environment. Others,", "bbox": [69.0, 129.0, 426.0, 148.0]}, {"text": "such as pet dander, are far easier to address. If you", "bbox": [69.0, 149.0, 427.0, 167.0]}, {"text": "remove the family pet from your home, and you are", "bbox": [69.0, 169.0, 427.0, 187.0]}, {"text": "then able to rid your home of any pet allergen left", "bbox": [69.0, 189.0, 427.0, 208.0]}, {"text": "behind, your child will likely have a significant lessen-", "bbox": [69.0, 209.0, 425.0, 228.0]}, {"text": "ing in allergy and asthma symptoms, as well as", "bbox": [69.0, 229.0, 427.0, 248.0]}, {"text": "decreased medication requirements.", "bbox": [69.0, 249.0, 302.0, 267.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "If you are not willing to relocate your pet for the health", "bbox": [69.0, 289.0, 427.0, 308.0]}, {"text": "benefits it will provide your child, then you should at", "bbox": [69.0, 308.0, 427.0, 328.0]}, {"text": "minimum reduce the child's exposure to pet allergen. You", "bbox": [69.0, 329.0, 427.0, 347.0]}, {"text": "should make sure that the allergic child's bedroom", "bbox": [69.0, 349.0, 427.0, 367.0]}, {"text": "remains off limits to the pet and that the bedroom is kept", "bbox": [69.0, 369.0, 427.0, 388.0]}, {"text": "as allergen-free as possible. An allergist can provide you", "bbox": [69.0, 388.0, 427.0, 408.0]}, {"text": "with specific recommendations depending on what type", "bbox": [69.0, 408.0, 426.0, 427.0]}, {"text": "of pet you have and the layout of your home.", "bbox": [69.0, 429.0, 346.0, 448.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "99. How can I make sure that my child’s", "bbox": [71.0, 470.0, 410.0, 494.0]}, {"text": "school staff can cope with his or her", "bbox": [70.0, 497.0, 366.0, 518.0]}, {"text": "asthma? What about summer camp staff?", "bbox": [69.0, 520.0, 426.0, 545.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "The best way to make sure that your child's school or", "bbox": [69.0, 547.0, 426.0, 567.0]}, {"text": "camp is in a position to cope with your child's asthma", "bbox": [69.0, 568.0, 427.0, 588.0]}, {"text": "is to teach your child about asthma and to establish", "bbox": [69.0, 589.0, 427.0, 608.0]}, {"text": "good communication with the school and camp", "bbox": [69.0, 609.0, 427.0, 627.0]}, {"text": "administration. Even though asthma is a very common", "bbox": [69.0, 629.0, 427.0, 648.0]}, {"text": "condition throughout childhood and adolescence, it is", "bbox": [69.0, 649.0, 427.0, 668.0]}, {"text": "still a good idea to make sure that school and camp", "bbox": [69.0, 669.0, 427.0, 688.0]}, {"text": "staff know that your child carries a diagnosis of", "bbox": [69.0, 689.0, 428.0, 707.0]}, {"text": "asthma. Several measures are helpful to ensure that", "bbox": [69.0, 709.0, 427.0, 727.0]}, {"text": "your child's asthma remains well-controlled at school", "bbox": [69.0, 729.0, 427.0, 748.0]}, {"text": "or camp. Familiarize yourself with the school or camp", "bbox": [69.0, 749.0, 426.0, 768.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 204}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#0#uə.pliq) pue emqtsA :>iqoT lei>əds无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:21:56"}
{"id": 1042058, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "8a8cd34e-8d89-471c-92d7-05f68d7df973", "title": null, "text": "【0】页码:2\n\n【1】## Senior Managing Editor: Kevork Topalian © 2007 By Amolca.\n\n【2】\n All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any form or by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as US government employees are not covered by the above mentioned copyright.\n\n【3】 Original edition in Spanish: 1.001 Tips en Ortodoncia y sus secretos ISBN: 978-958-8328-02-7\n\n【4】 English edition 2008 1,001 Tips for Orthodontics and its Secrets ISBN 978-958-8328-46-1\n\n【5】 English translation: Marco Grimshaw\n\n【6】 Layout: Gregorio González\n\n【7】 Impreso en Colombia por: D'vinni S.A.\n\n【8】 USA 9247 S.W. 209 Terrace Miami, FL 33189 USA Telephone: 305-316-99-29 amolca@amolca.us\n\n【9】 Venezuela 1ra. Avenida Sur de Altamira, Edificio Rokaje, Planta 3, Urb. Altamira - Aptdo Postal 68772 - 1062-A. Caracas - Venezuela Telfs: (58 212) 266.6176 - 266.86.01 - Fax: (58 212) 264.4608 amolca@telcel.net.ve - www.amolca.com.ve", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Senior Managing Editor: Kevork Topalian", "bbox": [62.0, 252.0, 270.0, 268.0]}, {"text": "© 2007 by AMOLCA.", "bbox": [62.0, 266.0, 163.0, 282.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any", "bbox": [62.0, 293.0, 517.0, 310.0]}, {"text": "form or by any means, including photocopying, or utilized by any information storage and retrieval", "bbox": [61.0, 305.0, 500.0, 327.0]}, {"text": "system without written permission from the copyright owner, except for brief quotations embodied in", "bbox": [61.0, 321.0, 512.0, 336.0]}, {"text": "critical articles and reviews. Materials appearing in this book prepared by individuals as part of their", "bbox": [61.0, 332.0, 504.0, 353.0]}, {"text": "official duties as US government employees are not covered by the above mentioned copyright.", "bbox": [61.0, 345.0, 481.0, 365.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Original edition in Spanish:", "bbox": [61.0, 373.0, 187.0, 388.0]}, {"text": "1.001 Tips en Ortodoncia y sus secretos", "bbox": [61.0, 386.0, 259.0, 403.0]}, {"text": "ISBN: 978-958-8328-02-7", "bbox": [61.0, 400.0, 178.0, 414.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "English edition 2008", "bbox": [61.0, 426.0, 155.0, 441.0]}, {"text": "1,001 Tips for Orthodontics and its Secrets", "bbox": [61.0, 438.0, 274.0, 455.0]}, {"text": "ISBN 978-958-8328-46-1", "bbox": [61.0, 452.0, 177.0, 467.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "English translation: Marco Grimshaw", "bbox": [60.0, 480.0, 230.0, 495.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Layout: Gregorio González", "bbox": [60.0, 507.0, 185.0, 523.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Impreso en Colombia por: D'vinni S.A.", "bbox": [60.0, 533.0, 250.0, 549.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "USA", "bbox": [367.0, 776.0, 394.0, 792.0]}, {"text": "9247 S.W. 209 Terrace", "bbox": [329.0, 788.0, 433.0, 806.0]}, {"text": "Miami, FL 33189 USA", "bbox": [329.0, 804.0, 434.0, 818.0]}, {"text": "Telephone: 305-316-99-29", "bbox": [323.0, 816.0, 440.0, 830.0]}, {"text": "amolca@amolca.us", "bbox": [336.0, 831.0, 426.0, 844.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Venezuela", "bbox": [352.0, 876.0, 410.0, 893.0]}, {"text": "1ra. Avenida Sur de Altamira, Edificio Rokaje, Planta 3, Urb. Altamira - Aptdo", "bbox": [212.0, 888.0, 551.0, 904.0]}, {"text": "Postal 68772 - 1062-A. Caracas - Venezuela", "bbox": [283.0, 901.0, 479.0, 920.0]}, {"text": "Telfs: (58 212) 266.6176 - 266.86.01 - Fax: (58 212) 264.4608", "bbox": [246.0, 914.0, 518.0, 932.0]}, {"text": "amolca@telcel.net.ve - www.amolca.com.ve", "bbox": [283.0, 927.0, 481.0, 944.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 2}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "", "type4": null, "type5": null, "type6": "有用性#0#9#版权信息的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:32:17"}
{"id": 1042057, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "6c76c256-f344-472d-9129-d88a32180324", "title": null, "text": "【0】页码:2\n\n【1】## Bell'S Palsy Handbook\n\n【2】\n Facial Nerve Palsy or Bell's Palsy Facial Paralysis Causes, Symptoms, Treatment, Face Exercises & Recovery All Covered\n\n【3】## Alan Mcdonald\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "BELL'S PALSY HANDBOOK", "bbox": [167.0, 170.0, 649.0, 214.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "Facial Nerve Palsy or Bell's Palsy Facial Paralysis Causes, Symptoms,", "bbox": [93.0, 251.0, 724.0, 281.0]}, {"text": "Treatment, Face Exercises & Recovery All Covered", "bbox": [172.0, 280.0, 641.0, 305.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Alan McDonald", "bbox": [312.0, 345.0, 503.0, 375.0]}], "type": "Section-header", "position": 2}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 2}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:37:26"}
{"id": 1042056, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "39a18c89-446c-487e-8693-eb03a35ae635", "title": null, "text": "【0】页码:132\n 96. Sum Ping ST, Mehta MP, Symreng T.  Accuracy of the FEF CO2 detector in the assessment of endotracheal tube placement. Anesth Analg . 1992;74:415–419.\n\n【1】97. Ward KR, Yealy DM.  End-tidal carbon dioxide monitoring in emergency medicine. Part 2: clinical applications. Acad Emerg Med .\n\n【2】1998;5:637–646.\n\n【3】98. Tobias JD, Meyer DJ. Noninvasive monitoring of carbon dioxide during respiratory failure in toddlers and infants: end-tidal versus transcutaneous carbon dioxide. Anesth Analg . 1997;85:55–58.\n\n【4】1999.\n\n【5】Pelucio M, Halligan L, Dhindsa H. Out-of-hospital experience with the syringe esophageal detector device. Acad Emerg Med . 1997;4:563–568.\n\n【6】100. Baraka A, Khoury PJ, Siddik SS, Salem MR, Joseph NJ. Efficacy of the self-inflating bulb in differentiating esophageal from tracheal intubation in the parturient undergoing cesarean section. Anesth Analg . 1997;84: 533–537.\n\n【7】101. Davis DP, Stephen KA, Vilke GM.  Inaccuracy in endotracheal tube verification using a Toomey syringe. J Emerg Med . 1999;17:35–38.\n\n【8】102. Ewy GA, Hellman DA, McClung S, Taren D.  Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness. Crit Care Med . 1980;8:164–166.\n\n【9】103. Mehta KH, Turley A, Peyrasse P, Janes J, Hall JE. An assessment of the ability of impedance respirometry to distinguish oesophageal from tracheal intubation. Anaesthesia. 2002;57:1090–1093.\n\n【10】104. Yao YX, Jiang Z, Lu XH, He JH, Ma XX, Zhu JH. [A clinical study of impedance graph in verifying tracheal intubation]. Zhonghua Yi Xue Za Zhi . 2007;87:898–901.\n\n【11】105.\n\n【12】Absolom M, Roberts R, Bahlmann UB, Hall JE, Armstrong T, Turley A.\n\n【13】The use of impedance respirometry to confirm tracheal intubation in children. Anaesthesia. 2006;61:1145–1148.\n\n【14】106. Pytte M, Olasveengen TM, Steen PA, Sunde K.  Misplaced and dislodged endotracheal tubes may be detected by the defibrillator during cardiopulmonary resuscitation. Acta Anaesthesiol Scand . 2007;51: 770–772.\n\n【15】107. Kramer- Johansen J, Wik L, Steen PA.  Advanced cardiac life support before and after tracheal intubation—direct measurements of quality.\n\n【16】Resuscitation . 2006;68:61–69.\n\n【17】108. Yap SJ, Morris RW, Pybus DA.  Alterations in endotracheal tube position during general anaesthesia. Anaesth Intensive Care . 1994;22: 586 – 588.\n\n【18】109. Sugiyama K, Yokoyama K.  Displacement of the endotracheal tube caused by change of head position in pediatric anesthesia: evaluation by fiberoptic bronchoscopy. Anesth Analg. 1996;82:251–253.\n\n【19】110. King HK.  A new device: Tube Securer. An endotracheal tube holder with integrated bite-block. Acta Anaesthesiol Sin. 1997;35:257–259.\n\n【20】111. Falk JL, Sayre MR. Confirmation of airway placement. Prehosp Emerg Care . 1999;3:273–278.\n\n【21】112.\n\n【22】Wang HE, Kupas DF, Paris PM, Bates RR, Yealy DM.  Preliminary experience with a prospective, multi-centered evaluation of out-ofhospital endotracheal intubation. Resuscitation . 2003;58:49–58.\n\n【23】113. Kupas DF, Kauffman KF, Wang HE. Effect of airway-securing method on prehospital endotracheal tube dislodgment. Prehosp Emerg Care .\n\n【24】2010;14:26–30.\n\n【25】114. Levy H, Griego L.  A comparative study of oral endotracheal tube securing methods. Chest. 1993;104:1537–1540.\n\n【26】Tasota FJ, Hoffman LA, Zullo TG, Jamison G.  Evaluation of two 115.\n\n【27】methods used to stabilize oral endotracheal tubes. Heart Lung . 1987;16: 140–146.\n\n【28】116. Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite S, von Briesen C, Sparks CW, Conrad CJ, Provo TA, Lurie KG.\n\n【29】Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation. 2004;109:1960–1965.\n\n【30】117. O'Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients?\n\n【31】Resuscitation . 2007;73:82–85.\n\n【32】Berg RA, Kern KB, Sanders AB, Otto CW, Hilwig RW, Ewy GA.\n\n【33】118.\n\n【34】Bystander cardiopulmonary resuscitation. Is ventilation necessary?\n\n【35】Circulation . 1993;88:1907–1915.\n\n【36】119. Berg RA, Sanders AB, Kern KB, Hilwig RW, Heidenreich JW, Porter ME, Ewy GA.  Adverse hemodynamic effects of interrupting chest compressions for rescue breathing during cardiopulmonary resuscitation for ventricular fibrillation cardiac arrest. Circulation . 2001;104: 2465–2470.\n\n【37】120. Dorph E, Wik L, Steen PA.  Effectiveness of ventilation- compression ratios 1:5 and 2:15 in simulated single rescuer paediatric resuscitation.\n\n【38】Resuscitation . 2002;54:259–264.\n\n【39】 121. Hwang SO, Kim SH, Kim H, Jang YS, Zhao PG, Lee KH, Choi HJ, Shin TY.  Comparison of 15:1, 15:2, and 30:2 compression-to-ventilation ratios for cardiopulmonary resuscitation in a canine model of a simulated, witnessed cardiac arrest. Acad Emerg Med . 2008;15:183–189.\n\n【40】122. Yannopoulos D, Sigurdsson G, McKnite S, Benditt D, Lurie KG.\n\n【41】Reducing ventilation frequency combined with an inspiratory impedance device improves CPR efficiency in swine model of cardiac arrest. Resuscitation . 2004;61:75–82.\n\n【42】123. Yannopoulos D, Tang W, Roussos C, Aufderheide TP, Idris AH, Lurie KG.  Reducing ventilation frequency during cardiopulmonary resuscitation in a porcine model of cardiac arrest. Respir Care . 2005;50: 628 – 635.\n\n【43】124. Yannopoulos D, Aufderheide TP, Gabrielli A, Beiser DG, McKnite SH, Pirrallo RG, Wigginton J, Becker L, Vanden Hoek T, Tang W, Nadkarni VM, Klein JP, Idris AH, Lurie KG.  Clinical and hemodynamic comparison of 15:2 and 30:2 compression-to-ventilation ratios for cardiopulmonary resuscitation. Crit Care Med . 2006;34:1444–1449.\n\n【44】125. Abella BS, Edelson DP, Kim S, Retzer E, Myklebust H, Barry AM, O'Hearn N, Hoek TL, Becker LB.  CPR quality improvement during in-hospital cardiac arrest using a real-time audiovisual feedback system.\n\n【45】Resuscitation . 2007;73:54–61.\n\n【46】126. Weiss SJ, Ernst AA, Jones R, Ong M, Filbrun T, Augustin C, Barnum M, Nick TG. Automatic transport ventilator versus bag valve in the EMS setting: a prospective, randomized trial. South Med J . 2005;98:970–976.\n\n【47】127.\n\n【48】Johannigman JA, Branson RD, Johnson DJ, Davis K Jr, Hurst JM.\n\n【49】Out-of-hospital ventilation: bag-valve device vs transport ventilator.\n\n【50】Acad Emerg Med . 1995;2:719–724.\n\n【51】128. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L, Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. Ann Emerg Med .\n\n【52】2010;55:249–257.\n\n【53】129. Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.\n\n【54】130. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation in Rochester, Minnesota: experience over 18 years. Resuscitation. 2009; 80:1253–1258.\n\n【55】131. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK.\n\n【56】Hospital variation in time to defibrillation after in-hospital cardiac arrest.\n\n【57】Arch Intern Med . 2009;169:1265–1273.\n\n【58】132. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB.  Public use of automated external defibrillators. N Engl J Med . 2002;347:1242–1247.\n\n【59】133.\n\n【60】Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.\n\n【61】Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med . 2000;343:1206–1209.\n\n【62】134. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T.\n\n【63】Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med . 1999;341:871–878.\n\n【64】135. Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac arrest—a meta-analysis. Resuscitation. 2000;45:161–166.\n\n【65】Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A.\n\n【66】136.\n\n【67】Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med . 2002;346:884–890.\n\n【68】137. Stiell IG, Wells GA, Field B, Spaite DW, Nesbitt LP, De Maio VJ, Nichol G, Cousineau D, Blackburn J, Munkley D, Luinstra-Toohey L, Campeau T, Dagnone E, Lyver M. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med . 2004;351:647–656.\n\n【69】138. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L.\n\n【70】Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA . 2009;302:2222–2229.\n\n【71】139. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of hands-off time during CPR with manual and semi-automatic defibrillation in a manikin model. Resuscitation . 2007;73:131–136.\n\n【72】140. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA.\n\n【73】Pauses in chest compression and inappropriate shocks: a comparison of manual and semi-automatic defibrillation attempts. Resuscitation . 2007;73: 212–220.\n\n【74】141. Eftestol T, Wik L, Sunde K, Steen PA.  Effects of cardiopulmonary resuscitation on predictors of ventricular fibrillation defibrillation success during out-of-hospital cardiac arrest. Circulation . 2004;110: 10–15.\n\n【75】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "96. Sum Ping ST, Mehta MP, Symreng T.  Accuracy of the FEF CO2", "bbox": [66.0, 85.0, 375.0, 97.0]}, {"text": "detector in the assessment of endotracheal tube placement. Anesth", "bbox": [83.0, 98.0, 376.0, 109.0]}, {"text": "Analg . 1992;74:415–419.", "bbox": [83.0, 109.0, 189.0, 120.0]}, {"text": "97. Ward KR, Yealy DM.  End-tidal carbon dioxide monitoring in", "bbox": [66.0, 122.0, 376.0, 134.0]}, {"text": "emergency medicine. Part 2: clinical applications. Acad Emerg Med .", "bbox": [83.0, 135.0, 375.0, 147.0]}, {"text": "1998;5:637–646.", "bbox": [84.0, 147.0, 154.0, 158.0]}, {"text": "98. Tobias JD, Meyer DJ. Noninvasive monitoring of carbon dioxide during", "bbox": [65.0, 157.0, 375.0, 172.0]}, {"text": "respiratory failure in toddlers and infants: end-tidal versus transcu-", "bbox": [83.0, 171.0, 374.0, 183.0]}, {"text": "taneous carbon dioxide. Anesth Analg . 1997;85:55–58.", "bbox": [83.0, 184.0, 308.0, 195.0]}, {"text": "1999.", "bbox": [65.0, 195.0, 81.0, 207.0]}, {"text": "Pelucio M, Halligan L, Dhindsa H. Out-of-hospital experience with the", "bbox": [81.0, 195.0, 375.0, 207.0]}, {"text": "syringe esophageal detector device. Acad Emerg Med . 1997;4:563–568.", "bbox": [83.0, 208.0, 375.0, 220.0]}, {"text": "100. Baraka A, Khoury PJ, Siddik SS, Salem MR, Joseph NJ. Efficacy of the", "bbox": [61.0, 220.0, 375.0, 232.0]}, {"text": "self-inflating bulb in differentiating esophageal from tracheal intubation", "bbox": [83.0, 234.0, 376.0, 245.0]}, {"text": "in the parturient undergoing cesarean section. Anesth Analg . 1997;84:", "bbox": [84.0, 245.0, 375.0, 256.0]}, {"text": "533–537.", "bbox": [84.0, 257.0, 124.0, 267.0]}, {"text": "101. Davis DP, Stephen KA, Vilke GM.  Inaccuracy in endotracheal tube", "bbox": [61.0, 269.0, 375.0, 281.0]}, {"text": "verification using a Toomey syringe. J Emerg Med . 1999;17:35–38.", "bbox": [84.0, 282.0, 364.0, 294.0]}, {"text": "102. Ewy GA, Hellman DA, McClung S, Taren D.  Influence of ventilation", "bbox": [61.0, 294.0, 376.0, 306.0]}, {"text": "phase on transthoracic impedance and defibrillation effectiveness. Crit", "bbox": [84.0, 307.0, 376.0, 317.0]}, {"text": "Care Med . 1980;8:164–166.", "bbox": [83.0, 318.0, 202.0, 329.0]}, {"text": "103. Mehta KH, Turley A, Peyrasse P, Janes J, Hall JE. An assessment of the", "bbox": [61.0, 330.0, 376.0, 342.0]}, {"text": "ability of impedance respirometry to distinguish oesophageal from", "bbox": [83.0, 342.0, 376.0, 354.0]}, {"text": "tracheal intubation. Anaesthesia. 2002;57:1090–1093.", "bbox": [83.0, 355.0, 306.0, 367.0]}, {"text": "104. Yao YX, Jiang Z, Lu XH, He JH, Ma XX, Zhu JH. [A clinical study of", "bbox": [61.0, 368.0, 376.0, 379.0]}, {"text": "impedance graph in verifying tracheal intubation]. Zhonghua Yi Xue Za", "bbox": [84.0, 380.0, 375.0, 392.0]}, {"text": "Zhi . 2007;87:898–901.", "bbox": [84.0, 391.0, 177.0, 402.0]}, {"text": "105.", "bbox": [61.0, 403.0, 82.0, 414.0]}, {"text": "Absolom M, Roberts R, Bahlmann UB, Hall JE, Armstrong T, Turley A.", "bbox": [80.0, 403.0, 375.0, 415.0]}, {"text": "The use of impedance respirometry to confirm tracheal intubation in", "bbox": [84.0, 416.0, 377.0, 428.0]}, {"text": "children. Anaesthesia. 2006;61:1145–1148.", "bbox": [83.0, 428.0, 261.0, 440.0]}, {"text": "106. Pytte M, Olasveengen TM, Steen PA, Sunde K.  Misplaced and dis-", "bbox": [61.0, 441.0, 375.0, 452.0]}, {"text": "lodged endotracheal tubes may be detected by the defibrillator during", "bbox": [83.0, 453.0, 375.0, 464.0]}, {"text": "cardiopulmonary resuscitation. Acta Anaesthesiol Scand . 2007;51:", "bbox": [83.0, 466.0, 375.0, 477.0]}, {"text": "770–772.", "bbox": [84.0, 478.0, 124.0, 488.0]}, {"text": "107. Kramer- Johansen J, Wik L, Steen PA.  Advanced cardiac life support", "bbox": [61.0, 489.0, 376.0, 501.0]}, {"text": "before and after tracheal intubation—direct measurements of quality.", "bbox": [84.0, 501.0, 375.0, 514.0]}, {"text": "Resuscitation . 2006;68:61–69.", "bbox": [84.0, 515.0, 209.0, 526.0]}, {"text": "108. Yap SJ, Morris RW, Pybus DA.  Alterations in endotracheal tube", "bbox": [61.0, 526.0, 375.0, 538.0]}, {"text": "position during general anaesthesia. Anaesth Intensive Care . 1994;22:", "bbox": [84.0, 540.0, 375.0, 550.0]}, {"text": "586 – 588.", "bbox": [84.0, 551.0, 125.0, 562.0]}, {"text": "109. Sugiyama K, Yokoyama K.  Displacement of the endotracheal tube", "bbox": [61.0, 563.0, 375.0, 575.0]}, {"text": "caused by change of head position in pediatric anesthesia: evaluation by", "bbox": [83.0, 575.0, 375.0, 587.0]}, {"text": "fiberoptic bronchoscopy. Anesth Analg. 1996;82:251–253.", "bbox": [84.0, 588.0, 323.0, 600.0]}, {"text": "110. King HK.  A new device: Tube Securer. An endotracheal tube holder", "bbox": [61.0, 600.0, 375.0, 611.0]}, {"text": "with integrated bite-block. Acta Anaesthesiol Sin. 1997;35:257–259.", "bbox": [85.0, 613.0, 365.0, 624.0]}, {"text": "111. Falk JL, Sayre MR. Confirmation of airway placement. Prehosp Emerg", "bbox": [61.0, 624.0, 376.0, 635.0]}, {"text": "Care . 1999;3:273–278.", "bbox": [84.0, 637.0, 178.0, 649.0]}, {"text": "112.", "bbox": [61.0, 649.0, 81.0, 660.0]}, {"text": "Wang HE, Kupas DF, Paris PM, Bates RR, Yealy DM.  Preliminary", "bbox": [81.0, 649.0, 375.0, 660.0]}, {"text": "experience with a prospective, multi-centered evaluation of out-of-", "bbox": [83.0, 662.0, 375.0, 674.0]}, {"text": "hospital endotracheal intubation. Resuscitation . 2003;58:49–58.", "bbox": [83.0, 673.0, 346.0, 684.0]}, {"text": "113. Kupas DF, Kauffman KF, Wang HE. Effect of airway-securing method", "bbox": [61.0, 686.0, 376.0, 697.0]}, {"text": "on prehospital endotracheal tube dislodgment. Prehosp Emerg Care .", "bbox": [83.0, 697.0, 375.0, 709.0]}, {"text": "2010;14:26–30.", "bbox": [84.0, 710.0, 150.0, 722.0]}, {"text": "114. Levy H, Griego L.  A comparative study of oral endotracheal tube", "bbox": [61.0, 722.0, 376.0, 735.0]}, {"text": "securing methods. Chest. 1993;104:1537–1540.", "bbox": [84.0, 735.0, 279.0, 746.0]}, {"text": "Tasota FJ, Hoffman LA, Zullo TG, Jamison G.  Evaluation of two", "bbox": [81.0, 746.0, 376.0, 758.0]}, {"text": "115.", "bbox": [61.0, 747.0, 81.0, 757.0]}, {"text": "methods used to stabilize oral endotracheal tubes. Heart Lung . 1987;16:", "bbox": [85.0, 759.0, 375.0, 770.0]}, {"text": "140–146.", "bbox": [84.0, 771.0, 125.0, 782.0]}, {"text": "116. Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite", "bbox": [61.0, 783.0, 375.0, 796.0]}, {"text": "S, von Briesen C, Sparks CW, Conrad CJ, Provo TA, Lurie KG.", "bbox": [83.0, 795.0, 375.0, 808.0]}, {"text": "Hyperventilation-induced hypotension during cardiopulmonary resusci-", "bbox": [83.0, 808.0, 375.0, 820.0]}, {"text": "tation. Circulation. 2004;109:1960–1965.", "bbox": [83.0, 820.0, 256.0, 831.0]}, {"text": "117. O'Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients?", "bbox": [61.0, 832.0, 376.0, 844.0]}, {"text": "Resuscitation . 2007;73:82–85.", "bbox": [84.0, 846.0, 209.0, 855.0]}, {"text": "Berg RA, Kern KB, Sanders AB, Otto CW, Hilwig RW, Ewy GA.", "bbox": [82.0, 856.0, 375.0, 869.0]}, {"text": "118.", "bbox": [61.0, 857.0, 79.0, 868.0]}, {"text": "Bystander cardiopulmonary resuscitation. Is ventilation necessary?", "bbox": [83.0, 870.0, 375.0, 882.0]}, {"text": "Circulation . 1993;88:1907–1915.", "bbox": [83.0, 882.0, 220.0, 893.0]}, {"text": "119. Berg RA, Sanders AB, Kern KB, Hilwig RW, Heidenreich JW, Porter", "bbox": [61.0, 893.0, 376.0, 906.0]}, {"text": "ME, Ewy GA.  Adverse hemodynamic effects of interrupting chest", "bbox": [83.0, 906.0, 376.0, 917.0]}, {"text": "compressions for rescue breathing during cardiopulmonary resuscitation", "bbox": [83.0, 919.0, 375.0, 930.0]}, {"text": "for ventricular fibrillation cardiac arrest. Circulation . 2001;104:", "bbox": [83.0, 930.0, 375.0, 942.0]}, {"text": "2465–2470.", "bbox": [84.0, 943.0, 133.0, 955.0]}, {"text": "120. Dorph E, Wik L, Steen PA.  Effectiveness of ventilation- compression", "bbox": [61.0, 955.0, 376.0, 966.0]}, {"text": "ratios 1:5 and 2:15 in simulated single rescuer paediatric resuscitation.", "bbox": [84.0, 968.0, 375.0, 979.0]}, {"text": "Resuscitation . 2002;54:259–264.", "bbox": [84.0, 979.0, 219.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "121. Hwang SO, Kim SH, Kim H, Jang YS, Zhao PG, Lee KH, Choi HJ, Shin", "bbox": [405.0, 85.0, 720.0, 98.0]}, {"text": "TY.  Comparison of 15:1, 15:2, and 30:2 compression-to-ventilation", "bbox": [428.0, 98.0, 720.0, 110.0]}, {"text": "ratios for cardiopulmonary resuscitation in a canine model of a sim-", "bbox": [427.0, 111.0, 718.0, 122.0]}, {"text": "ulated, witnessed cardiac arrest. Acad Emerg Med . 2008;15:183–189.", "bbox": [427.0, 123.0, 714.0, 134.0]}, {"text": "122. Yannopoulos D, Sigurdsson G, McKnite S, Benditt D, Lurie KG.", "bbox": [405.0, 136.0, 719.0, 147.0]}, {"text": "Reducing ventilation frequency combined with an inspiratory", "bbox": [427.0, 147.0, 719.0, 159.0]}, {"text": "impedance device improves CPR efficiency in swine model of cardiac", "bbox": [427.0, 160.0, 719.0, 172.0]}, {"text": "arrest. Resuscitation . 2004;61:75–82.", "bbox": [427.0, 173.0, 581.0, 183.0]}, {"text": "123. Yannopoulos D, Tang W, Roussos C, Aufderheide TP, Idris AH, Lurie", "bbox": [405.0, 185.0, 720.0, 197.0]}, {"text": "KG.  Reducing ventilation frequency during cardiopulmonary resusci-", "bbox": [427.0, 197.0, 719.0, 209.0]}, {"text": "tation in a porcine model of cardiac arrest. Respir Care . 2005;50:", "bbox": [427.0, 210.0, 719.0, 221.0]}, {"text": "628 – 635.", "bbox": [427.0, 222.0, 469.0, 233.0]}, {"text": "124. Yannopoulos D, Aufderheide TP, Gabrielli A, Beiser DG, McKnite SH,", "bbox": [405.0, 234.0, 720.0, 246.0]}, {"text": "Pirrallo RG, Wigginton J, Becker L, Vanden Hoek T, Tang W, Nadkarni", "bbox": [427.0, 247.0, 720.0, 259.0]}, {"text": "VM, Klein JP, Idris AH, Lurie KG.  Clinical and hemodynamic com-", "bbox": [427.0, 259.0, 719.0, 271.0]}, {"text": "parison of 15:2 and 30:2 compression-to-ventilation ratios for cardiopul-", "bbox": [427.0, 272.0, 718.0, 283.0]}, {"text": "monary resuscitation. Crit Care Med . 2006;34:1444–1449.", "bbox": [427.0, 286.0, 671.0, 295.0]}, {"text": "125. Abella BS, Edelson DP, Kim S, Retzer E, Myklebust H, Barry AM,", "bbox": [406.0, 296.0, 720.0, 308.0]}, {"text": "O'Hearn N, Hoek TL, Becker LB.  CPR quality improvement during", "bbox": [427.0, 309.0, 719.0, 321.0]}, {"text": "in-hospital cardiac arrest using a real-time audiovisual feedback system.", "bbox": [427.0, 321.0, 719.0, 333.0]}, {"text": "Resuscitation . 2007;73:54–61.", "bbox": [427.0, 334.0, 554.0, 346.0]}, {"text": "126. Weiss SJ, Ernst AA, Jones R, Ong M, Filbrun T, Augustin C, Barnum", "bbox": [405.0, 346.0, 720.0, 359.0]}, {"text": "M, Nick TG. Automatic transport ventilator versus bag valve in the EMS", "bbox": [427.0, 359.0, 720.0, 371.0]}, {"text": "setting: a prospective, randomized trial. South Med J . 2005;98:970–976.", "bbox": [427.0, 371.0, 719.0, 383.0]}, {"text": "127.", "bbox": [405.0, 383.0, 425.0, 394.0]}, {"text": "Johannigman JA, Branson RD, Johnson DJ, Davis K Jr, Hurst JM.", "bbox": [425.0, 383.0, 719.0, 395.0]}, {"text": "Out-of-hospital ventilation: bag-valve device vs transport ventilator.", "bbox": [427.0, 396.0, 719.0, 408.0]}, {"text": "Acad Emerg Med . 1995;2:719–724.", "bbox": [427.0, 408.0, 576.0, 420.0]}, {"text": "128. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh", "bbox": [405.0, 421.0, 720.0, 433.0]}, {"text": "S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L,", "bbox": [427.0, 433.0, 720.0, 445.0]}, {"text": "Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital", "bbox": [427.0, 446.0, 720.0, 458.0]}, {"text": "cardiac arrest: role of the Utstein data elements. Ann Emerg Med .", "bbox": [428.0, 458.0, 719.0, 470.0]}, {"text": "2010;55:249–257.", "bbox": [427.0, 469.0, 503.0, 483.0]}, {"text": "129. Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival", "bbox": [405.0, 482.0, 721.0, 496.0]}, {"text": "from out-of-hospital cardiac arrest: a systematic review and meta-anal-", "bbox": [427.0, 495.0, 719.0, 507.0]}, {"text": "ysis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.", "bbox": [427.0, 508.0, 651.0, 520.0]}, {"text": "130. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation", "bbox": [405.0, 520.0, 720.0, 531.0]}, {"text": "in Rochester, Minnesota: experience over 18 years. Resuscitation. 2009;", "bbox": [427.0, 533.0, 718.0, 544.0]}, {"text": "80:1253–1258.", "bbox": [427.0, 544.0, 490.0, 555.0]}, {"text": "131. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK.", "bbox": [405.0, 557.0, 718.0, 569.0]}, {"text": "Hospital variation in time to defibrillation after in-hospital cardiac arrest.", "bbox": [427.0, 570.0, 720.0, 582.0]}, {"text": "Arch Intern Med . 2009;169:1265–1273.", "bbox": [427.0, 582.0, 591.0, 594.0]}, {"text": "132. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB.  Public use of", "bbox": [405.0, 595.0, 720.0, 607.0]}, {"text": "automated external defibrillators. N Engl J Med . 2002;347:1242–1247.", "bbox": [428.0, 607.0, 719.0, 619.0]}, {"text": "133.", "bbox": [406.0, 620.0, 425.0, 630.0]}, {"text": "Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.", "bbox": [426.0, 620.0, 719.0, 631.0]}, {"text": "Outcomes of rapid defibrillation by security officers after cardiac arrest", "bbox": [427.0, 631.0, 720.0, 642.0]}, {"text": "in casinos. N Engl J Med . 2000;343:1206–1209.", "bbox": [427.0, 644.0, 628.0, 656.0]}, {"text": "134. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM,", "bbox": [405.0, 656.0, 720.0, 669.0]}, {"text": "Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T.", "bbox": [427.0, 669.0, 720.0, 681.0]}, {"text": "Amiodarone for resuscitation after out-of-hospital cardiac arrest due to", "bbox": [428.0, 682.0, 721.0, 694.0]}, {"text": "ventricular fibrillation. N Engl J Med . 1999;341:871–878.", "bbox": [427.0, 694.0, 668.0, 705.0]}, {"text": "135. Vandycke C, Martens P. High dose versus standard dose epinephrine in", "bbox": [405.0, 707.0, 720.0, 718.0]}, {"text": "cardiac arrest—a meta-analysis. Resuscitation. 2000;45:161–166.", "bbox": [427.0, 719.0, 696.0, 729.0]}, {"text": "Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A.", "bbox": [425.0, 731.0, 720.0, 743.0]}, {"text": "136.", "bbox": [406.0, 732.0, 425.0, 742.0]}, {"text": "Amiodarone as compared with lidocaine for shock-resistant ventricular", "bbox": [428.0, 744.0, 720.0, 755.0]}, {"text": "fibrillation. N Engl J Med . 2002;346:884–890.", "bbox": [427.0, 756.0, 622.0, 768.0]}, {"text": "137. Stiell IG, Wells GA, Field B, Spaite DW, Nesbitt LP, De Maio VJ,", "bbox": [405.0, 768.0, 719.0, 781.0]}, {"text": "Nichol G, Cousineau D, Blackburn J, Munkley D, Luinstra-Toohey L,", "bbox": [427.0, 781.0, 720.0, 792.0]}, {"text": "Campeau T, Dagnone E, Lyver M. Advanced cardiac life support in", "bbox": [427.0, 794.0, 720.0, 805.0]}, {"text": "out-of-hospital cardiac arrest. N Engl J Med . 2004;351:647–656.", "bbox": [427.0, 805.0, 696.0, 816.0]}, {"text": "138. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L.", "bbox": [405.0, 818.0, 719.0, 830.0]}, {"text": "Intravenous drug administration during out-of-hospital cardiac arrest: a", "bbox": [427.0, 830.0, 721.0, 843.0]}, {"text": "randomized trial. JAMA . 2009;302:2222–2229.", "bbox": [427.0, 843.0, 621.0, 855.0]}, {"text": "139. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of", "bbox": [406.0, 856.0, 720.0, 868.0]}, {"text": "hands-off time during CPR with manual and semi-automatic defibril-", "bbox": [427.0, 868.0, 718.0, 879.0]}, {"text": "lation in a manikin model. Resuscitation . 2007;73:131–136.", "bbox": [427.0, 881.0, 674.0, 892.0]}, {"text": "140. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA.", "bbox": [405.0, 892.0, 719.0, 903.0]}, {"text": "Pauses in chest compression and inappropriate shocks: a comparison of", "bbox": [427.0, 905.0, 720.0, 916.0]}, {"text": "manual and semi-automatic defibrillation attempts. Resuscitation . 2007;73:", "bbox": [427.0, 916.0, 720.0, 929.0]}, {"text": "212–220.", "bbox": [427.0, 930.0, 466.0, 942.0]}, {"text": "141. Eftestol T, Wik L, Sunde K, Steen PA.  Effects of cardiopulmonary", "bbox": [404.0, 943.0, 720.0, 955.0]}, {"text": "resuscitation on predictors of ventricular fibrillation defibrillation", "bbox": [427.0, 955.0, 720.0, 966.0]}, {"text": "success during out-of-hospital cardiac arrest. Circulation . 2004;110:", "bbox": [428.0, 968.0, 719.0, 979.0]}, {"text": "10–15.", "bbox": [428.0, 980.0, 458.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 132}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "", "type4": null, "type5": null, "type6": "有用性#0#75#全文都是参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:52:30"}
{"id": 1042055, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "ff3346db-047e-4935-90dc-7c5b005d174a", "title": null, "text": "【0】页码:180\n Alteration of the mandibular mechanics during aper¬ ture: during this movement, the condyle of the side of the deviation will suffer a rotation movement; meanwhile the other side has a downward and forward movement. This alteration can induce asymmetric growth of the mandible, therefore this problem must be immediately treated as soon as it is detected. (13) The most frequent presentation of this malocclusion ■ is a unilateral posterior cross bite, generally associated to a functional mandibular deviation. (16) From the cephalometric point of view we can find: ■\n\n【1】 In the sagittal sense, there is a slight tendency to a osseo-dental Class III, a distal position of the upper molar, more linguoversion and retrusion of the upper incisors and moderate protrusion of the lower incisors.\n\n【2】In the vertically, we can find a dolychofacial ten¬ dency. (2)\n\n【3】 To make this diagnosis, we must manipulate the mandible to centric relation without dental occlusion. If the cross bite is functional, the midlines will coincide, the chin deviation will disappear and unstable transversal cusp to cusp rela¬ tion becomes evident. (13)\n\n【4】 Treatment: sometimes they are corrected by eliminating the interference with occlusal grinding or crown remodel¬ ing of one or more teeth. In some cases the use of a dento alveolar expander will be needed. (13)\n Fig. 24. Unilateral functional posterior cross bite.\n\n【5】## 2.\n\n【6】Dentoalveolar Cross Bite\n\n【7】\n It can affect one tooth or a group of them.\n\n【8】■ In this malocclusion, there is an alteration in the di- ■ rection of the longer axis of the upper and/or lower teeth, but the basal bone is not altered.\n\n【9】 The buccal cusps of the upper premolars and/or molar n occlude in the fossas of the opposing lower teeth.\n\n【10】They are very frequent, in the primary and in the ■ mixed and permanent dentition.\n\n【11】Generally, unilateral dento alveolar cross bites are l functional, they are the most frequent alterations that af¬ fect a single tooth. (12-13.16)\n\n【12】 Treatment: Expanders like the Quad Helix, the Tandem or the palatine expander are used. (13)\n Fig. 25. Dento alveolar posterior cross bite affecting only one upper premolar.\n\n【13】## Skeletal Cross Bites 3.\n\n【14】\n They are produced by alterations in the transversal ■ dimensions of the maxilla or the mandible, provoked by a growth alteration in some or both of them and can be observed in any stage of development. (13) The most frequent alteration is the insufficient growth of the upper maxilla. If the cross bite is unilateral it is usu¬ ally a transversal hypo-expansion of the maxilla, capable of premature cuspid contacts, that can result in a lateral deviation of the mandible. (36) The etiological factors can be mouth breathing habits, ■ atypical deglutition and thumb sucking, and can only be treated with orthopedics, only if the patient still has growth potential; if not, it must be corrected by surgical disjunction or surgically assisted orthopedic disjunction. ( 13 ) The most frequent cause for this type of cross bite is ■ mouth breathing, where we can observe a notorious com¬ pression of the maxilla that shortens the distance between molars, premolars and canines.\n\n【15】It can also occur as a consequence of an asymmetry ■ of the shape of the mandible (laterognatia). Mandibular", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Alteration of the mandibular mechanics during aper¬", "bbox": [97.0, 86.0, 384.0, 102.0]}, {"text": "ture: during this movement, the condyle of the side of the", "bbox": [70.0, 104.0, 385.0, 119.0]}, {"text": "deviation will suffer a rotation movement; meanwhile the", "bbox": [70.0, 121.0, 385.0, 137.0]}, {"text": "other side has a downward and forward movement. This", "bbox": [70.0, 139.0, 385.0, 155.0]}, {"text": "alteration can induce asymmetric growth of the mandible,", "bbox": [71.0, 157.0, 385.0, 171.0]}, {"text": "therefore this problem must be immediately treated as", "bbox": [70.0, 173.0, 386.0, 189.0]}, {"text": "soon as it is detected. (13)", "bbox": [71.0, 191.0, 204.0, 207.0]}, {"text": "The most frequent presentation of this malocclusion", "bbox": [98.0, 207.0, 386.0, 223.0]}, {"text": "■", "bbox": [71.0, 211.0, 83.0, 223.0]}, {"text": "is a unilateral posterior cross bite, generally associated to", "bbox": [70.0, 225.0, 386.0, 241.0]}, {"text": "a functional mandibular deviation. (16)", "bbox": [70.0, 243.0, 275.0, 258.0]}, {"text": "From the cephalometric point of view we can find:", "bbox": [97.0, 259.0, 377.0, 276.0]}, {"text": "■", "bbox": [72.0, 263.0, 84.0, 276.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "In the sagittal sense, there is a slight tendency to", "bbox": [115.0, 294.0, 387.0, 309.0]}, {"text": "a osseo-dental Class III, a distal position of the", "bbox": [117.0, 311.0, 386.0, 327.0]}, {"text": "upper molar, more linguoversion and retrusion", "bbox": [117.0, 329.0, 386.0, 345.0]}, {"text": "of the upper incisors and moderate protrusion of", "bbox": [117.0, 347.0, 387.0, 362.0]}, {"text": "the lower incisors.", "bbox": [117.0, 364.0, 221.0, 379.0]}, {"text": "In the vertically, we can find a dolychofacial ten¬", "bbox": [116.0, 382.0, 385.0, 396.0]}, {"text": "dency. (2)", "bbox": [117.0, 400.0, 165.0, 417.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "To make this diagnosis, we must manipulate the mandible", "bbox": [72.0, 437.0, 387.0, 454.0]}, {"text": "to centric relation without dental occlusion. If the cross bite", "bbox": [72.0, 456.0, 387.0, 470.0]}, {"text": "is functional, the midlines will coincide, the chin deviation", "bbox": [72.0, 473.0, 387.0, 488.0]}, {"text": "will disappear and unstable transversal cusp to cusp rela¬", "bbox": [72.0, 490.0, 385.0, 506.0]}, {"text": "tion becomes evident. (13)", "bbox": [72.0, 509.0, 209.0, 523.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Treatment: sometimes they are corrected by eliminating", "bbox": [72.0, 542.0, 387.0, 557.0]}, {"text": "the interference with occlusal grinding or crown remodel¬", "bbox": [72.0, 559.0, 385.0, 575.0]}, {"text": "ing of one or more teeth. In some cases the use of a dento", "bbox": [72.0, 577.0, 387.0, 592.0]}, {"text": "alveolar expander will be needed. (13)", "bbox": [72.0, 595.0, 270.0, 610.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Fig. 24. Unilateral functional posterior cross bite.", "bbox": [121.0, 801.0, 338.0, 813.0]}], "type": "Caption", "position": 6}, {"raw_context": [{"text": "2.", "bbox": [72.0, 872.0, 88.0, 887.0]}, {"text": "Dentoalveolar cross bite", "bbox": [99.0, 872.0, 255.0, 887.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "It can affect one tooth or a group of them.", "bbox": [99.0, 905.0, 333.0, 922.0]}, {"text": "■", "bbox": [72.0, 909.0, 86.0, 921.0]}, {"text": "In this malocclusion, there is an alteration in the di-", "bbox": [99.0, 923.0, 387.0, 938.0]}, {"text": "■", "bbox": [73.0, 926.0, 86.0, 938.0]}, {"text": "rection of the longer axis of the upper and/or lower teeth,", "bbox": [72.0, 941.0, 388.0, 956.0]}, {"text": "but the basal bone is not altered.", "bbox": [72.0, 958.0, 255.0, 974.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "The buccal cusps of the upper premolars and/or molar", "bbox": [433.0, 85.0, 721.0, 101.0]}, {"text": "n", "bbox": [408.0, 87.0, 420.0, 101.0]}, {"text": "occlude in the fossas of the opposing lower teeth.", "bbox": [407.0, 104.0, 678.0, 117.0]}, {"text": "They are very frequent, in the primary and in the", "bbox": [433.0, 119.0, 721.0, 135.0]}, {"text": "■", "bbox": [408.0, 122.0, 420.0, 135.0]}, {"text": "mixed and permanent dentition.", "bbox": [408.0, 138.0, 588.0, 152.0]}, {"text": "Generally, unilateral dento alveolar cross bites are", "bbox": [432.0, 154.0, 721.0, 170.0]}, {"text": "l", "bbox": [408.0, 158.0, 420.0, 170.0]}, {"text": "functional, they are the most frequent alterations that af¬", "bbox": [408.0, 172.0, 720.0, 188.0]}, {"text": "fect a single tooth. (12-13.16)", "bbox": [408.0, 191.0, 543.0, 204.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Treatment: Expanders like the Quad Helix, the Tandem", "bbox": [408.0, 224.0, 722.0, 238.0]}, {"text": "or the palatine expander are used. (13)", "bbox": [408.0, 242.0, 611.0, 256.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Fig. 25. Dento alveolar posterior cross bite affecting", "bbox": [410.0, 521.0, 639.0, 534.0]}, {"text": "only one upper premolar.", "bbox": [410.0, 536.0, 522.0, 549.0]}], "type": "Caption", "position": 12}, {"raw_context": [{"text": "Skeletal cross bites", "bbox": [435.0, 589.0, 559.0, 606.0]}, {"text": "3.", "bbox": [410.0, 592.0, 424.0, 606.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "They are produced by alterations in the transversal", "bbox": [435.0, 625.0, 724.0, 639.0]}, {"text": "■", "bbox": [410.0, 627.0, 422.0, 641.0]}, {"text": "dimensions of the maxilla or the mandible, provoked by", "bbox": [409.0, 641.0, 723.0, 657.0]}, {"text": "a growth alteration in some or both of them and can be", "bbox": [410.0, 660.0, 724.0, 674.0]}, {"text": "observed in any stage of development. (13)", "bbox": [409.0, 677.0, 633.0, 692.0]}, {"text": "The most frequent alteration is the insufficient growth", "bbox": [436.0, 695.0, 725.0, 708.0]}, {"text": "of the upper maxilla. If the cross bite is unilateral it is usu¬", "bbox": [410.0, 711.0, 723.0, 727.0]}, {"text": "ally a transversal hypo-expansion of the maxilla, capable", "bbox": [410.0, 728.0, 724.0, 743.0]}, {"text": "of premature cuspid contacts, that can result in a lateral", "bbox": [410.0, 745.0, 725.0, 761.0]}, {"text": "deviation of the mandible. (36)", "bbox": [410.0, 763.0, 568.0, 779.0]}, {"text": "The etiological factors can be mouth breathing habits,", "bbox": [437.0, 779.0, 724.0, 796.0]}, {"text": "■", "bbox": [411.0, 784.0, 422.0, 796.0]}, {"text": "atypical deglutition and thumb sucking, and can only be", "bbox": [410.0, 797.0, 725.0, 814.0]}, {"text": "treated with orthopedics, only if the patient still has growth", "bbox": [410.0, 816.0, 725.0, 830.0]}, {"text": "potential; if not, it must be corrected by surgical disjunction", "bbox": [410.0, 833.0, 725.0, 847.0]}, {"text": "or surgically assisted orthopedic disjunction. ( 13 )", "bbox": [410.0, 851.0, 662.0, 865.0]}, {"text": "The most frequent cause for this type of cross bite is", "bbox": [438.0, 866.0, 726.0, 882.0]}, {"text": "■", "bbox": [411.0, 870.0, 422.0, 882.0]}, {"text": "mouth breathing, where we can observe a notorious com¬", "bbox": [410.0, 884.0, 724.0, 900.0]}, {"text": "pression of the maxilla that shortens the distance between", "bbox": [410.0, 902.0, 725.0, 918.0]}, {"text": "molars, premolars and canines.", "bbox": [410.0, 919.0, 584.0, 934.0]}, {"text": "It can also occur as a consequence of an asymmetry", "bbox": [436.0, 935.0, 725.0, 952.0]}, {"text": "■", "bbox": [411.0, 940.0, 424.0, 952.0]}, {"text": "of the shape of the mandible (laterognatia). Mandibular", "bbox": [410.0, 954.0, 725.0, 968.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 180}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#0#0#The most frequent另起一行\n缺少换行#0#0#From the cephalometric另起一行\n标点错误#2#2#ten¬不需要这个标点\n标点错误#3#3#cusp rela¬不需要这个标点\n标点错误#4#4#remodel¬不需要这个标点\n标点错误#11#11#that af¬不需要这个标点\n序号格式不一致#13#13#Skeletal Cross Bites 3.序号应该在前面，前后颠倒了\n缺少换行#14#14#The most frequen另起一行\nThe etiological factors另起一行\nThe most frequent cause另起一行\n序号不一致#0#0#malocclusion ■和can find: ■序号应该在句首\n序号不一致#8#8#di- ■ rection和■ In this malocclusion序号应该在句首\n序号不一致#10#10#the ■ mixed序号应该在句首\n序号不一致#14#14# 类似transversal ■序号应该在句首\n序号不一致#15#15# asymmetry ■序号应该在句首", "type3": "无关文本#0#15#detected. (13) 出现在句尾的无关数字引用，应用全文", "type4": null, "type6": "有用性#4#4#Fig. 24. Unilateral functional posterior cross bite.图片描述\n有用性#12#12#Fig. 25. Dento alveolar posterior cross bite affecting only one upper premolar.图片描述\n"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:17:48"}
{"id": 1042054, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "90627a34-ff5d-41d0-aed7-855443eeb9c8", "title": null, "text": "【0】页码:5\n\n【1】## Part 4. Asthma: Treatment Strategies\n\n【2】\n 71\n\n【3】 Questions 41–56 detail different methods of managing and treating asthma: • What are written asthma management and action plans?\n\n【4】• Why should I use medicine if I feel fine?\n\n【5】• What are the goals of asthma treatment?\n\n【6】 • My asthma is active; how do I know whether I should go to the nearest hospital emergency room?\n\n【7】 • How do I know if my physician is a specialist in asthma treatment?\n\n【8】## Part 5. Asthma Medications: New And Old\n\n【9】\n 99\n\n【10】 Questions 57–72 focus on medications used in asthma treatment:\n\n【11】 • What medications are helpful for asthma?\n\n【12】• What is the difference between a medicine's generic name and brand name?\n\n【13】• Why are so many asthma medicines in inhaler form?\n\n【14】 • What is the correct way to use to use my dry powder inhaler (DPI)?\n\n【15】 • How can I tell when my inhaler is nearly empty?\n\n【16】 • Are steroids dangerous medicines?\n\n【17】## Part 6. Asthma: A Healthy Lifestyle\n\n【18】\n 137\n\n【19】 Questions 73–83 emphasize day to day living with asthma, including: • What's new in asthma treatment?\n\n【20】 • My asthma worsens each month near my period. Is that possible?\n\n【21】• Should I take extra vitamins or mineral supplements because I have asthma?\n\n【22】 • Is obesity related to asthma?\n\n【23】• Is caffeine good for people with asthma?\n\n【24】 • What sports are especially beneficial for asthma?\n\n【25】• Is asthma mostly a psychological disease?\n\n【26】## Part 7. Special Topic: Asthma And Pregnancy\n\n【27】\n 173\n\n【28】 Questions 84–88 answer common questions of women in pregnancy, such as: • Are asthma medications harmful to my unborn child?\n\n【29】 • Will pregnancy worsen my asthma?\n\n【30】• Will I be able to breast-feed my baby if I'm taking medicine for my asthma?", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Part 4. Asthma: Treatment Strategies", "bbox": [70.0, 69.0, 308.0, 86.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "71", "bbox": [488.0, 72.0, 504.0, 86.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Questions 41–56 detail different methods of managing and treating asthma:", "bbox": [70.0, 91.0, 462.0, 107.0]}, {"text": "• What are written asthma management and action plans?", "bbox": [78.0, 109.0, 380.0, 124.0]}, {"text": "• Why should I use medicine if I feel fine?", "bbox": [77.0, 126.0, 300.0, 141.0]}, {"text": "• What are the goals of asthma treatment?", "bbox": [77.0, 144.0, 300.0, 159.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "• My asthma is active; how do I know whether I should go to the nearest hospital", "bbox": [78.0, 161.0, 499.0, 175.0]}, {"text": "emergency room?", "bbox": [90.0, 177.0, 182.0, 191.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "• How do I know if my physician is a specialist in asthma treatment?", "bbox": [78.0, 192.0, 433.0, 208.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Part 5. Asthma Medications: New and Old", "bbox": [71.0, 229.0, 342.0, 246.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "99", "bbox": [488.0, 231.0, 505.0, 244.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Questions 57–72 focus on medications used in asthma treatment:", "bbox": [70.0, 251.0, 408.0, 267.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "• What medications are helpful for asthma?", "bbox": [78.0, 269.0, 308.0, 284.0]}, {"text": "• What is the difference between a medicine's generic name and brand name?", "bbox": [77.0, 286.0, 478.0, 303.0]}, {"text": "• Why are so many asthma medicines in inhaler form?", "bbox": [77.0, 303.0, 361.0, 319.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "• What is the correct way to use to use my dry powder inhaler (DPI)?", "bbox": [77.0, 321.0, 437.0, 336.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "• How can I tell when my inhaler is nearly empty?", "bbox": [78.0, 338.0, 340.0, 353.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "• Are steroids dangerous medicines?", "bbox": [78.0, 356.0, 268.0, 370.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Part 6. Asthma: A Healthy Lifestyle", "bbox": [70.0, 390.0, 299.0, 409.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "137", "bbox": [482.0, 394.0, 505.0, 408.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Questions 73–83 emphasize day to day living with asthma, including:", "bbox": [70.0, 414.0, 429.0, 429.0]}, {"text": "• What's new in asthma treatment?", "bbox": [78.0, 432.0, 265.0, 447.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "• My asthma worsens each month near my period. Is that possible?", "bbox": [77.0, 450.0, 425.0, 465.0]}, {"text": "• Should I take extra vitamins or mineral supplements because I have asthma?", "bbox": [78.0, 467.0, 480.0, 482.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "• Is obesity related to asthma?", "bbox": [78.0, 484.0, 237.0, 499.0]}, {"text": "• Is caffeine good for people with asthma?", "bbox": [78.0, 501.0, 299.0, 516.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "• What sports are especially beneficial for asthma?", "bbox": [78.0, 519.0, 339.0, 534.0]}, {"text": "• Is asthma mostly a psychological disease?", "bbox": [78.0, 536.0, 302.0, 551.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Part 7. Special Topic: Asthma and Pregnancy", "bbox": [71.0, 572.0, 354.0, 589.0]}], "type": "Section-header", "position": 19}, {"raw_context": [{"text": "173", "bbox": [482.0, 573.0, 505.0, 589.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Questions 84–88 answer common questions of women in pregnancy, such as:", "bbox": [70.0, 593.0, 468.0, 610.0]}, {"text": "• Are asthma medications harmful to my unborn child?", "bbox": [77.0, 612.0, 365.0, 627.0]}], "type": "Text", "position": 21}, {"raw_context": [{"text": "• Will pregnancy worsen my asthma?", "bbox": [77.0, 630.0, 274.0, 645.0]}, {"text": "• Will I be able to breast-feed my baby if I'm taking medicine for my asthma?", "bbox": [78.0, 646.0, 479.0, 662.0]}], "type": "Text", "position": 22}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 5}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#1#30#都是属于目录内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:18:07"}
{"id": 1042053, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "d4f9329f-a449-4803-9586-68b0c57c6064", "title": null, "text": "【0】页码:57\n# Taming The Killingfields\n\n【1】\n By Daniel Lovering • Photographs by Mark Leong\n\n【2】 nombs from the Vietnam War continue amper agricultural development e cleanup project required ades:old.computer\n\n【3】 OMB TECHNICIANS follo\n\n【4】 thr 2001 Se\n\n【5】 ericant, 16", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Taming the", "bbox": [167.0, 53.0, 417.0, 118.0]}, {"text": "KillingFields", "bbox": [184.0, 115.0, 661.0, 257.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "By Daniel Lovering • Photographs by Mark Leong", "bbox": [171.0, 252.0, 655.0, 283.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "nombs from the Vietnam War continue", "bbox": [348.0, 815.0, 733.0, 834.0]}, {"text": "amper agricultural development", "bbox": [403.0, 839.0, 731.0, 862.0]}, {"text": "e cleanup project required", "bbox": [467.0, 866.0, 731.0, 892.0]}, {"text": "ades:old.computer", "bbox": [488.0, 890.0, 684.0, 916.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "OMB TECHNICIANS follo", "bbox": [400.0, 952.0, 507.0, 965.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "thr 2001 Se", "bbox": [325.0, 999.0, 382.0, 1011.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "ericant, 16", "bbox": [438.0, 1001.0, 480.0, 1013.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 57}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type3": "", "type6": "有用性#0#5#全文为封面内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:16:56"}
{"id": 1042052, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "9fa7d24b-0cad-4794-b325-ef35e3afe249", "title": null, "text": "【0】页码:259\n\n【1】## Simultaneous Actions\n\n【2】\n BLS (whether for a child or adult) is presented as a series of sequential events with the assumption that there is only one responder, but PALS usually takes place in an environment where many rescuers are rapidly mobilized and actions are performed simultaneously. The challenge is to organize the rescuers into an efficient team. Important considerations for the greatest chance of a successful resuscitation from cardiac arrest include the following:\n • Chest compressions should be immediately started by one rescuer, while a second rescuer prepares to start ventilations with a bag and mask. Ventilation is extremely important in pediatrics because of the large percentage of\n\n【3】 asphyxial arrests in which best results are obtained by a combination of chest compressions and ventilations. 8 Unfortunately ventilations are sometimes delayed because equipment (bag, mask, oxygen, airway) must be mobilized.\n\n【4】Chest compressions require only the hands of a willing\n rescuer. Therefore, start CPR with chest compressions immediately, while a second rescuer prepares to provide ventilations (Class I, LOE C).\n\n【5】• The effectiveness of PALS is dependent on high-quality CPR, which requires an adequate compression rate (at least 100 compressions/min), an adequate compression depth (at least one third of the AP diameter of the chest or approximately 1 ½ inches [4 cm] in infants and approximately 2 inches [5 cm] in children), allowing complete recoil of the chest after each compression, minimizing interruptions in compressions, and avoiding excessive ventilation. Reasons for not performing high-quality CPR include rescuer inat-\n\n【6】 tention to detail, rescuer fatigue, and long or frequent interruptions to secure the airway, check the heart rhythm, and move the patient. 22 Optimal chest compressions are best delivered with the victim on a firm surface. 23.24 • While one rescuer performs chest compressions and another performs ventilations, other rescuers should obtain a monitor/defibrillator, establish vascular access, and calculate and prepare the anticipated medications.\n\n【7】## Monitored Patients\n\n【8】\n Many in-hospital patients, especially if they are in an ICU, are monitored and some have an advanced airway and are receiving mechanical ventilation. If the patient has an indwelling arterial catheter, use the waveform as feedback to evaluate hand position and chest compression depth. A minor adjustment of hand position or depth of compression can significantly improve the amplitude of the arterial waveform, reflecting better chest compression-induced stroke volume.\n\n【9】The arterial waveform may also be useful in identification of return of spontaneous circulation (ROSC). If the patient's end-tidal CO 2 (P ETCO 2 ) is being monitored, it can be used to evaluate the quality of chest compressions; it can also provide an indication of ROSC (see below).\n\n【10】## Respiratory Failure\n\n【11】\n Respiratory failure is characterized by inadequate ventilation, insufficient oxygenation, or both. Anticipate respiratory failure if any of the following signs is present:\n • An increased respiratory rate, particularly with signs of distress (eg, increased respiratory effort including nasal flaring, retractions, seesaw breathing, or grunting) • An inadequate respiratory rate, effort, or chest excursion (eg, diminished breath sounds or gasping), especially if mental status is depressed • Cyanosis with abnormal breathing despite supplementary oxygen\n\n【12】## Shock\n\n【13】\n Shock results from inadequate blood flow and oxygen delivery to meet tissue metabolic demands. The most common type of shock in children is hypovolemic, including shock due to hemorrhage. Distributive, cardiogenic, and obstructive shock occur less frequently. Shock progresses over a continuum of severity, from a compensated to a decompensated state. Compensatory mechanisms include tachycardia and increased systemic vascular resistance (vasoconstriction) in an effort to maintain cardiac output and perfusion pressure respectively. Decompensation occurs when compensatory mechanisms fail and results in hypotensive shock.\n\n【14】Typical signs of compensated shock include\n • Tachycardia\n • Cool and pale distal extremities • Prolonged (> 2 seconds) capillary refill (despite warm ambient temperature) • Weak peripheral pulses compared with central pulses • Normal systolic blood pressure\n\n【15】 As compensatory mechanisms fail, signs of inadequate end-organ perfusion develop. In addition to the above, these signs include\n\n【16】 • Depressed mental status\n • Decreased urine output • Metabolic acidosis\n • Tachypnea\n • Weak central pulses • Deterioration in color (eg, mottling, see below)\n\n【17】 Decompensated shock is characterized by signs and symptoms consistent with inadequate delivery of oxygen to tissues (pallor, peripheral cyanosis, tachypnea, mottling of the skin, decreased urine output, metabolic acidosis, depressed mental status), weak or absent peripheral pulses, weak central pulses, and hypotension.\n\n【18】Learn to integrate the signs of shock because no single sign confirms the diagnosis. For example:\n • Capillary refill time alone is not a good indicator of circulatory volume, but a capillary refill time > 2 seconds is a useful indicator of moderate dehydration when combined with decreased urine output, absent tears, dry mucous membranes, and a generally ill appearance. Capillary refill time is influenced by ambient temperature, 25 site, and age and its interpretation can be influenced by lighting. 26 • Tachycardia is a common sign of shock, but it can also\n\n【19】 result from other causes, such as pain, anxiety, and fever.\n\n【20】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Simultaneous Actions", "bbox": [60.0, 84.0, 194.0, 99.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "BLS (whether for a child or adult) is presented as a series of", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "sequential events with the assumption that there is only one", "bbox": [60.0, 115.0, 376.0, 129.0]}, {"text": "responder, but PALS usually takes place in an environment", "bbox": [60.0, 132.0, 376.0, 145.0]}, {"text": "where many rescuers are rapidly mobilized and actions are", "bbox": [60.0, 147.0, 376.0, 161.0]}, {"text": "performed simultaneously. The challenge is to organize the", "bbox": [60.0, 163.0, 376.0, 176.0]}, {"text": "rescuers into an efficient team. Important considerations for", "bbox": [60.0, 178.0, 376.0, 193.0]}, {"text": "the greatest chance of a successful resuscitation from cardiac", "bbox": [60.0, 194.0, 375.0, 207.0]}, {"text": "arrest include the following:", "bbox": [60.0, 209.0, 209.0, 223.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "• Chest compressions should be immediately started by one", "bbox": [60.0, 234.0, 376.0, 249.0]}, {"text": "rescuer, while a second rescuer prepares to start ventila-", "bbox": [71.0, 251.0, 375.0, 265.0]}, {"text": "tions with a bag and mask. Ventilation is extremely", "bbox": [71.0, 267.0, 376.0, 281.0]}, {"text": "important in pediatrics because of the large percentage of", "bbox": [71.0, 282.0, 377.0, 296.0]}], "type": "List-item", "position": 5}, {"raw_context": [{"text": "asphyxial arrests in which best results are obtained by a", "bbox": [71.0, 298.0, 377.0, 312.0]}, {"text": "combination of chest compressions and ventilations. 8 Un-", "bbox": [71.0, 314.0, 376.0, 327.0]}, {"text": "fortunately ventilations are sometimes delayed because", "bbox": [72.0, 329.0, 376.0, 342.0]}, {"text": "equipment (bag, mask, oxygen, airway) must be mobilized.", "bbox": [71.0, 344.0, 375.0, 358.0]}, {"text": "Chest compressions require only the hands of a willing", "bbox": [71.0, 360.0, 376.0, 374.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "rescuer. Therefore, start CPR with chest compressions", "bbox": [72.0, 375.0, 376.0, 389.0]}, {"text": "immediately, while a second rescuer prepares to provide", "bbox": [72.0, 390.0, 376.0, 405.0]}, {"text": "ventilations (Class I, LOE C).", "bbox": [72.0, 407.0, 230.0, 420.0]}, {"text": "• The effectiveness of PALS is dependent on high-quality", "bbox": [61.0, 421.0, 375.0, 436.0]}, {"text": "CPR, which requires an adequate compression rate (at least", "bbox": [71.0, 438.0, 376.0, 451.0]}, {"text": "100 compressions/min), an adequate compression depth (at", "bbox": [73.0, 453.0, 377.0, 468.0]}, {"text": "least one third of the AP diameter of the chest or approx-", "bbox": [72.0, 469.0, 375.0, 482.0]}, {"text": "imately 1 ½ inches [4 cm] in infants and approximately 2", "bbox": [72.0, 484.0, 376.0, 498.0]}, {"text": "inches [5 cm] in children), allowing complete recoil of the", "bbox": [72.0, 500.0, 376.0, 514.0]}, {"text": "chest after each compression, minimizing interruptions in", "bbox": [71.0, 515.0, 377.0, 529.0]}, {"text": "compressions, and avoiding excessive ventilation. Reasons", "bbox": [71.0, 531.0, 376.0, 545.0]}, {"text": "for not performing high-quality CPR include rescuer inat-", "bbox": [72.0, 547.0, 375.0, 560.0]}], "type": "List-item", "position": 7}, {"raw_context": [{"text": "tention to detail, rescuer fatigue, and long or frequent", "bbox": [71.0, 562.0, 376.0, 576.0]}, {"text": "interruptions to secure the airway, check the heart rhythm,", "bbox": [72.0, 578.0, 376.0, 591.0]}, {"text": "and move the patient. 22 Optimal chest compressions are", "bbox": [72.0, 592.0, 376.0, 608.0]}, {"text": "best delivered with the victim on a firm surface. 23.24", "bbox": [71.0, 609.0, 347.0, 622.0]}, {"text": "• While one rescuer performs chest compressions and an-", "bbox": [60.0, 623.0, 375.0, 639.0]}, {"text": "other performs ventilations, other rescuers should obtain a", "bbox": [71.0, 640.0, 377.0, 653.0]}, {"text": "monitor/defibrillator, establish vascular access, and calcu-", "bbox": [72.0, 655.0, 375.0, 669.0]}, {"text": "late and prepare the anticipated medications.", "bbox": [72.0, 671.0, 306.0, 684.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Monitored Patients", "bbox": [60.0, 699.0, 182.0, 714.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Many in-hospital patients, especially if they are in an ICU, are", "bbox": [60.0, 715.0, 376.0, 729.0]}, {"text": "monitored and some have an advanced airway and are", "bbox": [60.0, 730.0, 376.0, 744.0]}, {"text": "receiving mechanical ventilation. If the patient has an in-", "bbox": [60.0, 746.0, 375.0, 760.0]}, {"text": "dwelling arterial catheter, use the waveform as feedback to", "bbox": [60.0, 762.0, 377.0, 776.0]}, {"text": "evaluate hand position and chest compression depth. A minor", "bbox": [60.0, 777.0, 376.0, 791.0]}, {"text": "adjustment of hand position or depth of compression can", "bbox": [60.0, 793.0, 376.0, 806.0]}, {"text": "significantly improve the amplitude of the arterial waveform,", "bbox": [60.0, 808.0, 376.0, 823.0]}, {"text": "reflecting better chest compression-induced stroke volume.", "bbox": [60.0, 824.0, 375.0, 837.0]}, {"text": "The arterial waveform may also be useful in identification of", "bbox": [60.0, 839.0, 377.0, 854.0]}, {"text": "return of spontaneous circulation (ROSC). If the patient's", "bbox": [60.0, 856.0, 377.0, 869.0]}, {"text": "end-tidal CO 2 (P ETCO 2 ) is being monitored, it can be used to", "bbox": [60.0, 870.0, 377.0, 885.0]}, {"text": "evaluate the quality of chest compressions; it can also provide", "bbox": [60.0, 886.0, 376.0, 900.0]}, {"text": "an indication of ROSC (see below).", "bbox": [60.0, 902.0, 250.0, 916.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Respiratory Failure", "bbox": [60.0, 930.0, 183.0, 945.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Respiratory failure is characterized by inadequate ventilation,", "bbox": [60.0, 946.0, 376.0, 960.0]}, {"text": "insufficient oxygenation, or both. Anticipate respiratory fail-", "bbox": [60.0, 963.0, 375.0, 976.0]}, {"text": "ure if any of the following signs is present:", "bbox": [60.0, 977.0, 289.0, 991.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "• An increased respiratory rate, particularly with signs of", "bbox": [404.0, 84.0, 721.0, 99.0]}, {"text": "distress (eg, increased respiratory effort including nasal", "bbox": [416.0, 100.0, 721.0, 114.0]}, {"text": "flaring, retractions, seesaw breathing, or grunting)", "bbox": [416.0, 117.0, 680.0, 130.0]}, {"text": "• An inadequate respiratory rate, effort, or chest excursion", "bbox": [404.0, 132.0, 721.0, 147.0]}, {"text": "(eg, diminished breath sounds or gasping), especially if", "bbox": [416.0, 148.0, 721.0, 162.0]}, {"text": "mental status is depressed", "bbox": [416.0, 164.0, 555.0, 178.0]}, {"text": "• Cyanosis with abnormal breathing despite supplementary", "bbox": [404.0, 180.0, 720.0, 195.0]}, {"text": "oxygen", "bbox": [416.0, 195.0, 458.0, 210.0]}], "type": "List-item", "position": 13}, {"raw_context": [{"text": "Shock", "bbox": [403.0, 225.0, 444.0, 239.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "Shock results from inadequate blood flow and oxygen deliv-", "bbox": [403.0, 240.0, 720.0, 255.0]}, {"text": "ery to meet tissue metabolic demands. The most common", "bbox": [403.0, 257.0, 720.0, 270.0]}, {"text": "type of shock in children is hypovolemic, including shock due", "bbox": [403.0, 273.0, 720.0, 287.0]}, {"text": "to hemorrhage. Distributive, cardiogenic, and obstructive", "bbox": [403.0, 288.0, 720.0, 302.0]}, {"text": "shock occur less frequently. Shock progresses over a contin-", "bbox": [403.0, 304.0, 720.0, 319.0]}, {"text": "uum of severity, from a compensated to a decompensated", "bbox": [403.0, 321.0, 721.0, 334.0]}, {"text": "state. Compensatory mechanisms include tachycardia and", "bbox": [404.0, 337.0, 720.0, 350.0]}, {"text": "increased systemic vascular resistance (vasoconstriction) in", "bbox": [403.0, 352.0, 721.0, 367.0]}, {"text": "an effort to maintain cardiac output and perfusion pressure", "bbox": [404.0, 368.0, 720.0, 381.0]}, {"text": "respectively. Decompensation occurs when compensatory", "bbox": [403.0, 384.0, 720.0, 398.0]}, {"text": "mechanisms fail and results in hypotensive shock.", "bbox": [404.0, 400.0, 666.0, 414.0]}, {"text": "Typical signs of compensated shock include", "bbox": [417.0, 415.0, 650.0, 429.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "• Tachycardia", "bbox": [403.0, 442.0, 483.0, 457.0]}], "type": "List-item", "position": 16}, {"raw_context": [{"text": "• Cool and pale distal extremities", "bbox": [403.0, 457.0, 584.0, 473.0]}, {"text": "• Prolonged (> 2 seconds) capillary refill (despite warm", "bbox": [403.0, 474.0, 721.0, 489.0]}, {"text": "ambient temperature)", "bbox": [417.0, 490.0, 531.0, 503.0]}, {"text": "• Weak peripheral pulses compared with central pulses", "bbox": [403.0, 505.0, 696.0, 520.0]}, {"text": "• Normal systolic blood pressure", "bbox": [403.0, 521.0, 581.0, 535.0]}], "type": "List-item", "position": 17}, {"raw_context": [{"text": "As compensatory mechanisms fail, signs of inadequate", "bbox": [417.0, 548.0, 720.0, 562.0]}, {"text": "end-organ perfusion develop. In addition to the above, these", "bbox": [403.0, 564.0, 720.0, 579.0]}, {"text": "signs include", "bbox": [403.0, 581.0, 476.0, 595.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "• Depressed mental status", "bbox": [403.0, 606.0, 545.0, 621.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "• Decreased urine output", "bbox": [403.0, 622.0, 540.0, 635.0]}, {"text": "• Metabolic acidosis", "bbox": [403.0, 638.0, 516.0, 652.0]}], "type": "List-item", "position": 20}, {"raw_context": [{"text": "• Tachypnea", "bbox": [403.0, 654.0, 477.0, 669.0]}], "type": "List-item", "position": 21}, {"raw_context": [{"text": "• Weak central pulses", "bbox": [403.0, 669.0, 524.0, 686.0]}, {"text": "• Deterioration in color (eg, mottling, see below)", "bbox": [403.0, 686.0, 666.0, 701.0]}], "type": "List-item", "position": 22}, {"raw_context": [{"text": "Decompensated shock is characterized by signs and symp-", "bbox": [416.0, 713.0, 719.0, 726.0]}, {"text": "toms consistent with inadequate delivery of oxygen to tissues", "bbox": [403.0, 729.0, 721.0, 742.0]}, {"text": "(pallor, peripheral cyanosis, tachypnea, mottling of the skin,", "bbox": [403.0, 744.0, 720.0, 758.0]}, {"text": "decreased urine output, metabolic acidosis, depressed mental", "bbox": [403.0, 760.0, 720.0, 775.0]}, {"text": "status), weak or absent peripheral pulses, weak central pulses,", "bbox": [403.0, 776.0, 720.0, 790.0]}, {"text": "and hypotension.", "bbox": [404.0, 792.0, 494.0, 805.0]}, {"text": "Learn to integrate the signs of shock because no single sign", "bbox": [416.0, 807.0, 721.0, 822.0]}, {"text": "confirms the diagnosis. For example:", "bbox": [403.0, 823.0, 600.0, 837.0]}], "type": "Text", "position": 23}, {"raw_context": [{"text": "• Capillary refill time alone is not a good indicator of", "bbox": [404.0, 850.0, 721.0, 864.0]}, {"text": "circulatory volume, but a capillary refill time > 2 seconds is", "bbox": [416.0, 866.0, 721.0, 880.0]}, {"text": "a useful indicator of moderate dehydration when combined", "bbox": [416.0, 883.0, 720.0, 896.0]}, {"text": "with decreased urine output, absent tears, dry mucous", "bbox": [416.0, 897.0, 720.0, 911.0]}, {"text": "membranes, and a generally ill appearance. Capillary refill", "bbox": [416.0, 914.0, 721.0, 928.0]}, {"text": "time is influenced by ambient temperature, 25 site, and age", "bbox": [416.0, 930.0, 720.0, 943.0]}, {"text": "and its interpretation can be influenced by lighting. 26", "bbox": [416.0, 945.0, 694.0, 959.0]}, {"text": "• Tachycardia is a common sign of shock, but it can also", "bbox": [404.0, 961.0, 721.0, 976.0]}], "type": "List-item", "position": 24}, {"raw_context": [{"text": "result from other causes, such as pain, anxiety, and fever.", "bbox": [416.0, 977.0, 719.0, 991.0]}], "type": "Text", "position": 25}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 26}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 259}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#3#3#• Chest compressions should ...provide ventilations (Class I, LOE C).与2后面是一段话\n多余换行#4#4#rescuer. Therefore, start CPR with...与...hands of a willing是一段文字\n多余换行#6#6#...with the victim on a firm surface.与上面5是有一段话\n缺少换行#6#6# • While one rescuer performs chest...应该另起一行\n缺少换行#11#11# • An inadequate respiratory rate...\n• Cyanosis with abnormal breathing...都应该另起一行\n缺少换行#14#14#• Prolonged (> 2 seconds) ...\n • Weak peripheral pulses ...\n • Normal systolic ...都应该另起一行\n缺少换行#16#16# • Metabolic acidosis\n• Deterioration in color ...都应该另起一行\n缺少换行#18#18# • Tachycardia is a common sign ...应该另起一行\n多余换行#19#19# result from other causes, such as pain, anxiety, and fever.与上面18后面相联", "type3": "无关文本#6#6#22  23.24 \n无关文本#18#18#25  26\n无关文本#20#20#页脚内容与正文无关", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 19:03:59"}
{"id": 1042051, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "0330555c-659f-4309-8fbd-70efb722cbcf", "title": null, "text": "【0】页码:227\n 1, for example, you would count all persons on that date who were ever told by a medical professional that they had a diagnosis of asthma.\n\n【1】 Puberty: The time at which sexual maturation begins is the start of puberty. Also refers to the time when reproductive organs develop to allow reproduction.\n\n【2】 Pulmonary Function Tests (PFTs): Include the measurement of lung volumes, spirometry, diffusion, and sometimes ABGs.\n\n【3】 Pulmonary embolus: A clot, usually originating in the leg veins that becomes lodged in the lung circulation. The diagnosis of pulmonary embolus can be very difficult. Pulmonary embolus leads to a variety of symptoms which can include breathlessness and wheezing. A large or massive pulmonary embolus can be a cause of sudden death.\n\n【4】 Pulmonary symptomatology:  Symptoms experienced by an individual and related to the lungs and to the act of breathing. Wheezing, cough, breathlessness, mucus production are examples of pulmonary symptomatology.\n\n【5】 Pulmonologist: A physician specialist with extra training and qualifications in the diagnosis and treatment of the different lung diseases. Some pulmonologists are pediatric specialists, as well; such specialists are known as \"pediatric pulmonologists,\" Pediatric pulmonologists treat babies, children, and adolescents with lung diseases.\n\n【6】The other \"type\" of pulmonologist is\n\n【7】 an internist, who limits their practice to adults with respiratory conditions.\n\n【8】RAST: RAST is a laboratory allergy test that detects and measures the level of IgE antibodies directed against specific antigens in a blood sample. Measuring blood RAST is one way of assessing the possible presence of an allergy. If a person is suspected of being allergic to grass, for example, their doctor might send a blood sample for RAST testing.\n\n【9】The doctor would request a test that would detect significant levels of IgE directed against grasses. The absence of any detectable IgE to grasses would argue against a grass allergy. RAST is an abbreviation for \"RadioAllergoSorbentTest,\" a trademark of Pharmacia Diagnostics that originated and developed the first RAST test.\n\n【10】RDA: Refer to the Recommended\n\n【11】 Dietary Allowance, guidelines established by the United States National Academy of Sciences' National Research Council. The RDAs advise what nutrients males and females should eat at different ages. In 1997, The National Academy of Science' Institute of Medicine report introduced the concept of Dietary Reference Intakes (DRI) which have supplanted the RDAs.\n\n【12】Remission: When used in a medical\n\n【13】 context, a remission refers to the subsiding of disease symptoms. A person with asthma who enters a period in which they experience no asthma symptoms has entered a period of asthma remission. The disease is still", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "1, for example, you would count all", "bbox": [71.0, 69.0, 278.0, 84.0]}, {"text": "persons on that date who were ever", "bbox": [70.0, 87.0, 277.0, 102.0]}, {"text": "told by a medical professional that", "bbox": [70.0, 104.0, 277.0, 120.0]}, {"text": "they had a diagnosis of asthma.", "bbox": [70.0, 121.0, 242.0, 137.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Puberty: The time at which sexual", "bbox": [70.0, 142.0, 277.0, 160.0]}, {"text": "maturation begins is the start of", "bbox": [70.0, 161.0, 279.0, 177.0]}, {"text": "puberty. Also refers to the time when", "bbox": [70.0, 178.0, 277.0, 194.0]}, {"text": "reproductive organs develop to allow", "bbox": [70.0, 195.0, 277.0, 211.0]}, {"text": "reproduction.", "bbox": [70.0, 213.0, 147.0, 228.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Pulmonary Function Tests (PFTs):", "bbox": [70.0, 235.0, 277.0, 252.0]}, {"text": "Include the measurement of lung vol-", "bbox": [70.0, 253.0, 276.0, 269.0]}, {"text": "umes, spirometry, diffusion, and", "bbox": [70.0, 270.0, 277.0, 286.0]}, {"text": "sometimes ABGs.", "bbox": [70.0, 288.0, 172.0, 303.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Pulmonary embolus: A clot, usually", "bbox": [70.0, 311.0, 276.0, 326.0]}, {"text": "originating in the leg veins that", "bbox": [70.0, 328.0, 277.0, 343.0]}, {"text": "becomes lodged in the lung circula-", "bbox": [70.0, 345.0, 276.0, 360.0]}, {"text": "tion. The diagnosis of pulmonary", "bbox": [70.0, 362.0, 276.0, 378.0]}, {"text": "embolus can be very difficult. Pul-", "bbox": [70.0, 380.0, 276.0, 395.0]}, {"text": "monary embolus leads to a variety of", "bbox": [70.0, 397.0, 278.0, 412.0]}, {"text": "symptoms which can include breath-", "bbox": [70.0, 414.0, 276.0, 430.0]}, {"text": "lessness and wheezing. A large or", "bbox": [70.0, 432.0, 277.0, 447.0]}, {"text": "massive pulmonary embolus can be a", "bbox": [70.0, 449.0, 277.0, 465.0]}, {"text": "cause of sudden death.", "bbox": [70.0, 466.0, 196.0, 482.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Pulmonary symptomatology:  Symp-", "bbox": [70.0, 488.0, 276.0, 504.0]}, {"text": "toms experienced by an individual", "bbox": [70.0, 506.0, 277.0, 522.0]}, {"text": "and related to the lungs and to the", "bbox": [70.0, 523.0, 277.0, 539.0]}, {"text": "act of breathing. Wheezing, cough,", "bbox": [70.0, 540.0, 277.0, 556.0]}, {"text": "breathlessness, mucus production", "bbox": [70.0, 558.0, 277.0, 573.0]}, {"text": "are examples of pulmonary sympto-", "bbox": [70.0, 575.0, 276.0, 591.0]}, {"text": "matology.", "bbox": [70.0, 593.0, 129.0, 609.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Pulmonologist: A physician specialist", "bbox": [70.0, 615.0, 277.0, 631.0]}, {"text": "with extra training and qualifications", "bbox": [70.0, 632.0, 277.0, 648.0]}, {"text": "in the diagnosis and treatment of the", "bbox": [70.0, 650.0, 277.0, 666.0]}, {"text": "different lung diseases. Some pulmo-", "bbox": [70.0, 667.0, 276.0, 683.0]}, {"text": "nologists are pediatric specialists, as", "bbox": [70.0, 684.0, 277.0, 700.0]}, {"text": "well; such specialists are known as", "bbox": [70.0, 702.0, 277.0, 717.0]}, {"text": "\"pediatric pulmonologists,\" Pediatric", "bbox": [70.0, 720.0, 277.0, 735.0]}, {"text": "pulmonologists treat babies, children,", "bbox": [70.0, 737.0, 277.0, 752.0]}, {"text": "and adolescents with lung diseases.", "bbox": [70.0, 754.0, 276.0, 770.0]}, {"text": "The other \"type\" of pulmonologist is", "bbox": [70.0, 771.0, 277.0, 787.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "an internist, who limits their practice", "bbox": [300.0, 69.0, 507.0, 85.0]}, {"text": "to adults with respiratory conditions.", "bbox": [301.0, 87.0, 496.0, 102.0]}, {"text": "RAST: RAST is a laboratory allergy", "bbox": [301.0, 105.0, 507.0, 122.0]}, {"text": "test that detects and measures the", "bbox": [300.0, 124.0, 507.0, 140.0]}, {"text": "level of IgE antibodies directed", "bbox": [300.0, 141.0, 508.0, 157.0]}, {"text": "against specific antigens in a blood", "bbox": [300.0, 159.0, 508.0, 174.0]}, {"text": "sample. Measuring blood RAST is", "bbox": [300.0, 176.0, 508.0, 192.0]}, {"text": "one way of assessing the possible", "bbox": [300.0, 193.0, 507.0, 209.0]}, {"text": "presence of an allergy. If a person is", "bbox": [300.0, 210.0, 508.0, 226.0]}, {"text": "suspected of being allergic to grass,", "bbox": [300.0, 228.0, 507.0, 244.0]}, {"text": "for example, their doctor might send", "bbox": [300.0, 245.0, 508.0, 261.0]}, {"text": "a blood sample for RAST testing.", "bbox": [300.0, 263.0, 507.0, 278.0]}, {"text": "The doctor would request a test that", "bbox": [300.0, 280.0, 508.0, 296.0]}, {"text": "would detect significant levels of", "bbox": [301.0, 298.0, 509.0, 313.0]}, {"text": "IgE directed against grasses. The", "bbox": [301.0, 315.0, 508.0, 331.0]}, {"text": "absence of any detectable IgE to", "bbox": [300.0, 332.0, 508.0, 348.0]}, {"text": "grasses would argue against a grass", "bbox": [300.0, 349.0, 508.0, 365.0]}, {"text": "allergy. RAST is an abbreviation for", "bbox": [300.0, 367.0, 508.0, 383.0]}, {"text": "\"RadioAllergoSorbentTest,\" a trade-", "bbox": [300.0, 384.0, 507.0, 400.0]}, {"text": "mark of Pharmacia Diagnostics that", "bbox": [301.0, 401.0, 508.0, 417.0]}, {"text": "originated and developed the first", "bbox": [300.0, 419.0, 508.0, 434.0]}, {"text": "RAST test.", "bbox": [301.0, 437.0, 368.0, 452.0]}, {"text": "RDA: Refer to the Recommended", "bbox": [301.0, 456.0, 508.0, 472.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Dietary Allowance, guidelines estab-", "bbox": [301.0, 473.0, 507.0, 489.0]}, {"text": "lished by the United States National", "bbox": [300.0, 491.0, 508.0, 506.0]}, {"text": "Academy of Sciences' National", "bbox": [301.0, 508.0, 508.0, 524.0]}, {"text": "Research Council. The RDAs advise", "bbox": [301.0, 524.0, 508.0, 542.0]}, {"text": "what nutrients males and females", "bbox": [301.0, 542.0, 508.0, 558.0]}, {"text": "should eat at different ages. In 1997,", "bbox": [300.0, 560.0, 507.0, 576.0]}, {"text": "The National Academy of Science'", "bbox": [300.0, 578.0, 507.0, 594.0]}, {"text": "Institute of Medicine report intro-", "bbox": [300.0, 594.0, 507.0, 610.0]}, {"text": "duced the concept of Dietary Refer-", "bbox": [300.0, 612.0, 507.0, 628.0]}, {"text": "ence Intakes (DRI) which have", "bbox": [300.0, 630.0, 507.0, 645.0]}, {"text": "supplanted the RDAs.", "bbox": [300.0, 647.0, 427.0, 663.0]}, {"text": "Remission: When used in a medical", "bbox": [301.0, 667.0, 508.0, 683.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "context, a remission refers to the sub-", "bbox": [300.0, 684.0, 507.0, 700.0]}, {"text": "siding of disease symptoms. A person", "bbox": [300.0, 702.0, 508.0, 717.0]}, {"text": "with asthma who enters a period in", "bbox": [300.0, 719.0, 508.0, 735.0]}, {"text": "which they experience no asthma", "bbox": [300.0, 737.0, 508.0, 753.0]}, {"text": "symptoms has entered a period of", "bbox": [300.0, 753.0, 509.0, 770.0]}, {"text": "asthma remission. The disease is still", "bbox": [300.0, 771.0, 508.0, 787.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 227}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type6": "信息有用性#0#13#非正文 无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:25:03"}
{"id": 1042050, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "fc2eb608-5096-4f32-add6-a6ebb4be80b5", "title": null, "text": "【0】页码:117\n\n【1】## Retroligatures (Lace Backs) 4.\n\n【2】\n In 1990 a method for space closure that employs sliding mechanics was described. In 1989, Robinson demonstrated that molars mesialized 1.76 mm with retro ligatures, but incisors moved distally 1 mm. In cases where no retroliga¬ ture was used, molars mesialized 1.53 mm and the incisors 1.4mm, meaning that the anterior segment proclined. So, when retro ligatures are employed, posterior anchorage is lost, but we gain anchorage in the anterior segment (2.5mm per quadrant).\n\n【3】 Drs. McLaughlin, Bennett and Trevisi (MBT) suggest the use of stainless steel 0.019\" x 0.025\" arch wires in a 0.022\" spot, because the arches of this dimension provide\n\n【4】 good overbite control and allow posterior sector sliding.\n\n【5】Overbite and torque are not well controlled with smaller arches. Bigger arches limit posterior sector sliding. These arches have 0.7\" soldered brass hooks. These hooks are placed with 36 mm or 38 mm of separation between them in the upper arch and with 26 mm in the lower arch. This measurement is taken following the curvature of the arch.\n\n【6】The 26 mm measurement in the lower arch is valid for the majority of cases but in the upper arch individual variabil¬ ity is greater due to the variations in the size of the upper lateral incisors. Therefore, we must have a great inventory with different distances between hooks. (2.13)\n\n【7】 According to the MBT technique, there are three ways to close spaces:\n Figs. 108 and 109. MBT arches with brass hooks.\n Figs. 110 and 111. The brass hook is bended to facilitate elastic and ligature insertion.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "RETROLIGATURES (LACE BACKS)", "bbox": [93.0, 86.0, 330.0, 106.0]}, {"text": "4.", "bbox": [67.0, 89.0, 86.0, 105.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "In 1990 a method for space closure that employs sliding", "bbox": [68.0, 119.0, 382.0, 136.0]}, {"text": "mechanics was described. In 1989, Robinson demonstrated", "bbox": [68.0, 138.0, 382.0, 154.0]}, {"text": "that molars mesialized 1.76 mm with retro ligatures, but", "bbox": [68.0, 156.0, 382.0, 171.0]}, {"text": "incisors moved distally 1 mm. In cases where no retroliga¬", "bbox": [68.0, 173.0, 381.0, 189.0]}, {"text": "ture was used, molars mesialized 1.53 mm and the incisors", "bbox": [69.0, 190.0, 382.0, 205.0]}, {"text": "1.4mm, meaning that the anterior segment proclined. So,", "bbox": [69.0, 207.0, 382.0, 223.0]}, {"text": "when retro ligatures are employed, posterior anchorage", "bbox": [69.0, 224.0, 383.0, 241.0]}, {"text": "is lost, but we gain anchorage in the anterior segment", "bbox": [69.0, 242.0, 383.0, 258.0]}, {"text": "(2.5mm per quadrant).", "bbox": [69.0, 260.0, 196.0, 276.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Drs. McLaughlin, Bennett and Trevisi (MBT) suggest", "bbox": [69.0, 293.0, 383.0, 309.0]}, {"text": "the use of stainless steel 0.019\" x 0.025\" arch wires in a", "bbox": [69.0, 311.0, 383.0, 327.0]}, {"text": "0.022\" spot, because the arches of this dimension provide", "bbox": [69.0, 329.0, 383.0, 343.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "good overbite control and allow posterior sector sliding.", "bbox": [403.0, 85.0, 717.0, 101.0]}, {"text": "Overbite and torque are not well controlled with smaller", "bbox": [402.0, 102.0, 718.0, 118.0]}, {"text": "arches. Bigger arches limit posterior sector sliding. These", "bbox": [403.0, 119.0, 719.0, 135.0]}, {"text": "arches have 0.7\" soldered brass hooks. These hooks are", "bbox": [403.0, 137.0, 719.0, 152.0]}, {"text": "placed with 36 mm or 38 mm of separation between them", "bbox": [403.0, 154.0, 719.0, 170.0]}, {"text": "in the upper arch and with 26 mm in the lower arch. This", "bbox": [403.0, 172.0, 719.0, 188.0]}, {"text": "measurement is taken following the curvature of the arch.", "bbox": [404.0, 190.0, 719.0, 204.0]}, {"text": "The 26 mm measurement in the lower arch is valid for the", "bbox": [404.0, 206.0, 719.0, 222.0]}, {"text": "majority of cases but in the upper arch individual variabil¬", "bbox": [404.0, 224.0, 718.0, 239.0]}, {"text": "ity is greater due to the variations in the size of the upper", "bbox": [404.0, 241.0, 719.0, 257.0]}, {"text": "lateral incisors. Therefore, we must have a great inventory", "bbox": [404.0, 259.0, 719.0, 274.0]}, {"text": "with different distances between hooks. (2.13)", "bbox": [405.0, 277.0, 642.0, 291.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "According to the MBT technique, there are three ways to", "bbox": [405.0, 310.0, 721.0, 326.0]}, {"text": "close spaces:", "bbox": [405.0, 329.0, 477.0, 344.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Figs. 108 and 109. MBT arches with brass hooks.", "bbox": [287.0, 644.0, 503.0, 657.0]}], "type": "Caption", "position": 7}, {"raw_context": [{"text": "Figs. 110 and 111. The brass hook is bended to facilitate elastic and ligature insertion.", "bbox": [211.0, 940.0, 584.0, 956.0]}], "type": "Caption", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 117}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "序号格式不一致#1#1#Retroligatures (Lace Backs) 4.  序号应该在前面\n多余换行#4#4# good overbite control and allow ...与上面3段联接", "type3": "无关文本#6#6# (2.13)", "type4": null, "type5": null, "type6": "有用性#7#7#Figs. 108 and 109. MBT arches with brass hooks.\nFigs. 110 and 111. The brass hook is bended to facilitate elastic and ligature insertion.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:57:35"}
{"id": 1042049, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "d77f376f-8598-4730-96c8-aeb0cdd79a04", "title": null, "text": "【0】页码:32\n\n【1】## Robot, Heal Thyself Computers That Fix Themselves Are The First Application Of Artificial Self-Replication\n\n【2】\n LAUSANNE, SWITZERLAND—Not many researchers encourage the wanton destruction of equipment in their labs. Daniel Mange, however, likes it when visitors walk up to one of his inventions and press the button marked KILL. The lights on the panel go out; a small box full of circuitry is toast. Early in May his team unveiled its latest contraption at a science festival here—a wall-size digital clock whose components you can zap at will—and told the public: Give it your best shot. See if you can crash the system.\n\n【3】The goal of Mange and his team is to instill electronic circuits with the ability to take a lickin’ and keep on tickin’—just like living things. Flesh-and-blood creatures might not be so good at calculating π to the millionth digit, but they can get through the day without someone pressing Ctrl-Alt-Del. Combining the precision of digital hardware with the resilience of biological wetware is a leading challenge for modern electronics.\n\n【4】Electronics engineers have been working on fault-tolerant circuits ever since there were electronics engineers [see \"Redundancy in Computers,\" by William H. Pierce; S CIENTIFIC American, February 1964]. Computer modems would still be dribbling data at 1200 baud if it weren’t for error detection and correction. In many applications, simple quality-control checks, such as extra data bits, suffice. More complex systems provide entire backup computers. The space shuttle, for example, has five processors. Four of them perform the same calculations; the fifth checks whether they agree and pulls the plug on any dissenter.\n\n【5】 The problem with these systems, though, is that they rely on centralized control. What if that control unit goes bad?\n\n【6】Nature has solved that problem through radical decentralization. Cells in the body are all basically identical; each takes on a specialized task, performs it autonomously and, in the event of infection or failure, commits hara-kiri so that its tasks can be taken up by new cells. These are the attributes that Mange, a professor at the Swiss Federal Institute of Technology here, and others have sought since 1993 to emulate in circuitry, as part of the \"Embryonics\" (embryonic electronics) project.\n\n【7】One of their earlier inventions, the MICTREE (microinstruction tree) artificial cell, consisted of a simple processor and four bits of data storage. The cell is contained in a plastic box roughly the size of a pack of Post-its. Electrical contacts run along the sides so that cells can be snapped together like Legos. As in cellular automata, the models used to study the theory of self-replication, the MICTREE cells are connected only to their immediate neighbors. The communication burden on each cell is thus independent of the total number of cells. The system, in other words, is easily scalable— unlike many parallel-computing architectures.\n\n【8】Cells follow the instructions in their “genome,” a program written in a subset of the Pascal computer language. Like their biological antecedents, the cells all contain the exact same genome and execute part of it based on their position within the array, which each cell calculates relative to its neighbors. Waste-", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "ROBOT, HEAL THYSELF", "bbox": [61.0, 68.0, 414.0, 107.0]}, {"text": "Computers that fix themselves are the first application of artificial self-replication", "bbox": [63.0, 107.0, 553.0, 126.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "LAUSANNE, SWITZERLAND—Not many researchers encourage the", "bbox": [65.0, 135.0, 356.0, 149.0]}, {"text": "wanton destruction of equipment in their labs. Daniel Mange,", "bbox": [65.0, 152.0, 358.0, 165.0]}, {"text": "however, likes it when visitors walk up to one of his inventions and", "bbox": [65.0, 167.0, 384.0, 181.0]}, {"text": "press the button marked KILL. The lights on the panel go out; a ", "bbox": [65.0, 184.0, 364.0, 197.0]}, {"text": "small box full of circuitry is toast. Early in May his team unveiled ", "bbox": [65.0, 199.0, 375.0, 214.0]}, {"text": "its latest contraption at a science festival here—a wall-size digital", "bbox": [65.0, 215.0, 383.0, 229.0]}, {"text": "clock whose components you can zap at will—and told the public:", "bbox": [65.0, 231.0, 378.0, 245.0]}, {"text": "Give it your best shot. See if you can crash the system.", "bbox": [65.0, 247.0, 328.0, 261.0]}, {"text": "The goal of Mange and his team is to instill electronic circuits", "bbox": [84.0, 264.0, 377.0, 277.0]}, {"text": "with the ability to take a lickin’ and keep on tickin’—just like living", "bbox": [65.0, 279.0, 380.0, 294.0]}, {"text": "things. Flesh-and-blood creatures might not be so good at ", "bbox": [65.0, 295.0, 345.0, 309.0]}, {"text": "calculating π to the millionth digit, but they can get through the", "bbox": [65.0, 312.0, 371.0, 325.0]}, {"text": "day without someone pressing Ctrl-Alt-Del. Combining the", "bbox": [65.0, 327.0, 343.0, 342.0]}, {"text": "precision of digital hardware with the resilience of biological", "bbox": [65.0, 344.0, 355.0, 357.0]}, {"text": "wetware is a leading challenge for modern electronics.", "bbox": [65.0, 360.0, 326.0, 374.0]}, {"text": "Electronics engineers have been working on fault-tolerant", "bbox": [83.0, 375.0, 364.0, 390.0]}, {"text": "circuits ever since there were electronics engineers [see", "bbox": [65.0, 392.0, 340.0, 405.0]}, {"text": "\"Redundancy in Computers,\" by William H. Pierce; S CIENTIFIC", "bbox": [66.0, 408.0, 347.0, 422.0]}, {"text": "American, February 1964]. Computer modems would still be", "bbox": [65.0, 423.0, 349.0, 438.0]}, {"text": "dribbling data at 1200 baud if it weren’t for error detection and", "bbox": [65.0, 440.0, 367.0, 453.0]}, {"text": "correction. In many applications, simple quality-control checks,", "bbox": [65.0, 455.0, 372.0, 470.0]}, {"text": "such as extra data bits, suffice. More complex systems provide", "bbox": [65.0, 472.0, 369.0, 485.0]}, {"text": "entire backup computers. The space shuttle, for example, has five", "bbox": [65.0, 488.0, 381.0, 501.0]}, {"text": "processors. Four of them perform the same calculations; the fifth", "bbox": [65.0, 503.0, 379.0, 518.0]}, {"text": "checks whether they agree and pulls the plug on any dissenter.", "bbox": [65.0, 520.0, 369.0, 534.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "The problem with these systems, though, is that they rely on", "bbox": [399.0, 135.0, 691.0, 149.0]}, {"text": "centralized control. What if that control unit goes bad?", "bbox": [399.0, 152.0, 662.0, 165.0]}, {"text": "Nature has solved that problem through radical decentral-", "bbox": [418.0, 167.0, 698.0, 181.0]}, {"text": "ization. Cells in the body are all basically identical; each takes on a", "bbox": [399.0, 184.0, 720.0, 197.0]}, {"text": "specialized task, performs it autonomously and, in the event of", "bbox": [399.0, 200.0, 704.0, 214.0]}, {"text": "infection or failure, commits hara-kiri so that its tasks can be", "bbox": [399.0, 216.0, 694.0, 229.0]}, {"text": "taken up by new cells. These are the attributes that Mange, a", "bbox": [399.0, 232.0, 693.0, 245.0]}, {"text": "professor at the Swiss Federal Institute of Technology here, and", "bbox": [399.0, 247.0, 707.0, 261.0]}, {"text": "others have sought since 1993 to emulate in circuitry, as part of", "bbox": [399.0, 264.0, 709.0, 277.0]}, {"text": "the \"Embryonics\" (embryonic electronics) project.", "bbox": [399.0, 279.0, 642.0, 294.0]}, {"text": "One of their earlier inventions, the MICTREE (microinstruction", "bbox": [417.0, 295.0, 707.0, 309.0]}, {"text": "tree) artificial cell, consisted of a simple processor and four bits of", "bbox": [399.0, 312.0, 710.0, 325.0]}, {"text": "data storage. The cell is contained in a plastic box roughly the size of", "bbox": [399.0, 327.0, 720.0, 342.0]}, {"text": "a pack of Post-its. Electrical contacts run along the sides so that", "bbox": [399.0, 344.0, 701.0, 357.0]}, {"text": "cells can be snapped together like Legos. As in cellular automata,", "bbox": [399.0, 360.0, 705.0, 374.0]}, {"text": "the models used to study the theory of self-replication, the MICTREE", "bbox": [399.0, 375.0, 718.0, 390.0]}, {"text": "cells are connected only to their immediate neighbors. The", "bbox": [399.0, 392.0, 675.0, 405.0]}, {"text": "communication burden on each cell is thus independent of the total", "bbox": [399.0, 408.0, 717.0, 421.0]}, {"text": "number of cells. The system, in other words, is easily scalable—", "bbox": [399.0, 423.0, 693.0, 438.0]}, {"text": "unlike many parallel-computing architectures.", "bbox": [399.0, 440.0, 618.0, 453.0]}, {"text": "Cells follow the instructions in their “genome,” a program ", "bbox": [418.0, 455.0, 693.0, 469.0]}, {"text": "written in a subset of the Pascal computer language. Like their", "bbox": [399.0, 472.0, 700.0, 485.0]}, {"text": "biological antecedents, the cells all contain the exact same", "bbox": [399.0, 488.0, 686.0, 501.0]}, {"text": "genome and execute part of it based on their position within the ", "bbox": [400.0, 503.0, 707.0, 517.0]}, {"text": "array, which each cell calculates relative to its neighbors. Waste-", "bbox": [401.0, 520.0, 711.0, 534.0]}], "type": "Text", "position": 2}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 32}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#1#1#Computers That Fix Themselves另起一行", "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:33:48"}
{"id": 1042048, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "f36fb712-818d-4d5a-908c-a32328203deb", "title": null, "text": "【0】页码:2\n\n【1】## Hayalet Uzuv\n\n【2】\n Giriş ( Hayalet uzuv nedir?)\n\n【3】 Hayalet Uzuv tanımının tarihçesi ve görüşler\n\n【4】 I.\n\n【5】 II.\n\n【6】 Yeniden haritalanma\n\n【7】 III.\n\n【8】 Hayalet uzuv deneyimleri\n\n【9】 A. Steve Macken – Nereyi kaşıyacağını bilmek\n\n【10】 B.  Beth Brieter\n\n【11】 Ayna tekniği - Komut: Beyni kandır!\n\n【12】 IV.\n\n【13】 Sonuç\n\n【14】 Kaynakça", "tags": {}, "lang": "None", "attr": {"raw_info": [{"raw_context": [{"text": "HAYALET UZUV", "bbox": [89.0, 88.0, 262.0, 121.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "Giriş ( Hayalet uzuv nedir?)", "bbox": [89.0, 155.0, 277.0, 179.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Hayalet Uzuv tanımının tarihçesi ve görüşler", "bbox": [185.0, 182.0, 481.0, 206.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "I.", "bbox": [137.0, 185.0, 156.0, 206.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "II.", "bbox": [137.0, 212.0, 160.0, 234.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Yeniden haritalanma", "bbox": [186.0, 210.0, 328.0, 234.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "III.", "bbox": [137.0, 239.0, 166.0, 261.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Hayalet uzuv deneyimleri", "bbox": [185.0, 237.0, 358.0, 261.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "A. Steve Macken – Nereyi kaşıyacağını bilmek", "bbox": [185.0, 265.0, 499.0, 290.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "B.  Beth Brieter", "bbox": [184.0, 292.0, 295.0, 317.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Ayna tekniği - Komut: Beyni kandır!", "bbox": [184.0, 320.0, 429.0, 344.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "IV.", "bbox": [137.0, 322.0, 166.0, 344.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Sonuç", "bbox": [90.0, 349.0, 138.0, 373.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Kaynakça", "bbox": [91.0, 376.0, 162.0, 399.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/HAYALET UZUV (ONURHAN DEMİR) (Z-Library).pdf", "page_num": 2}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#14#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:58:21"}
{"id": 1042047, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "cbddd54b-b420-49e5-9abb-226b3dd701c7", "title": null, "text": "【0】页码:74\n How do changes in the solar wind affect conditions in the space surrounding the earth? In other words, how can the wind overcome the barrier of the geomagnetic field and drive the motions of the plasma inside the magnetosphere?\n\n【1】## Blowing In The Solar Wind\n\n【2】\n ONE ANSWER, PROPOSED IN 1960 by Frank Johnson of Lockheed Missiles and Space Division, is that the magnetosphere is essentially closed. According to this hypothesis, the solar wind could transfer energy and momentum to the plasma surrounding the earth only by wave motions along the magnetopause.\n\n【3】The motions would be produced by viscous interaction between the solar-wind plasma and the magnetosphere plasma; the process is analogous to the generation of waves by the flow of\n\n【4】 wind over water. Waves are in fact observed along the magnetopause. But they do not seem capable of driving the large-scale circulation of the magnetosphere or the great disturbances that often occur there. Such waves also would not allow the efficient entry of accelerated solar-wind plasma into the magnetosphere.\n\n【5】For these reasons, magnetopause waves are not considered the primary means by which the solar wind affects the magnetosphere. An alternative mechanism called magnetic reconnection—first proposed in 1961 by British physicist James W.\n\n【6】Dungey— is generally thought to be a better explanation. In this process, the field lines of the IMF become temporarily interconnected with the geomagnetic field lines on the dayside of the magnetopause [ see illustration on page 89 ]. This tangling of the field lines allows large amounts of plasma and magnetic ener-\n SCIENTIFIC AMERICAN", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "How do changes in the solar wind affect conditions in the space", "bbox": [61.0, 86.0, 392.0, 101.0]}, {"text": "surrounding the earth? In other words, how can the wind over-", "bbox": [61.0, 103.0, 391.0, 117.0]}, {"text": "come the barrier of the geomagnetic field and drive the motions", "bbox": [61.0, 119.0, 392.0, 133.0]}, {"text": "of the plasma inside the magnetosphere?", "bbox": [61.0, 135.0, 279.0, 149.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Blowing in the Solar Wind", "bbox": [61.0, 165.0, 236.0, 182.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "ONE ANSWER, PROPOSED IN 1960 by Frank Johnson of Lock-", "bbox": [61.0, 182.0, 390.0, 197.0]}, {"text": "heed Missiles and Space Division, is that the magnetosphere is", "bbox": [61.0, 199.0, 391.0, 214.0]}, {"text": "essentially closed. According to this hypothesis, the solar wind", "bbox": [61.0, 215.0, 391.0, 229.0]}, {"text": "could transfer energy and momentum to the plasma surround-", "bbox": [61.0, 231.0, 391.0, 245.0]}, {"text": "ing the earth only by wave motions along the magnetopause.", "bbox": [61.0, 247.0, 391.0, 262.0]}, {"text": "The motions would be produced by viscous interaction between", "bbox": [61.0, 263.0, 391.0, 277.0]}, {"text": "the solar-wind plasma and the magnetosphere plasma; the", "bbox": [61.0, 278.0, 391.0, 294.0]}, {"text": "process is analogous to the generation of waves by the flow of", "bbox": [61.0, 295.0, 392.0, 309.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "wind over water. Waves are in fact observed along the magne-", "bbox": [403.0, 86.0, 731.0, 101.0]}, {"text": "topause. But they do not seem capable of driving the large-scale", "bbox": [403.0, 103.0, 734.0, 117.0]}, {"text": "circulation of the magnetosphere or the great disturbances that", "bbox": [403.0, 119.0, 734.0, 133.0]}, {"text": "often occur there. Such waves also would not allow the efficient", "bbox": [403.0, 135.0, 734.0, 149.0]}, {"text": "entry of accelerated solar-wind plasma into the magnetosphere.", "bbox": [403.0, 151.0, 733.0, 165.0]}, {"text": "For these reasons, magnetopause waves are not considered", "bbox": [422.0, 166.0, 733.0, 181.0]}, {"text": "the primary means by which the solar wind affects the magneto-", "bbox": [403.0, 183.0, 733.0, 197.0]}, {"text": "sphere. An alternative mechanism called magnetic reconnec-", "bbox": [403.0, 199.0, 732.0, 214.0]}, {"text": "tion—first proposed in 1961 by British physicist James W.", "bbox": [403.0, 215.0, 733.0, 229.0]}, {"text": "Dungey— is generally thought to be a better explanation. In this", "bbox": [403.0, 230.0, 734.0, 245.0]}, {"text": "process, the field lines of the IMF become temporarily inter-", "bbox": [403.0, 247.0, 733.0, 261.0]}, {"text": "connected with the geomagnetic field lines on the dayside of the", "bbox": [403.0, 263.0, 734.0, 277.0]}, {"text": "magnetopause [ see illustration on page 89 ]. This tangling of the", "bbox": [403.0, 278.0, 734.0, 294.0]}, {"text": "field lines allows large amounts of plasma and magnetic ener-", "bbox": [403.0, 295.0, 733.0, 309.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "SCIENTIFIC AMERICAN", "bbox": [568.0, 987.0, 705.0, 1001.0]}], "type": "Caption", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 74}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#3#4#为同段内容", "type3": null, "type4": null, "type5": null, "type6": "信息有用性#6#6#SCIENTIFIC AMERICAN无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:17:09"}
{"id": 1042046, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "f02ce20d-2670-4779-9dad-8ab8e48e29da", "title": null, "text": "【0】页码:55\n Simplified Adult BLS\n Figure 1. Simplified adult BLS algorithm.\n\n【1】 untrained bystander should—at a minimum—activate the community emergency response system (eg, call 911, or if in an institution with an emergency response system, call that facility's emergency response number). If the victim also has absent or abnormal breathing (ie, only gasping), the rescuer should assume the victim is in cardiac arrest (Class I, LOE C). 19,24,34 The lay rescuer should phone the emergency response system once the rescuer finds that the victim is unresponsive—the dispatcher should be able to guide the lay rescuer through the check for breathing and the steps of CPR, if needed. The healthcare provider can check for response and look for no breathing or no normal breathing (ie, only gasping) almost simultaneously before activating the emergency response system. After activation of the emergency response system, all rescuers should immediately begin CPR (see steps below) for adult victims who are unresponsive with no breathing or no normal breathing (only gasping).\n\n【2】When phoning 911 for help, the rescuer should be prepared to answer the dispatcher's questions about the location of the incident, the events of the incident, the number and condition of the victim(s), and the type of aid provided. If rescuers never learned or have forgotten how to do CPR, they should also be prepared to follow the dispatcher's instructions.\n\n【3】Finally the rescuer making the phone call should hang up only when instructed to do so by the dispatcher.\n\n【4】## Pulse Check\n\n【5】\n Studies have shown that both lay rescuers and healthcare providers have difficulty detecting a pulse. 35–44 Healthcare providers also may take too long to check for a pulse. 38.41\n • The lay rescuer should not check for a pulse and should assume that cardiac arrest is present if an adult suddenly collapses or an unresponsive victim is not breathing normally.\n\n【6】• The healthcare provider should take no more than 10 seconds to check for a pulse and, if the rescuer does not definitely feel a pulse within that time period, the rescuer should start chest compressions (Class IIa, LOE C). 45.46\n\n【7】## Early Cpr\n\n【8】\n## Chest Compressions\n\n【9】\n Chest compressions consist of forceful rhythmic applications of pressure over the lower half of the sternum. These compressions create blood flow by increasing intrathoracic pressure and directly compressing the heart. This generates blood flow and oxygen delivery to the myocardium and brain.\n\n【10】 • Effective chest compressions are essential for providing blood flow during CPR. For this reason all patients in\n\n【11】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Simplified Adult BLS", "bbox": [146.0, 85.0, 257.0, 99.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Figure 1. Simplified adult BLS algorithm.", "bbox": [469.0, 336.0, 669.0, 350.0]}], "type": "Caption", "position": 5}, {"raw_context": [{"text": "untrained bystander should—at a minimum—activate the", "bbox": [60.0, 616.0, 376.0, 631.0]}, {"text": "community emergency response system (eg, call 911, or if in", "bbox": [60.0, 633.0, 376.0, 646.0]}, {"text": "an institution with an emergency response system, call that", "bbox": [60.0, 648.0, 376.0, 661.0]}, {"text": "facility's emergency response number). If the victim also has", "bbox": [60.0, 662.0, 376.0, 676.0]}, {"text": "absent or abnormal breathing (ie, only gasping), the rescuer", "bbox": [60.0, 678.0, 376.0, 691.0]}, {"text": "should assume the victim is in cardiac arrest (Class I,", "bbox": [60.0, 693.0, 376.0, 706.0]}, {"text": "LOE C). 19,24,34 The lay rescuer should phone the emergency", "bbox": [60.0, 707.0, 375.0, 722.0]}, {"text": "response system once the rescuer finds that the victim is", "bbox": [60.0, 722.0, 376.0, 737.0]}, {"text": "unresponsive—the dispatcher should be able to guide the lay", "bbox": [60.0, 737.0, 375.0, 750.0]}, {"text": "rescuer through the check for breathing and the steps of CPR,", "bbox": [60.0, 752.0, 375.0, 767.0]}, {"text": "if needed. The healthcare provider can check for response and", "bbox": [60.0, 768.0, 376.0, 782.0]}, {"text": "look for no breathing or no normal breathing (ie, only", "bbox": [60.0, 783.0, 375.0, 796.0]}, {"text": "gasping) almost simultaneously before activating the emer-", "bbox": [60.0, 797.0, 375.0, 811.0]}, {"text": "gency response system. After activation of the emergency", "bbox": [60.0, 813.0, 375.0, 826.0]}, {"text": "response system, all rescuers should immediately begin CPR", "bbox": [60.0, 828.0, 376.0, 841.0]}, {"text": "(see steps below) for adult victims who are unresponsive with", "bbox": [60.0, 843.0, 376.0, 856.0]}, {"text": "no breathing or no normal breathing (only gasping).", "bbox": [60.0, 857.0, 335.0, 871.0]}, {"text": "When phoning 911 for help, the rescuer should be prepared", "bbox": [73.0, 873.0, 376.0, 886.0]}, {"text": "to answer the dispatcher's questions about the location of the", "bbox": [60.0, 888.0, 376.0, 901.0]}, {"text": "incident, the events of the incident, the number and condition", "bbox": [60.0, 903.0, 376.0, 916.0]}, {"text": "of the victim(s), and the type of aid provided. If rescuers", "bbox": [60.0, 918.0, 376.0, 931.0]}, {"text": "never learned or have forgotten how to do CPR, they should", "bbox": [60.0, 932.0, 376.0, 946.0]}, {"text": "also be prepared to follow the dispatcher's instructions.", "bbox": [60.0, 947.0, 375.0, 962.0]}, {"text": "Finally the rescuer making the phone call should hang up", "bbox": [60.0, 963.0, 376.0, 977.0]}, {"text": "only when instructed to do so by the dispatcher.", "bbox": [60.0, 977.0, 315.0, 991.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Pulse Check", "bbox": [404.0, 616.0, 482.0, 631.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Studies have shown that both lay rescuers and healthcare", "bbox": [404.0, 633.0, 720.0, 649.0]}, {"text": "providers have difficulty detecting a pulse. 35–44 Healthcare", "bbox": [403.0, 650.0, 720.0, 663.0]}, {"text": "providers also may take too long to check for a pulse. 38.41", "bbox": [404.0, 665.0, 710.0, 679.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "• The lay rescuer should not check for a pulse and should", "bbox": [403.0, 691.0, 720.0, 705.0]}, {"text": "assume that cardiac arrest is present if an adult suddenly", "bbox": [416.0, 707.0, 719.0, 722.0]}, {"text": "collapses or an unresponsive victim is not breathing", "bbox": [416.0, 723.0, 720.0, 736.0]}, {"text": "normally.", "bbox": [416.0, 739.0, 468.0, 753.0]}, {"text": "• The healthcare provider should take no more than 10", "bbox": [404.0, 755.0, 721.0, 769.0]}, {"text": "seconds to check for a pulse and, if the rescuer does not", "bbox": [416.0, 772.0, 720.0, 785.0]}, {"text": "definitely feel a pulse within that time period, the rescuer", "bbox": [416.0, 787.0, 720.0, 802.0]}, {"text": "should start chest compressions (Class IIa, LOE C). 45.46", "bbox": [416.0, 803.0, 710.0, 816.0]}], "type": "List-item", "position": 9}, {"raw_context": [{"text": "Early CPR", "bbox": [404.0, 832.0, 474.0, 849.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Chest Compressions", "bbox": [403.0, 856.0, 515.0, 870.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Chest compressions consist of forceful rhythmic applications", "bbox": [403.0, 870.0, 721.0, 884.0]}, {"text": "of pressure over the lower half of the sternum. These", "bbox": [403.0, 887.0, 720.0, 900.0]}, {"text": "compressions create blood flow by increasing intrathoracic", "bbox": [403.0, 902.0, 720.0, 916.0]}, {"text": "pressure and directly compressing the heart. This generates", "bbox": [404.0, 918.0, 720.0, 931.0]}, {"text": "blood flow and oxygen delivery to the myocardium and brain.", "bbox": [403.0, 934.0, 720.0, 948.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "• Effective chest compressions are essential for providing", "bbox": [403.0, 961.0, 720.0, 977.0]}, {"text": "blood flow during CPR. For this reason all patients in", "bbox": [416.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 14}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 55}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#1#10# 19,24,34 The lay rescuer should ...像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#11#11#属于页脚的内容，和正文无关", "type4": null, "type5": null, "type6": "有用性#0#0#Simplified Adult BLS图表的标题但文中并没有图表"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:44:40"}
{"id": 1042045, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "e0df3ba8-de27-40e7-806c-a16bc00c52f5", "title": null, "text": "【0】页码:280\n 46. Stockinger ZT, McSwain NE, Jr. Prehospital endotracheal intubation for trauma does not improve survival over bag-valve-mask ventilation.\n\n【1】J Trauma . 2004;56:531–536.\n\n【2】47. Pitetti R, Glustein JZ, Bhende MS.  Prehospital care and outcome of pediatric out-of-hospital cardiac arrest. Prehosp Emerg Care . 2002;6: 283–290.\n\n【3】48. Gerritse BM, Draaisma JM, Schalkwijk A, van Grunsven PM, Scheffer GJ. Should EMS-paramedics perform paediatric tracheal intubation in the field? Resuscitation . 2008;79:225–229.\n\n【4】49. A prospective multicenter evaluation of prehospital airway management performance in a large metropolitan region. Prehosp Emerg Care. 2009 ; 13:304–310.\n\n【5】50. Garza AG, Algren DA, Gratton MC, Ma OJ.  Populations at risk for intubation nonattempt and failure in the prehospital setting. Prehosp Emerg Care . 2005;9:163–166.\n\n【6】51.\n\n【7】Hon KL, Olsen H, Totapally B, Leung TF. Hyperventilation at referring hospitals is common before transport in intubated children with neurological diseases. Pediatr Emerg Care . 2005;21:662–666.\n\n【8】52. Wang HE, Lave JR, Sirio CA, Yealy DM. Paramedic intubation errors: isolated events or symptoms of larger problems? Health Aff ( Millwood ).\n\n【9】2006;25:501–509.\n\n【10】53. Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A study of chest compression rates during cardiopulmonary resuscitation in humans: the importance of rate-directed chest compressions. Arch Intern Med . 1992;152:145–149.\n\n【11】Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite 54.\n\n【12】S, von Briesen C, Sparks CW, Conrad CJ, Provo TA, Lurie KG.\n\n【13】Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation. 2004;109:1960–1965.\n\n【14】55.\n\n【15】Wik L, Kramer-Johansen J, Myklebust H, Sorebo H, Svensson L, Fellows B, Steen PA. Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest. JAMA . 2005;293:299–304.\n\n【16】56.\n\n【17】Gausche-Hill M, Lewis RJ, Gunter CS, Henderson DP, Haynes BE, Stratton SJ. Design and implementation of a controlled trial of pediatric endotracheal intubation in the out-of-hospital setting. Ann Emerg Med .\n\n【18】2000;36:356–365.\n\n【19】57. Jesudian MC, Harrison RR, Keenan RL, Maull KI.  Bag-valve-mask ventilation; two rescuers are better than one: preliminary report. Crit Care Med . 1985;13:122–123.\n\n【20】58. Davidovic L, LaCovey D, Pitetti RD. Comparison of 1- versus 2-person bag-valve-mask techniques for manikin ventilation of infants and children. Ann Emerg Med . 2005;46:37–42.\n\n【21】59. Berg MD, Idris AH, Berg RA. Severe ventilatory compromise due to gastric distention during pediatric cardiopulmonary resuscitation.\n\n【22】Resuscitation. 1998;36:71–73.\n\n【23】60. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of cricoid pressure on preventing gastric insufflation in infants and children. Anesthesiology . 1993;78:652–656.\n\n【24】Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure 61.\n\n【25】in preventing gastric inflation during bag-mask ventilation in pediatric patients. Anesthesiology . 1974;40:96–98.\n\n【26】1062.\n\n【27】Sellick BA.  Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia. Lancet. 1961;2:404–406.\n\n【28】63.\n\n【29】Hartsilver EL, Vanner RG.  Airway obstruction with cricoid pressure.\n\n【30】Anaesthesia . 2000;55:208–211.\n\n【31】64. Sirbaugh PE, Pepe PE, Shook JE, Kimball KT, Goldman MJ, Ward MA, Mann DM. A prospective, population-based study of the demographics, epidemiology, management, and outcome of out-of-hospital pediatric cardiopulmonary arrest. Ann Emerg Med . 1999;33:174–184.\n\n【32】100.\n\n【33】Brownstein DR, Quan L, Orr R, Wentz KR, Copass MK.  Paramedic intubation training in a pediatric operating room. Am J Emerg Med .\n\n【34】1992;10:418–420.\n\n【35】Vilke GM, Steen PJ, Smith AM, Chan TC.  Out-of-hospital pediatric 66.\n\n【36】intubation by paramedics: the San Diego experience. J Emerg Med .\n\n【37】2002;22:71–74.\n\n【38】67. Ma OJ, Atchley RB, Hatley T, Green M, Young J, Brady W. Intubation success rates improve for an air medical program after implementing the use of neuromuscular blocking agents. Am J Emerg Med . 1998;16: 125–127.\n\n【39】Sing RF, Rotondo MF, Zonies DH, Schwab CW, Kauder DR, Ross SE, 68.\n\n【40】Brathwaite CC.  Rapid sequence induction for intubation by an aeromedical transport team: a critical analysis. Am J Emerg Med . 1998;16: 598–602.\n\n【41】 69. Sagarin MJ, Chiang V, Sakles JC, Barton ED, Wolfe RE, Vissers RJ, Walls RM. Rapid sequence intubation for pediatric emergency airway management. Pediatr Emerg Care. 2002;18:417–423.\n\n【42】70. Black K, Barnett P, Wolfe R, Young S. Are methods used to estimate weight in children accurate? Emerg Med ( Fremantle ). 2002;14: 160–165.\n\n【43】71. Chan GM, Moyer-Mileur L, Rallison L. An easy and accurate method of estimating newborn birthweight for resuscitation. Am J Perinatol .\n\n【44】9(5–6):371–373, 1992.\n\n【45】72. Garland JS, Kishaba RG, Nelson DB, Losek JD, Sobocinski KA. A rapid and accurate method of estimating body weight. Am J Emerg Med .\n\n【46】1986;4:390–393.\n\n【47】73. Krieser D, Nguyen K, Kerr D, Jolley D, Clooney M, Kelly AM. Parental weight estimation of their child's weight is more accurate than other weight estimation methods for determining children's weight in an emergency department? Emerg Med J. 2007;24:756–759.\n\n【48】74. Lubitz DS, Seidel JS, Chameides L, Luten RC, Zaritsky AL, Campbell FW.  A rapid method for estimating weight and resuscitation drug dosages from length in the pediatric age group. Ann Emerg Med . 1988; 17:576–581.\n\n【49】75. Varghese A, Vasudevan VK, Lewin S, Indumathi CK, Dinakar C, Rao SD. Do the length-based (Broselow) Tape, APLS, Argall and Nelson's formulae accurately estimate weight of Indian children? Indian Pediatr .\n\n【50】2006;43:889–894.\n\n【51】Vilke GM, Marino A, Fisher R, Chan TC. Estimation of pediatric patient weight by EMT-PS. J Emerg Med . 2001;21:125–128.\n\n【52】77. Hofer CK, Ganter M, Tucci M, Klaghofer R, Zollinger A. How reliable is length-based determination of body weight and tracheal tube size in the paediatric age group? The Broselow tape reconsidered. Br J Anaesth .\n\n【53】2002;88:283–285.\n\n【54】78. DuBois D, Baldwin S, King WD.  Accuracy of weight estimation methods for children. Pediatr Emerg Care . 2007;23:227–230.\n\n【55】79. Yamamoto LG, Inaba AS, Young LL, Anderson KM.  Improving length-based weight estimates by adding a body habitus (obesity) icon.\n\n【56】Am J Emerg Med . 2009;27:810–815.\n\n【57】80. Johnson TN. The problems in scaling adult drug doses to children. Arch Dis Child . 2008;93:207–211.\n\n【58】81. Mahmood I. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age. Ther Drug Monit . 2007;29: 271–278.\n\n【59】82. Edginton AN, Schmitt W, Willmann S. Development and evaluation of a generic physiologically based pharmacokinetic model for children.\n\n【60】Clin Pharmacokinet . 2006;45:1013–1034.\n\n【61】Gill MA, Ueda CT.  Novel method for the determination of pediatric dosages. Am J Hosp Pharm. 1976;33:389–392.\n\n【62】84. Rodriguez W, Selen A, Avant D, Chaurasia C, Crescenzi T, Gieser G, Di Giacinto J, Huang SM, Lee P, Mathis L, Murphy D, Murphy S, Roberts R, Sachs HC, Suarez S, Tandon V, Uppoor RS.  Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics .\n\n【63】2008;121:530–539.\n\n【64】85. Traub SL, Kichen L. Estimating ideal body mass in children. Am J Hosp Pharm. 1983;40:107–110.\n\n【65】Ellis DY, Harris T, Zideman D.  Cricoid pressure in emergency department rapid sequence tracheal intubations: a risk-benefit analysis.\n\n【66】Ann Emerg Med . 2007;50:653–665.\n\n【67】87. Walker RW, Ravi R, Haylett K. Effect of cricoid force on airway calibre in children: a bronchoscopic assessment. Br J Anaesth . 2010;104:71–74.\n\n【68】88.\n\n【69】Khine HH, Corddry DH, Kettrick RG, Martin TM, McCloskey JJ, Rose JB, Theroux MC, Zagnoev M. Comparison of cuffed and uncuffed endotracheal tubes in young children during general anesthesia. Anesthesiology . 1997; 86:627–631; discussion 627A.\n\n【70】89.\n\n【71】Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth . 2009;103:867–873.\n\n【72】90. Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P, Bonnard C, Chassard D. Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth . 2002;12: 762–769.\n\n【73】91. Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus uncuffed endotracheal tubes in pediatric intensive care. J Pediatr . 2004; 144:333–337.\n\n【74】92. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in pediatric intensive care. J Pediatr . 1994;125:57–62.\n\n【75】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "46. Stockinger ZT, McSwain NE, Jr. Prehospital endotracheal intubation for", "bbox": [66.0, 85.0, 376.0, 97.0]}, {"text": "trauma does not improve survival over bag-valve-mask ventilation.", "bbox": [84.0, 98.0, 375.0, 109.0]}, {"text": "J Trauma . 2004;56:531–536.", "bbox": [84.0, 110.0, 204.0, 121.0]}, {"text": "47. Pitetti R, Glustein JZ, Bhende MS.  Prehospital care and outcome of", "bbox": [66.0, 122.0, 376.0, 134.0]}, {"text": "pediatric out-of-hospital cardiac arrest. Prehosp Emerg Care . 2002;6:", "bbox": [84.0, 136.0, 375.0, 147.0]}, {"text": "283–290.", "bbox": [84.0, 147.0, 123.0, 159.0]}, {"text": "48. Gerritse BM, Draaisma JM, Schalkwijk A, van Grunsven PM, Scheffer", "bbox": [66.0, 159.0, 375.0, 172.0]}, {"text": "GJ. Should EMS-paramedics perform paediatric tracheal intubation in", "bbox": [83.0, 172.0, 376.0, 183.0]}, {"text": "the field? Resuscitation . 2008;79:225–229.", "bbox": [83.0, 185.0, 258.0, 196.0]}, {"text": "49. A prospective multicenter evaluation of prehospital airway management", "bbox": [66.0, 195.0, 376.0, 211.0]}, {"text": "performance in a large metropolitan region. Prehosp Emerg Care. 2009 ;", "bbox": [84.0, 209.0, 375.0, 221.0]}, {"text": "13:304–310.", "bbox": [84.0, 221.0, 137.0, 233.0]}, {"text": "50. Garza AG, Algren DA, Gratton MC, Ma OJ.  Populations at risk for", "bbox": [66.0, 234.0, 376.0, 246.0]}, {"text": "intubation nonattempt and failure in the prehospital setting. Prehosp", "bbox": [83.0, 247.0, 376.0, 259.0]}, {"text": "Emerg Care . 2005;9:163–166.", "bbox": [84.0, 259.0, 209.0, 270.0]}, {"text": "51.", "bbox": [66.0, 272.0, 80.0, 282.0]}, {"text": "Hon KL, Olsen H, Totapally B, Leung TF. Hyperventilation at referring", "bbox": [81.0, 272.0, 375.0, 284.0]}, {"text": "hospitals is common before transport in intubated children with neuro-", "bbox": [83.0, 285.0, 374.0, 296.0]}, {"text": "logical diseases. Pediatr Emerg Care . 2005;21:662–666.", "bbox": [84.0, 296.0, 317.0, 308.0]}, {"text": "52. Wang HE, Lave JR, Sirio CA, Yealy DM. Paramedic intubation errors:", "bbox": [66.0, 308.0, 376.0, 321.0]}, {"text": "isolated events or symptoms of larger problems? Health Aff ( Millwood ).", "bbox": [84.0, 321.0, 375.0, 334.0]}, {"text": "2006;25:501–509.", "bbox": [84.0, 334.0, 157.0, 345.0]}, {"text": "53. Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A", "bbox": [66.0, 346.0, 376.0, 358.0]}, {"text": "study of chest compression rates during cardiopulmonary resuscitation", "bbox": [84.0, 359.0, 376.0, 371.0]}, {"text": "in humans: the importance of rate-directed chest compressions. Arch", "bbox": [83.0, 372.0, 376.0, 383.0]}, {"text": "Intern Med . 1992;152:145–149.", "bbox": [84.0, 383.0, 214.0, 394.0]}, {"text": "Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite", "bbox": [80.0, 394.0, 375.0, 407.0]}, {"text": "54.", "bbox": [66.0, 395.0, 82.0, 406.0]}, {"text": "S, von Briesen C, Sparks CW, Conrad CJ, Provo TA, Lurie KG.", "bbox": [83.0, 408.0, 375.0, 420.0]}, {"text": "Hyperventilation-induced hypotension during cardiopulmonary resusci-", "bbox": [83.0, 421.0, 375.0, 433.0]}, {"text": "tation. Circulation. 2004;109:1960–1965.", "bbox": [83.0, 433.0, 254.0, 444.0]}, {"text": "55.", "bbox": [66.0, 445.0, 82.0, 456.0]}, {"text": "Wik L, Kramer-Johansen J, Myklebust H, Sorebo H, Svensson L,", "bbox": [80.0, 446.0, 375.0, 457.0]}, {"text": "Fellows B, Steen PA. Quality of cardiopulmonary resuscitation during", "bbox": [83.0, 459.0, 376.0, 470.0]}, {"text": "out-of-hospital cardiac arrest. JAMA . 2005;293:299–304.", "bbox": [83.0, 470.0, 317.0, 482.0]}, {"text": "56.", "bbox": [66.0, 482.0, 82.0, 493.0]}, {"text": "Gausche-Hill M, Lewis RJ, Gunter CS, Henderson DP, Haynes BE,", "bbox": [80.0, 484.0, 375.0, 494.0]}, {"text": "Stratton SJ. Design and implementation of a controlled trial of pediatric", "bbox": [83.0, 495.0, 375.0, 507.0]}, {"text": "endotracheal intubation in the out-of-hospital setting. Ann Emerg Med .", "bbox": [84.0, 508.0, 375.0, 520.0]}, {"text": "2000;36:356–365.", "bbox": [84.0, 520.0, 160.0, 531.0]}, {"text": "57. Jesudian MC, Harrison RR, Keenan RL, Maull KI.  Bag-valve-mask", "bbox": [66.0, 533.0, 375.0, 544.0]}, {"text": "ventilation; two rescuers are better than one: preliminary report. Crit", "bbox": [84.0, 544.0, 376.0, 556.0]}, {"text": "Care Med . 1985;13:122–123.", "bbox": [84.0, 557.0, 204.0, 568.0]}, {"text": "58. Davidovic L, LaCovey D, Pitetti RD. Comparison of 1- versus 2-person", "bbox": [66.0, 568.0, 376.0, 582.0]}, {"text": "bag-valve-mask techniques for manikin ventilation of infants and", "bbox": [83.0, 582.0, 376.0, 594.0]}, {"text": "children. Ann Emerg Med . 2005;46:37–42.", "bbox": [83.0, 595.0, 261.0, 607.0]}, {"text": "59. Berg MD, Idris AH, Berg RA. Severe ventilatory compromise due to", "bbox": [66.0, 607.0, 377.0, 620.0]}, {"text": "gastric distention during pediatric cardiopulmonary resuscitation.", "bbox": [84.0, 620.0, 374.0, 631.0]}, {"text": "Resuscitation. 1998;36:71–73.", "bbox": [83.0, 631.0, 215.0, 642.0]}, {"text": "60. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The", "bbox": [66.0, 644.0, 375.0, 656.0]}, {"text": "effect of cricoid pressure on preventing gastric insufflation in infants and", "bbox": [83.0, 657.0, 376.0, 669.0]}, {"text": "children. Anesthesiology . 1993;78:652–656.", "bbox": [83.0, 669.0, 263.0, 681.0]}, {"text": "Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure", "bbox": [81.0, 681.0, 375.0, 694.0]}, {"text": "61.", "bbox": [65.0, 682.0, 81.0, 693.0]}, {"text": "in preventing gastric inflation during bag-mask ventilation in pediatric", "bbox": [83.0, 694.0, 375.0, 705.0]}, {"text": "patients. Anesthesiology . 1974;40:96–98.", "bbox": [84.0, 707.0, 252.0, 718.0]}, {"text": "1062.", "bbox": [66.0, 718.0, 81.0, 729.0]}, {"text": "Sellick BA.  Cricoid pressure to control regurgitation of stomach", "bbox": [81.0, 718.0, 376.0, 730.0]}, {"text": "contents during induction of anaesthesia. Lancet. 1961;2:404–406.", "bbox": [85.0, 731.0, 360.0, 743.0]}, {"text": "63.", "bbox": [65.0, 743.0, 81.0, 753.0]}, {"text": "Hartsilver EL, Vanner RG.  Airway obstruction with cricoid pressure.", "bbox": [81.0, 744.0, 375.0, 755.0]}, {"text": "Anaesthesia . 2000;55:208–211.", "bbox": [83.0, 756.0, 213.0, 767.0]}, {"text": "64. Sirbaugh PE, Pepe PE, Shook JE, Kimball KT, Goldman MJ, Ward MA,", "bbox": [65.0, 769.0, 375.0, 781.0]}, {"text": "Mann DM. A prospective, population-based study of the demographics,", "bbox": [84.0, 781.0, 376.0, 792.0]}, {"text": "epidemiology, management, and outcome of out-of-hospital pediatric", "bbox": [83.0, 794.0, 375.0, 805.0]}, {"text": "cardiopulmonary arrest. Ann Emerg Med . 1999;33:174–184.", "bbox": [83.0, 805.0, 332.0, 816.0]}, {"text": "100.", "bbox": [65.0, 818.0, 82.0, 829.0]}, {"text": "Brownstein DR, Quan L, Orr R, Wentz KR, Copass MK.  Paramedic", "bbox": [80.0, 818.0, 375.0, 829.0]}, {"text": "intubation training in a pediatric operating room. Am J Emerg Med .", "bbox": [84.0, 830.0, 375.0, 843.0]}, {"text": "1992;10:418–420.", "bbox": [84.0, 843.0, 160.0, 854.0]}, {"text": "Vilke GM, Steen PJ, Smith AM, Chan TC.  Out-of-hospital pediatric", "bbox": [81.0, 855.0, 375.0, 868.0]}, {"text": "66.", "bbox": [65.0, 856.0, 81.0, 865.0]}, {"text": "intubation by paramedics: the San Diego experience. J Emerg Med .", "bbox": [84.0, 868.0, 375.0, 879.0]}, {"text": "2002;22:71–74.", "bbox": [84.0, 881.0, 147.0, 892.0]}, {"text": "67. Ma OJ, Atchley RB, Hatley T, Green M, Young J, Brady W. Intubation", "bbox": [65.0, 892.0, 376.0, 904.0]}, {"text": "success rates improve for an air medical program after implementing the", "bbox": [84.0, 905.0, 375.0, 916.0]}, {"text": "use of neuromuscular blocking agents. Am J Emerg Med . 1998;16:", "bbox": [84.0, 917.0, 375.0, 930.0]}, {"text": "125–127.", "bbox": [84.0, 930.0, 123.0, 941.0]}, {"text": "Sing RF, Rotondo MF, Zonies DH, Schwab CW, Kauder DR, Ross SE,", "bbox": [80.0, 941.0, 375.0, 956.0]}, {"text": "68.", "bbox": [65.0, 943.0, 82.0, 954.0]}, {"text": "Brathwaite CC.  Rapid sequence induction for intubation by an aero-", "bbox": [83.0, 955.0, 375.0, 966.0]}, {"text": "medical transport team: a critical analysis. Am J Emerg Med . 1998;16:", "bbox": [84.0, 968.0, 375.0, 979.0]}, {"text": "598–602.", "bbox": [84.0, 979.0, 126.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "69. Sagarin MJ, Chiang V, Sakles JC, Barton ED, Wolfe RE, Vissers RJ,", "bbox": [409.0, 85.0, 720.0, 97.0]}, {"text": "Walls RM. Rapid sequence intubation for pediatric emergency airway", "bbox": [427.0, 98.0, 719.0, 109.0]}, {"text": "management. Pediatr Emerg Care. 2002;18:417–423.", "bbox": [428.0, 110.0, 650.0, 121.0]}, {"text": "70. Black K, Barnett P, Wolfe R, Young S. Are methods used to estimate", "bbox": [410.0, 122.0, 720.0, 134.0]}, {"text": "weight in children accurate? Emerg Med ( Fremantle ). 2002;14:", "bbox": [428.0, 136.0, 720.0, 147.0]}, {"text": "160–165.", "bbox": [428.0, 147.0, 467.0, 159.0]}, {"text": "71. Chan GM, Moyer-Mileur L, Rallison L. An easy and accurate method of", "bbox": [410.0, 159.0, 720.0, 172.0]}, {"text": "estimating newborn birthweight for resuscitation. Am J Perinatol .", "bbox": [427.0, 172.0, 718.0, 184.0]}, {"text": "9(5–6):371–373, 1992.", "bbox": [427.0, 185.0, 521.0, 196.0]}, {"text": "72. Garland JS, Kishaba RG, Nelson DB, Losek JD, Sobocinski KA. A rapid", "bbox": [410.0, 197.0, 720.0, 209.0]}, {"text": "and accurate method of estimating body weight. Am J Emerg Med .", "bbox": [429.0, 210.0, 719.0, 221.0]}, {"text": "1986;4:390–393.", "bbox": [428.0, 222.0, 499.0, 232.0]}, {"text": "73. Krieser D, Nguyen K, Kerr D, Jolley D, Clooney M, Kelly AM. Parental", "bbox": [410.0, 234.0, 720.0, 246.0]}, {"text": "weight estimation of their child's weight is more accurate than other", "bbox": [428.0, 247.0, 720.0, 259.0]}, {"text": "weight estimation methods for determining children's weight in an", "bbox": [427.0, 259.0, 720.0, 270.0]}, {"text": "emergency department? Emerg Med J. 2007;24:756–759.", "bbox": [428.0, 272.0, 664.0, 283.0]}, {"text": "74. Lubitz DS, Seidel JS, Chameides L, Luten RC, Zaritsky AL, Campbell", "bbox": [410.0, 283.0, 721.0, 297.0]}, {"text": "FW.  A rapid method for estimating weight and resuscitation drug", "bbox": [427.0, 296.0, 719.0, 308.0]}, {"text": "dosages from length in the pediatric age group. Ann Emerg Med . 1988;", "bbox": [427.0, 309.0, 720.0, 321.0]}, {"text": "17:576–581.", "bbox": [428.0, 321.0, 480.0, 333.0]}, {"text": "75. Varghese A, Vasudevan VK, Lewin S, Indumathi CK, Dinakar C, Rao", "bbox": [410.0, 333.0, 721.0, 346.0]}, {"text": "SD. Do the length-based (Broselow) Tape, APLS, Argall and Nelson's", "bbox": [427.0, 346.0, 721.0, 357.0]}, {"text": "formulae accurately estimate weight of Indian children? Indian Pediatr .", "bbox": [427.0, 359.0, 718.0, 370.0]}, {"text": "2006;43:889–894.", "bbox": [428.0, 371.0, 506.0, 381.0]}, {"text": "Vilke GM, Marino A, Fisher R, Chan TC. Estimation of pediatric patient", "bbox": [426.0, 383.0, 720.0, 395.0]}, {"text": "weight by EMT-PS. J Emerg Med . 2001;21:125–128.", "bbox": [427.0, 395.0, 650.0, 408.0]}, {"text": "77. Hofer CK, Ganter M, Tucci M, Klaghofer R, Zollinger A. How reliable", "bbox": [410.0, 408.0, 720.0, 420.0]}, {"text": "is length-based determination of body weight and tracheal tube size in", "bbox": [427.0, 421.0, 720.0, 433.0]}, {"text": "the paediatric age group? The Broselow tape reconsidered. Br J Anaesth .", "bbox": [427.0, 433.0, 720.0, 445.0]}, {"text": "2002;88:283–285.", "bbox": [428.0, 446.0, 500.0, 457.0]}, {"text": "78. DuBois D, Baldwin S, King WD.  Accuracy of weight estimation", "bbox": [410.0, 457.0, 720.0, 471.0]}, {"text": "methods for children. Pediatr Emerg Care . 2007;23:227–230.", "bbox": [427.0, 470.0, 682.0, 482.0]}, {"text": "79. Yamamoto LG, Inaba AS, Young LL, Anderson KM.  Improving", "bbox": [410.0, 483.0, 720.0, 495.0]}, {"text": "length-based weight estimates by adding a body habitus (obesity) icon.", "bbox": [427.0, 495.0, 719.0, 507.0]}, {"text": "Am J Emerg Med . 2009;27:810–815.", "bbox": [428.0, 508.0, 584.0, 520.0]}, {"text": "80. Johnson TN. The problems in scaling adult drug doses to children. Arch", "bbox": [409.0, 520.0, 720.0, 532.0]}, {"text": "Dis Child . 2008;93:207–211.", "bbox": [427.0, 533.0, 546.0, 544.0]}, {"text": "81. Mahmood I. Prediction of drug clearance in children: impact of allo-", "bbox": [409.0, 544.0, 719.0, 556.0]}, {"text": "metric exponents, body weight, and age. Ther Drug Monit . 2007;29:", "bbox": [428.0, 557.0, 719.0, 569.0]}, {"text": "271–278.", "bbox": [427.0, 570.0, 467.0, 582.0]}, {"text": "82. Edginton AN, Schmitt W, Willmann S. Development and evaluation of", "bbox": [409.0, 582.0, 720.0, 594.0]}, {"text": "a generic physiologically based pharmacokinetic model for children.", "bbox": [427.0, 595.0, 719.0, 607.0]}, {"text": "Clin Pharmacokinet . 2006;45:1013–1034.", "bbox": [427.0, 608.0, 601.0, 618.0]}, {"text": "Gill MA, Ueda CT.  Novel method for the determination of pediatric", "bbox": [424.0, 619.0, 719.0, 631.0]}, {"text": "dosages. Am J Hosp Pharm. 1976;33:389–392.", "bbox": [427.0, 631.0, 624.0, 642.0]}, {"text": "84. Rodriguez W, Selen A, Avant D, Chaurasia C, Crescenzi T, Gieser G, Di", "bbox": [409.0, 644.0, 720.0, 656.0]}, {"text": "Giacinto J, Huang SM, Lee P, Mathis L, Murphy D, Murphy S, Roberts", "bbox": [427.0, 656.0, 720.0, 669.0]}, {"text": "R, Sachs HC, Suarez S, Tandon V, Uppoor RS.  Improving pediatric", "bbox": [427.0, 669.0, 720.0, 681.0]}, {"text": "dosing through pediatric initiatives: what we have learned. Pediatrics .", "bbox": [428.0, 682.0, 719.0, 694.0]}, {"text": "2008;121:530–539.", "bbox": [427.0, 694.0, 508.0, 705.0]}, {"text": "85. Traub SL, Kichen L. Estimating ideal body mass in children. Am J Hosp", "bbox": [409.0, 707.0, 721.0, 719.0]}, {"text": "Pharm. 1983;40:107–110.", "bbox": [427.0, 718.0, 536.0, 729.0]}, {"text": "Ellis DY, Harris T, Zideman D.  Cricoid pressure in emergency", "bbox": [427.0, 731.0, 719.0, 743.0]}, {"text": "department rapid sequence tracheal intubations: a risk-benefit analysis.", "bbox": [427.0, 743.0, 719.0, 755.0]}, {"text": "Ann Emerg Med . 2007;50:653–665.", "bbox": [428.0, 756.0, 575.0, 767.0]}, {"text": "87. Walker RW, Ravi R, Haylett K. Effect of cricoid force on airway calibre", "bbox": [409.0, 769.0, 720.0, 781.0]}, {"text": "in children: a bronchoscopic assessment. Br J Anaesth . 2010;104:71–74.", "bbox": [427.0, 781.0, 719.0, 792.0]}, {"text": "88.", "bbox": [409.0, 794.0, 425.0, 804.0]}, {"text": "Khine HH, Corddry DH, Kettrick RG, Martin TM, McCloskey JJ, Rose JB,", "bbox": [424.0, 794.0, 719.0, 805.0]}, {"text": "Theroux MC, Zagnoev M. Comparison of cuffed and uncuffed endotracheal", "bbox": [428.0, 805.0, 720.0, 816.0]}, {"text": "tubes in young children during general anesthesia. Anesthesiology . 1997;", "bbox": [427.0, 818.0, 720.0, 830.0]}, {"text": "86:627–631; discussion 627A.", "bbox": [427.0, 831.0, 549.0, 841.0]}, {"text": "89.", "bbox": [409.0, 843.0, 425.0, 853.0]}, {"text": "Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective", "bbox": [425.0, 843.0, 720.0, 855.0]}, {"text": "randomized controlled multi-centre trial of cuffed or uncuffed endo-", "bbox": [427.0, 855.0, 718.0, 869.0]}, {"text": "tracheal tubes in small children. Br J Anaesth . 2009;103:867–873.", "bbox": [427.0, 868.0, 703.0, 879.0]}, {"text": "90. Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P,", "bbox": [409.0, 881.0, 719.0, 892.0]}, {"text": "Bonnard C, Chassard D. Risk factors for airway complications during", "bbox": [427.0, 892.0, 720.0, 903.0]}, {"text": "general anaesthesia in paediatric patients. Paediatr Anaesth . 2002;12:", "bbox": [428.0, 905.0, 719.0, 916.0]}, {"text": "762–769.", "bbox": [428.0, 917.0, 468.0, 928.0]}, {"text": "91. Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus", "bbox": [409.0, 930.0, 720.0, 942.0]}, {"text": "uncuffed endotracheal tubes in pediatric intensive care. J Pediatr . 2004;", "bbox": [428.0, 943.0, 720.0, 955.0]}, {"text": "144:333–337.", "bbox": [427.0, 955.0, 484.0, 965.0]}, {"text": "92. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal", "bbox": [409.0, 966.0, 720.0, 979.0]}, {"text": "tubes in pediatric intensive care. J Pediatr . 1994;125:57–62.", "bbox": [427.0, 979.0, 677.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1001.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 280}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#75#都是参考文献的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:29:10"}
{"id": 1042044, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "c9f3fc90-a7ff-475a-9fa8-bce48a78d985", "title": null, "text": "【0】页码:65\n page 80 ]. These ubiquitous minerals feel slick when wet because their atoms form flat, smooth layers. The surfaces of these layers frequently carry an electric charge, which might be able to attract organic molecules and hold them in place. Experiments later confirmed these speculations. In the late 1970s an Israeli research group demonstrated that amino acids can concentrate on clay surfaces and then link up into short chains that resemble biological proteins. These chemical reactions occurred when the investigators evaporated a water-based solution containing amino acids from a vessel containing clays—a situation not unlike the evaporation of a shallow pond or tidal pool with a muddy bottom.\n\n【1】More recently, separate research teams led by James P. Ferris of the Rensselaer Polytechnic Institute and by Gustaf Arrhenius of the Scripps Institution of Oceanography demonstrated that clays and other layered minerals can attract and assemble a variety of organic molecules. In a tour de force series of experiments during the past decade, the team at Rensselaer found that clays can act as scaffolds for the building blocks of RNA, the molecule in living organisms that translates genetic instructions into proteins.\n\n【2】Once organic molecules had attached\n\n【3】 cules that would become biologically important. Recent experiments show, once again, that minerals may have played a central role in this task.\n\n【4】## Preferential Treatment\n\n【5】\n perhaps the most mysterious episode of selection left all living organisms with a strange predominance of one type of amino acid. Like many organic molecules, amino acids come in two forms.\n\n【6】Each version comprises the same types of atoms, but the two molecules are constructed as mirror images of each other.\n\n【7】The phenomenon is called chirality, but for simplicity's sake scientists refer to the two versions as \"left-handed\" (or \"L\") and \"right-handed\" (or \"D\"). Organic synthesis experiments like Miller's invariably produce 50–50 mixtures of L and D molecules, but the excess of lefthanded amino acids in living organisms is nearly 100 percent.\n\n【8】Researchers have proposed a dozen theories—from the mundane to the exotic—to account for this bizarre occurrence. Some astrophysicists have argued that the earth might have formed with an excess of L amino acids—a consequence of processes that took place in the cloud of dust and gas that became the solar system. The main problem with this theory\n\n【9】 feature of the physical environment selected one version over the other. To me, the most obvious candidates for this specialized physical environment are crystal faces whose surface structures are mirror images of each other [ see box on page 80 ]. Last spring I narrowed in on calcite, the common mineral that forms limestone and marble, in part because it often displays magnificent pairs of mirror-image faces. The chemical structure of calcite in many mollusk shells bonds strongly to amino acids. Knowing this, I began to suspect that calcite surfaces may feature chemical bonding sites that are ideally suited to only one type of amino acid or the other. With the help of my Carnegie colleague Timothy Filley (now at Purdue University) and Glenn Goodfriend of George Washington University, I ran more than 100 tests of this hypothesis.\n\n【10】Our experiments were simple in concept, although they required meticulous clean-room procedures to avoid contamination by the amino acids that exist everywhere in the environment. We immersed a well-formed, fist-size crystal of calcite into a 50–50 solution of aspartic acid, a common amino acid. After 24 hours we removed the crystal from this solution, washed it in water and carefully collected all the molecules that had ad-\n Crystal faces of certain minerals could have ACTIVELY SELECTED and concentrated molecules that were destined to become biologically important.\n\n【11】 themselves to a mineral scaffold, various types of complex molecules could have been forged. But only a chosen few were eventually incorporated into living cells.\n\n【12】That means that some kind of template must have selected the primitive mole-\n\n【13】 is that in most situations such processes yield only the slightest excess—less than 1 percent—of L or D molecules.\n\n【14】Alternatively, the world might have started with a 50–50 mixture of L and D amino acids, and then some important\n\n【15】 THE AUTHOR\n\n【16】 ROBERT M. HAZEN has explored the behavior of minerals under high pressure at the Carnegie Institution of Washington's Geophysical Laboratory since 1976. In the past five years he has designed many of his mineral experiments to mimic the high-pressure environments of deepsea hydrothermal vents. Rocks and minerals first piqued Hazen's curiosity as a child growing up in northern New Jersey, a region known for its unusual ore deposits. After receiving a doctorate in earth sciences at Harvard University in 1975 and spending a year at the University of Cambridge, he joined the staff at Carnegie. In 1990 Hazen took on a second position, as professor of earth science at George Mason University. He is also a part-time professional trumpeter and the author of numerous articles and books on science, education, history and music.\n\n【17】 hered to specific crystal faces. In one experiment after another we observed that calcite's \"left-handed\" faces selected L- amino acids, and vice versa, with excesses approaching 40 percent in some cases.\n\n【18】Curiously, calcite faces with finely terraced surfaces displayed the greatest selectivity. This outcome led us to speculate that these terraced edges might force the L and D amino acids to line up in neat rows on their respective faces. Under the right environmental conditions, these organized rows of amino acids might chemically join to form proteinlike molecules—some made entirely of L", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "page 80 ]. These ubiquitous minerals feel", "bbox": [45.0, 86.0, 262.0, 101.0]}, {"text": "slick when wet because their atoms form", "bbox": [44.0, 104.0, 261.0, 117.0]}, {"text": "flat, smooth layers. The surfaces of these", "bbox": [44.0, 120.0, 261.0, 133.0]}, {"text": "layers frequently carry an electric charge,", "bbox": [44.0, 135.0, 261.0, 149.0]}, {"text": "which might be able to attract organic", "bbox": [45.0, 151.0, 261.0, 165.0]}, {"text": "molecules and hold them in place. Ex-", "bbox": [45.0, 167.0, 260.0, 181.0]}, {"text": "periments later confirmed these specula-", "bbox": [45.0, 183.0, 260.0, 197.0]}, {"text": "tions. In the late 1970s an Israeli research", "bbox": [45.0, 199.0, 261.0, 214.0]}, {"text": "group demonstrated that amino acids", "bbox": [45.0, 215.0, 261.0, 229.0]}, {"text": "can concentrate on clay surfaces and then", "bbox": [45.0, 231.0, 261.0, 245.0]}, {"text": "link up into short chains that resemble bi-", "bbox": [45.0, 247.0, 261.0, 261.0]}, {"text": "ological proteins. These chemical reac-", "bbox": [45.0, 264.0, 260.0, 277.0]}, {"text": "tions occurred when the investigators", "bbox": [44.0, 279.0, 261.0, 294.0]}, {"text": "evaporated a water-based solution con-", "bbox": [45.0, 295.0, 261.0, 309.0]}, {"text": "taining amino acids from a vessel con-", "bbox": [45.0, 312.0, 260.0, 325.0]}, {"text": "taining clays—a situation not unlike the", "bbox": [44.0, 327.0, 261.0, 342.0]}, {"text": "evaporation of a shallow pond or tidal", "bbox": [45.0, 344.0, 261.0, 357.0]}, {"text": "pool with a muddy bottom.", "bbox": [45.0, 360.0, 194.0, 374.0]}, {"text": "More recently, separate research teams", "bbox": [65.0, 375.0, 261.0, 390.0]}, {"text": "led by James P. Ferris of the Rensselaer", "bbox": [44.0, 392.0, 261.0, 405.0]}, {"text": "Polytechnic Institute and by Gustaf Ar-", "bbox": [45.0, 407.0, 260.0, 422.0]}, {"text": "rhenius of the Scripps Institution of Ocean-", "bbox": [44.0, 423.0, 260.0, 438.0]}, {"text": "ography demonstrated that clays and", "bbox": [45.0, 440.0, 261.0, 453.0]}, {"text": "other layered minerals can attract and as-", "bbox": [45.0, 455.0, 260.0, 470.0]}, {"text": "semble a variety of organic molecules. In", "bbox": [45.0, 472.0, 261.0, 485.0]}, {"text": "a tour de force series of experiments dur-", "bbox": [45.0, 488.0, 260.0, 501.0]}, {"text": "ing the past decade, the team at Rensse-", "bbox": [45.0, 503.0, 259.0, 517.0]}, {"text": "laer found that clays can act as scaffolds", "bbox": [45.0, 519.0, 261.0, 534.0]}, {"text": "for the building blocks of RNA, the mol-", "bbox": [45.0, 535.0, 261.0, 549.0]}, {"text": "ecule in living organisms that translates", "bbox": [45.0, 552.0, 261.0, 565.0]}, {"text": "genetic instructions into proteins.", "bbox": [45.0, 567.0, 225.0, 582.0]}, {"text": "Once organic molecules had attached", "bbox": [65.0, 583.0, 263.0, 597.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "cules that would become biologically im-", "bbox": [273.0, 86.0, 489.0, 101.0]}, {"text": "portant. Recent experiments show, once", "bbox": [273.0, 104.0, 490.0, 117.0]}, {"text": "again, that minerals may have played a", "bbox": [274.0, 120.0, 489.0, 133.0]}, {"text": "central role in this task.", "bbox": [274.0, 135.0, 399.0, 149.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Preferential Treatment", "bbox": [273.0, 165.0, 427.0, 181.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "perhaps the most mysterious epi-", "bbox": [273.0, 183.0, 488.0, 197.0]}, {"text": "sode of selection left all living organisms", "bbox": [273.0, 199.0, 490.0, 214.0]}, {"text": "with a strange predominance of one type", "bbox": [274.0, 215.0, 489.0, 229.0]}, {"text": "of amino acid. Like many organic mole-", "bbox": [273.0, 231.0, 487.0, 245.0]}, {"text": "cules, amino acids come in two forms.", "bbox": [273.0, 247.0, 489.0, 261.0]}, {"text": "Each version comprises the same types of", "bbox": [273.0, 264.0, 489.0, 277.0]}, {"text": "atoms, but the two molecules are con-", "bbox": [274.0, 279.0, 488.0, 294.0]}, {"text": "structed as mirror images of each other.", "bbox": [273.0, 295.0, 488.0, 309.0]}, {"text": "The phenomenon is called chirality, but", "bbox": [275.0, 312.0, 489.0, 325.0]}, {"text": "for simplicity's sake scientists refer to the", "bbox": [273.0, 327.0, 490.0, 342.0]}, {"text": "two versions as \"left-handed\" (or \"L\")", "bbox": [273.0, 344.0, 489.0, 357.0]}, {"text": "and \"right-handed\" (or \"D\"). Organic", "bbox": [274.0, 359.0, 490.0, 373.0]}, {"text": "synthesis experiments like Miller's in-", "bbox": [273.0, 374.0, 488.0, 390.0]}, {"text": "variably produce 50–50 mixtures of L", "bbox": [274.0, 392.0, 489.0, 405.0]}, {"text": "and D molecules, but the excess of left-", "bbox": [274.0, 407.0, 488.0, 422.0]}, {"text": "handed amino acids in living organisms", "bbox": [273.0, 423.0, 489.0, 438.0]}, {"text": "is nearly 100 percent.", "bbox": [273.0, 440.0, 390.0, 453.0]}, {"text": "Researchers have proposed a dozen", "bbox": [292.0, 455.0, 489.0, 470.0]}, {"text": "theories—from the mundane to the exot-", "bbox": [273.0, 471.0, 488.0, 485.0]}, {"text": "ic—to account for this bizarre occur-", "bbox": [273.0, 488.0, 488.0, 501.0]}, {"text": "rence. Some astrophysicists have argued", "bbox": [274.0, 503.0, 489.0, 517.0]}, {"text": "that the earth might have formed with an", "bbox": [273.0, 519.0, 489.0, 534.0]}, {"text": "excess of L amino acids—a consequence", "bbox": [273.0, 536.0, 489.0, 549.0]}, {"text": "of processes that took place in the cloud", "bbox": [273.0, 551.0, 490.0, 565.0]}, {"text": "of dust and gas that became the solar sys-", "bbox": [273.0, 567.0, 488.0, 582.0]}, {"text": "tem. The main problem with this theory", "bbox": [273.0, 583.0, 490.0, 597.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "feature of the physical environment se-", "bbox": [502.0, 86.0, 716.0, 101.0]}, {"text": "lected one version over the other. To me,", "bbox": [501.0, 104.0, 717.0, 117.0]}, {"text": "the most obvious candidates for this spe-", "bbox": [502.0, 120.0, 716.0, 133.0]}, {"text": "cialized physical environment are crystal", "bbox": [502.0, 135.0, 718.0, 149.0]}, {"text": "faces whose surface structures are mirror", "bbox": [502.0, 151.0, 718.0, 165.0]}, {"text": "images of each other [ see box on page", "bbox": [502.0, 167.0, 718.0, 181.0]}, {"text": "80 ]. Last spring I narrowed in on calcite,", "bbox": [502.0, 184.0, 717.0, 197.0]}, {"text": "the common mineral that forms lime-", "bbox": [502.0, 199.0, 716.0, 214.0]}, {"text": "stone and marble, in part because it often", "bbox": [502.0, 215.0, 718.0, 229.0]}, {"text": "displays magnificent pairs of mirror-im-", "bbox": [502.0, 231.0, 716.0, 245.0]}, {"text": "age faces. The chemical structure of cal-", "bbox": [502.0, 247.0, 717.0, 261.0]}, {"text": "cite in many mollusk shells bonds strong-", "bbox": [501.0, 264.0, 716.0, 277.0]}, {"text": "ly to amino acids. Knowing this, I began", "bbox": [502.0, 279.0, 718.0, 294.0]}, {"text": "to suspect that calcite surfaces may fea-", "bbox": [502.0, 295.0, 717.0, 309.0]}, {"text": "ture chemical bonding sites that are ide-", "bbox": [502.0, 312.0, 716.0, 325.0]}, {"text": "ally suited to only one type of amino acid", "bbox": [502.0, 327.0, 718.0, 342.0]}, {"text": "or the other. With the help of my Carne-", "bbox": [502.0, 344.0, 716.0, 357.0]}, {"text": "gie colleague Timothy Filley (now at Pur-", "bbox": [502.0, 359.0, 716.0, 374.0]}, {"text": "due University) and Glenn Goodfriend of", "bbox": [502.0, 375.0, 718.0, 390.0]}, {"text": "George Washington University, I ran", "bbox": [502.0, 392.0, 718.0, 405.0]}, {"text": "more than 100 tests of this hypothesis.", "bbox": [502.0, 407.0, 709.0, 422.0]}, {"text": "Our experiments were simple in con-", "bbox": [520.0, 423.0, 716.0, 437.0]}, {"text": "cept, although they required meticulous", "bbox": [502.0, 440.0, 718.0, 453.0]}, {"text": "clean-room procedures to avoid contam-", "bbox": [501.0, 455.0, 716.0, 470.0]}, {"text": "ination by the amino acids that exist", "bbox": [502.0, 472.0, 718.0, 485.0]}, {"text": "everywhere in the environment. We im-", "bbox": [502.0, 488.0, 717.0, 501.0]}, {"text": "mersed a well-formed, fist-size crystal of", "bbox": [502.0, 503.0, 718.0, 517.0]}, {"text": "calcite into a 50–50 solution of aspartic", "bbox": [502.0, 519.0, 718.0, 534.0]}, {"text": "acid, a common amino acid. After 24", "bbox": [502.0, 535.0, 718.0, 549.0]}, {"text": "hours we removed the crystal from this", "bbox": [502.0, 551.0, 718.0, 565.0]}, {"text": "solution, washed it in water and careful-", "bbox": [502.0, 567.0, 716.0, 581.0]}, {"text": "ly collected all the molecules that had ad-", "bbox": [501.0, 583.0, 717.0, 597.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Crystal faces of certain minerals could have", "bbox": [212.0, 614.0, 720.0, 643.0]}, {"text": "ACTIVELY SELECTED and concentrated molecules", "bbox": [71.0, 637.0, 720.0, 686.0]}, {"text": "that were destined to become biologically important.", "bbox": [103.0, 684.0, 718.0, 713.0]}], "type": "Formula", "position": 5}, {"raw_context": [{"text": "themselves to a mineral scaffold, various", "bbox": [44.0, 727.0, 263.0, 742.0]}, {"text": "types of complex molecules could have", "bbox": [44.0, 743.0, 261.0, 757.0]}, {"text": "been forged. But only a chosen few were", "bbox": [45.0, 760.0, 261.0, 773.0]}, {"text": "eventually incorporated into living cells.", "bbox": [45.0, 775.0, 260.0, 790.0]}, {"text": "That means that some kind of template", "bbox": [47.0, 792.0, 261.0, 805.0]}, {"text": "must have selected the primitive mole-", "bbox": [45.0, 808.0, 260.0, 822.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "is that in most situations such processes", "bbox": [273.0, 727.0, 490.0, 742.0]}, {"text": "yield only the slightest excess—less than", "bbox": [274.0, 743.0, 490.0, 758.0]}, {"text": "1 percent—of L or D molecules.", "bbox": [275.0, 760.0, 443.0, 773.0]}, {"text": "Alternatively, the world might have", "bbox": [293.0, 775.0, 490.0, 790.0]}, {"text": "started with a 50–50 mixture of L and D", "bbox": [273.0, 791.0, 490.0, 805.0]}, {"text": "amino acids, and then some important", "bbox": [274.0, 807.0, 489.0, 822.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "THE AUTHOR", "bbox": [48.0, 850.0, 64.0, 943.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "ROBERT M. HAZEN has explored the behavior of minerals under high pressure at the Carnegie", "bbox": [70.0, 844.0, 489.0, 860.0]}, {"text": "Institution of Washington's Geophysical Laboratory since 1976. In the past five years he has", "bbox": [72.0, 860.0, 489.0, 872.0]}, {"text": "designed many of his mineral experiments to mimic the high-pressure environments of deep-", "bbox": [71.0, 872.0, 489.0, 885.0]}, {"text": "sea hydrothermal vents. Rocks and minerals first piqued Hazen's curiosity as a child growing", "bbox": [72.0, 885.0, 490.0, 899.0]}, {"text": "up in northern New Jersey, a region known for its unusual ore deposits. After receiving a doc-", "bbox": [71.0, 898.0, 488.0, 911.0]}, {"text": "torate in earth sciences at Harvard University in 1975 and spending a year at the University of", "bbox": [72.0, 913.0, 489.0, 925.0]}, {"text": "Cambridge, he joined the staff at Carnegie. In 1990 Hazen took on a second position, as pro-", "bbox": [71.0, 925.0, 489.0, 938.0]}, {"text": "fessor of earth science at George Mason University. He is also a part-time professional trum-", "bbox": [72.0, 939.0, 488.0, 952.0]}, {"text": "peter and the author of numerous articles and books on science, education, history and music.", "bbox": [71.0, 952.0, 488.0, 965.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "hered to specific crystal faces. In one ex-", "bbox": [501.0, 727.0, 717.0, 742.0]}, {"text": "periment after another we observed that", "bbox": [502.0, 743.0, 718.0, 757.0]}, {"text": "calcite's \"left-handed\" faces selected L-", "bbox": [502.0, 760.0, 716.0, 774.0]}, {"text": "amino acids, and vice versa, with excess-", "bbox": [502.0, 775.0, 716.0, 790.0]}, {"text": "es approaching 40 percent in some cases.", "bbox": [502.0, 792.0, 717.0, 806.0]}, {"text": "Curiously, calcite faces with finely", "bbox": [520.0, 808.0, 717.0, 821.0]}, {"text": "terraced surfaces displayed the greatest", "bbox": [502.0, 823.0, 718.0, 838.0]}, {"text": "selectivity. This outcome led us to spec-", "bbox": [502.0, 840.0, 716.0, 853.0]}, {"text": "ulate that these terraced edges might", "bbox": [502.0, 855.0, 718.0, 869.0]}, {"text": "force the L and D amino acids to line up", "bbox": [502.0, 872.0, 718.0, 885.0]}, {"text": "in neat rows on their respective faces. Un-", "bbox": [502.0, 887.0, 717.0, 902.0]}, {"text": "der the right environmental conditions,", "bbox": [502.0, 903.0, 717.0, 917.0]}, {"text": "these organized rows of amino acids", "bbox": [502.0, 920.0, 718.0, 933.0]}, {"text": "might chemically join to form proteinlike", "bbox": [502.0, 935.0, 718.0, 950.0]}, {"text": "molecules—some made entirely of L", "bbox": [502.0, 952.0, 718.0, 965.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 65}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "", "type4": "栏目混乱#3#14#栏目混乱，内容互相穿插", "type6": "有用性#15#16#附加文献的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:22:43"}
{"id": 1042043, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "d062afb1-6c52-4a59-9611-a68f03abc7ed", "title": null, "text": "【0】页码:53\n current is thought to assist the restoration of nerve function and overall muscle tone.\n\n【1】 Electrical stimulation should be carried out under the supervision of a specialist.\n\n【2】Without the guidance of an expert, patients are advised not to attempt it in any case. The technique may cause problems if it is carried out without adequate supervision.\n\n【3】 It's important to keep in mind that the facial nerve is capable of recovering naturally. Therefore, therapists and medical experts give time for the nerve to heal without any intervention. Meanwhile, patients are encouraged to carry out facial massages tenderly that will assist blood circulation and maintain muscle health. At the start of the recovery phase, patients must try to focus more on massaging their face and protecting their eye. They can gently massage their face in a circular motion by using their fingers.\n\n【4】 Once the facial nerve starts recovering, it begins to emit electrical signals in the facial muscles.\n\n【5】 If the facial muscles are unable to regain their natural tone, patients can go ahead with electrical stimulation after consulting a certified healthcare professional.\n\n【6】 As mentioned earlier, the technique has to be carried out very carefully. Failure to do so can result in overstimulation of the muscles. This can be a painful experience for patients since muscles become stiff and can twitch uncontrollably.\n\n【7】 Electrical stimulation helps improve the contraction of muscles, which helps achieve facial symmetry.\n\n【8】## Biofeedback Therapy\n\n【9】\n Facial paralysis, at some point, causes a disruption in nerve signals sent to the facial muscles. When this confusion continues to exist, there are interruptions in the feedback sent to the brain about the affected side of the face. Since your mind is always busy, it ultimately forgets about the lack of communication on the affected side of the face. It only relies on the good side and you may notice that the facial muscles that remain unaffected slowly begin to dominate.\n\n【10】## What Is Biofeedback?\n\n【11】\n Bell's palsy rehabilitation via biofeedback is all about getting your entire face", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "current is thought to assist the restoration of nerve function and overall muscle", "bbox": [93.0, 97.0, 723.0, 117.0]}, {"text": "tone.", "bbox": [93.0, 120.0, 136.0, 139.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Electrical stimulation should be carried out under the supervision of a specialist.", "bbox": [93.0, 154.0, 719.0, 173.0]}, {"text": "Without the guidance of an expert, patients are advised not to attempt it in any", "bbox": [93.0, 176.0, 722.0, 195.0]}, {"text": "case. The technique may cause problems if it is carried out without adequate", "bbox": [93.0, 198.0, 723.0, 217.0]}, {"text": "supervision.", "bbox": [93.0, 220.0, 193.0, 240.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "It's important to keep in mind that the facial nerve is capable of recovering", "bbox": [93.0, 256.0, 725.0, 275.0]}, {"text": "naturally. Therefore, therapists and medical experts give time for the nerve to", "bbox": [93.0, 278.0, 724.0, 297.0]}, {"text": "heal without any intervention. Meanwhile, patients are encouraged to carry out", "bbox": [93.0, 300.0, 724.0, 319.0]}, {"text": "facial massages tenderly that will assist blood circulation and maintain muscle", "bbox": [93.0, 322.0, 724.0, 341.0]}, {"text": "health. At the start of the recovery phase, patients must try to focus more on", "bbox": [93.0, 344.0, 724.0, 363.0]}, {"text": "massaging their face and protecting their eye. They can gently massage their", "bbox": [93.0, 366.0, 724.0, 385.0]}, {"text": "face in a circular motion by using their fingers.", "bbox": [93.0, 388.0, 460.0, 407.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Once the facial nerve starts recovering, it begins to emit electrical signals in the", "bbox": [93.0, 423.0, 722.0, 442.0]}, {"text": "facial muscles.", "bbox": [93.0, 445.0, 213.0, 464.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "If the facial muscles are unable to regain their natural tone, patients can go ahead", "bbox": [93.0, 478.0, 724.0, 498.0]}, {"text": "with electrical stimulation after consulting a certified healthcare professional.", "bbox": [93.0, 501.0, 694.0, 520.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "As mentioned earlier, the technique has to be carried out very carefully. Failure", "bbox": [93.0, 536.0, 722.0, 556.0]}, {"text": "to do so can result in overstimulation of the muscles. This can be a painful", "bbox": [93.0, 559.0, 724.0, 578.0]}, {"text": "experience for patients since muscles become stiff and can twitch", "bbox": [93.0, 581.0, 724.0, 600.0]}, {"text": "uncontrollably.", "bbox": [93.0, 603.0, 216.0, 622.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Electrical stimulation helps improve the contraction of muscles, which helps", "bbox": [93.0, 638.0, 724.0, 657.0]}, {"text": "achieve facial symmetry.", "bbox": [93.0, 660.0, 291.0, 679.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Biofeedback Therapy", "bbox": [93.0, 700.0, 274.0, 720.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Facial paralysis, at some point, causes a disruption in nerve signals sent to the", "bbox": [93.0, 738.0, 722.0, 758.0]}, {"text": "facial muscles. When this confusion continues to exist, there are interruptions in", "bbox": [93.0, 761.0, 724.0, 780.0]}, {"text": "the feedback sent to the brain about the affected side of the face. Since your", "bbox": [93.0, 783.0, 724.0, 802.0]}, {"text": "mind is always busy, it ultimately forgets about the lack of communication on", "bbox": [93.0, 805.0, 724.0, 824.0]}, {"text": "the affected side of the face. It only relies on the good side and you may notice", "bbox": [93.0, 827.0, 722.0, 846.0]}, {"text": "that the facial muscles that remain unaffected slowly begin to dominate.", "bbox": [93.0, 849.0, 651.0, 868.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "What Is Biofeedback?", "bbox": [94.0, 883.0, 279.0, 903.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Bell's palsy rehabilitation via biofeedback is all about getting your entire face", "bbox": [93.0, 921.0, 723.0, 940.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 53}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 23:39:53"}
{"id": 1042042, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "0d0458fa-30d3-4fe7-8934-22f64c36c686", "title": null, "text": "【0】页码:276\n milrinone). In cases of toxicity the cardiovascular effects may persist for several hours even after the infusion is discontinued.\n\n【1】## Neurologic System\n\n【2】\n A primary goal of resuscitation is to preserve brain function.\n\n【3】Limit the risk of secondary neuronal injury by adhering to the following precautions:\n • Do not routinely provide excessive ventilation or hyperventilation. Hyperventilation has no benefit and may impair neurologic outcome by adversely affecting cardiac\n\n【4】 output and cerebral perfusion. 445 Intentional brief hyperventilation may be used as temporizing rescue therapy in response to signs of impending cerebral herniation (eg, sudden rise in measured intracranial pressure, dilated pupil[s] not responsive to light, bradycardia, hypertension).\n\n【5】Therapeutic hypothermia (32°C to 34°C) may be considered for children who remain comatose after resuscitation from cardiac arrest (Class IIb, LOE C). 446,447 It is reasonable for adolescents resuscitated from sudden, witnessed, out-of-hospital VF cardiac arrest (Class IIa, LOE C).\n\n【6】Although there are no randomized studies in the pediatric population on the effect of therapeutic hypothermia, it is of benefit in adults following witnessed out-of-hospital VF arrest448.449 and in asphyxiated newborns.450,451\n The ideal method and duration of cooling and rewarming are not known. Prevent shivering by providing sedation and, if needed, neuromuscular blockade, recognizing that this can mask seizure activity. Closely watch for signs of infection.\n\n【7】Other potential complications of hypothermia include diminished cardiac output, arrhythmia, pancreatitis, coagulopathy, thrombocytopenia, hypophosphatemia, hypovolemia from cold diuresis, hypokalemia, and hypomagnesemia.\n\n【8】Monitor temperature continuously, if possible, and treat fever (>38°C) aggressively with antipyretics and cooling devices because fever adversely influences recovery from ischemic brain injury (Class IIa, LOE C). 452–458 • Treat postischemic seizures aggressively; search for a correctable metabolic cause such as hypoglycemia or electrolyte imbalance.\n\n【9】• Avoid rewarming from 32 to 34°C faster than 0.5°C per 2 hours unless the patient requires rapid rewarming for clinical reasons.\n\n【10】## Renal System\n\n【11】\n Decreased urine output (<1 mL/kg per hour in infants and children or <30 mL/hour in adolescents) may be caused by prerenal conditions (eg, dehydration, inadequate systemic perfusion), renal ischemic damage, or a combination of factors.\n\n【12】Avoid nephrotoxic medications and adjust the dose of medications excreted by the kidneys until you have checked renal function.\n\n【13】## Interhospital Transport\n\n【14】\n Ideally postresuscitation care should be provided by a trained team from a pediatric tertiary care facility. Contact such a team as early as possible during the resuscitation attempt and coordinate transportation with the receiving unit. 459 Transport team members should be trained and experienced in the care of critically ill and injured children 103.460 and supervised by a\n\n【15】 pediatric emergency medicine or pediatric critical care physician. The mode of transport and composition of the team should be established for each system based on the care required by each patient. 461 Monitor exhaled CO2 (qualitative colorimetric detector or capnography) during interhospital or intrahospital transport of intubated patients (Class IIa, LOE B). 116,413\n\n【16】## Family Presence During Resuscitation\n\n【17】\n Family presence during CPR is increasingly common, and most parents would like to be given the opportunity to be present during resuscitation of their child. 462–471 Studies show that family members who are present at a resuscitation would recommend it to others. 462 ,463 ,465 ,471 ,472 Parents of chronically ill children are comfortable with medical equipment and emergency procedures, but even family members with no medical background who were at the side of a loved one to say goodbye during the final moments of life believe that their presence was beneficial to the patient, 462 – 464 , 466 , 471 – 476 comforting for them, 462–465,468–471,476 and helpful in their adjustment 463 – 465 , 472 , 473 , 476 , 477 and grieving process. 477 Standardized psychological examinations suggest that, compared with those not present, family members present during attempted resuscitations have less anxiety and depression and more constructive grieving behavior. 477 Parents or family members often fail to ask, but healthcare providers should offer the opportunity in most situations. 474 , 478 , 479 Whenever possible, provide family members with the option of being present during resuscitation of an infant or child (Class I, LOE B). 474,478,479 Family presence during resuscitation, in general, is not disruptive, 464 , 472 , 475 , 476 , 480 , 481 and does not create stress among staff or negatively affect their performance. 462 , 464 , 480 , 482 If the presence of family members creates undue staff stress or is considered detrimental to the resuscitation, 483 then family members should be respectfully asked to leave (Class IIa, LOE C).\n\n【18】Members of the resuscitation team must be sensitive to the presence of family members, and one person should be assigned to remain with the family to comfort, answer questions, and support the family. 484\n\n【19】## Termination Of Resuscitative Efforts There Are No Reliable Predictors Of Outcome To Guide When To\n\n【20】\n terminate resuscitative efforts in children.\n\n【21】Clinical variables associated with survival include length of CPR, number of doses of epinephrine, age, witnessed versus unwitnessed cardiac arrest, and the first and subsequent rhythm. 6, 7,11–13,15,16,151,485–489 None of these associations, however, predict outcome. Witnessed collapse, bystander CPR, and a short interval from collapse to arrival of professionals improve the chances of a successful resuscitation. Intact survival has been documented after unusually prolonged in-hospital resuscitation. 13 , 133 , 134 , 151 , 490 , 491\n\n【22】## Sudden Unexplained Deaths\n\n【23】\n Increasing evidence demonstrates that some cases of sudden infant death syndrome (SIDS) and sudden death in older children and young adults may be associated with genetic mutations causing cardiac ion channelopathies. Channelopathies are dysfunctional myocyte ion channels that result in abnormal movement of electrolytes into and/or out of the cell and predispose the\n\n【24】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "milrinone). In cases of toxicity the cardiovascular effects may", "bbox": [60.0, 84.0, 375.0, 99.0]}, {"text": "persist for several hours even after the infusion is discontinued.", "bbox": [60.0, 100.0, 375.0, 113.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Neurologic System", "bbox": [60.0, 129.0, 177.0, 143.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "A primary goal of resuscitation is to preserve brain function.", "bbox": [60.0, 144.0, 375.0, 159.0]}, {"text": "Limit the risk of secondary neuronal injury by adhering to the", "bbox": [60.0, 160.0, 376.0, 174.0]}, {"text": "following precautions:", "bbox": [60.0, 176.0, 179.0, 189.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "• Do not routinely provide excessive ventilation or hyper-", "bbox": [60.0, 202.0, 375.0, 216.0]}, {"text": "ventilation. Hyperventilation has no benefit and may im-", "bbox": [72.0, 218.0, 375.0, 232.0]}, {"text": "pair neurologic outcome by adversely affecting cardiac", "bbox": [71.0, 234.0, 376.0, 247.0]}], "type": "List-item", "position": 6}, {"raw_context": [{"text": "output and cerebral perfusion. 445 Intentional brief hyper-", "bbox": [71.0, 247.0, 375.0, 262.0]}, {"text": "ventilation may be used as temporizing rescue therapy in", "bbox": [72.0, 264.0, 377.0, 279.0]}, {"text": "response to signs of impending cerebral herniation (eg,", "bbox": [71.0, 280.0, 376.0, 294.0]}, {"text": "sudden rise in measured intracranial pressure, dilated", "bbox": [72.0, 295.0, 376.0, 309.0]}, {"text": "pupil[s] not responsive to light, bradycardia, hypertension).", "bbox": [72.0, 311.0, 375.0, 325.0]}, {"text": "Therapeutic hypothermia (32°C to 34°C) may be consid-", "bbox": [70.0, 327.0, 375.0, 341.0]}, {"text": "ered for children who remain comatose after resuscitation", "bbox": [71.0, 342.0, 377.0, 356.0]}, {"text": "from cardiac arrest (Class IIb, LOE C). 446,447 It is reason-", "bbox": [72.0, 358.0, 375.0, 371.0]}, {"text": "able for adolescents resuscitated from sudden, witnessed,", "bbox": [71.0, 373.0, 375.0, 388.0]}, {"text": "out-of-hospital VF cardiac arrest (Class IIa, LOE C).", "bbox": [71.0, 389.0, 376.0, 402.0]}, {"text": "Although there are no randomized studies in the pediatric", "bbox": [72.0, 404.0, 376.0, 419.0]}, {"text": "population on the effect of therapeutic hypothermia, it is of", "bbox": [72.0, 421.0, 377.0, 434.0]}, {"text": "benefit in adults following witnessed out-of-hospital VF", "bbox": [72.0, 435.0, 375.0, 450.0]}, {"text": "arrest448.449 and in asphyxiated newborns.450,451", "bbox": [72.0, 450.0, 317.0, 465.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "The ideal method and duration of cooling and rewarming", "bbox": [70.0, 467.0, 375.0, 481.0]}, {"text": "are not known. Prevent shivering by providing sedation and, if", "bbox": [72.0, 482.0, 376.0, 496.0]}, {"text": "needed, neuromuscular blockade, recognizing that this can", "bbox": [71.0, 498.0, 376.0, 513.0]}, {"text": "mask seizure activity. Closely watch for signs of infection.", "bbox": [71.0, 514.0, 375.0, 528.0]}, {"text": "Other potential complications of hypothermia include dimin-", "bbox": [71.0, 529.0, 375.0, 544.0]}, {"text": "ished cardiac output, arrhythmia, pancreatitis, coagulopathy,", "bbox": [71.0, 545.0, 376.0, 559.0]}, {"text": "thrombocytopenia, hypophosphatemia, hypovolemia from", "bbox": [71.0, 561.0, 376.0, 574.0]}, {"text": "cold diuresis, hypokalemia, and hypomagnesemia.", "bbox": [71.0, 576.0, 323.0, 589.0]}, {"text": "Monitor temperature continuously, if possible, and treat", "bbox": [70.0, 591.0, 376.0, 605.0]}, {"text": "fever (>38°C) aggressively with antipyretics and cooling", "bbox": [72.0, 607.0, 376.0, 621.0]}, {"text": "devices because fever adversely influences recovery from", "bbox": [71.0, 622.0, 377.0, 636.0]}, {"text": "ischemic brain injury (Class IIa, LOE C). 452–458", "bbox": [71.0, 638.0, 323.0, 652.0]}, {"text": "• Treat postischemic seizures aggressively; search for a", "bbox": [60.0, 654.0, 377.0, 668.0]}, {"text": "correctable metabolic cause such as hypoglycemia or", "bbox": [71.0, 669.0, 376.0, 683.0]}, {"text": "electrolyte imbalance.", "bbox": [71.0, 685.0, 187.0, 698.0]}, {"text": "• Avoid rewarming from 32 to 34°C faster than 0.5°C per 2", "bbox": [60.0, 700.0, 376.0, 715.0]}, {"text": "hours unless the patient requires rapid rewarming for", "bbox": [71.0, 716.0, 375.0, 729.0]}, {"text": "clinical reasons.", "bbox": [71.0, 731.0, 157.0, 745.0]}], "type": "List-item", "position": 8}, {"raw_context": [{"text": "Renal System", "bbox": [60.0, 760.0, 146.0, 775.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Decreased urine output (<1 mL/kg per hour in infants and", "bbox": [60.0, 776.0, 376.0, 789.0]}, {"text": "children or <30 mL/hour in adolescents) may be caused by", "bbox": [60.0, 790.0, 375.0, 807.0]}, {"text": "prerenal conditions (eg, dehydration, inadequate systemic per-", "bbox": [60.0, 807.0, 375.0, 821.0]}, {"text": "fusion), renal ischemic damage, or a combination of factors.", "bbox": [60.0, 823.0, 375.0, 836.0]}, {"text": "Avoid nephrotoxic medications and adjust the dose of medications", "bbox": [60.0, 838.0, 375.0, 851.0]}, {"text": "excreted by the kidneys until you have checked renal function.", "bbox": [60.0, 853.0, 360.0, 868.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Interhospital Transport", "bbox": [138.0, 883.0, 299.0, 899.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Ideally postresuscitation care should be provided by a trained", "bbox": [60.0, 900.0, 376.0, 914.0]}, {"text": "team from a pediatric tertiary care facility. Contact such a", "bbox": [60.0, 916.0, 377.0, 929.0]}, {"text": "team as early as possible during the resuscitation attempt and", "bbox": [60.0, 930.0, 376.0, 944.0]}, {"text": "coordinate transportation with the receiving unit. 459 Transport", "bbox": [60.0, 946.0, 377.0, 960.0]}, {"text": "team members should be trained and experienced in the care", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "of critically ill and injured children 103.460 and supervised by a", "bbox": [60.0, 977.0, 377.0, 991.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "pediatric emergency medicine or pediatric critical care physi-", "bbox": [403.0, 84.0, 719.0, 99.0]}, {"text": "cian. The mode of transport and composition of the team should", "bbox": [403.0, 100.0, 720.0, 113.0]}, {"text": "be established for each system based on the care required by", "bbox": [403.0, 115.0, 720.0, 129.0]}, {"text": "each patient. 461 Monitor exhaled CO2 (qualitative colorimetric", "bbox": [403.0, 130.0, 720.0, 146.0]}, {"text": "detector or capnography) during interhospital or intrahospital", "bbox": [403.0, 146.0, 720.0, 160.0]}, {"text": "transport of intubated patients (Class IIa, LOE B). 116,413", "bbox": [403.0, 161.0, 683.0, 176.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Family Presence During Resuscitation", "bbox": [434.0, 191.0, 692.0, 207.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "Family presence during CPR is increasingly common, and", "bbox": [403.0, 207.0, 721.0, 221.0]}, {"text": "most parents would like to be given the opportunity to be", "bbox": [403.0, 223.0, 720.0, 237.0]}, {"text": "present during resuscitation of their child. 462–471 Studies show", "bbox": [404.0, 237.0, 720.0, 252.0]}, {"text": "that family members who are present at a resuscitation would", "bbox": [403.0, 254.0, 720.0, 267.0]}, {"text": "recommend it to others. 462 ,463 ,465 ,471 ,472 Parents of chronically", "bbox": [403.0, 267.0, 720.0, 283.0]}, {"text": "ill children are comfortable with medical equipment and", "bbox": [403.0, 284.0, 720.0, 298.0]}, {"text": "emergency procedures, but even family members with no", "bbox": [403.0, 300.0, 721.0, 314.0]}, {"text": "medical background who were at the side of a loved one to", "bbox": [404.0, 316.0, 721.0, 329.0]}, {"text": "say goodbye during the final moments of life believe that", "bbox": [403.0, 331.0, 721.0, 344.0]}, {"text": "their presence was beneficial to the patient, 462 – 464 , 466 , 471 – 476", "bbox": [403.0, 347.0, 720.0, 359.0]}, {"text": "comforting for them, 462–465,468–471,476 and helpful in their", "bbox": [403.0, 361.0, 720.0, 374.0]}, {"text": "adjustment 463 – 465 , 472 , 473 , 476 , 477 and grieving process. 477 Stan-", "bbox": [404.0, 374.0, 720.0, 393.0]}, {"text": "dardized psychological examinations suggest that, compared", "bbox": [403.0, 393.0, 720.0, 406.0]}, {"text": "with those not present, family members present during attempted", "bbox": [403.0, 408.0, 720.0, 422.0]}, {"text": "resuscitations have less anxiety and depression and more con-", "bbox": [403.0, 424.0, 719.0, 437.0]}, {"text": "structive grieving behavior. 477 Parents or family members often", "bbox": [404.0, 438.0, 720.0, 453.0]}, {"text": "fail to ask, but healthcare providers should offer the opportunity", "bbox": [404.0, 455.0, 720.0, 468.0]}, {"text": "in most situations. 474 , 478 , 479 Whenever possible, provide family", "bbox": [403.0, 469.0, 720.0, 483.0]}, {"text": "members with the option of being present during resuscitation of", "bbox": [403.0, 484.0, 720.0, 499.0]}, {"text": "an infant or child (Class I, LOE B). 474,478,479", "bbox": [404.0, 501.0, 625.0, 514.0]}, {"text": "Family presence during resuscitation, in general, is not dis-", "bbox": [416.0, 516.0, 720.0, 530.0]}, {"text": "ruptive, 464 , 472 , 475 , 476 , 480 , 481 and does not create stress among staff", "bbox": [403.0, 531.0, 720.0, 546.0]}, {"text": "or negatively affect their performance. 462 , 464 , 480 , 482 If the pres-", "bbox": [403.0, 546.0, 718.0, 561.0]}, {"text": "ence of family members creates undue staff stress or is consid-", "bbox": [403.0, 562.0, 719.0, 576.0]}, {"text": "ered detrimental to the resuscitation, 483 then family members", "bbox": [403.0, 577.0, 720.0, 592.0]}, {"text": "should be respectfully asked to leave (Class IIa, LOE C).", "bbox": [403.0, 594.0, 720.0, 608.0]}, {"text": "Members of the resuscitation team must be sensitive to the", "bbox": [404.0, 608.0, 720.0, 622.0]}, {"text": "presence of family members, and one person should be assigned", "bbox": [403.0, 624.0, 720.0, 638.0]}, {"text": "to remain with the family to comfort, answer questions, and", "bbox": [403.0, 640.0, 720.0, 653.0]}, {"text": "support the family. 484", "bbox": [404.0, 655.0, 513.0, 669.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Termination of Resuscitative Efforts", "bbox": [439.0, 684.0, 687.0, 698.0]}, {"text": "There are no reliable predictors of outcome to guide when to", "bbox": [404.0, 700.0, 721.0, 715.0]}], "type": "Section-header", "position": 16}, {"raw_context": [{"text": "terminate resuscitative efforts in children.", "bbox": [403.0, 716.0, 623.0, 729.0]}, {"text": "Clinical variables associated with survival include length", "bbox": [416.0, 731.0, 720.0, 745.0]}, {"text": "of CPR, number of doses of epinephrine, age, witnessed", "bbox": [403.0, 747.0, 720.0, 761.0]}, {"text": "versus unwitnessed cardiac arrest, and the first and subse-", "bbox": [404.0, 762.0, 719.0, 776.0]}, {"text": "quent rhythm. 6, 7,11–13,15,16,151,485–489 None of these associa-", "bbox": [403.0, 776.0, 720.0, 791.0]}, {"text": "tions, however, predict outcome. Witnessed collapse, by-", "bbox": [403.0, 792.0, 720.0, 806.0]}, {"text": "stander CPR, and a short interval from collapse to arrival of", "bbox": [403.0, 808.0, 721.0, 823.0]}, {"text": "professionals improve the chances of a successful resuscita-", "bbox": [403.0, 824.0, 719.0, 837.0]}, {"text": "tion. Intact survival has been documented after unusually", "bbox": [403.0, 839.0, 720.0, 854.0]}, {"text": "prolonged in-hospital resuscitation. 13 , 133 , 134 , 151 , 490 , 491", "bbox": [404.0, 856.0, 672.0, 867.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Sudden Unexplained Deaths", "bbox": [466.0, 884.0, 658.0, 899.0]}], "type": "Section-header", "position": 18}, {"raw_context": [{"text": "Increasing evidence demonstrates that some cases of sudden", "bbox": [404.0, 901.0, 720.0, 914.0]}, {"text": "infant death syndrome (SIDS) and sudden death in older chil-", "bbox": [403.0, 916.0, 719.0, 930.0]}, {"text": "dren and young adults may be associated with genetic mutations", "bbox": [403.0, 931.0, 720.0, 945.0]}, {"text": "causing cardiac ion channelopathies. Channelopathies are dys-", "bbox": [403.0, 946.0, 719.0, 960.0]}, {"text": "functional myocyte ion channels that result in abnormal move-", "bbox": [404.0, 963.0, 718.0, 976.0]}, {"text": "ment of electrolytes into and/or out of the cell and predispose the", "bbox": [403.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 20}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 276}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#3#4#为同段\n多余换行#14#15#为同段内容\n缺少换行#17#17#Family presence during resuscitation,这里开始应与前文分行\n缺少换行#19#19# There Are No Reliable这里开始应与前文换行\n多余换行#19#20#19后半部和20为同段", "type3": "无关文本#0#0#全文存在多处无关数字", "type6": "信息有用性#24#24#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:48:23"}
{"id": 1042041, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "f8c4a9e0-3ba1-4dd1-9651-7117b15a2389", "title": null, "text": "【0】页码:79\n tems in the 1990s. Louis Rosenberg, the company's chairman, says the key hardware component is a 25-gram motor that can move up and down, imparting about 150 grams of force against the user's hand.\n\n【1】The mouse can also vibrate up to 300 times a second, enabling the device to reproduce a wide range of sensations. For example, Immersion's special-effects software library allows Web site developers to enhance pages with simulated textures such as corduroy or sandpaper. When the iFeel user drags the cursor across such a page, the mouse rapidly jiggles up and down, as if it were traveling over a rough surface.\n\n【2】Trying out the iFeel mouse for the first\n\n【3】 time can be disconcerting. The installation is straightforward: just plug this USB device into an appropriate computer port and load the driver software from a CD- ROM. (Mac users are out of luck; so far the mouse works only with Windows.) Once connected, the iFeel fundamentally alters one's perception of Windows' familiar screens. If you slide the cursor across one of the desktop program icons, the mouse shakes like dice in a cup. If you glide the mouse over the selections in a menu bar, it feels like a set of chattering false teeth. Push the iFeel back and forth over the options in a pull-down menu, and it hums like an electric shaver. The mouse also shakes up Web pages (iFeel works with either Explorer or Netscape, but Explorer must be installed on the computer even if you use only Netscape).\n\n【4】The most noticeable sensation is the bump that occurs when the cursor crosses a hot link or menu choice.\n\n【5】For anyone accustomed to an inert mouse, such physical cues may be distracting. Because people have different thresholds for sensing force, Immersion's software developers have provided access to an onscreen control for adjusting the strength of the feedback. Another control allows you to choose a different set of sensations. In addition to the default setting (which simulates the feeling of tapping a wooden surface), the iFeel offers six oth-\n\n【6】 er options: crisp, metallic, spongy, rubbery, steel drum and sonic vibe.\n\n【7】With continued use, something unexpected happens: the iFeel's twitching becomes an organic part of the computing experience. The mouse's motions provide\n\n【8】 gentle reinforcement when one is steering the cursor to a desired point on the screen.\n\n【9】In poorly designed Web pages crowded with text, the iFeel can make it easier to find and click on links to other sites. And when a program crashes, the mouse's pal-\n\n【10】 technology is recognized by NASA, raved about by xtolled worldwide by over 25,000 sleep clinics and essionals. Yet this miracle must be felt to be believed.\n\n【11】 While the thick, ornate pads that cover most mattresses are necessary to keep the hard steel springs inside, they create a hammock effect outside—and can actually cause pressure points.\n\n【12】our beds, billions of microporoscopic memory cells as molecular springs that contour precisely to every curve and angle. They give your body perfect support Tempur-Pedic's Swedish scientists used NASA's anti-G-force research to invent Tempur material—a new kind of viscoelastic that reacts to body mass and heat. It self-adjusts to your exact shape. And it's the reason why millions love our high-tech Weightless Sleep System, the first really new bed in 75 years.\n\n【13】wonder that 3 out of 4 Tempur-Pedic owners go out of their to recommend our Swedish Sleep System\" to close friends relatives. 82% tell us it's the best bed they've ever had!\n\n【14】rings you FREE DEMO KIT. Better yet, phone or fax", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "tems in the 1990s. Louis Rosenberg, the", "bbox": [61.0, 150.0, 278.0, 165.0]}, {"text": "company's chairman, says the key hard-", "bbox": [61.0, 167.0, 276.0, 181.0]}, {"text": "ware component is a 25-gram motor that", "bbox": [61.0, 183.0, 277.0, 197.0]}, {"text": "can move up and down, imparting about", "bbox": [61.0, 199.0, 277.0, 214.0]}, {"text": "150 grams of force against the user's hand.", "bbox": [63.0, 215.0, 276.0, 229.0]}, {"text": "The mouse can also vibrate up to 300", "bbox": [63.0, 231.0, 278.0, 245.0]}, {"text": "times a second, enabling the device to re-", "bbox": [61.0, 247.0, 276.0, 261.0]}, {"text": "produce a wide range of sensations. For", "bbox": [61.0, 263.0, 277.0, 277.0]}, {"text": "example, Immersion's special-effects soft-", "bbox": [61.0, 279.0, 276.0, 294.0]}, {"text": "ware library allows Web site developers", "bbox": [61.0, 295.0, 278.0, 309.0]}, {"text": "to enhance pages with simulated textures", "bbox": [61.0, 311.0, 278.0, 325.0]}, {"text": "such as corduroy or sandpaper. When the", "bbox": [61.0, 327.0, 278.0, 342.0]}, {"text": "iFeel user drags the cursor across such a", "bbox": [61.0, 344.0, 278.0, 357.0]}, {"text": "page, the mouse rapidly jiggles up and", "bbox": [61.0, 359.0, 279.0, 374.0]}, {"text": "down, as if it were traveling over a rough", "bbox": [61.0, 375.0, 279.0, 390.0]}, {"text": "surface.", "bbox": [61.0, 392.0, 105.0, 405.0]}, {"text": "Trying out the iFeel mouse for the first", "bbox": [81.0, 406.0, 278.0, 422.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "time can be disconcerting. The installa-", "bbox": [61.0, 423.0, 277.0, 437.0]}, {"text": "tion is straightforward: just plug this USB", "bbox": [61.0, 440.0, 278.0, 453.0]}, {"text": "device into an appropriate computer port", "bbox": [61.0, 454.0, 278.0, 469.0]}, {"text": "and load the driver software from a CD-", "bbox": [61.0, 471.0, 276.0, 485.0]}, {"text": "ROM. (Mac users are out of luck; so far", "bbox": [61.0, 487.0, 278.0, 501.0]}, {"text": "the mouse works only with Windows.)", "bbox": [61.0, 503.0, 278.0, 517.0]}, {"text": "Once connected, the iFeel fundamental-", "bbox": [61.0, 519.0, 276.0, 534.0]}, {"text": "ly alters one's perception of Windows' fa-", "bbox": [61.0, 535.0, 276.0, 549.0]}, {"text": "miliar screens. If you slide the cursor", "bbox": [61.0, 551.0, 277.0, 565.0]}, {"text": "across one of the desktop program icons,", "bbox": [61.0, 567.0, 277.0, 581.0]}, {"text": "the mouse shakes like dice in a cup. If you", "bbox": [61.0, 583.0, 278.0, 597.0]}, {"text": "glide the mouse over the selections in a", "bbox": [61.0, 599.0, 278.0, 614.0]}, {"text": "menu bar, it feels like a set of chattering", "bbox": [61.0, 615.0, 278.0, 629.0]}, {"text": "false teeth. Push the iFeel back and forth", "bbox": [61.0, 631.0, 278.0, 645.0]}, {"text": "over the options in a pull-down menu,", "bbox": [61.0, 647.0, 278.0, 662.0]}, {"text": "and it hums like an electric shaver. The", "bbox": [61.0, 663.0, 277.0, 677.0]}, {"text": "mouse also shakes up Web pages (iFeel", "bbox": [61.0, 679.0, 278.0, 694.0]}, {"text": "works with either Explorer or Netscape,", "bbox": [61.0, 694.0, 278.0, 710.0]}, {"text": "but Explorer must be installed on the", "bbox": [61.0, 712.0, 277.0, 724.0]}, {"text": "computer even if you use only Netscape).", "bbox": [61.0, 727.0, 277.0, 742.0]}, {"text": "The most noticeable sensation is the", "bbox": [62.0, 743.0, 278.0, 757.0]}, {"text": "bump that occurs when the cursor cross-", "bbox": [61.0, 759.0, 276.0, 773.0]}, {"text": "es a hot link or menu choice.", "bbox": [61.0, 774.0, 215.0, 789.0]}, {"text": "For anyone accustomed to an inert", "bbox": [80.0, 792.0, 278.0, 805.0]}, {"text": "mouse, such physical cues may be dis-", "bbox": [61.0, 807.0, 276.0, 821.0]}, {"text": "tracting. Because people have different", "bbox": [61.0, 823.0, 277.0, 837.0]}, {"text": "thresholds for sensing force, Immersion's", "bbox": [61.0, 839.0, 278.0, 853.0]}, {"text": "software developers have provided access", "bbox": [61.0, 855.0, 278.0, 869.0]}, {"text": "to an onscreen control for adjusting the", "bbox": [61.0, 871.0, 277.0, 885.0]}, {"text": "strength of the feedback. Another control", "bbox": [61.0, 887.0, 278.0, 901.0]}, {"text": "allows you to choose a different set of sen-", "bbox": [61.0, 903.0, 276.0, 917.0]}, {"text": "sations. In addition to the default setting", "bbox": [61.0, 919.0, 278.0, 933.0]}, {"text": "(which simulates the feeling of tapping a", "bbox": [61.0, 935.0, 278.0, 949.0]}, {"text": "wooden surface), the iFeel offers six oth-", "bbox": [62.0, 951.0, 276.0, 965.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "er options: crisp, metallic, spongy, rubbery,", "bbox": [289.0, 149.0, 507.0, 167.0]}, {"text": "steel drum and sonic vibe.", "bbox": [289.0, 167.0, 427.0, 181.0]}, {"text": "With continued use, something unex-", "bbox": [309.0, 183.0, 505.0, 197.0]}, {"text": "pected happens: the iFeel's twitching be-", "bbox": [289.0, 199.0, 505.0, 213.0]}, {"text": "comes an organic part of the computing", "bbox": [289.0, 215.0, 506.0, 229.0]}, {"text": "experience. The mouse's motions provide", "bbox": [289.0, 231.0, 506.0, 245.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "gentle reinforcement when one is steering", "bbox": [517.0, 150.0, 734.0, 165.0]}, {"text": "the cursor to a desired point on the screen.", "bbox": [518.0, 167.0, 732.0, 181.0]}, {"text": "In poorly designed Web pages crowded", "bbox": [518.0, 183.0, 734.0, 197.0]}, {"text": "with text, the iFeel can make it easier to", "bbox": [518.0, 199.0, 734.0, 213.0]}, {"text": "find and click on links to other sites. And", "bbox": [518.0, 215.0, 733.0, 229.0]}, {"text": "when a program crashes, the mouse's pal-", "bbox": [518.0, 231.0, 733.0, 245.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "technology is recognized by NASA, raved about by", "bbox": [341.0, 665.0, 546.0, 675.0]}, {"text": "xtolled worldwide by over 25,000 sleep clinics and", "bbox": [349.0, 679.0, 548.0, 689.0]}, {"text": "essionals. Yet this miracle must be felt to be believed.", "bbox": [346.0, 694.0, 546.0, 703.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "While the thick, ornate pads that cover most mattresses are nec-", "bbox": [301.0, 712.0, 546.0, 722.0]}, {"text": "essary to keep the hard steel springs inside, they create a ham-", "bbox": [301.0, 726.0, 546.0, 737.0]}, {"text": "mock effect outside—and can actually cause pressure points.", "bbox": [303.0, 741.0, 546.0, 751.0]}, {"text": "our beds, billions of microporoscopic memory cells", "bbox": [328.0, 755.0, 548.0, 765.0]}, {"text": "as molecular springs that contour precisely to", "bbox": [337.0, 768.0, 528.0, 779.0]}, {"text": "every curve and angle. They give your body perfect support", "bbox": [302.0, 783.0, 525.0, 792.0]}, {"text": "Tempur-Pedic's Swedish scientists used NASA's anti-G-force", "bbox": [303.0, 800.0, 547.0, 810.0]}, {"text": "research to invent Tempur material—a new kind of viscoelastic", "bbox": [302.0, 816.0, 547.0, 825.0]}, {"text": "that reacts to body mass and heat. It self-adjusts to your exact", "bbox": [302.0, 829.0, 549.0, 840.0]}, {"text": "shape. And it's the reason why millions love our high-tech", "bbox": [303.0, 844.0, 549.0, 853.0]}, {"text": "Weightless Sleep System, the first really new bed in 75 years.", "bbox": [302.0, 857.0, 540.0, 868.0]}, {"text": "wonder that 3 out of 4 Tempur-Pedic owners go out of their", "bbox": [316.0, 875.0, 548.0, 885.0]}, {"text": "to recommend our Swedish Sleep System\" to close friends", "bbox": [320.0, 889.0, 549.0, 900.0]}, {"text": "relatives. 82% tell us it's the best bed they've ever had!", "bbox": [318.0, 903.0, 536.0, 915.0]}, {"text": "rings you FREE DEMO KIT. Better yet, phone or fax", "bbox": [341.0, 921.0, 539.0, 933.0]}], "type": "Text", "position": 6}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 79}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#3#为同段\n多余换行#5#6#为同段\n多余换行#7#8#为同段", "type3": null, "type4": null, "type5": null, "type6": "信息有用性#10#14#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 22:32:46"}
{"id": 1042040, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "1fd23a03-0e6b-4936-9ba6-88bd049c6f1a", "title": null, "text": "【0】页码:260\n\n【1】## Postural Habits\n\n【2】\n Dental arches can suffer deformities caused by anomalous position pressures during sleep or while being seated, be¬ ing the most frequent the habit of sleeping with the face reclined on a hand, on a forearm or the use of pillows.\n\n【3】The type of malocclusion caused by this habit usually is unilateral and located in the upper arch. (23)\n Figs. 15 and 16.\n\n【4】 What happens is that the weight of the head is passed to the tissues of the maxillary region by the action of the hand, the arm or the pillow. The maxillary teeth tend to incline toward the palate causing a unilateral posterior cross bite without a deviation of the dental midline, meanwhile, the mandibular tissues are not affected because it is a mobile bone and escapes the pressure by sliding. (23)\n\n【5】 When a shift of the midline is present, the cause of the cross bite will not be the posture habit but a mandibular shift caused probably by a premature contact of the deciduous canines (functional or false posterior cross bite) (please refer to Cross Bite chapter).\n\n【6】## Correction\n\n【7】\n For the correction of a posture habit, the use of a Hawley plate with a buccal grill on the side where the cross bite is being produced is indicated. This appliance will serve as a reminder to the patient, and whenever the patient leans the head on the hand or the arm, they will squeeze the cheek against this grill.\n\n【8】 For the correction of true unilateral cross bites in the per¬ manent dentition, we can use \"Z\" 1/8\" diameter elastics, from the palatine aspects of the upper teeth to the buccal aspects of the lower teeth on the side where the cross bite is located (please refer to Cross Bite chapter).\n\n【9】 Now then, if the unilateral cross bite is in the deciduous dentition, it can be corrected with a plate with a unilateral expansion screw.\n\n【10】## Mouth Breathing Habit\n\n【11】\n Normal breathing, also called nasal breathing, is the one in which the air flows freely through the nose with a si¬ multaneous closure of the oral cavity, therefore creating a negative pressure between the tongue and the hard palate at the moment of aspiration; the tongue is elevated and it leans against the palate, exerting a positive development stimuli. When the patient breathes through the mouth the tongue adopts a descendant position to allow the flow of air. Oral breathing is normally associated to patients with lingual and lip interposition.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Postural habits", "bbox": [66.0, 118.0, 181.0, 138.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "Dental arches can suffer deformities caused by anomalous", "bbox": [66.0, 155.0, 381.0, 171.0]}, {"text": "position pressures during sleep or while being seated, be¬", "bbox": [66.0, 173.0, 379.0, 189.0]}, {"text": "ing the most frequent the habit of sleeping with the face", "bbox": [66.0, 190.0, 381.0, 205.0]}, {"text": "reclined on a hand, on a forearm or the use of pillows.", "bbox": [66.0, 208.0, 381.0, 222.0]}, {"text": "The type of malocclusion caused by this habit usually is", "bbox": [66.0, 224.0, 381.0, 240.0]}, {"text": "unilateral and located in the upper arch. (23)", "bbox": [66.0, 242.0, 302.0, 257.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Figs. 15 and 16.", "bbox": [191.0, 957.0, 261.0, 971.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "What happens is that the weight of the head is passed to", "bbox": [402.0, 106.0, 717.0, 121.0]}, {"text": "the tissues of the maxillary region by the action of the hand,", "bbox": [402.0, 123.0, 716.0, 139.0]}, {"text": "the arm or the pillow. The maxillary teeth tend to incline", "bbox": [402.0, 141.0, 716.0, 156.0]}, {"text": "toward the palate causing a unilateral posterior cross bite", "bbox": [402.0, 158.0, 717.0, 174.0]}, {"text": "without a deviation of the dental midline, meanwhile, the", "bbox": [402.0, 175.0, 717.0, 191.0]}, {"text": "mandibular tissues are not affected because it is a mobile", "bbox": [403.0, 194.0, 717.0, 207.0]}, {"text": "bone and escapes the pressure by sliding. (23)", "bbox": [402.0, 210.0, 643.0, 226.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "When a shift of the midline is present, the cause of the cross", "bbox": [403.0, 244.0, 717.0, 261.0]}, {"text": "bite will not be the posture habit but a mandibular shift", "bbox": [402.0, 262.0, 717.0, 277.0]}, {"text": "caused probably by a premature contact of the deciduous", "bbox": [402.0, 279.0, 718.0, 294.0]}, {"text": "canines (functional or false posterior cross bite) (please", "bbox": [402.0, 296.0, 717.0, 312.0]}, {"text": "refer to Cross Bite chapter).", "bbox": [403.0, 314.0, 557.0, 330.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Correction", "bbox": [403.0, 366.0, 472.0, 381.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "For the correction of a posture habit, the use of a Hawley", "bbox": [404.0, 417.0, 718.0, 433.0]}, {"text": "plate with a buccal grill on the side where the cross bite is", "bbox": [404.0, 435.0, 719.0, 451.0]}, {"text": "being produced is indicated. This appliance will serve as a", "bbox": [404.0, 452.0, 719.0, 467.0]}, {"text": "reminder to the patient, and whenever the patient leans the", "bbox": [405.0, 471.0, 719.0, 484.0]}, {"text": "head on the hand or the arm, they will squeeze the cheek", "bbox": [404.0, 487.0, 719.0, 503.0]}, {"text": "against this grill.", "bbox": [404.0, 505.0, 494.0, 521.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "For the correction of true unilateral cross bites in the per¬", "bbox": [404.0, 539.0, 717.0, 554.0]}, {"text": "manent dentition, we can use \"Z\" 1/8\" diameter elastics,", "bbox": [405.0, 556.0, 718.0, 571.0]}, {"text": "from the palatine aspects of the upper teeth to the buccal", "bbox": [405.0, 573.0, 719.0, 589.0]}, {"text": "aspects of the lower teeth on the side where the cross bite", "bbox": [405.0, 591.0, 719.0, 606.0]}, {"text": "is located (please refer to Cross Bite chapter).", "bbox": [405.0, 608.0, 649.0, 624.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Now then, if the unilateral cross bite is in the deciduous", "bbox": [405.0, 642.0, 719.0, 658.0]}, {"text": "dentition, it can be corrected with a plate with a unilateral", "bbox": [405.0, 660.0, 719.0, 675.0]}, {"text": "expansion screw.", "bbox": [405.0, 678.0, 499.0, 694.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Mouth breathing habit", "bbox": [405.0, 744.0, 577.0, 762.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Normal breathing, also called nasal breathing, is the one", "bbox": [405.0, 782.0, 720.0, 796.0]}, {"text": "in which the air flows freely through the nose with a si¬", "bbox": [405.0, 798.0, 719.0, 814.0]}, {"text": "multaneous closure of the oral cavity, therefore creating a", "bbox": [405.0, 816.0, 720.0, 831.0]}, {"text": "negative pressure between the tongue and the hard palate", "bbox": [405.0, 833.0, 720.0, 848.0]}, {"text": "at the moment of aspiration; the tongue is elevated and it", "bbox": [405.0, 850.0, 721.0, 866.0]}, {"text": "leans against the palate, exerting a positive development", "bbox": [405.0, 869.0, 720.0, 882.0]}, {"text": "stimuli. When the patient breathes through the mouth the", "bbox": [405.0, 885.0, 721.0, 901.0]}, {"text": "tongue adopts a descendant position to allow the flow of", "bbox": [405.0, 903.0, 721.0, 918.0]}, {"text": "air. Oral breathing is normally associated to patients with", "bbox": [406.0, 920.0, 720.0, 935.0]}, {"text": "lingual and lip interposition.", "bbox": [406.0, 938.0, 564.0, 953.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 260}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "", "type3": "无关文本#3#3#(23)Figs. 15 and 16.\n无关文本#4#4# (23)", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 18:35:06"}
{"id": 1042039, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "41b25076-bda4-4fce-9410-d7b5dde85ebc", "title": null, "text": "【0】页码:274\n\n【1】## Disadvantages\n\n【2】\n 1.\n\n【3】 2.\n\n【4】 3.\n\n【5】 We must invest laboratory time to elaborate it.\n\n【6】Because it is an intraoral mobile appliance, the thin¬ nest part of the union with the button can fracture due to the force exerted by the tongue.\n\n【7】The patient can experience a bit of difficulty during speech or while eating until he or she becomes accustomed to the appliance.\n\n【8】## Recommendations\n\n【9】\n Encourage the patient to constantly \"play around\" with 1.\n\n【10】the rocker using the tongue, this way the reprogram¬ ming stimuli will be always present.\n\n【11】2.\n\n【12】We must indicate to the patient that the tip of the tongue must be placed on the omega of the appli¬ ance and to do the swinging movements and at the same time swallow saliva, and that during meal times every time the patient is going to swallow the tongue must be placed in the same place. In this manner the tongue is induced to place itself to a more physiologic position during deglutition and at the same time the atypical deglutition habit will be corrected.\n\n【13】## Lip Bumper\n\n【14】\n The Lip Bumper is considered a true myofunctional ap¬ pliance, it is widely indicated in cases in which there is an inadequate pressure of the lower lip over the lower dento alveolar complex, and in cases that, due to an excessive overjet, a lip interposition or sucking habit is beginning. (1424) They are made of 0.036\" stainless steel wire, the anterior section can or cannot be covered with acrylic, the acrylic must be 2 mm to 3 mm separated from the buccal aspect of the lower incisors, we can also find pre fabricated versions in a wide size selection. Normally lip bumpers are soldered to the lower molar bands or they can be removable, these\n Fig. 56 Lip Bumper.\n\n【15】 are inserted in the accessory tubes of the molar bands, or we can rarely find them placed in a removable acrylic plate.\n\n【16】(please refer to Anchorage chapter).\n\n【17】 Their function consists in preventing incorrect lip pressure during deglutition, and to free the lower dental arch from the tonicity of the lip and of the muscles of the chin. (14.24)\n Flig. 57. The buccal shield must be separated 2 mm to 3 mm from the buccal aspects of the incisors.\n Figs. 58 and 59. Prefabricated lip bumpers.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Disadvantages", "bbox": [78.0, 88.0, 183.0, 103.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "1.", "bbox": [80.0, 124.0, 93.0, 137.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "2.", "bbox": [78.0, 141.0, 93.0, 155.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "3.", "bbox": [78.0, 191.0, 93.0, 205.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "We must invest laboratory time to elaborate it.", "bbox": [105.0, 122.0, 362.0, 137.0]}, {"text": "Because it is an intraoral mobile appliance, the thin¬", "bbox": [104.0, 139.0, 392.0, 155.0]}, {"text": "nest part of the union with the button can fracture", "bbox": [105.0, 157.0, 393.0, 171.0]}, {"text": "due to the force exerted by the tongue.", "bbox": [104.0, 173.0, 318.0, 189.0]}, {"text": "The patient can experience a bit of difficulty during", "bbox": [104.0, 189.0, 393.0, 204.0]}, {"text": "speech or while eating until he or she becomes ac-", "bbox": [104.0, 206.0, 391.0, 222.0]}, {"text": "customed to the appliance.", "bbox": [104.0, 224.0, 255.0, 239.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Recommendations", "bbox": [78.0, 257.0, 209.0, 273.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Encourage the patient to constantly \"play around\" with", "bbox": [104.0, 291.0, 393.0, 307.0]}, {"text": "1.", "bbox": [80.0, 293.0, 93.0, 307.0]}, {"text": "the rocker using the tongue, this way the reprogram¬", "bbox": [104.0, 308.0, 392.0, 324.0]}, {"text": "ming stimuli will be always present.", "bbox": [105.0, 325.0, 302.0, 340.0]}, {"text": "2.", "bbox": [78.0, 341.0, 92.0, 357.0]}, {"text": "We must indicate to the patient that the tip of the", "bbox": [105.0, 342.0, 393.0, 358.0]}, {"text": "tongue must be placed on the omega of the appli¬", "bbox": [105.0, 359.0, 392.0, 375.0]}, {"text": "ance and to do the swinging movements and at the", "bbox": [104.0, 376.0, 393.0, 392.0]}, {"text": "same time swallow saliva, and that during meal times", "bbox": [104.0, 393.0, 393.0, 409.0]}, {"text": "every time the patient is going to swallow the tongue", "bbox": [104.0, 411.0, 393.0, 426.0]}, {"text": "must be placed in the same place. In this manner the", "bbox": [104.0, 427.0, 393.0, 443.0]}, {"text": "tongue is induced to place itself to a more physiologic", "bbox": [105.0, 445.0, 393.0, 460.0]}, {"text": "position during deglutition and at the same time the", "bbox": [105.0, 462.0, 393.0, 478.0]}, {"text": "atypical deglutition habit will be corrected.", "bbox": [104.0, 480.0, 343.0, 495.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Lip Bumper", "bbox": [78.0, 550.0, 144.0, 564.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "The Lip Bumper is considered a true myofunctional ap¬", "bbox": [79.0, 583.0, 392.0, 597.0]}, {"text": "pliance, it is widely indicated in cases in which there is an", "bbox": [78.0, 599.0, 393.0, 615.0]}, {"text": "inadequate pressure of the lower lip over the lower dento", "bbox": [78.0, 616.0, 393.0, 631.0]}, {"text": "alveolar complex, and in cases that, due to an excessive", "bbox": [78.0, 633.0, 393.0, 648.0]}, {"text": "overjet, a lip interposition or sucking habit is beginning. (1424)", "bbox": [78.0, 651.0, 393.0, 664.0]}, {"text": "They are made of 0.036\" stainless steel wire, the anterior", "bbox": [80.0, 666.0, 393.0, 682.0]}, {"text": "section can or cannot be covered with acrylic, the acrylic", "bbox": [78.0, 683.0, 393.0, 698.0]}, {"text": "must be 2 mm to 3 mm separated from the buccal aspect of", "bbox": [78.0, 700.0, 393.0, 714.0]}, {"text": "the lower incisors, we can also find pre fabricated versions", "bbox": [78.0, 715.0, 393.0, 731.0]}, {"text": "in a wide size selection. Normally lip bumpers are soldered", "bbox": [78.0, 733.0, 393.0, 747.0]}, {"text": "to the lower molar bands or they can be removable, these", "bbox": [78.0, 749.0, 393.0, 765.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Fig. 56 Lip Bumper.", "bbox": [191.0, 958.0, 281.0, 972.0]}], "type": "Caption", "position": 11}, {"raw_context": [{"text": "are inserted in the accessory tubes of the molar bands, or", "bbox": [415.0, 87.0, 729.0, 102.0]}, {"text": "we can rarely find them placed in a removable acrylic plate.", "bbox": [416.0, 104.0, 729.0, 119.0]}, {"text": "(please refer to Anchorage chapter).", "bbox": [416.0, 121.0, 609.0, 136.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Their function consists in preventing incorrect lip pressure", "bbox": [416.0, 155.0, 729.0, 171.0]}, {"text": "during deglutition, and to free the lower dental arch from", "bbox": [416.0, 173.0, 730.0, 189.0]}, {"text": "the tonicity of the lip and of the muscles of the chin. (14.24)", "bbox": [416.0, 190.0, 725.0, 205.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Flig. 57. The buccal shield must be separated 2 mm to 3 mm", "bbox": [416.0, 460.0, 680.0, 476.0]}, {"text": "from the buccal aspects of the incisors.", "bbox": [416.0, 477.0, 587.0, 490.0]}], "type": "Caption", "position": 15}, {"raw_context": [{"text": "Figs. 58 and 59. Prefabricated lip bumpers.", "bbox": [481.0, 957.0, 668.0, 970.0]}], "type": "Caption", "position": 18}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 274}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#7#序号和内容分类，2段应该对应5段的内容，以此往下\n序号格式不一致#9#9#Encourage the patient to constantly “play around” with 1.  序号应该在内容前面\n多余换行#10#10#the rocker using the tongue...与上面第9段联接\n多余换行#12#12#We must indicate to the patient that...与11段的序号联接不换行\n多余换行#15#15# are inserted in the accessory tubes ...与14段... they can be removable, these相连接", "type3": "无关文本#17#17#(14.24)", "type4": null, "type5": null, "type6": "有用性#14#14#Fig. 56 Lip Bumper.图片的描述\n有用性#17#17#Flig. 57. The buccal shield must be separated 2 mm to 3 mm from the buccal aspects of the incisors.\nFigs. 58 and 59. Prefabricated lip bumpers.图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:53", "update_time": "2024-04-28 21:51:03"}
{"id": 1042038, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "b6c64d3e-f526-4b7a-a79b-dc8093bbfc1b", "title": null, "text": "【0】页码:153\n Guidelines Part 9: Post–Cardiac Arrest Care: Writing Group Disclosures, Continued\n\n【1】 Inting Group Research Grant Ownership Interest Member Employment Support Bureau/Honoraria Board Other Andrea Gabrielli University of Florida–Professor of †NH-Biomarkers and Traumatic\n  None None None None None Mayo Clinic Fiorida–Chair, Scott M. Silvers None None Nane None None None ront of Em\n Medipren's Hospital of the King's Board for NH-sponsore Arno L. Zaritsky None None None None None clinical trial of after pediatric car Raina Merchant University of None Nane None rch fellow University of Chicago–Asso Terry L. Vander 06/04-04/30/10 DOD/Office None None None Induction Patents r Vital Signs: Mappl to Triage and Guide Resuscitation of Hemorrhagic Shock. This research grant is awarded to the Steven L. Kranick University of Michigan Health None Reviewed a single case None Nane None None sistant Profe than 4 hours work total This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure\n\n【2】\n Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be \"significant\" if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be \"modest\" if it is less than \"significant\" under the preceding definition.\n\n【3】*Modest.\n\n【4】↑ Significant.\n\n【5】## References\n\n【6】\n 1. HACA. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med . 2002;346:549–556.\n\n【7】Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, 2.\n\n【8】Smith K.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med . 2002;346:557–563.\n\n【9】Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Jr., Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation . 2008;118: 2452–2483.\n\n【10】Safar P. Resuscitation from clinical death: Pathophysiologic limits and 1. 4.\n\n【11】therapeutic potentials. Crit Care Med . 1988;16:923–941.\n\n【12】5. Negovsky VA.  The second step in resuscitation–the treatment of the 'post-resuscitation disease.' Resuscitation . 1972;1:1–7.\n\n【13】Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, 1. 6.\n\n【14】Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest.\n\n【15】J Am Coll Cardiol . 2002;40:2110–2116.\n\n【16】Skrifvars MB, Pettila V, Rosenberg PH, Castren M. A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation.\n\n【17】Resuscitation . 2003;59:319–328.\n\n【18】Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW.  Inter- 8.\n\n【19】hospital variability in post-cardiac arrest mortality. Resuscitation. 2009 ; 80:30–34.\n\n【20】9. Callaway CW, Schmicker R, Kampmeyer M, Powell J, Rea TD, Daya MR, Aufderheide TP, Davis DP, Rittenberger JC, Idris AH, Nichol G Receiving hospital characteristics associated with survival after out-ofhospital cardiac arrest. Resuscitation ; 2010;81:524–529.\n\n【21】 10. Kirves H, Skrifvars MB, Vahakuopus M, Ekstrom K, Martikainen M, Castren M. Adherence to resuscitation guidelines during prehospital care of cardiac arrest patients. Eur J Emerg Med . 2007;14:75–81.\n\n【22】11. Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C, Draegni T, Steen PA.  Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest.\n\n【23】Resuscitation . 2007;73:29–39.\n\n【24】12. Gaieski DF, Band RA, Abella BS, Neumar RW, Fuchs BD, Kolansky DM, Merchant RM, Carr BG, Becker LB, Maguire C, Klair A, Hylton J, Goyal M. Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation . 2009;80:418–424.\n\n【25】13. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med .\n\n【26】2004;30:2126–2128.\n\n【27】14. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, Carli P.  Immediate coronary angiography in survivors of out-ofhospital cardiac arrest. N Engl J Med . 1997;336:1629–1633.\n\n【28】15.\n\n【29】Anyfantakis ZA, Baron G, Aubry P, Himbert D, Feldman LJ, Juliard JM, Ricard-Hibon A, Burnod A, Cokkinos DV, Steg PG. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. Am Heart J . 2009;157:312–318.\n\n【30】16. Reynolds JC, Callaway CW, El Khoudary SR, Moore CG, Alvarez RJ, Rittenberger JC. Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis. J Intensive Care Med . 2009;24:179–186.\n\n【31】17. Dumas F, Cariou A, Manzo-Silberman S, Grimaldi D, Vivien B, Rosencher J, Empana J-P, Carli P, Mira J-P, Jouven X, Spaulding C.\n\n【32】Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry. Circ Cardiovasc Interv . 2010;3:200–207.\n\n【33】18. Booth CM, Boone RH, Tomlinson G, Detsky AS. Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA . 2004;291:870–879.\n\n【34】19. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, Hammill SC, Shen WK, Packer DL. Long-term outcomes of outof-hospital cardiac arrest after successful early defibrillation. N Engl J Med . 2003;348:2626–2633.\n\n【35】20. Belliard G, Catez E, Charron C, Caille V, Aegerter P, Dubourg O, Jardin F, Vieillard-Baron A. Efficacy of therapeutic hypothermia after out-ofhospital cardiac arrest due to ventricular fibrillation. Resuscitation .\n\n【36】2007;75:252–259.\n\n【37】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Guidelines Part 9: Post–Cardiac Arrest Care: Writing Group Disclosures, Continued", "bbox": [60.0, 81.0, 464.0, 98.0]}], "type": "Caption", "position": 3}, {"raw_context": [{"text": "Inting Group", "bbox": [67.0, 106.0, 100.0, 117.0]}, {"text": "Research Grant", "bbox": [263.0, 114.0, 307.0, 123.0]}, {"text": "Ownership Interest", "bbox": [502.0, 114.0, 554.0, 123.0]}, {"text": "Member", "bbox": [61.0, 115.0, 86.0, 123.0]}, {"text": "Employment", "bbox": [158.0, 115.0, 194.0, 122.0]}, {"text": "Support", "bbox": [367.0, 115.0, 390.0, 123.0]}, {"text": "Bureau/Honoraria", "bbox": [430.0, 115.0, 479.0, 123.0]}, {"text": "Board", "bbox": [594.0, 115.0, 614.0, 123.0]}, {"text": "Other", "bbox": [674.0, 115.0, 691.0, 122.0]}, {"text": "Andrea Gabrielli", "bbox": [61.0, 129.0, 106.0, 138.0]}, {"text": "University of Florida–Professor of", "bbox": [131.0, 129.0, 223.0, 147.0]}, {"text": "†NH-Biomarkers and Traumatic\n ", "bbox": [240.0, 129.0, 328.0, 145.0]}, {"text": "None", "bbox": [370.0, 130.0, 386.0, 138.0]}, {"text": "None", "bbox": [447.0, 130.0, 462.0, 137.0]}, {"text": "None", "bbox": [520.0, 130.0, 535.0, 137.0]}, {"text": "None", "bbox": [596.0, 130.0, 611.0, 137.0]}, {"text": "None", "bbox": [675.0, 130.0, 690.0, 137.0]}, {"text": "Mayo Clinic Fiorida–Chair,", "bbox": [139.0, 149.0, 211.0, 158.0]}, {"text": "Scott M. Silvers", "bbox": [61.0, 150.0, 106.0, 159.0]}, {"text": "None", "bbox": [275.0, 150.0, 292.0, 158.0]}, {"text": "None", "bbox": [370.0, 151.0, 386.0, 159.0]}, {"text": "Nane", "bbox": [446.0, 151.0, 462.0, 158.0]}, {"text": "None", "bbox": [519.0, 151.0, 535.0, 158.0]}, {"text": "None", "bbox": [596.0, 151.0, 612.0, 158.0]}, {"text": "None", "bbox": [674.0, 151.0, 690.0, 158.0]}, {"text": "ront of Em\n Medi-", "bbox": [161.0, 162.0, 189.0, 167.0]}, {"text": "pren's Hospital of the King's", "bbox": [147.0, 178.0, 219.0, 196.0]}, {"text": "Board for NH-sponsore", "bbox": [570.0, 177.0, 634.0, 198.0]}, {"text": "Arno L. Zaritsky", "bbox": [61.0, 179.0, 106.0, 189.0]}, {"text": "None", "bbox": [276.0, 179.0, 292.0, 189.0]}, {"text": "None", "bbox": [370.0, 179.0, 386.0, 189.0]}, {"text": "None", "bbox": [446.0, 179.0, 462.0, 189.0]}, {"text": "None", "bbox": [519.0, 179.0, 535.0, 189.0]}, {"text": "None", "bbox": [675.0, 179.0, 690.0, 189.0]}, {"text": "clinical trial of", "bbox": [584.0, 195.0, 625.0, 203.0]}, {"text": "after pediatric car", "bbox": [573.0, 202.0, 624.0, 217.0]}, {"text": "Raina Merchant", "bbox": [61.0, 230.0, 105.0, 238.0]}, {"text": "University of", "bbox": [158.0, 231.0, 195.0, 240.0]}, {"text": "None", "bbox": [370.0, 231.0, 385.0, 238.0]}, {"text": "Nane", "bbox": [447.0, 232.0, 461.0, 238.0]}, {"text": "None", "bbox": [597.0, 232.0, 610.0, 237.0]}, {"text": "rch fellow", "bbox": [190.0, 238.0, 217.0, 244.0]}, {"text": "University of Chicago–Asso", "bbox": [131.0, 250.0, 206.0, 259.0]}, {"text": "Terry L. Vander", "bbox": [61.0, 252.0, 103.0, 260.0]}, {"text": "06/04-04/30/10 DOD/Office", "bbox": [246.0, 252.0, 325.0, 267.0]}, {"text": "None", "bbox": [370.0, 252.0, 384.0, 259.0]}, {"text": "None", "bbox": [447.0, 253.0, 460.0, 259.0]}, {"text": "None", "bbox": [676.0, 253.0, 689.0, 259.0]}, {"text": "Induction Patents", "bbox": [501.0, 259.0, 546.0, 268.0]}, {"text": "r Vital Signs: Mappl", "bbox": [263.0, 265.0, 317.0, 291.0]}, {"text": "to Triage and Guide Resuscitation", "bbox": [236.0, 288.0, 331.0, 305.0]}, {"text": "of Hemorrhagic Shock. This", "bbox": [247.0, 303.0, 323.0, 311.0]}, {"text": "research grant is awarded to the", "bbox": [238.0, 310.0, 330.0, 325.0]}, {"text": "Steven L. Kranick", "bbox": [61.0, 331.0, 112.0, 340.0]}, {"text": "University of Michigan Health", "bbox": [135.0, 331.0, 215.0, 346.0]}, {"text": "None", "bbox": [275.0, 331.0, 291.0, 339.0]}, {"text": "Reviewed a single case", "bbox": [649.0, 331.0, 718.0, 348.0]}, {"text": "None", "bbox": [370.0, 332.0, 386.0, 340.0]}, {"text": "Nane", "bbox": [446.0, 332.0, 462.0, 339.0]}, {"text": "None", "bbox": [519.0, 332.0, 536.0, 339.0]}, {"text": "None", "bbox": [596.0, 332.0, 612.0, 339.0]}, {"text": "sistant Profe", "bbox": [157.0, 346.0, 189.0, 355.0]}, {"text": "than 4 hours work total", "bbox": [651.0, 347.0, 718.0, 363.0]}, {"text": "This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure", "bbox": [70.0, 368.0, 719.0, 381.0]}], "type": "Table", "position": 4}, {"raw_context": [{"text": "Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be \"significant\" if (a) the person receives $10 000", "bbox": [61.0, 383.0, 720.0, 394.0]}, {"text": "or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns", "bbox": [61.0, 396.0, 720.0, 408.0]}, {"text": "$10 000 or more of the fair market value of the entity. A relationship is considered to be \"modest\" if it is less than \"significant\" under the preceding definition.", "bbox": [61.0, 408.0, 679.0, 421.0]}, {"text": "*Modest.", "bbox": [72.0, 422.0, 109.0, 434.0]}, {"text": "↑ Significant.", "bbox": [72.0, 436.0, 122.0, 448.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "References", "bbox": [181.0, 471.0, 256.0, 485.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "1. HACA. Hypothermia After Cardiac Arrest Study Group. Mild thera-", "bbox": [71.0, 488.0, 375.0, 499.0]}, {"text": "peutic hypothermia to improve the neurologic outcome after cardiac", "bbox": [83.0, 500.0, 375.0, 511.0]}, {"text": "arrest. N Engl J Med . 2002;346:549–556.", "bbox": [83.0, 512.0, 255.0, 524.0]}, {"text": "Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G,", "bbox": [81.0, 524.0, 375.0, 536.0]}, {"text": "2.", "bbox": [71.0, 525.0, 80.0, 535.0]}, {"text": "Smith K.  Treatment of comatose survivors of out-of-hospital cardiac", "bbox": [84.0, 537.0, 375.0, 548.0]}, {"text": "arrest with induced hypothermia. N Engl J Med . 2002;346:557–563.", "bbox": [84.0, 549.0, 365.0, 562.0]}, {"text": "Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW,", "bbox": [81.0, 562.0, 375.0, 573.0]}, {"text": "Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I,", "bbox": [82.0, 575.0, 375.0, 586.0]}, {"text": "Longstreth WT, Jr., Merchant RM, Morley P, Morrison LJ, Nadkarni V,", "bbox": [83.0, 586.0, 375.0, 597.0]}, {"text": "Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C,", "bbox": [83.0, 599.0, 375.0, 610.0]}, {"text": "Sunde K, Vanden Hoek T. Post-cardiac arrest syndrome: epidemiology,", "bbox": [83.0, 610.0, 375.0, 622.0]}, {"text": "pathophysiology, treatment, and prognostication. A consensus statement", "bbox": [83.0, 623.0, 376.0, 635.0]}, {"text": "from the International Liaison Committee on Resuscitation (American", "bbox": [83.0, 635.0, 376.0, 646.0]}, {"text": "Heart Association, Australian and New Zealand Council on Resusci-", "bbox": [83.0, 648.0, 375.0, 659.0]}, {"text": "tation, European Resuscitation Council, Heart and Stroke Foundation of", "bbox": [83.0, 660.0, 375.0, 670.0]}, {"text": "Canada, InterAmerican Heart Foundation, Resuscitation Council of", "bbox": [83.0, 672.0, 375.0, 684.0]}, {"text": "Asia, and the Resuscitation Council of Southern Africa); the American", "bbox": [83.0, 685.0, 376.0, 696.0]}, {"text": "Heart Association Emergency Cardiovascular Care Committee; the", "bbox": [83.0, 697.0, 375.0, 709.0]}, {"text": "Council on Cardiovascular Surgery and Anesthesia; the Council on", "bbox": [83.0, 709.0, 376.0, 721.0]}, {"text": "Cardiopulmonary, Perioperative, and Critical Care; the Council on", "bbox": [83.0, 722.0, 375.0, 733.0]}, {"text": "Clinical Cardiology; and the Stroke Council. Circulation . 2008;118:", "bbox": [83.0, 735.0, 375.0, 746.0]}, {"text": "2452–2483.", "bbox": [84.0, 746.0, 132.0, 756.0]}, {"text": "Safar P. Resuscitation from clinical death: Pathophysiologic limits and", "bbox": [80.0, 758.0, 376.0, 770.0]}, {"text": "1. 4.", "bbox": [71.0, 759.0, 81.0, 769.0]}, {"text": "therapeutic potentials. Crit Care Med . 1988;16:923–941.", "bbox": [83.0, 770.0, 318.0, 782.0]}, {"text": "5. Negovsky VA.  The second step in resuscitation–the treatment of the", "bbox": [71.0, 783.0, 375.0, 795.0]}, {"text": "'post-resuscitation disease.' Resuscitation . 1972;1:1–7.", "bbox": [85.0, 796.0, 308.0, 806.0]}, {"text": "Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B,", "bbox": [80.0, 807.0, 375.0, 819.0]}, {"text": "1. 6.", "bbox": [70.0, 809.0, 81.0, 818.0]}, {"text": "Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF. Reversible", "bbox": [83.0, 820.0, 375.0, 830.0]}, {"text": "myocardial dysfunction in survivors of out-of-hospital cardiac arrest.", "bbox": [83.0, 832.0, 375.0, 843.0]}, {"text": "J Am Coll Cardiol . 2002;40:2110–2116.", "bbox": [83.0, 844.0, 251.0, 855.0]}, {"text": "Skrifvars MB, Pettila V, Rosenberg PH, Castren M. A multiple logistic", "bbox": [82.0, 856.0, 375.0, 869.0]}, {"text": "regression analysis of in-hospital factors related to survival at six months", "bbox": [83.0, 869.0, 375.0, 880.0]}, {"text": "in patients resuscitated from out-of-hospital ventricular fibrillation.", "bbox": [83.0, 882.0, 373.0, 893.0]}, {"text": "Resuscitation . 2003;59:319–328.", "bbox": [83.0, 894.0, 218.0, 904.0]}, {"text": "Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW.  Inter-", "bbox": [81.0, 905.0, 375.0, 917.0]}, {"text": "8.", "bbox": [71.0, 906.0, 79.0, 916.0]}, {"text": "hospital variability in post-cardiac arrest mortality. Resuscitation. 2009 ;", "bbox": [83.0, 918.0, 375.0, 930.0]}, {"text": "80:30–34.", "bbox": [83.0, 930.0, 126.0, 941.0]}, {"text": "9. Callaway CW, Schmicker R, Kampmeyer M, Powell J, Rea TD, Daya", "bbox": [71.0, 943.0, 376.0, 955.0]}, {"text": "MR, Aufderheide TP, Davis DP, Rittenberger JC, Idris AH, Nichol G", "bbox": [83.0, 955.0, 375.0, 966.0]}, {"text": "Receiving hospital characteristics associated with survival after out-of-", "bbox": [83.0, 968.0, 375.0, 979.0]}, {"text": "hospital cardiac arrest. Resuscitation ; 2010;81:524–529.", "bbox": [83.0, 979.0, 315.0, 990.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "10. Kirves H, Skrifvars MB, Vahakuopus M, Ekstrom K, Martikainen M,", "bbox": [410.0, 470.0, 719.0, 482.0]}, {"text": "Castren M. Adherence to resuscitation guidelines during prehospital care", "bbox": [427.0, 483.0, 719.0, 495.0]}, {"text": "of cardiac arrest patients. Eur J Emerg Med . 2007;14:75–81.", "bbox": [427.0, 495.0, 678.0, 507.0]}, {"text": "11. Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C,", "bbox": [410.0, 507.0, 718.0, 520.0]}, {"text": "Draegni T, Steen PA.  Implementation of a standardised treatment", "bbox": [427.0, 520.0, 720.0, 531.0]}, {"text": "protocol for post resuscitation care after out-of-hospital cardiac arrest.", "bbox": [428.0, 533.0, 718.0, 543.0]}, {"text": "Resuscitation . 2007;73:29–39.", "bbox": [428.0, 543.0, 551.0, 555.0]}, {"text": "12. Gaieski DF, Band RA, Abella BS, Neumar RW, Fuchs BD, Kolansky", "bbox": [410.0, 555.0, 719.0, 567.0]}, {"text": "DM, Merchant RM, Carr BG, Becker LB, Maguire C, Klair A, Hylton", "bbox": [427.0, 567.0, 719.0, 580.0]}, {"text": "J, Goyal M. Early goal-directed hemodynamic optimization combined", "bbox": [427.0, 580.0, 720.0, 590.0]}, {"text": "with therapeutic hypothermia in comatose survivors of out-of-hospital", "bbox": [428.0, 592.0, 720.0, 603.0]}, {"text": "cardiac arrest. Resuscitation . 2009;80:418–424.", "bbox": [427.0, 603.0, 625.0, 615.0]}, {"text": "13. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to", "bbox": [410.0, 616.0, 720.0, 629.0]}, {"text": "an intensive care unit following cardiac arrest. Intensive Care Med .", "bbox": [427.0, 629.0, 719.0, 641.0]}, {"text": "2004;30:2126–2128.", "bbox": [428.0, 641.0, 512.0, 652.0]}, {"text": "14. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut", "bbox": [410.0, 652.0, 720.0, 664.0]}, {"text": "JF, Carli P.  Immediate coronary angiography in survivors of out-of-", "bbox": [427.0, 665.0, 718.0, 677.0]}, {"text": "hospital cardiac arrest. N Engl J Med . 1997;336:1629–1633.", "bbox": [427.0, 676.0, 676.0, 688.0]}, {"text": "15.", "bbox": [410.0, 689.0, 425.0, 698.0]}, {"text": "Anyfantakis ZA, Baron G, Aubry P, Himbert D, Feldman LJ, Juliard", "bbox": [424.0, 689.0, 720.0, 701.0]}, {"text": "JM, Ricard-Hibon A, Burnod A, Cokkinos DV, Steg PG. Acute coronary", "bbox": [427.0, 701.0, 718.0, 712.0]}, {"text": "angiographic findings in survivors of out-of-hospital cardiac arrest. Am", "bbox": [428.0, 713.0, 720.0, 725.0]}, {"text": "Heart J . 2009;157:312–318.", "bbox": [427.0, 725.0, 542.0, 736.0]}, {"text": "16. Reynolds JC, Callaway CW, El Khoudary SR, Moore CG, Alvarez RJ,", "bbox": [410.0, 736.0, 718.0, 749.0]}, {"text": "Rittenberger JC. Coronary angiography predicts improved outcome fol-", "bbox": [427.0, 749.0, 718.0, 761.0]}, {"text": "lowing cardiac arrest: propensity-adjusted analysis. J Intensive Care", "bbox": [427.0, 762.0, 719.0, 774.0]}, {"text": "Med . 2009;24:179–186.", "bbox": [428.0, 774.0, 525.0, 784.0]}, {"text": "17. Dumas F, Cariou A, Manzo-Silberman S, Grimaldi D, Vivien B,", "bbox": [410.0, 785.0, 718.0, 797.0]}, {"text": "Rosencher J, Empana J-P, Carli P, Mira J-P, Jouven X, Spaulding C.", "bbox": [427.0, 797.0, 718.0, 809.0]}, {"text": "Immediate percutaneous coronary intervention is associated with better", "bbox": [427.0, 810.0, 719.0, 822.0]}, {"text": "survival after out-of-hospital cardiac arrest: insights from the PROCAT", "bbox": [428.0, 822.0, 719.0, 833.0]}, {"text": "(Parisian Region Out of Hospital Cardiac Arrest) Registry. Circ Car-", "bbox": [427.0, 835.0, 718.0, 846.0]}, {"text": "diovasc Interv . 2010;3:200–207.", "bbox": [427.0, 847.0, 561.0, 858.0]}, {"text": "18. Booth CM, Boone RH, Tomlinson G, Detsky AS. Is this patient dead,", "bbox": [410.0, 858.0, 719.0, 870.0]}, {"text": "vegetative, or severely neurologically impaired? Assessing outcome for", "bbox": [427.0, 870.0, 718.0, 883.0]}, {"text": "comatose survivors of cardiac arrest. JAMA . 2004;291:870–879.", "bbox": [427.0, 884.0, 695.0, 893.0]}, {"text": "19. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman", "bbox": [410.0, 895.0, 719.0, 906.0]}, {"text": "KV, Hammill SC, Shen WK, Packer DL. Long-term outcomes of out-", "bbox": [427.0, 906.0, 718.0, 918.0]}, {"text": "of-hospital cardiac arrest after successful early defibrillation. N Engl", "bbox": [428.0, 919.0, 720.0, 930.0]}, {"text": "J Med . 2003;348:2626–2633.", "bbox": [427.0, 930.0, 549.0, 942.0]}, {"text": "20. Belliard G, Catez E, Charron C, Caille V, Aegerter P, Dubourg O, Jardin", "bbox": [410.0, 943.0, 720.0, 956.0]}, {"text": "F, Vieillard-Baron A. Efficacy of therapeutic hypothermia after out-of-", "bbox": [427.0, 956.0, 718.0, 968.0]}, {"text": "hospital cardiac arrest due to ventricular fibrillation. Resuscitation .", "bbox": [427.0, 968.0, 718.0, 979.0]}, {"text": "2007;75:252–259.", "bbox": [428.0, 979.0, 503.0, 990.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 153}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#37#37#属于页脚的内容", "type4": null, "type5": null, "type6": "有用性#0#5#属于表格的内容，但有些杂乱无章\n有用性#6#36#属于参考文献的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:29:38"}
{"id": 1042037, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "79977e5a-74de-4a71-b76f-41059d7fcd63", "title": null, "text": "【0】页码:93\n\n【1】## Is There Any Evolutionary Advantage To Gigantism? Did The Sauropod Dinosaurs Continue To Grow Throughout Their Lives, As Some Reptiles And Fish Do?\n\n【2】—A Lexandra C Hang , M Iami , F La .\n\n【3】\n Gregory S. Paul, freelance scientist, artist, and editor of the Scientific American Book of Dinosaurs , offers this explanation: Gigantism has been a common feature of land animals since the beginning of the Jurassic period, more than 200 million years ago. The first true giants of the land were small-headed, long-necked, sauropod dinosaurs. Toward the end of the Jurassic many sauropods reached 10 to 20 metric tons, some weighed as much as 50 metric tons, and a few may have exceeded 100 metric tons and 150 feet in length, rivaling the largest modern whales.\n\n【4】Why do animals become gigantic? Some reasons are simple. The bigger an animal is, the safer it is from predators and the better it is able to kill prey. Antelope are easy prey for lions, hyenas and hunting dogs, but adult elephants and rhinos are nearly immune—and their young benefit from the protection of their huge parents. For herbivores, being gigantic means being taller and therefore able to access higher foliage.\n\n【5】Giraffes and elephants can reach over 18 feet high, and elephants can use their great bulk to push over even taller trees.\n\n【6】Other reasons for being gargantuan, though important, are less obvious. The cost of locomotion decreases with increasing size; thus, it is much cheaper for a five-metric-ton elephant to walk a mile than it is for a five-metric-ton herd of gazelle to move the same distance. Metabolic rate also de-\n\n【7】 creases with increasing size. A shrew must therefore frantically eat more than its own weight each day. The elephant, on the other hand, needs to take in only 5 percent of its own weight. Also, as size increases, great bulk acts as a form of mass insulation, and so large animals are less affected by Experiment is temperature extremes.\n\n【8】But there are disadvantages the sole interpreter to being big. Because big aniof the artifices mals eat more, there cannot be of Nature.\n\n【9】as many of them. Before hu- -LEONARDO DA VINCI man hunting, the population of elephants and rhinos in Africa was in the low millions. Rodents, in contrast, number in the countless billions. Nor can giants do a lot of things that smaller creatures can do, such as burrow into the ground, climb trees or fly.\n\n【10】On land only dinosaurs and mammals have become gigantic; reptiles have never done so (the biggest tortoises and lizards have only weighed one metric ton). One reason may be the rate of growth. Land reptiles cannot grow rapidly. It takes many years for an alligator to reach 100 pounds, whereas an ostrich does so in less than a year.\n\n【11】a\n\n【12】 For the complete text of this answer, and answers to many other questions, visit Ask the Experts ( www.sciam.\n\n【13】com/askexpert).\n\n【14】 Scientific American (ISSN 0036-8733), published monthly by Scientific American, Inc., 415 Madison Avenue, New York, N.Y. 10017-1111. Copyright © 2001 by Scientific American, Inc. All rights reserved. No part of this issue may be reproduced by any mechanical, photographic or electronic process, or in the form of a phonographic recording, nor may it be stored in a retrieval system, transmitted or otherwise copied for public or private use without written permission of the publisher. Periodicals postage paid at New York, N.Y., and at additional mailing offices. Canada Post International Publications Mail (Canadian Distribution) Sales Agreement No. 242764. Canadian BN No. 127387652RT; QST No.\n\n【15】Q1015332537. Subscription rates: one year $34.97, Canada $49, International $55. Postmaster: Send address changes to Scientific American, Box 3187, Harlan, Iowa 51537. Reprints available: write Reprint Department, Scientific American, Inc., 415 Madison Avenue, New York, N.Y. 10017-1111; (212) 451-8877; fax: (212) 355-0408 or send e-mail to sacust@sciam.com Subscription inquiries: U.S. and Canada (800) 333-1199; other (515) 247-7631. Printed in U.S.A.\n\n【16】 TOON BY HAL MAY FORTH", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Is there any evolutionary advantage to gigantism? Did the", "bbox": [62.0, 233.0, 632.0, 262.0]}, {"text": "sauropod dinosaurs continue to grow throughout their lives,", "bbox": [107.0, 260.0, 703.0, 285.0]}, {"text": "as some reptiles and fish do?", "bbox": [75.0, 288.0, 362.0, 311.0]}, {"text": "—A LEXANDRA C HANG , M IAMI , F LA .", "bbox": [367.0, 295.0, 543.0, 311.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "Gregory S. Paul, freelance scientist, artist, and editor of the", "bbox": [61.0, 326.0, 377.0, 342.0]}, {"text": "Scientific American Book of Dinosaurs , offers this explanation:", "bbox": [61.0, 344.0, 375.0, 356.0]}, {"text": "Gigantism has been a common feature of land animals since", "bbox": [61.0, 359.0, 376.0, 373.0]}, {"text": "the beginning of the Jurassic period, more than 200 million", "bbox": [61.0, 374.0, 375.0, 390.0]}, {"text": "years ago. The first true giants of the land were small-head-", "bbox": [61.0, 391.0, 375.0, 405.0]}, {"text": "ed, long-necked, sauropod dinosaurs. Toward the end of the", "bbox": [61.0, 407.0, 375.0, 422.0]}, {"text": "Jurassic many sauropods reached 10 to 20 metric tons, some", "bbox": [62.0, 423.0, 375.0, 437.0]}, {"text": "weighed as much as 50 metric tons, and a few may have ex-", "bbox": [61.0, 439.0, 374.0, 453.0]}, {"text": "ceeded 100 metric tons and 150 feet in length, rivaling the", "bbox": [61.0, 454.0, 375.0, 470.0]}, {"text": "largest modern whales.", "bbox": [61.0, 471.0, 187.0, 485.0]}, {"text": "Why do animals become gigantic? Some reasons are sim-", "bbox": [81.0, 486.0, 375.0, 501.0]}, {"text": "ple. The bigger an animal is, the safer it is from predators and", "bbox": [61.0, 503.0, 375.0, 517.0]}, {"text": "the better it is able to kill prey. Antelope are easy prey for li-", "bbox": [61.0, 519.0, 375.0, 534.0]}, {"text": "ons, hyenas and hunting dogs, but adult elephants and rhinos", "bbox": [61.0, 535.0, 375.0, 549.0]}, {"text": "are nearly immune—and their young benefit from the protec-", "bbox": [61.0, 551.0, 374.0, 565.0]}, {"text": "tion of their huge parents. For herbivores, being gigantic", "bbox": [61.0, 567.0, 375.0, 581.0]}, {"text": "means being taller and therefore able to access higher foliage.", "bbox": [61.0, 583.0, 375.0, 597.0]}, {"text": "Giraffes and elephants can reach over 18 feet high, and ele-", "bbox": [61.0, 599.0, 374.0, 614.0]}, {"text": "phants can use their great bulk to push over even taller trees.", "bbox": [61.0, 615.0, 375.0, 629.0]}, {"text": "Other reasons for being gargantuan, though important,", "bbox": [81.0, 631.0, 375.0, 645.0]}, {"text": "are less obvious. The cost of locomotion decreases with in-", "bbox": [61.0, 647.0, 375.0, 662.0]}, {"text": "creasing size; thus, it is much cheaper for a five-metric-ton", "bbox": [61.0, 663.0, 375.0, 677.0]}, {"text": "elephant to walk a mile than it is for a five-metric-ton herd of", "bbox": [61.0, 679.0, 375.0, 694.0]}, {"text": "gazelle to move the same distance. Metabolic rate also de-", "bbox": [61.0, 695.0, 374.0, 710.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "creases with increasing size. A shrew must therefore franti-", "bbox": [385.0, 326.0, 700.0, 342.0]}, {"text": "cally eat more than its own weight each day. The elephant,", "bbox": [387.0, 344.0, 702.0, 357.0]}, {"text": "on the other hand, needs to take in only 5 percent of its own", "bbox": [388.0, 359.0, 702.0, 374.0]}, {"text": "weight. Also, as size increases, great bulk acts as a form of", "bbox": [388.0, 375.0, 701.0, 390.0]}, {"text": "mass insulation, and so large", "bbox": [388.0, 392.0, 547.0, 405.0]}, {"text": "animals are less affected by", "bbox": [388.0, 407.0, 547.0, 422.0]}, {"text": "Experiment is", "bbox": [627.0, 421.0, 724.0, 436.0]}, {"text": "temperature extremes.", "bbox": [388.0, 423.0, 508.0, 437.0]}, {"text": "But there are disadvantages", "bbox": [406.0, 440.0, 548.0, 453.0]}, {"text": "the sole interpreter", "bbox": [592.0, 442.0, 723.0, 454.0]}, {"text": "to being big. Because big ani-", "bbox": [388.0, 455.0, 548.0, 469.0]}, {"text": "of the artifices", "bbox": [621.0, 460.0, 723.0, 473.0]}, {"text": "mals eat more, there cannot be", "bbox": [388.0, 471.0, 549.0, 485.0]}, {"text": "of Nature.", "bbox": [653.0, 478.0, 721.0, 491.0]}, {"text": "as many of them. Before hu-", "bbox": [388.0, 487.0, 547.0, 501.0]}, {"text": "-LEONARDO DA VINCI", "bbox": [625.0, 497.0, 724.0, 509.0]}, {"text": "man hunting, the population", "bbox": [388.0, 503.0, 548.0, 517.0]}, {"text": "of elephants and rhinos in", "bbox": [388.0, 519.0, 547.0, 534.0]}, {"text": "Africa was in the low millions. Rodents, in contrast, num-", "bbox": [388.0, 534.0, 700.0, 549.0]}, {"text": "ber in the countless billions. Nor can giants do a lot of things", "bbox": [388.0, 551.0, 702.0, 565.0]}, {"text": "that smaller creatures can do, such as burrow into the", "bbox": [387.0, 567.0, 702.0, 581.0]}, {"text": "ground, climb trees or fly.", "bbox": [388.0, 583.0, 527.0, 597.0]}, {"text": "On land only dinosaurs and mammals have become gi-", "bbox": [406.0, 599.0, 701.0, 614.0]}, {"text": "gantic; reptiles have never done so (the biggest tortoises and", "bbox": [388.0, 615.0, 702.0, 629.0]}, {"text": "lizards have only weighed one metric ton). One reason may", "bbox": [388.0, 631.0, 701.0, 645.0]}, {"text": "be the rate of growth. Land reptiles cannot grow rapidly. It", "bbox": [388.0, 647.0, 702.0, 662.0]}, {"text": "takes many years for an alligator to reach 100 pounds,", "bbox": [388.0, 663.0, 702.0, 677.0]}, {"text": "whereas an ostrich does so in less than a year.", "bbox": [388.0, 679.0, 638.0, 694.0]}, {"text": "a", "bbox": [690.0, 681.0, 703.0, 693.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "For the complete text of this answer, and answers to", "bbox": [388.0, 711.0, 667.0, 724.0]}, {"text": "many other questions, visit Ask the Experts ( www.sciam.", "bbox": [388.0, 727.0, 693.0, 742.0]}, {"text": "com/askexpert).", "bbox": [388.0, 743.0, 476.0, 757.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Scientific American (ISSN 0036-8733), published monthly by Scientific American,", "bbox": [388.0, 786.0, 700.0, 798.0]}, {"text": "Inc., 415 Madison Avenue, New York, N.Y. 10017-1111. Copyright © 2001 by", "bbox": [389.0, 798.0, 700.0, 810.0]}, {"text": "Scientific American, Inc. All rights reserved. No part of this issue may be repro-", "bbox": [388.0, 811.0, 700.0, 823.0]}, {"text": "duced by any mechanical, photographic or electronic process, or in the form of a", "bbox": [389.0, 823.0, 700.0, 835.0]}, {"text": "phonographic recording, nor may it be stored in a retrieval system, transmitted", "bbox": [388.0, 835.0, 702.0, 847.0]}, {"text": "or otherwise copied for public or private use without written permission of the", "bbox": [389.0, 847.0, 700.0, 859.0]}, {"text": "publisher. Periodicals postage paid at New York, N.Y., and at additional mail-", "bbox": [388.0, 859.0, 700.0, 871.0]}, {"text": "ing offices. Canada Post International Publications Mail (Canadian Distribution)", "bbox": [389.0, 871.0, 701.0, 883.0]}, {"text": "Sales Agreement No. 242764. Canadian BN No. 127387652RT; QST No.", "bbox": [388.0, 881.0, 700.0, 896.0]}, {"text": "Q1015332537. Subscription rates: one year $34.97, Canada $49, International", "bbox": [389.0, 895.0, 701.0, 907.0]}, {"text": "$55. Postmaster: Send address changes to Scientific American, Box 3187, Har-", "bbox": [388.0, 906.0, 700.0, 918.0]}, {"text": "lan, Iowa 51537. Reprints available: write Reprint Department, Scientific Amer-", "bbox": [388.0, 919.0, 700.0, 931.0]}, {"text": "ican, Inc., 415 Madison Avenue, New York, N.Y. 10017-1111; (212) 451-8877;", "bbox": [388.0, 930.0, 702.0, 943.0]}, {"text": "fax: (212) 355-0408 or send e-mail to sacust@sciam.com Subscription inquiries:", "bbox": [389.0, 943.0, 700.0, 954.0]}, {"text": "U.S. and Canada (800) 333-1199; other (515) 247-7631. Printed in U.S.A.", "bbox": [387.0, 954.0, 689.0, 966.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "TOON BY HAL MAY FORTH", "bbox": [746.0, 866.0, 759.0, 951.0]}], "type": "Text", "position": 6}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 93}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#7#7# creases with increasing size. A shrew...与上面的6段联接\n多余换行#9#9#as many of them. ...与上面第8段后面...eat more, there cannot be相连接", "type3": "无关文本#11#11#a与原文没有关系的内容\n无关文本#8#8#there cannot be of Nature.里面的of Nature是旁边补充里的\n无关文本#9#9#Before hu- -LEONARDO DA VINCI man hunting,里面的 -LEONARDO DA VINCI 是旁边补充里的", "type6": "有用性#12#16#对文章的补充说明和相关文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:59:39"}
{"id": 1042036, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "b9ebfdf2-43d6-4d95-b7b4-299761b06ccb", "title": null, "text": "【0】页码:309\n\n【1】## Bibliography\n\n【2】\n 1. Altug Zahir, Arslan Aysegul Dalkiran. A mini-maxilary protractor for Class III correction. JCO Sep 2005. Vol XXXIX # 9. Pp. 552-525.\n\n【3】2.\n\n【4】Alvear de Rubira Jimmy Andrés, Rodríguez Yáñez Esequiel Eduardo, Casasa Araujo Rogelio. Ortodoncia y Periodoncia.\n\n【5】www.geodental.net November 2004.\n\n【6】3. Amadio Peter Jr., Cummings Doyle, Amadio Patricia.\n\n【7】Antiinflamatorios no esteroideos. Postgraduate Medicine.\n\n【8】McGraw-Hill. Pp. 7-25.\n\n【9】Avalos Rodriguez Jose Victor, Rodriguez Yanez Esequiel 4.\n\n【10】E., Casasa Araujo Rogelio. Lesiones faticas por tratamiento ortodontico. Revista Dentista y Paciente. September 2001.\n\n【11】Volumen 10 # 111. Pp. 52-57.\n\n【12】5. Ávila Zambrano Rosa María, Coutino Escobar Carlos, Ro¬ driguez Yanez Esequiel, Casasa Araujo Rogelio. Reabsorcion Radicular. www.geodental.net July 2005.\n\n【13】6. Garcia Chagoya Gisella Yunue, Pacheco Garcia Virginia, Rocha Saldaña Alejandro, Rodríguez Yañez Esequiel Eduardo, Casasa Araujo Rogelio. Interrelacion Orto-Perio. Revista Dentista y Paciente. Editorial CARMA. January 2003 Garcia Estrada Aracely, Rodriguez Yanez Esequiel, Casasa Araujo Rogelio. Reabsorcion radicular en ortodoncia. Rev.\n\n【14】Dentista y Paciente. April 2002. Edit. Carma.\n\n【15】8. Garcia Lopez Alejandro, Rocha Saldana Alejandro, Rodriguez Yanez Esequiel, Casasa Araujo Rogelio. Aplicacion del laser en ortodoncia. Revista Dentista y paciente. Especial de ortodoncia 8. Editorial Carma 2002.\n\n【16】Goodman Gilman. Analgesicos-antipireticos y antiinflamatorios y farmacos antigotosos. Las bases farmacologicas de la terapeutica. McGraw-Hill-Interamericana. Novena Edicion. Vol. 1. Pp. 661-670.\n\n【17】10.\n\n【18】Graber T. M. Tipos de fuerzas que causan menos reabsor¬ cion radicular, Ortodoncia Teoria y Practica. 3* edicion.\n\n【19】Editorial Interamericana. Mexico 1974. Pp: 481-482.\n\n【20】11.\n\n【21】Holland Gary, Wallace David, Mondino Bartly. The severe ocular lesions of the orthodontic headgear. JCO November 1985. Pp. 819-822 12. Inger Kjaer. Revisiting Root Resorption. American Journal of Orthodontics and Dentofacial Orthopedics. April 2000.\n\n【22】Volumen 117. # 4.\n\n【23】13. Jones M.L., Chan C. The pain in the early phases of orth¬ odontic treatment. JCO. May 92. Pp. 311-313 14. Lee Y. Are dental anomalies risk factors for apical root resorption in orthodontic patients?. American Journal of Orthodontics and Dentofacial Orthopedics. August 1999.\n\n【24】Lucea M. Antonio. El manejo de las urgencias en ortodoncia.\n\n【25】15.\n\n【26】Ortodoncia Clinica 2003;6(3):159-164\n\n【27】 16.\n\n【28】Parker Williams. Root resorption long term out come.\n\n【29】American Journal of Orthodontics and Dentofacial Or¬ thopedics.1997.\n\n【30】17.\n\n【31】Polat Omur, Karaman Ali Ihya, Durmus Ercan. Effects of Preoperative Ibuprofen and of the sodium of Naproxen in orthodontic pain. The Angle Orthodontist. May 2004.\n\n【32】Vol. 75 Pp; 791-796.\n\n【33】Radlanski R.J., Jager A. The clinical help. The vestibular 18.\n\n【34】shield. JCO April. 1987. Pp: 272-272.\n\n【35】Robbins Cotran Kumar. Inflamacion y reparacion. Patologia 19.\n\n【36】estructural y funcional. McGraw-Hill-Interamericana. 4 Edicion. Pp. 39-86.\n\n【37】20. Rodríguez Yáñez Esequiel, Casasa Araujo Rogelio. Reabsorción radicular en ortodoncia. Ortodoncia Contemporanea. Diagnostico y Tratamiento. Editorial AMOLCA. Pp. 203-209.\n\n【38】21. Sameshima Glenn. Predicting and preventing root re¬ sorption: Part II. Treatment factors. American Journal of Orthodontics and Dentofacial Orthopedics.2001 22. Samuels R. The securities catch for a Kloehn facebow. JCO.\n\n【39】Sep 93 Pp 138-141.\n\n【40】23. Samuelson Greg, Rakes George, Aiello Anne. Visible light polymerized the periodontal preparation for the treat¬ ment of trauma of the orthodontic apparatuses. JCO.\n\n【41】Sep 90. Pp: 564-566.\n\n【42】24. Simmons KE, Brandt M. Control of orthodontic pain. J Indiana Dent Assoc. 1992. Jul-Aug;71(4):8-10 25.\n\n【43】Ste. Marie Stacy, Powers Michael, Sheridan John. Estimulo vibratorio como metodo para reducir el dolor despues del ajuste ortodontico. Journal of Clinical Orthodontics. April del 2003. Vol XXXVII. # 4.\n\n【44】26. Ttilin Taner, Semra Ciger, Yesim Sencift. Evaluation of api¬ cal root resorption following extraction therapy in subjects with Class I and Class II malocclusions. American Journal of Orthodontics and Dentofacial Orthopedics. March 2000.\n\n【45】Volumen 117. # 3.\n\n【46】27. Vellini Ferreira Flavio. Biomecanica del movimiento dentario. Ortodoncia. Diagnostico y Planificacion clinica.\n\n【47】Editorial Artes Medicas. 2 Edicion 2004. Pp. 363-374.\n\n【48】Wang Fulung. Clinical aid protecting mucosa from archwire 28.\n\n【49】impingement. JCO, Ago 1990.\n\n【50】White Larry W. The Pain and Cooperation in the Orth¬ 29.\n\n【51】odontic Treatment. Journal of Clinical Orthodontics.\n\n【52】Aug 1984. Pp. 572-575 www.jorge-alonso.com/new/contenido_pacientes_ 30.\n\n【53】cuidado_y_salud_dental_08.html 31.\n\n【54】www.odontomarket.com/casos/EMBARAZADAS.asp 32.\n\n【55】www.oral-b.com www.lasertech-tm.com 33.\n\n【56】www.red-dental.com 34.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Bibliography", "bbox": [68.0, 114.0, 166.0, 138.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "1. Altug Zahir, Arslan Aysegul Dalkiran. A mini-maxilary", "bbox": [79.0, 152.0, 381.0, 168.0]}, {"text": "protractor for Class III correction. JCO Sep 2005. Vol", "bbox": [96.0, 168.0, 381.0, 181.0]}, {"text": "XXXIX # 9. Pp. 552-525.", "bbox": [96.0, 182.0, 220.0, 196.0]}, {"text": "2.", "bbox": [78.0, 196.0, 91.0, 208.0]}, {"text": "Alvear de Rubira Jimmy Andrés, Rodríguez Yáñez Esequiel", "bbox": [92.0, 196.0, 381.0, 211.0]}, {"text": "Eduardo, Casasa Araujo Rogelio. Ortodoncia y Periodoncia.", "bbox": [95.0, 209.0, 381.0, 226.0]}, {"text": "www.geodental.net November 2004.", "bbox": [95.0, 226.0, 275.0, 239.0]}, {"text": "3. Amadio Peter Jr., Cummings Doyle, Amadio Patricia.", "bbox": [78.0, 239.0, 381.0, 256.0]}, {"text": "Antiinflamatorios no esteroideos. Postgraduate Medicine.", "bbox": [95.0, 255.0, 381.0, 269.0]}, {"text": "McGraw-Hill. Pp. 7-25.", "bbox": [95.0, 269.0, 211.0, 283.0]}, {"text": "Avalos Rodriguez Jose Victor, Rodriguez Yanez Esequiel", "bbox": [93.0, 284.0, 381.0, 298.0]}, {"text": "4.", "bbox": [78.0, 285.0, 91.0, 297.0]}, {"text": "E., Casasa Araujo Rogelio. Lesiones faticas por tratamiento", "bbox": [93.0, 299.0, 381.0, 313.0]}, {"text": "ortodontico. Revista Dentista y Paciente. September 2001.", "bbox": [94.0, 315.0, 381.0, 328.0]}, {"text": "Volumen 10 # 111. Pp. 52-57.", "bbox": [94.0, 329.0, 239.0, 342.0]}, {"text": "5. Ávila Zambrano Rosa María, Coutino Escobar Carlos, Ro¬", "bbox": [77.0, 342.0, 379.0, 357.0]}, {"text": "driguez Yanez Esequiel, Casasa Araujo Rogelio. Reabsorcion", "bbox": [93.0, 357.0, 381.0, 372.0]}, {"text": "Radicular. www.geodental.net July 2005.", "bbox": [94.0, 372.0, 292.0, 386.0]}, {"text": "6. Garcia Chagoya Gisella Yunue, Pacheco Garcia Virginia, Ro-", "bbox": [77.0, 386.0, 379.0, 401.0]}, {"text": "cha Saldaña Alejandro, Rodríguez Yañez Esequiel Eduardo,", "bbox": [93.0, 401.0, 380.0, 416.0]}, {"text": "Casasa Araujo Rogelio. Interrelacion Orto-Perio. Revista", "bbox": [93.0, 417.0, 381.0, 430.0]}, {"text": "Dentista y Paciente. Editorial CARMA. January 2003", "bbox": [93.0, 431.0, 356.0, 444.0]}, {"text": "Garcia Estrada Aracely, Rodriguez Yanez Esequiel, Casasa", "bbox": [91.0, 445.0, 381.0, 459.0]}, {"text": "Araujo Rogelio. Reabsorcion radicular en ortodoncia. Rev.", "bbox": [93.0, 460.0, 380.0, 474.0]}, {"text": "Dentista y Paciente. April 2002. Edit. Carma.", "bbox": [93.0, 476.0, 314.0, 489.0]}, {"text": "8. Garcia Lopez Alejandro, Rocha Saldana Alejandro, Rodri-", "bbox": [78.0, 489.0, 379.0, 505.0]}, {"text": "guez Yanez Esequiel, Casasa Araujo Rogelio. Aplicacion del", "bbox": [93.0, 503.0, 380.0, 520.0]}, {"text": "laser en ortodoncia. Revista Dentista y paciente. Especial", "bbox": [93.0, 519.0, 380.0, 533.0]}, {"text": "de ortodoncia 8. Editorial Carma 2002.", "bbox": [93.0, 532.0, 286.0, 548.0]}, {"text": "Goodman Gilman. Analgesicos-antipireticos y antiinflama-", "bbox": [90.0, 546.0, 379.0, 563.0]}, {"text": "torios y farmacos antigotosos. Las bases farmacologicas", "bbox": [93.0, 562.0, 381.0, 577.0]}, {"text": "de la terapeutica. McGraw-Hill-Interamericana. Novena", "bbox": [93.0, 578.0, 380.0, 591.0]}, {"text": "Edicion. Vol. 1. Pp. 661-670.", "bbox": [93.0, 592.0, 234.0, 605.0]}, {"text": "10.", "bbox": [72.0, 606.0, 91.0, 618.0]}, {"text": "Graber T. M. Tipos de fuerzas que causan menos reabsor¬", "bbox": [89.0, 606.0, 379.0, 620.0]}, {"text": "cion radicular, Ortodoncia Teoria y Practica. 3* edicion.", "bbox": [93.0, 621.0, 379.0, 635.0]}, {"text": "Editorial Interamericana. Mexico 1974. Pp: 481-482.", "bbox": [93.0, 636.0, 351.0, 650.0]}, {"text": "11.", "bbox": [72.0, 650.0, 91.0, 663.0]}, {"text": "Holland Gary, Wallace David, Mondino Bartly. The severe", "bbox": [90.0, 651.0, 379.0, 664.0]}, {"text": "ocular lesions of the orthodontic headgear. JCO November", "bbox": [93.0, 666.0, 379.0, 679.0]}, {"text": "1985. Pp. 819-822", "bbox": [93.0, 679.0, 184.0, 693.0]}, {"text": "12. Inger Kjaer. Revisiting Root Resorption. American Journal", "bbox": [71.0, 693.0, 379.0, 709.0]}, {"text": "of Orthodontics and Dentofacial Orthopedics. April 2000.", "bbox": [92.0, 708.0, 379.0, 723.0]}, {"text": "Volumen 117. # 4.", "bbox": [93.0, 724.0, 184.0, 737.0]}, {"text": "13. Jones M.L., Chan C. The pain in the early phases of orth¬", "bbox": [71.0, 737.0, 378.0, 752.0]}, {"text": "odontic treatment. JCO. May 92. Pp. 311-313", "bbox": [93.0, 753.0, 318.0, 766.0]}, {"text": "14. Lee Y. Are dental anomalies risk factors for apical root", "bbox": [71.0, 768.0, 379.0, 781.0]}, {"text": "resorption in orthodontic patients?. American Journal of", "bbox": [93.0, 782.0, 379.0, 796.0]}, {"text": "Orthodontics and Dentofacial Orthopedics. August 1999.", "bbox": [92.0, 798.0, 377.0, 811.0]}, {"text": "Lucea M. Antonio. El manejo de las urgencias en ortodoncia.", "bbox": [90.0, 811.0, 378.0, 827.0]}, {"text": "15.", "bbox": [71.0, 812.0, 91.0, 824.0]}, {"text": "Ortodoncia Clinica 2003;6(3):159-164", "bbox": [91.0, 825.0, 282.0, 840.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "16.", "bbox": [410.0, 129.0, 430.0, 141.0]}, {"text": "Parker Williams. Root resorption long term out come.", "bbox": [429.0, 129.0, 716.0, 143.0]}, {"text": "American Journal of Orthodontics and Dentofacial Or¬", "bbox": [431.0, 143.0, 716.0, 157.0]}, {"text": "thopedics.1997.", "bbox": [430.0, 158.0, 514.0, 171.0]}, {"text": "17.", "bbox": [410.0, 172.0, 426.0, 185.0]}, {"text": "Polat Omur, Karaman Ali Ihya, Durmus Ercan. Effects of", "bbox": [429.0, 172.0, 718.0, 186.0]}, {"text": "Preoperative Ibuprofen and of the sodium of Naproxen", "bbox": [431.0, 187.0, 717.0, 201.0]}, {"text": "in orthodontic pain. The Angle Orthodontist. May 2004.", "bbox": [431.0, 203.0, 717.0, 216.0]}, {"text": "Vol. 75 Pp; 791-796.", "bbox": [431.0, 217.0, 533.0, 230.0]}, {"text": "Radlanski R.J., Jager A. The clinical help. The vestibular", "bbox": [428.0, 229.0, 717.0, 245.0]}, {"text": "18.", "bbox": [410.0, 231.0, 430.0, 243.0]}, {"text": "shield. JCO April. 1987. Pp: 272-272.", "bbox": [430.0, 245.0, 613.0, 260.0]}, {"text": "Robbins Cotran Kumar. Inflamacion y reparacion. Patologia", "bbox": [428.0, 260.0, 717.0, 275.0]}, {"text": "19.", "bbox": [409.0, 261.0, 428.0, 272.0]}, {"text": "estructural y funcional. McGraw-Hill-Interamericana. 4", "bbox": [430.0, 274.0, 717.0, 289.0]}, {"text": "Edicion. Pp. 39-86.", "bbox": [430.0, 290.0, 526.0, 302.0]}, {"text": "20. Rodríguez Yáñez Esequiel, Casasa Araujo Rogelio. Reabsorción", "bbox": [408.0, 303.0, 717.0, 318.0]}, {"text": "radicular en ortodoncia. Ortodoncia Contemporanea. Diag-", "bbox": [430.0, 317.0, 715.0, 333.0]}, {"text": "nostico y Tratamiento. Editorial AMOLCA. Pp. 203-209.", "bbox": [430.0, 333.0, 700.0, 347.0]}, {"text": "21. Sameshima Glenn. Predicting and preventing root re¬", "bbox": [408.0, 347.0, 715.0, 363.0]}, {"text": "sorption: Part II. Treatment factors. American Journal of", "bbox": [430.0, 363.0, 717.0, 377.0]}, {"text": "Orthodontics and Dentofacial Orthopedics.2001", "bbox": [430.0, 378.0, 671.0, 391.0]}, {"text": "22. Samuels R. The securities catch for a Kloehn facebow. JCO.", "bbox": [408.0, 391.0, 715.0, 407.0]}, {"text": "Sep 93 Pp 138-141.", "bbox": [430.0, 407.0, 526.0, 421.0]}, {"text": "23. Samuelson Greg, Rakes George, Aiello Anne. Visible light", "bbox": [406.0, 420.0, 716.0, 437.0]}, {"text": "polymerized the periodontal preparation for the treat¬", "bbox": [429.0, 433.0, 715.0, 452.0]}, {"text": "ment of trauma of the orthodontic apparatuses. JCO.", "bbox": [429.0, 450.0, 716.0, 465.0]}, {"text": "Sep 90. Pp: 564-566.", "bbox": [430.0, 466.0, 537.0, 478.0]}, {"text": "24. Simmons KE, Brandt M. Control of orthodontic pain. J", "bbox": [408.0, 480.0, 717.0, 494.0]}, {"text": "Indiana Dent Assoc. 1992. Jul-Aug;71(4):8-10", "bbox": [429.0, 494.0, 656.0, 508.0]}, {"text": "25.", "bbox": [408.0, 509.0, 428.0, 522.0]}, {"text": "Ste. Marie Stacy, Powers Michael, Sheridan John. Estimulo", "bbox": [425.0, 509.0, 716.0, 523.0]}, {"text": "vibratorio como metodo para reducir el dolor despues del", "bbox": [429.0, 524.0, 716.0, 538.0]}, {"text": "ajuste ortodontico. Journal of Clinical Orthodontics. April", "bbox": [430.0, 539.0, 716.0, 553.0]}, {"text": "del 2003. Vol XXXVII. # 4.", "bbox": [430.0, 554.0, 561.0, 567.0]}, {"text": "26. Ttilin Taner, Semra Ciger, Yesim Sencift. Evaluation of api¬", "bbox": [407.0, 566.0, 715.0, 583.0]}, {"text": "cal root resorption following extraction therapy in subjects", "bbox": [429.0, 582.0, 716.0, 597.0]}, {"text": "with Class I and Class II malocclusions. American Journal", "bbox": [430.0, 597.0, 716.0, 611.0]}, {"text": "of Orthodontics and Dentofacial Orthopedics. March 2000.", "bbox": [429.0, 611.0, 715.0, 626.0]}, {"text": "Volumen 117. # 3.", "bbox": [430.0, 627.0, 520.0, 639.0]}, {"text": "27. Vellini Ferreira Flavio. Biomecanica del movimiento", "bbox": [407.0, 639.0, 717.0, 655.0]}, {"text": "dentario. Ortodoncia. Diagnostico y Planificacion clinica.", "bbox": [430.0, 656.0, 715.0, 669.0]}, {"text": "Editorial Artes Medicas. 2 Edicion 2004. Pp. 363-374.", "bbox": [429.0, 670.0, 694.0, 684.0]}, {"text": "Wang Fulung. Clinical aid protecting mucosa from archwire", "bbox": [428.0, 684.0, 716.0, 699.0]}, {"text": "28.", "bbox": [408.0, 685.0, 425.0, 698.0]}, {"text": "impingement. JCO, Ago 1990.", "bbox": [429.0, 700.0, 578.0, 713.0]}, {"text": "White Larry W. The Pain and Cooperation in the Orth¬", "bbox": [428.0, 713.0, 715.0, 729.0]}, {"text": "29.", "bbox": [408.0, 714.0, 424.0, 726.0]}, {"text": "odontic Treatment. Journal of Clinical Orthodontics.", "bbox": [428.0, 729.0, 715.0, 743.0]}, {"text": "Aug 1984. Pp. 572-575", "bbox": [430.0, 743.0, 548.0, 757.0]}, {"text": "www.jorge-alonso.com/new/contenido_pacientes_", "bbox": [426.0, 756.0, 714.0, 774.0]}, {"text": "30.", "bbox": [408.0, 758.0, 425.0, 770.0]}, {"text": "cuidado_y_salud_dental_08.html", "bbox": [428.0, 772.0, 594.0, 787.0]}, {"text": "31.", "bbox": [407.0, 787.0, 424.0, 799.0]}, {"text": "www.odontomarket.com/casos/EMBARAZADAS.asp", "bbox": [427.0, 787.0, 699.0, 802.0]}, {"text": "32.", "bbox": [407.0, 802.0, 424.0, 814.0]}, {"text": "www.oral-b.com", "bbox": [427.0, 802.0, 514.0, 815.0]}, {"text": "www.lasertech-tm.com", "bbox": [427.0, 816.0, 546.0, 830.0]}, {"text": "33.", "bbox": [407.0, 817.0, 425.0, 829.0]}, {"text": "www.red-dental.com", "bbox": [426.0, 831.0, 535.0, 845.0]}, {"text": "34.", "bbox": [407.0, 832.0, 424.0, 844.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 309}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#1#56#全部都是参考文献的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:58:27"}
{"id": 1042035, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "3a5640e1-8adf-4a6d-bf53-58fd7ce83967", "title": null, "text": "【0】页码:61\n Figs. 52 and 53. Forward arches\n\n【1】## Disadvantages\n\n【2】\n 1.\n\n【3】2.\n\n【4】3.\n\n【5】 The stop of the loop must be placed gingivally, be¬ cause if it is placed occlusally can make contact with the antagonist tubes and braces and provoke their debonding.\n\n【6】It can provoke localized gingival inflammation localized between the premolar and molar, due to food accumulation.\n\n【7】A strict appointment control is imperative since it is a minimal anchorage appliance, and too much anchorage may be lost.\n\n【8】## Recommendations\n\n【9】\n 1.\n\n【10】2.\n\n【11】3.\n\n【12】 It is very advisable to make the loop of the stop as high as the gingival margin of the posterior sector, because if we do not do so, gingival laceration can occur.\n\n【13】If we put an active arch wire (forward arch) to correct an anterior cross bite, the activations must be made in a paused manner (no more than 2 mm between the arch and the slot), otherwise the wire would be too forced and the buccal braces may debond.\n\n【14】It can be used in combination with other types of anchorage.\n\n【15】## B)\n\n【16】\n## Tip Back\n\n【17】\n The main objective of this bend is to provide minimal an¬ chorage. It is made at the end of the wire arch. The bend is done round (0.020\") or rectangular (0.017\" x 0.025\") at 45° toward the gingival margin producing a tip or molar angulation. (25)\n\n【18】 Fig. 54. The Tip back is done at 45° toward the gingival margin at the end of the wire arch.\n\n【19】## Advantages\n\n【20】\n 1.\n\n【21】 2.\n\n【22】1.13.\n\n【23】 4.\n\n【24】## Disadvantages\n\n【25】\n 1.\n\n【26】2.\n\n【27】 May provoke an anterior open bite due to the intru¬ sion of the anterosuperior segment.\n\n【28】May provoke TMJ alterations due to premature con¬ tacts that can develop after molar inclination.\n\n【29】## Recommendations\n\n【30】\n 1.\n\n【31】 2.\n\n【32】 3.\n\n【33】 Do not use it in patients with open bite.\n\n【34】In case of pain in the TMJ due to premature contact points, remove the wire immediately.\n\n【35】This type of anchorage can be used in conjunction with another one in deep bite cases. At the moment of placement of the wire in the molar tubes (with the Tip Back bend), the anterior segment of the arch wire tends to displace itself gingivally producing an intrusive force in the anterior sector.\n\n【36】 Fast and easy to make.\n\n【37】No patient cooperation dependence.\n\n【38】Distal crown inclination and mesial root inclination in molars make them more resistant to mesial movement.\n\n【39】It is cheap.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Figs. 52 and 53. Forward arches", "bbox": [147.0, 440.0, 287.0, 454.0]}], "type": "Caption", "position": 2}, {"raw_context": [{"text": "Disadvantages", "bbox": [60.0, 520.0, 165.0, 536.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "1.", "bbox": [62.0, 556.0, 74.0, 570.0]}, {"text": "2.", "bbox": [59.0, 623.0, 74.0, 639.0]}, {"text": "3.", "bbox": [60.0, 676.0, 74.0, 691.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "The stop of the loop must be placed gingivally, be¬", "bbox": [86.0, 554.0, 372.0, 570.0]}, {"text": "cause if it is placed occlusally can make contact with", "bbox": [87.0, 572.0, 374.0, 588.0]}, {"text": "the antagonist tubes and braces and provoke their", "bbox": [87.0, 590.0, 373.0, 605.0]}, {"text": "debonding.", "bbox": [87.0, 607.0, 151.0, 623.0]}, {"text": "It can provoke localized gingival inflammation local-", "bbox": [86.0, 625.0, 371.0, 640.0]}, {"text": "ized between the premolar and molar, due to food", "bbox": [87.0, 641.0, 373.0, 657.0]}, {"text": "accumulation.", "bbox": [87.0, 659.0, 166.0, 674.0]}, {"text": "A strict appointment control is imperative since it is a", "bbox": [86.0, 676.0, 374.0, 691.0]}, {"text": "minimal anchorage appliance, and too much anchor-", "bbox": [87.0, 694.0, 371.0, 709.0]}, {"text": "age may be lost.", "bbox": [87.0, 711.0, 176.0, 727.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Recommendations", "bbox": [60.0, 744.0, 191.0, 760.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "1.", "bbox": [62.0, 782.0, 74.0, 795.0]}, {"text": "2.", "bbox": [59.0, 848.0, 74.0, 864.0]}, {"text": "3.", "bbox": [60.0, 935.0, 73.0, 951.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "It is very advisable to make the loop of the stop as", "bbox": [86.0, 780.0, 374.0, 796.0]}, {"text": "high as the gingival margin of the posterior sector,", "bbox": [86.0, 798.0, 373.0, 814.0]}, {"text": "because if we do not do so, gingival laceration can", "bbox": [86.0, 816.0, 374.0, 831.0]}, {"text": "occur.", "bbox": [87.0, 832.0, 127.0, 847.0]}, {"text": "If we put an active arch wire (forward arch) to correct", "bbox": [86.0, 849.0, 373.0, 865.0]}, {"text": "an anterior cross bite, the activations must be made in", "bbox": [87.0, 867.0, 374.0, 882.0]}, {"text": "a paused manner (no more than 2 mm between the", "bbox": [86.0, 884.0, 374.0, 900.0]}, {"text": "arch and the slot), otherwise the wire would be too", "bbox": [86.0, 902.0, 374.0, 917.0]}, {"text": "forced and the buccal braces may debond.", "bbox": [86.0, 918.0, 318.0, 935.0]}, {"text": "It can be used in combination with other types of", "bbox": [86.0, 936.0, 374.0, 952.0]}, {"text": "anchorage.", "bbox": [87.0, 954.0, 152.0, 969.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "b)", "bbox": [396.0, 93.0, 415.0, 109.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Tip back", "bbox": [421.0, 93.0, 477.0, 110.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "The main objective of this bend is to provide minimal an¬", "bbox": [397.0, 129.0, 709.0, 145.0]}, {"text": "chorage. It is made at the end of the wire arch. The bend", "bbox": [396.0, 146.0, 710.0, 162.0]}, {"text": "is done round (0.020\") or rectangular (0.017\" x 0.025\") at", "bbox": [396.0, 164.0, 710.0, 179.0]}, {"text": "45° toward the gingival margin producing a tip or molar", "bbox": [396.0, 179.0, 710.0, 198.0]}, {"text": "angulation. (25)", "bbox": [396.0, 198.0, 472.0, 213.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Fig. 54. The Tip back is done at 45° toward the gingival margin at the", "bbox": [396.0, 444.0, 710.0, 461.0]}, {"text": "end of the wire arch.", "bbox": [397.0, 461.0, 487.0, 473.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Advantages", "bbox": [395.0, 500.0, 482.0, 515.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "1.", "bbox": [397.0, 537.0, 410.0, 550.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "2.", "bbox": [396.0, 554.0, 409.0, 568.0]}, {"text": "1.13.", "bbox": [396.0, 571.0, 410.0, 584.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "4.", "bbox": [396.0, 624.0, 409.0, 637.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Disadvantages", "bbox": [396.0, 656.0, 501.0, 671.0]}], "type": "Section-header", "position": 18}, {"raw_context": [{"text": "1.", "bbox": [397.0, 693.0, 409.0, 706.0]}, {"text": "2.", "bbox": [396.0, 727.0, 410.0, 741.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "May provoke an anterior open bite due to the intru¬", "bbox": [422.0, 691.0, 709.0, 706.0]}, {"text": "sion of the anterosuperior segment.", "bbox": [422.0, 708.0, 620.0, 724.0]}, {"text": "May provoke TMJ alterations due to premature con¬", "bbox": [422.0, 726.0, 709.0, 742.0]}, {"text": "tacts that can develop after molar inclination.", "bbox": [422.0, 743.0, 674.0, 758.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Recommendations", "bbox": [395.0, 776.0, 526.0, 792.0]}], "type": "Section-header", "position": 21}, {"raw_context": [{"text": "1.", "bbox": [397.0, 814.0, 410.0, 828.0]}], "type": "Text", "position": 22}, {"raw_context": [{"text": "2.", "bbox": [396.0, 831.0, 409.0, 845.0]}], "type": "Text", "position": 23}, {"raw_context": [{"text": "3.", "bbox": [396.0, 865.0, 409.0, 879.0]}], "type": "Text", "position": 24}, {"raw_context": [{"text": "Do not use it in patients with open bite.", "bbox": [422.0, 812.0, 642.0, 828.0]}, {"text": "In case of pain in the TMJ due to premature contact", "bbox": [422.0, 830.0, 710.0, 845.0]}, {"text": "points, remove the wire immediately.", "bbox": [422.0, 846.0, 627.0, 862.0]}, {"text": "This type of anchorage can be used in conjunction", "bbox": [422.0, 863.0, 710.0, 881.0]}, {"text": "with another one in deep bite cases. At the moment", "bbox": [422.0, 882.0, 710.0, 897.0]}, {"text": "of placement of the wire in the molar tubes (with", "bbox": [422.0, 899.0, 711.0, 915.0]}, {"text": "the Tip Back bend), the anterior segment of the arch", "bbox": [422.0, 917.0, 710.0, 932.0]}, {"text": "wire tends to displace itself gingivally producing an", "bbox": [422.0, 933.0, 710.0, 949.0]}, {"text": "intrusive force in the anterior sector.", "bbox": [422.0, 951.0, 625.0, 966.0]}], "type": "Text", "position": 25}, {"raw_context": [{"text": "Fast and easy to make.", "bbox": [422.0, 535.0, 547.0, 551.0]}, {"text": "No patient cooperation dependence.", "bbox": [422.0, 553.0, 625.0, 568.0]}, {"text": "Distal crown inclination and mesial root inclination", "bbox": [422.0, 569.0, 710.0, 585.0]}, {"text": "in molars make them more resistant to mesial move-", "bbox": [422.0, 587.0, 707.0, 602.0]}, {"text": "ment.", "bbox": [422.0, 605.0, 457.0, 620.0]}, {"text": "It is cheap.", "bbox": [421.0, 622.0, 483.0, 638.0]}], "type": "Text", "position": 26}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 61}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#7#序号与内容分离1. 和The stop of the loop must是一句话，以此类推\n多余换行#9#14#序号与内容分离1. 和 It is very advisable to make是一句话，以此类推\n多余换行#15#16#B)Tip Back是一句话\n多余换行#25#28#序号与内容分离1. 和May provoke an anterior是一句话，以此类推\n多余换行#30#35#序号与内容分离1. 和Do not use it in patients是一句话，以此类推\n多余换行#36#39#是接第20到23条，1. 和Fast and easy to make.是一句话，以此类推", "type3": "无关文本#17#17#molar angulation. (25)出现在句末的无关数字引用\n无关文本#22#22#1.1", "type4": "栏目混乱#36#39#内容出现的顺序不对，应该接20条", "type6": "有用性#0#0#Figs. 52 and 53. Forward arches图片描述\n有用性#18#18# Fig. 54. The Tip back is done at 45° toward the gingival margin at the end of the wire arch.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:39:27"}
{"id": 1042034, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "847cb9ee-3f36-4656-a642-51a5188cb081", "title": null, "text": "【0】页码:122\n patients who have undergone cardiac transplantation because the transplanted heart lacks vagal innervation. One small uncontrolled study documented paradoxical slowing of the heart rate and high-degree AV block when atropine was administered to patients after cardiac transplantation. 369 Avoid relying on atropine in type II second-degree or thirddegree AV block or in patients with third-degree AV block with a new wide-QRS complex where the location of block is likely to be in non-nodal tissue (such as in the bundle of His or more distal conduction system). These bradyarrhythmias are not likely to be responsive to reversal of cholinergic effects by atropine and are preferably treated with TCP or β -adrenergic support as temporizing measures while the patient is prepared for transvenous pacing (Figure 3, Box 6 ).\n\n【1】 Pacing TCP may be useful for the treatment of symptomatic bradycardias. There are limited studies comparing TCP with drug therapy for the treatment of symptomatic bradycardia. A randomized controlled trial in which atropine and glycopyrrolate were compared with TCP showed few differences in outcome and survival, although the TCP group obtained a more consistent heart rate. 363 In a study evaluating the feasibility of treatment with dopamine as compared with TCP, no differences were observed between treatment groups in survival to hospital discharge. 370 TCP is, at best, a temporizing measure. TCP is painful in conscious patients, and, whether effective or not (achieving inconsistent capture), the patient should be prepared for transvenous pacing and expert consultation should be obtained. It is reasonable for healthcare providers to initiate TCP in unstable patients who do not respond to atropine (Class IIa, LOE B). Immediate pacing might be considered in unstable patients with high-degree AV block when IV access is not available (Class IIb, LOE C). If the patient does not respond to drugs or TCP, transvenous pacing is probably indicated (Class IIa, LOE C) (Figure 3, Box 6).\n\n【2】 Alternative Drugs to Consider Although not first-line agents for treatment of symptomatic bradycardia, dopamine, epinephrine, and isoproterenol are alternatives when a bradyarrhythmia is unresponsive to or inappropriate for treatment with atropine, or as a temporizing measure while awaiting the availability of a pacemaker.\n\n【3】Alternative drugs may also be appropriate in special circumstances such as the overdose of a β -blocker or calcium channel blocker.\n\n【4】 Dopamine.  Dopamine hydrochloride is a catecholamine with both α - and β -adrenergic actions. It can be titrated to more selectively target heart rate or vasoconstriction. At lower doses dopamine has a more selective effect on inotropy and heart rate; at higher doses (>10 mcg/kg per minute), it also has vasoconstrictive effects. Dopamine infusion may be used for patients with symptomatic bradycardia, particularly if associated with hypotension, in whom atropine may be inappropriate or after atropine fails (Class IIb, LOE B). Begin dopamine infusion at 2 to 10 mcg/kg per minute and titrate to patient response. 370 Use of vasoconstrictors requires that the recipient be assessed for adequate intravascular volume and volume status supported as needed.\n\n【5】 Epinephrine . Epinephrine is a catecholamine with α - and b -adrenergic actions. Epinephrine infusion may be used for patients with symptomatic bradycardia, particularly if associated with hypotension, for whom atropine may be inappropriate or after atropine fails (Class IIb, LOE B). Begin the infusion at 2 to 10 mcg/min and titrate to patient response. Use of vasoconstrictors requires that the recipient be assessed for adequate intravascular volume and volume status supported as needed.\n\n【6】 Isoproterenol.  Isoproterenol is a β -adrenergic agent with β -1 and β -2 effects, resulting in an increase in heart rate and vasodilation. The recommended adult dose is 2 to 10 mcg/ min by IV infusion, titrated according to heart rate and rhythm response.\n\n【7】## Tachycardia\n\n【8】\n This section summarizes the management of a wide variety of tachyarrhythmias. Following the overview of tachyarrhythmias and summary of the initial evaluation and treatment of tachycardia, common antiarrhythmic drugs used in the treatment of tachycardia are presented. See the Tachycardia Algorithm, Figure 4. Box numbers in the text refer to the numbered boxes in the algorithm.\n\n【9】## Classification Of Tachyarrhythmias\n\n【10】\n Tachycardias can be classified in several ways, based on the appearance of the QRS complex, heart rate, and regularity.\n\n【11】ACLS professionals should be able to recognize and differentiate between sinus tachycardia, narrow-complex supraventricular tachycardia (SVT), and wide-complex tachycardia.\n\n【12】Because ACLS providers may be unable to distinguish between supraventricular and ventricular rhythms, they should be aware that most wide-complex (broad-complex) tachycardias are ventricular in origin.\n • Narrow–QRS-complex (SVT) tachycardias (QRS <0.12 second), in order of frequency • Sinus tachycardia • Atrial fibrillation\n • Atrial flutter\n • AV nodal reentry\n • Accessory pathway–mediated tachycardia • Atrial tachycardia (including automatic and reentry forms)\n • Multifocal atrial tachycardia (MAT) • Junctional tachycardia (rare in adults) • Wide–QRS-complex tachycardias (QRS ≥0.12 second) • Ventricular tachycardia (VT) and ventricular fibrillation (VF)\n • SVT with aberrancy • Pre-excited tachycardias (Wolff-Parkinson-White [WPW] syndrome) • Ventricular paced rhythms\n\n【13】 Irregular narrow-complex tachycardias are likely atrial fibrillation or MAT; occasionally atrial flutter is irregular.\n\n【14】The management of atrial fibrillation and flutter is discussed in the section \"Irregular Tachycardias\" below.\n\n【15】 Initial Evaluation and Treatment of Tachyarrhythmias Tachycardia is defined as an arrhythmia with a rate of > 100 beats per minute, although, as with defining bradycardia, the\n\n【16】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "patients who have undergone cardiac transplantation because", "bbox": [60.0, 85.0, 376.0, 99.0]}, {"text": "the transplanted heart lacks vagal innervation. One small", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "uncontrolled study documented paradoxical slowing of the", "bbox": [60.0, 115.0, 376.0, 130.0]}, {"text": "heart rate and high-degree AV block when atropine was", "bbox": [60.0, 132.0, 375.0, 145.0]}, {"text": "administered to patients after cardiac transplantation. 369", "bbox": [60.0, 147.0, 349.0, 160.0]}, {"text": "Avoid relying on atropine in type II second-degree or third-", "bbox": [74.0, 162.0, 375.0, 176.0]}, {"text": "degree AV block or in patients with third-degree AV block with", "bbox": [60.0, 177.0, 376.0, 192.0]}, {"text": "a new wide-QRS complex where the location of block is likely", "bbox": [60.0, 194.0, 375.0, 207.0]}, {"text": "to be in non-nodal tissue (such as in the bundle of His or more", "bbox": [60.0, 208.0, 376.0, 222.0]}, {"text": "distal conduction system). These bradyarrhythmias are not likely", "bbox": [60.0, 224.0, 375.0, 238.0]}, {"text": "to be responsive to reversal of cholinergic effects by atropine and", "bbox": [60.0, 240.0, 376.0, 253.0]}, {"text": "are preferably treated with TCP or β -adrenergic support as", "bbox": [60.0, 254.0, 376.0, 269.0]}, {"text": "temporizing measures while the patient is prepared for trans-", "bbox": [60.0, 271.0, 375.0, 284.0]}, {"text": "venous pacing (Figure 3, Box 6 ).", "bbox": [60.0, 286.0, 228.0, 301.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Pacing", "bbox": [60.0, 311.0, 100.0, 325.0]}, {"text": "TCP may be useful for the treatment of symptomatic bradycar-", "bbox": [60.0, 325.0, 375.0, 340.0]}, {"text": "dias. There are limited studies comparing TCP with drug therapy", "bbox": [60.0, 341.0, 375.0, 354.0]}, {"text": "for the treatment of symptomatic bradycardia. A randomized", "bbox": [60.0, 356.0, 377.0, 370.0]}, {"text": "controlled trial in which atropine and glycopyrrolate were", "bbox": [60.0, 372.0, 375.0, 385.0]}, {"text": "compared with TCP showed few differences in outcome and", "bbox": [60.0, 387.0, 376.0, 401.0]}, {"text": "survival, although the TCP group obtained a more consistent", "bbox": [60.0, 403.0, 376.0, 416.0]}, {"text": "heart rate. 363 In a study evaluating the feasibility of treatment", "bbox": [60.0, 418.0, 376.0, 433.0]}, {"text": "with dopamine as compared with TCP, no differences were", "bbox": [60.0, 434.0, 376.0, 448.0]}, {"text": "observed between treatment groups in survival to hospital", "bbox": [60.0, 448.0, 376.0, 462.0]}, {"text": "discharge. 370 TCP is, at best, a temporizing measure. TCP is", "bbox": [60.0, 463.0, 376.0, 478.0]}, {"text": "painful in conscious patients, and, whether effective or not", "bbox": [60.0, 480.0, 376.0, 494.0]}, {"text": "(achieving inconsistent capture), the patient should be prepared", "bbox": [60.0, 495.0, 377.0, 509.0]}, {"text": "for transvenous pacing and expert consultation should be ob-", "bbox": [60.0, 511.0, 375.0, 524.0]}, {"text": "tained. It is reasonable for healthcare providers to initiate TCP in", "bbox": [60.0, 526.0, 377.0, 541.0]}, {"text": "unstable patients who do not respond to atropine (Class IIa, LOE", "bbox": [60.0, 542.0, 375.0, 555.0]}, {"text": "B). Immediate pacing might be considered in unstable patients", "bbox": [60.0, 557.0, 376.0, 571.0]}, {"text": "with high-degree AV block when IV access is not available", "bbox": [60.0, 573.0, 376.0, 587.0]}, {"text": "(Class IIb, LOE C). If the patient does not respond to drugs or", "bbox": [60.0, 588.0, 376.0, 601.0]}, {"text": "TCP, transvenous pacing is probably indicated (Class IIa, LOE", "bbox": [60.0, 603.0, 376.0, 617.0]}, {"text": "C) (Figure 3, Box 6).", "bbox": [60.0, 619.0, 169.0, 634.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Alternative Drugs to Consider", "bbox": [60.0, 643.0, 221.0, 657.0]}, {"text": "Although not first-line agents for treatment of symptomatic", "bbox": [60.0, 658.0, 376.0, 673.0]}, {"text": "bradycardia, dopamine, epinephrine, and isoproterenol are", "bbox": [60.0, 675.0, 375.0, 688.0]}, {"text": "alternatives when a bradyarrhythmia is unresponsive to or", "bbox": [60.0, 689.0, 376.0, 703.0]}, {"text": "inappropriate for treatment with atropine, or as a temporizing", "bbox": [60.0, 705.0, 376.0, 719.0]}, {"text": "measure while awaiting the availability of a pacemaker.", "bbox": [60.0, 720.0, 375.0, 734.0]}, {"text": "Alternative drugs may also be appropriate in special circum-", "bbox": [60.0, 736.0, 375.0, 749.0]}, {"text": "stances such as the overdose of a β -blocker or calcium", "bbox": [60.0, 751.0, 376.0, 765.0]}, {"text": "channel blocker.", "bbox": [60.0, 766.0, 147.0, 781.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Dopamine.  Dopamine hydrochloride is a catecholamine with", "bbox": [60.0, 790.0, 377.0, 805.0]}, {"text": "both α - and β -adrenergic actions. It can be titrated to more", "bbox": [60.0, 807.0, 375.0, 820.0]}, {"text": "selectively target heart rate or vasoconstriction. At lower", "bbox": [60.0, 822.0, 376.0, 836.0]}, {"text": "doses dopamine has a more selective effect on inotropy and", "bbox": [60.0, 838.0, 376.0, 851.0]}, {"text": "heart rate; at higher doses (>10 mcg/kg per minute), it also", "bbox": [60.0, 853.0, 377.0, 868.0]}, {"text": "has vasoconstrictive effects. Dopamine infusion may be used", "bbox": [60.0, 869.0, 377.0, 883.0]}, {"text": "for patients with symptomatic bradycardia, particularly if", "bbox": [60.0, 884.0, 377.0, 898.0]}, {"text": "associated with hypotension, in whom atropine may be", "bbox": [60.0, 899.0, 376.0, 914.0]}, {"text": "inappropriate or after atropine fails (Class IIb, LOE B). Begin", "bbox": [60.0, 915.0, 377.0, 929.0]}, {"text": "dopamine infusion at 2 to 10 mcg/kg per minute and titrate to", "bbox": [60.0, 930.0, 376.0, 944.0]}, {"text": "patient response. 370 Use of vasoconstrictors requires that the", "bbox": [60.0, 946.0, 376.0, 960.0]}, {"text": "recipient be assessed for adequate intravascular volume and", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "volume status supported as needed.", "bbox": [60.0, 977.0, 245.0, 991.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Epinephrine . Epinephrine is a catecholamine with α - and", "bbox": [404.0, 84.0, 721.0, 99.0]}, {"text": "b -adrenergic actions. Epinephrine infusion may be used for", "bbox": [404.0, 100.0, 720.0, 113.0]}, {"text": "patients with symptomatic bradycardia, particularly if associated", "bbox": [403.0, 114.0, 720.0, 128.0]}, {"text": "with hypotension, for whom atropine may be inappropriate or", "bbox": [404.0, 130.0, 720.0, 144.0]}, {"text": "after atropine fails (Class IIb, LOE B). Begin the infusion at 2 to", "bbox": [404.0, 146.0, 720.0, 159.0]}, {"text": "10 mcg/min and titrate to patient response. Use of vasoconstric-", "bbox": [405.0, 160.0, 719.0, 174.0]}, {"text": "tors requires that the recipient be assessed for adequate intravas-", "bbox": [403.0, 175.0, 718.0, 189.0]}, {"text": "cular volume and volume status supported as needed.", "bbox": [404.0, 191.0, 672.0, 204.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Isoproterenol.  Isoproterenol is a β -adrenergic agent with β -1", "bbox": [404.0, 215.0, 720.0, 229.0]}, {"text": "and β -2 effects, resulting in an increase in heart rate and", "bbox": [404.0, 230.0, 720.0, 245.0]}, {"text": "vasodilation. The recommended adult dose is 2 to 10 mcg/", "bbox": [404.0, 246.0, 720.0, 260.0]}, {"text": "min by IV infusion, titrated according to heart rate and", "bbox": [404.0, 260.0, 720.0, 274.0]}, {"text": "rhythm response.", "bbox": [403.0, 275.0, 494.0, 290.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Tachycardia", "bbox": [404.0, 304.0, 483.0, 318.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "This section summarizes the management of a wide variety of", "bbox": [404.0, 320.0, 720.0, 333.0]}, {"text": "tachyarrhythmias. Following the overview of tachyarrhythmias", "bbox": [403.0, 334.0, 720.0, 348.0]}, {"text": "and summary of the initial evaluation and treatment of", "bbox": [404.0, 349.0, 720.0, 363.0]}, {"text": "tachycardia, common antiarrhythmic drugs used in the treatment", "bbox": [404.0, 365.0, 720.0, 378.0]}, {"text": "of tachycardia are presented. See the Tachycardia Algorithm,", "bbox": [403.0, 380.0, 720.0, 394.0]}, {"text": "Figure 4. Box numbers in the text refer to the numbered boxes", "bbox": [403.0, 394.0, 720.0, 408.0]}, {"text": "in the algorithm.", "bbox": [403.0, 410.0, 489.0, 424.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Classification of Tachyarrhythmias", "bbox": [403.0, 435.0, 595.0, 448.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Tachycardias can be classified in several ways, based on the", "bbox": [404.0, 449.0, 720.0, 462.0]}, {"text": "appearance of the QRS complex, heart rate, and regularity.", "bbox": [404.0, 463.0, 719.0, 477.0]}, {"text": "ACLS professionals should be able to recognize and differ-", "bbox": [404.0, 479.0, 719.0, 492.0]}, {"text": "entiate between sinus tachycardia, narrow-complex supraven-", "bbox": [403.0, 494.0, 719.0, 507.0]}, {"text": "tricular tachycardia (SVT), and wide-complex tachycardia.", "bbox": [403.0, 508.0, 720.0, 523.0]}, {"text": "Because ACLS providers may be unable to distinguish", "bbox": [404.0, 524.0, 720.0, 538.0]}, {"text": "between supraventricular and ventricular rhythms, they", "bbox": [403.0, 539.0, 720.0, 553.0]}, {"text": "should be aware that most wide-complex (broad-complex)", "bbox": [403.0, 555.0, 721.0, 568.0]}, {"text": "tachycardias are ventricular in origin.", "bbox": [403.0, 570.0, 601.0, 583.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "• Narrow–QRS-complex (SVT) tachycardias (QRS <0.12", "bbox": [404.0, 595.0, 721.0, 609.0]}, {"text": "second), in order of frequency", "bbox": [416.0, 610.0, 575.0, 624.0]}, {"text": "• Sinus tachycardia", "bbox": [416.0, 626.0, 523.0, 639.0]}, {"text": "• Atrial fibrillation", "bbox": [416.0, 641.0, 521.0, 655.0]}], "type": "List-item", "position": 13}, {"raw_context": [{"text": "• Atrial flutter", "bbox": [416.0, 655.0, 497.0, 669.0]}], "type": "List-item", "position": 14}, {"raw_context": [{"text": "• AV nodal reentry", "bbox": [416.0, 671.0, 522.0, 684.0]}], "type": "List-item", "position": 15}, {"raw_context": [{"text": "• Accessory pathway–mediated tachycardia", "bbox": [416.0, 686.0, 649.0, 701.0]}, {"text": "• Atrial tachycardia (including automatic and reentry", "bbox": [416.0, 701.0, 720.0, 716.0]}, {"text": "forms)", "bbox": [430.0, 718.0, 467.0, 729.0]}], "type": "List-item", "position": 16}, {"raw_context": [{"text": "• Multifocal atrial tachycardia (MAT)", "bbox": [417.0, 731.0, 620.0, 746.0]}, {"text": "• Junctional tachycardia (rare in adults)", "bbox": [416.0, 747.0, 628.0, 760.0]}, {"text": "• Wide–QRS-complex tachycardias (QRS ≥0.12 second)", "bbox": [404.0, 762.0, 709.0, 775.0]}, {"text": "• Ventricular tachycardia (VT) and ventricular fibrillation", "bbox": [416.0, 776.0, 720.0, 790.0]}, {"text": "(VF)", "bbox": [429.0, 791.0, 457.0, 805.0]}], "type": "List-item", "position": 17}, {"raw_context": [{"text": "• SVT with aberrancy", "bbox": [416.0, 807.0, 536.0, 821.0]}, {"text": "• Pre-excited tachycardias (Wolff-Parkinson-White", "bbox": [416.0, 822.0, 720.0, 836.0]}, {"text": "[WPW] syndrome)", "bbox": [429.0, 837.0, 531.0, 851.0]}, {"text": "• Ventricular paced rhythms", "bbox": [417.0, 852.0, 570.0, 867.0]}], "type": "List-item", "position": 18}, {"raw_context": [{"text": "Irregular narrow-complex tachycardias are likely atrial", "bbox": [416.0, 878.0, 721.0, 892.0]}, {"text": "fibrillation or MAT; occasionally atrial flutter is irregular.", "bbox": [404.0, 894.0, 719.0, 907.0]}, {"text": "The management of atrial fibrillation and flutter is discussed", "bbox": [404.0, 909.0, 720.0, 923.0]}, {"text": "in the section \"Irregular Tachycardias\" below.", "bbox": [404.0, 923.0, 646.0, 937.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "Initial Evaluation and Treatment of Tachyarrhythmias", "bbox": [404.0, 949.0, 701.0, 963.0]}, {"text": "Tachycardia is defined as an arrhythmia with a rate of > 100", "bbox": [404.0, 964.0, 721.0, 976.0]}, {"text": "beats per minute, although, as with defining bradycardia, the", "bbox": [404.0, 978.0, 720.0, 992.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 21}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 122}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#0#0#Avoid relying on atropine in ...应该另起一行\n缺少换行#1#1# TCP may be useful for the treatment...正文内容和标题分开，另起一行\n缺少换行#2#2#Although not first-line agents for...正文内容和标题分开，另起一行\n缺少换行#12#12# • Sinus tachycardia\n • Atrial fibrillation\n • Atrial tachycardia (including automatic...\n • Junctional tachycardia (rare in adults) \n• Wide–QRS-complex tachycardias\n • Ventricular tachycardia (VT)...\n • Pre-excited tachycardias ...\n • Ventricular paced rhythms都要另起一行", "type3": "无关文本#0#15#363 In a study evaluating the feasibility...\n...cardiac transplantation. 369像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#16#16#属于页脚的内容，和正文无关", "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:34:52"}
{"id": 1042033, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "b66f5bb0-28e6-4192-b1c9-c172af39f5e6", "title": null, "text": "【0】页码:242\n# American Heart Association Learn And Lives\n\n【1】\n Part 13: Pediatric Basic Life Support : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Marc D. Berg, Stephen M. Schexnayder, Leon Chameides, Mark Terry, Aaron Donoghue, Robert W. Hickey, Robert A. Berg, Robert M. Sutton and Mary Fran Hazinski\n\n【2】 Circulation 2010, 122:S862-S875 doi: 10.1161/CIRCULATIONAHA.110.971085 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514 Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539\n\n【3】 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circ.ahajournals.org/content/122/18_suppl_3/S862\n\n【4】 Subscriptions: Information about subscribing to Circulation is online at http://circ.ahajournals.org//subscriptions/\n\n【5】 Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax: 410-528-8550. E-mail: journalpermissions@lww.com\n\n【6】 Reprints: Information about reprints can be found online at http://www.lww.com/reprints", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "American Heart", "bbox": [520.0, 125.0, 676.0, 149.0]}, {"text": "Association", "bbox": [563.0, 153.0, 674.0, 172.0]}, {"text": "Learn and Lives", "bbox": [570.0, 189.0, 715.0, 207.0]}], "type": "Title", "position": 2}, {"raw_context": [{"text": "Part 13: Pediatric Basic Life Support : 2010 American Heart Association", "bbox": [139.0, 267.0, 641.0, 284.0]}, {"text": "Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular", "bbox": [116.0, 283.0, 662.0, 298.0]}, {"text": "Care", "bbox": [369.0, 300.0, 408.0, 314.0]}, {"text": "Marc D. Berg, Stephen M. Schexnayder, Leon Chameides, Mark Terry, Aaron", "bbox": [135.0, 314.0, 644.0, 334.0]}, {"text": "Donoghue, Robert W. Hickey, Robert A. Berg, Robert M. Sutton and Mary Fran", "bbox": [130.0, 331.0, 650.0, 348.0]}, {"text": "Hazinski", "bbox": [358.0, 348.0, 419.0, 362.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Circulation 2010, 122:S862-S875", "bbox": [278.0, 397.0, 499.0, 414.0]}, {"text": "doi: 10.1161/CIRCULATIONAHA.110.971085", "bbox": [232.0, 414.0, 544.0, 429.0]}, {"text": "Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX", "bbox": [125.0, 428.0, 652.0, 443.0]}, {"text": "72514", "bbox": [369.0, 442.0, 407.0, 457.0]}, {"text": "Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online", "bbox": [122.0, 455.0, 657.0, 470.0]}, {"text": "ISSN: 1524-4539", "bbox": [339.0, 469.0, 437.0, 482.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The online version of this article, along with updated information and services, is", "bbox": [128.0, 585.0, 651.0, 601.0]}, {"text": "located on the World Wide Web at:", "bbox": [271.0, 602.0, 503.0, 617.0]}, {"text": "http://circ.ahajournals.org/content/122/18_suppl_3/S862", "bbox": [206.0, 616.0, 571.0, 633.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Subscriptions: Information about subscribing to Circulation is online at", "bbox": [123.0, 807.0, 506.0, 823.0]}, {"text": "http://circ.ahajournals.org//subscriptions/", "bbox": [122.0, 822.0, 344.0, 836.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters", "bbox": [123.0, 846.0, 637.0, 863.0]}, {"text": "Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax:", "bbox": [123.0, 859.0, 653.0, 876.0]}, {"text": "410-528-8550. E-mail:", "bbox": [122.0, 874.0, 248.0, 889.0]}, {"text": "journalpermissions@lww.com", "bbox": [122.0, 888.0, 289.0, 903.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Reprints: Information about reprints can be found online at", "bbox": [122.0, 915.0, 441.0, 930.0]}, {"text": "http://www.lww.com/reprints", "bbox": [122.0, 929.0, 284.0, 942.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 242}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#6#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:45:02"}
{"id": 1042032, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "5abf1f4b-4d0c-40ca-9079-13cf8083da39", "title": null, "text": "【0】页码:199\n (or the last time the patient was known to be normal), triage and transport the patient, and provide prearrival notification to the most appropriate receiving hospital. 31, 41–44 Patients with acute stroke are at risk for respiratory compromise from aspiration, upper airway obstruction, hypoventilation, and (rarely) neurogenic pulmonary edema. The combination of poor perfusion and hypoxemia will exacerbate and extend ischemic brain injury and has been associated with worse outcome from stroke. 45 Both out-of-hospital and in-hospital medical personnel should administer supplemental oxygen to hypoxemic (ie, oxygen saturation < 94%) stroke patients (Class I, LOE C) or those with unknown oxygen saturation.\n\n【1】Although blood pressure management is a component of the ED care of stroke patients, there are no data to support initiation of hypertension intervention in the prehospital environment. Unless the patient is hypotensive (systolic blood pressure < 90 mm Hg), prehospital intervention for blood pressure is not recommended (Class III, LOE C).\n\n【2】## Transport And Destination Hospital\n\n【3】\n EMS providers should consider transporting a witness, family member, or caregiver with the patient to verify the time of stroke symptom onset. En route to the facility, providers should continue to support cardiopulmonary function, monitor neurologic status, check blood glucose if possible, and provide prehospital notification.\n\n【4】Prearrival hospital notification by the transporting EMS unit has been found to significantly increase the percentage of patients with acute stroke who receive fibrinolytic therapy. 46 – 48 Bypass of community hospitals in favor of transporting patients directly to a stroke center has undergone investigations that merit attention. Investigators in New York, Canada, Italy, and Australia have performed before-and-after studies examining the difference in rates of rtPA administration after implementation of a hospital bypass protocol for EMS.  All have found significantly larger percentages of patients with ischemic stroke treated with rtPA when patients are transported directly to stroke centers. 47, 49, 50 Recently investigators have begun to examine the impact of direct activation of stroke teams by EMS. 50 , 51 EMS providers must rapidly deliver the patient to a medical facility capable of providing acute stroke care and provide prearrival notification to the receiving facility. 41,46,48 Each receiving hospital should define its capability for treating patients with acute stroke using the definitions established for strokeprepared hospitals, primary stroke centers, and comprehensive stroke centers 3,6,7 and should communicate this information to the EMS system and the community. Although not every hospital is capable of organizing the necessary resources to safely administer fibrinolytic therapy, every hospital with an ED should have a written plan that is communicated to EMS systems describing how patients with acute stroke are to be managed in that institution. The plan should detail the roles of healthcare professionals in the care of patients with acute stroke and define which patients will be treated with fibrinolytic therapy at that facility and when transfer to another hospital with a dedicated stroke unit is appropriate.\n\n【5】The role of stroke centers and in particular stroke units continues to be defined, but a growing body of evi-\n\n【6】 dence 47.49. so,s2– 58 indicates a favorable benefit from triage of stroke patients directly to designated stroke centers (Class I, LOE B). EMS systems should establish a stroke destination preplan to enable EMS providers to direct patients with acute stroke to appropriate facilities. When multiple stroke hospitals are within similar transport distances, EMS personnel should consider triage to the stroke center with the highest capability of stroke care.\n\n【7】Multiple randomized clinical trials and meta-analyses in adults 50.59 – 62 document consistent improvement in 1-year survival rate, functional outcome, and quality of life when patients hospitalized with acute stroke are cared for in a dedicated stroke unit by a multidisciplinary team experienced in managing stroke. Although the studies reported were conducted outside the United States at in-hospital units that provided both acute care and rehabilitation, the improved outcomes were apparent very early in stroke care. These results should be relevant to the outcome of dedicated stroke units staffed with experienced multidisciplinary teams in the United States. When such a facility is available within a reasonable transport interval, stroke patients who require hospitalization should be admitted there (Class I, LOE B).\n\n【8】## In-Hospital Care\n\n【9】\n## Initial Ed Assessment And Stabilization (Box 3)\n\n【10】\n Protocols should be used in the ED to minimize delay to definitive diagnosis and therapy: \"Time is Brain.\" 43 As a goal, ED personnel should assess the patient with suspected stroke within 10 minutes of arrival in the ED. General care includes assessment, cardiopulmonary support (airway, breathing, circulation), and evaluation of baseline vital signs.\n\n【11】Administration of oxygen to hypoxemic patients with stroke (oxygen saturation < 94%) is recommended (Class I, LOE C).\n\n【12】On arrival ED personnel should establish or confirm IV access and obtain blood samples for baseline studies (eg, complete blood count, coagulation studies, blood glucose). If not already identified in the prehospital setting, ED staff should promptly identify and treat hypoglycemia. The ED physician should perform a neurologic screening assessment, order an emergent computed tomography (CT) scan of the brain, and activate the stroke team or arrange for consultation with a stroke expert.\n\n【13】A 12-lead electrocardiogram (ECG) does not take priority over the CT scan but may identify a recent acute myocardial infarction or arrhythmias (eg, atrial fibrillation) as the cause of an embolic stroke. If the patient is hemodynamically stable, treatment of other arrhythmias, including bradycardia, premature atrial or ventricular contractions, or asymptomatic atrioventricular conduction block, may not be necessary. 63 There is general agreement to recommend cardiac monitoring during the first 24 hours of evaluation in patients with acute ischemic stroke to detect atrial fibrillation and potentially life-threatening arrhythmias. 64\n\n【14】## Assessment (Box 4)\n\n【15】\n The treating physician should review the patient's history and verify time of onset of symptoms. 65 -67 This may require interviewing out-of-hospital providers, witnesses, and family members to establish the time that the patient was last known to be normal. Neurologic assessment is performed, incorpo-\n\n【16】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "(or the last time the patient was known to be normal), triage", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "and transport the patient, and provide prearrival notification", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "to the most appropriate receiving hospital. 31, 41–44", "bbox": [60.0, 115.0, 315.0, 129.0]}, {"text": "Patients with acute stroke are at risk for respiratory compro-", "bbox": [72.0, 131.0, 375.0, 145.0]}, {"text": "mise from aspiration, upper airway obstruction, hypoventilation,", "bbox": [60.0, 146.0, 375.0, 160.0]}, {"text": "and (rarely) neurogenic pulmonary edema. The combination of", "bbox": [60.0, 161.0, 376.0, 176.0]}, {"text": "poor perfusion and hypoxemia will exacerbate and extend", "bbox": [60.0, 177.0, 377.0, 191.0]}, {"text": "ischemic brain injury and has been associated with worse", "bbox": [60.0, 192.0, 376.0, 207.0]}, {"text": "outcome from stroke. 45 Both out-of-hospital and in-hospital", "bbox": [60.0, 207.0, 376.0, 222.0]}, {"text": "medical personnel should administer supplemental oxygen to", "bbox": [60.0, 223.0, 377.0, 238.0]}, {"text": "hypoxemic (ie, oxygen saturation < 94%) stroke patients (Class", "bbox": [60.0, 240.0, 376.0, 253.0]}, {"text": "I, LOE C) or those with unknown oxygen saturation.", "bbox": [60.0, 254.0, 327.0, 268.0]}, {"text": "Although blood pressure management is a component of", "bbox": [72.0, 270.0, 377.0, 284.0]}, {"text": "the ED care of stroke patients, there are no data to support", "bbox": [60.0, 285.0, 377.0, 299.0]}, {"text": "initiation of hypertension intervention in the prehospital", "bbox": [60.0, 301.0, 376.0, 314.0]}, {"text": "environment. Unless the patient is hypotensive (systolic", "bbox": [60.0, 316.0, 376.0, 330.0]}, {"text": "blood pressure < 90 mm Hg), prehospital intervention for", "bbox": [60.0, 331.0, 376.0, 346.0]}, {"text": "blood pressure is not recommended (Class III, LOE C).", "bbox": [60.0, 348.0, 353.0, 361.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Transport and Destination Hospital", "bbox": [60.0, 375.0, 282.0, 390.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "EMS providers should consider transporting a witness, family", "bbox": [60.0, 392.0, 376.0, 405.0]}, {"text": "member, or caregiver with the patient to verify the time of", "bbox": [60.0, 407.0, 376.0, 421.0]}, {"text": "stroke symptom onset. En route to the facility, providers", "bbox": [60.0, 421.0, 376.0, 436.0]}, {"text": "should continue to support cardiopulmonary function, moni-", "bbox": [60.0, 438.0, 375.0, 451.0]}, {"text": "tor neurologic status, check blood glucose if possible, and", "bbox": [60.0, 453.0, 376.0, 468.0]}, {"text": "provide prehospital notification.", "bbox": [60.0, 468.0, 228.0, 482.0]}, {"text": "Prearrival hospital notification by the transporting EMS", "bbox": [72.0, 483.0, 376.0, 497.0]}, {"text": "unit has been found to significantly increase the percentage", "bbox": [60.0, 499.0, 376.0, 513.0]}, {"text": "of patients with acute stroke who receive fibrinolytic the-", "bbox": [60.0, 515.0, 375.0, 528.0]}, {"text": "rapy. 46 – 48 Bypass of community hospitals in favor of trans-", "bbox": [60.0, 529.0, 375.0, 544.0]}, {"text": "porting patients directly to a stroke center has undergone", "bbox": [60.0, 546.0, 375.0, 559.0]}, {"text": "investigations that merit attention. Investigators in New York,", "bbox": [60.0, 561.0, 375.0, 575.0]}, {"text": "Canada, Italy, and Australia have performed before-and-after", "bbox": [60.0, 576.0, 376.0, 590.0]}, {"text": "studies examining the difference in rates of rtPA administra-", "bbox": [60.0, 592.0, 375.0, 605.0]}, {"text": "tion after implementation of a hospital bypass protocol for", "bbox": [60.0, 607.0, 376.0, 621.0]}, {"text": "EMS.  All have found significantly larger percentages of", "bbox": [60.0, 622.0, 377.0, 635.0]}, {"text": "patients with ischemic stroke treated with rtPA when patients", "bbox": [60.0, 637.0, 376.0, 652.0]}, {"text": "are transported directly to stroke centers. 47, 49, 50 Recently", "bbox": [60.0, 652.0, 375.0, 667.0]}, {"text": "investigators have begun to examine the impact of direct", "bbox": [60.0, 669.0, 376.0, 682.0]}, {"text": "activation of stroke teams by EMS. 50 , 51", "bbox": [60.0, 684.0, 266.0, 698.0]}, {"text": "EMS providers must rapidly deliver the patient to a medical", "bbox": [72.0, 699.0, 376.0, 714.0]}, {"text": "facility capable of providing acute stroke care and provide", "bbox": [60.0, 715.0, 375.0, 729.0]}, {"text": "prearrival notification to the receiving facility. 41,46,48 Each re-", "bbox": [60.0, 730.0, 375.0, 744.0]}, {"text": "ceiving hospital should define its capability for treating patients", "bbox": [60.0, 745.0, 376.0, 760.0]}, {"text": "with acute stroke using the definitions established for stroke-", "bbox": [60.0, 762.0, 375.0, 775.0]}, {"text": "prepared hospitals, primary stroke centers, and comprehensive", "bbox": [60.0, 776.0, 376.0, 791.0]}, {"text": "stroke centers 3,6,7 and should communicate this information to", "bbox": [60.0, 792.0, 376.0, 806.0]}, {"text": "the EMS system and the community. Although not every", "bbox": [60.0, 808.0, 375.0, 822.0]}, {"text": "hospital is capable of organizing the necessary resources to", "bbox": [60.0, 823.0, 377.0, 837.0]}, {"text": "safely administer fibrinolytic therapy, every hospital with an ED", "bbox": [60.0, 838.0, 376.0, 852.0]}, {"text": "should have a written plan that is communicated to EMS", "bbox": [60.0, 853.0, 376.0, 868.0]}, {"text": "systems describing how patients with acute stroke are to be", "bbox": [60.0, 870.0, 376.0, 883.0]}, {"text": "managed in that institution. The plan should detail the roles of", "bbox": [60.0, 884.0, 376.0, 899.0]}, {"text": "healthcare professionals in the care of patients with acute stroke", "bbox": [60.0, 901.0, 376.0, 914.0]}, {"text": "and define which patients will be treated with fibrinolytic", "bbox": [60.0, 916.0, 375.0, 930.0]}, {"text": "therapy at that facility and when transfer to another hospital with", "bbox": [60.0, 931.0, 376.0, 945.0]}, {"text": "a dedicated stroke unit is appropriate.", "bbox": [60.0, 947.0, 248.0, 961.0]}, {"text": "The role of stroke centers and in particular stroke units", "bbox": [73.0, 963.0, 376.0, 976.0]}, {"text": "continues to be defined, but a growing body of evi-", "bbox": [60.0, 977.0, 375.0, 991.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "dence 47.49. so,s2– 58 indicates a favorable benefit from triage of", "bbox": [403.0, 82.0, 721.0, 100.0]}, {"text": "stroke patients directly to designated stroke centers (Class I,", "bbox": [403.0, 100.0, 720.0, 113.0]}, {"text": "LOE B). EMS systems should establish a stroke destination", "bbox": [403.0, 115.0, 720.0, 129.0]}, {"text": "preplan to enable EMS providers to direct patients with acute", "bbox": [403.0, 131.0, 720.0, 145.0]}, {"text": "stroke to appropriate facilities. When multiple stroke hospi-", "bbox": [403.0, 146.0, 720.0, 160.0]}, {"text": "tals are within similar transport distances, EMS personnel", "bbox": [403.0, 161.0, 720.0, 175.0]}, {"text": "should consider triage to the stroke center with the highest", "bbox": [404.0, 177.0, 720.0, 190.0]}, {"text": "capability of stroke care.", "bbox": [403.0, 192.0, 534.0, 206.0]}, {"text": "Multiple randomized clinical trials and meta-analyses in", "bbox": [416.0, 207.0, 721.0, 221.0]}, {"text": "adults 50.59 – 62 document consistent improvement in 1-year", "bbox": [404.0, 222.0, 720.0, 237.0]}, {"text": "survival rate, functional outcome, and quality of life when", "bbox": [403.0, 238.0, 721.0, 253.0]}, {"text": "patients hospitalized with acute stroke are cared for in a", "bbox": [403.0, 254.0, 721.0, 267.0]}, {"text": "dedicated stroke unit by a multidisciplinary team experienced", "bbox": [403.0, 268.0, 720.0, 283.0]}, {"text": "in managing stroke. Although the studies reported were", "bbox": [403.0, 284.0, 720.0, 298.0]}, {"text": "conducted outside the United States at in-hospital units that", "bbox": [403.0, 300.0, 720.0, 314.0]}, {"text": "provided both acute care and rehabilitation, the improved", "bbox": [403.0, 315.0, 720.0, 328.0]}, {"text": "outcomes were apparent very early in stroke care. These", "bbox": [403.0, 330.0, 720.0, 343.0]}, {"text": "results should be relevant to the outcome of dedicated stroke", "bbox": [403.0, 345.0, 720.0, 360.0]}, {"text": "units staffed with experienced multidisciplinary teams in the", "bbox": [403.0, 361.0, 720.0, 374.0]}, {"text": "United States. When such a facility is available within a", "bbox": [404.0, 376.0, 721.0, 390.0]}, {"text": "reasonable transport interval, stroke patients who require", "bbox": [403.0, 391.0, 720.0, 405.0]}, {"text": "hospitalization should be admitted there (Class I, LOE B).", "bbox": [403.0, 407.0, 711.0, 421.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "In-Hospital Care", "bbox": [504.0, 436.0, 620.0, 452.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Initial ED Assessment and Stabilization (Box 3)", "bbox": [404.0, 457.0, 698.0, 472.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Protocols should be used in the ED to minimize delay to", "bbox": [404.0, 474.0, 721.0, 487.0]}, {"text": "definitive diagnosis and therapy: \"Time is Brain.\" 43 As a", "bbox": [403.0, 488.0, 721.0, 503.0]}, {"text": "goal, ED personnel should assess the patient with suspected", "bbox": [404.0, 504.0, 720.0, 517.0]}, {"text": "stroke within 10 minutes of arrival in the ED. General care", "bbox": [404.0, 519.0, 720.0, 534.0]}, {"text": "includes assessment, cardiopulmonary support (airway,", "bbox": [403.0, 535.0, 720.0, 548.0]}, {"text": "breathing, circulation), and evaluation of baseline vital signs.", "bbox": [403.0, 549.0, 720.0, 563.0]}, {"text": "Administration of oxygen to hypoxemic patients with stroke", "bbox": [404.0, 565.0, 720.0, 579.0]}, {"text": "(oxygen saturation < 94%) is recommended (Class I, LOE C).", "bbox": [404.0, 581.0, 719.0, 594.0]}, {"text": "On arrival ED personnel should establish or confirm IV", "bbox": [416.0, 595.0, 719.0, 610.0]}, {"text": "access and obtain blood samples for baseline studies (eg,", "bbox": [404.0, 611.0, 720.0, 625.0]}, {"text": "complete blood count, coagulation studies, blood glucose). If not", "bbox": [403.0, 627.0, 720.0, 641.0]}, {"text": "already identified in the prehospital setting, ED staff should", "bbox": [404.0, 642.0, 720.0, 656.0]}, {"text": "promptly identify and treat hypoglycemia. The ED physician", "bbox": [403.0, 657.0, 720.0, 671.0]}, {"text": "should perform a neurologic screening assessment, order an emer-", "bbox": [404.0, 672.0, 718.0, 687.0]}, {"text": "gent computed tomography (CT) scan of the brain, and activate the", "bbox": [404.0, 689.0, 720.0, 702.0]}, {"text": "stroke team or arrange for consultation with a stroke expert.", "bbox": [404.0, 703.0, 690.0, 717.0]}, {"text": "A 12-lead electrocardiogram (ECG) does not take priority", "bbox": [417.0, 719.0, 720.0, 732.0]}, {"text": "over the CT scan but may identify a recent acute myocardial", "bbox": [404.0, 734.0, 720.0, 748.0]}, {"text": "infarction or arrhythmias (eg, atrial fibrillation) as the cause", "bbox": [403.0, 749.0, 720.0, 763.0]}, {"text": "of an embolic stroke. If the patient is hemodynamically", "bbox": [403.0, 765.0, 720.0, 778.0]}, {"text": "stable, treatment of other arrhythmias, including bradycardia,", "bbox": [403.0, 780.0, 720.0, 794.0]}, {"text": "premature atrial or ventricular contractions, or asymptomatic", "bbox": [403.0, 796.0, 720.0, 809.0]}, {"text": "atrioventricular conduction block, may not be necessary. 63", "bbox": [403.0, 810.0, 720.0, 824.0]}, {"text": "There is general agreement to recommend cardiac monitoring", "bbox": [404.0, 826.0, 720.0, 840.0]}, {"text": "during the first 24 hours of evaluation in patients with acute", "bbox": [403.0, 842.0, 720.0, 855.0]}, {"text": "ischemic stroke to detect atrial fibrillation and potentially", "bbox": [404.0, 856.0, 719.0, 870.0]}, {"text": "life-threatening arrhythmias. 64", "bbox": [404.0, 872.0, 562.0, 886.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Assessment (Box 4)", "bbox": [404.0, 901.0, 525.0, 915.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "The treating physician should review the patient's history and", "bbox": [404.0, 916.0, 721.0, 929.0]}, {"text": "verify time of onset of symptoms. 65 -67 This may require", "bbox": [404.0, 931.0, 720.0, 944.0]}, {"text": "interviewing out-of-hospital providers, witnesses, and family", "bbox": [403.0, 946.0, 719.0, 961.0]}, {"text": "members to establish the time that the patient was last known", "bbox": [403.0, 962.0, 720.0, 976.0]}, {"text": "to be normal. Neurologic assessment is performed, incorpo-", "bbox": [403.0, 977.0, 718.0, 991.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 199}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#4#4#EMS providers must rapidly ...应该另起一行\n多余换行#6#6# dence 47.49. so,s2– 58 indicates a...与上面5段相连接", "type3": "无关文本#0#15#31, 41–44 Patients with ...\n...outcome from stroke. 45像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#16#16#是页脚的内容", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 19:44:06"}
{"id": 1042031, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "3b9a14f6-c161-4042-8551-5c2127b22111", "title": null, "text": "【0】页码:215\n\n【1】## Defibrillation\n\n【2】\n## Magnesium Sulfate Toxicity\n\n【3】\n## Preeclampsia/Eclampsia\n\n【4】\n## Treatment Of Reversible Causes The Same Reversible Causes Of Cardiac Arrest That Occur In\n\n【5】\n## Life-Threatening Pulmonary Embolism (Pe)\n\n【6】\n## Cardiac Disease\n\n【7】\n## Amniotic Fluid Embolism\n\n【8】\n## Anesthetic Complications\n\n【9】\n medications or doses should be altered during management of cardiac arrest in pregnancy; therefore, current recommended drug dosages for use in resuscitation of adults should also be used in resuscitation of the pregnant patient.\n\n【10】 fibrinolytics are relatively contraindicated in pregnancy, PCI is the reperfusion strategy of choice for ST-elevation myocardial infarction.\n\n【11】The number of babies born with congenital heart disease who now survive to adulthood has increased exponentially over the last 3 decades. 139,140 It is estimated that 85% of neonates born with congenital heart disease will survive to adulthood. Therefore, more women with congenital heart disease are surviving to have children, which translates into higher risk for a cardiac event during pregnancy. In fact, illnesses related to congenital heart disease and pulmonary hypertension are the third most common cause of maternal cardiac deaths. 92\n\n【12】 Defibrillation should be performed at the recommended ACLS defibrillation doses (Class I, LOE C). 122 Although there are no studies documenting matemal or fetal complications with defibrillation, there are case reports 123 – 130 and case series 131 – 133 that describe potential harm to the fetus when an accidental electric shock (lightning, electric circuit) is delivered directly to the mother. After a pregnant woman receives an electric shock, the range of clinical presentations varies from the mother feeling only a strange sensation with no fetal effects to fetal death either immediately or a few days after the shock. Risk factors for adverse fetal outcomes include the magnitude of current and duration of contact. The greatest predictor of risk for adverse fetal outcome is if the current travels through the uterus, because amniotic fluid most likely transmits current in a manner similar to that transmitted via other body fluids, which could increase the risk of fetal death or burns.\n\n【13】Although there is a small risk of inducing fetal arrhythmias, cardioversion and defibrillation on the external chest are considered safe at all stages of pregnancy. 134 – 136 Some experts have raised concern that electric arcing may occur if fetal monitors are attached during defibrillation of a pregnant woman, but there is no evidence to support this.\n\n【14】Overall it is reasonable to assume that if the shock is delivered to the mother's thorax, there is very low to no risk of electric arcing to fetal monitors. If internal or external fetal monitors are attached during cardiac arrest in a pregnant woman, it is reasonable to remove them (Class IIb, LOE C).\n\n【15】 Patients with magnesium toxicity present with cardiac effects ranging from ECG interval changes (prolonged PR, QRS and QT intervals) at magnesium levels of 2.5–5 mmol/L to AV nodal conduction block, bradycardia, hypotension and cardiac arrest at levels of 6–10 mmol/L. Neurological effects ranging from loss of tendon reflexes, sedation, severe muscular weakness, and respiratory depression are seen at levels of 4–5 mmol/L. Other signs of magnesium toxicity include gastrointestinal symptoms (nausea and vomiting), skin changes (flushing), and electrolyte/ fluid abnormalities (hypophosphatemia, hyperosmolar dehydration). Patients with renal failure and metabolic derangements can develop toxicity after relatively lower magnesium doses.\n\n【16】Iatrogenic overdose is possible in the pregnant woman who receives magnesium sulfate, particularly if the woman becomes oliguric. Empirical calcium administration may be lifesaving in these cases. 141–143\n\n【17】 Preeclampsia/eclampsia develops after the 20th week of gestation and can produce severe hypertension and ultimately diffuse organ-system failure. If untreated, maternal and fetal morbidity and mortality may result.\n\n【18】 nonpregnant women can occur during pregnancy. Providers should be familiar with pregnancy-specific diseases and procedural complications and during resuscitation attempts should try to identify common and reversible causes of cardiac arrest in pregnancy. 92\n\n【19】 Successful use of fibrinolytics in pregnant women has been reported for massive, life-threatening PE 144 –146 and ischemic stroke. 147 Pregnant women in cardiac arrest with suspected PE should be treated in accordance with the ACLS guidelines (see Part 12.5: \"Cardiac Arrest Associated With Pulmonary Embolism\").\n\n【20】 Cardiac disease is the primary cause of maternal mortality, according to the 2003 to 2005 Confidential Enquiries into Maternal and Child Health report.92 For example, the number of deaths from cardiac disease was 2.27 per 100,000 pregnancies, whereas the number of deaths from thrombosis and thromboembolism was 1.94 per 100,000 pregnancies. 92 The number of cardiac deaths during pregnancy has increased steadily since 1991. The most common causes of maternal death from cardiac disease are myocardial infarction, followed by aortic dissection. 92 A study completed in California also found that the incidence of myocardial infarction in pregnancy increased throughout the 1990s. 137 In addition, a nationwide review of myocardial infarction in pregnancy in the United States found that the risk of myocardial infarction in pregnancy is 3 to 4 times that of nonpregnant women of reproductive age. 138 Women are deferring pregnancy to older ages, increasing the chance that they will have atherosclerotic heart disease. Because\n\n【21】 Clinicians have reported successful use of cardiopulmonary bypass for pregnant women with a life-threatening amniotic fluid embolism during labor and delivery. 148 The use of perimortem cesarean section has resulted in maternal and neonatal survival. 149\n\n【22】 Anesthesia-related maternal morbidity and mortality continue to be a major concern, which has led to development of specialized obstetric anesthesia techniques. 118 Cardiac arrest may result from spinal shock as a result of regional anesthesia. Induction of general anesthesia may lead to loss of airway control or pulmonary aspiration, and emergence from anesthesia can be associated with hypoventilation or airway obstruction, leading to cardiac arrest. 150–155\n\n【23】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Defibrillation", "bbox": [60.0, 155.0, 135.0, 169.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Magnesium Sulfate Toxicity", "bbox": [404.0, 280.0, 557.0, 294.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Preeclampsia/Eclampsia", "bbox": [404.0, 552.0, 536.0, 566.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Treatment of Reversible Causes", "bbox": [60.0, 600.0, 258.0, 614.0]}, {"text": "The same reversible causes of cardiac arrest that occur in", "bbox": [60.0, 615.0, 377.0, 629.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Life-Threatening Pulmonary Embolism (PE)", "bbox": [404.0, 636.0, 646.0, 650.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Cardiac Disease", "bbox": [60.0, 717.0, 149.0, 730.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Amniotic Fluid Embolism", "bbox": [404.0, 754.0, 545.0, 768.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Anesthetic Complications", "bbox": [404.0, 855.0, 542.0, 869.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "medications or doses should be altered during management of", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "cardiac arrest in pregnancy; therefore, current recommended", "bbox": [60.0, 100.0, 377.0, 113.0]}, {"text": "drug dosages for use in resuscitation of adults should also be", "bbox": [60.0, 115.0, 376.0, 129.0]}, {"text": "used in resuscitation of the pregnant patient.", "bbox": [60.0, 131.0, 282.0, 145.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "fibrinolytics are relatively contraindicated in pregnancy, PCI is", "bbox": [403.0, 84.0, 720.0, 99.0]}, {"text": "the reperfusion strategy of choice for ST-elevation myocardial", "bbox": [403.0, 100.0, 720.0, 113.0]}, {"text": "infarction.", "bbox": [403.0, 115.0, 458.0, 129.0]}, {"text": "The number of babies born with congenital heart disease who", "bbox": [417.0, 131.0, 721.0, 145.0]}, {"text": "now survive to adulthood has increased exponentially over the", "bbox": [404.0, 147.0, 720.0, 160.0]}, {"text": "last 3 decades. 139,140 It is estimated that 85% of neonates born", "bbox": [404.0, 161.0, 721.0, 178.0]}, {"text": "with congenital heart disease will survive to adulthood. There-", "bbox": [403.0, 177.0, 719.0, 191.0]}, {"text": "fore, more women with congenital heart disease are surviving to", "bbox": [404.0, 194.0, 721.0, 207.0]}, {"text": "have children, which translates into higher risk for a cardiac", "bbox": [403.0, 208.0, 720.0, 222.0]}, {"text": "event during pregnancy. In fact, illnesses related to congenital", "bbox": [403.0, 224.0, 720.0, 238.0]}, {"text": "heart disease and pulmonary hypertension are the third most", "bbox": [403.0, 240.0, 720.0, 254.0]}, {"text": "common cause of maternal cardiac deaths. 92", "bbox": [404.0, 255.0, 626.0, 269.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Defibrillation should be performed at the recommended", "bbox": [60.0, 169.0, 377.0, 183.0]}, {"text": "ACLS defibrillation doses (Class I, LOE C). 122", "bbox": [60.0, 185.0, 308.0, 200.0]}, {"text": "Although there are no studies documenting matemal or fetal", "bbox": [73.0, 201.0, 376.0, 214.0]}, {"text": "complications with defibrillation, there are case reports 123 – 130", "bbox": [60.0, 216.0, 375.0, 230.0]}, {"text": "and case series 131 – 133 that describe potential harm to the fetus", "bbox": [60.0, 232.0, 376.0, 246.0]}, {"text": "when an accidental electric shock (lightning, electric circuit) is", "bbox": [60.0, 247.0, 376.0, 260.0]}, {"text": "delivered directly to the mother. After a pregnant woman", "bbox": [60.0, 262.0, 376.0, 276.0]}, {"text": "receives an electric shock, the range of clinical presentations", "bbox": [60.0, 278.0, 376.0, 291.0]}, {"text": "varies from the mother feeling only a strange sensation with no", "bbox": [60.0, 293.0, 376.0, 307.0]}, {"text": "fetal effects to fetal death either immediately or a few days after", "bbox": [60.0, 309.0, 375.0, 322.0]}, {"text": "the shock. Risk factors for adverse fetal outcomes include the", "bbox": [60.0, 324.0, 376.0, 338.0]}, {"text": "magnitude of current and duration of contact. The greatest", "bbox": [60.0, 340.0, 375.0, 354.0]}, {"text": "predictor of risk for adverse fetal outcome is if the current travels", "bbox": [60.0, 354.0, 376.0, 368.0]}, {"text": "through the uterus, because amniotic fluid most likely transmits", "bbox": [60.0, 370.0, 376.0, 384.0]}, {"text": "current in a manner similar to that transmitted via other body", "bbox": [60.0, 386.0, 375.0, 399.0]}, {"text": "fluids, which could increase the risk of fetal death or burns.", "bbox": [60.0, 401.0, 360.0, 415.0]}, {"text": "Although there is a small risk of inducing fetal arrhythmias,", "bbox": [74.0, 417.0, 375.0, 430.0]}, {"text": "cardioversion and defibrillation on the external chest are consid-", "bbox": [60.0, 432.0, 375.0, 445.0]}, {"text": "ered safe at all stages of pregnancy. 134 – 136", "bbox": [60.0, 448.0, 271.0, 461.0]}, {"text": "Some experts have raised concern that electric arcing may", "bbox": [72.0, 462.0, 375.0, 476.0]}, {"text": "occur if fetal monitors are attached during defibrillation of a", "bbox": [60.0, 478.0, 377.0, 492.0]}, {"text": "pregnant woman, but there is no evidence to support this.", "bbox": [60.0, 494.0, 375.0, 507.0]}, {"text": "Overall it is reasonable to assume that if the shock is delivered", "bbox": [60.0, 509.0, 377.0, 523.0]}, {"text": "to the mother's thorax, there is very low to no risk of electric", "bbox": [60.0, 525.0, 375.0, 538.0]}, {"text": "arcing to fetal monitors. If internal or external fetal monitors are", "bbox": [60.0, 540.0, 376.0, 554.0]}, {"text": "attached during cardiac arrest in a pregnant woman, it is", "bbox": [60.0, 555.0, 376.0, 569.0]}, {"text": "reasonable to remove them (Class IIb, LOE C).", "bbox": [60.0, 570.0, 298.0, 584.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Patients with magnesium toxicity present with cardiac effects", "bbox": [404.0, 294.0, 720.0, 308.0]}, {"text": "ranging from ECG interval changes (prolonged PR, QRS and", "bbox": [403.0, 309.0, 720.0, 323.0]}, {"text": "QT intervals) at magnesium levels of 2.5–5 mmol/L to AV nodal", "bbox": [403.0, 326.0, 720.0, 339.0]}, {"text": "conduction block, bradycardia, hypotension and cardiac arrest at", "bbox": [403.0, 341.0, 720.0, 354.0]}, {"text": "levels of 6–10 mmol/L. Neurological effects ranging from loss", "bbox": [403.0, 356.0, 720.0, 370.0]}, {"text": "of tendon reflexes, sedation, severe muscular weakness, and", "bbox": [403.0, 372.0, 720.0, 385.0]}, {"text": "respiratory depression are seen at levels of 4–5 mmol/L. Other", "bbox": [403.0, 387.0, 720.0, 401.0]}, {"text": "signs of magnesium toxicity include gastrointestinal symptoms", "bbox": [403.0, 403.0, 720.0, 416.0]}, {"text": "(nausea and vomiting), skin changes (flushing), and electrolyte/", "bbox": [403.0, 418.0, 720.0, 433.0]}, {"text": "fluid abnormalities (hypophosphatemia, hyperosmolar dehydra-", "bbox": [404.0, 434.0, 719.0, 448.0]}, {"text": "tion). Patients with renal failure and metabolic derangements can", "bbox": [403.0, 449.0, 720.0, 463.0]}, {"text": "develop toxicity after relatively lower magnesium doses.", "bbox": [403.0, 465.0, 687.0, 479.0]}, {"text": "Iatrogenic overdose is possible in the pregnant woman who", "bbox": [416.0, 481.0, 721.0, 494.0]}, {"text": "receives magnesium sulfate, particularly if the woman becomes", "bbox": [404.0, 495.0, 720.0, 509.0]}, {"text": "oliguric. Empirical calcium administration may be lifesaving in", "bbox": [403.0, 511.0, 721.0, 525.0]}, {"text": "these cases. 141–143", "bbox": [403.0, 526.0, 494.0, 541.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Preeclampsia/eclampsia develops after the 20th week of gesta-", "bbox": [404.0, 565.0, 719.0, 580.0]}, {"text": "tion and can produce severe hypertension and ultimately diffuse", "bbox": [403.0, 582.0, 720.0, 595.0]}, {"text": "organ-system failure. If untreated, maternal and fetal morbidity", "bbox": [403.0, 597.0, 720.0, 610.0]}, {"text": "and mortality may result.", "bbox": [404.0, 612.0, 531.0, 627.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "nonpregnant women can occur during pregnancy. Providers", "bbox": [60.0, 630.0, 376.0, 644.0]}, {"text": "should be familiar with pregnancy-specific diseases and proce-", "bbox": [60.0, 646.0, 375.0, 660.0]}, {"text": "dural complications and during resuscitation attempts should try", "bbox": [60.0, 662.0, 375.0, 675.0]}, {"text": "to identify common and reversible causes of cardiac arrest in", "bbox": [60.0, 676.0, 376.0, 690.0]}, {"text": "pregnancy. 92", "bbox": [60.0, 692.0, 126.0, 705.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Successful use of fibrinolytics in pregnant women has been", "bbox": [404.0, 651.0, 721.0, 666.0]}, {"text": "reported for massive, life-threatening PE 144 –146 and ische-", "bbox": [403.0, 667.0, 719.0, 680.0]}, {"text": "mic stroke. 147 Pregnant women in cardiac arrest with", "bbox": [403.0, 681.0, 721.0, 697.0]}, {"text": "suspected PE should be treated in accordance with the", "bbox": [404.0, 697.0, 720.0, 711.0]}, {"text": "ACLS guidelines (see Part 12.5: \"Cardiac Arrest Associ-", "bbox": [404.0, 713.0, 719.0, 727.0]}, {"text": "ated With Pulmonary Embolism\").", "bbox": [404.0, 728.0, 596.0, 742.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Cardiac disease is the primary cause of maternal mortality,", "bbox": [60.0, 729.0, 377.0, 744.0]}, {"text": "according to the 2003 to 2005 Confidential Enquiries into", "bbox": [60.0, 745.0, 377.0, 760.0]}, {"text": "Maternal and Child Health report.92 For example, the number of", "bbox": [60.0, 762.0, 376.0, 775.0]}, {"text": "deaths from cardiac disease was 2.27 per 100,000 pregnancies,", "bbox": [60.0, 776.0, 375.0, 791.0]}, {"text": "whereas the number of deaths from thrombosis and thrombo-", "bbox": [60.0, 793.0, 375.0, 806.0]}, {"text": "embolism was 1.94 per 100,000 pregnancies. 92 The number of", "bbox": [60.0, 808.0, 376.0, 822.0]}, {"text": "cardiac deaths during pregnancy has increased steadily since", "bbox": [60.0, 823.0, 376.0, 837.0]}, {"text": "1991. The most common causes of maternal death from cardiac", "bbox": [61.0, 838.0, 375.0, 852.0]}, {"text": "disease are myocardial infarction, followed by aortic dissec-", "bbox": [60.0, 854.0, 375.0, 868.0]}, {"text": "tion. 92 A study completed in California also found that the", "bbox": [60.0, 870.0, 375.0, 883.0]}, {"text": "incidence of myocardial infarction in pregnancy increased", "bbox": [60.0, 884.0, 376.0, 899.0]}, {"text": "throughout the 1990s. 137 In addition, a nationwide review of", "bbox": [60.0, 900.0, 376.0, 914.0]}, {"text": "myocardial infarction in pregnancy in the United States found", "bbox": [60.0, 915.0, 377.0, 930.0]}, {"text": "that the risk of myocardial infarction in pregnancy is 3 to 4 times", "bbox": [60.0, 931.0, 375.0, 945.0]}, {"text": "that of nonpregnant women of reproductive age. 138", "bbox": [60.0, 947.0, 315.0, 961.0]}, {"text": "Women are deferring pregnancy to older ages, increasing the", "bbox": [73.0, 963.0, 376.0, 976.0]}, {"text": "chance that they will have atherosclerotic heart disease. Because", "bbox": [60.0, 977.0, 376.0, 991.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Clinicians have reported successful use of cardiopulmonary", "bbox": [403.0, 768.0, 720.0, 782.0]}, {"text": "bypass for pregnant women with a life-threatening amniotic", "bbox": [403.0, 783.0, 720.0, 797.0]}, {"text": "fluid embolism during labor and delivery. 148 The use of peri-", "bbox": [403.0, 799.0, 719.0, 812.0]}, {"text": "mortem cesarean section has resulted in maternal and neonatal", "bbox": [403.0, 815.0, 720.0, 828.0]}, {"text": "survival. 149", "bbox": [404.0, 829.0, 462.0, 843.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "Anesthesia-related maternal morbidity and mortality continue to", "bbox": [404.0, 868.0, 721.0, 883.0]}, {"text": "be a major concern, which has led to development of specialized", "bbox": [403.0, 884.0, 720.0, 898.0]}, {"text": "obstetric anesthesia techniques. 118 Cardiac arrest may result", "bbox": [403.0, 900.0, 720.0, 914.0]}, {"text": "from spinal shock as a result of regional anesthesia. Induction of", "bbox": [404.0, 915.0, 721.0, 929.0]}, {"text": "general anesthesia may lead to loss of airway control or", "bbox": [404.0, 930.0, 720.0, 944.0]}, {"text": "pulmonary aspiration, and emergence from anesthesia can be", "bbox": [404.0, 946.0, 720.0, 960.0]}, {"text": "associated with hypoventilation or airway obstruction, leading to", "bbox": [404.0, 962.0, 721.0, 976.0]}, {"text": "cardiac arrest. 150–155", "bbox": [404.0, 978.0, 505.0, 991.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 21}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 215}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#12#12#Although there are no studies documenting ...应该另起一行\n缺少换行#13#13# Some experts have raised concern that ...应该另起一行\n缺少换行#20#20#Women are deferring pregnancy to ...应该另起一行", "type3": "无关文本#11#22#66...of maternal cardiac deaths. 92\n...over the last 3 decades. 139,140像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#23#23#页脚的内容和正文无关", "type4": "栏目混乱#1#22#标题和内容分离，下面正文内容互相穿插，没有顺序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 21:41:00"}
{"id": 1042030, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "81c62a45-5859-4541-86a8-a3bdf9a41471", "title": null, "text": "【0】页码:316\n medical emergency team and categorization of cardiopulmonary arrests in a children's center. Arch Pediatr Adolesc Med . 2008;162:117–122.\n\n【1】255. Brilli RJ, Gibson R, Luria JW, Wheeler TA, Shaw J, Linam M, Kheir J, McLain P, Lingsch T, Hall-Haering A, McBride M. Implementation of a medical emergency team in a large pediatric teaching hospital prevents respiratory and cardiopulmonary arrests outside the intensive care unit.\n\n【2】Pediatr Crit Care Med . 2007;8:236–246.\n\n【3】256. Sharek PJ, Parast LM, Leong K, Coombs J, Earnest K, Sullivan J, Frankel LR, Roth SJ. Effect of a rapid response team on hospital-wide mortality and code rates outside the ICU in a children's hospital. JAMA .\n\n【4】2007;298:2267–2274.\n\n【5】257. Tibballs J, Kinney S. Reduction of hospital mortality and of preventable cardiac arrest and death on introduction of a pediatric medical emergency team. Pediatr Crit Care Med . 2009;10:306–312.\n\n【6】258. Tibballs J, Kinney S, Duke T, Oakley E, Hennessy M. Reduction of paediatric in-patient cardiac arrest and death with a medical emergency team: preliminary results. Arch Dis Child . 2005;90:1148–1152.\n\n【7】259. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid response teams: a systematic review and meta-analysis. Arch Intern Med. 2010; 170:18–26.\n\n【8】260.\n\n【9】DeVita MA, Smith GB, Adam SK, Adams-Pizarro I, Buist M, Bellomo R, Bonello R, Cerchiari E, Farlow B, Goldsmith D, Haskell H, Hillman K, Howell M, Hravnak M, Hunt EA, Hvarfner A, Kellett J, Lighthall GK, Lippert A, Lippert FK, Mahroof R, Myers JS, Rosen M, Reynolds S, Rotondi A, Rubulotta F, Winters B. \"Identifying the hospitalised patient in crisis\": a consensus conference on the afferent limb of rapid response systems. Resuscitation . 2010;81:375–382.\n\n【10】261.\n\n【11】Engdahl J, Abrahamsson P, Bang A, Lindqvist J, Karlsson T, Herlitz J.\n\n【12】Is hospital care of major importance for outcome after out-of-hospital cardiac arrest? Experience acquired from patients with out-of-hospital cardiac arrest resuscitated by the same Emergency Medical Service and admitted to one of two hospitals over a 16-year period in the municipality of Goteborg. Resuscitation . 2000;43:201–211.\n\n【13】262.\n\n【14】Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K, Steen PA.\n\n【15】In-hospital factors associated with improved outcome after out-ofhospital cardiac arrest: a comparison between four regions in Norway.\n\n【16】Resuscitation. 2003;56:247–263.\n\n【17】263. Carr BG, Goyal M, Band RA, Gaieski DF, Abella BS, Merchant RM, Branas CC, Becker LB, Neumar RW. A national analysis of the relationship between hospital factors and post-cardiac arrest mortality.\n\n【18】Intensive Care Med . 2009;35:505–511.\n\n【19】264. Liu JM, Yang Q, Pirrallo RG, Klein JP, Aufderheide TP.  Hospital variability of out-of-hospital cardiac arrest survival. Prehosp Emerg Care . 2008;12:339–346.\n\n【20】265. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW.  Interhospital variability in post-cardiac arrest mortality. Resuscitation. 2009 ; 80:30–34.\n\n【21】266. Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J, Holmberg S. Major differences in 1-month survival between hospitals in Sweden among initial survivors of out-of-hospital cardiac arrest. Resuscitation . 2006;70:404–409.\n\n【22】Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H.\n\n【23】267.\n\n【24】Variation in length of intensive care unit stay after cardiac arrest: where you are is as important as who you are. Crit Care Med . 2007;35: 836–841.\n\n【25】268. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med . 2006;34: 1865–1873.\n\n【26】269.\n\n【27】Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C, Draegni T, Steen PA.  Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest.\n\n【28】Resuscitation . 2007;73:29–39.\n\n【29】270. Knafelj R, Radsel P, Ploj T, Noc M.  Primary percutaneous coronary intervention and mild induced hypothermia in comatose survivors of ventricular fibrillation with ST-elevation acute myocardial infarction.\n\n【30】Resuscitation . 2007;74:227–234.\n\n【31】271. Wolfrum S, Pierau C, Radke PW, Schunkert H, Kurowski V.  Mild therapeutic hypothermia in patients after out-of-hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention. Crit Care Med. 2008 ; 36:1780–1786.\n\n【32】Gaieski DF, Band RA, Abella BS, Neumar RW, Fuchs BD, Kolansky 272.\n\n【33】DM, Merchant RM, Carr BG, Becker LB, Maguire C, Klair A, Hylton J, Goyal M. Early goal-directed hemodynamic optimization combined\n\n【34】 with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation . 2009;80:418–424.\n\n【35】273. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, Roumanis SA, Curtis JP, Nallamothu BK, Magid DJ, McNamara RL, Parkosewich J, Loeb JM, Krumholz HM.  Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med .\n\n【36】2006;355:2308–2320.\n\n【37】274. LaMonte MP, Bahouth MN, Magder LS, Alcorta RL, Bass RR, Browne BJ, Floccare DJ, Gaasch WR. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial. Ann Emerg Med . 2009;54:319–327.\n\n【38】275. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007 Oct 17;CD000197.\n\n【39】MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, 276.\n\n【40】Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med . 2006;354: 366 – 378.\n\n【41】277. Nichol G, Aufderheide TP, Eigel B, Neumar RW, Lurie KG, Bufalino VJ, Callaway CW, Menon V, Bass RR, Abella BS, Sayre M, Dougherty CM, Racht EM, Kleinman ME, O'Connor RE, Reilly JP, Ossmann EW, Peterson E. Regional systems of care for out-of-hospital cardiac arrest: a policy statement from the American Heart Association. Circulation .\n\n【42】2010;121:709–729.\n\n【43】278. Ali J, Adam R, Stedman M, Howard M, Williams J.  Cognitive and attitudinal impact of the Advanced Trauma Life Support program in a developing country. J Trauma . 1994;36:695–702.\n\n【44】279. Bergman S, Deckelbaum D, Lett R, Haas B, Demyttenaere S, Munthali V, Mbembati N, Museru L, Razek T. Assessing the impact of the trauma team training program in Tanzania. J Trauma . 2008;65:879–883.\n\n【45】280. Bhat BV, Biswal N, Bhatia BD, Nalini P.  Undergraduate training in neonatal resuscitation: a modified approach. Indian J Matern Child Health. 1993;4:87–88.\n\n【46】281. Carlo WA, Wright LL, Chomba E, McClure EM, Carlo ME, Bann CM, Collins M, Harris H. Educational impact of the neonatal resuscitation program in low-risk delivery centers in a developing country. J Pediatr.\n\n【47】2009;154:504–508.e5.\n\n【48】282. Couper ID, Thurley JD, Hugo JF.  The neonatal resuscitation training project in rural South Africa. Rural Remote Health. 2005;5:459.\n\n【49】283.\n\n【50】Ergenekon E, Koc E, Atalay Y, Soysal S. Neonatal resuscitation course experience in Turkey. Resuscitation. 2000;45:225–227 .\n\n【51】284. Husum H, Gilbert M, Wisborg T. Training pre-hospital trauma care in low-income countries: the \"Village University\" experience. Med Teach .\n\n【52】2003;25:142–148.\n\n【53】285. Jabir MM, Doglioni N, Fadhil T, Zanardo V, Trevisanuto D. Knowledge and practical performance gained by Iraqi residents after participation to a neonatal resuscitation program course. Acta Paediatr . 2009;98: 1265–1268.\n\n【54】286.\n\n【55】Kimura A, Okada K, Kobayashi K, Inaka A, Hagiwara Y, Sakamoto T, Sugimoto N, Nakamura M, Nakamura K, Horiuchi K, Hujii Y, Murota C, Emoto M.  Introductory adult cardiac life support course for Vietnamese healthcare workers. Resuscitation . 2008;79:511–512.\n\n【56】287. McClure EM, Carlo WA, Wright LL, Chomba E, Uxa F, Lincetto O, Bann C.  Evaluation of the educational impact of the WHO Essential Newborn Care course in Zambia. Acta Paediatr . 2007;96:1135–1138.\n\n【57】288.\n\n【58】Trevisanuto D, Ibrahim SA, Doglioni N, Salvadori S, Ferrarese P, Zanardo V. Neonatal resuscitation courses for pediatric residents: comparison between Khartoum (Sudan) and Padova (Italy). Paediatr Anaesth . 2007;17:28–31.\n\n【59】289. Urbano J, Matamoros MM, Lopez-Herce J, Carrillo AP, Ordonez F, Moral R, Mencia S. A paediatric cardiopulmonary resuscitation training project in Honduras. Resuscitation . 2010;81:472–476.\n\n【60】290. Zaeem ul H, Qureshi F, Hafeez A, Zafar S, Mohamud BK, Southal DP.\n\n【61】Evidence for improvement in the quality of care given during emergencies in pregnancy, infancy and childhood following training in lifesaving skills: a postal survey. J Pak Med Assoc . 2009;59:22–26.\n\n【62】291. Ali J, Adam R, Butler AK, Chang H, Howard M, Gonsalves D, Pitt- Miller P, Stedman M, Winn J, Williams JI. Trauma outcome improves following the advanced trauma life support program in a developing country. J Trauma . 1993;34:890–898.\n\n【63】292. Ali J, Adam RU, Gana TJ, Williams JI. Trauma patient outcome after the Prehospital Trauma Life Support program. J Trauma. 1997;42: 1018–1021.\n\n【64】293. Arreola-Risa C, Mock C, Herrera-Escamilla AJ, Contreras I, Vargas J.\n\n【65】Cost-effectiveness and benefit of alternatives to improve training for\n\n【66】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "medical emergency team and categorization of cardiopulmonary arrests", "bbox": [84.0, 86.0, 376.0, 97.0]}, {"text": "in a children's center. Arch Pediatr Adolesc Med . 2008;162:117–122.", "bbox": [84.0, 98.0, 371.0, 109.0]}, {"text": "255. Brilli RJ, Gibson R, Luria JW, Wheeler TA, Shaw J, Linam M, Kheir J,", "bbox": [61.0, 109.0, 375.0, 120.0]}, {"text": "McLain P, Lingsch T, Hall-Haering A, McBride M. Implementation of", "bbox": [83.0, 122.0, 376.0, 133.0]}, {"text": "a medical emergency team in a large pediatric teaching hospital prevents", "bbox": [83.0, 133.0, 375.0, 146.0]}, {"text": "respiratory and cardiopulmonary arrests outside the intensive care unit.", "bbox": [83.0, 147.0, 375.0, 158.0]}, {"text": "Pediatr Crit Care Med . 2007;8:236–246.", "bbox": [84.0, 158.0, 255.0, 169.0]}, {"text": "256. Sharek PJ, Parast LM, Leong K, Coombs J, Earnest K, Sullivan J,", "bbox": [61.0, 169.0, 375.0, 183.0]}, {"text": "Frankel LR, Roth SJ. Effect of a rapid response team on hospital-wide", "bbox": [83.0, 182.0, 376.0, 194.0]}, {"text": "mortality and code rates outside the ICU in a children's hospital. JAMA .", "bbox": [84.0, 195.0, 375.0, 207.0]}, {"text": "2007;298:2267–2274.", "bbox": [84.0, 207.0, 174.0, 218.0]}, {"text": "257. Tibballs J, Kinney S. Reduction of hospital mortality and of preventable", "bbox": [61.0, 219.0, 375.0, 231.0]}, {"text": "cardiac arrest and death on introduction of a pediatric medical", "bbox": [83.0, 230.0, 375.0, 242.0]}, {"text": "emergency team. Pediatr Crit Care Med . 2009;10:306–312.", "bbox": [83.0, 242.0, 332.0, 254.0]}, {"text": "258. Tibballs J, Kinney S, Duke T, Oakley E, Hennessy M. Reduction of", "bbox": [61.0, 254.0, 375.0, 267.0]}, {"text": "paediatric in-patient cardiac arrest and death with a medical emergency", "bbox": [84.0, 267.0, 375.0, 278.0]}, {"text": "team: preliminary results. Arch Dis Child . 2005;90:1148–1152.", "bbox": [84.0, 279.0, 344.0, 290.0]}, {"text": "259. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid response", "bbox": [61.0, 290.0, 375.0, 301.0]}, {"text": "teams: a systematic review and meta-analysis. Arch Intern Med. 2010;", "bbox": [83.0, 303.0, 375.0, 314.0]}, {"text": "170:18–26.", "bbox": [84.0, 315.0, 132.0, 326.0]}, {"text": "260.", "bbox": [61.0, 327.0, 81.0, 339.0]}, {"text": "DeVita MA, Smith GB, Adam SK, Adams-Pizarro I, Buist M, Bellomo", "bbox": [81.0, 327.0, 375.0, 339.0]}, {"text": "R, Bonello R, Cerchiari E, Farlow B, Goldsmith D, Haskell H, Hillman", "bbox": [83.0, 339.0, 375.0, 351.0]}, {"text": "K, Howell M, Hravnak M, Hunt EA, Hvarfner A, Kellett J, Lighthall", "bbox": [83.0, 352.0, 376.0, 363.0]}, {"text": "GK, Lippert A, Lippert FK, Mahroof R, Myers JS, Rosen M, Reynolds", "bbox": [82.0, 364.0, 375.0, 374.0]}, {"text": "S, Rotondi A, Rubulotta F, Winters B. \"Identifying the hospitalised", "bbox": [83.0, 376.0, 376.0, 388.0]}, {"text": "patient in crisis\": a consensus conference on the afferent limb of rapid", "bbox": [83.0, 388.0, 376.0, 399.0]}, {"text": "response systems. Resuscitation . 2010;81:375–382.", "bbox": [83.0, 401.0, 293.0, 412.0]}, {"text": "261.", "bbox": [61.0, 412.0, 80.0, 422.0]}, {"text": "Engdahl J, Abrahamsson P, Bang A, Lindqvist J, Karlsson T, Herlitz J.", "bbox": [81.0, 412.0, 375.0, 423.0]}, {"text": "Is hospital care of major importance for outcome after out-of-hospital", "bbox": [83.0, 424.0, 376.0, 435.0]}, {"text": "cardiac arrest? Experience acquired from patients with out-of-hospital", "bbox": [83.0, 435.0, 375.0, 448.0]}, {"text": "cardiac arrest resuscitated by the same Emergency Medical Service and", "bbox": [83.0, 448.0, 376.0, 460.0]}, {"text": "admitted to one of two hospitals over a 16-year period in the munici-", "bbox": [84.0, 461.0, 375.0, 472.0]}, {"text": "pality of Goteborg. Resuscitation . 2000;43:201–211.", "bbox": [84.0, 474.0, 299.0, 483.0]}, {"text": "262.", "bbox": [61.0, 484.0, 81.0, 495.0]}, {"text": "Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K, Steen PA.", "bbox": [81.0, 484.0, 375.0, 496.0]}, {"text": "In-hospital factors associated with improved outcome after out-of-", "bbox": [83.0, 497.0, 375.0, 508.0]}, {"text": "hospital cardiac arrest: a comparison between four regions in Norway.", "bbox": [84.0, 508.0, 375.0, 521.0]}, {"text": "Resuscitation. 2003;56:247–263.", "bbox": [84.0, 520.0, 219.0, 531.0]}, {"text": "263. Carr BG, Goyal M, Band RA, Gaieski DF, Abella BS, Merchant RM,", "bbox": [61.0, 533.0, 375.0, 544.0]}, {"text": "Branas CC, Becker LB, Neumar RW. A national analysis of the rela-", "bbox": [83.0, 544.0, 375.0, 555.0]}, {"text": "tionship between hospital factors and post-cardiac arrest mortality.", "bbox": [84.0, 557.0, 375.0, 568.0]}, {"text": "Intensive Care Med . 2009;35:505–511.", "bbox": [84.0, 568.0, 245.0, 580.0]}, {"text": "264. Liu JM, Yang Q, Pirrallo RG, Klein JP, Aufderheide TP.  Hospital", "bbox": [61.0, 581.0, 377.0, 593.0]}, {"text": "variability of out-of-hospital cardiac arrest survival. Prehosp Emerg", "bbox": [84.0, 593.0, 376.0, 604.0]}, {"text": "Care . 2008;12:339–346.", "bbox": [84.0, 605.0, 186.0, 615.0]}, {"text": "265. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW.  Inter-", "bbox": [61.0, 617.0, 375.0, 629.0]}, {"text": "hospital variability in post-cardiac arrest mortality. Resuscitation. 2009 ;", "bbox": [83.0, 630.0, 375.0, 642.0]}, {"text": "80:30–34.", "bbox": [84.0, 642.0, 126.0, 653.0]}, {"text": "266. Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J,", "bbox": [61.0, 652.0, 375.0, 667.0]}, {"text": "Holmberg S. Major differences in 1-month survival between hospitals in", "bbox": [84.0, 665.0, 376.0, 677.0]}, {"text": "Sweden among initial survivors of out-of-hospital cardiac arrest. Resus-", "bbox": [84.0, 678.0, 375.0, 689.0]}, {"text": "citation . 2006;70:404–409.", "bbox": [84.0, 689.0, 196.0, 701.0]}, {"text": "Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H.", "bbox": [81.0, 701.0, 375.0, 714.0]}, {"text": "267.", "bbox": [61.0, 702.0, 81.0, 712.0]}, {"text": "Variation in length of intensive care unit stay after cardiac arrest: where", "bbox": [84.0, 714.0, 375.0, 726.0]}, {"text": "you are is as important as who you are. Crit Care Med . 2007;35:", "bbox": [84.0, 725.0, 375.0, 737.0]}, {"text": "836–841.", "bbox": [84.0, 738.0, 125.0, 749.0]}, {"text": "268. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to", "bbox": [61.0, 749.0, 376.0, 761.0]}, {"text": "clinical practice: effective implementation of therapeutic hypothermia to", "bbox": [83.0, 762.0, 376.0, 774.0]}, {"text": "improve patient outcome after cardiac arrest. Crit Care Med . 2006;34:", "bbox": [84.0, 774.0, 376.0, 785.0]}, {"text": "1865–1873.", "bbox": [84.0, 787.0, 133.0, 797.0]}, {"text": "269.", "bbox": [61.0, 798.0, 81.0, 809.0]}, {"text": "Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C,", "bbox": [81.0, 798.0, 375.0, 809.0]}, {"text": "Draegni T, Steen PA.  Implementation of a standardised treatment", "bbox": [83.0, 811.0, 376.0, 823.0]}, {"text": "protocol for post resuscitation care after out-of-hospital cardiac arrest.", "bbox": [84.0, 823.0, 375.0, 834.0]}, {"text": "Resuscitation . 2007;73:29–39.", "bbox": [84.0, 835.0, 209.0, 846.0]}, {"text": "270. Knafelj R, Radsel P, Ploj T, Noc M.  Primary percutaneous coronary", "bbox": [61.0, 846.0, 375.0, 858.0]}, {"text": "intervention and mild induced hypothermia in comatose survivors of", "bbox": [83.0, 859.0, 376.0, 871.0]}, {"text": "ventricular fibrillation with ST-elevation acute myocardial infarction.", "bbox": [84.0, 871.0, 375.0, 883.0]}, {"text": "Resuscitation . 2007;74:227–234.", "bbox": [84.0, 883.0, 219.0, 893.0]}, {"text": "271. Wolfrum S, Pierau C, Radke PW, Schunkert H, Kurowski V.  Mild", "bbox": [61.0, 895.0, 376.0, 906.0]}, {"text": "therapeutic hypothermia in patients after out-of-hospital cardiac arrest", "bbox": [83.0, 907.0, 376.0, 917.0]}, {"text": "due to acute ST-segment elevation myocardial infarction undergoing", "bbox": [84.0, 919.0, 375.0, 930.0]}, {"text": "immediate percutaneous coronary intervention. Crit Care Med. 2008 ;", "bbox": [84.0, 931.0, 375.0, 943.0]}, {"text": "36:1780–1786.", "bbox": [84.0, 943.0, 146.0, 955.0]}, {"text": "Gaieski DF, Band RA, Abella BS, Neumar RW, Fuchs BD, Kolansky", "bbox": [81.0, 955.0, 375.0, 967.0]}, {"text": "272.", "bbox": [61.0, 956.0, 81.0, 966.0]}, {"text": "DM, Merchant RM, Carr BG, Becker LB, Maguire C, Klair A, Hylton", "bbox": [84.0, 968.0, 375.0, 979.0]}, {"text": "J, Goyal M. Early goal-directed hemodynamic optimization combined", "bbox": [83.0, 980.0, 376.0, 991.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "with therapeutic hypothermia in comatose survivors of out-of-hospital", "bbox": [427.0, 86.0, 721.0, 96.0]}, {"text": "cardiac arrest. Resuscitation . 2009;80:418–424.", "bbox": [429.0, 98.0, 624.0, 109.0]}, {"text": "273. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA,", "bbox": [404.0, 109.0, 720.0, 121.0]}, {"text": "Roumanis SA, Curtis JP, Nallamothu BK, Magid DJ, McNamara RL,", "bbox": [427.0, 122.0, 718.0, 134.0]}, {"text": "Parkosewich J, Loeb JM, Krumholz HM.  Strategies for reducing the", "bbox": [427.0, 134.0, 720.0, 147.0]}, {"text": "door-to-balloon time in acute myocardial infarction. N Engl J Med .", "bbox": [428.0, 147.0, 719.0, 159.0]}, {"text": "2006;355:2308–2320.", "bbox": [427.0, 158.0, 521.0, 169.0]}, {"text": "274. LaMonte MP, Bahouth MN, Magder LS, Alcorta RL, Bass RR, Browne", "bbox": [404.0, 171.0, 720.0, 183.0]}, {"text": "BJ, Floccare DJ, Gaasch WR. A regional system of stroke care provides", "bbox": [427.0, 184.0, 720.0, 196.0]}, {"text": "thrombolytic outcomes comparable with the NINDS stroke trial. Ann", "bbox": [428.0, 195.0, 720.0, 207.0]}, {"text": "Emerg Med . 2009;54:319–327.", "bbox": [427.0, 207.0, 557.0, 219.0]}, {"text": "275. Organised inpatient (stroke unit) care for stroke. Cochrane Database", "bbox": [404.0, 220.0, 720.0, 232.0]}, {"text": "Syst Rev. 2007 Oct 17;CD000197.", "bbox": [427.0, 233.0, 571.0, 244.0]}, {"text": "MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP,", "bbox": [426.0, 244.0, 719.0, 256.0]}, {"text": "276.", "bbox": [404.0, 245.0, 425.0, 255.0]}, {"text": "Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the", "bbox": [427.0, 257.0, 719.0, 268.0]}, {"text": "effect of trauma-center care on mortality. N Engl J Med . 2006;354:", "bbox": [427.0, 269.0, 720.0, 281.0]}, {"text": "366 – 378.", "bbox": [428.0, 282.0, 467.0, 292.0]}, {"text": "277. Nichol G, Aufderheide TP, Eigel B, Neumar RW, Lurie KG, Bufalino", "bbox": [404.0, 293.0, 720.0, 305.0]}, {"text": "VJ, Callaway CW, Menon V, Bass RR, Abella BS, Sayre M, Dougherty", "bbox": [427.0, 306.0, 719.0, 318.0]}, {"text": "CM, Racht EM, Kleinman ME, O'Connor RE, Reilly JP, Ossmann EW,", "bbox": [427.0, 318.0, 718.0, 329.0]}, {"text": "Peterson E. Regional systems of care for out-of-hospital cardiac arrest:", "bbox": [427.0, 331.0, 719.0, 342.0]}, {"text": "a policy statement from the American Heart Association. Circulation .", "bbox": [427.0, 342.0, 720.0, 354.0]}, {"text": "2010;121:709–729.", "bbox": [428.0, 355.0, 510.0, 367.0]}, {"text": "278. Ali J, Adam R, Stedman M, Howard M, Williams J.  Cognitive and", "bbox": [404.0, 367.0, 720.0, 379.0]}, {"text": "attitudinal impact of the Advanced Trauma Life Support program in a", "bbox": [428.0, 380.0, 720.0, 392.0]}, {"text": "developing country. J Trauma . 1994;36:695–702.", "bbox": [427.0, 391.0, 631.0, 402.0]}, {"text": "279. Bergman S, Deckelbaum D, Lett R, Haas B, Demyttenaere S, Munthali", "bbox": [404.0, 403.0, 720.0, 416.0]}, {"text": "V, Mbembati N, Museru L, Razek T. Assessing the impact of the trauma", "bbox": [427.0, 416.0, 720.0, 428.0]}, {"text": "team training program in Tanzania. J Trauma . 2008;65:879–883.", "bbox": [427.0, 428.0, 698.0, 441.0]}, {"text": "280. Bhat BV, Biswal N, Bhatia BD, Nalini P.  Undergraduate training in", "bbox": [404.0, 441.0, 720.0, 452.0]}, {"text": "neonatal resuscitation: a modified approach. Indian J Matern Child", "bbox": [428.0, 453.0, 720.0, 465.0]}, {"text": "Health. 1993;4:87–88.", "bbox": [427.0, 465.0, 522.0, 475.0]}, {"text": "281. Carlo WA, Wright LL, Chomba E, McClure EM, Carlo ME, Bann CM,", "bbox": [404.0, 477.0, 720.0, 489.0]}, {"text": "Collins M, Harris H. Educational impact of the neonatal resuscitation", "bbox": [427.0, 489.0, 720.0, 501.0]}, {"text": "program in low-risk delivery centers in a developing country. J Pediatr.", "bbox": [428.0, 501.0, 718.0, 514.0]}, {"text": "2009;154:504–508.e5.", "bbox": [428.0, 515.0, 520.0, 525.0]}, {"text": "282. Couper ID, Thurley JD, Hugo JF.  The neonatal resuscitation training", "bbox": [404.0, 526.0, 720.0, 538.0]}, {"text": "project in rural South Africa. Rural Remote Health. 2005;5:459.", "bbox": [428.0, 540.0, 694.0, 550.0]}, {"text": "283.", "bbox": [406.0, 551.0, 425.0, 562.0]}, {"text": "Ergenekon E, Koc E, Atalay Y, Soysal S. Neonatal resuscitation course", "bbox": [425.0, 551.0, 720.0, 562.0]}, {"text": "experience in Turkey. Resuscitation. 2000;45:225–227 .", "bbox": [429.0, 564.0, 655.0, 575.0]}, {"text": "284. Husum H, Gilbert M, Wisborg T. Training pre-hospital trauma care in", "bbox": [404.0, 575.0, 720.0, 587.0]}, {"text": "low-income countries: the \"Village University\" experience. Med Teach .", "bbox": [427.0, 588.0, 719.0, 600.0]}, {"text": "2003;25:142–148.", "bbox": [428.0, 600.0, 501.0, 611.0]}, {"text": "285. Jabir MM, Doglioni N, Fadhil T, Zanardo V, Trevisanuto D. Knowledge", "bbox": [405.0, 612.0, 720.0, 624.0]}, {"text": "and practical performance gained by Iraqi residents after participation to", "bbox": [427.0, 624.0, 720.0, 635.0]}, {"text": "a neonatal resuscitation program course. Acta Paediatr . 2009;98:", "bbox": [428.0, 637.0, 719.0, 649.0]}, {"text": "1265–1268.", "bbox": [427.0, 649.0, 477.0, 660.0]}, {"text": "286.", "bbox": [405.0, 662.0, 425.0, 673.0]}, {"text": "Kimura A, Okada K, Kobayashi K, Inaka A, Hagiwara Y, Sakamoto T,", "bbox": [425.0, 662.0, 719.0, 674.0]}, {"text": "Sugimoto N, Nakamura M, Nakamura K, Horiuchi K, Hujii Y, Murota", "bbox": [427.0, 674.0, 720.0, 685.0]}, {"text": "C, Emoto M.  Introductory adult cardiac life support course for Viet-", "bbox": [427.0, 686.0, 718.0, 697.0]}, {"text": "namese healthcare workers. Resuscitation . 2008;79:511–512.", "bbox": [427.0, 697.0, 677.0, 709.0]}, {"text": "287. McClure EM, Carlo WA, Wright LL, Chomba E, Uxa F, Lincetto O,", "bbox": [405.0, 709.0, 719.0, 722.0]}, {"text": "Bann C.  Evaluation of the educational impact of the WHO Essential", "bbox": [427.0, 722.0, 720.0, 734.0]}, {"text": "Newborn Care course in Zambia. Acta Paediatr . 2007;96:1135–1138.", "bbox": [427.0, 735.0, 715.0, 746.0]}, {"text": "288.", "bbox": [404.0, 747.0, 425.0, 757.0]}, {"text": "Trevisanuto D, Ibrahim SA, Doglioni N, Salvadori S, Ferrarese P,", "bbox": [426.0, 747.0, 720.0, 758.0]}, {"text": "Zanardo V. Neonatal resuscitation courses for pediatric residents: com-", "bbox": [427.0, 759.0, 719.0, 770.0]}, {"text": "parison between Khartoum (Sudan) and Padova (Italy). Paediatr", "bbox": [427.0, 771.0, 720.0, 782.0]}, {"text": "Anaesth . 2007;17:28–31.", "bbox": [428.0, 783.0, 531.0, 795.0]}, {"text": "289. Urbano J, Matamoros MM, Lopez-Herce J, Carrillo AP, Ordonez F,", "bbox": [404.0, 796.0, 720.0, 808.0]}, {"text": "Moral R, Mencia S. A paediatric cardiopulmonary resuscitation training", "bbox": [427.0, 808.0, 720.0, 820.0]}, {"text": "project in Honduras. Resuscitation . 2010;81:472–476.", "bbox": [428.0, 821.0, 650.0, 832.0]}, {"text": "290. Zaeem ul H, Qureshi F, Hafeez A, Zafar S, Mohamud BK, Southal DP.", "bbox": [404.0, 832.0, 719.0, 844.0]}, {"text": "Evidence for improvement in the quality of care given during emer-", "bbox": [427.0, 845.0, 718.0, 857.0]}, {"text": "gencies in pregnancy, infancy and childhood following training in life-", "bbox": [427.0, 856.0, 718.0, 869.0]}, {"text": "saving skills: a postal survey. J Pak Med Assoc . 2009;59:22–26.", "bbox": [428.0, 870.0, 694.0, 882.0]}, {"text": "291. Ali J, Adam R, Butler AK, Chang H, Howard M, Gonsalves D, Pitt-", "bbox": [404.0, 882.0, 719.0, 893.0]}, {"text": "Miller P, Stedman M, Winn J, Williams JI. Trauma outcome improves", "bbox": [427.0, 894.0, 720.0, 906.0]}, {"text": "following the advanced trauma life support program in a developing", "bbox": [427.0, 906.0, 720.0, 917.0]}, {"text": "country. J Trauma . 1993;34:890–898.", "bbox": [429.0, 919.0, 585.0, 929.0]}, {"text": "292. Ali J, Adam RU, Gana TJ, Williams JI. Trauma patient outcome after", "bbox": [404.0, 930.0, 720.0, 942.0]}, {"text": "the Prehospital Trauma Life Support program. J Trauma. 1997;42:", "bbox": [427.0, 943.0, 719.0, 955.0]}, {"text": "1018–1021.", "bbox": [427.0, 955.0, 479.0, 966.0]}, {"text": "293. Arreola-Risa C, Mock C, Herrera-Escamilla AJ, Contreras I, Vargas J.", "bbox": [405.0, 967.0, 718.0, 979.0]}, {"text": "Cost-effectiveness and benefit of alternatives to improve training for", "bbox": [427.0, 980.0, 720.0, 991.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 316}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#66#全篇参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:31:31"}
{"id": 1042029, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "d7e77660-e78c-46c5-9b34-3fca5d5980e3", "title": null, "text": "【0】页码:66\n\n【1】## Guidelines Part 5: Adult Basic Life Support: Writing Group Disclosures, Continued\n\n【2】\n Guidelines Part 5: Adult Basic Life Support: Writing Group Disclosures, Continued Iriting Group Research Grant Other Research Support: Quorship Interest Member Employment Bureau Honoran Board Other E. Brooker Visconsin – Association †Title: Croulation Improving Resusciation Bookholder in Medronic\nPrizer, and General\nElectric None None None None Corporaton Role: Consulant Principal\n12/2006 – 8/2010 Total Funding to MCV Profes ing to MON $345,000 funding is receive trial. My institution receives support to tunds are used for other members of report generator for the trial Thomas D.\n\n【3】University of Washingto \"In the past, I have received unn *We conducted an AED training None \"I serve on a DSMB Physician–Associate and PhysioControl. The topics were equipment for the research. I did not for a trial sponsored Emergency Medical related to improving resuscitation evaluate quantitative Services Division of Public proprietary information or equipment.\n\n【4】receive any of this equipm VF waveform care. I receive no -Seatle & K s pat of this, I an drectly involved inimize (eliminal lable on the Philips MRX. The fdbk avail any conflict ROC is also evaluating the impedance company that makes the impodance wice. I am participants threshold device. I am participating in a\ntrial of chest compression only vs chest\ndepatch-assisted CPR-supported in part by Laerdal Foundation. I recei than 5% salary support.\n\n【5】Michael R.\n\n【6】The Ohio State University- None None None None None None Associate Professor Robert A. Swar Beaumont Hospital–Director None None None None None None EVS Programs This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the\n\n【7】\n Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be \"significant\" if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be \"modest\" if it is less than \"significant\" under the preceding definition.\n\n【8】*Modest.\n\n【9】 ↑ Significant.\n\n【10】## References\n\n【11】\n 1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J.\n\n【12】Executive summary: heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121: 948 – 954.\n\n【13】Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg 2.\n\n【14】M. Increasing use of cardiopulmonary resuscitation during out-ofhospital ventricular fibrillation arrest: survival implications of guideline changes. Circulation . 2006;114:2760–2765.\n\n【15】1. S.\n\n【16】Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I.\n\n【17】Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA . 2008;300:1423–1431.\n\n【18】Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK.\n\n【19】1. 4.\n\n【20】Hospital variation in time to defibrillation after in-hospital cardiac arrest.\n\n【21】Arch Intern Med . 2009;169:1265–1273.\n\n【22】5.\n\n【23】Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and metaanalysis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.\n\n【24】6.\n\n【25】Christenson J, Andrusiek D, Everson-Stewart S, Kudenchuk P, Hostler D, Powell J, Callaway CW, Bishop D, Vaillancourt C, Davis D, Aufderheide TP, Idris A, Stouffer JA, Stiell I, Berg R. Chest compression fraction determines survival in patients with out-of-hospital ventricular fibrillation. Circulation . 2009;120:1241–1247.\n\n【26】7.\n\n【27】Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. Circulation. 1997;96:3308–3313.\n\n【28】8. Chan PS, Krumholz HM, Nichol G, Nallamothu BK. Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med . 2008; 358:9–17.\n\n【29】 9. Hallstrom AP, Ornato JP, Weisfeldt M, Travers A, Christenson J, McBurnie MA, Zalenski R, Becker LB, Schron EB, Proschan M. Publicaccess defibrillation and survival after out-of-hospital cardiac arrest.\n\n【30】N Engl J Med . 2004;351:637–646.\n\n【31】10. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.\n\n【32】Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med . 2000;343:1206–1209.\n\n【33】11. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation in Rochester, Minnesota: experience over 18 years. Resuscitation. 2009 ; 80:1253–1258.\n\n【34】12. Eisenberg MS, Hallstrom AP, Copass MK, Bergner L, Short F, Pierce J.\n\n【35】Treatment of ventricular fibrillation: emergency medical technician defibrillation and paramedic services. JAMA . 1984;251:1723–1726.\n\n【36】13. Rho RW, Page RL. The automated external defibrillator. J Cardiovasc Electrophysiol . 2007;18:896–899.\n\n【37】14. Becker LB, Pepe PE.  Ensuring the effectiveness of community- wide emergency cardiac care. Ann Emerg Med . 22(pt 2):354–365, 1993.\n\n【38】15. Calle PA, Lagaert L, Vanhaute O, Buylaert WA.  Do victims of an out-of-hospital cardiac arrest benefit from a training program for emergency medical dispatchers? Resuscitation . 1997;35:213–218.\n\n【39】16. Emergency medical dispatching: rapid identification and treatment of acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee. Am J Emerg Med .\n\n【40】1995;13:67–73.\n\n【41】17. Hallstrom A, Cobb L, Johnson E, Copass M.  Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation.\n\n【42】N Engl J Med . 2000;342:1546–1553.\n\n【43】18. Culley LL, Clark JJ, Eisenberg MS, Larsen MP.  Dispatcher-assisted telephone CPR: common delays and time standards for delivery. Ann Emerg Med . 1991;20:362–366.\n\n【44】19. Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW.\n\n【45】Importance of the first link: description and recognition of an out-ofhospital cardiac arrest in an emergency call. Circulation. 2009;119: 2096–2102.\n\n【46】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Guidelines Part 5: Adult Basic Life Support: Writing Group Disclosures, Continued", "bbox": [60.0, 81.0, 460.0, 99.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Guidelines Part 5: Adult Basic Life Support: Writing Group Disclosures, Continued", "bbox": [60.0, 81.0, 460.0, 99.0]}, {"text": "Iriting Group", "bbox": [66.0, 106.0, 98.0, 116.0]}, {"text": "Research Grant", "bbox": [235.0, 113.0, 279.0, 123.0]}, {"text": "Other Research Support:", "bbox": [341.0, 114.0, 409.0, 123.0]}, {"text": "Quorship Interest", "bbox": [512.0, 114.0, 565.0, 123.0]}, {"text": "Member", "bbox": [61.0, 115.0, 85.0, 123.0]}, {"text": "Employment", "bbox": [136.0, 115.0, 172.0, 123.0]}, {"text": "Bureau Honoran", "bbox": [441.0, 115.0, 483.0, 123.0]}, {"text": "Board", "bbox": [609.0, 115.0, 627.0, 123.0]}, {"text": "Other", "bbox": [681.0, 115.0, 696.0, 123.0]}, {"text": "E. Brooker", "bbox": [61.0, 129.0, 89.0, 143.0]}, {"text": "Visconsin – Association", "bbox": [128.0, 129.0, 180.0, 144.0]}, {"text": "†Title: Croulation Improving Resusciation", "bbox": [323.0, 129.0, 419.0, 145.0]}, {"text": "Bookholder in Medronic\nPrizer, and General\nElectric", "bbox": [508.0, 129.0, 571.0, 153.0]}, {"text": "None", "bbox": [249.0, 130.0, 265.0, 137.0]}, {"text": "None", "bbox": [456.0, 130.0, 471.0, 137.0]}, {"text": "None", "bbox": [610.0, 130.0, 625.0, 137.0]}, {"text": "None", "bbox": [681.0, 130.0, 696.0, 137.0]}, {"text": "Corporaton Role: Consulant Principal\n12/2006 – 8/2010 Total Funding to MCV", "bbox": [322.0, 143.0, 424.0, 166.0]}, {"text": "Profes", "bbox": [141.0, 144.0, 158.0, 153.0]}, {"text": "ing to MON", "bbox": [395.0, 159.0, 426.0, 165.0]}, {"text": "$345,000 funding is receive", "bbox": [327.0, 167.0, 397.0, 176.0]}, {"text": "trial. My institution receives support to", "bbox": [326.0, 174.0, 421.0, 190.0]}, {"text": "tunds are used for other members of", "bbox": [322.0, 187.0, 414.0, 211.0]}, {"text": "report generator for the trial", "bbox": [339.0, 209.0, 411.0, 234.0]}, {"text": "Thomas D.", "bbox": [61.0, 238.0, 91.0, 248.0]}, {"text": "University of Washingto", "bbox": [120.0, 237.0, 183.0, 248.0]}, {"text": "\"In the past, I have received unn", "bbox": [206.0, 238.0, 287.0, 248.0]}, {"text": "*We conducted an AED training", "bbox": [331.0, 237.0, 420.0, 248.0]}, {"text": "None", "bbox": [529.0, 238.0, 547.0, 248.0]}, {"text": "\"I serve on a DSMB", "bbox": [661.0, 238.0, 718.0, 249.0]}, {"text": "Physician–Associate", "bbox": [128.0, 247.0, 183.0, 263.0]}, {"text": "and PhysioControl. The topics were", "bbox": [212.0, 247.0, 309.0, 263.0]}, {"text": "equipment for the research. I did not", "bbox": [323.0, 247.0, 426.0, 270.0]}, {"text": "for a trial sponsored", "bbox": [659.0, 247.0, 718.0, 263.0]}, {"text": "Emergency Medical", "bbox": [127.0, 261.0, 182.0, 269.0]}, {"text": "related to improving resuscitation", "bbox": [214.0, 261.0, 302.0, 269.0]}, {"text": "evaluate quantitative", "bbox": [659.0, 261.0, 717.0, 269.0]}, {"text": "Services Division of Public", "bbox": [118.0, 268.0, 190.0, 277.0]}, {"text": "proprietary information or equipment.", "bbox": [206.0, 267.0, 306.0, 291.0]}, {"text": "receive any of this equipm", "bbox": [334.0, 268.0, 407.0, 278.0]}, {"text": "VF waveform", "bbox": [670.0, 269.0, 705.0, 277.0]}, {"text": "care. I receive no", "bbox": [663.0, 275.0, 717.0, 291.0]}, {"text": "-Seatle & K", "bbox": [143.0, 276.0, 176.0, 282.0]}, {"text": "s pat of this, I an drectly involved", "bbox": [210.0, 289.0, 306.0, 316.0]}, {"text": "inimize (eliminal", "bbox": [666.0, 289.0, 706.0, 314.0]}, {"text": "lable on the Philips MRX. The", "bbox": [232.0, 313.0, 307.0, 321.0]}, {"text": "fdbk avail", "bbox": [207.0, 314.0, 232.0, 321.0]}, {"text": "any conflict", "bbox": [672.0, 314.0, 703.0, 321.0]}, {"text": "ROC is also evaluating the impedance", "bbox": [207.0, 321.0, 304.0, 336.0]}, {"text": "company that makes the impodance", "bbox": [209.0, 334.0, 307.0, 358.0]}, {"text": "wice. I am participants", "bbox": [238.0, 350.0, 297.0, 380.0]}, {"text": "threshold device. I am participating in a\ntrial of chest compression only vs chest\ndepatch-assisted CPR-supported in part", "bbox": [206.0, 355.0, 310.0, 390.0]}, {"text": "by Laerdal Foundation. I recei", "bbox": [209.0, 388.0, 287.0, 394.0]}, {"text": "than 5% salary support.", "bbox": [225.0, 393.0, 289.0, 401.0]}, {"text": "Michael R.", "bbox": [61.0, 405.0, 92.0, 415.0]}, {"text": "The Ohio State University-", "bbox": [118.0, 405.0, 189.0, 416.0]}, {"text": "None", "bbox": [456.0, 406.0, 471.0, 414.0]}, {"text": "None", "bbox": [610.0, 406.0, 625.0, 414.0]}, {"text": "None", "bbox": [248.0, 407.0, 265.0, 414.0]}, {"text": "None", "bbox": [367.0, 407.0, 382.0, 414.0]}, {"text": "None", "bbox": [529.0, 407.0, 546.0, 414.0]}, {"text": "None", "bbox": [681.0, 407.0, 697.0, 414.0]}, {"text": "Associate Professor", "bbox": [126.0, 414.0, 180.0, 422.0]}, {"text": "Robert A. Swar", "bbox": [61.0, 428.0, 105.0, 436.0]}, {"text": "Beaumont Hospital–Director", "bbox": [113.0, 428.0, 191.0, 436.0]}, {"text": "None", "bbox": [367.0, 428.0, 382.0, 436.0]}, {"text": "None", "bbox": [456.0, 428.0, 471.0, 436.0]}, {"text": "None", "bbox": [530.0, 428.0, 546.0, 436.0]}, {"text": "None", "bbox": [610.0, 428.0, 625.0, 436.0]}, {"text": "None", "bbox": [681.0, 428.0, 697.0, 436.0]}, {"text": "None", "bbox": [248.0, 429.0, 265.0, 436.0]}, {"text": "EVS Programs", "bbox": [133.0, 435.0, 174.0, 443.0]}, {"text": "This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the", "bbox": [70.0, 449.0, 720.0, 464.0]}], "type": "Table", "position": 4}, {"raw_context": [{"text": "Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be \"significant\" if (a) the person", "bbox": [61.0, 464.0, 720.0, 477.0]}, {"text": "receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share", "bbox": [61.0, 478.0, 720.0, 489.0]}, {"text": "of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be \"modest\" if it is less than \"significant\" under the", "bbox": [61.0, 491.0, 719.0, 503.0]}, {"text": "preceding definition.", "bbox": [61.0, 505.0, 143.0, 516.0]}, {"text": "*Modest.", "bbox": [72.0, 517.0, 108.0, 531.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "↑ Significant.", "bbox": [72.0, 531.0, 122.0, 543.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "References", "bbox": [180.0, 563.0, 256.0, 576.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone", "bbox": [71.0, 578.0, 375.0, 590.0]}, {"text": "G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K,", "bbox": [83.0, 591.0, 375.0, 602.0]}, {"text": "Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland", "bbox": [83.0, 603.0, 375.0, 615.0]}, {"text": "D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D,", "bbox": [83.0, 616.0, 375.0, 628.0]}, {"text": "Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P,", "bbox": [84.0, 628.0, 375.0, 639.0]}, {"text": "Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J.", "bbox": [84.0, 641.0, 375.0, 651.0]}, {"text": "Executive summary: heart disease and stroke statistics–2010 update: a", "bbox": [84.0, 652.0, 376.0, 663.0]}, {"text": "report from the American Heart Association. Circulation. 2010;121:", "bbox": [83.0, 664.0, 375.0, 675.0]}, {"text": "948 – 954.", "bbox": [83.0, 676.0, 122.0, 687.0]}, {"text": "Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg", "bbox": [81.0, 688.0, 375.0, 701.0]}, {"text": "2.", "bbox": [71.0, 689.0, 79.0, 699.0]}, {"text": "M. Increasing use of cardiopulmonary resuscitation during out-of-", "bbox": [84.0, 701.0, 374.0, 712.0]}, {"text": "hospital ventricular fibrillation arrest: survival implications of guideline", "bbox": [83.0, 714.0, 375.0, 724.0]}, {"text": "changes. Circulation . 2006;114:2760–2765.", "bbox": [84.0, 724.0, 263.0, 736.0]}, {"text": "1. S.", "bbox": [71.0, 736.0, 81.0, 746.0]}, {"text": "Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide", "bbox": [81.0, 737.0, 375.0, 747.0]}, {"text": "TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I.", "bbox": [84.0, 749.0, 375.0, 761.0]}, {"text": "Regional variation in out-of-hospital cardiac arrest incidence and", "bbox": [83.0, 762.0, 375.0, 773.0]}, {"text": "outcome. JAMA . 2008;300:1423–1431.", "bbox": [84.0, 773.0, 244.0, 784.0]}, {"text": "Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK.", "bbox": [81.0, 785.0, 374.0, 797.0]}, {"text": "1. 4.", "bbox": [71.0, 786.0, 81.0, 795.0]}, {"text": "Hospital variation in time to defibrillation after in-hospital cardiac arrest.", "bbox": [84.0, 797.0, 374.0, 809.0]}, {"text": "Arch Intern Med . 2009;169:1265–1273.", "bbox": [83.0, 810.0, 246.0, 820.0]}, {"text": "5.", "bbox": [71.0, 822.0, 79.0, 832.0]}, {"text": "Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival", "bbox": [81.0, 822.0, 375.0, 833.0]}, {"text": "from out-of-hospital cardiac arrest: a systematic review and meta-", "bbox": [84.0, 833.0, 374.0, 846.0]}, {"text": "analysis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.", "bbox": [84.0, 846.0, 322.0, 857.0]}, {"text": "6.", "bbox": [71.0, 858.0, 79.0, 868.0]}, {"text": "Christenson J, Andrusiek D, Everson-Stewart S, Kudenchuk P, Hostler", "bbox": [81.0, 857.0, 375.0, 869.0]}, {"text": "D, Powell J, Callaway CW, Bishop D, Vaillancourt C, Davis D,", "bbox": [83.0, 870.0, 375.0, 882.0]}, {"text": "Aufderheide TP, Idris A, Stouffer JA, Stiell I, Berg R. Chest com-", "bbox": [84.0, 883.0, 374.0, 894.0]}, {"text": "pression fraction determines survival in patients with out-of-hospital", "bbox": [83.0, 895.0, 375.0, 907.0]}, {"text": "ventricular fibrillation. Circulation . 2009;120:1241–1247.", "bbox": [84.0, 906.0, 320.0, 917.0]}, {"text": "7.", "bbox": [71.0, 918.0, 80.0, 928.0]}, {"text": "Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating", "bbox": [81.0, 919.0, 375.0, 930.0]}, {"text": "effectiveness of cardiac arrest interventions: a logistic regression", "bbox": [83.0, 930.0, 375.0, 942.0]}, {"text": "survival model. Circulation. 1997;96:3308–3313.", "bbox": [84.0, 943.0, 287.0, 955.0]}, {"text": "8. Chan PS, Krumholz HM, Nichol G, Nallamothu BK. Delayed time to", "bbox": [71.0, 954.0, 376.0, 967.0]}, {"text": "defibrillation after in-hospital cardiac arrest. N Engl J Med . 2008;", "bbox": [84.0, 968.0, 375.0, 979.0]}, {"text": "358:9–17.", "bbox": [84.0, 979.0, 128.0, 990.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "9. Hallstrom AP, Ornato JP, Weisfeldt M, Travers A, Christenson J,", "bbox": [414.0, 561.0, 719.0, 573.0]}, {"text": "McBurnie MA, Zalenski R, Becker LB, Schron EB, Proschan M. Public-", "bbox": [427.0, 575.0, 718.0, 586.0]}, {"text": "access defibrillation and survival after out-of-hospital cardiac arrest.", "bbox": [428.0, 588.0, 718.0, 600.0]}, {"text": "N Engl J Med . 2004;351:637–646.", "bbox": [427.0, 600.0, 570.0, 611.0]}, {"text": "10. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.", "bbox": [410.0, 613.0, 718.0, 624.0]}, {"text": "Outcomes of rapid defibrillation by security officers after cardiac arrest", "bbox": [427.0, 626.0, 720.0, 637.0]}, {"text": "in casinos. N Engl J Med . 2000;343:1206–1209.", "bbox": [427.0, 638.0, 627.0, 649.0]}, {"text": "11. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation", "bbox": [410.0, 651.0, 720.0, 662.0]}, {"text": "in Rochester, Minnesota: experience over 18 years. Resuscitation. 2009 ;", "bbox": [427.0, 663.0, 719.0, 675.0]}, {"text": "80:1253–1258.", "bbox": [427.0, 675.0, 488.0, 687.0]}, {"text": "12. Eisenberg MS, Hallstrom AP, Copass MK, Bergner L, Short F, Pierce J.", "bbox": [410.0, 688.0, 718.0, 701.0]}, {"text": "Treatment of ventricular fibrillation: emergency medical technician defi-", "bbox": [428.0, 700.0, 718.0, 714.0]}, {"text": "brillation and paramedic services. JAMA . 1984;251:1723–1726.", "bbox": [427.0, 714.0, 687.0, 725.0]}, {"text": "13. Rho RW, Page RL. The automated external defibrillator. J Cardiovasc", "bbox": [410.0, 727.0, 719.0, 739.0]}, {"text": "Electrophysiol . 2007;18:896–899.", "bbox": [428.0, 739.0, 568.0, 750.0]}, {"text": "14. Becker LB, Pepe PE.  Ensuring the effectiveness of community- wide", "bbox": [410.0, 752.0, 719.0, 763.0]}, {"text": "emergency cardiac care. Ann Emerg Med . 22(pt 2):354–365, 1993.", "bbox": [430.0, 766.0, 705.0, 776.0]}, {"text": "15. Calle PA, Lagaert L, Vanhaute O, Buylaert WA.  Do victims of an", "bbox": [410.0, 777.0, 720.0, 789.0]}, {"text": "out-of-hospital cardiac arrest benefit from a training program for", "bbox": [428.0, 790.0, 719.0, 802.0]}, {"text": "emergency medical dispatchers? Resuscitation . 1997;35:213–218.", "bbox": [427.0, 803.0, 698.0, 814.0]}, {"text": "16. Emergency medical dispatching: rapid identification and treatment of", "bbox": [410.0, 816.0, 719.0, 827.0]}, {"text": "acute myocardial infarction. National Heart Attack Alert Program Coor-", "bbox": [428.0, 829.0, 717.0, 839.0]}, {"text": "dinating Committee Access to Care Subcommittee. Am J Emerg Med .", "bbox": [428.0, 840.0, 718.0, 851.0]}, {"text": "1995;13:67–73.", "bbox": [428.0, 853.0, 490.0, 864.0]}, {"text": "17. Hallstrom A, Cobb L, Johnson E, Copass M.  Cardiopulmonary resus-", "bbox": [410.0, 866.0, 718.0, 878.0]}, {"text": "citation by chest compression alone or with mouth-to-mouth ventilation.", "bbox": [427.0, 878.0, 718.0, 890.0]}, {"text": "N Engl J Med . 2000;342:1546–1553.", "bbox": [427.0, 891.0, 581.0, 903.0]}, {"text": "18. Culley LL, Clark JJ, Eisenberg MS, Larsen MP.  Dispatcher-assisted", "bbox": [410.0, 903.0, 720.0, 915.0]}, {"text": "telephone CPR: common delays and time standards for delivery. Ann", "bbox": [427.0, 916.0, 719.0, 928.0]}, {"text": "Emerg Med . 1991;20:362–366.", "bbox": [427.0, 930.0, 555.0, 941.0]}, {"text": "19. Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW.", "bbox": [410.0, 942.0, 718.0, 953.0]}, {"text": "Importance of the first link: description and recognition of an out-of-", "bbox": [427.0, 954.0, 718.0, 966.0]}, {"text": "hospital cardiac arrest in an emergency call. Circulation. 2009;119:", "bbox": [427.0, 968.0, 718.0, 979.0]}, {"text": "2096–2102.", "bbox": [428.0, 979.0, 477.0, 990.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 66}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#1#11#表格的内容，但是内容混乱互相穿插\n有用性#12#46#都是参考文献的内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:09:27"}
{"id": 1042028, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "77d7afb1-7381-4dfa-9404-41d35fc2ef88", "title": null, "text": "【0】页码:197\n\n【1】## Disadvantages\n\n【2】\n We must invest laboratory time to elaborate the ap¬ l, pliance.\n\n【3】2.\n\n【4】Bad hygiene can provoke food particle accumulation and gingival irritation.\n\n【5】3.\n\n【6】The force exerted by the elastics can provoke the debonding of the upper or lower flat skidding sur¬ faces.\n\n【7】4.\n\n【8】We need 100% cooperation of the patient.\n\n【9】5.\n\n【10】The elastics can cause lip irritation.\n\n【11】6.\n\n【12】The patient can refer pain in the retromolar zone due to the opening of the pterygo-maxillary suture. (32)\n\n【13】## Recommendations\n\n【14】\n 1.\n\n【15】Following the maxillary protraction protocol, we must begin with the upper expansion in order to disarticulate the sutures and to facilitate the advance of the maxilla, so we must indicate to the patient that the expander must be activated twice a day, once in the morning and once at night.\n\n【16】2.\n\n【17】The Tandem must be used between 10 and 12 hours a day. (15) 3.\n\n【18】If the patient tolerates the use of the Tandem during sleeping hours, we must encourage the patient to wear it during sleep, because the growth hormone is liberated during this period and the skeletal changes will be much more favorable.\n\n【19】4.\n\n【20】The elastics used for protraction will be '4\", which will generate heavy forces, following this use sequence:\n\n【21】 8 ounces at the beginning of treatment (230 g).\n\n【22】a.\n\n【23】14 ounces at the end of the treatment (400 g).\n\n【24】b.\n\n【25】 5.\n\n【26】We recommend periodic appointments to inspect the expander and to evaluate the changes in the soft tissue (every 4 to 6 weeks).\n\n【27】## Mini-Maxillary Protractor\n\n【28】\n The mini-maxillary protractor, like the Tandem and the face mask, is an anterior maxillary protraction appliance that is indicated in patients that are growing and have an anterior cross bite (Class III patients with skeletal maxillary deficiency). This appliance has three components: (15)\n\n【29】## 1.\n\n【30】\n## Fixed\n\n【31】\n Upper adhesion Hass Type expander with flat and a.\n\n【32】skidding surfaces and protraction hooks.\n\n【33】 2.\n\n【34】## Removable\n\n【35】\n Anterior protraction arch with chin cup.\n\n【36】a.\n\n【37】Neck pad.\n\n【38】b.\n\n【39】 The advancement of the maxilla and its dento-alveolar pro¬ cess is obtained as an effect of the force exerted by the 5/16\" elastics upon the intraoral appliances. These heavy elastics\n Fig. 76. Front view of the Mini-maxillary protractor.\n Fig. 77. Lateral view of the Mini-maxillary protractor.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Disadvantages", "bbox": [70.0, 84.0, 174.0, 100.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "We must invest laboratory time to elaborate the ap¬", "bbox": [96.0, 119.0, 381.0, 135.0]}, {"text": "l,", "bbox": [70.0, 120.0, 83.0, 135.0]}, {"text": "pliance.", "bbox": [95.0, 137.0, 140.0, 151.0]}, {"text": "2.", "bbox": [69.0, 153.0, 82.0, 170.0]}, {"text": "Bad hygiene can provoke food particle accumulation", "bbox": [95.0, 154.0, 383.0, 170.0]}, {"text": "and gingival irritation.", "bbox": [95.0, 172.0, 221.0, 187.0]}, {"text": "3.", "bbox": [69.0, 188.0, 82.0, 204.0]}, {"text": "The force exerted by the elastics can provoke the", "bbox": [95.0, 189.0, 383.0, 204.0]}, {"text": "debonding of the upper or lower flat skidding sur¬", "bbox": [95.0, 206.0, 381.0, 222.0]}, {"text": "faces.", "bbox": [95.0, 223.0, 130.0, 238.0]}, {"text": "4.", "bbox": [69.0, 240.0, 82.0, 256.0]}, {"text": "We need 100% cooperation of the patient.", "bbox": [95.0, 240.0, 326.0, 256.0]}, {"text": "5.", "bbox": [69.0, 258.0, 82.0, 274.0]}, {"text": "The elastics can cause lip irritation.", "bbox": [95.0, 258.0, 290.0, 274.0]}, {"text": "6.", "bbox": [69.0, 276.0, 82.0, 291.0]}, {"text": "The patient can refer pain in the retromolar zone due", "bbox": [95.0, 276.0, 383.0, 291.0]}, {"text": "to the opening of the pterygo-maxillary suture. (32)", "bbox": [95.0, 292.0, 367.0, 309.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Recommendations", "bbox": [69.0, 326.0, 199.0, 343.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "1.", "bbox": [70.0, 363.0, 82.0, 377.0]}, {"text": "Following the maxillary protraction protocol, we", "bbox": [95.0, 362.0, 383.0, 378.0]}, {"text": "must begin with the upper expansion in order to", "bbox": [95.0, 379.0, 383.0, 395.0]}, {"text": "disarticulate the sutures and to facilitate the advance", "bbox": [95.0, 396.0, 382.0, 413.0]}, {"text": "of the maxilla, so we must indicate to the patient that", "bbox": [95.0, 414.0, 382.0, 429.0]}, {"text": "the expander must be activated twice a day, once in", "bbox": [95.0, 431.0, 383.0, 447.0]}, {"text": "the morning and once at night.", "bbox": [95.0, 449.0, 271.0, 464.0]}, {"text": "2.", "bbox": [68.0, 464.0, 82.0, 481.0]}, {"text": "The Tandem must be used between 10 and 12 hours a", "bbox": [95.0, 466.0, 383.0, 481.0]}, {"text": "day. (15)", "bbox": [95.0, 482.0, 132.0, 498.0]}, {"text": "3.", "bbox": [68.0, 498.0, 81.0, 515.0]}, {"text": "If the patient tolerates the use of the Tandem during", "bbox": [94.0, 500.0, 383.0, 516.0]}, {"text": "sleeping hours, we must encourage the patient to", "bbox": [95.0, 517.0, 382.0, 534.0]}, {"text": "wear it during sleep, because the growth hormone is", "bbox": [95.0, 535.0, 383.0, 551.0]}, {"text": "liberated during this period and the skeletal changes", "bbox": [95.0, 553.0, 382.0, 568.0]}, {"text": "will be much more favorable.", "bbox": [95.0, 569.0, 256.0, 585.0]}, {"text": "4.", "bbox": [68.0, 586.0, 81.0, 602.0]}, {"text": "The elastics used for protraction will be '4\", which will", "bbox": [95.0, 587.0, 382.0, 602.0]}, {"text": "generate heavy forces, following this use sequence:", "bbox": [95.0, 604.0, 367.0, 620.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "8 ounces at the beginning of treatment (230 g).", "bbox": [120.0, 639.0, 373.0, 655.0]}, {"text": "a.", "bbox": [95.0, 641.0, 107.0, 653.0]}, {"text": "14 ounces at the end of the treatment (400 g).", "bbox": [121.0, 655.0, 371.0, 673.0]}, {"text": "b.", "bbox": [94.0, 657.0, 107.0, 670.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "5.", "bbox": [67.0, 689.0, 81.0, 706.0]}, {"text": "We recommend periodic appointments to inspect", "bbox": [94.0, 690.0, 382.0, 706.0]}, {"text": "the expander and to evaluate the changes in the soft", "bbox": [93.0, 708.0, 381.0, 724.0]}, {"text": "tissue (every 4 to 6 weeks).", "bbox": [93.0, 726.0, 244.0, 741.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Mini-maxillary protractor", "bbox": [67.0, 773.0, 259.0, 795.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "The mini-maxillary protractor, like the Tandem and the", "bbox": [68.0, 812.0, 382.0, 828.0]}, {"text": "face mask, is an anterior maxillary protraction appliance", "bbox": [67.0, 829.0, 381.0, 846.0]}, {"text": "that is indicated in patients that are growing and have an", "bbox": [67.0, 846.0, 381.0, 862.0]}, {"text": "anterior cross bite (Class III patients with skeletal maxillary", "bbox": [67.0, 864.0, 381.0, 880.0]}, {"text": "deficiency). This appliance has three components: (15)", "bbox": [67.0, 881.0, 355.0, 897.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "1.", "bbox": [68.0, 916.0, 82.0, 931.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Fixed", "bbox": [93.0, 916.0, 131.0, 931.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Upper adhesion Hass Type expander with flat", "bbox": [119.0, 933.0, 381.0, 949.0]}, {"text": "and a.", "bbox": [93.0, 935.0, 107.0, 948.0]}, {"text": "skidding surfaces and protraction hooks.", "bbox": [120.0, 950.0, 346.0, 967.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "2.", "bbox": [402.0, 86.0, 419.0, 101.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Removable", "bbox": [429.0, 86.0, 499.0, 101.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "Anterior protraction arch with chin cup.", "bbox": [456.0, 103.0, 680.0, 118.0]}, {"text": "a.", "bbox": [430.0, 106.0, 442.0, 117.0]}, {"text": "Neck pad.", "bbox": [455.0, 120.0, 514.0, 136.0]}, {"text": "b.", "bbox": [430.0, 121.0, 444.0, 135.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "The advancement of the maxilla and its dento-alveolar pro¬", "bbox": [404.0, 154.0, 716.0, 171.0]}, {"text": "cess is obtained as an effect of the force exerted by the 5/16\"", "bbox": [403.0, 172.0, 717.0, 189.0]}, {"text": "elastics upon the intraoral appliances. These heavy elastics", "bbox": [403.0, 189.0, 717.0, 206.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Fig. 76. Front view of the Mini-maxillary protractor.", "bbox": [446.0, 535.0, 674.0, 548.0]}], "type": "Caption", "position": 17}, {"raw_context": [{"text": "Fig. 77. Lateral view of the Mini-maxillary protractor.", "bbox": [441.0, 958.0, 677.0, 973.0]}], "type": "Caption", "position": 19}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 197}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#12#序号和正文分离\n", "type3": "无关文本#12#12#(32)\n无关文本#17#17#(15)\n无关文本#28#28#(15)\n无关文本#39#39#Fig. 76. Front view of the Mini-maxillary protractor.", "type4": "栏目混乱#13#26#序号和正文分离并且位置杂乱\n栏目混乱#29#39#序号和正文分离并且位置杂乱", "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 01:20:16"}
{"id": 1042027, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "cbd0bc1e-280c-4dcd-8837-9da0d1556490", "title": null, "text": "【0】页码:91\n Any indicated medication should be prescribed and taken as directed. An effective asthma regimen will succeed in achieving a minimal requirement for short¬ acting β 2 agonist \"rescue\" medication. An effective asthma regimen will also ensure minimal, if any, side effects from the prescribed medicines. Lung function should normalize with proper asthma care. Symptoms should be absent or minimal during the daytime, as well as at night (Table 21). Sleep should be restful and uninterrupted. There should be no absences from work or school due to asthma. Exacerbations should also be few (or none), and far between. When an exacerbation does develop, it should be recognized immediately and treated aggressively. When people can \"forget\" that they have asthma, except for the fact that they have to take medicine, and when they can fully participate in work, play, and sports, and enjoy life without limitation, then the principal goal of asthma treatment has been successfully met.\n\n【1】## Table 21  Major Goals Of Asthma Treatment\n\n【2】\n • Daytime symptoms should be absent or minimal.\n\n【3】• Nocturnal symptoms should be absent or minimal; sleep should be restful and uninterrupted.\n • Elimination of absences from work or school because of asthma; parents of children with asthma should similarly not have any missed days of work because of the child's asthma.\n • Full participation in sports and team competitions; regular aerobic exercise is an important component of good asthma management, as well as a key feature of a healthy lifestyle.\n\n【4】Exacerbations should be nonexistent or \"few and far between.\" They should be addressed and treated promptly and effectively.\n Requirement for \"rescue treatment,\" usually in the form of a shortacting inhaled β 2 agonist (inhaled or oral, in the case of young children), should be minimal.\n\n【5】Medicines for asthma treatment should be associated with minimal, if any, side effects.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Any indicated medication should be prescribed and", "bbox": [150.0, 70.0, 508.0, 87.0]}, {"text": "taken as directed. An effective asthma regimen will", "bbox": [149.0, 89.0, 508.0, 108.0]}, {"text": "succeed in achieving a minimal requirement for short¬", "bbox": [150.0, 111.0, 507.0, 126.0]}, {"text": "acting β 2 agonist \"rescue\" medication. An effective", "bbox": [150.0, 129.0, 508.0, 148.0]}, {"text": "asthma regimen will also ensure minimal, if any, side", "bbox": [149.0, 149.0, 508.0, 167.0]}, {"text": "effects from the prescribed medicines. Lung function", "bbox": [150.0, 170.0, 508.0, 187.0]}, {"text": "should normalize with proper asthma care. Symptoms", "bbox": [150.0, 190.0, 507.0, 208.0]}, {"text": "should be absent or minimal during the daytime, as", "bbox": [149.0, 209.0, 508.0, 228.0]}, {"text": "well as at night (Table 21). Sleep should be restful and", "bbox": [149.0, 228.0, 508.0, 248.0]}, {"text": "uninterrupted. There should be no absences from work", "bbox": [149.0, 249.0, 509.0, 267.0]}, {"text": "or school due to asthma. Exacerbations should also be", "bbox": [150.0, 270.0, 508.0, 288.0]}, {"text": "few (or none), and far between. When an exacerbation", "bbox": [149.0, 289.0, 508.0, 308.0]}, {"text": "does develop, it should be recognized immediately and", "bbox": [150.0, 310.0, 509.0, 327.0]}, {"text": "treated aggressively. When people can \"forget\" that", "bbox": [149.0, 329.0, 508.0, 347.0]}, {"text": "they have asthma, except for the fact that they have to", "bbox": [149.0, 349.0, 508.0, 367.0]}, {"text": "take medicine, and when they can fully participate in", "bbox": [149.0, 369.0, 508.0, 388.0]}, {"text": "work, play, and sports, and enjoy life without limita-", "bbox": [149.0, 389.0, 507.0, 408.0]}, {"text": "tion, then the principal goal of asthma treatment has", "bbox": [149.0, 409.0, 508.0, 428.0]}, {"text": "been successfully met.", "bbox": [150.0, 430.0, 296.0, 447.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Table 21  Major Goals of Asthma Treatment", "bbox": [150.0, 483.0, 361.0, 498.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "• Daytime symptoms should be absent or minimal.", "bbox": [154.0, 518.0, 405.0, 531.0]}, {"text": "• Nocturnal symptoms should be absent or minimal; sleep should be", "bbox": [154.0, 534.0, 491.0, 549.0]}, {"text": "restful and uninterrupted.", "bbox": [166.0, 550.0, 292.0, 563.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "• Elimination of absences from work or school because of asthma;", "bbox": [154.0, 565.0, 478.0, 580.0]}, {"text": "parents of children with asthma should similarly not have any missed", "bbox": [166.0, 579.0, 502.0, 592.0]}, {"text": "days of work because of the child's asthma.", "bbox": [166.0, 594.0, 374.0, 606.0]}], "type": "Footnote", "position": 4}, {"raw_context": [{"text": "• Full participation in sports and team competitions; regular aerobic", "bbox": [154.0, 610.0, 488.0, 623.0]}, {"text": "exercise is an important component of good asthma management, as", "bbox": [166.0, 624.0, 499.0, 636.0]}, {"text": "well as a key feature of a healthy lifestyle.", "bbox": [166.0, 637.0, 367.0, 650.0]}, {"text": "Exacerbations should be nonexistent or \"few and far between.\" They", "bbox": [165.0, 653.0, 498.0, 668.0]}, {"text": "should be addressed and treated promptly and effectively.", "bbox": [166.0, 668.0, 445.0, 681.0]}], "type": "Footnote", "position": 5}, {"raw_context": [{"text": "Requirement for \"rescue treatment,\" usually in the form of a short-", "bbox": [165.0, 684.0, 490.0, 699.0]}, {"text": "acting inhaled β 2 agonist (inhaled or oral, in the case of young chil-", "bbox": [166.0, 699.0, 493.0, 712.0]}, {"text": "dren), should be minimal.", "bbox": [165.0, 712.0, 293.0, 725.0]}, {"text": "Medicines for asthma treatment should be associated with minimal,", "bbox": [165.0, 727.0, 496.0, 743.0]}, {"text": "if any, side effects.", "bbox": [166.0, 743.0, 257.0, 756.0]}], "type": "Footnote", "position": 6}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 91}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "序号格式不一致#2#5#有的句子前面没序号", "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:15:26"}
{"id": 1042026, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "ff59b28d-8b85-443e-a5d1-feffba878ff3", "title": null, "text": "【0】页码:311\n 27. Roppolo LP, Pepe PE, Campbell L, Ohman K, Kulkarni H, Miller R, Idris A, Bean L, Bettes TN, Idris AH. Prospective, randomized trial of the effectiveness and retention of 30-min layperson training for cardiopulmonary resuscitation and automated external defibrillators: the American Airlines Study. Resuscitation . 2007;74:276–285.\n\n【1】28.\n\n【2】Batcheller AM, Brennan RT, Braslow A, Urrutia A, Kaye W. Cardiopulmonary resuscitation performance of subjects over forty is better following half-hour video self-instruction compared to traditional four-hour classroom training. Resuscitation . 2000;43:101–110.\n\n【3】29. Isbye DL, Rasmussen LS, Lippert FK, Rudolph SF, Ringsted CV.\n\n【4】Laypersons may learn basic life support in 24 min using a personal resuscitation manikin. Resuscitation . 2006;69:435–442.\n\n【5】30.\n\n【6】Moule P, Albarran JW, Bessant E, Brownfield C, Pollock J.  A nonrandomized comparison of e-learning and classroom delivery of basic life support with automated external defibrillator use: a pilot study. Int J Nurs Pract. 2008;14:427–434.\n\n【7】Liberman M, Golberg N, Mulder D, Sampalis J. Teaching cardiopul- 31.\n\n【8】monary resuscitation to CEGEP students in Quebec: a pilot project.\n\n【9】Resuscitation. 2000;47:249–257.\n\n【10】32.\n\n【11】Jones I, Handley AJ, Whitfield R, Newcombe R, Chamberlain D.  A preliminary feasibility study of a short DVD-based distance-learning package for basic life support. Resuscitation . 2007;75:350–356.\n\n【12】33. Braslow A, Brennan RT, Newman MM, Bircher NG, Batcheller AM, Kaye W.  CPR training without an instructor: development and evaluation of a video self-instructional system for effective performance of cardiopulmonary resuscitation. Resuscitation. 1997;34:207–220.\n\n【13】34. Ahmad F, Senadhira DCA, Charters J, Acquilla S.  Transmission of salmonella via mouth-to-mouth resuscitation. Lancet . 1990;335: 787–788.\n\n【14】35. Chalumeau M, Bidet P, Lina G, Mokhtari M, Andre MC, Gendrel D, Bingen E, Raymond J. Transmission of Panton-Valentine leukocidinproducing Staphylococcus aureus to a physician during resuscitation of a child. Clin Infect Dis . 2005;41:e29–e30.\n\n【15】36. Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T, Wallington T, Gold WL, Mederski B, Green K, Low DE. Possible SARS coronavirus transmission during cardiopulmonary resuscitation.\n\n【16】Emerg Infect Dis . 2004;10:287–293.\n\n【17】37. Feldman HA.  Some recollections of the meningococcal diseases: the first Harry F. Dowling lecture. JAMA . 1972;220:1107–1112.\n\n【18】38.\n\n【19】Finkelhor RS, Lampman JH. Herpes simplex infection following cardiopulmonary resuscitation. JAMA . 1980;243:650.\n\n【20】39. Heilman KM, Muschenheim C.  Primary cutaneous tuberculosis resulting from mouth-to-mouth respiration. N Engl J Med . 1965;273: 1035–1036.\n\n【21】40. Hendricks AA, Shapiro EP. Primary herpes simplex infection following mouth-to-mouth resuscitation. JAMA . 1980;243:257–258.\n\n【22】41. Todd MA, Bell JS.  Shigellosis from cardiopulmonary resuscitation.\n\n【23】JAMA . 1980;243:331.\n\n【24】42. Valenzuela TD, Hooton TM, Kaplan EL, Schlievert P. Transmission of \"toxic strep\" syndrome from an infected child to a firefighter during CPR. Ann Emerg Med. 1991;20:90–92.\n\n【25】43. Neiman R. Post manikin resuscitation stomatitis. J Ky Med Assoc .\n\n【26】1982;80:813–814.\n\n【27】44. Nicklin G. Manikin tracheitis. JAMA . 1980;244:2046–2047.\n\n【28】45. Lam KK, Lau FL, Chan WK, Wong WN. Effect of severe acute respiratory syndrome on bystander willingness to perform cardiopulmonary resuscitation (CPR): is compression-only preferred to standard CPR?\n\n【29】Prehosp Disaster Med . 2007;22:325–329.\n\n【30】Locke CJ, Berg RA, Sanders AB, Davis MF, Milander MM, Kern KB, 46.\n\n【31】Ewy GA.  Bystander cardiopulmonary resuscitation: concerns about mouth-to-mouth contact. Arch Intern Med. 1995;155:938–943.\n\n【32】47. Hamasu S, Morimoto T, Kuramoto N, Horiguchi M, Iwami T, Nishiyama C, Takada K, Kubota Y, Seki S, Maeda Y, Sakai Y, Hiraide A. Effects of BLS training on factors associated with attitude toward CPR in college students. Resuscitation. 2009;80:359–364.\n\n【33】Bobrow BJ, Zuercher M, Ewy GA, Clark L, Chikani V, Donahue D, Sanders AB, Hilwig RW, Berg RA, Kern KB. Gasping during cardiac arrest in humans is frequent and associated with improved survival.\n\n【34】Circulation . 2008;118:2550–2554.\n\n【35】49. Perkins GD, Walker G, Christensen K, Hulme J, Monsieurs KG.\n\n【36】Teaching recognition of agonal breathing improves accuracy of diagnosing cardiac arrest. Resuscitation . 2006;70:432–437.\n\n【37】50. Culley LL, Clark JJ, Eisenberg MS, Larsen MP.  Dispatcher-assisted telephone CPR: common delays and time standards for delivery. Ann Emerg Med . 1991;20:362–366.\n\n【38】 51. Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low bystander CPR rates: a systematic review of the literature. CJEM .\n\n【39】2008;10:51–65.\n\n【40】52. Van Hoeyweghen RJ, Verbruggen G, Rademakers F, Bossaert LL. The physiologic response of CPR training. Ann Emerg Med . 1991;20: 279–282.\n\n【41】53. Lonergan JH, Youngberg JZ, Kaplan JA.  Cardiopulmonary resuscitation: physical stress on the rescuer. Crit Care Med . 1981;9:793–795.\n\n【42】54. Tsou JY, Chi CH, Hsu RM, Wu HF, Su FC. Mechanical loading of the low back during cardiopulmonary resuscitation. Resuscitation . 2009;80: 1181–1186.\n\n【43】55. Peberdy MA, Ottingham LV, Groh WJ, Hedges J, Terndrup TE, Pirrallo RG, Mann NC, Sehra R. Adverse events associated with lay emergency response programs: the Public Access Defibrillation Trial experience.\n\n【44】Resuscitation. 2006;70:59–65.\n\n【45】56. Hallstrom AP, Ornato JP, Weisfeldt M, Travers A, Christenson J, McBurnie MA, Zalenski R, Becker LB, Schron EB, Proschan M. Publicaccess defibrillation and survival after out-of-hospital cardiac arrest.\n\n【46】N Engl J Med . 2004;351:637–646.\n\n【47】57. Cheung W, Gullick J, Thanakrishnan G, Jacobs R, Au W, Uy J, Fick M, Narayan P, Ralston S, Tan J. Injuries occurring in hospital staff attending medical emergency team (MET) calls: a prospective, observational study. Resuscitation . 2009;80:1351–1356.\n\n【48】58. Jones AY. Can cardiopulmonary resuscitation injure the back?\n\n【49】Resuscitation . 2004;61:63–67.\n\n【50】59. Jones AY, Lee RY. Cardiopulmonary resuscitation and back injury in ambulance officers. Int Arch Occup Environ Health . 2005;78:332–336 .\n\n【51】Thierbach AR, Piepho T, Kunde M, Wolcke BB, Golecki N, Kleine- Weischede B, Werner C. Two-rescuer CPR results in hyperventilation in the ventilating rescuer. Resuscitation . 2005;65:185–190.\n\n【52】61. Thierbach AR, Wolcke BB, Krummenauer F, Kunde M, Janig C, Dick WF. Artificial ventilation for basic life support leads to hyperventilation in first aid providers. Resuscitation. 2003;57:269–277.\n\n【53】62. Walker GM, Liddle R. Prolonged two-man basic life support may result in hypocarbia in the ventilating rescuer. Resuscitation . 2001;50: 179–183.\n\n【54】63. Greenberg M. CPR: a report of observed medical complications during training. Ann Emerg Med . 1983;12:194–195.\n\n【55】64. Macauley CA, Todd CT.  Physical disability among cardiopulmonary resuscitation students. Occup Health Nurs. 1978;26:17–19.\n\n【56】65. Steinhoff JP, Pattavina C, Renzi R. Puncture wound during CPR from sternotomy wires: case report and discussion of periresuscitation infection risks. Heart Lung . 2001;30:159–160.\n\n【57】66.\n\n【58】Shimokawa A, Tateyama S, Shimizu Y, Muramatsu I, Takasaki M.\n\n【59】Anterior interosseous nerve palsy after cardiopulmonary resuscitation in a resuscitator with undiagnosed muscle anomaly. Anesth Analg. 2001; 93:290–291.\n\n【60】67. Sullivan F, Avstreih D. Pneumothorax during CPR training: case report and review of the CPR literature. Prehosp Disaster Med . 2000;15: 64–69.\n\n【61】Memon AM, Salzer JE, Hillman EC Jr, Marshall CL. Fatal myocardial 68.\n\n【62】infarct following CPR training: the question of risk. Ann Emerg Med .\n\n【63】1982;11:322–323.\n\n【64】69. Axelsson A, Herlitz J, Ekstrom L, Holmberg S.  Bystander-initiated cardiopulmonary resuscitation out-of-hospital: a first description of the bystanders and their experiences. Resuscitation . 1996;33:3–11.\n\n【65】70. Gamble M. A debriefing approach to dealing with the stress of CPR attempts. Prof Nurse . 2001;17:157–160.\n\n【66】71.\n\n【67】Lyster T, Jorgenson D, Morgan C. The safe use of automated external defibrillators in a wet environment. Prehosp Emerg Care . 2003;7: 307–311.\n\n【68】72. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation: an analysis of electrical current flow through rescuers in direct contact with patients during biphasic external defibrillation. Circulation . 2008; 117:2510–2514.\n\n【69】73. Capucci A, Aschieri D, Piepoli MF.  Improving survival with early defibrillation. Cardiol Rev. 2003;20:12–14.\n\n【70】74. Page RL, Joglar JA, Kowal RC, Zagrodzky JD, Nelson LL, Ramaswamy K, Barbera SJ, Hamdan MH, McKenas DK. Use of automated external defibrillators by a U.S. airline. N Engl J Med . 2000;343:1210–1216.\n\n【71】75. Jorgenson DB, Skarr T, Russell JK, Snyder DE, Uhrbrock K. AED use in businesses, public facilities and homes by minimally trained first responders. Resuscitation . 2003;59:225–233.\n\n【72】76. Hoke RS, Heinroth K, Trappe HJ, Werdan K. Is external defibrillation an electric threat for bystanders? Resuscitation . 2009;80:395–401.\n\n【73】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "27. Roppolo LP, Pepe PE, Campbell L, Ohman K, Kulkarni H, Miller R,", "bbox": [66.0, 85.0, 375.0, 97.0]}, {"text": "Idris A, Bean L, Bettes TN, Idris AH. Prospective, randomized trial of", "bbox": [83.0, 98.0, 376.0, 109.0]}, {"text": "the effectiveness and retention of 30-min layperson training for cardio-", "bbox": [83.0, 109.0, 375.0, 120.0]}, {"text": "pulmonary resuscitation and automated external defibrillators: the", "bbox": [84.0, 122.0, 375.0, 133.0]}, {"text": "American Airlines Study. Resuscitation . 2007;74:276–285.", "bbox": [84.0, 133.0, 326.0, 145.0]}, {"text": "28.", "bbox": [66.0, 145.0, 80.0, 156.0]}, {"text": "Batcheller AM, Brennan RT, Braslow A, Urrutia A, Kaye W. Cardiopul-", "bbox": [81.0, 147.0, 375.0, 157.0]}, {"text": "monary resuscitation performance of subjects over forty is better fol-", "bbox": [83.0, 158.0, 375.0, 169.0]}, {"text": "lowing half-hour video self-instruction compared to traditional", "bbox": [83.0, 170.0, 376.0, 181.0]}, {"text": "four-hour classroom training. Resuscitation . 2000;43:101–110.", "bbox": [84.0, 182.0, 341.0, 194.0]}, {"text": "29. Isbye DL, Rasmussen LS, Lippert FK, Rudolph SF, Ringsted CV.", "bbox": [66.0, 194.0, 375.0, 207.0]}, {"text": "Laypersons may learn basic life support in 24 min using a personal", "bbox": [83.0, 207.0, 376.0, 218.0]}, {"text": "resuscitation manikin. Resuscitation . 2006;69:435–442.", "bbox": [83.0, 220.0, 312.0, 231.0]}, {"text": "30.", "bbox": [66.0, 231.0, 80.0, 241.0]}, {"text": "Moule P, Albarran JW, Bessant E, Brownfield C, Pollock J.  A non-", "bbox": [81.0, 231.0, 375.0, 242.0]}, {"text": "randomized comparison of e-learning and classroom delivery of basic", "bbox": [83.0, 243.0, 375.0, 254.0]}, {"text": "life support with automated external defibrillator use: a pilot study. Int", "bbox": [84.0, 254.0, 375.0, 267.0]}, {"text": "J Nurs Pract. 2008;14:427–434.", "bbox": [83.0, 266.0, 218.0, 277.0]}, {"text": "Liberman M, Golberg N, Mulder D, Sampalis J. Teaching cardiopul-", "bbox": [80.0, 278.0, 375.0, 290.0]}, {"text": "31.", "bbox": [66.0, 279.0, 82.0, 289.0]}, {"text": "monary resuscitation to CEGEP students in Quebec: a pilot project.", "bbox": [84.0, 290.0, 375.0, 301.0]}, {"text": "Resuscitation. 2000;47:249–257.", "bbox": [84.0, 303.0, 219.0, 314.0]}, {"text": "32.", "bbox": [66.0, 315.0, 81.0, 326.0]}, {"text": "Jones I, Handley AJ, Whitfield R, Newcombe R, Chamberlain D.  A", "bbox": [81.0, 315.0, 377.0, 327.0]}, {"text": "preliminary feasibility study of a short DVD-based distance-learning", "bbox": [83.0, 327.0, 375.0, 340.0]}, {"text": "package for basic life support. Resuscitation . 2007;75:350–356.", "bbox": [83.0, 340.0, 348.0, 350.0]}, {"text": "33. Braslow A, Brennan RT, Newman MM, Bircher NG, Batcheller AM,", "bbox": [66.0, 351.0, 375.0, 364.0]}, {"text": "Kaye W.  CPR training without an instructor: development and eval-", "bbox": [83.0, 363.0, 375.0, 374.0]}, {"text": "uation of a video self-instructional system for effective performance of", "bbox": [83.0, 376.0, 376.0, 388.0]}, {"text": "cardiopulmonary resuscitation. Resuscitation. 1997;34:207–220.", "bbox": [83.0, 388.0, 347.0, 399.0]}, {"text": "34. Ahmad F, Senadhira DCA, Charters J, Acquilla S.  Transmission of", "bbox": [66.0, 400.0, 376.0, 412.0]}, {"text": "salmonella via mouth-to-mouth resuscitation. Lancet . 1990;335:", "bbox": [84.0, 412.0, 375.0, 423.0]}, {"text": "787–788.", "bbox": [84.0, 424.0, 125.0, 434.0]}, {"text": "35. Chalumeau M, Bidet P, Lina G, Mokhtari M, Andre MC, Gendrel D,", "bbox": [66.0, 435.0, 375.0, 448.0]}, {"text": "Bingen E, Raymond J. Transmission of Panton-Valentine leukocidin-", "bbox": [83.0, 449.0, 375.0, 458.0]}, {"text": "producing Staphylococcus aureus to a physician during resuscitation of", "bbox": [83.0, 460.0, 375.0, 472.0]}, {"text": "a child. Clin Infect Dis . 2005;41:e29–e30.", "bbox": [83.0, 473.0, 260.0, 484.0]}, {"text": "36. Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong", "bbox": [66.0, 484.0, 375.0, 496.0]}, {"text": "T, Wallington T, Gold WL, Mederski B, Green K, Low DE. Possible", "bbox": [84.0, 497.0, 376.0, 509.0]}, {"text": "SARS coronavirus transmission during cardiopulmonary resuscitation.", "bbox": [84.0, 508.0, 375.0, 521.0]}, {"text": "Emerg Infect Dis . 2004;10:287–293.", "bbox": [84.0, 521.0, 235.0, 531.0]}, {"text": "37. Feldman HA.  Some recollections of the meningococcal diseases: the", "bbox": [66.0, 533.0, 375.0, 544.0]}, {"text": "first Harry F. Dowling lecture. JAMA . 1972;220:1107–1112.", "bbox": [84.0, 544.0, 333.0, 555.0]}, {"text": "38.", "bbox": [66.0, 556.0, 82.0, 568.0]}, {"text": "Finkelhor RS, Lampman JH. Herpes simplex infection following car-", "bbox": [81.0, 557.0, 375.0, 568.0]}, {"text": "diopulmonary resuscitation. JAMA . 1980;243:650.", "bbox": [83.0, 568.0, 290.0, 580.0]}, {"text": "39. Heilman KM, Muschenheim C.  Primary cutaneous tuberculosis", "bbox": [66.0, 581.0, 376.0, 593.0]}, {"text": "resulting from mouth-to-mouth respiration. N Engl J Med . 1965;273:", "bbox": [84.0, 593.0, 375.0, 604.0]}, {"text": "1035–1036.", "bbox": [84.0, 603.0, 134.0, 616.0]}, {"text": "40. Hendricks AA, Shapiro EP. Primary herpes simplex infection following", "bbox": [66.0, 617.0, 376.0, 629.0]}, {"text": "mouth-to-mouth resuscitation. JAMA . 1980;243:257–258.", "bbox": [84.0, 630.0, 320.0, 642.0]}, {"text": "41. Todd MA, Bell JS.  Shigellosis from cardiopulmonary resuscitation.", "bbox": [66.0, 642.0, 375.0, 653.0]}, {"text": "JAMA . 1980;243:331.", "bbox": [84.0, 654.0, 175.0, 664.0]}, {"text": "42. Valenzuela TD, Hooton TM, Kaplan EL, Schlievert P. Transmission of", "bbox": [66.0, 665.0, 376.0, 677.0]}, {"text": "\"toxic strep\" syndrome from an infected child to a firefighter during", "bbox": [85.0, 677.0, 376.0, 689.0]}, {"text": "CPR. Ann Emerg Med. 1991;20:90–92.", "bbox": [83.0, 690.0, 248.0, 701.0]}, {"text": "43. Neiman R. Post manikin resuscitation stomatitis. J Ky Med Assoc .", "bbox": [66.0, 701.0, 375.0, 713.0]}, {"text": "1982;80:813–814.", "bbox": [84.0, 714.0, 159.0, 725.0]}, {"text": "44. Nicklin G. Manikin tracheitis. JAMA . 1980;244:2046–2047.", "bbox": [66.0, 724.0, 332.0, 736.0]}, {"text": "45. Lam KK, Lau FL, Chan WK, Wong WN. Effect of severe acute respi-", "bbox": [66.0, 738.0, 375.0, 749.0]}, {"text": "ratory syndrome on bystander willingness to perform cardiopulmonary", "bbox": [83.0, 749.0, 375.0, 761.0]}, {"text": "resuscitation (CPR): is compression-only preferred to standard CPR?", "bbox": [83.0, 762.0, 375.0, 774.0]}, {"text": "Prehosp Disaster Med . 2007;22:325–329.", "bbox": [83.0, 774.0, 256.0, 785.0]}, {"text": "Locke CJ, Berg RA, Sanders AB, Davis MF, Milander MM, Kern KB,", "bbox": [81.0, 786.0, 375.0, 798.0]}, {"text": "46.", "bbox": [66.0, 787.0, 79.0, 797.0]}, {"text": "Ewy GA.  Bystander cardiopulmonary resuscitation: concerns about", "bbox": [83.0, 798.0, 375.0, 809.0]}, {"text": "mouth-to-mouth contact. Arch Intern Med. 1995;155:938–943.", "bbox": [84.0, 811.0, 342.0, 823.0]}, {"text": "47. Hamasu S, Morimoto T, Kuramoto N, Horiguchi M, Iwami T,", "bbox": [66.0, 823.0, 375.0, 834.0]}, {"text": "Nishiyama C, Takada K, Kubota Y, Seki S, Maeda Y, Sakai Y, Hiraide", "bbox": [84.0, 835.0, 376.0, 847.0]}, {"text": "A. Effects of BLS training on factors associated with attitude toward", "bbox": [84.0, 847.0, 376.0, 858.0]}, {"text": "CPR in college students. Resuscitation. 2009;80:359–364.", "bbox": [82.0, 859.0, 324.0, 870.0]}, {"text": "Bobrow BJ, Zuercher M, Ewy GA, Clark L, Chikani V, Donahue D,", "bbox": [81.0, 870.0, 375.0, 883.0]}, {"text": "Sanders AB, Hilwig RW, Berg RA, Kern KB. Gasping during cardiac", "bbox": [83.0, 883.0, 375.0, 896.0]}, {"text": "arrest in humans is frequent and associated with improved survival.", "bbox": [84.0, 895.0, 375.0, 907.0]}, {"text": "Circulation . 2008;118:2550–2554.", "bbox": [83.0, 906.0, 227.0, 917.0]}, {"text": "49. Perkins GD, Walker G, Christensen K, Hulme J, Monsieurs KG.", "bbox": [66.0, 918.0, 375.0, 930.0]}, {"text": "Teaching recognition of agonal breathing improves accuracy of diag-", "bbox": [84.0, 931.0, 375.0, 943.0]}, {"text": "nosing cardiac arrest. Resuscitation . 2006;70:432–437.", "bbox": [83.0, 943.0, 310.0, 956.0]}, {"text": "50. Culley LL, Clark JJ, Eisenberg MS, Larsen MP.  Dispatcher-assisted", "bbox": [66.0, 956.0, 376.0, 967.0]}, {"text": "telephone CPR: common delays and time standards for delivery. Ann", "bbox": [83.0, 968.0, 375.0, 979.0]}, {"text": "Emerg Med . 1991;20:362–366.", "bbox": [84.0, 979.0, 212.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "51. Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low", "bbox": [409.0, 85.0, 720.0, 96.0]}, {"text": "bystander CPR rates: a systematic review of the literature. CJEM .", "bbox": [428.0, 98.0, 719.0, 109.0]}, {"text": "2008;10:51–65.", "bbox": [428.0, 109.0, 493.0, 120.0]}, {"text": "52. Van Hoeyweghen RJ, Verbruggen G, Rademakers F, Bossaert LL. The", "bbox": [409.0, 121.0, 720.0, 133.0]}, {"text": "physiologic response of CPR training. Ann Emerg Med . 1991;20:", "bbox": [428.0, 133.0, 719.0, 145.0]}, {"text": "279–282.", "bbox": [428.0, 147.0, 468.0, 155.0]}, {"text": "53. Lonergan JH, Youngberg JZ, Kaplan JA.  Cardiopulmonary resusci-", "bbox": [410.0, 157.0, 718.0, 169.0]}, {"text": "tation: physical stress on the rescuer. Crit Care Med . 1981;9:793–795.", "bbox": [427.0, 170.0, 719.0, 181.0]}, {"text": "54. Tsou JY, Chi CH, Hsu RM, Wu HF, Su FC. Mechanical loading of the", "bbox": [409.0, 182.0, 720.0, 194.0]}, {"text": "low back during cardiopulmonary resuscitation. Resuscitation . 2009;80:", "bbox": [427.0, 195.0, 720.0, 207.0]}, {"text": "1181–1186.", "bbox": [427.0, 207.0, 477.0, 218.0]}, {"text": "55. Peberdy MA, Ottingham LV, Groh WJ, Hedges J, Terndrup TE, Pirrallo", "bbox": [409.0, 218.0, 721.0, 231.0]}, {"text": "RG, Mann NC, Sehra R. Adverse events associated with lay emergency", "bbox": [427.0, 230.0, 719.0, 242.0]}, {"text": "response programs: the Public Access Defibrillation Trial experience.", "bbox": [427.0, 243.0, 719.0, 254.0]}, {"text": "Resuscitation. 2006;70:59–65.", "bbox": [427.0, 255.0, 554.0, 266.0]}, {"text": "56. Hallstrom AP, Ornato JP, Weisfeldt M, Travers A, Christenson J,", "bbox": [409.0, 266.0, 720.0, 278.0]}, {"text": "McBurnie MA, Zalenski R, Becker LB, Schron EB, Proschan M. Public-", "bbox": [427.0, 279.0, 719.0, 290.0]}, {"text": "access defibrillation and survival after out-of-hospital cardiac arrest.", "bbox": [427.0, 290.0, 719.0, 301.0]}, {"text": "N Engl J Med . 2004;351:637–646.", "bbox": [427.0, 303.0, 573.0, 314.0]}, {"text": "57. Cheung W, Gullick J, Thanakrishnan G, Jacobs R, Au W, Uy J, Fick M,", "bbox": [409.0, 315.0, 720.0, 327.0]}, {"text": "Narayan P, Ralston S, Tan J. Injuries occurring in hospital staff", "bbox": [427.0, 327.0, 720.0, 340.0]}, {"text": "attending medical emergency team (MET) calls: a prospective, obser-", "bbox": [427.0, 338.0, 718.0, 352.0]}, {"text": "vational study. Resuscitation . 2009;80:1351–1356.", "bbox": [428.0, 352.0, 635.0, 363.0]}, {"text": "58. Jones AY. Can cardiopulmonary resuscitation injure the back?", "bbox": [410.0, 363.0, 720.0, 375.0]}, {"text": "Resuscitation . 2004;61:63–67.", "bbox": [427.0, 376.0, 558.0, 388.0]}, {"text": "59. Jones AY, Lee RY. Cardiopulmonary resuscitation and back injury in", "bbox": [410.0, 388.0, 721.0, 399.0]}, {"text": "ambulance officers. Int Arch Occup Environ Health . 2005;78:332–336 .", "bbox": [428.0, 401.0, 719.0, 411.0]}, {"text": "Thierbach AR, Piepho T, Kunde M, Wolcke BB, Golecki N, Kleine-", "bbox": [427.0, 411.0, 718.0, 423.0]}, {"text": "Weischede B, Werner C. Two-rescuer CPR results in hyperventilation in", "bbox": [427.0, 423.0, 720.0, 435.0]}, {"text": "the ventilating rescuer. Resuscitation . 2005;65:185–190.", "bbox": [428.0, 435.0, 658.0, 448.0]}, {"text": "61. Thierbach AR, Wolcke BB, Krummenauer F, Kunde M, Janig C, Dick", "bbox": [409.0, 448.0, 720.0, 461.0]}, {"text": "WF. Artificial ventilation for basic life support leads to hyperventilation", "bbox": [428.0, 461.0, 720.0, 472.0]}, {"text": "in first aid providers. Resuscitation. 2003;57:269–277.", "bbox": [427.0, 473.0, 653.0, 485.0]}, {"text": "62. Walker GM, Liddle R. Prolonged two-man basic life support may result", "bbox": [409.0, 484.0, 720.0, 496.0]}, {"text": "in hypocarbia in the ventilating rescuer. Resuscitation . 2001;50:", "bbox": [427.0, 497.0, 719.0, 508.0]}, {"text": "179–183.", "bbox": [428.0, 508.0, 468.0, 520.0]}, {"text": "63. Greenberg M. CPR: a report of observed medical complications during", "bbox": [409.0, 520.0, 720.0, 532.0]}, {"text": "training. Ann Emerg Med . 1983;12:194–195.", "bbox": [427.0, 533.0, 612.0, 544.0]}, {"text": "64. Macauley CA, Todd CT.  Physical disability among cardiopulmonary", "bbox": [409.0, 544.0, 720.0, 555.0]}, {"text": "resuscitation students. Occup Health Nurs. 1978;26:17–19.", "bbox": [428.0, 557.0, 671.0, 568.0]}, {"text": "65. Steinhoff JP, Pattavina C, Renzi R. Puncture wound during CPR from", "bbox": [409.0, 568.0, 721.0, 580.0]}, {"text": "sternotomy wires: case report and discussion of periresuscitation", "bbox": [427.0, 582.0, 720.0, 593.0]}, {"text": "infection risks. Heart Lung . 2001;30:159–160.", "bbox": [427.0, 593.0, 621.0, 604.0]}, {"text": "66.", "bbox": [409.0, 605.0, 425.0, 614.0]}, {"text": "Shimokawa A, Tateyama S, Shimizu Y, Muramatsu I, Takasaki M.", "bbox": [424.0, 606.0, 720.0, 616.0]}, {"text": "Anterior interosseous nerve palsy after cardiopulmonary resuscitation in", "bbox": [428.0, 617.0, 720.0, 629.0]}, {"text": "a resuscitator with undiagnosed muscle anomaly. Anesth Analg. 2001;", "bbox": [427.0, 630.0, 720.0, 642.0]}, {"text": "93:290–291.", "bbox": [427.0, 642.0, 480.0, 653.0]}, {"text": "67. Sullivan F, Avstreih D. Pneumothorax during CPR training: case report", "bbox": [409.0, 653.0, 720.0, 666.0]}, {"text": "and review of the CPR literature. Prehosp Disaster Med . 2000;15:", "bbox": [427.0, 665.0, 720.0, 677.0]}, {"text": "64–69.", "bbox": [427.0, 679.0, 459.0, 687.0]}, {"text": "Memon AM, Salzer JE, Hillman EC Jr, Marshall CL. Fatal myocardial", "bbox": [425.0, 688.0, 720.0, 702.0]}, {"text": "68.", "bbox": [409.0, 689.0, 425.0, 701.0]}, {"text": "infarct following CPR training: the question of risk. Ann Emerg Med .", "bbox": [427.0, 702.0, 719.0, 714.0]}, {"text": "1982;11:322–323.", "bbox": [428.0, 714.0, 501.0, 725.0]}, {"text": "69. Axelsson A, Herlitz J, Ekstrom L, Holmberg S.  Bystander-initiated", "bbox": [409.0, 725.0, 721.0, 737.0]}, {"text": "cardiopulmonary resuscitation out-of-hospital: a first description of the", "bbox": [428.0, 738.0, 720.0, 749.0]}, {"text": "bystanders and their experiences. Resuscitation . 1996;33:3–11.", "bbox": [427.0, 749.0, 687.0, 761.0]}, {"text": "70. Gamble M. A debriefing approach to dealing with the stress of CPR", "bbox": [410.0, 762.0, 720.0, 774.0]}, {"text": "attempts. Prof Nurse . 2001;17:157–160.", "bbox": [427.0, 774.0, 594.0, 785.0]}, {"text": "71.", "bbox": [410.0, 787.0, 425.0, 797.0]}, {"text": "Lyster T, Jorgenson D, Morgan C. The safe use of automated external", "bbox": [425.0, 787.0, 720.0, 798.0]}, {"text": "defibrillators in a wet environment. Prehosp Emerg Care . 2003;7:", "bbox": [427.0, 798.0, 719.0, 809.0]}, {"text": "307–311.", "bbox": [428.0, 811.0, 467.0, 822.0]}, {"text": "72. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation:", "bbox": [410.0, 822.0, 719.0, 834.0]}, {"text": "an analysis of electrical current flow through rescuers in direct contact", "bbox": [427.0, 835.0, 720.0, 846.0]}, {"text": "with patients during biphasic external defibrillation. Circulation . 2008;", "bbox": [428.0, 846.0, 720.0, 858.0]}, {"text": "117:2510–2514.", "bbox": [427.0, 859.0, 497.0, 870.0]}, {"text": "73. Capucci A, Aschieri D, Piepoli MF.  Improving survival with early", "bbox": [410.0, 870.0, 719.0, 883.0]}, {"text": "defibrillation. Cardiol Rev. 2003;20:12–14.", "bbox": [427.0, 883.0, 607.0, 893.0]}, {"text": "74. Page RL, Joglar JA, Kowal RC, Zagrodzky JD, Nelson LL, Ramaswamy", "bbox": [410.0, 895.0, 719.0, 907.0]}, {"text": "K, Barbera SJ, Hamdan MH, McKenas DK. Use of automated external", "bbox": [427.0, 906.0, 720.0, 917.0]}, {"text": "defibrillators by a U.S. airline. N Engl J Med . 2000;343:1210–1216.", "bbox": [427.0, 919.0, 712.0, 930.0]}, {"text": "75. Jorgenson DB, Skarr T, Russell JK, Snyder DE, Uhrbrock K. AED use", "bbox": [410.0, 930.0, 720.0, 943.0]}, {"text": "in businesses, public facilities and homes by minimally trained first", "bbox": [427.0, 943.0, 720.0, 956.0]}, {"text": "responders. Resuscitation . 2003;59:225–233.", "bbox": [427.0, 957.0, 611.0, 966.0]}, {"text": "76. Hoke RS, Heinroth K, Trappe HJ, Werdan K. Is external defibrillation", "bbox": [410.0, 968.0, 720.0, 979.0]}, {"text": "an electric threat for bystanders? Resuscitation . 2009;80:395–401.", "bbox": [427.0, 980.0, 702.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 311}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#73#参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:41:43"}
{"id": 1042025, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "934e1378-8f84-4552-bff3-7bdd3dc8acff", "title": null, "text": "【0】页码:282\n 138. Thiagarajan RR, Laussen PC, Rycus PT, Bartlett RH, Bratton SL.\n\n【1】Extracorporeal membrane oxygenation to aid cardiopulmonary resuscitation in infants and children. Circulation . 2007;116:1693–1700.\n\n【2】139. Lequier L, Joffe AR, Robertson CM, Dinu IA, Wongswadiwat Y, Anton NR, Ross DB, Rebeyka IM.  Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age. J Thorac Cardiovasc Surg . 2008;136:976–983 e973.\n\n【3】140. Mahle WT, Forbess JM, Kirshbom PM, Cuadrado AR, Simsic JM, Kanter KR.  Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children. J Thorac Cardiovasc Surg . 2005; 129:1084–1090.\n\n【4】141. Aharon AS, Drinkwater DC, Jr., Churchwell KB, Quisling SV, Reddy VS, Taylor M, Hix S, Christian KG, Pietsch JB, Deshpande JK, Kambam J, Graham TP, Chang PA. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann Thorac Surg . 72:2095–2101, 2001; discussion 2101–2092.\n\n【5】142.\n\n【6】Barrett CS, Bratton SL, Salvin JW, Laussen PC, Rycus PT, Thiagarajan RR. Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation. Pediatr Crit Care Med .\n\n【7】2009;10:445–451.\n\n【8】143. Baslaim G, Bashore J, Al-Malki F, Jamjoom A.  Can the outcome of pediatric extracorporeal membrane oxygenation after cardiac surgery be predicted? Ann Thorac Cardiovasc Surg . 2006;12:21–27.\n\n【9】144. Ghez O, Feier H, Ughetto F, Fraisse A, Kreitmann B, Metras D.\n\n【10】Postoperative extracorporeal life support in pediatric cardiac surgery: recent results. ASAIO J. 2005;51:513–516.\n\n【11】145. Cochran JB, Tecklenburg FW, Lau YR, Habib DM. Emergency cardiopulmonary bypass for cardiac arrest refractory to pediatric advanced life support. Pediatr Emerg Care . 1999;15:30–32.\n\n【12】146.\n\n【13】Dalton HJ, Siewers RD, Fuhrman BP, Del Nido P, Thompson AE, Shaver MG, Dowhy M.  Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction. Crit Care Med . 1993;21:1020–1028.\n\n【14】147.\n\n【15】del Nido PJ. Extracorporeal membrane oxygenation for cardiac support in children. Ann Thorac Surg . 61:336–339, 1996; discussion 340–341.\n\n【16】148. Ghez O, Fouilloux V, Charpentier A, Fesquet P, Lion F, Lebrun L, Commandeur M, Fraisse A, Metras D, Kreitmann B. Absence of rapid deployment extracorporeal membrane oxygenation (ECMO) team does not preclude resuscitation ecmo in pediatric cardiac patients with good results. ASAIO J . 2007;53:692–695.\n\n【17】149. Jaggers JJ, Forbess JM, Shah AS, Meliones JN, Kirshbom PM, Miller CE, Ungerleider RM. Extracorporeal membrane oxygenation for infant postcardiotomy support: significance of shunt management. Ann Thorac Surg . 2000;69:1476–1483.\n\n【18】150. Kelly RB, Porter PA, Meier AH, Myers JL, Thomas NJ. Duration of cardiopulmonary resuscitation before extracorporeal rescue: how long is not long enough? ASAIO J . 2005;51:665–667.\n\n【19】151. Parra DA, Totapally BR, Zahn E, Jacobs J, Aldousany A, Burke RP, Chang AC.  Outcome of cardiopulmonary resuscitation in a pediatric cardiac intensive care unit. Crit Care Med . 2000;28:3296–3300.\n\n【20】152. Ravishankar C, Dominguez TE, Kreutzer J, Wernovsky G, Marino BS, Godinez R, Priestley MA, Gruber PJ, Gaynor WJ, Nicolson SC, Spray TL, Tabbutt S.  Extracorporeal membrane oxygenation after stage I reconstruction for hypoplastic left heart syndrome. Pediatr Crit Care Med . 2006;7:319–323.\n\n【21】153. Shah SA, Shankar V, Churchwell KB, Taylor MB, Scott BP, Bartilson R, Byrne DW, Christian KG, Drinkwater DC. Clinical outcomes of 84 children with congenital heart disease managed with extracorporeal membrane oxygenation after cardiac surgery. ASAIO J . 2005;51: 504–507.\n\n【22】154. Thourani VH, Kirshbom PM, Kanter KR, Simsic J, Kogon BE, Wagoner S, Dykes F, Fortenberry J, Forbess JM.  Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg . 82:138–144, 2006; discussion 144–135.\n\n【23】155. Blaivas M, Fox JC. Outcome in cardiac arrest patients found to have cardiac standstill on the bedside emergency department echocardiogram.\n\n【24】Acad Emerg Med . 2001;8:616–621.\n\n【25】156. Menaker J, Cushman J, Vermillion JM, Rosenthal RE, Scalea TM.\n\n【26】Ultrasound-diagnosed cardiac tamponade after blunt abdominal traumatreated with emergent thoracotomy. J Emerg Med . 2007;32:99–103.\n\n【27】157.\n\n【28】Niendorff DF, Rassias AJ, Palac R, Beach ML, Costa S, Greenberg M.\n\n【29】Rapid cardiac ultrasound of inpatients suffering PEA arrest performed by nonexpert sonographers. Resuscitation . 2005;67:81–87.\n\n【30】 158. Querellou E, Meyran D, Petitjean F, Le Dreff P, Maurin O. Ventricular fibrillation diagnosed with trans-thoracic echocardiography. Resuscitation .\n\n【31】2009;80:1211–1213.\n\n【32】159. Salen P, Melniker L, Chooljian C, Rose JS, Alteveer J, Reed J, Heller M.\n\n【33】Does the presence or absence of sonographically identified cardiac activity predict resuscitation outcomes of cardiac arrest patients? Am J Emerg Med . 2005;23:459–462.\n\n【34】160. Salen P, O'Connor R, Sierzenski P, Passarello B, Pancu D, Melanson S, Arcona S, Reed J, Heller M. Can cardiac sonography and capnography be used independently and in combination to predict resuscitation outcomes? Acad Emerg Med . 2001;8:610–615.\n\n【35】161. Tayal VS, Kline JA. Emergency echocardiography to detect pericardial effusion in patients in PEA and near-PEA states. Resuscitation . 2003; 59:315–318.\n\n【36】162. Varriale P, Maldonado JM.  Echocardiographic observations during inhospital cardiopulmonary resuscitation. Crit Care Med . 1997;25: 1717–1720.\n\n【37】163. Li Y, Ristagno G, Bisera J, Tang W, Deng Q, Weil MH. Electrocardiogram waveforms for monitoring effectiveness of chest compression during cardiopulmonary resuscitation. Crit Care Med . 2008;36: 211–215.\n\n【38】164. Ristagno G, Tang W, Chang YT, Jorgenson DB, Russell JK, Huang L, Wang T, Sun S, Weil MH. The quality of chest compressions during cardiopulmonary resuscitation overrides importance of timing of defibrillation. Chest . 2007;132:70–75.\n\n【39】165. Berg RA, Sanders AB, Milander M, Tellez D, Liu P, Beyda D. Efficacy of audio-prompted rate guidance in improving resuscitator performance of cardiopulmonary resuscitation on children. Acad Emerg Med . 1994; 1:35–40.\n\n【40】166. Ornato JP, Gonzalez ER, Garnett AR, Levine RL, McClung BK. Effect of cardiopulmonary resuscitation compression rate on end-tidal carbon dioxide concentration and arterial pressure in man. Crit Care Med .\n\n【41】1988;16:241–245.\n\n【42】167. Guly UM, Robertson CE. Active decompression improves the haemodynamic state during cardiopulmonary resuscitation. Br Heart J . 1995; 73:372–376.\n\n【43】168. Rubertsson S, Karlsten R. Increased cortical cerebral blood flow with LUCAS; a new device for mechanical chest compressions compared to standard external compressions during experimental cardiopulmonary resuscitation. Resuscitation . 2005;65:357–363.\n\n【44】169. Wik L, Naess PA, Ilebekk A, Nicolaysen G, Steen PA. Effects of various degrees of compression and active decompression on haemodynamics, end-tidal CO2, and ventilation during cardiopulmonary resuscitation of pigs. Resuscitation. 1996;31:45–57.\n\n【45】170. Grmec S, Krizmaric M, Mally S, Kozelj A, Spindler M, Lesnik B.\n\n【46】Utstein style analysis of out-of-hospital cardiac arrest–bystander CPR and end expired carbon dioxide. Resuscitation . 2007;72:404–414.\n\n【47】171. Pokorna M, Necas E, Kratochvil J, Skripsky R, Andrlik M, Franek O. A Sudden Increase in Partial Pressure End-tidal Carbon Dioxide (P(ET)CO2) at the Moment of Return of Spontaneous Circulation.\n\n【48】J Emerg Med. 2009.\n\n【49】172. Rosetti VA, Thompson BM, Miller J, Mateer JR, Aprahamian C.\n\n【50】Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med . 1985;14:885–888.\n\n【51】173. Brunette DD, Fischer R. Intravascular access in pediatric cardiac arrest.\n\n【52】Am J Emerg Med . 1988;6:577–579.\n\n【53】174. Seigler RS, Tecklenburg FW, Shealy R.  Prehospital intraosseous infusion by emergency medical services personnel: a prospective study.\n\n【54】Pediatrics . 1989;84:173–177.\n\n【55】175. Glaeser PW, Hellmich TR, Szewczuga D, Losek JD, Smith DS.\n\n【56】Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med . 1993;22:1119–1124.\n\n【57】176. Ellemunter H, Simma B, Trawoger R, Maurer H. Intraosseous lines in preterm and full term neonates. Arch Dis Child Fetal Neonatal Ed .\n\n【58】1999;80:F74–F75.\n\n【59】177.\n\n【60】Claudet I, Baunin C, Laporte-Turpin E, Marcoux MO, Grouteau E, Cahuzac JP.  Long-term effects on tibial growth after intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care .\n\n【61】2003;19:397–401.\n\n【62】178. Fiorito BA, Mirza F, Doran TM, Oberle AN, Cruz EC, Wendtland CL, Abd-Allah SA.  Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med . 2005;6:50–53.\n\n【63】179. Horton MA, Beamer C.  Powered intraosseous insertion provides safe and effective vascular access for pediatric emergency patients. Pediatr Emerg Care . 2008;24:347–350.\n\n【64】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "138. Thiagarajan RR, Laussen PC, Rycus PT, Bartlett RH, Bratton SL.", "bbox": [61.0, 85.0, 375.0, 98.0]}, {"text": "Extracorporeal membrane oxygenation to aid cardiopulmonary resusci-", "bbox": [84.0, 98.0, 375.0, 110.0]}, {"text": "tation in infants and children. Circulation . 2007;116:1693–1700.", "bbox": [83.0, 110.0, 351.0, 122.0]}, {"text": "139. Lequier L, Joffe AR, Robertson CM, Dinu IA, Wongswadiwat Y, Anton", "bbox": [61.0, 122.0, 376.0, 134.0]}, {"text": "NR, Ross DB, Rebeyka IM.  Two-year survival, mental, and motor", "bbox": [83.0, 135.0, 375.0, 147.0]}, {"text": "outcomes after cardiac extracorporeal life support at less than five years", "bbox": [83.0, 147.0, 376.0, 159.0]}, {"text": "of age. J Thorac Cardiovasc Surg . 2008;136:976–983 e973.", "bbox": [83.0, 160.0, 334.0, 172.0]}, {"text": "140. Mahle WT, Forbess JM, Kirshbom PM, Cuadrado AR, Simsic JM,", "bbox": [61.0, 172.0, 375.0, 183.0]}, {"text": "Kanter KR.  Cost-utility analysis of salvage cardiac extracorporeal", "bbox": [83.0, 185.0, 376.0, 197.0]}, {"text": "membrane oxygenation in children. J Thorac Cardiovasc Surg . 2005;", "bbox": [84.0, 197.0, 375.0, 209.0]}, {"text": "129:1084–1090.", "bbox": [84.0, 209.0, 151.0, 220.0]}, {"text": "141. Aharon AS, Drinkwater DC, Jr., Churchwell KB, Quisling SV, Reddy", "bbox": [61.0, 220.0, 375.0, 234.0]}, {"text": "VS, Taylor M, Hix S, Christian KG, Pietsch JB, Deshpande JK,", "bbox": [84.0, 234.0, 375.0, 246.0]}, {"text": "Kambam J, Graham TP, Chang PA. Extracorporeal membrane oxygen-", "bbox": [84.0, 247.0, 375.0, 259.0]}, {"text": "ation in children after repair of congenital cardiac lesions. Ann Thorac", "bbox": [84.0, 259.0, 375.0, 271.0]}, {"text": "Surg . 72:2095–2101, 2001; discussion 2101–2092.", "bbox": [84.0, 272.0, 291.0, 283.0]}, {"text": "142.", "bbox": [61.0, 284.0, 81.0, 295.0]}, {"text": "Barrett CS, Bratton SL, Salvin JW, Laussen PC, Rycus PT, Thiagarajan", "bbox": [81.0, 284.0, 376.0, 296.0]}, {"text": "RR. Neurological injury after extracorporeal membrane oxygenation use", "bbox": [83.0, 296.0, 375.0, 308.0]}, {"text": "to aid pediatric cardiopulmonary resuscitation. Pediatr Crit Care Med .", "bbox": [83.0, 309.0, 375.0, 321.0]}, {"text": "2009;10:445–451.", "bbox": [85.0, 321.0, 159.0, 333.0]}, {"text": "143. Baslaim G, Bashore J, Al-Malki F, Jamjoom A.  Can the outcome of", "bbox": [61.0, 333.0, 376.0, 346.0]}, {"text": "pediatric extracorporeal membrane oxygenation after cardiac surgery be", "bbox": [84.0, 346.0, 375.0, 358.0]}, {"text": "predicted? Ann Thorac Cardiovasc Surg . 2006;12:21–27.", "bbox": [84.0, 359.0, 319.0, 371.0]}, {"text": "144. Ghez O, Feier H, Ughetto F, Fraisse A, Kreitmann B, Metras D.", "bbox": [61.0, 371.0, 375.0, 384.0]}, {"text": "Postoperative extracorporeal life support in pediatric cardiac surgery:", "bbox": [83.0, 383.0, 375.0, 395.0]}, {"text": "recent results. ASAIO J. 2005;51:513–516.", "bbox": [83.0, 397.0, 261.0, 407.0]}, {"text": "145. Cochran JB, Tecklenburg FW, Lau YR, Habib DM. Emergency cardio-", "bbox": [61.0, 408.0, 375.0, 420.0]}, {"text": "pulmonary bypass for cardiac arrest refractory to pediatric advanced life", "bbox": [84.0, 421.0, 375.0, 433.0]}, {"text": "support. Pediatr Emerg Care . 1999;15:30–32.", "bbox": [84.0, 433.0, 273.0, 444.0]}, {"text": "146.", "bbox": [61.0, 445.0, 82.0, 456.0]}, {"text": "Dalton HJ, Siewers RD, Fuhrman BP, Del Nido P, Thompson AE,", "bbox": [80.0, 446.0, 375.0, 457.0]}, {"text": "Shaver MG, Dowhy M.  Extracorporeal membrane oxygenation for", "bbox": [84.0, 458.0, 376.0, 470.0]}, {"text": "cardiac rescue in children with severe myocardial dysfunction. Crit Care", "bbox": [83.0, 470.0, 375.0, 482.0]}, {"text": "Med . 1993;21:1020–1028.", "bbox": [84.0, 483.0, 194.0, 494.0]}, {"text": "147.", "bbox": [61.0, 495.0, 81.0, 506.0]}, {"text": "del Nido PJ. Extracorporeal membrane oxygenation for cardiac support", "bbox": [81.0, 495.0, 376.0, 507.0]}, {"text": "in children. Ann Thorac Surg . 61:336–339, 1996; discussion 340–341.", "bbox": [84.0, 508.0, 375.0, 520.0]}, {"text": "148. Ghez O, Fouilloux V, Charpentier A, Fesquet P, Lion F, Lebrun L,", "bbox": [61.0, 520.0, 375.0, 532.0]}, {"text": "Commandeur M, Fraisse A, Metras D, Kreitmann B. Absence of rapid", "bbox": [83.0, 533.0, 376.0, 544.0]}, {"text": "deployment extracorporeal membrane oxygenation (ECMO) team does", "bbox": [83.0, 544.0, 376.0, 556.0]}, {"text": "not preclude resuscitation ecmo in pediatric cardiac patients with good", "bbox": [83.0, 557.0, 375.0, 569.0]}, {"text": "results. ASAIO J . 2007;53:692–695.", "bbox": [83.0, 569.0, 232.0, 582.0]}, {"text": "149. Jaggers JJ, Forbess JM, Shah AS, Meliones JN, Kirshbom PM, Miller", "bbox": [61.0, 582.0, 376.0, 594.0]}, {"text": "CE, Ungerleider RM. Extracorporeal membrane oxygenation for infant", "bbox": [82.0, 595.0, 376.0, 607.0]}, {"text": "postcardiotomy support: significance of shunt management. Ann Thorac", "bbox": [84.0, 607.0, 375.0, 619.0]}, {"text": "Surg . 2000;69:1476–1483.", "bbox": [84.0, 620.0, 194.0, 631.0]}, {"text": "150. Kelly RB, Porter PA, Meier AH, Myers JL, Thomas NJ. Duration of", "bbox": [61.0, 631.0, 376.0, 643.0]}, {"text": "cardiopulmonary resuscitation before extracorporeal rescue: how long is", "bbox": [83.0, 644.0, 376.0, 656.0]}, {"text": "not long enough? ASAIO J . 2005;51:665–667.", "bbox": [83.0, 656.0, 274.0, 668.0]}, {"text": "151. Parra DA, Totapally BR, Zahn E, Jacobs J, Aldousany A, Burke RP,", "bbox": [61.0, 669.0, 375.0, 681.0]}, {"text": "Chang AC.  Outcome of cardiopulmonary resuscitation in a pediatric", "bbox": [83.0, 682.0, 375.0, 694.0]}, {"text": "cardiac intensive care unit. Crit Care Med . 2000;28:3296–3300.", "bbox": [83.0, 694.0, 349.0, 705.0]}, {"text": "152. Ravishankar C, Dominguez TE, Kreutzer J, Wernovsky G, Marino BS,", "bbox": [61.0, 707.0, 375.0, 718.0]}, {"text": "Godinez R, Priestley MA, Gruber PJ, Gaynor WJ, Nicolson SC, Spray", "bbox": [83.0, 718.0, 375.0, 729.0]}, {"text": "TL, Tabbutt S.  Extracorporeal membrane oxygenation after stage I", "bbox": [84.0, 731.0, 375.0, 743.0]}, {"text": "reconstruction for hypoplastic left heart syndrome. Pediatr Crit Care", "bbox": [84.0, 744.0, 375.0, 756.0]}, {"text": "Med . 2006;7:319–323.", "bbox": [84.0, 756.0, 176.0, 767.0]}, {"text": "153. Shah SA, Shankar V, Churchwell KB, Taylor MB, Scott BP, Bartilson", "bbox": [61.0, 767.0, 376.0, 782.0]}, {"text": "R, Byrne DW, Christian KG, Drinkwater DC. Clinical outcomes of 84", "bbox": [83.0, 781.0, 376.0, 792.0]}, {"text": "children with congenital heart disease managed with extracorporeal", "bbox": [83.0, 794.0, 376.0, 805.0]}, {"text": "membrane oxygenation after cardiac surgery. ASAIO J . 2005;51:", "bbox": [84.0, 805.0, 375.0, 817.0]}, {"text": "504–507.", "bbox": [84.0, 818.0, 124.0, 829.0]}, {"text": "154. Thourani VH, Kirshbom PM, Kanter KR, Simsic J, Kogon BE, Wagoner", "bbox": [61.0, 830.0, 376.0, 843.0]}, {"text": "S, Dykes F, Fortenberry J, Forbess JM.  Venoarterial extracorporeal", "bbox": [83.0, 843.0, 375.0, 855.0]}, {"text": "membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann", "bbox": [84.0, 856.0, 375.0, 868.0]}, {"text": "Thorac Surg . 82:138–144, 2006; discussion 144–135.", "bbox": [84.0, 867.0, 307.0, 879.0]}, {"text": "155. Blaivas M, Fox JC. Outcome in cardiac arrest patients found to have", "bbox": [61.0, 881.0, 375.0, 892.0]}, {"text": "cardiac standstill on the bedside emergency department echocardiogram.", "bbox": [83.0, 892.0, 375.0, 904.0]}, {"text": "Acad Emerg Med . 2001;8:616–621.", "bbox": [84.0, 905.0, 232.0, 916.0]}, {"text": "156. Menaker J, Cushman J, Vermillion JM, Rosenthal RE, Scalea TM.", "bbox": [61.0, 916.0, 375.0, 929.0]}, {"text": "Ultrasound-diagnosed cardiac tamponade after blunt abdominal trauma-", "bbox": [83.0, 930.0, 373.0, 942.0]}, {"text": "treated with emergent thoracotomy. J Emerg Med . 2007;32:99–103.", "bbox": [83.0, 943.0, 365.0, 955.0]}, {"text": "157.", "bbox": [61.0, 955.0, 79.0, 965.0]}, {"text": "Niendorff DF, Rassias AJ, Palac R, Beach ML, Costa S, Greenberg M.", "bbox": [82.0, 955.0, 375.0, 966.0]}, {"text": "Rapid cardiac ultrasound of inpatients suffering PEA arrest performed", "bbox": [83.0, 968.0, 376.0, 978.0]}, {"text": "by nonexpert sonographers. Resuscitation . 2005;67:81–87.", "bbox": [83.0, 979.0, 325.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "158. Querellou E, Meyran D, Petitjean F, Le Dreff P, Maurin O. Ventricular", "bbox": [406.0, 85.0, 720.0, 97.0]}, {"text": "fibrillation diagnosed with trans-thoracic echocardiography. Resuscitation .", "bbox": [428.0, 98.0, 718.0, 109.0]}, {"text": "2009;80:1211–1213.", "bbox": [428.0, 109.0, 509.0, 120.0]}, {"text": "159. Salen P, Melniker L, Chooljian C, Rose JS, Alteveer J, Reed J, Heller M.", "bbox": [405.0, 121.0, 719.0, 133.0]}, {"text": "Does the presence or absence of sonographically identified cardiac", "bbox": [427.0, 133.0, 719.0, 145.0]}, {"text": "activity predict resuscitation outcomes of cardiac arrest patients? Am J", "bbox": [428.0, 147.0, 720.0, 158.0]}, {"text": "Emerg Med . 2005;23:459–462.", "bbox": [427.0, 158.0, 558.0, 169.0]}, {"text": "160. Salen P, O'Connor R, Sierzenski P, Passarello B, Pancu D, Melanson S,", "bbox": [406.0, 170.0, 720.0, 182.0]}, {"text": "Arcona S, Reed J, Heller M. Can cardiac sonography and capnography", "bbox": [428.0, 182.0, 719.0, 194.0]}, {"text": "be used independently and in combination to predict resuscitation", "bbox": [427.0, 195.0, 720.0, 207.0]}, {"text": "outcomes? Acad Emerg Med . 2001;8:610–615.", "bbox": [427.0, 207.0, 624.0, 218.0]}, {"text": "161. Tayal VS, Kline JA. Emergency echocardiography to detect pericardial", "bbox": [405.0, 219.0, 720.0, 231.0]}, {"text": "effusion in patients in PEA and near-PEA states. Resuscitation . 2003;", "bbox": [427.0, 231.0, 720.0, 242.0]}, {"text": "59:315–318.", "bbox": [427.0, 242.0, 481.0, 253.0]}, {"text": "162. Varriale P, Maldonado JM.  Echocardiographic observations during", "bbox": [406.0, 254.0, 719.0, 267.0]}, {"text": "inhospital cardiopulmonary resuscitation. Crit Care Med . 1997;25:", "bbox": [427.0, 267.0, 719.0, 279.0]}, {"text": "1717–1720.", "bbox": [428.0, 279.0, 477.0, 290.0]}, {"text": "163. Li Y, Ristagno G, Bisera J, Tang W, Deng Q, Weil MH. Electrocardio-", "bbox": [405.0, 290.0, 719.0, 302.0]}, {"text": "gram waveforms for monitoring effectiveness of chest compression", "bbox": [427.0, 303.0, 720.0, 315.0]}, {"text": "during cardiopulmonary resuscitation. Crit Care Med . 2008;36:", "bbox": [427.0, 315.0, 720.0, 327.0]}, {"text": "211–215.", "bbox": [428.0, 328.0, 468.0, 339.0]}, {"text": "164. Ristagno G, Tang W, Chang YT, Jorgenson DB, Russell JK, Huang L,", "bbox": [405.0, 339.0, 720.0, 352.0]}, {"text": "Wang T, Sun S, Weil MH. The quality of chest compressions during", "bbox": [427.0, 352.0, 719.0, 364.0]}, {"text": "cardiopulmonary resuscitation overrides importance of timing of defi-", "bbox": [427.0, 363.0, 718.0, 375.0]}, {"text": "brillation. Chest . 2007;132:70–75.", "bbox": [427.0, 376.0, 569.0, 388.0]}, {"text": "165. Berg RA, Sanders AB, Milander M, Tellez D, Liu P, Beyda D. Efficacy", "bbox": [405.0, 387.0, 720.0, 399.0]}, {"text": "of audio-prompted rate guidance in improving resuscitator performance", "bbox": [427.0, 401.0, 720.0, 412.0]}, {"text": "of cardiopulmonary resuscitation on children. Acad Emerg Med . 1994;", "bbox": [427.0, 412.0, 720.0, 423.0]}, {"text": "1:35–40.", "bbox": [427.0, 424.0, 467.0, 433.0]}, {"text": "166. Ornato JP, Gonzalez ER, Garnett AR, Levine RL, McClung BK. Effect", "bbox": [406.0, 435.0, 720.0, 448.0]}, {"text": "of cardiopulmonary resuscitation compression rate on end-tidal carbon", "bbox": [427.0, 447.0, 720.0, 461.0]}, {"text": "dioxide concentration and arterial pressure in man. Crit Care Med .", "bbox": [428.0, 461.0, 719.0, 472.0]}, {"text": "1988;16:241–245.", "bbox": [428.0, 473.0, 503.0, 483.0]}, {"text": "167. Guly UM, Robertson CE. Active decompression improves the haemo-", "bbox": [406.0, 484.0, 718.0, 496.0]}, {"text": "dynamic state during cardiopulmonary resuscitation. Br Heart J . 1995;", "bbox": [427.0, 497.0, 720.0, 508.0]}, {"text": "73:372–376.", "bbox": [428.0, 508.0, 479.0, 520.0]}, {"text": "168. Rubertsson S, Karlsten R. Increased cortical cerebral blood flow with", "bbox": [406.0, 520.0, 720.0, 532.0]}, {"text": "LUCAS; a new device for mechanical chest compressions compared to", "bbox": [427.0, 533.0, 720.0, 544.0]}, {"text": "standard external compressions during experimental cardiopulmonary", "bbox": [427.0, 544.0, 720.0, 555.0]}, {"text": "resuscitation. Resuscitation . 2005;65:357–363.", "bbox": [428.0, 557.0, 618.0, 568.0]}, {"text": "169. Wik L, Naess PA, Ilebekk A, Nicolaysen G, Steen PA. Effects of various", "bbox": [406.0, 568.0, 720.0, 580.0]}, {"text": "degrees of compression and active decompression on haemodynamics,", "bbox": [427.0, 582.0, 719.0, 593.0]}, {"text": "end-tidal CO2, and ventilation during cardiopulmonary resuscitation of", "bbox": [427.0, 593.0, 719.0, 604.0]}, {"text": "pigs. Resuscitation. 1996;31:45–57.", "bbox": [427.0, 605.0, 575.0, 616.0]}, {"text": "170. Grmec S, Krizmaric M, Mally S, Kozelj A, Spindler M, Lesnik B.", "bbox": [406.0, 617.0, 718.0, 629.0]}, {"text": "Utstein style analysis of out-of-hospital cardiac arrest–bystander CPR", "bbox": [427.0, 630.0, 719.0, 642.0]}, {"text": "and end expired carbon dioxide. Resuscitation . 2007;72:404–414.", "bbox": [428.0, 641.0, 700.0, 653.0]}, {"text": "171. Pokorna M, Necas E, Kratochvil J, Skripsky R, Andrlik M, Franek O. A", "bbox": [405.0, 653.0, 720.0, 666.0]}, {"text": "Sudden Increase in Partial Pressure End-tidal Carbon Dioxide", "bbox": [427.0, 665.0, 720.0, 677.0]}, {"text": "(P(ET)CO2) at the Moment of Return of Spontaneous Circulation.", "bbox": [427.0, 678.0, 719.0, 689.0]}, {"text": "J Emerg Med. 2009.", "bbox": [428.0, 689.0, 514.0, 701.0]}, {"text": "172. Rosetti VA, Thompson BM, Miller J, Mateer JR, Aprahamian C.", "bbox": [405.0, 701.0, 718.0, 713.0]}, {"text": "Intraosseous infusion: an alternative route of pediatric intravascular", "bbox": [427.0, 714.0, 720.0, 726.0]}, {"text": "access. Ann Emerg Med . 1985;14:885–888.", "bbox": [428.0, 725.0, 607.0, 736.0]}, {"text": "173. Brunette DD, Fischer R. Intravascular access in pediatric cardiac arrest.", "bbox": [406.0, 737.0, 720.0, 750.0]}, {"text": "Am J Emerg Med . 1988;6:577–579.", "bbox": [428.0, 749.0, 575.0, 761.0]}, {"text": "174. Seigler RS, Tecklenburg FW, Shealy R.  Prehospital intraosseous", "bbox": [405.0, 762.0, 720.0, 774.0]}, {"text": "infusion by emergency medical services personnel: a prospective study.", "bbox": [427.0, 774.0, 719.0, 786.0]}, {"text": "Pediatrics . 1989;84:173–177.", "bbox": [427.0, 787.0, 549.0, 798.0]}, {"text": "175. Glaeser PW, Hellmich TR, Szewczuga D, Losek JD, Smith DS.", "bbox": [405.0, 798.0, 718.0, 810.0]}, {"text": "Five-year experience in prehospital intraosseous infusions in children", "bbox": [427.0, 811.0, 720.0, 823.0]}, {"text": "and adults. Ann Emerg Med . 1993;22:1119–1124.", "bbox": [428.0, 823.0, 633.0, 834.0]}, {"text": "176. Ellemunter H, Simma B, Trawoger R, Maurer H. Intraosseous lines in", "bbox": [405.0, 835.0, 720.0, 847.0]}, {"text": "preterm and full term neonates. Arch Dis Child Fetal Neonatal Ed .", "bbox": [428.0, 847.0, 718.0, 858.0]}, {"text": "1999;80:F74–F75.", "bbox": [428.0, 859.0, 505.0, 869.0]}, {"text": "177.", "bbox": [405.0, 870.0, 425.0, 882.0]}, {"text": "Claudet I, Baunin C, Laporte-Turpin E, Marcoux MO, Grouteau E,", "bbox": [424.0, 870.0, 719.0, 883.0]}, {"text": "Cahuzac JP.  Long-term effects on tibial growth after intraosseous", "bbox": [427.0, 883.0, 719.0, 894.0]}, {"text": "infusion: a prospective, radiographic analysis. Pediatr Emerg Care .", "bbox": [427.0, 895.0, 718.0, 907.0]}, {"text": "2003;19:397–401.", "bbox": [428.0, 906.0, 503.0, 917.0]}, {"text": "178. Fiorito BA, Mirza F, Doran TM, Oberle AN, Cruz EC, Wendtland CL,", "bbox": [405.0, 918.0, 718.0, 930.0]}, {"text": "Abd-Allah SA.  Intraosseous access in the setting of pediatric critical", "bbox": [428.0, 931.0, 720.0, 943.0]}, {"text": "care transport. Pediatr Crit Care Med . 2005;6:50–53.", "bbox": [427.0, 943.0, 650.0, 956.0]}, {"text": "179. Horton MA, Beamer C.  Powered intraosseous insertion provides safe", "bbox": [405.0, 956.0, 720.0, 968.0]}, {"text": "and effective vascular access for pediatric emergency patients. Pediatr", "bbox": [428.0, 968.0, 720.0, 980.0]}, {"text": "Emerg Care . 2008;24:347–350.", "bbox": [428.0, 979.0, 559.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 282}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#64#参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:36:23"}
{"id": 1042024, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "a659802f-1912-4d2c-b84e-2f2113a4c88e", "title": null, "text": "【0】页码:204\n\n【1】## Recommendations\n\n【2】\n## Advantages\n\n【3】\n## Disadvantages\n\n【4】\n## Quad Helix\n\n【5】\n tition, the expansion can be accomplished in about two months depending on the severity of the case. Expansion in adolescents can take 3 months, and in adult patients the expansion will take more time. (17)\n\n【6】 The retention period must oscillate between 50% and 100% of the time it took to complete the expansion.\n\n【7】We always recommend over expanding 1 mm to 2 mm to compensate the tendency that the posterior sector has to return to its original state.\n\n【8】We must control the vertical component in patients with increased lower inferior third.\n\n【9】We recommend the use of a head gear for vertical control of the eruption of maxillary molars while the molar Class II is corrected.\n\n【10】Once the transversal discrepancy is corrected, the expander must remain in the mouth the necessary time to correct any buccal inclination that can occur in the initial expansion process. (17) If a molar is very much rotated, we must manipulate the coupling keys to provoke gradual activations. This obeys to two principles:\n\n【11】 The expander is made in eight sizes that range between 26 mm to 47 mm with a 3 mm difference between them.\n\n【12】Generally, the expansion need range is between 4 mm to 5 mm (2 to 2.5 mm per side), and in order to select the appliance we can take a compass and measure the distance between the palatal sheaths, add 4 mm to this distance and then select the appliance. ( 13 )\n\n【13】 The appliance is light and comfortable to the pa¬ tient.\n\n【14】 1.\n\n【15】2.\n\n【16】3.\n\n【17】 6.\n\n【18】 Hygienic.\n\n【19】2.\n\n【20】Because it is a prefabricated appliance, we do not 3.\n\n【21】need impression appointments nor sending any work model to the laboratory, because we can adapt it directly to the mouth due to the characteristics of the NiTi alloy used in its construction. (13.17) It reduces costs and chair time.\n\n【22】4.\n\n【23】The expander can be used simultaneously with con¬ 5.\n\n【24】ventional fixed appliances; it only needs the addition of sheaths on the molar bands. (17) The ARNDT Tandem loop generates optimal, con¬ 6.\n\n【25】stant and uniform expansion forces. (8) 7.\n\n【26】It is a very effective expander.\n\n【27】It does not need any manipulation on behalf of the 8.\n\n【28】patient, and the operator can control the appliance easily.\n\n【29】It can be programmed to expand exactly the amount 9.\n\n【30】of expansion needed, so we can eliminate the pos¬ sibility of over expanding the arch. (13) It produces light, soft and continuous forces.\n\n【31】10.\n\n【32】It can also derotate molars.\n\n【33】11.\n\n【34】12. It can maintain vertical control of the molars. (13)\n\n【35】 Not to exert excessive forces on the molars.\n\n【36】a.\n\n【37】Avoid excessive displacements of the lateral arms b.\n\n【38】toward the midline, which will undermine the tolerance of the patient to this appliance in the initial phases.\n\n【39】 4.\n\n【40】5.\n\n【41】6.\n\n【42】7.\n\n【43】8.\n\n【44】 The NiTi rods of the Tandem loop occupy part of the space of the tongue and will be submitted to the pressures exerted by the tongue, this is why it is an ap¬ propriate appliance for vertical control of the molars.\n\n【45】(13) If we only want to expand the molars in patients in the permanent dentition, we can use the expander without the lateral arms, but only if the main arch wires are in place, because these wires control the expansion. (13) Pain killers are rarely needed in young patients, but if needed, we can prescribe children's Tylenol during the first 2 or 3 days. (21)\n\n【46】 The patient can refer slight initial pain as soon as the appliance is in place and body temperature begins activating the appliance.\n\n【47】The steel arms can irritate the palatal mucosa if these produce certain degree of ischemia. (13) Patients repose position of the tongue is in contact with the palate can present indentations. We recom¬ mend the use of orthodontic wax during the adaptation period in these patients. (21)\n\n【48】 1.\n\n【49】2.\n\n【50】3.\n\n【51】 The Quad Helix was introduced in the 60's by Dr Ricketts.\n\n【52】It is a palatal expander made with 0.038\" Elgiloy blue wire that incorporates in its design four helicoidal loops. It is an efficient appliance for slight expansions when anterior overcrowding is not the major concern and posterior dento alveolar modifications are seeked, although some studies indicate that this appliance exerts a widening effect in the palatal suture in young patients. Change is slow and not as\n\n【53】 1.11.\n\n【54】 2.\n\n【55】 3.\n\n【56】 4.\n\n【57】 5.\n\n【58】 7.\n\n【59】 8.\n\n【60】 9.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Recommendations", "bbox": [413.0, 84.0, 544.0, 100.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "Advantages", "bbox": [77.0, 307.0, 162.0, 324.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Disadvantages", "bbox": [76.0, 774.0, 182.0, 791.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Quad Helix", "bbox": [413.0, 791.0, 496.0, 810.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "tition, the expansion can be accomplished in about two", "bbox": [77.0, 83.0, 392.0, 99.0]}, {"text": "months depending on the severity of the case. Expansion", "bbox": [77.0, 101.0, 391.0, 116.0]}, {"text": "in adolescents can take 3 months, and in adult patients the", "bbox": [77.0, 118.0, 392.0, 133.0]}, {"text": "expansion will take more time. (17)", "bbox": [77.0, 135.0, 260.0, 151.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The retention period must oscillate between 50% and", "bbox": [440.0, 118.0, 727.0, 134.0]}, {"text": "100% of the time it took to complete the expansion.", "bbox": [440.0, 136.0, 723.0, 152.0]}, {"text": "We always recommend over expanding 1 mm to 2", "bbox": [440.0, 154.0, 727.0, 169.0]}, {"text": "mm to compensate the tendency that the posterior", "bbox": [440.0, 172.0, 727.0, 186.0]}, {"text": "sector has to return to its original state.", "bbox": [440.0, 189.0, 657.0, 204.0]}, {"text": "We must control the vertical component in patients", "bbox": [440.0, 205.0, 727.0, 221.0]}, {"text": "with increased lower inferior third.", "bbox": [440.0, 223.0, 633.0, 238.0]}, {"text": "We recommend the use of a head gear for vertical", "bbox": [440.0, 240.0, 728.0, 256.0]}, {"text": "control of the eruption of maxillary molars while the", "bbox": [440.0, 258.0, 727.0, 273.0]}, {"text": "molar Class II is corrected.", "bbox": [440.0, 276.0, 589.0, 291.0]}, {"text": "Once the transversal discrepancy is corrected, the", "bbox": [440.0, 291.0, 727.0, 307.0]}, {"text": "expander must remain in the mouth the necessary", "bbox": [440.0, 309.0, 727.0, 324.0]}, {"text": "time to correct any buccal inclination that can occur", "bbox": [440.0, 326.0, 727.0, 342.0]}, {"text": "in the initial expansion process. (17)", "bbox": [440.0, 344.0, 626.0, 360.0]}, {"text": "If a molar is very much rotated, we must manipulate", "bbox": [439.0, 362.0, 727.0, 376.0]}, {"text": "the coupling keys to provoke gradual activations. This", "bbox": [440.0, 379.0, 727.0, 394.0]}, {"text": "obeys to two principles:", "bbox": [440.0, 396.0, 573.0, 411.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "The expander is made in eight sizes that range between", "bbox": [77.0, 169.0, 392.0, 186.0]}, {"text": "26 mm to 47 mm with a 3 mm difference between them.", "bbox": [77.0, 187.0, 391.0, 203.0]}, {"text": "Generally, the expansion need range is between 4 mm to", "bbox": [77.0, 204.0, 392.0, 219.0]}, {"text": "5 mm (2 to 2.5 mm per side), and in order to select the", "bbox": [76.0, 221.0, 392.0, 237.0]}, {"text": "appliance we can take a compass and measure the distance", "bbox": [77.0, 239.0, 391.0, 254.0]}, {"text": "between the palatal sheaths, add 4 mm to this distance and", "bbox": [76.0, 256.0, 391.0, 272.0]}, {"text": "then select the appliance. ( 13 )", "bbox": [76.0, 274.0, 230.0, 290.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "The appliance is light and comfortable to the pa¬", "bbox": [103.0, 343.0, 390.0, 358.0]}, {"text": "tient.", "bbox": [103.0, 361.0, 134.0, 376.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "1.", "bbox": [78.0, 345.0, 91.0, 358.0]}, {"text": "2.", "bbox": [77.0, 379.0, 90.0, 392.0]}, {"text": "3.", "bbox": [77.0, 396.0, 91.0, 410.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "6.", "bbox": [414.0, 364.0, 427.0, 377.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Hygienic.", "bbox": [103.0, 378.0, 158.0, 393.0]}, {"text": "2.", "bbox": [77.0, 379.0, 90.0, 392.0]}, {"text": "Because it is a prefabricated appliance, we do not", "bbox": [103.0, 394.0, 391.0, 410.0]}, {"text": "3.", "bbox": [77.0, 396.0, 91.0, 410.0]}, {"text": "need impression appointments nor sending any", "bbox": [103.0, 412.0, 391.0, 428.0]}, {"text": "work model to the laboratory, because we can adapt", "bbox": [103.0, 430.0, 391.0, 444.0]}, {"text": "it directly to the mouth due to the characteristics of", "bbox": [103.0, 447.0, 392.0, 462.0]}, {"text": "the NiTi alloy used in its construction. (13.17)", "bbox": [103.0, 464.0, 338.0, 480.0]}, {"text": "It reduces costs and chair time.", "bbox": [103.0, 481.0, 275.0, 496.0]}, {"text": "4.", "bbox": [77.0, 483.0, 89.0, 496.0]}, {"text": "The expander can be used simultaneously with con¬", "bbox": [103.0, 498.0, 390.0, 514.0]}, {"text": "5.", "bbox": [76.0, 499.0, 90.0, 514.0]}, {"text": "ventional fixed appliances; it only needs the addition", "bbox": [103.0, 516.0, 391.0, 531.0]}, {"text": "of sheaths on the molar bands. (17)", "bbox": [103.0, 533.0, 285.0, 549.0]}, {"text": "The ARNDT Tandem loop generates optimal, con¬", "bbox": [103.0, 550.0, 389.0, 566.0]}, {"text": "6.", "bbox": [76.0, 552.0, 91.0, 566.0]}, {"text": "stant and uniform expansion forces. (8)", "bbox": [103.0, 568.0, 310.0, 583.0]}, {"text": "7.", "bbox": [76.0, 584.0, 90.0, 600.0]}, {"text": "It is a very effective expander.", "bbox": [102.0, 585.0, 265.0, 600.0]}, {"text": "It does not need any manipulation on behalf of the", "bbox": [102.0, 602.0, 391.0, 618.0]}, {"text": "8.", "bbox": [76.0, 604.0, 91.0, 618.0]}, {"text": "patient, and the operator can control the appliance", "bbox": [103.0, 620.0, 391.0, 635.0]}, {"text": "easily.", "bbox": [103.0, 638.0, 139.0, 653.0]}, {"text": "It can be programmed to expand exactly the amount", "bbox": [101.0, 655.0, 391.0, 670.0]}, {"text": "9.", "bbox": [76.0, 656.0, 91.0, 670.0]}, {"text": "of expansion needed, so we can eliminate the pos¬", "bbox": [103.0, 671.0, 389.0, 687.0]}, {"text": "sibility of over expanding the arch. (13)", "bbox": [103.0, 689.0, 307.0, 705.0]}, {"text": "It produces light, soft and continuous forces.", "bbox": [100.0, 706.0, 350.0, 721.0]}, {"text": "10.", "bbox": [78.0, 708.0, 99.0, 720.0]}, {"text": "It can also derotate molars.", "bbox": [100.0, 723.0, 254.0, 739.0]}, {"text": "11.", "bbox": [78.0, 725.0, 99.0, 738.0]}, {"text": "12. It can maintain vertical control of the molars. (13)", "bbox": [77.0, 741.0, 367.0, 755.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Not to exert excessive forces on the molars.", "bbox": [466.0, 430.0, 707.0, 446.0]}, {"text": "a.", "bbox": [440.0, 434.0, 453.0, 446.0]}, {"text": "Avoid excessive displacements of the lateral arms", "bbox": [466.0, 448.0, 727.0, 463.0]}, {"text": "b.", "bbox": [440.0, 450.0, 454.0, 463.0]}, {"text": "toward the midline, which will undermine the", "bbox": [466.0, 465.0, 727.0, 481.0]}, {"text": "tolerance of the patient to this appliance in the", "bbox": [466.0, 482.0, 727.0, 497.0]}, {"text": "initial phases.", "bbox": [466.0, 499.0, 543.0, 515.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "4.", "bbox": [77.0, 483.0, 89.0, 496.0]}, {"text": "5.", "bbox": [76.0, 499.0, 90.0, 514.0]}, {"text": "6.", "bbox": [76.0, 552.0, 91.0, 566.0]}, {"text": "7.", "bbox": [76.0, 584.0, 90.0, 600.0]}, {"text": "8.", "bbox": [76.0, 604.0, 91.0, 618.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "The NiTi rods of the Tandem loop occupy part of", "bbox": [440.0, 534.0, 729.0, 549.0]}, {"text": "the space of the tongue and will be submitted to the", "bbox": [440.0, 551.0, 727.0, 567.0]}, {"text": "pressures exerted by the tongue, this is why it is an ap¬", "bbox": [440.0, 568.0, 725.0, 584.0]}, {"text": "propriate appliance for vertical control of the molars.", "bbox": [440.0, 586.0, 726.0, 601.0]}, {"text": "(13)", "bbox": [440.0, 604.0, 455.0, 615.0]}, {"text": "If we only want to expand the molars in patients in", "bbox": [440.0, 621.0, 727.0, 636.0]}, {"text": "the permanent dentition, we can use the expander", "bbox": [440.0, 639.0, 727.0, 654.0]}, {"text": "without the lateral arms, but only if the main arch", "bbox": [440.0, 656.0, 727.0, 670.0]}, {"text": "wires are in place, because these wires control the", "bbox": [440.0, 673.0, 727.0, 688.0]}, {"text": "expansion. (13)", "bbox": [440.0, 690.0, 514.0, 705.0]}, {"text": "Pain killers are rarely needed in young patients, but", "bbox": [440.0, 707.0, 727.0, 723.0]}, {"text": "if needed, we can prescribe children's Tylenol during", "bbox": [440.0, 725.0, 727.0, 740.0]}, {"text": "the first 2 or 3 days. (21)", "bbox": [440.0, 742.0, 563.0, 758.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "The patient can refer slight initial pain as soon as the", "bbox": [102.0, 810.0, 391.0, 826.0]}, {"text": "appliance is in place and body temperature begins", "bbox": [103.0, 827.0, 392.0, 843.0]}, {"text": "activating the appliance.", "bbox": [103.0, 845.0, 238.0, 860.0]}, {"text": "The steel arms can irritate the palatal mucosa if these", "bbox": [103.0, 861.0, 391.0, 877.0]}, {"text": "produce certain degree of ischemia. (13)", "bbox": [103.0, 879.0, 313.0, 894.0]}, {"text": "Patients repose position of the tongue is in contact", "bbox": [102.0, 897.0, 391.0, 912.0]}, {"text": "with the palate can present indentations. We recom¬", "bbox": [103.0, 914.0, 389.0, 930.0]}, {"text": "mend the use of orthodontic wax during the adapta-", "bbox": [103.0, 932.0, 389.0, 947.0]}, {"text": "tion period in these patients. (21)", "bbox": [103.0, 948.0, 275.0, 964.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "1.", "bbox": [78.0, 812.0, 90.0, 825.0]}, {"text": "2.", "bbox": [76.0, 863.0, 89.0, 877.0]}, {"text": "3.", "bbox": [76.0, 898.0, 91.0, 912.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "The Quad Helix was introduced in the 60's by Dr Ricketts.", "bbox": [414.0, 828.0, 727.0, 844.0]}, {"text": "It is a palatal expander made with 0.038\" Elgiloy blue wire", "bbox": [413.0, 845.0, 727.0, 861.0]}, {"text": "that incorporates in its design four helicoidal loops. It is", "bbox": [413.0, 863.0, 728.0, 878.0]}, {"text": "an efficient appliance for slight expansions when anterior", "bbox": [413.0, 880.0, 727.0, 896.0]}, {"text": "overcrowding is not the major concern and posterior dento", "bbox": [413.0, 898.0, 727.0, 913.0]}, {"text": "alveolar modifications are seeked, although some studies", "bbox": [413.0, 915.0, 727.0, 931.0]}, {"text": "indicate that this appliance exerts a widening effect in the", "bbox": [413.0, 933.0, 727.0, 948.0]}, {"text": "palatal suture in young patients. Change is slow and not as", "bbox": [413.0, 950.0, 727.0, 966.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "1.11.", "bbox": [414.0, 121.0, 427.0, 134.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "2.", "bbox": [414.0, 155.0, 427.0, 169.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "3.", "bbox": [413.0, 206.0, 427.0, 221.0]}], "type": "Text", "position": 21}, {"raw_context": [{"text": "4.", "bbox": [414.0, 243.0, 428.0, 256.0]}], "type": "Text", "position": 22}, {"raw_context": [{"text": "5.", "bbox": [413.0, 293.0, 428.0, 308.0]}], "type": "Text", "position": 23}, {"raw_context": [{"text": "7.", "bbox": [414.0, 537.0, 427.0, 550.0]}], "type": "Text", "position": 24}, {"raw_context": [{"text": "8.", "bbox": [413.0, 623.0, 427.0, 637.0]}], "type": "Text", "position": 25}, {"raw_context": [{"text": "9.", "bbox": [414.0, 709.0, 428.0, 722.0]}], "type": "Text", "position": 26}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 204}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#10#10#If a molar is very much另起一行\n标点错误#13#13#pa¬不需要这个标点\n缺少换行#21#21#It reduces costs and chair time.另起一行\n标点错误#23#23#con¬不需要这个标点\n标点错误#24#24#con¬不需要这个标点\n缺少换行#24#24#The ARNDT Tandem另起一行\n缺少换行#30#30#It produces light,另起一行\n缺少换行#45#45#Pain killers are rarely needed另起一行\n缺少换行#47#47#Patients repose position另起一行\n", "type3": "无关文本#5#52#more time. (17)类似这样的无关数字引用，应用全文\n无关文本#16#16#3. \n无关文本#17#17#6.\n无关文本#19#19#2.\n无关文本#53#60#多余出现的序号", "type4": "栏目混乱#0#60#小标题和正文内容分开，并且正文内容穿插出现；\n栏目混乱#13#52# Hygienic.\n2.\nBecause it is a prefabricated appliance, we do not 3.序号和内容前后颠倒，或序号出现在正文中间，导致正文内容分割开", "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:06:32"}
{"id": 1042023, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "f98d0f16-4bda-4ffc-9adc-31e6d2fa1780", "title": null, "text": "【0】页码:40\n\n【1】## Extended Side Stretch\n\n【2】\n Use this posture to help tone and strengthen your legs, improve lung capacity, and stimulate the organs in the abdomen.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "EXTENDED SIDE", "bbox": [94.0, 62.0, 232.0, 79.0]}, {"text": "STRETCH", "bbox": [94.0, 80.0, 173.0, 95.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "Use this posture to help", "bbox": [94.0, 96.0, 211.0, 108.0]}, {"text": "tone and strengthen your", "bbox": [94.0, 110.0, 216.0, 122.0]}, {"text": "legs, improve lung capacity, and", "bbox": [35.0, 123.0, 195.0, 135.0]}, {"text": "stimulate the organs in the abdomen.", "bbox": [36.0, 136.0, 216.0, 148.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/101 Essential Tips Yoga (Dorling Kindersley (DK)) (Z-Library).pdf", "page_num": 40}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:24:07"}
{"id": 1042022, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "524cc189-773f-4f7a-bea7-7ebf173ab521", "title": null, "text": "【0】页码:10\n A Mercator-like flat map of the brain can be viewed in three ways:\n\n【1】 ■ Euclidean, which is flat like a road map. Distance is measured or scaled as expected.\n\n【2】 = Hyperbolic, which is disk-shaped and allows the map focus to be changed so that the chosen center is in sharp focus and the edges distorted, much like moving a magnifying glass over a piece of paper.\n\n【3】 ■ Spherical, which wraps a flattened brain image around a sphere.\n\n【4】 mensional curved surface can be flattened while preserving the angular information, thereby yielding a so-called conformal map.\n\n【5】To flatten the cortex, Hurdal takes anatomical information from a high-resolution, 3-D MRI scan and feeds it into her program. Within a few minutes, several algorithms convert the surface of the brain into a network of thousands or even millions of cortical points (the number depends on the size of the area to be flattened), each connected to\n\n【6】 into single flat maps (shown here in Euclidean and hyperbolic views) to reveal details that are normally hidden in the brain's folds.\n\n【7】 its nearest neighbors by lines. The result is a triangulated mesh.\n\n【8】The key to flattening this landscape of convoluted triangles lies in a Greek theorem called circle packing. It says that three circles can always be drawn around the corners of a triangle so that each circle just touches the other two. Any two of these circles also belong to a neighboring triangle. Hence thousands of triangles in a flat plane can perfect-\n\n【9】 ly pack that plane with thousands of circles.\n\n【10】Applying the theorem to the brain may sound easy enough, but there is one problem, Hurdal notes: the triangles that represent the surface of a brain are not lying flat, so the touching circles will stick out. To fix this, the program employs a contemporary version of circle packing. It extends the theorem to three dimensions, moving all the cortical points until they settle down with the circles into a well-packed plane. Because the resulting maps are not perfect conformal maps, Hurdal calls them quasi-conformal. She has already flat-mapped the cerebellum and various bits of the cortex. To match precise regions with brain activity, researchers can take images from subsequent scans, flatten them and overlay them on the initial MRI.\n\n【11】Surgeons may eventually rely on the maps in brain surgery, particularly in epilepsy operations in which cutting out chunks of the cortex is necessary to help stop seizures.\n\n【12】Werner K. Doyle, a neurosurgeon who performs more than 200 such operations every year at New York University–Mount Sinai Comprehensive Epilepsy Center, says, \"Which parts are removed is often an educated guess.\" The most commonly used method to locate malfunctioning regions is electroencephalography (EEG). It requires placing several electrodes directly on the surface of the brain and waiting for a seizure. Unfortunately, EEG readings don't always mark the right spot, and so too much cortex or the wrong region is sometimes removed. Flat maps turn the 3-D brain into a 2-D image, which, Doyle says, \"will make it easier and safer for neurologists to navigate the mind.\" Ideally, no one will get lost, because directions aren't included.\n\n【13】 Diane Martindale is a science writer based in New York City .\n\n【14】 COURTESY OF MONICA K.\n\n【15】## The Peak Of Success\n\n【16】\n## The Big Bang Theory Clicks Together Better Than Ever   By George Musser\n\n【17】\n / henever Scientific American runs an article on cosmology, we get letters complaining that cosmology isn't a science, just unconstrained speculation. But even if that used to be the case, it is certainly not true anymore. The past several months\n\n【18】 alone have seen a remarkable outpouring of high-precision observations of the universe on its largest scales. Not only do they give the big bang theory a new quantitative rigor, they hint at secondary effects—perhaps the longsought signatures of cosmic inflation and cold", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "A Mercator-like flat map of the brain", "bbox": [51.0, 355.0, 202.0, 366.0]}, {"text": "can be viewed in three ways:", "bbox": [81.0, 368.0, 203.0, 380.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "■ Euclidean, which is flat like a road", "bbox": [51.0, 393.0, 204.0, 405.0]}, {"text": "map. Distance is measured or", "bbox": [76.0, 407.0, 203.0, 418.0]}, {"text": "scaled as expected.", "bbox": [117.0, 420.0, 202.0, 432.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "= Hyperbolic, which is disk-shaped", "bbox": [53.0, 446.0, 203.0, 459.0]}, {"text": "and allows the map focus to be", "bbox": [72.0, 460.0, 203.0, 473.0]}, {"text": "changed so that the chosen", "bbox": [83.0, 474.0, 203.0, 486.0]}, {"text": "center is in sharp focus and the", "bbox": [69.0, 487.0, 203.0, 499.0]}, {"text": "edges distorted, much like", "bbox": [89.0, 500.0, 203.0, 512.0]}, {"text": "moving a magnifying glass over", "bbox": [68.0, 513.0, 203.0, 527.0]}, {"text": "a piece of paper.", "bbox": [130.0, 527.0, 203.0, 540.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "■ Spherical, which wraps a flattened", "bbox": [48.0, 554.0, 204.0, 566.0]}, {"text": "brain image around a sphere.", "bbox": [79.0, 568.0, 202.0, 579.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "mensional curved surface can be flattened", "bbox": [232.0, 55.0, 469.0, 69.0]}, {"text": "while preserving the angular information,", "bbox": [232.0, 71.0, 468.0, 85.0]}, {"text": "thereby yielding a so-called conformal map.", "bbox": [231.0, 87.0, 463.0, 101.0]}, {"text": "To flatten the cortex, Hurdal takes", "bbox": [250.0, 103.0, 469.0, 117.0]}, {"text": "anatomical information from a high-resolu-", "bbox": [232.0, 119.0, 467.0, 133.0]}, {"text": "tion, 3-D MRI scan and feeds it into her pro-", "bbox": [231.0, 135.0, 468.0, 149.0]}, {"text": "gram. Within a few minutes, several algo-", "bbox": [232.0, 151.0, 467.0, 165.0]}, {"text": "rithms convert the surface of the brain into a", "bbox": [231.0, 167.0, 468.0, 181.0]}, {"text": "network of thousands or even millions of cor-", "bbox": [231.0, 183.0, 467.0, 197.0]}, {"text": "tical points (the number depends on the size", "bbox": [231.0, 199.0, 469.0, 214.0]}, {"text": "of the area to be flattened), each connected to", "bbox": [231.0, 215.0, 469.0, 229.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "into single flat maps (shown here in Euclidean and", "bbox": [231.0, 500.0, 445.0, 511.0]}, {"text": "hyperbolic views) to reveal details that are normally", "bbox": [232.0, 513.0, 451.0, 525.0]}, {"text": "hidden in the brain's folds.", "bbox": [231.0, 527.0, 341.0, 539.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "its nearest neighbors by lines. The result is a", "bbox": [231.0, 567.0, 468.0, 582.0]}, {"text": "triangulated mesh.", "bbox": [231.0, 583.0, 333.0, 597.0]}, {"text": "The key to flattening this landscape of", "bbox": [250.0, 599.0, 468.0, 614.0]}, {"text": "convoluted triangles lies in a Greek theorem", "bbox": [230.0, 615.0, 468.0, 629.0]}, {"text": "called circle packing. It says that three circles", "bbox": [230.0, 631.0, 468.0, 645.0]}, {"text": "can always be drawn around the corners of", "bbox": [230.0, 647.0, 468.0, 662.0]}, {"text": "a triangle so that each circle just touches the", "bbox": [231.0, 663.0, 468.0, 677.0]}, {"text": "other two. Any two of these circles also be-", "bbox": [231.0, 679.0, 466.0, 694.0]}, {"text": "long to a neighboring triangle. Hence thou-", "bbox": [231.0, 695.0, 467.0, 710.0]}, {"text": "sands of triangles in a flat plane can perfect-", "bbox": [232.0, 712.0, 467.0, 725.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "ly pack that plane with thousands of circles.", "bbox": [479.0, 55.0, 717.0, 69.0]}, {"text": "Applying the theorem to the brain may", "bbox": [499.0, 71.0, 717.0, 85.0]}, {"text": "sound easy enough, but there is one problem,", "bbox": [481.0, 87.0, 718.0, 102.0]}, {"text": "Hurdal notes: the triangles that represent the", "bbox": [481.0, 103.0, 718.0, 117.0]}, {"text": "surface of a brain are not lying flat, so the", "bbox": [481.0, 119.0, 718.0, 133.0]}, {"text": "touching circles will stick out. To fix this, the", "bbox": [480.0, 135.0, 718.0, 149.0]}, {"text": "program employs a contemporary version of", "bbox": [481.0, 151.0, 718.0, 165.0]}, {"text": "circle packing. It extends the theorem to three", "bbox": [480.0, 167.0, 718.0, 181.0]}, {"text": "dimensions, moving all the cortical points un-", "bbox": [480.0, 183.0, 717.0, 197.0]}, {"text": "til they settle down with the circles into a", "bbox": [480.0, 199.0, 718.0, 214.0]}, {"text": "well-packed plane. Because the resulting", "bbox": [481.0, 215.0, 718.0, 229.0]}, {"text": "maps are not perfect conformal maps,", "bbox": [481.0, 231.0, 718.0, 245.0]}, {"text": "Hurdal calls them quasi-conformal. She has", "bbox": [480.0, 247.0, 718.0, 262.0]}, {"text": "already flat-mapped the cerebellum and var-", "bbox": [481.0, 264.0, 717.0, 277.0]}, {"text": "ious bits of the cortex. To match precise re-", "bbox": [481.0, 279.0, 716.0, 294.0]}, {"text": "gions with brain activity, researchers can take", "bbox": [481.0, 295.0, 718.0, 309.0]}, {"text": "images from subsequent scans, flatten them", "bbox": [481.0, 311.0, 718.0, 325.0]}, {"text": "and overlay them on the initial MRI.", "bbox": [481.0, 327.0, 677.0, 342.0]}, {"text": "Surgeons may eventually rely on the maps", "bbox": [499.0, 344.0, 718.0, 357.0]}, {"text": "in brain surgery, particularly in epilepsy op-", "bbox": [480.0, 359.0, 717.0, 374.0]}, {"text": "erations in which cutting out chunks of the", "bbox": [479.0, 375.0, 718.0, 390.0]}, {"text": "cortex is necessary to help stop seizures.", "bbox": [480.0, 392.0, 718.0, 405.0]}, {"text": "Werner K. Doyle, a neurosurgeon who per-", "bbox": [481.0, 407.0, 717.0, 422.0]}, {"text": "forms more than 200 such operations every", "bbox": [481.0, 423.0, 718.0, 437.0]}, {"text": "year at New York University–Mount Sinai", "bbox": [481.0, 439.0, 718.0, 453.0]}, {"text": "Comprehensive Epilepsy Center, says, \"Which", "bbox": [480.0, 454.0, 718.0, 469.0]}, {"text": "parts are removed is often an educated guess.\"", "bbox": [480.0, 471.0, 716.0, 485.0]}, {"text": "The most commonly used method to lo-", "bbox": [500.0, 488.0, 717.0, 501.0]}, {"text": "cate malfunctioning regions is electroen-", "bbox": [479.0, 503.0, 717.0, 517.0]}, {"text": "cephalography (EEG). It requires placing sev-", "bbox": [479.0, 519.0, 716.0, 534.0]}, {"text": "eral electrodes directly on the surface of the", "bbox": [480.0, 535.0, 718.0, 549.0]}, {"text": "brain and waiting for a seizure. Unfortunate-", "bbox": [481.0, 551.0, 716.0, 565.0]}, {"text": "ly, EEG readings don't always mark the right", "bbox": [480.0, 567.0, 718.0, 582.0]}, {"text": "spot, and so too much cortex or the wrong re-", "bbox": [481.0, 583.0, 716.0, 597.0]}, {"text": "gion is sometimes removed. Flat maps turn the", "bbox": [481.0, 599.0, 718.0, 614.0]}, {"text": "3-D brain into a 2-D image, which, Doyle says,", "bbox": [481.0, 615.0, 718.0, 629.0]}, {"text": "\"will make it easier and safer for neurologists", "bbox": [481.0, 631.0, 718.0, 645.0]}, {"text": "to navigate the mind.\" Ideally, no one will get", "bbox": [480.0, 647.0, 718.0, 662.0]}, {"text": "lost, because directions aren't included.", "bbox": [481.0, 663.0, 686.0, 677.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Diane Martindale is a science writer based", "bbox": [481.0, 695.0, 709.0, 710.0]}, {"text": "in New York City .", "bbox": [481.0, 712.0, 581.0, 725.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "COURTESY OF MONICA K.", "bbox": [746.0, 636.0, 759.0, 720.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "The Peak of Success", "bbox": [256.0, 788.0, 640.0, 829.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "THE BIG BANG THEORY CLICKS TOGETHER BETTER THAN EVER   BY GEORGE MUSSER", "bbox": [230.0, 836.0, 677.0, 854.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "/ henever Scientific American runs an", "bbox": [266.0, 871.0, 469.0, 885.0]}, {"text": "article on cosmology, we get letters", "bbox": [273.0, 887.0, 468.0, 902.0]}, {"text": "complaining that cosmology isn't a", "bbox": [273.0, 903.0, 468.0, 917.0]}, {"text": "science, just unconstrained speculation. But", "bbox": [229.0, 919.0, 468.0, 933.0]}, {"text": "even if that used to be the case, it is certainly", "bbox": [229.0, 935.0, 467.0, 949.0]}, {"text": "not true anymore. The past several months", "bbox": [229.0, 952.0, 468.0, 965.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "alone have seen a remarkable outpouring of", "bbox": [479.0, 871.0, 718.0, 885.0]}, {"text": "high-precision observations of the universe", "bbox": [479.0, 887.0, 718.0, 902.0]}, {"text": "on its largest scales. Not only do they give the", "bbox": [479.0, 903.0, 718.0, 917.0]}, {"text": "big bang theory a new quantitative rigor, they", "bbox": [479.0, 919.0, 717.0, 933.0]}, {"text": "hint at secondary effects—perhaps the long-", "bbox": [479.0, 935.0, 716.0, 950.0]}, {"text": "sought signatures of cosmic inflation and cold", "bbox": [479.0, 952.0, 718.0, 965.0]}], "type": "Text", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 10}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#17#17#/ henever应该为whenever", "type2": "多余换行#5#7# 5和7为同段\n多余换行#8#9#为同段\n缺少换行#12#12#The most commonly u这里开始应与前面换行\n多余换行#17#18#为同段内容", "type3": "无关文本#0#3#非正文内容\n无关文本#6#6#非正文内容\n", "type4": "\n", "type6": "信息有用性#13#14#无用内容\n"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:58:28"}
{"id": 1042021, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "6101bb4f-692c-44b9-8d69-477296a67786", "title": null, "text": "【0】页码:18\n\n【1】## Need To Know:\n\n【2】\n High cholesterol is defined as amounts greater than 240 milligrams per deciliter of blood.\n\n【3】Hypertension is defined as having a medically untreated systolic blood pressure (the first number in a reading) of at least 140 millimeters of mercury or a diastolic pressure (the second number) of at least 90. Obesity is defined as a body mass index of 30 or greater (calculated by dividing the weight in kilograms by the square of the height in meters). Pulmonary disease mortality includes deaths from emphysema, chronic bronchitis, asthma and other obstructive diseases of the lungs.\n\n【4】\n## Lifestyle Blues\n\n【5】\n## When It Comes To Combating Health Problems Brought On By High Living, The Recent Improvements May Be Over    By Rodger Doyle\n\n【6】\n the six leading killers of Americans—coronary heart disease, stroke, lung cancer, colon cancer, diabetes and chronic obstructive pulmonary disease—were responsible for 43 percent of all deaths in 1998. These six are also the major \"lifestyle\" diseases– that is, diseases that trace mainly to imprudent living, such as poor diet, obesity, lack of exercise, and cigarette smoking. Indeed, shifts in lifestyle account for much of the change in mortality rates over recent decades. Coronary heart disease (CHD), stroke and colon cancer rates declined among both sexes.\n\n【7】Rates of lung cancer and chronic obstructive pulmonary disease (COPD), both of which result overwhelmingly from cigarette smoking, declined among men but have been rising among women, a pattern that reflects the later adoption and subsequent abandonment of cigarettes by women as compared to use\n\n【8】## Risk-Factor Prevalence In U.S.\n\n【9】\n by men in the years after World War II. Lung cancer and COPD rates among women, however, are expected to turn down eventually because of women's declining use of cigarettes since the 1970s. Diabetes registered a big increase in mortality rates, apparently resulting from the growing trend to obesity.\n\n【10】The prospect for future declines in the leading chronic diseases depends in part on trends in risk factors. Prevalence of cigarette smoking, which sends more than 400,000 Americans a year to a premature death, appears to be stabilizing at about 25 percent of the population. More disappointing is the rise in obesity. The substantial declines in prevalence of high serum cholesterol and high blood pressure of recent decades may be difficult to maintain, as those most concerned about their health have already mended their destructive ways, whereas those practicing a less prudent lifestyle will be less inclined to change. That suggests that mortality rates of the major chronic diseases will not decline as fast in the coming years as in the past, but it is likely that the number of deaths from lifestyle diseases will climb dramatically after 2010, when the baby boomers enter old age.\n\n【11】With few exceptions, such as the discovery of insulin, \"magic bullets\" have played a minor role in the prevention, cure and palliation of lifestyle diseases. This could change because of new work now under way, including genetic research and promising cancer treatments. Such research, if successful, will probably have its greatest impact beginning in the next decade.\n\n【12】## The Six Leading Lifestyle Diseases\n\n【13】\n INE RISK FACTORS CORONARY HEART DISEASE 460 47-47 C,H,S,O,P STROKE 158 -38 C,H,S,0 LUNG CANCER 155 +6 S CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113 +34 s DIABETES 1065 +35 0 COLON CANCER 57 D,P 24–24 ALL CAUSES 2,337 19–19 Risk-factor abbreviations: C = high serum cholesterol; H = hypertension; S = smoking cigarettes; 0 = obesity;\n\n【14】\n P = physically inactive; D = diet inadequate (for example, insufficient fruits or vegetables) SOURCE: American Public Health Association. Changes in mortality rates are based on age-adjusted data.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "NEED TO KNOW:", "bbox": [61.0, 229.0, 143.0, 245.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "High cholesterol is defined as", "bbox": [66.0, 275.0, 202.0, 288.0]}, {"text": "amounts greater than 240", "bbox": [90.0, 289.0, 202.0, 301.0]}, {"text": "milligrams per deciliter of blood.", "bbox": [66.0, 303.0, 201.0, 315.0]}, {"text": "Hypertension is defined as", "bbox": [79.0, 317.0, 202.0, 328.0]}, {"text": "having a medically untreated", "bbox": [77.0, 330.0, 202.0, 342.0]}, {"text": "systolic blood pressure (the first", "bbox": [63.0, 344.0, 202.0, 356.0]}, {"text": "number in a reading) of at least", "bbox": [69.0, 356.0, 202.0, 368.0]}, {"text": "140 millimeters of mercury or", "bbox": [76.0, 369.0, 203.0, 380.0]}, {"text": "a diastolic pressure (the second", "bbox": [65.0, 383.0, 202.0, 394.0]}, {"text": "number) of at least 90. Obesity", "bbox": [66.0, 396.0, 202.0, 408.0]}, {"text": "is defined as a body mass index of", "bbox": [58.0, 410.0, 203.0, 422.0]}, {"text": "30 or greater (calculated by", "bbox": [84.0, 423.0, 202.0, 436.0]}, {"text": "dividing the weight in kilograms", "bbox": [66.0, 437.0, 202.0, 448.0]}, {"text": "by the square of the height", "bbox": [87.0, 450.0, 202.0, 462.0]}, {"text": "in meters). Pulmonary disease", "bbox": [61.0, 463.0, 202.0, 475.0]}, {"text": "mortality includes deaths from", "bbox": [69.0, 476.0, 202.0, 488.0]}, {"text": "emphysema, chronic bronchitis,", "bbox": [64.0, 490.0, 203.0, 501.0]}, {"text": "asthma and other obstructive", "bbox": [76.0, 503.0, 202.0, 515.0]}, {"text": "diseases of the lungs.", "bbox": [107.0, 516.0, 201.0, 528.0]}], "type": "Table", "position": 3}, {"raw_context": [{"text": "Lifestyle Blues", "bbox": [256.0, 84.0, 548.0, 134.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "WHEN IT COMES TO COMBATING HEALTH PROBLEMS BROUGHT ON BY HIGH LIVING,", "bbox": [231.0, 135.0, 644.0, 153.0]}, {"text": "THE RECENT IMPROVEMENTS MAY BE OVER    BY RODGER DOYLE", "bbox": [231.0, 153.0, 560.0, 168.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "the six leading killers of Americans—coro-", "bbox": [252.0, 183.0, 467.0, 197.0]}, {"text": "nary heart disease, stroke, lung cancer,", "bbox": [252.0, 198.0, 467.0, 214.0]}, {"text": "colon cancer, diabetes and chronic ob-", "bbox": [252.0, 215.0, 466.0, 229.0]}, {"text": "structive pulmonary disease—were responsi-", "bbox": [231.0, 231.0, 466.0, 245.0]}, {"text": "ble for 43 percent of all deaths in 1998. These", "bbox": [231.0, 247.0, 468.0, 261.0]}, {"text": "six are also the major \"lifestyle\" diseases–", "bbox": [232.0, 264.0, 462.0, 277.0]}, {"text": "that is, diseases that trace mainly to impru-", "bbox": [231.0, 279.0, 466.0, 294.0]}, {"text": "dent living, such as poor diet, obesity, lack of", "bbox": [231.0, 295.0, 467.0, 309.0]}, {"text": "exercise, and cigarette smoking. Indeed, shifts", "bbox": [231.0, 312.0, 468.0, 325.0]}, {"text": "in lifestyle account for much of the change in", "bbox": [231.0, 327.0, 468.0, 342.0]}, {"text": "mortality rates over recent decades. Coro-", "bbox": [231.0, 344.0, 466.0, 357.0]}, {"text": "nary heart disease (CHD), stroke and colon", "bbox": [231.0, 359.0, 467.0, 374.0]}, {"text": "cancer rates declined among both sexes.", "bbox": [230.0, 375.0, 466.0, 390.0]}, {"text": "Rates of lung cancer and chronic obstructive", "bbox": [232.0, 392.0, 468.0, 405.0]}, {"text": "pulmonary disease (COPD), both of which", "bbox": [231.0, 407.0, 467.0, 422.0]}, {"text": "result overwhelmingly from cigarette smok-", "bbox": [231.0, 423.0, 466.0, 438.0]}, {"text": "ing, declined among men but have been ris-", "bbox": [231.0, 440.0, 466.0, 454.0]}, {"text": "ing among women, a pattern that reflects the", "bbox": [231.0, 455.0, 467.0, 470.0]}, {"text": "later adoption and subsequent abandonment", "bbox": [231.0, 472.0, 467.0, 485.0]}, {"text": "of cigarettes by women as compared to use", "bbox": [231.0, 488.0, 467.0, 501.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "RISK-FACTOR PREVALENCE IN U.S.", "bbox": [232.0, 512.0, 403.0, 528.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "by men in the years after World War II. Lung", "bbox": [479.0, 183.0, 717.0, 197.0]}, {"text": "cancer and COPD rates among women, how-", "bbox": [479.0, 199.0, 716.0, 213.0]}, {"text": "ever, are expected to turn down eventually", "bbox": [479.0, 215.0, 716.0, 229.0]}, {"text": "because of women's declining use of ciga-", "bbox": [479.0, 231.0, 716.0, 245.0]}, {"text": "rettes since the 1970s. Diabetes registered a", "bbox": [479.0, 247.0, 717.0, 261.0]}, {"text": "big increase in mortality rates, apparently re-", "bbox": [479.0, 264.0, 715.0, 277.0]}, {"text": "sulting from the growing trend to obesity.", "bbox": [479.0, 279.0, 703.0, 294.0]}, {"text": "The prospect for future declines in the", "bbox": [499.0, 295.0, 717.0, 309.0]}, {"text": "leading chronic diseases depends in part on", "bbox": [479.0, 312.0, 716.0, 325.0]}, {"text": "trends in risk factors. Prevalence of cigarette", "bbox": [479.0, 327.0, 716.0, 342.0]}, {"text": "smoking, which sends more than 400,000", "bbox": [480.0, 344.0, 716.0, 357.0]}, {"text": "Americans a year to a premature death, ap-", "bbox": [481.0, 360.0, 716.0, 374.0]}, {"text": "pears to be stabilizing at about 25 percent of", "bbox": [479.0, 375.0, 717.0, 390.0]}, {"text": "the population. More disappointing is the rise", "bbox": [479.0, 392.0, 717.0, 405.0]}, {"text": "in obesity. The substantial declines in preva-", "bbox": [479.0, 407.0, 716.0, 422.0]}, {"text": "lence of high serum cholesterol and high", "bbox": [479.0, 423.0, 717.0, 437.0]}, {"text": "blood pressure of recent decades may be dif-", "bbox": [479.0, 440.0, 716.0, 453.0]}, {"text": "ficult to maintain, as those most concerned", "bbox": [479.0, 455.0, 717.0, 469.0]}, {"text": "about their health have already mended their", "bbox": [479.0, 472.0, 716.0, 485.0]}, {"text": "destructive ways, whereas those practicing a", "bbox": [479.0, 488.0, 717.0, 501.0]}, {"text": "less prudent lifestyle will be less inclined to", "bbox": [479.0, 503.0, 717.0, 517.0]}, {"text": "change. That suggests that mortality rates of", "bbox": [479.0, 519.0, 717.0, 534.0]}, {"text": "the major chronic diseases will not decline as", "bbox": [479.0, 536.0, 717.0, 549.0]}, {"text": "fast in the coming years as in the past, but it", "bbox": [479.0, 552.0, 717.0, 565.0]}, {"text": "is likely that the number of deaths from", "bbox": [479.0, 567.0, 717.0, 581.0]}, {"text": "lifestyle diseases will climb dramatically after", "bbox": [479.0, 583.0, 716.0, 597.0]}, {"text": "2010, when the baby boomers enter old age.", "bbox": [480.0, 599.0, 714.0, 614.0]}, {"text": "With few exceptions, such as the discov-", "bbox": [499.0, 615.0, 716.0, 629.0]}, {"text": "ery of insulin, \"magic bullets\" have played a", "bbox": [479.0, 632.0, 717.0, 645.0]}, {"text": "minor role in the prevention, cure and pallia-", "bbox": [479.0, 647.0, 716.0, 662.0]}, {"text": "tion of lifestyle diseases. This could change be-", "bbox": [479.0, 663.0, 715.0, 677.0]}, {"text": "cause of new work now under way, including", "bbox": [479.0, 680.0, 717.0, 694.0]}, {"text": "genetic research and promising cancer treat-", "bbox": [479.0, 695.0, 716.0, 710.0]}, {"text": "ments. Such research, if successful, will prob-", "bbox": [479.0, 712.0, 715.0, 725.0]}, {"text": "ably have its greatest impact beginning in the", "bbox": [480.0, 727.0, 717.0, 742.0]}, {"text": "next decade.", "bbox": [479.0, 743.0, 548.0, 757.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "THE SIX LEADING LIFESTYLE DISEASES", "bbox": [231.0, 778.0, 427.0, 793.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "INE RISK FACTORS", "bbox": [653.0, 795.0, 710.0, 804.0]}, {"text": "CORONARY HEART DISEASE", "bbox": [232.0, 817.0, 341.0, 829.0]}, {"text": "460", "bbox": [467.0, 817.0, 487.0, 829.0]}, {"text": "47-47", "bbox": [599.0, 817.0, 613.0, 827.0]}, {"text": "C,H,S,O,P", "bbox": [674.0, 817.0, 714.0, 829.0]}, {"text": "STROKE", "bbox": [232.0, 832.0, 265.0, 844.0]}, {"text": "158", "bbox": [467.0, 833.0, 486.0, 844.0]}, {"text": "-38", "bbox": [596.0, 833.0, 614.0, 844.0]}, {"text": "C,H,S,0", "bbox": [681.0, 833.0, 714.0, 844.0]}, {"text": "LUNG CANCER", "bbox": [232.0, 847.0, 291.0, 859.0]}, {"text": "155", "bbox": [467.0, 847.0, 487.0, 859.0]}, {"text": "+6", "bbox": [599.0, 847.0, 614.0, 859.0]}, {"text": "S", "bbox": [705.0, 850.0, 713.0, 858.0]}, {"text": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "bbox": [232.0, 860.0, 414.0, 872.0]}, {"text": "113", "bbox": [468.0, 861.0, 487.0, 872.0]}, {"text": "+34", "bbox": [594.0, 861.0, 614.0, 872.0]}, {"text": "s", "bbox": [705.0, 863.0, 713.0, 872.0]}, {"text": "DIABETES", "bbox": [232.0, 875.0, 273.0, 888.0]}, {"text": "1065", "bbox": [471.0, 877.0, 486.0, 888.0]}, {"text": "+35", "bbox": [594.0, 877.0, 614.0, 888.0]}, {"text": "0", "bbox": [705.0, 878.0, 714.0, 888.0]}, {"text": "COLON CANCER", "bbox": [232.0, 890.0, 295.0, 903.0]}, {"text": "57", "bbox": [472.0, 891.0, 486.0, 903.0]}, {"text": "D,P", "bbox": [697.0, 891.0, 713.0, 903.0]}, {"text": "24–24", "bbox": [595.0, 892.0, 614.0, 903.0]}, {"text": "ALL CAUSES", "bbox": [232.0, 904.0, 281.0, 917.0]}, {"text": "2,337", "bbox": [458.0, 906.0, 486.0, 917.0]}, {"text": "19–19", "bbox": [598.0, 906.0, 614.0, 917.0]}, {"text": "Risk-factor abbreviations: C = high serum cholesterol; H = hypertension; S = smoking cigarettes; 0 = obesity;", "bbox": [232.0, 922.0, 680.0, 935.0]}], "type": "Table", "position": 11}, {"raw_context": [{"text": "P = physically inactive; D = diet inadequate (for example, insufficient fruits or vegetables)", "bbox": [231.0, 936.0, 604.0, 948.0]}, {"text": "SOURCE: American Public Health Association. Changes in mortality rates are based on age-adjusted data.", "bbox": [231.0, 952.0, 661.0, 965.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 18}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#7#9# 7和9为同段", "type3": "无关文本#1#3#非正文内容\n无关文本#12#14#非正文内容", "type4": null, "type6": ""}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:07:14"}
{"id": 1042020, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "9e0e791e-dc38-4a8e-ab61-d182fb752cca", "title": null, "text": "【0】页码:325\n treatment with intravenous fluids. Do not try to force the victim to drink liquids.\n\n【1】## Drowning\n\n【2】\n Drowning is a major cause of unintentional death. Methods of preventing drowning include isolation fencing around swimming pools (gates should be self-closing and self-latching), 190 wearing personal flotation devices (life jackets) while in, around, or on water, never swimming alone, and avoiding swimming or operating motorized watercraft while intoxicated. Outcome following drowning depends on the duration of the submersion, the water temperature, and how promptly CPR is started. 191,192 Occasional case reports have documented intact neurological survival in children following prolonged submersion in icy waters. 193,194 Remove the victim rapidly and safely from the water, but do not place yourself in danger. If you have special training, you can start rescue breathing while the victim is still in the water195 providing that it does not delay removing the victim from the water. There is no evidence that water acts as an obstructive foreign body, so do not waste time trying to remove it with abdominal or chest thrusts. Start CPR and, if you are alone, continue with about 5 cycles (about 2 minutes) of chest compressions and ventilations before activating EMS. If 2 rescuers are present, send 1 rescuer to activate EMS immediately.\n\n【3】## Poison Emergencies\n\n【4】\n If the patient exhibits any signs or symptoms of a lifethreatening condition, (eg, sleepiness, seizures, difficulty breathing, vomiting) after exposure to a poison, activate the EMS immediately.\n\n【5】## Poison Control Centers\n\n【6】\n There are many poisonous substances in the home and worksite. It is important to understand the toxic nature of the chemical substances in the environment and the proper protective equipment and emergency procedures in case of toxic exposure. The Poison Help hotline of the American Association of Poison Control Centers (800-222-1222) is an excellent resource in the United States for information about treating ingestion of, or exposure to, a potential poison.\n\n【7】Further information is available at www.aapcc.org. Similar resources may be available internationally, and their contact information (eg, 112 in Europe) should be standard in international first aid training. When phoning a poison control center or other emergency medical services, know the nature and time of exposure and the name of the product or toxic substance.\n\n【8】## Chemical Burns\n\n【9】\n Brush powdered chemicals off the skin with a gloved hand or piece of cloth. Remove all contaminated clothing from the victim, making sure you do not contaminate yourself in the process. In case of exposure to an acid or alkali on the skin196–202 or eye, 203–208 immediately irrigate the affected area with copious amounts of water (Class I, LOE B).\n\n【10】## Toxic Eye Injury\n\n【11】\n Rinse eyes exposed to toxic substances immediately with a copious amount of water (Class I, LOE C 203 , 209 , 210 ), unless a specific antidote is available. 203 , 210 , 211\n\n【12】## Ingested Poisons\n\n【13】\n## Treatment With Milk Or Water\n\n【14】\n Do not administer anything by mouth for any poison ingestion unless advised to do so by a poison control center or emergency medical personnel because it may be harmful (Class III, LOE C). There is insufficient evidence that dilution of the ingested poison with water or milk is of any benefit as a first aid measure. Animal studies 212 -216 have shown that dilution or neutralization of a caustic agent with water or milk reduces tissue injury, but no human studies have shown a clinical benefit. Possible adverse effects of water or milk administration include emesis and aspiration.\n\n【15】## Activated Charcoal\n\n【16】\n Do not administer activated charcoal to a victim who has ingested a poisonous substance unless you are advised to do so by poison control center or emergency medical personnel (Class IIb, LOE C). There is no evidence that activated charcoal is effective as a component of first aid. It may be safe to administer, 217,218 but it has not been shown to be beneficial, and there are reports of it causing harm. 219–221 In addition the majority of children will not take the recommended dose. 222\n\n【17】## Ipecac\n\n【18】\n Do not administer syrup of ipecac for ingestions of toxins (Class III, LOE B). Several studies 223–225 found that there is no clinically relevant advantage to administering syrup of ipecac; its administration is not associated with decreased healthcare utilization. 226 Untoward effects of ipecac administration include intractable emesis and delayed care in an advanced medical facility. 227,228", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "treatment with intravenous fluids. Do not try to force the", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "victim to drink liquids.", "bbox": [60.0, 100.0, 181.0, 113.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Drowning", "bbox": [60.0, 128.0, 124.0, 142.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Drowning is a major cause of unintentional death. Methods of", "bbox": [60.0, 142.0, 377.0, 157.0]}, {"text": "preventing drowning include isolation fencing around swim-", "bbox": [60.0, 160.0, 375.0, 173.0]}, {"text": "ming pools (gates should be self-closing and self-latching), 190", "bbox": [60.0, 174.0, 375.0, 188.0]}, {"text": "wearing personal flotation devices (life jackets) while in,", "bbox": [60.0, 190.0, 376.0, 203.0]}, {"text": "around, or on water, never swimming alone, and avoiding", "bbox": [60.0, 205.0, 376.0, 219.0]}, {"text": "swimming or operating motorized watercraft while intoxi-", "bbox": [60.0, 220.0, 375.0, 234.0]}, {"text": "cated. Outcome following drowning depends on the duration", "bbox": [60.0, 236.0, 376.0, 249.0]}, {"text": "of the submersion, the water temperature, and how promptly", "bbox": [60.0, 251.0, 375.0, 265.0]}, {"text": "CPR is started. 191,192 Occasional case reports have docu-", "bbox": [60.0, 265.0, 375.0, 281.0]}, {"text": "mented intact neurological survival in children following", "bbox": [60.0, 281.0, 376.0, 295.0]}, {"text": "prolonged submersion in icy waters. 193,194", "bbox": [60.0, 298.0, 280.0, 311.0]}, {"text": "Remove the victim rapidly and safely from the water, but", "bbox": [73.0, 312.0, 376.0, 326.0]}, {"text": "do not place yourself in danger. If you have special training,", "bbox": [60.0, 327.0, 376.0, 341.0]}, {"text": "you can start rescue breathing while the victim is still in the", "bbox": [60.0, 343.0, 375.0, 357.0]}, {"text": "water195 providing that it does not delay removing the victim", "bbox": [60.0, 358.0, 377.0, 372.0]}, {"text": "from the water. There is no evidence that water acts as an", "bbox": [60.0, 374.0, 377.0, 388.0]}, {"text": "obstructive foreign body, so do not waste time trying to", "bbox": [60.0, 389.0, 376.0, 402.0]}, {"text": "remove it with abdominal or chest thrusts. Start CPR and, if", "bbox": [60.0, 404.0, 376.0, 418.0]}, {"text": "you are alone, continue with about 5 cycles (about 2 minutes)", "bbox": [60.0, 420.0, 377.0, 434.0]}, {"text": "of chest compressions and ventilations before activating", "bbox": [60.0, 435.0, 376.0, 448.0]}, {"text": "EMS. If 2 rescuers are present, send 1 rescuer to activate", "bbox": [60.0, 450.0, 375.0, 464.0]}, {"text": "EMS immediately.", "bbox": [60.0, 466.0, 160.0, 480.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Poison Emergencies", "bbox": [150.0, 501.0, 286.0, 518.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "If the patient exhibits any signs or symptoms of a life-", "bbox": [60.0, 518.0, 375.0, 531.0]}, {"text": "threatening condition, (eg, sleepiness, seizures, difficulty", "bbox": [60.0, 533.0, 375.0, 548.0]}, {"text": "breathing, vomiting) after exposure to a poison, activate the", "bbox": [60.0, 548.0, 375.0, 563.0]}, {"text": "EMS immediately.", "bbox": [60.0, 563.0, 161.0, 577.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Poison Control Centers", "bbox": [60.0, 598.0, 207.0, 613.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "There are many poisonous substances in the home and", "bbox": [60.0, 614.0, 376.0, 628.0]}, {"text": "worksite. It is important to understand the toxic nature of the", "bbox": [60.0, 629.0, 376.0, 643.0]}, {"text": "chemical substances in the environment and the proper", "bbox": [60.0, 645.0, 376.0, 659.0]}, {"text": "protective equipment and emergency procedures in case of", "bbox": [60.0, 661.0, 376.0, 674.0]}, {"text": "toxic exposure. The Poison Help hotline of the American", "bbox": [60.0, 675.0, 377.0, 690.0]}, {"text": "Association of Poison Control Centers (800-222-1222) is an", "bbox": [61.0, 691.0, 377.0, 705.0]}, {"text": "excellent resource in the United States for information about", "bbox": [60.0, 706.0, 376.0, 720.0]}, {"text": "treating ingestion of, or exposure to, a potential poison.", "bbox": [60.0, 722.0, 375.0, 736.0]}, {"text": "Further information is available at www.aapcc.org. Similar", "bbox": [60.0, 737.0, 376.0, 750.0]}, {"text": "resources may be available internationally, and their contact", "bbox": [60.0, 752.0, 377.0, 767.0]}, {"text": "information (eg, 112 in Europe) should be standard in", "bbox": [60.0, 768.0, 376.0, 782.0]}, {"text": "international first aid training. When phoning a poison control", "bbox": [60.0, 783.0, 377.0, 796.0]}, {"text": "center or other emergency medical services, know the nature", "bbox": [60.0, 798.0, 375.0, 812.0]}, {"text": "and time of exposure and the name of the product or toxic", "bbox": [60.0, 814.0, 375.0, 828.0]}, {"text": "substance.", "bbox": [60.0, 829.0, 115.0, 843.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Chemical Burns", "bbox": [403.0, 84.0, 506.0, 99.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Brush powdered chemicals off the skin with a gloved hand or", "bbox": [404.0, 100.0, 720.0, 113.0]}, {"text": "piece of cloth. Remove all contaminated clothing from the", "bbox": [403.0, 115.0, 720.0, 130.0]}, {"text": "victim, making sure you do not contaminate yourself in the", "bbox": [404.0, 133.0, 720.0, 145.0]}, {"text": "process. In case of exposure to an acid or alkali on the skin196–202", "bbox": [404.0, 148.0, 720.0, 162.0]}, {"text": "or eye, 203–208 immediately irrigate the affected area with copious", "bbox": [403.0, 163.0, 720.0, 179.0]}, {"text": "amounts of water (Class I, LOE B).", "bbox": [404.0, 180.0, 585.0, 194.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Toxic Eye Injury", "bbox": [404.0, 219.0, 511.0, 233.0]}], "type": "Section-header", "position": 12}, {"raw_context": [{"text": "Rinse eyes exposed to toxic substances immediately with a", "bbox": [404.0, 234.0, 721.0, 248.0]}, {"text": "copious amount of water (Class I, LOE C 203 , 209 , 210 ), unless a", "bbox": [403.0, 250.0, 721.0, 263.0]}, {"text": "specific antidote is available. 203 , 210 , 211", "bbox": [404.0, 267.0, 601.0, 279.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Ingested Poisons", "bbox": [404.0, 303.0, 508.0, 319.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "Treatment With Milk or Water", "bbox": [404.0, 334.0, 572.0, 348.0]}], "type": "Section-header", "position": 15}, {"raw_context": [{"text": "Do not administer anything by mouth for any poison", "bbox": [404.0, 348.0, 721.0, 363.0]}, {"text": "ingestion unless advised to do so by a poison control center", "bbox": [404.0, 365.0, 720.0, 378.0]}, {"text": "or emergency medical personnel because it may be harmful", "bbox": [403.0, 380.0, 721.0, 394.0]}, {"text": "(Class III, LOE C). There is insufficient evidence that", "bbox": [403.0, 396.0, 721.0, 410.0]}, {"text": "dilution of the ingested poison with water or milk is of any", "bbox": [403.0, 412.0, 720.0, 426.0]}, {"text": "benefit as a first aid measure. Animal studies 212 -216 have", "bbox": [403.0, 429.0, 720.0, 442.0]}, {"text": "shown that dilution or neutralization of a caustic agent", "bbox": [403.0, 444.0, 720.0, 458.0]}, {"text": "with water or milk reduces tissue injury, but no human", "bbox": [403.0, 460.0, 721.0, 475.0]}, {"text": "studies have shown a clinical benefit. Possible adverse", "bbox": [404.0, 476.0, 720.0, 489.0]}, {"text": "effects of water or milk administration include emesis and", "bbox": [403.0, 492.0, 720.0, 506.0]}, {"text": "aspiration.", "bbox": [403.0, 508.0, 464.0, 522.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Activated Charcoal", "bbox": [404.0, 542.0, 510.0, 555.0]}], "type": "Section-header", "position": 17}, {"raw_context": [{"text": "Do not administer activated charcoal to a victim who has", "bbox": [404.0, 556.0, 720.0, 570.0]}, {"text": "ingested a poisonous substance unless you are advised to do", "bbox": [403.0, 573.0, 721.0, 586.0]}, {"text": "so by poison control center or emergency medical personnel", "bbox": [403.0, 588.0, 721.0, 602.0]}, {"text": "(Class IIb, LOE C). There is no evidence that activated", "bbox": [403.0, 604.0, 720.0, 618.0]}, {"text": "charcoal is effective as a component of first aid. It may be", "bbox": [403.0, 620.0, 720.0, 635.0]}, {"text": "safe to administer, 217,218 but it has not been shown to be", "bbox": [403.0, 635.0, 720.0, 649.0]}, {"text": "beneficial, and there are reports of it causing harm. 219–221 In", "bbox": [403.0, 652.0, 721.0, 666.0]}, {"text": "addition the majority of children will not take the recom-", "bbox": [404.0, 668.0, 719.0, 682.0]}, {"text": "mended dose. 222", "bbox": [404.0, 684.0, 492.0, 698.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Ipecac", "bbox": [404.0, 720.0, 442.0, 733.0]}], "type": "Section-header", "position": 19}, {"raw_context": [{"text": "Do not administer syrup of ipecac for ingestions of toxins", "bbox": [404.0, 732.0, 720.0, 747.0]}, {"text": "(Class III, LOE B). Several studies 223–225 found that there is", "bbox": [403.0, 748.0, 721.0, 763.0]}, {"text": "no clinically relevant advantage to administering syrup of", "bbox": [403.0, 765.0, 721.0, 779.0]}, {"text": "ipecac; its administration is not associated with decreased", "bbox": [403.0, 781.0, 720.0, 796.0]}, {"text": "healthcare utilization. 226 Untoward effects of ipecac admin-", "bbox": [403.0, 796.0, 719.0, 811.0]}, {"text": "istration include intractable emesis and delayed care in an", "bbox": [403.0, 812.0, 720.0, 827.0]}, {"text": "advanced medical facility. 227,228", "bbox": [404.0, 829.0, 571.0, 843.0]}], "type": "Text", "position": 20}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 325}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#2#2#Remove the victim rapidly另起一行", "type3": "无关文本#0#18#类似CPR is started. 191,192出现在逗号或者句号后面以及句中句末的无关数字引用，应用全文\n"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:02:30"}
{"id": 1042019, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "a2960db2-fab4-418b-8549-073e91f604e2", "title": null, "text": "【0】页码:57\n your big toes touching. Keep your spine straight. Clasp one wrist with the other hand.\n\n【1】 L and chest down as far as possible, bending from the hips. Continue folding forward until your forehead rests on the mat.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "your big toes touching. Keep", "bbox": [48.0, 333.0, 173.0, 344.0]}, {"text": "your spine straight. Clasp one", "bbox": [36.0, 345.0, 164.0, 356.0]}, {"text": "wrist with the other hand.", "bbox": [36.0, 357.0, 143.0, 368.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "L and chest down as far as possible, bending", "bbox": [204.0, 333.0, 401.0, 344.0]}, {"text": "from the hips. Continue folding forward until", "bbox": [199.0, 345.0, 384.0, 356.0]}, {"text": "your forehead rests on the mat.", "bbox": [199.0, 357.0, 332.0, 368.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/101 Essential Tips Yoga (Dorling Kindersley (DK)) (Z-Library).pdf", "page_num": 57}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息不完整#0#1#前后内容不完整"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:18:23"}
{"id": 1042018, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "c64886f7-d6b6-4aeb-bc10-5293791f714f", "title": null, "text": "【0】页码:36\n# Genetically Modified Foods:\n\n【1】\n## The World Seems Increasingly\n\n【2】\n modified (GM) foods and those who fear them.\n\n【3】Advocates assert that growing genetically altered crops can be kinder to the environment and that eating foods from those plants is perfectly safe. And, they say, genetic engineering—which can induce plants to grow in poor soils or to produce more nutritious foods—will soon become an essential tool for helping to feed the world's burgeoning population. Skeptics contend that GM crops could pose unique risks to the environment and to health—risks too troubling to accept placidly. Taking that view, many European countries are restricting the planting and importation of GM agricultural products. Much of the debate hinges on perceptions of safety.\n\n【4】But what exactly does recent scientific research say about the hazards?\n\n【5】The answers, too often lost in reports on the controversy, are served up in the pages that follow. —The Editors", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "GENETICALLY MODIFIED FOODS:", "bbox": [138.0, 204.0, 544.0, 244.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "The world seems increasingly", "bbox": [76.0, 515.0, 323.0, 534.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "modified (GM) foods and those who fear them.", "bbox": [81.0, 551.0, 321.0, 565.0]}, {"text": "Advocates assert that growing genetically", "bbox": [102.0, 567.0, 323.0, 582.0]}, {"text": "altered crops can be kinder to the environment", "bbox": [78.0, 583.0, 323.0, 597.0]}, {"text": "and that eating foods from those plants is", "bbox": [102.0, 599.0, 323.0, 614.0]}, {"text": "perfectly safe. And, they say, genetic", "bbox": [128.0, 615.0, 323.0, 630.0]}, {"text": "engineering—which can induce plants to grow", "bbox": [83.0, 631.0, 323.0, 645.0]}, {"text": "in poor soils or to produce more nutritious", "bbox": [104.0, 647.0, 322.0, 662.0]}, {"text": "foods—will soon become an essential tool for", "bbox": [87.0, 663.0, 323.0, 677.0]}, {"text": "helping to feed the world's burgeoning", "bbox": [121.0, 679.0, 323.0, 694.0]}, {"text": "population. Skeptics contend that GM crops", "bbox": [94.0, 694.0, 322.0, 710.0]}, {"text": "could pose unique risks to the environment", "bbox": [96.0, 712.0, 323.0, 725.0]}, {"text": "and to health—risks too troubling to accept", "bbox": [97.0, 727.0, 322.0, 742.0]}, {"text": "placidly. Taking that view, many European", "bbox": [102.0, 743.0, 323.0, 758.0]}, {"text": "countries are restricting the planting and", "bbox": [109.0, 759.0, 323.0, 774.0]}, {"text": "importation of GM agricultural products. Much", "bbox": [85.0, 774.0, 323.0, 790.0]}, {"text": "of the debate hinges on perceptions of safety.", "bbox": [81.0, 791.0, 321.0, 806.0]}, {"text": "But what exactly does recent scientific", "bbox": [118.0, 807.0, 323.0, 822.0]}, {"text": "research say about the hazards?", "bbox": [148.0, 823.0, 321.0, 838.0]}, {"text": "The answers, too often lost in reports", "bbox": [128.0, 839.0, 322.0, 853.0]}, {"text": "on the controversy, are served up", "bbox": [146.0, 855.0, 322.0, 869.0]}, {"text": "in the pages that follow. —The Editors", "bbox": [128.0, 871.0, 321.0, 885.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 36}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#2#modified (GM) foods and those who fear them.与前面1段联接", "type3": null, "type4": "语义不完整#1#1# Seems Increasingly后面缺少内容", "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 21:54:00"}
{"id": 1042017, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "6864fcbe-4d74-449f-8ccb-66ce9c82c56e", "title": null, "text": "【0】页码:253\n 2.\n\n【1】## 3.\n\n【2】\n## Intensity:\n\n【3】\n Frequency: It can be intermittent (diurnal) or con¬ tinuous (nocturnal). Some children suck at any time of the day and some only in the night or while preparing to go to sleep. (21)\n\n【4】 Low intensity: When the insertion of the finger a.\n\n【5】is passive, without any major muscular activity, primordially the buccinators. Generally the fin¬ ger is not completely inserted in the mouth.\n\n【6】b.\n\n【7】Intense: When we can easily appreciate the contraction of the buccinators and the muscles around the lips. (21)\n\n【8】 4.\n\n【9】 The age in which it begins, if the habit starts at an early age it will cause more damage, because the bone is developing and it is more moldable. (3)\n\n【10】 The habits that alter occlusion with more frequency are: persistent immature deglutition, thumb sucking and mouth breathing. Other abnormal habits that can cause malocclusions are lower lip interposition or sucking, pacifier suction or nail biting (onychophagia). (5)\n\n【11】 stimulus to the oral region, in a way that when something contacts the lips or the cheeks, the infant directs his move¬ ments to the stimuli and will try to introduce the stimulat¬ ing object into the mouth. This early nerve organization allows the child to feed from his mother, so prenatal and neonatal suction is physiologic. (18,20,25) This suction reflex is considered normal until 3 years of age, moment in which, with the appearance of the deciduous teeth it is gradually replaced with mastication; this is why it is considered a\n Figs. 5-7. Finger sucking.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "2.", "bbox": [61.0, 83.0, 78.0, 98.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "3.", "bbox": [61.0, 169.0, 78.0, 185.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "Intensity:", "bbox": [88.0, 169.0, 149.0, 186.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "Frequency: It can be intermittent (diurnal) or con¬", "bbox": [88.0, 82.0, 374.0, 101.0]}, {"text": "tinuous (nocturnal). Some children suck at any time of", "bbox": [88.0, 99.0, 376.0, 119.0]}, {"text": "the day and some only in the night or while preparing", "bbox": [88.0, 118.0, 376.0, 134.0]}, {"text": "to go to sleep. (21)", "bbox": [88.0, 135.0, 180.0, 151.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Low intensity: When the insertion of the finger", "bbox": [113.0, 203.0, 374.0, 223.0]}, {"text": "a.", "bbox": [88.0, 206.0, 103.0, 219.0]}, {"text": "is passive, without any major muscular activity,", "bbox": [114.0, 222.0, 375.0, 238.0]}, {"text": "primordially the buccinators. Generally the fin¬", "bbox": [114.0, 240.0, 373.0, 256.0]}, {"text": "ger is not completely inserted in the mouth.", "bbox": [114.0, 256.0, 356.0, 274.0]}, {"text": "b.", "bbox": [87.0, 273.0, 104.0, 290.0]}, {"text": "Intense: When we can easily appreciate the", "bbox": [113.0, 272.0, 375.0, 292.0]}, {"text": "contraction of the buccinators and the muscles", "bbox": [114.0, 290.0, 374.0, 310.0]}, {"text": "around the lips. (21)", "bbox": [114.0, 308.0, 217.0, 324.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "4.", "bbox": [61.0, 342.0, 77.0, 358.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "The age in which it begins, if the habit starts at an", "bbox": [87.0, 343.0, 374.0, 360.0]}, {"text": "early age it will cause more damage, because the bone", "bbox": [88.0, 361.0, 374.0, 377.0]}, {"text": "is developing and it is more moldable. (3)", "bbox": [88.0, 378.0, 305.0, 393.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The habits that alter occlusion with more frequency are:", "bbox": [61.0, 412.0, 373.0, 429.0]}, {"text": "persistent immature deglutition, thumb sucking and mouth", "bbox": [61.0, 428.0, 374.0, 448.0]}, {"text": "breathing. Other abnormal habits that can cause maloc-", "bbox": [60.0, 446.0, 371.0, 464.0]}, {"text": "clusions are lower lip interposition or sucking, pacifier", "bbox": [60.0, 465.0, 373.0, 481.0]}, {"text": "suction or nail biting (onychophagia). (5)", "bbox": [61.0, 481.0, 277.0, 497.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "stimulus to the oral region, in a way that when something", "bbox": [397.0, 85.0, 711.0, 102.0]}, {"text": "contacts the lips or the cheeks, the infant directs his move¬", "bbox": [397.0, 102.0, 709.0, 118.0]}, {"text": "ments to the stimuli and will try to introduce the stimulat¬", "bbox": [397.0, 120.0, 709.0, 136.0]}, {"text": "ing object into the mouth. This early nerve organization", "bbox": [397.0, 136.0, 711.0, 154.0]}, {"text": "allows the child to feed from his mother, so prenatal and", "bbox": [397.0, 155.0, 711.0, 171.0]}, {"text": "neonatal suction is physiologic. (18,20,25) This suction reflex is", "bbox": [397.0, 172.0, 711.0, 189.0]}, {"text": "considered normal until 3 years of age, moment in which,", "bbox": [397.0, 189.0, 711.0, 205.0]}, {"text": "with the appearance of the deciduous teeth it is gradually", "bbox": [397.0, 206.0, 710.0, 223.0]}, {"text": "replaced with mastication; this is why it is considered a", "bbox": [397.0, 224.0, 711.0, 240.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Figs. 5-7. Finger sucking.", "bbox": [333.0, 948.0, 443.0, 963.0]}], "type": "Caption", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 253}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "标点错误#3#3#con¬不需要这个标点\n标点错误#5#5#fin¬不需要这个标点\n标点错误#11#11#move¬不需要这个标点\nstimulat¬不需要这个标点\n多余换行#4#5# Low intensity: When到inserted in the mouth.是一句话\n", "type3": "无关文本#0#11#go to sleep. (21)出现在句末的无关数字引用，应用全文\n", "type4": "栏目混乱#0#5#序号和正文分离，正文内容穿插出现", "type6": "有用性#11#11#Figs. 5-7. Finger sucking.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:30:22"}
{"id": 1042016, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "cfe35b5a-c498-467d-9798-14f51d56af87", "title": null, "text": "【0】页码:103\n\n【1】## Advantages\n\n【2】\n 1.\n\n【3】 2.\n\n【4】3.\n\n【5】4.\n\n【6】5.\n\n【7】 NiTi closed coils close spaces faster in comparison with elastic chain (almost double the rate).\n\n【8】There is no need to change the NiTi coils every three or four weeks, as recommended for elastic chain.\n\n【9】This minimizes the need for individual dental move¬ ment monitoring so we can focus in more important aspects as anchorage control, overbite and overjet control, skeletal and facial profile management.\n\n【10】They are easy to place and to take off.\n\n【11】They maintain a constant force.\n\n【12】They do not keep foul odors.\n\n【13】## Disadvantages\n\n【14】\n 10.1.\n\n【15】2.\n\n【16】 The high cost of the coil.\n\n【17】In occasions the coil can entrap food and nip the oral mucosa.\n\n【18】## Recommendations\n\n【19】\n 1.\n\n【20】2.\n\n【21】3.\n\n【22】4.\n\n【23】5.\n\n【24】19.6.\n\n【25】 We recommend the use of bigger inner diameter coils, because the force is more constant and movement is faster (Bell, 1951).\n\n【26】They are ideal for large space closure.\n\n【27】The placement of a heavy gauge arch wire will dimin¬ ish undesired canine tip.\n\n【28】Use 150 g to 200g coils.\n\n【29】Place the eyelet of the coil at the distal wings of the canine and wire ligature or elastomeric tie on the mesial wings. This will diminish undesired canine rotation.\n\n【30】Because it is a violent movement, we must be careful placing this appliance on a tooth with short roots.\n\n【31】## Space Closure With Open And Closed Coils A)\n\n【32】\n Another way to close extraction sites or diastemas is with the combination of two forces: a traction and a pushing force; for example, a closed NiTi coil with an open NiTi\n Figs. 66 and 67. Closed and open coils.\n Figs. 64 and 65. Elastomeric tie on the mesial wings of the canine.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Advantages", "bbox": [64.0, 81.0, 149.0, 98.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "1.", "bbox": [64.0, 116.0, 78.0, 132.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "2.", "bbox": [64.0, 151.0, 77.0, 166.0]}, {"text": "3.", "bbox": [64.0, 255.0, 78.0, 271.0]}, {"text": "4.", "bbox": [64.0, 273.0, 77.0, 288.0]}, {"text": "5.", "bbox": [64.0, 290.0, 77.0, 306.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "NiTi closed coils close spaces faster in comparison", "bbox": [89.0, 116.0, 377.0, 132.0]}, {"text": "with elastic chain (almost double the rate).", "bbox": [90.0, 134.0, 325.0, 149.0]}, {"text": "There is no need to change the NiTi coils every three", "bbox": [90.0, 151.0, 377.0, 167.0]}, {"text": "or four weeks, as recommended for elastic chain.", "bbox": [90.0, 168.0, 377.0, 185.0]}, {"text": "This minimizes the need for individual dental move¬", "bbox": [90.0, 186.0, 375.0, 202.0]}, {"text": "ment monitoring so we can focus in more important", "bbox": [90.0, 203.0, 377.0, 219.0]}, {"text": "aspects as anchorage control, overbite and overjet", "bbox": [90.0, 220.0, 377.0, 236.0]}, {"text": "control, skeletal and facial profile management.", "bbox": [90.0, 238.0, 350.0, 253.0]}, {"text": "They are easy to place and to take off.", "bbox": [90.0, 255.0, 297.0, 271.0]}, {"text": "They maintain a constant force.", "bbox": [90.0, 273.0, 265.0, 288.0]}, {"text": "They do not keep foul odors.", "bbox": [90.0, 290.0, 250.0, 306.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Disadvantages", "bbox": [64.0, 323.0, 169.0, 340.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "10.1.", "bbox": [64.0, 361.0, 78.0, 374.0]}, {"text": "2.", "bbox": [64.0, 377.0, 78.0, 392.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The high cost of the coil.", "bbox": [89.0, 359.0, 228.0, 374.0]}, {"text": "In occasions the coil can entrap food and nip the oral", "bbox": [89.0, 377.0, 377.0, 392.0]}, {"text": "mucosa.", "bbox": [90.0, 393.0, 138.0, 409.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Recommendations", "bbox": [64.0, 427.0, 194.0, 444.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "1.", "bbox": [64.0, 465.0, 78.0, 478.0]}, {"text": "2.", "bbox": [64.0, 514.0, 78.0, 530.0]}, {"text": "3.", "bbox": [63.0, 532.0, 78.0, 548.0]}, {"text": "4.", "bbox": [63.0, 567.0, 77.0, 582.0]}, {"text": "5.", "bbox": [64.0, 584.0, 78.0, 599.0]}, {"text": "19.6.", "bbox": [64.0, 656.0, 77.0, 669.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "We recommend the use of bigger inner diameter coils,", "bbox": [90.0, 463.0, 377.0, 479.0]}, {"text": "because the force is more constant and movement is", "bbox": [90.0, 479.0, 377.0, 497.0]}, {"text": "faster (Bell, 1951).", "bbox": [90.0, 497.0, 191.0, 513.0]}, {"text": "They are ideal for large space closure.", "bbox": [90.0, 515.0, 295.0, 530.0]}, {"text": "The placement of a heavy gauge arch wire will dimin¬", "bbox": [90.0, 532.0, 376.0, 549.0]}, {"text": "ish undesired canine tip.", "bbox": [90.0, 550.0, 226.0, 565.0]}, {"text": "Use 150 g to 200g coils.", "bbox": [89.0, 567.0, 220.0, 583.0]}, {"text": "Place the eyelet of the coil at the distal wings of the", "bbox": [89.0, 583.0, 377.0, 600.0]}, {"text": "canine and wire ligature or elastomeric tie on the", "bbox": [90.0, 601.0, 377.0, 617.0]}, {"text": "mesial wings. This will diminish undesired canine", "bbox": [90.0, 618.0, 377.0, 635.0]}, {"text": "rotation.", "bbox": [90.0, 637.0, 142.0, 652.0]}, {"text": "Because it is a violent movement, we must be careful", "bbox": [90.0, 654.0, 377.0, 669.0]}, {"text": "placing this appliance on a tooth with short roots.", "bbox": [90.0, 670.0, 365.0, 686.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Space closure with open and closed coils", "bbox": [426.0, 85.0, 711.0, 102.0]}, {"text": "a)", "bbox": [400.0, 86.0, 418.0, 102.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Another way to close extraction sites or diastemas is with", "bbox": [400.0, 120.0, 714.0, 137.0]}, {"text": "the combination of two forces: a traction and a pushing", "bbox": [400.0, 138.0, 713.0, 154.0]}, {"text": "force; for example, a closed NiTi coil with an open NiTi", "bbox": [400.0, 156.0, 714.0, 172.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Figs. 66 and 67. Closed and open coils.", "bbox": [471.0, 688.0, 641.0, 703.0]}], "type": "Caption", "position": 14}, {"raw_context": [{"text": "Figs. 64 and 65. Elastomeric tie on the mesial wings of the canine.", "bbox": [243.0, 955.0, 533.0, 971.0]}], "type": "Caption", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 103}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#2#12#序号和内容被分开，2的序号对应7的内容。9段应该联接8段内容This minimizes the need...连接上面...recommended for elastic chain.\n多余换行#19#30#序号和内容被分开19对应25，依次对应", "type3": "无关文本#14#14#10.1.  里面的10.不需要\n无关文本#24#24#19.6.里面的19.不需要\n", "type6": "有用性#32#32#Figs. 66 and 67. Closed and open coils\nFigs. 64 and 65. Elastomeric tie on the mesial wings of the canine. 图片描述内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:28:21"}
{"id": 1042015, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "79b48d6e-6f64-4aaf-a44d-05edd7e14edc", "title": null, "text": "【0】页码:38\n insecticides on a cotton field seven to 14 times during a single growing season. \"If you choose a Bt cotton product, you may have little or no use for these pretty harsh chemicals,\" he notes.\n\n【1】Growers of Bt corn and potatoes report less of a pesticide reduction, partly because those plants normally require fewer pesticides and face fluctuating numbers of pests.\n\n【2】Defining the environmental risks of GM crops seems even harder than calculating their benefits. At the moment, public attention is most trained on Bt crops, thanks to several negative\n\n【3】 studies. Regulators, too, are surveying the risks intensely. This spring or summer the EPA is expected to issue major new guidelines for Bt crops, ordering seed producers to show more thoroughly that the crops can be planted safely and monitored in farm fields.\n\n【4】In the face of mounting consumer concern, scientists are stepping up research into the consequences of Bt and other GM crops. Among their questions: How do Bt crops affect \"nontarget\" organisms—the innocent bugs, birds, worms and other\n\n【5】 SCIENTIFIC AMERICAN", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "insecticides on a cotton field seven to 14 times during a single", "bbox": [61.0, 822.0, 393.0, 838.0]}, {"text": "growing season. \"If you choose a Bt cotton product, you may", "bbox": [61.0, 839.0, 391.0, 853.0]}, {"text": "have little or no use for these pretty harsh chemicals,\" he notes.", "bbox": [61.0, 854.0, 391.0, 869.0]}, {"text": "Growers of Bt corn and potatoes report less of a pesticide", "bbox": [61.0, 871.0, 392.0, 886.0]}, {"text": "reduction, partly because those plants normally require fewer", "bbox": [61.0, 887.0, 392.0, 902.0]}, {"text": "pesticides and face fluctuating numbers of pests.", "bbox": [61.0, 902.0, 315.0, 917.0]}, {"text": "Defining the environmental risks of GM crops seems even", "bbox": [80.0, 918.0, 393.0, 933.0]}, {"text": "harder than calculating their benefits. At the moment, public", "bbox": [61.0, 935.0, 393.0, 949.0]}, {"text": "attention is most trained on Bt crops, thanks to several negative", "bbox": [61.0, 950.0, 393.0, 965.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "studies. Regulators, too, are surveying the risks intensely. This", "bbox": [402.0, 823.0, 735.0, 837.0]}, {"text": "spring or summer the EPA is expected to issue major new", "bbox": [403.0, 839.0, 734.0, 853.0]}, {"text": "guidelines for Bt crops, ordering seed producers to show more", "bbox": [403.0, 854.0, 734.0, 869.0]}, {"text": "thoroughly that the crops can be planted safely and monitored", "bbox": [403.0, 871.0, 735.0, 886.0]}, {"text": "in farm fields.", "bbox": [403.0, 887.0, 481.0, 902.0]}, {"text": "In the face of mounting consumer concern, scientists are", "bbox": [421.0, 902.0, 734.0, 917.0]}, {"text": "stepping up research into the consequences of Bt and other GM", "bbox": [403.0, 919.0, 735.0, 933.0]}, {"text": "crops. Among their questions: How do Bt crops affect \"non-", "bbox": [403.0, 935.0, 733.0, 949.0]}, {"text": "target\" organisms—the innocent bugs, birds, worms and other", "bbox": [403.0, 950.0, 734.0, 965.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "SCIENTIFIC AMERICAN", "bbox": [567.0, 986.0, 709.0, 1001.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 38}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#3#为同段内容", "type3": null, "type4": null, "type5": null, "type6": "信息有用性#5#5#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 21:50:10"}
{"id": 1042014, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "9d963b33-5274-4e3d-91b9-aa81cb348074", "title": null, "text": "【0】页码:3\n# American Heart Association Learn And Liver\n\n【1】\n Part 1: Executive Summary : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care John M. Field, Mary Fran Hazinski, Michael R. Sayre, Leon Chameides, Stephen M.\n\n【2】Schexnayder, Robin Hemphill, Ricardo A. Samson, John Kattwinkel, Robert A. Berg, Farhan Bhanji, Diana M. Cave, Edward C. Jauch, Peter J. Kudenchuk, Robert W.\n\n【3】Neumar, Mary Ann Peberdy, Jeffrey M. Perlman, Elizabeth Sinz, Andrew H. Travers, Marc D. Berg, John E. Billi, Brian Eigel, Robert W. Hickey, Monica E. Kleinman, Mark S. Link, Laurie J. Morrison, Robert E. O'Connor, Michael Shuster, Clifton W.\n\n【4】Callaway, Brett Cucchiara, Jeffrey D. Ferguson, Thomas D. Rea and Terry L. Vanden Hoek\n\n【5】 Circulation 2010, 122:S640-S656 doi: 10.1161/CIRCULATIONAHA.110.970889 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514 Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539\n\n【6】 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circ.ahajournals.org/content/122/18_suppl_3/S640\n\n【7】 Subscriptions: Information about subscribing to Circulation is online at http://circ.ahajournals.org//subscriptions/\n\n【8】 Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax: 410-528-8550. E-mail: journalpermissions@lww.com\n\n【9】 Reprints: Information about reprints can be found online at http://www.lww.com/reprints", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "American Heart", "bbox": [521.0, 129.0, 678.0, 147.0]}, {"text": "Association", "bbox": [563.0, 152.0, 673.0, 173.0]}, {"text": "Learn and Liver", "bbox": [570.0, 190.0, 711.0, 207.0]}], "type": "Title", "position": 3}, {"raw_context": [{"text": "Part 1: Executive Summary : 2010 American Heart Association Guidelines for", "bbox": [120.0, 267.0, 658.0, 283.0]}, {"text": "Cardiopulmonary Resuscitation and Emergency Cardiovascular Care", "bbox": [146.0, 283.0, 627.0, 299.0]}, {"text": "John M. Field, Mary Fran Hazinski, Michael R. Sayre, Leon Chameides, Stephen M.", "bbox": [115.0, 300.0, 662.0, 315.0]}, {"text": "Schexnayder, Robin Hemphill, Ricardo A. Samson, John Kattwinkel, Robert A. Berg,", "bbox": [112.0, 316.0, 666.0, 331.0]}, {"text": "Farhan Bhanji, Diana M. Cave, Edward C. Jauch, Peter J. Kudenchuk, Robert W.", "bbox": [127.0, 331.0, 651.0, 348.0]}, {"text": "Neumar, Mary Ann Peberdy, Jeffrey M. Perlman, Elizabeth Sinz, Andrew H. Travers,", "bbox": [112.0, 348.0, 666.0, 363.0]}, {"text": "Marc D. Berg, John E. Billi, Brian Eigel, Robert W. Hickey, Monica E. Kleinman,", "bbox": [122.0, 363.0, 655.0, 379.0]}, {"text": "Mark S. Link, Laurie J. Morrison, Robert E. O'Connor, Michael Shuster, Clifton W.", "bbox": [118.0, 379.0, 658.0, 395.0]}, {"text": "Callaway, Brett Cucchiara, Jeffrey D. Ferguson, Thomas D. Rea and Terry L. Vanden", "bbox": [112.0, 394.0, 666.0, 412.0]}, {"text": "Hoek", "bbox": [367.0, 412.0, 406.0, 427.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Circulation 2010, 122:S640-S656", "bbox": [278.0, 461.0, 500.0, 478.0]}, {"text": "doi: 10.1161/CIRCULATIONAHA.110.970889", "bbox": [232.0, 477.0, 545.0, 494.0]}, {"text": "Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX", "bbox": [126.0, 492.0, 651.0, 508.0]}, {"text": "72514", "bbox": [369.0, 508.0, 406.0, 521.0]}, {"text": "Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online", "bbox": [122.0, 519.0, 656.0, 535.0]}, {"text": "ISSN: 1524-4539", "bbox": [338.0, 533.0, 436.0, 548.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The online version of this article, along with updated information and services, is", "bbox": [128.0, 649.0, 651.0, 665.0]}, {"text": "located on the World Wide Web at:", "bbox": [271.0, 666.0, 501.0, 681.0]}, {"text": "http://circ.ahajournals.org/content/122/18_suppl_3/S640", "bbox": [206.0, 682.0, 572.0, 697.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Subscriptions: Information about subscribing to Circulation is online at", "bbox": [123.0, 806.0, 505.0, 823.0]}, {"text": "http://circ.ahajournals.org//subscriptions/", "bbox": [122.0, 822.0, 342.0, 836.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters", "bbox": [123.0, 846.0, 637.0, 862.0]}, {"text": "Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax:", "bbox": [123.0, 860.0, 653.0, 876.0]}, {"text": "410-528-8550. E-mail:", "bbox": [122.0, 874.0, 247.0, 889.0]}, {"text": "journalpermissions@lww.com", "bbox": [123.0, 888.0, 288.0, 903.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Reprints: Information about reprints can be found online at", "bbox": [122.0, 915.0, 441.0, 930.0]}, {"text": "http://www.lww.com/reprints", "bbox": [123.0, 930.0, 283.0, 942.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 3}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#9#全篇为封面内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:54:49"}
{"id": 1042013, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "489d3a92-f62a-436d-84a2-0dafd186e5ec", "title": null, "text": "【0】页码:21\n chromosomes has yielded interesting results, but an \"asthma gene\" has yet to be discovered. Advances in molecular biology will hopefully lead not only to the identification of primary asthma genes, but also to the genes responsible for disease severity (asthma severitymodifying genes), as well as for response to standard treatments (asthma treatment-modifying genes).\n\n【1】 Clinicians have long noted that certain viral infections seem to be related to the development of asthma in predisposed individuals. Physicians for example describe \"asthmagenic\" viruses that cause typical respiratory infection and symptoms at first, only to leave the patient with an asthma-like condition. Asthma often goes hand-in-hand with allergies, especially in children and teens. Asthma is more common in persons with atopy, allergic rhinitis, and eczema. Some types of asthma, called occupational asthma (discussed in Question 40), are related to specific industrial settings and exposures.\n\n【2】 The above observations, along with a large body of research findings, have lead to the current view that asthma is probably \"caused\" by a complex interaction between a \"susceptible\" individual and certain environmental conditions (Figure 2).\n\n【3】## Gemma'S Comment:\n\n【4】\n It's especially important to remember that asthma is tricky: changing weather conditions, humidity holding particles in the air, smoke, and volatile organic compounds all can produce asthma symptoms. In the city where renovations, con¬ struction, street repair, cleaning heating systems, and blowing stacks can occur at any time, its important to keep a sharp eye (ear and nose, as well) on the ever-modifying environment.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "chromosomes has yielded interesting results, but an", "bbox": [149.0, 69.0, 508.0, 87.0]}, {"text": "\"asthma gene\" has yet to be discovered. Advances in", "bbox": [150.0, 88.0, 508.0, 108.0]}, {"text": "molecular biology will hopefully lead not only to the", "bbox": [149.0, 109.0, 507.0, 127.0]}, {"text": "identification of primary asthma genes, but also to the", "bbox": [149.0, 128.0, 507.0, 147.0]}, {"text": "genes responsible for disease severity (asthma severity-", "bbox": [150.0, 149.0, 506.0, 167.0]}, {"text": "modifying genes), as well as for response to standard", "bbox": [149.0, 169.0, 508.0, 187.0]}, {"text": "treatments (asthma treatment-modifying genes).", "bbox": [150.0, 189.0, 466.0, 208.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Clinicians have long noted that certain viral infections", "bbox": [149.0, 221.0, 507.0, 239.0]}, {"text": "seem to be related to the development of asthma in", "bbox": [149.0, 241.0, 508.0, 259.0]}, {"text": "predisposed individuals. Physicians for example", "bbox": [149.0, 261.0, 507.0, 280.0]}, {"text": "describe \"asthmagenic\" viruses that cause typical respi-", "bbox": [149.0, 281.0, 507.0, 299.0]}, {"text": "ratory infection and symptoms at first, only to leave", "bbox": [149.0, 301.0, 507.0, 319.0]}, {"text": "the patient with an asthma-like condition. Asthma", "bbox": [149.0, 321.0, 508.0, 339.0]}, {"text": "often goes hand-in-hand with allergies, especially in", "bbox": [149.0, 341.0, 508.0, 360.0]}, {"text": "children and teens. Asthma is more common in per-", "bbox": [149.0, 361.0, 506.0, 380.0]}, {"text": "sons with atopy, allergic rhinitis, and eczema. Some", "bbox": [149.0, 381.0, 507.0, 400.0]}, {"text": "types of asthma, called occupational asthma (discussed", "bbox": [150.0, 401.0, 508.0, 419.0]}, {"text": "in Question 40), are related to specific industrial set-", "bbox": [149.0, 421.0, 506.0, 439.0]}, {"text": "tings and exposures.", "bbox": [150.0, 442.0, 284.0, 460.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "The above observations, along with a large body of", "bbox": [150.0, 473.0, 509.0, 491.0]}, {"text": "research findings, have lead to the current view that", "bbox": [149.0, 493.0, 508.0, 511.0]}, {"text": "asthma is probably \"caused\" by a complex interaction", "bbox": [149.0, 512.0, 508.0, 532.0]}, {"text": "between a \"susceptible\" individual and certain environ-", "bbox": [149.0, 532.0, 506.0, 552.0]}, {"text": "mental conditions (Figure 2).", "bbox": [149.0, 553.0, 343.0, 572.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Gemma's comment:", "bbox": [150.0, 584.0, 283.0, 605.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "It's especially important to remember that asthma is tricky:", "bbox": [150.0, 612.0, 507.0, 631.0]}, {"text": "changing weather conditions, humidity holding particles in", "bbox": [149.0, 633.0, 508.0, 651.0]}, {"text": "the air, smoke, and volatile organic compounds all can pro-", "bbox": [150.0, 653.0, 507.0, 671.0]}, {"text": "duce asthma symptoms. In the city where renovations, con¬", "bbox": [149.0, 673.0, 507.0, 691.0]}, {"text": "struction, street repair, cleaning heating systems, and", "bbox": [150.0, 693.0, 509.0, 712.0]}, {"text": "blowing stacks can occur at any time, its important to keep", "bbox": [150.0, 713.0, 508.0, 732.0]}, {"text": "a sharp eye (ear and nose, as well) on the ever-modifying", "bbox": [150.0, 733.0, 508.0, 752.0]}, {"text": "environment.", "bbox": [150.0, 753.0, 235.0, 771.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 21}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:57:17"}
{"id": 1042012, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "a0c698ca-0a35-45c4-ad86-07dcb0d788d5", "title": null, "text": "【0】页码:25\n malignancy often contain different mutations, and no clear pattern perfectly matches the supposed cause to actual human disease. Cells taken from patients' tumors typically translate their mutant genes into a mere trickle of protein, in contrast to the flood of mutated protein churning in cells transformed by a virus.\n\n【1】Beginning with his 1983 paper, Duesberg has also picked at theoretical weak spots in the orthodox view. Some tumors are caused by asbestos and other carcinogens that are chemically incapable of mutating specific genes, he points out. Mice genetically engineered to lack tumor suppressor genes and to overexpress oncogenes should all develop cancer in infancy—but they don't. Given the measured rate of spontaneous mutations and the number of cells in the human body, the average person should harbor 100,000 cancer cells if even one dominant oncogene existed in the genome, Duesberg calculated in a paper last year. But if simultaneous mutations to three genes were required,\n\n【2】 ANEUPLOIDY , seen in the aberrant chromosomes of this breast tumor cell analyzed by Robert A. Weinberg's group at the Whitehead Institute, is so common in cancer that it must be a cause, Duesberg argues. A normal female cell has two copies of each chromosome (except Y), for a total of 23 pairs. The cancerous cell contained three or more copies, as well as chromosomes with transposed pieces (such as 1, 6 and 22) or missing segments (1, 3 and 13).\n\n【3】 then only one in 100 billion people would ever acquire cancer.\n\n【4】In 1997 Duesberg published what he thought was a better hypothesis. There is one characteristic common to almost every malignant tumor ever studied: nearly all the cancerous cells in it have abnormal chromosomes. In advanced cancers the cells often have two or three times the normal complement of 46 chromosomes. In new tumors the gross number may be normal, but closer examination usually reveals that parts of the chromosomes are duplicated and misplaced.\n\n【5】German biologist Theodor Boveri noted this so-called aneuploidy of tumor cells almost a century ago and suggested that it could be the cause of cancer. But that idea lost traction when no one could find a particular pattern of aneuploidy that correlated with malignancy, except in chronic myelogenous leukemia, which is not a true cancer because it doesn't spread from the blood to other parts of the body.\n\n【6】Recently, however, Duesberg and a few other scientists analyzed aneuploidy more closely and argued that it can explain\n\n【7】 many of the mysteries of cancer better than the current dogma can. Their alternative story begins when a carcinogen interferes with a dividing cell, causing it to produce daughter cells with unbalanced chromosomes. These aneuploid cells usually die of their deformities. If the damage is minor, however, they may survive yet become genetically unstable, so that the chromosomes are altered further in the next cell division. The cells in tumors thus show a variety of mutations to the genes and the chromosomes.\n\n【8】Because each chromosome hosts thousands of genes, aneuploidy creates massive genetic chaos inside the cell. \"The cell becomes essentially a whole new species unto itself,\" Duesberg says.\n\n【9】Any new \"species\" of cell is extremely unlikely to do better in the body than a native human cell—and that may explain why tumors take so long to develop even after intense exposure to a carcinogen, he argues. The aneuploid cells must go through many divisions, evolving at each one, before they hit on a combination that can grow more or less uncontrollably anywhere in the body.\n\n【10】So far Duesberg has only a scattering of experimental evidence to support his hypothesis. In 1998 he showed that there is a roughly 50-50 chance that a highly aneuploid human cancer cell will gain or lose a chromosome each time it divides. Last December he reported that aneuploid hamster cells quickly developed resistance to multiple drugs—a hallmark of cancer— whereas normal cells from the same culture did not.\n\n【11】But it isn't easy to do experiments when every one of his last 22 grant proposals to nonprivate funding agencies was rejected, he says. Although Duesberg maintained a facade of defiance in Milan, he acknowledged in a moment of fatigue that \"it is depressing that even private foundations are unwilling to fund research that has high risk but high potential payoff.\" His mood had lifted somewhat by May, when I visited his lab. A letter from Abraham Katz tacked to the door stated that his request was approved: he would be getting $100,000, enough to keep the lab running for another nine months.\n\n【12】It seems unlikely that nine months will be enough to persuade other researchers to take his aneuploidy hypothesis seriously. But it is possible. Numerous papers in major journals this year have pointed out the importance of \"chromosome instability,\" a synonymous phrase, in cancer formation. Lengauer and Bert Vogelstein, also at Johns Hopkins, have been particularly active in promoting the idea that aneuploidy—which Lengauer insists must be a consequence of gene mutations—may be a necessary step for any tumor to progress.\n\n【13】Is Duesberg now willing to lay down his lance and play within the rules of polite scientific society? He recognizes that his combative stance in the HIV debate came across as arrogant. \"With AIDS, I was asking for it a bit,\" he concedes. \"At the time, I thought I was invulnerable.\" The experience may have tempered his ego, although he still mentions the Nobel Prize four times in a three-hour interview. Duesberg himself is pessimistic that he will ever be welcomed back into the club. \"When you are out of the orthodoxy,\" he says softly, \"they don't recall you.\"\n\n【14】 BRIAN ELENBAAS ET AL., © 2001GENES & DEVELOPMENT,\nCOLD SPRING HARBOR LABORATORY PRESS", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "malignancy often contain different mutations, and no clear pat-", "bbox": [45.0, 135.0, 375.0, 149.0]}, {"text": "tern perfectly matches the supposed cause to actual human dis-", "bbox": [44.0, 151.0, 375.0, 165.0]}, {"text": "ease. Cells taken from patients' tumors typically translate their", "bbox": [44.0, 167.0, 375.0, 181.0]}, {"text": "mutant genes into a mere trickle of protein, in contrast to the", "bbox": [44.0, 183.0, 375.0, 197.0]}, {"text": "flood of mutated protein churning in cells transformed by a virus.", "bbox": [45.0, 199.0, 375.0, 214.0]}, {"text": "Beginning with his 1983 paper, Duesberg has also picked", "bbox": [65.0, 215.0, 375.0, 229.0]}, {"text": "at theoretical weak spots in the orthodox view. Some tumors are", "bbox": [45.0, 231.0, 375.0, 245.0]}, {"text": "caused by asbestos and other carcinogens that are chemically in-", "bbox": [44.0, 247.0, 375.0, 261.0]}, {"text": "capable of mutating specific genes, he points out. Mice geneti-", "bbox": [44.0, 263.0, 375.0, 277.0]}, {"text": "cally engineered to lack tumor suppressor genes and to overex-", "bbox": [44.0, 279.0, 375.0, 294.0]}, {"text": "press oncogenes should all develop cancer in infancy—but they", "bbox": [45.0, 295.0, 375.0, 309.0]}, {"text": "don't. Given the measured rate of spontaneous mutations and", "bbox": [44.0, 311.0, 375.0, 325.0]}, {"text": "the number of cells in the human body, the average person", "bbox": [44.0, 327.0, 375.0, 342.0]}, {"text": "should harbor 100,000 cancer cells if even one dominant onco-", "bbox": [45.0, 344.0, 375.0, 357.0]}, {"text": "gene existed in the genome, Duesberg calculated in a paper last", "bbox": [44.0, 359.0, 375.0, 374.0]}, {"text": "year. But if simultaneous mutations to three genes were required,", "bbox": [45.0, 375.0, 375.0, 390.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "ANEUPLOIDY , seen in the aberrant chromosomes of this breast tumor cell", "bbox": [47.0, 571.0, 358.0, 583.0]}, {"text": "analyzed by Robert A. Weinberg's group at the Whitehead Institute, is so", "bbox": [46.0, 584.0, 349.0, 597.0]}, {"text": "common in cancer that it must be a cause, Duesberg argues. A normal female", "bbox": [46.0, 599.0, 367.0, 611.0]}, {"text": "cell has two copies of each chromosome (except Y), for a total of 23 pairs. The", "bbox": [46.0, 612.0, 370.0, 624.0]}, {"text": "cancerous cell contained three or more copies, as well as chromosomes with", "bbox": [46.0, 625.0, 367.0, 638.0]}, {"text": "transposed pieces (such as 1, 6 and 22) or missing segments (1, 3 and 13).", "bbox": [46.0, 636.0, 364.0, 652.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "then only one in 100 billion people would ever acquire cancer.", "bbox": [44.0, 678.0, 374.0, 694.0]}, {"text": "In 1997 Duesberg published what he thought was a better", "bbox": [64.0, 694.0, 375.0, 710.0]}, {"text": "hypothesis. There is one characteristic common to almost every", "bbox": [44.0, 712.0, 375.0, 724.0]}, {"text": "malignant tumor ever studied: nearly all the cancerous cells in it", "bbox": [44.0, 727.0, 375.0, 742.0]}, {"text": "have abnormal chromosomes. In advanced cancers the cells of-", "bbox": [44.0, 743.0, 375.0, 757.0]}, {"text": "ten have two or three times the normal complement of 46 chro-", "bbox": [44.0, 759.0, 375.0, 773.0]}, {"text": "mosomes. In new tumors the gross number may be normal, but", "bbox": [44.0, 775.0, 375.0, 789.0]}, {"text": "closer examination usually reveals that parts of the chromo-", "bbox": [44.0, 791.0, 375.0, 805.0]}, {"text": "somes are duplicated and misplaced.", "bbox": [45.0, 807.0, 239.0, 821.0]}, {"text": "German biologist Theodor Boveri noted this so-called aneu-", "bbox": [65.0, 823.0, 375.0, 837.0]}, {"text": "ploidy of tumor cells almost a century ago and suggested that it", "bbox": [45.0, 839.0, 376.0, 853.0]}, {"text": "could be the cause of cancer. But that idea lost traction when no", "bbox": [44.0, 855.0, 375.0, 869.0]}, {"text": "one could find a particular pattern of aneuploidy that correlat-", "bbox": [44.0, 871.0, 375.0, 885.0]}, {"text": "ed with malignancy, except in chronic myelogenous leukemia,", "bbox": [44.0, 887.0, 375.0, 902.0]}, {"text": "which is not a true cancer because it doesn't spread from the", "bbox": [44.0, 903.0, 375.0, 917.0]}, {"text": "blood to other parts of the body.", "bbox": [44.0, 919.0, 219.0, 933.0]}, {"text": "Recently, however, Duesberg and a few other scientists ana-", "bbox": [65.0, 935.0, 375.0, 950.0]}, {"text": "lyzed aneuploidy more closely and argued that it can explain", "bbox": [44.0, 952.0, 376.0, 965.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "many of the mysteries of cancer better than the current dogma", "bbox": [388.0, 135.0, 717.0, 149.0]}, {"text": "can. Their alternative story begins when a carcinogen interferes", "bbox": [388.0, 151.0, 718.0, 165.0]}, {"text": "with a dividing cell, causing it to produce daughter cells with un-", "bbox": [388.0, 167.0, 717.0, 181.0]}, {"text": "balanced chromosomes. These aneuploid cells usually die of their", "bbox": [388.0, 183.0, 718.0, 197.0]}, {"text": "deformities. If the damage is minor, however, they may survive", "bbox": [388.0, 199.0, 718.0, 213.0]}, {"text": "yet become genetically unstable, so that the chromosomes are al-", "bbox": [388.0, 215.0, 717.0, 229.0]}, {"text": "tered further in the next cell division. The cells in tumors thus", "bbox": [388.0, 231.0, 718.0, 245.0]}, {"text": "show a variety of mutations to the genes and the chromosomes.", "bbox": [388.0, 247.0, 716.0, 261.0]}, {"text": "Because each chromosome hosts thousands of genes, aneu-", "bbox": [406.0, 263.0, 716.0, 277.0]}, {"text": "ploidy creates massive genetic chaos inside the cell. \"The cell be-", "bbox": [388.0, 279.0, 716.0, 294.0]}, {"text": "comes essentially a whole new species unto itself,\" Duesberg says.", "bbox": [388.0, 295.0, 717.0, 310.0]}, {"text": "Any new \"species\" of cell is extremely unlikely to do better in the", "bbox": [388.0, 311.0, 718.0, 325.0]}, {"text": "body than a native human cell—and that may explain why tu-", "bbox": [388.0, 327.0, 716.0, 342.0]}, {"text": "mors take so long to develop even after intense exposure to a car-", "bbox": [388.0, 344.0, 716.0, 357.0]}, {"text": "cinogen, he argues. The aneuploid cells must go through many", "bbox": [388.0, 359.0, 718.0, 374.0]}, {"text": "divisions, evolving at each one, before they hit on a combination", "bbox": [388.0, 374.0, 718.0, 389.0]}, {"text": "that can grow more or less uncontrollably anywhere in the body.", "bbox": [388.0, 391.0, 718.0, 405.0]}, {"text": "So far Duesberg has only a scattering of experimental evi-", "bbox": [406.0, 407.0, 717.0, 422.0]}, {"text": "dence to support his hypothesis. In 1998 he showed that there", "bbox": [388.0, 423.0, 718.0, 437.0]}, {"text": "is a roughly 50-50 chance that a highly aneuploid human can-", "bbox": [388.0, 439.0, 716.0, 453.0]}, {"text": "cer cell will gain or lose a chromosome each time it divides. Last", "bbox": [388.0, 454.0, 718.0, 469.0]}, {"text": "December he reported that aneuploid hamster cells quickly de-", "bbox": [388.0, 471.0, 716.0, 485.0]}, {"text": "veloped resistance to multiple drugs—a hallmark of cancer—", "bbox": [388.0, 487.0, 715.0, 501.0]}, {"text": "whereas normal cells from the same culture did not.", "bbox": [388.0, 503.0, 663.0, 517.0]}, {"text": "But it isn't easy to do experiments when every one of his last", "bbox": [406.0, 519.0, 718.0, 534.0]}, {"text": "22 grant proposals to nonprivate funding agencies was reject-", "bbox": [388.0, 534.0, 716.0, 550.0]}, {"text": "ed, he says. Although Duesberg maintained a facade of defiance", "bbox": [388.0, 551.0, 718.0, 565.0]}, {"text": "in Milan, he acknowledged in a moment of fatigue that \"it is de-", "bbox": [388.0, 567.0, 716.0, 581.0]}, {"text": "pressing that even private foundations are unwilling to fund re-", "bbox": [388.0, 583.0, 716.0, 597.0]}, {"text": "search that has high risk but high potential payoff.\"", "bbox": [388.0, 599.0, 658.0, 614.0]}, {"text": "His mood had lifted somewhat by May, when I visited his", "bbox": [406.0, 615.0, 718.0, 629.0]}, {"text": "lab. A letter from Abraham Katz tacked to the door stated that", "bbox": [387.0, 631.0, 718.0, 645.0]}, {"text": "his request was approved: he would be getting $100,000,", "bbox": [387.0, 647.0, 718.0, 662.0]}, {"text": "enough to keep the lab running for another nine months.", "bbox": [388.0, 663.0, 687.0, 677.0]}, {"text": "It seems unlikely that nine months will be enough to per-", "bbox": [406.0, 679.0, 716.0, 694.0]}, {"text": "suade other researchers to take his aneuploidy hypothesis seri-", "bbox": [388.0, 695.0, 717.0, 710.0]}, {"text": "ously. But it is possible. Numerous papers in major journals this", "bbox": [388.0, 712.0, 718.0, 724.0]}, {"text": "year have pointed out the importance of \"chromosome insta-", "bbox": [388.0, 726.0, 716.0, 742.0]}, {"text": "bility,\" a synonymous phrase, in cancer formation. Lengauer", "bbox": [388.0, 743.0, 717.0, 757.0]}, {"text": "and Bert Vogelstein, also at Johns Hopkins, have been particu-", "bbox": [388.0, 759.0, 716.0, 773.0]}, {"text": "larly active in promoting the idea that aneuploidy—which", "bbox": [388.0, 774.0, 717.0, 791.0]}, {"text": "Lengauer insists must be a consequence of gene mutations—may", "bbox": [388.0, 791.0, 716.0, 805.0]}, {"text": "be a necessary step for any tumor to progress.", "bbox": [388.0, 807.0, 628.0, 821.0]}, {"text": "Is Duesberg now willing to lay down his lance and play with-", "bbox": [406.0, 823.0, 716.0, 837.0]}, {"text": "in the rules of polite scientific society? He recognizes that his com-", "bbox": [388.0, 839.0, 716.0, 853.0]}, {"text": "bative stance in the HIV debate came across as arrogant. \"With", "bbox": [388.0, 855.0, 717.0, 869.0]}, {"text": "AIDS, I was asking for it a bit,\" he concedes. \"At the time, I", "bbox": [388.0, 871.0, 718.0, 885.0]}, {"text": "thought I was invulnerable.\" The experience may have tempered", "bbox": [388.0, 887.0, 717.0, 903.0]}, {"text": "his ego, although he still mentions the Nobel Prize four times in", "bbox": [388.0, 903.0, 718.0, 917.0]}, {"text": "a three-hour interview. Duesberg himself is pessimistic that he", "bbox": [388.0, 919.0, 718.0, 933.0]}, {"text": "will ever be welcomed back into the club. \"When you are out of", "bbox": [388.0, 935.0, 717.0, 949.0]}, {"text": "the orthodoxy,\" he says softly, \"they don't recall you.\"", "bbox": [388.0, 951.0, 675.0, 965.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "BRIAN ELENBAAS ET AL., © 2001GENES & DEVELOPMENT,\nCOLD SPRING HARBOR LABORATORY PRESS", "bbox": [736.0, 761.0, 758.0, 964.0]}], "type": "Text", "position": 6}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 25}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#1#3# 1和3为同段\n多余换行#6#7#为同段\n缺少换行#11#11#His mood had lifted这里开始应与前面分行", "type3": "无关文本#2#2#非正文内容", "type4": "", "type6": "信息有用性#14#14#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:45:42"}
{"id": 1042011, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "7642e764-ed01-4704-9931-fedad4b02ce9", "title": null, "text": "【0】页码:13\n 8. Depressor labii – helps pull lower lip down\n\n【1】 9. Mentalis – helps stick bottom lip out\n\n【2】 10. Nasalis – helps 'wrinkle' the nose\n\n【3】## Can I Predict My Chances?\n\n【4】\n Bell's palsy affects 0.02% of the population. The incidence increases with age and people with certain medical conditions are simply more prone than others.\n\n【5】The disorder has been linked to cold sores, flu-like illness, diabetes, tumors, skull and facial injuries and Lyme disease.\n\n【6】 Bell's palsy, as we've discussed, tends to appear suddenly out of the blue – symptoms may start appearing without even the slightest warning. So you may go to bed with a perfectly symmetrical face and when you wake up the next morning; you may notice that your face has collapsed on one side.\n\n【7】 Some people feel numbness or weakness in their facial muscles a day or two before the symptoms first appear. If you notice pain behind your ear or normal sounds seem uncomfortably loud, do get it checked immediately.\n\n【8】 The signs and symptoms of Bell's palsy tend to reach their peak within a day or two after appearing. Most patients feel that they are having a stroke, but here’s something you need to remember. In the case of stroke, muscle weakness is also felt in other parts of the body, not just your face.\n\n【9】## Prognosis And Chances Of Recovery\n\n【10】\n The prognosis for Bell’s palsy is generally good; however, recovery times may vary from person to person. The extent of nerve damage is what determines how soon the condition will go away. Most people start to get better within two weeks with complete recovery in about 3 to 6 months. A small number of people may take longer to recover.\n\n【11】 The National Health Service UK states that 7 out of 10 people make a complete recovery. As mentioned earlier, the time will depend on the amount of nerve damage. The remaining 3 out of 10 people are stuck with the condition in severe cases, however, the majority of cases are treatable.\n\n【12】## What About Recurrence?\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "8. Depressor labii – helps pull lower lip down", "bbox": [106.0, 96.0, 469.0, 116.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "9. Mentalis – helps stick bottom lip out", "bbox": [106.0, 132.0, 419.0, 151.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "10. Nasalis – helps 'wrinkle' the nose", "bbox": [98.0, 167.0, 398.0, 185.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Can I Predict My Chances?", "bbox": [93.0, 208.0, 325.0, 227.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Bell's palsy affects 0.02% of the population. The incidence increases with age", "bbox": [93.0, 245.0, 722.0, 264.0]}, {"text": "and people with certain medical conditions are simply more prone than others.", "bbox": [93.0, 268.0, 722.0, 286.0]}, {"text": "The disorder has been linked to cold sores, flu-like illness, diabetes, tumors,", "bbox": [93.0, 290.0, 723.0, 309.0]}, {"text": "skull and facial injuries and Lyme disease.", "bbox": [93.0, 312.0, 425.0, 330.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Bell's palsy, as we've discussed, tends to appear suddenly out of the blue –", "bbox": [93.0, 346.0, 722.0, 366.0]}, {"text": "symptoms may start appearing without even the slightest warning. So you may", "bbox": [93.0, 369.0, 722.0, 388.0]}, {"text": "go to bed with a perfectly symmetrical face and when you wake up the next", "bbox": [93.0, 391.0, 722.0, 410.0]}, {"text": "morning; you may notice that your face has collapsed on one side.", "bbox": [93.0, 413.0, 607.0, 432.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Some people feel numbness or weakness in their facial muscles a day or two", "bbox": [93.0, 447.0, 723.0, 467.0]}, {"text": "before the symptoms first appear. If you notice pain behind your ear or normal", "bbox": [93.0, 469.0, 723.0, 489.0]}, {"text": "sounds seem uncomfortably loud, do get it checked immediately.", "bbox": [93.0, 492.0, 599.0, 511.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The signs and symptoms of Bell's palsy tend to reach their peak within a day or", "bbox": [93.0, 527.0, 723.0, 546.0]}, {"text": "two after appearing. Most patients feel that they are having a stroke, but here’s", "bbox": [93.0, 549.0, 724.0, 568.0]}, {"text": "something you need to remember. In the case of stroke, muscle weakness is also", "bbox": [93.0, 572.0, 723.0, 591.0]}, {"text": "felt in other parts of the body, not just your face.", "bbox": [93.0, 594.0, 470.0, 613.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Prognosis and Chances of Recovery", "bbox": [93.0, 635.0, 390.0, 654.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "The prognosis for Bell’s palsy is generally good; however, recovery times may", "bbox": [93.0, 671.0, 722.0, 691.0]}, {"text": "vary from person to person. The extent of nerve damage is what determines how", "bbox": [93.0, 694.0, 722.0, 713.0]}, {"text": "soon the condition will go away. Most people start to get better within two", "bbox": [93.0, 716.0, 722.0, 735.0]}, {"text": "weeks with complete recovery in about 3 to 6 months. A small number of people", "bbox": [93.0, 738.0, 723.0, 757.0]}, {"text": "may take longer to recover.", "bbox": [93.0, 761.0, 308.0, 780.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "The National Health Service UK states that 7 out of 10 people make a complete", "bbox": [93.0, 794.0, 722.0, 814.0]}, {"text": "recovery. As mentioned earlier, the time will depend on the amount of nerve", "bbox": [93.0, 817.0, 722.0, 836.0]}, {"text": "damage. The remaining 3 out of 10 people are stuck with the condition in severe", "bbox": [93.0, 839.0, 722.0, 858.0]}, {"text": "cases, however, the majority of cases are treatable.", "bbox": [93.0, 861.0, 487.0, 880.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "What about Recurrence?", "bbox": [95.0, 903.0, 303.0, 922.0]}], "type": "Section-header", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 13}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:04:06"}
{"id": 1042010, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "95dd2482-c40c-4af9-9d3b-62dfb0a36e2d", "title": null, "text": "【0】页码:210\n\n【1】## Methylxanthines\n\n【2】\n## Troubleshooting After Intubation\n\n【3】\n## Inhaled Anesthetics\n\n【4】\n## Assisted Ventilation\n\n【5】\n## Bls Modifications\n\n【6】\n patients with acute asthma. 29 Because the heliox mixture requires at least 70% helium for effect, it cannot be used if the patient requires > 30% oxygen.\n\n【7】 provider should use the largest endotracheal tube available (usually 8 or 9 mm) to decrease airway resistance. Immediately after intubation, endotracheal tube placement should be confirmed by clinical examination and waveform capnography. A chest radiograph should then be performed.\n\n【8】 Although once considered a mainstay in the treatment of acute asthma, methylxanthines are no longer recommended because of their erratic pharmacokinetics, known side effects, and lack of evidence of benefit. 30\n\n【9】 When severe bronchoconstriction is present, breath stacking (so-called auto-PEEP) can develop during positive-pressure ventilation, leading to complications such as hyperinflation, tension pneumothorax, and hypotension. During manual or mechanical ventilation, a slower respiratory rate should be used with smaller tidal volumes (eg, 6 to 8 mL/kg), 36 shorter inspiratory time (eg, adult inspiratory flow rate 80 to 100 mL/min), and longer expiratory time (eg, inspiratory to expiratory ratio 1:4 or 1:5) than generally would be provided to patients without asthma. 37 Management of mechanical ventilation will vary based on patient-ventilation characteristics. Expert consultation should be obtained.\n\n【10】Mild hypoventilation (permissive hypercapnia) reduces the risk of barotrauma. Hypercapnia is typically well tolerated. 38 . 39 Sedation is often required to optimize ventilation, decrease ventilator dyssynchrony (and therefore auto-PEEP), and minimize barotrauma after intubation. Because delivery of inhaled medications may be inadequate before intubation, the provider should continue to administer inhaled albuterol treatments through the endotracheal tube.\n\n【11】Four common causes of acute deterioration in any intubated patient are recalled by the mnemonic DOPE (tube Displacement, tube Obstruction, Pneumothorax, Equipment failure).\n\n【12】Auto-PEEP is another common cause of deterioration in patients with asthma. If the asthmatic patient's condition deteriorates or if it is difficult to ventilate the patient, check the ventilator for leaks or malfunction; verify endotracheal tube position; eliminate tube obstruction (eliminate any mucous plugs and kinks); evaluate for auto-PEEP; and rule out a pneumothorax.\n\n【13】High-end expiratory pressure can be reduced quickly by separating the patient from the ventilator circuit; this will allow PEEP to dissipate during passive exhalation. If auto-PEEP results in significant hypotension, assisting with exhalation by pressing on the chest wall after disconnection of the ventilator circuit will allow active exhalation and should lead to immediate resolution of hypotension. To minimize auto-PEEP, decrease the respiratory rate or tidal volume or both. If auto-PEEP persists and the patient displays ventilator dyssynchrony despite adequate sedation, paralytic agents may be considered.\n\n【14】In exceedingly rare circumstances, aggressive treatment for acute respiratory failure due to severe asthma will not provide adequate gas exchange. There are case reports that describe successful use of extracorporeal membrane oxygenation (ECMO) in adult and pediatric patients 40 – 43 with severe asthma after other aggressive measures have failed to reverse hyoxemia and hypercarbia.\n\n【15】 Leukotriene Antagonists Leukotriene antagonists improve lung function and decrease the need for short-acting β 2 -agonists for long-term asthma therapy, but their effectiveness during acute exacerbations of asthma is unproven.\n\n【16】 Case reports in adults 31 and children 32 suggest a benefit of the potent inhalation anesthetics sevoflurane and isoflurane for patients with life-threatening asthma unresponsive to maximal conventional therapy. These agents may have direct bronchodilator effects. In addition, the anesthetic effect of these drugs increases the ease of mechanical ventilation and reduces oxygen demand and carbon dioxide production. This therapy requires expert consultation in an intensive care setting, and its effectiveness has not been evaluated in randomized clinical studies.\n\n【17】 Noninvasive Positive-Pressure Ventilation Noninvasive positive-pressure ventilation (NIPPV) may offer short-term support for patients with acute respiratory failure and may delay or eliminate the need for endotracheal intubation. 33–35 This therapy requires that the patient is alert and has adequate spontaneous respiratory effort. Bilevel positive airway pressure (BiPAP), the most common method of delivering NIPPV, allows for separate control of inspiratory and expiratory pressures.\n\n【18】 Endotracheal Intubation With Mechanical Ventilation Endotracheal intubation is indicated for patients who present with apnea, coma, persistent or increasing hypercapnia, exhaustion, severe distress, and depression of mental status. Clinical judgment is necessary to assess the need for immediate endotracheal intubation for these critically ill patients. Endotracheal intubation does not solve the problem of small airway constriction in patients with severe asthma; thus, therapy directed toward relief of bronchoconstriction should be continued. Mechanical ventilation in the asthmatic patient can be difficult and associated risks require careful management. Intubation and positivepressure ventilation can trigger further bronchoconstriction and complications such as breath stacking that result from incomplete expiration, air trapping, and buildup of positive endexpiratory pressure (ie, intrinsic or auto-PEEP). This breath stacking can cause barotrauma. Decreasing tidal volume may avoid auto-PEEP and high peak airway pressures. Optimal ventilator management requires expert consultation and ongoing careful review of ventilation flow and pressure curves. Although endotracheal intubation introduces risks, it should be performed when necessary based on clinical condition.\n\n【19】Rapid sequence intubation is the technique of choice and should be performed by an expert in airway management. The\n\n【20】 BLS treatment of cardiac arrest in asthmatic patients is unchanged.\n\n【21】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Methylxanthines", "bbox": [60.0, 140.0, 151.0, 154.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Troubleshooting After Intubation", "bbox": [404.0, 178.0, 612.0, 194.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Inhaled Anesthetics", "bbox": [60.0, 308.0, 168.0, 322.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Assisted Ventilation", "bbox": [60.0, 474.0, 183.0, 489.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "BLS Modifications", "bbox": [404.0, 944.0, 521.0, 959.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "patients with acute asthma. 29 Because the heliox mixture re-", "bbox": [60.0, 83.0, 375.0, 98.0]}, {"text": "quires at least 70% helium for effect, it cannot be used if the", "bbox": [60.0, 100.0, 375.0, 113.0]}, {"text": "patient requires > 30% oxygen.", "bbox": [60.0, 114.0, 218.0, 129.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "provider should use the largest endotracheal tube available", "bbox": [403.0, 84.0, 720.0, 99.0]}, {"text": "(usually 8 or 9 mm) to decrease airway resistance. Immediately", "bbox": [403.0, 100.0, 720.0, 114.0]}, {"text": "after intubation, endotracheal tube placement should be con-", "bbox": [404.0, 116.0, 719.0, 130.0]}, {"text": "firmed by clinical examination and waveform capnography. A", "bbox": [404.0, 132.0, 721.0, 147.0]}, {"text": "chest radiograph should then be performed.", "bbox": [404.0, 148.0, 622.0, 162.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Although once considered a mainstay in the treatment of acute", "bbox": [60.0, 153.0, 376.0, 167.0]}, {"text": "asthma, methylxanthines are no longer recommended because of", "bbox": [60.0, 169.0, 376.0, 183.0]}, {"text": "their erratic pharmacokinetics, known side effects, and lack of", "bbox": [60.0, 185.0, 376.0, 199.0]}, {"text": "evidence of benefit. 30", "bbox": [60.0, 200.0, 169.0, 214.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "When severe bronchoconstriction is present, breath stacking", "bbox": [404.0, 194.0, 720.0, 209.0]}, {"text": "(so-called auto-PEEP) can develop during positive-pressure", "bbox": [403.0, 210.0, 720.0, 225.0]}, {"text": "ventilation, leading to complications such as hyperinflation,", "bbox": [404.0, 227.0, 720.0, 240.0]}, {"text": "tension pneumothorax, and hypotension. During manual or", "bbox": [403.0, 242.0, 720.0, 256.0]}, {"text": "mechanical ventilation, a slower respiratory rate should be used", "bbox": [403.0, 258.0, 721.0, 273.0]}, {"text": "with smaller tidal volumes (eg, 6 to 8 mL/kg), 36 shorter inspira-", "bbox": [404.0, 274.0, 719.0, 288.0]}, {"text": "tory time (eg, adult inspiratory flow rate 80 to 100 mL/min), and", "bbox": [403.0, 290.0, 720.0, 304.0]}, {"text": "longer expiratory time (eg, inspiratory to expiratory ratio 1:4 or", "bbox": [404.0, 306.0, 720.0, 321.0]}, {"text": "1:5) than generally would be provided to patients without", "bbox": [405.0, 322.0, 721.0, 336.0]}, {"text": "asthma. 37 Management of mechanical ventilation will vary", "bbox": [404.0, 338.0, 720.0, 353.0]}, {"text": "based on patient-ventilation characteristics. Expert consultation", "bbox": [403.0, 354.0, 720.0, 368.0]}, {"text": "should be obtained.", "bbox": [404.0, 370.0, 504.0, 384.0]}, {"text": "Mild hypoventilation (permissive hypercapnia) reduces the", "bbox": [416.0, 386.0, 721.0, 401.0]}, {"text": "risk of barotrauma. Hypercapnia is typically well tolerated. 38 . 39", "bbox": [403.0, 403.0, 720.0, 416.0]}, {"text": "Sedation is often required to optimize ventilation, decrease", "bbox": [404.0, 418.0, 720.0, 433.0]}, {"text": "ventilator dyssynchrony (and therefore auto-PEEP), and mini-", "bbox": [404.0, 435.0, 719.0, 448.0]}, {"text": "mize barotrauma after intubation. Because delivery of inhaled", "bbox": [403.0, 450.0, 720.0, 464.0]}, {"text": "medications may be inadequate before intubation, the provider", "bbox": [404.0, 466.0, 720.0, 481.0]}, {"text": "should continue to administer inhaled albuterol treatments", "bbox": [404.0, 482.0, 720.0, 496.0]}, {"text": "through the endotracheal tube.", "bbox": [403.0, 498.0, 556.0, 513.0]}, {"text": "Four common causes of acute deterioration in any intubated", "bbox": [416.0, 515.0, 721.0, 528.0]}, {"text": "patient are recalled by the mnemonic DOPE (tube Displace-", "bbox": [404.0, 530.0, 719.0, 544.0]}, {"text": "ment, tube Obstruction, Pneumothorax, Equipment failure).", "bbox": [404.0, 546.0, 720.0, 561.0]}, {"text": "Auto-PEEP is another common cause of deterioration in patients", "bbox": [404.0, 562.0, 720.0, 576.0]}, {"text": "with asthma. If the asthmatic patient's condition deteriorates or", "bbox": [404.0, 578.0, 720.0, 593.0]}, {"text": "if it is difficult to ventilate the patient, check the ventilator for", "bbox": [403.0, 595.0, 720.0, 608.0]}, {"text": "leaks or malfunction; verify endotracheal tube position; elimi-", "bbox": [403.0, 609.0, 719.0, 624.0]}, {"text": "nate tube obstruction (eliminate any mucous plugs and kinks);", "bbox": [404.0, 626.0, 721.0, 641.0]}, {"text": "evaluate for auto-PEEP; and rule out a pneumothorax.", "bbox": [403.0, 642.0, 676.0, 656.0]}, {"text": "High-end expiratory pressure can be reduced quickly by", "bbox": [416.0, 658.0, 720.0, 673.0]}, {"text": "separating the patient from the ventilator circuit; this will allow", "bbox": [404.0, 675.0, 720.0, 688.0]}, {"text": "PEEP to dissipate during passive exhalation. If auto-PEEP", "bbox": [404.0, 690.0, 720.0, 705.0]}, {"text": "results in significant hypotension, assisting with exhalation by", "bbox": [403.0, 706.0, 720.0, 720.0]}, {"text": "pressing on the chest wall after disconnection of the ventilator", "bbox": [404.0, 722.0, 720.0, 736.0]}, {"text": "circuit will allow active exhalation and should lead to immediate", "bbox": [403.0, 738.0, 720.0, 753.0]}, {"text": "resolution of hypotension. To minimize auto-PEEP, decrease the", "bbox": [403.0, 755.0, 720.0, 769.0]}, {"text": "respiratory rate or tidal volume or both. If auto-PEEP persists", "bbox": [403.0, 770.0, 720.0, 785.0]}, {"text": "and the patient displays ventilator dyssynchrony despite ade-", "bbox": [404.0, 787.0, 719.0, 802.0]}, {"text": "quate sedation, paralytic agents may be considered.", "bbox": [404.0, 803.0, 661.0, 817.0]}, {"text": "In exceedingly rare circumstances, aggressive treatment for", "bbox": [417.0, 819.0, 720.0, 834.0]}, {"text": "acute respiratory failure due to severe asthma will not provide", "bbox": [404.0, 836.0, 720.0, 849.0]}, {"text": "adequate gas exchange. There are case reports that describe", "bbox": [404.0, 851.0, 720.0, 865.0]}, {"text": "successful use of extracorporeal membrane oxygenation", "bbox": [404.0, 867.0, 720.0, 882.0]}, {"text": "(ECMO) in adult and pediatric patients 40 – 43 with severe asthma", "bbox": [403.0, 882.0, 720.0, 896.0]}, {"text": "after other aggressive measures have failed to reverse hyoxemia", "bbox": [404.0, 898.0, 721.0, 913.0]}, {"text": "and hypercarbia.", "bbox": [404.0, 915.0, 489.0, 929.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Leukotriene Antagonists", "bbox": [60.0, 225.0, 193.0, 239.0]}, {"text": "Leukotriene antagonists improve lung function and decrease the", "bbox": [60.0, 238.0, 376.0, 253.0]}, {"text": "need for short-acting β 2 -agonists for long-term asthma therapy,", "bbox": [60.0, 254.0, 376.0, 267.0]}, {"text": "but their effectiveness during acute exacerbations of asthma is", "bbox": [60.0, 269.0, 377.0, 283.0]}, {"text": "unproven.", "bbox": [60.0, 285.0, 112.0, 299.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Case reports in adults 31 and children 32 suggest a benefit of the", "bbox": [60.0, 322.0, 376.0, 337.0]}, {"text": "potent inhalation anesthetics sevoflurane and isoflurane for", "bbox": [60.0, 338.0, 375.0, 353.0]}, {"text": "patients with life-threatening asthma unresponsive to maximal", "bbox": [60.0, 354.0, 376.0, 368.0]}, {"text": "conventional therapy. These agents may have direct bronchodi-", "bbox": [60.0, 369.0, 375.0, 384.0]}, {"text": "lator effects. In addition, the anesthetic effect of these drugs", "bbox": [60.0, 385.0, 376.0, 399.0]}, {"text": "increases the ease of mechanical ventilation and reduces oxygen", "bbox": [60.0, 400.0, 377.0, 413.0]}, {"text": "demand and carbon dioxide production. This therapy requires", "bbox": [60.0, 414.0, 376.0, 429.0]}, {"text": "expert consultation in an intensive care setting, and its effective-", "bbox": [60.0, 431.0, 375.0, 444.0]}, {"text": "ness has not been evaluated in randomized clinical studies.", "bbox": [60.0, 446.0, 356.0, 460.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Noninvasive Positive-Pressure Ventilation", "bbox": [60.0, 495.0, 286.0, 509.0]}, {"text": "Noninvasive positive-pressure ventilation (NIPPV) may offer", "bbox": [60.0, 508.0, 376.0, 523.0]}, {"text": "short-term support for patients with acute respiratory failure and", "bbox": [60.0, 525.0, 376.0, 538.0]}, {"text": "may delay or eliminate the need for endotracheal intuba-", "bbox": [60.0, 540.0, 375.0, 554.0]}, {"text": "tion. 33–35 This therapy requires that the patient is alert and has", "bbox": [60.0, 553.0, 376.0, 571.0]}, {"text": "adequate spontaneous respiratory effort. Bilevel positive", "bbox": [60.0, 571.0, 376.0, 584.0]}, {"text": "airway pressure (BiPAP), the most common method of", "bbox": [60.0, 585.0, 376.0, 600.0]}, {"text": "delivering NIPPV, allows for separate control of inspiratory", "bbox": [60.0, 602.0, 375.0, 615.0]}, {"text": "and expiratory pressures.", "bbox": [60.0, 616.0, 191.0, 631.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Endotracheal Intubation With Mechanical Ventilation", "bbox": [60.0, 640.0, 354.0, 655.0]}, {"text": "Endotracheal intubation is indicated for patients who present", "bbox": [60.0, 655.0, 376.0, 669.0]}, {"text": "with apnea, coma, persistent or increasing hypercapnia, exhaus-", "bbox": [60.0, 671.0, 375.0, 684.0]}, {"text": "tion, severe distress, and depression of mental status. Clinical", "bbox": [60.0, 686.0, 376.0, 700.0]}, {"text": "judgment is necessary to assess the need for immediate endo-", "bbox": [60.0, 702.0, 375.0, 716.0]}, {"text": "tracheal intubation for these critically ill patients. Endotracheal", "bbox": [60.0, 716.0, 376.0, 730.0]}, {"text": "intubation does not solve the problem of small airway constric-", "bbox": [60.0, 732.0, 375.0, 746.0]}, {"text": "tion in patients with severe asthma; thus, therapy directed toward", "bbox": [60.0, 748.0, 376.0, 761.0]}, {"text": "relief of bronchoconstriction should be continued. Mechanical", "bbox": [60.0, 762.0, 377.0, 776.0]}, {"text": "ventilation in the asthmatic patient can be difficult and associ-", "bbox": [60.0, 777.0, 375.0, 792.0]}, {"text": "ated risks require careful management. Intubation and positive-", "bbox": [60.0, 793.0, 375.0, 807.0]}, {"text": "pressure ventilation can trigger further bronchoconstriction and", "bbox": [60.0, 809.0, 376.0, 823.0]}, {"text": "complications such as breath stacking that result from incom-", "bbox": [60.0, 824.0, 375.0, 837.0]}, {"text": "plete expiration, air trapping, and buildup of positive end-", "bbox": [60.0, 839.0, 375.0, 854.0]}, {"text": "expiratory pressure (ie, intrinsic or auto-PEEP). This breath", "bbox": [60.0, 855.0, 376.0, 869.0]}, {"text": "stacking can cause barotrauma. Decreasing tidal volume may", "bbox": [60.0, 870.0, 375.0, 883.0]}, {"text": "avoid auto-PEEP and high peak airway pressures. Optimal", "bbox": [60.0, 885.0, 376.0, 899.0]}, {"text": "ventilator management requires expert consultation and ongoing", "bbox": [60.0, 901.0, 375.0, 914.0]}, {"text": "careful review of ventilation flow and pressure curves. Although", "bbox": [60.0, 916.0, 376.0, 930.0]}, {"text": "endotracheal intubation introduces risks, it should be performed", "bbox": [60.0, 931.0, 376.0, 945.0]}, {"text": "when necessary based on clinical condition.", "bbox": [60.0, 947.0, 280.0, 960.0]}, {"text": "Rapid sequence intubation is the technique of choice and", "bbox": [72.0, 962.0, 377.0, 976.0]}, {"text": "should be performed by an expert in airway management. The", "bbox": [60.0, 977.0, 376.0, 991.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "BLS treatment of cardiac arrest in asthmatic patients is", "bbox": [404.0, 962.0, 720.0, 976.0]}, {"text": "unchanged.", "bbox": [404.0, 977.0, 464.0, 991.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 17}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 210}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type3": "无关文本#8#8#evidence of benefit. 30出现在句末的无关数字引用\n无关文本#9#9#volumes (eg, 6 to 8 mL/kg), 36和patients without asthma. 37 出现在逗号或句末的无关数字引用\n无关文本#10#10#well tolerated. 38 . 39出现句末的无关数字引用\n无关文本#14#14#patients 40 – 43出现在句中的无关数字引用\n无关文本#16#16# adults 31 and children 32出现在句中的无关数字引用\n无关文本#21#21#Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011页脚内容", "type4": "栏目混乱#0#20#小标题和正文内容分开，且正文内容穿插出现", "type6": ""}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:30:44"}
{"id": 1042009, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "ba5cce1a-41ec-44ca-9afd-56681dfcf0df", "title": null, "text": "【0】页码:79\n Studies of lay rescuer AED programs in airports 111 and casinos 112 , 113 and of first-responder programs with police officers 22 , 44 , 46 , 63 , 114 – 116 have shown survival rates of 41% to 74% from out-of-hospital witnessed VF SCA when immediate bystander CPR is provided and defibrillation occurs within about 3 to 5 minutes of collapse. 70,117a Other studies117b,118 have demonstrated decreased time intervals from collapse to delivery of the first shock when AEDs were used during adult out-of-hospital cardiac arrest. However, if no decrease in time to defibrillation is achieved, then high survival rates are not observed. 119 – 121 In the large prospective randomized trial Public Access Defibrillation Trial (PAD), 122 lay rescuer CPR + AED programs in targeted public settings doubled the number of survivors from out-of-hospital VF SCA when compared with programs that provided early EMS call and early CPR. The programs included a planned response, lay rescuer training, and frequent retraining/practice. In another large population-based study, AED use prior to EMS arrival resulted in a doubling of survival. 123 In a prospective population-based study of > 300 000 patients, increased penetration of AEDs resulted in increased defibrillation by bystanders and increased survival compared to historical control. 124 Lay rescuer AED programs will have the greatest potential impact on survival from SCA if the programs are created in locations where SCA is likely to occur. In the PAD trial, programs were established at sites with a history of at least 1 out-of-hospital cardiac arrest every 2 years or where at least 1 out-of-hospital SCA was predicted during the study period (ie, sites having > 250 adults over 50 years of age present for > 16 hours/d). 122 Other data suggest that there is benefit when 1 out-of-hospital arrest is likely every 5 years. 125,126 CPR and AED use by public safety first responders (traditional and nontraditional) is recommended to increase survival rates for SCA (Class I, LOE B). Establishment of AED programs in public locations where there is a reasonable likelihood of witnessed cardiac arrest (eg, airports, casinos, and sports facilities) is recommended (Class I, LOE B).\n\n【1】Because the improvement in survival rates in AED programs is affected by the time to CPR and to defibrillation, it is reasonable for sites that deploy AEDs to establish a response plan, train likely responders in CPR and AED use, maintain equipment, and coordinate with local EMS systems (Class IIa, LOE B). 109,110 Sites without these components are unlikely to demonstrate any improvement in survival rates. 126 Approximately 80% of out-of-hospital cardiac arrests occur in private or residential settings. 127 One study128 demonstrated that survival was not improved in homes of high-risk individuals equipped with AEDs compared with homes where only CPR training had been provided.\n\n【2】AEDs are of no value for arrest not caused by VF/pulseless VT, and they are not effective for treatment of nonshockable rhythms that may develop after termination of VF. Nonperfusing rhythms are present in most patients after shock delivery, 22 , 28 , 63 , 129 and in general, CPR is required until a perfusing rhythm returns. Therefore, the AED rescuer should be trained not only to recognize emergencies and use the AED, but also to provide CPR until the AED is retrieved and ready for shock delivery and immediately after shock delivery.\n\n【3】 The mere presence of an AED does not ensure that it will be used when SCA occurs. Even in the PAD trial, in which almost 20 000 rescuers were trained to respond to SCA, lay rescuers attempted resuscitation before EMS arrival for only half of the victims of witnessed SCA, and the on-site AED was used for only 34% of the victims who experienced an arrest at locations with AED programs. 122 These findings suggest that lay rescuers need frequent practice to optimize response to emergencies.\n\n【4】It is reasonable for lay rescuer AED programs to implement processes of continuous quality improvement (Class IIa, LOE C). These quality improvement efforts should use both routine inspections and postevent data (from AED recordings and responder reports) to evaluate the following 110 , 130 :\n • Performance of the emergency response plan, including accurate time intervals for key interventions (such as collapse to shock or no shock advisory to initiation of CPR), and patient outcome • Responder performance • AED function, including accuracy of the ECG rhythm analysis • Battery status and function • Electrode pad function and readiness, including expiration\n date\n\n【5】## Automated Rhythm Analysis\n\n【6】\n AEDs analyze multiple features of the surface ECG signal, including frequency, amplitude, and some integration of frequency and amplitude, such as slope or wave morphology.\n\n【7】Filters check for QRS-like signals, radio transmission, or 50- or 60-cycle interference, as well as loose electrodes and poor electrode contact. The AHA has recommended performance goals for AED arrhythmia analysis algorithms, specifying sensitivity and specificity for various arrhythmias. 131 AEDs have been tested extensively both in vitro against libraries of recorded cardiac rhythms and clinically in many field trials in adults 131 , 132 and children. 133 – 135 They are extremely accurate in rhythm analysis. Although AEDs are not designed to deliver synchronized shocks (ie, cardioversion for VT with pulses), AEDs will recommend a (nonsynchronized) shock for monomorphic and polymorphic VT if the rate and R-wave morphology exceed preset values.\n\n【8】Some devices are programmed to detect spontaneous movement by the patient or others. Prototype defibrillators were used in 2 recent clinical trials evaluating quality of CPR in the out-of-hospital and in-hospital settings, which led to the development of AEDs that prompt rescuers to improve the quality of CPR provided. 33,34\n\n【9】## Aed Use In Children\n\n【10】\n Cardiac arrest is less common in children than adults, and its causes are more diverse. 136–139 Although VF is not a common arrhythmia in children, it is observed in 5% to 15% of pediatric and adolescent arrests. 138,140–143 In these patients rapid defibrillation may improve outcomes. 143 . 144 The lowest-energy dose for effective defibrillation in infants and children is not known. The upper limit for safe defibrillation is also not known, but doses > 4 J/kg (as high as 9 J/kg) have effectively defibrillated children 60.61 and pediatric animal models 145 with no significant\n\n【11】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Studies of lay rescuer AED programs in airports 111 and", "bbox": [72.0, 84.0, 377.0, 99.0]}, {"text": "casinos 112 , 113 and of first-responder programs with police offi-", "bbox": [60.0, 99.0, 375.0, 113.0]}, {"text": "cers 22 , 44 , 46 , 63 , 114 – 116 have shown survival rates of 41% to 74%", "bbox": [60.0, 114.0, 375.0, 131.0]}, {"text": "from out-of-hospital witnessed VF SCA when immediate by-", "bbox": [60.0, 131.0, 375.0, 145.0]}, {"text": "stander CPR is provided and defibrillation occurs within about 3", "bbox": [60.0, 147.0, 377.0, 161.0]}, {"text": "to 5 minutes of collapse. 70,117a Other studies117b,118 have demon-", "bbox": [60.0, 162.0, 375.0, 176.0]}, {"text": "strated decreased time intervals from collapse to delivery of the", "bbox": [60.0, 178.0, 376.0, 193.0]}, {"text": "first shock when AEDs were used during adult out-of-hospital", "bbox": [60.0, 194.0, 377.0, 207.0]}, {"text": "cardiac arrest. However, if no decrease in time to defibrillation is", "bbox": [60.0, 209.0, 377.0, 224.0]}, {"text": "achieved, then high survival rates are not observed. 119 – 121", "bbox": [60.0, 226.0, 348.0, 239.0]}, {"text": "In the large prospective randomized trial Public Access", "bbox": [72.0, 240.0, 376.0, 255.0]}, {"text": "Defibrillation Trial (PAD), 122 lay rescuer CPR + AED pro-", "bbox": [60.0, 257.0, 375.0, 270.0]}, {"text": "grams in targeted public settings doubled the number of survi-", "bbox": [60.0, 272.0, 375.0, 287.0]}, {"text": "vors from out-of-hospital VF SCA when compared with pro-", "bbox": [60.0, 288.0, 375.0, 301.0]}, {"text": "grams that provided early EMS call and early CPR. The", "bbox": [60.0, 303.0, 376.0, 318.0]}, {"text": "programs included a planned response, lay rescuer training, and", "bbox": [60.0, 320.0, 376.0, 333.0]}, {"text": "frequent retraining/practice. In another large population-based", "bbox": [60.0, 334.0, 376.0, 349.0]}, {"text": "study, AED use prior to EMS arrival resulted in a doubling of", "bbox": [60.0, 351.0, 377.0, 364.0]}, {"text": "survival. 123 In a prospective population-based study of", "bbox": [60.0, 366.0, 377.0, 381.0]}, {"text": "> 300 000 patients, increased penetration of AEDs resulted in", "bbox": [60.0, 382.0, 377.0, 395.0]}, {"text": "increased defibrillation by bystanders and increased survival", "bbox": [60.0, 397.0, 376.0, 412.0]}, {"text": "compared to historical control. 124", "bbox": [60.0, 414.0, 228.0, 427.0]}, {"text": "Lay rescuer AED programs will have the greatest potential", "bbox": [72.0, 428.0, 377.0, 443.0]}, {"text": "impact on survival from SCA if the programs are created in", "bbox": [60.0, 445.0, 377.0, 459.0]}, {"text": "locations where SCA is likely to occur. In the PAD trial,", "bbox": [60.0, 461.0, 376.0, 475.0]}, {"text": "programs were established at sites with a history of at least 1", "bbox": [60.0, 476.0, 375.0, 490.0]}, {"text": "out-of-hospital cardiac arrest every 2 years or where at least 1", "bbox": [60.0, 491.0, 375.0, 506.0]}, {"text": "out-of-hospital SCA was predicted during the study period (ie,", "bbox": [60.0, 508.0, 376.0, 521.0]}, {"text": "sites having > 250 adults over 50 years of age present for > 16", "bbox": [60.0, 523.0, 377.0, 537.0]}, {"text": "hours/d). 122 Other data suggest that there is benefit when 1", "bbox": [60.0, 539.0, 375.0, 552.0]}, {"text": "out-of-hospital arrest is likely every 5 years. 125,126", "bbox": [60.0, 554.0, 309.0, 568.0]}, {"text": "CPR and AED use by public safety first responders (tradi-", "bbox": [72.0, 570.0, 375.0, 584.0]}, {"text": "tional and nontraditional) is recommended to increase survival", "bbox": [60.0, 586.0, 377.0, 600.0]}, {"text": "rates for SCA (Class I, LOE B). Establishment of AED pro-", "bbox": [60.0, 602.0, 375.0, 615.0]}, {"text": "grams in public locations where there is a reasonable likelihood", "bbox": [60.0, 617.0, 377.0, 631.0]}, {"text": "of witnessed cardiac arrest (eg, airports, casinos, and sports", "bbox": [60.0, 633.0, 376.0, 647.0]}, {"text": "facilities) is recommended (Class I, LOE B).", "bbox": [60.0, 649.0, 285.0, 662.0]}, {"text": "Because the improvement in survival rates in AED programs", "bbox": [73.0, 664.0, 376.0, 677.0]}, {"text": "is affected by the time to CPR and to defibrillation, it is", "bbox": [60.0, 679.0, 377.0, 694.0]}, {"text": "reasonable for sites that deploy AEDs to establish a response", "bbox": [60.0, 696.0, 376.0, 709.0]}, {"text": "plan, train likely responders in CPR and AED use, maintain", "bbox": [60.0, 710.0, 377.0, 725.0]}, {"text": "equipment, and coordinate with local EMS systems (Class IIa,", "bbox": [60.0, 727.0, 375.0, 740.0]}, {"text": "LOE B). 109,110 Sites without these components are unlikely to", "bbox": [60.0, 741.0, 377.0, 757.0]}, {"text": "demonstrate any improvement in survival rates. 126", "bbox": [60.0, 758.0, 310.0, 771.0]}, {"text": "Approximately 80% of out-of-hospital cardiac arrests oc-", "bbox": [73.0, 774.0, 375.0, 788.0]}, {"text": "cur in private or residential settings. 127 One study128 demon-", "bbox": [60.0, 789.0, 375.0, 803.0]}, {"text": "strated that survival was not improved in homes of high-risk", "bbox": [60.0, 804.0, 376.0, 819.0]}, {"text": "individuals equipped with AEDs compared with homes", "bbox": [60.0, 821.0, 376.0, 834.0]}, {"text": "where only CPR training had been provided.", "bbox": [60.0, 836.0, 295.0, 850.0]}, {"text": "AEDs are of no value for arrest not caused by VF/pulseless", "bbox": [73.0, 852.0, 376.0, 866.0]}, {"text": "VT, and they are not effective for treatment of nonshockable", "bbox": [60.0, 868.0, 376.0, 882.0]}, {"text": "rhythms that may develop after termination of VF. Nonperfusing", "bbox": [60.0, 883.0, 375.0, 897.0]}, {"text": "rhythms are present in most patients after shock deliv-", "bbox": [60.0, 899.0, 375.0, 913.0]}, {"text": "ery, 22 , 28 , 63 , 129 and in general, CPR is required until a perfusing", "bbox": [60.0, 915.0, 376.0, 929.0]}, {"text": "rhythm returns. Therefore, the AED rescuer should be trained", "bbox": [60.0, 930.0, 377.0, 944.0]}, {"text": "not only to recognize emergencies and use the AED, but also to", "bbox": [60.0, 946.0, 376.0, 960.0]}, {"text": "provide CPR until the AED is retrieved and ready for shock", "bbox": [60.0, 962.0, 375.0, 976.0]}, {"text": "delivery and immediately after shock delivery.", "bbox": [60.0, 977.0, 293.0, 991.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "The mere presence of an AED does not ensure that it will be", "bbox": [416.0, 84.0, 720.0, 99.0]}, {"text": "used when SCA occurs. Even in the PAD trial, in which almost", "bbox": [404.0, 100.0, 721.0, 113.0]}, {"text": "20 000 rescuers were trained to respond to SCA, lay rescuers", "bbox": [404.0, 115.0, 720.0, 130.0]}, {"text": "attempted resuscitation before EMS arrival for only half of the", "bbox": [404.0, 132.0, 720.0, 145.0]}, {"text": "victims of witnessed SCA, and the on-site AED was used for", "bbox": [404.0, 147.0, 721.0, 160.0]}, {"text": "only 34% of the victims who experienced an arrest at locations", "bbox": [404.0, 163.0, 720.0, 176.0]}, {"text": "with AED programs. 122 These findings suggest that lay rescuers", "bbox": [404.0, 177.0, 720.0, 192.0]}, {"text": "need frequent practice to optimize response to emergencies.", "bbox": [403.0, 194.0, 704.0, 207.0]}, {"text": "It is reasonable for lay rescuer AED programs to imple-", "bbox": [416.0, 209.0, 719.0, 224.0]}, {"text": "ment processes of continuous quality improvement (Class IIa,", "bbox": [404.0, 225.0, 720.0, 239.0]}, {"text": "LOE C). These quality improvement efforts should use both", "bbox": [403.0, 240.0, 721.0, 254.0]}, {"text": "routine inspections and postevent data (from AED recordings", "bbox": [403.0, 256.0, 720.0, 270.0]}, {"text": "and responder reports) to evaluate the following 110 , 130 :", "bbox": [404.0, 271.0, 689.0, 286.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "• Performance of the emergency response plan, including", "bbox": [404.0, 297.0, 720.0, 312.0]}, {"text": "accurate time intervals for key interventions (such as", "bbox": [416.0, 314.0, 720.0, 327.0]}, {"text": "collapse to shock or no shock advisory to initiation of", "bbox": [416.0, 329.0, 721.0, 343.0]}, {"text": "CPR), and patient outcome", "bbox": [416.0, 344.0, 560.0, 358.0]}, {"text": "• Responder performance", "bbox": [403.0, 360.0, 542.0, 374.0]}, {"text": "• AED function, including accuracy of the ECG rhythm", "bbox": [403.0, 375.0, 721.0, 390.0]}, {"text": "analysis", "bbox": [416.0, 391.0, 461.0, 405.0]}, {"text": "• Battery status and function", "bbox": [403.0, 407.0, 560.0, 420.0]}, {"text": "• Electrode pad function and readiness, including expiration", "bbox": [403.0, 421.0, 721.0, 437.0]}], "type": "List-item", "position": 5}, {"raw_context": [{"text": "date", "bbox": [417.0, 439.0, 442.0, 451.0]}], "type": "List-item", "position": 6}, {"raw_context": [{"text": "Automated Rhythm Analysis", "bbox": [404.0, 467.0, 584.0, 481.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "AEDs analyze multiple features of the surface ECG signal,", "bbox": [404.0, 482.0, 719.0, 496.0]}, {"text": "including frequency, amplitude, and some integration of", "bbox": [403.0, 498.0, 721.0, 511.0]}, {"text": "frequency and amplitude, such as slope or wave morphology.", "bbox": [404.0, 514.0, 719.0, 528.0]}, {"text": "Filters check for QRS-like signals, radio transmission, or 50-", "bbox": [404.0, 528.0, 720.0, 542.0]}, {"text": "or 60-cycle interference, as well as loose electrodes and poor", "bbox": [403.0, 544.0, 721.0, 558.0]}, {"text": "electrode contact. The AHA has recommended performance", "bbox": [403.0, 560.0, 720.0, 573.0]}, {"text": "goals for AED arrhythmia analysis algorithms, specifying", "bbox": [404.0, 575.0, 720.0, 589.0]}, {"text": "sensitivity and specificity for various arrhythmias. 131", "bbox": [404.0, 591.0, 680.0, 604.0]}, {"text": "AEDs have been tested extensively both in vitro against", "bbox": [417.0, 606.0, 721.0, 621.0]}, {"text": "libraries of recorded cardiac rhythms and clinically in many", "bbox": [404.0, 622.0, 720.0, 635.0]}, {"text": "field trials in adults 131 , 132 and children. 133 – 135 They are ex-", "bbox": [403.0, 636.0, 719.0, 651.0]}, {"text": "tremely accurate in rhythm analysis. Although AEDs are not", "bbox": [403.0, 653.0, 721.0, 667.0]}, {"text": "designed to deliver synchronized shocks (ie, cardioversion for", "bbox": [403.0, 669.0, 720.0, 682.0]}, {"text": "VT with pulses), AEDs will recommend a (nonsynchronized)", "bbox": [404.0, 684.0, 721.0, 698.0]}, {"text": "shock for monomorphic and polymorphic VT if the rate and", "bbox": [403.0, 700.0, 721.0, 714.0]}, {"text": "R-wave morphology exceed preset values.", "bbox": [404.0, 716.0, 625.0, 729.0]}, {"text": "Some devices are programmed to detect spontaneous", "bbox": [416.0, 731.0, 720.0, 744.0]}, {"text": "movement by the patient or others. Prototype defibrillators", "bbox": [404.0, 747.0, 720.0, 760.0]}, {"text": "were used in 2 recent clinical trials evaluating quality of CPR", "bbox": [404.0, 762.0, 720.0, 776.0]}, {"text": "in the out-of-hospital and in-hospital settings, which led to the", "bbox": [403.0, 777.0, 720.0, 791.0]}, {"text": "development of AEDs that prompt rescuers to improve the", "bbox": [403.0, 793.0, 720.0, 807.0]}, {"text": "quality of CPR provided. 33,34", "bbox": [403.0, 808.0, 557.0, 823.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "AED Use in Children", "bbox": [404.0, 837.0, 540.0, 851.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "Cardiac arrest is less common in children than adults, and its", "bbox": [403.0, 853.0, 721.0, 866.0]}, {"text": "causes are more diverse. 136–139 Although VF is not a common", "bbox": [403.0, 867.0, 720.0, 882.0]}, {"text": "arrhythmia in children, it is observed in 5% to 15% of pediatric", "bbox": [404.0, 884.0, 720.0, 897.0]}, {"text": "and adolescent arrests. 138,140–143 In these patients rapid defibril-", "bbox": [404.0, 898.0, 720.0, 913.0]}, {"text": "lation may improve outcomes. 143 . 144 The lowest-energy dose for", "bbox": [404.0, 914.0, 720.0, 929.0]}, {"text": "effective defibrillation in infants and children is not known. The", "bbox": [403.0, 930.0, 720.0, 944.0]}, {"text": "upper limit for safe defibrillation is also not known, but doses", "bbox": [403.0, 946.0, 720.0, 960.0]}, {"text": "> 4 J/kg (as high as 9 J/kg) have effectively defibrillated", "bbox": [404.0, 962.0, 720.0, 976.0]}, {"text": "children 60.61 and pediatric animal models 145 with no significant", "bbox": [403.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 79}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "缺少换行#0#0#In the large prospective另起一行\nLay rescuer AED programs will另起一行\nCPR and AED use by public另起一行\n缺少换行#1#1#Approximately 80% of 另起一行\n缺少换行#4#4#类似• Responder performance前面有点的应该另起一行\n多余换行#4#4#including expiration date是一句话\n缺少换行#7#7#AEDs have been tested extensively应该另起一行", "type3": "无关文本#0#11#airports 111出现在句中或者句末的无关数字引用多次出现，应用全文\n无关文本#11#11#Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011页脚内容", "type4": null, "type6": ""}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 21:58:41"}
{"id": 1042008, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "48a35582-20c4-460b-829a-450705ffe35e", "title": null, "text": "【0】页码:24\n 5. Inability to close eyelid fully\n\n【1】 6. Inability to blink\n\n【2】 7. Inability to squint\n\n【3】 8. Tearing\n\n【4】 9. Dry eyes\n\n【5】 10. Redness and soreness in the sclera – the white part of the eye\n\n【6】 11. Irritation and pain in the eyes\n\n【7】 12. Please note: seek medical help immediately if you are experiencing any problems with your eyes.\n\n【8】## Mouth\n\n【9】\n 1. Corner of the mouth droops or pulls down\n\n【10】 2. Difficulty speaking\n\n【11】 3. Difficulty smiling, eating and drinking\n\n【12】 4. Inability to whistle or blow out air\n\n【13】 5. Altered taste sensation, can be accompanied with tingling sensations on the affected side of the tongue\n\n【14】 6. Difficulty opening mouth, brushing, flossing and spitting\n\n【15】 7. Dry mouth\n\n【16】 8. Changes in quantities of saliva produced\n\n【17】 9. Inability to pull the lips back or pout\n\n【18】 Ears\n\n【19】 1. Sensitivity to sound\n\n【20】 2. Pain in the affected ear or behind the ear\n\n【21】 3. Loss of hearing", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "5. Inability to close eyelid fully", "bbox": [106.0, 96.0, 358.0, 117.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "6. Inability to blink", "bbox": [106.0, 131.0, 267.0, 151.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "7. Inability to squint", "bbox": [106.0, 166.0, 274.0, 186.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "8. Tearing", "bbox": [106.0, 201.0, 197.0, 221.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "9. Dry eyes", "bbox": [106.0, 234.0, 206.0, 256.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "10. Redness and soreness in the sclera – the white part of the eye", "bbox": [98.0, 271.0, 606.0, 292.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "11. Irritation and pain in the eyes", "bbox": [97.0, 306.0, 363.0, 326.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "12. Please note: seek medical help immediately if you are experiencing any", "bbox": [98.0, 340.0, 722.0, 361.0]}, {"text": "problems with your eyes.", "bbox": [131.0, 363.0, 330.0, 382.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Mouth", "bbox": [92.0, 401.0, 155.0, 424.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "1. Corner of the mouth droops or pulls down", "bbox": [106.0, 458.0, 461.0, 478.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "2. Difficulty speaking", "bbox": [106.0, 493.0, 285.0, 513.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "3. Difficulty smiling, eating and drinking", "bbox": [106.0, 528.0, 434.0, 548.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "4. Inability to whistle or blow out air", "bbox": [106.0, 563.0, 400.0, 583.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "5. Altered taste sensation, can be accompanied with tingling sensations on the", "bbox": [106.0, 597.0, 722.0, 617.0]}, {"text": "affected side of the tongue", "bbox": [131.0, 620.0, 340.0, 639.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "6. Difficulty opening mouth, brushing, flossing and spitting", "bbox": [106.0, 653.0, 576.0, 674.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "7. Dry mouth", "bbox": [106.0, 689.0, 221.0, 711.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "8. Changes in quantities of saliva produced", "bbox": [106.0, 725.0, 449.0, 744.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "9. Inability to pull the lips back or pout", "bbox": [106.0, 759.0, 418.0, 779.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Ears", "bbox": [93.0, 799.0, 138.0, 821.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "1. Sensitivity to sound", "bbox": [107.0, 855.0, 290.0, 875.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "2. Pain in the affected ear or behind the ear", "bbox": [106.0, 888.0, 448.0, 910.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "3. Loss of hearing", "bbox": [106.0, 924.0, 257.0, 945.0]}], "type": "Text", "position": 21}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 24}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": ""}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:21:50"}
{"id": 1042007, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "8f496d43-bce2-4266-b87e-cf51055e9a3e", "title": null, "text": "【0】页码:144\n Fig. 79. Lengths of the external arm.\n\n【1】 In order to make the force optimal, we must determine the length and angulation of the external arm, so the line of action of the force passes through the center of resistance of the molar. A molar inclination can accentuate the opening\n\n【2】## Asymmetrical Cervical Face Bow\n\n【3】\n This type of force is used for unilateral traction or for asymmetrical force. There are two simple ways to obtain this force:\n\n【4】 1.\n\n【5】 2.\n\n【6】 Bend the external arm away from the face of the patient on the side where is needed more force.\n\n【7】Another way to obtain an asymmetrical force is cutting a piece of wire of an external arm. This is sectioned at the first molar level. On the side that has been cut we will have less force, so the contra lateral side (the side that has not been cut) will exert almost\n triple the force compared to the side in which wire of the external arm was cut off. (17)\n Fig. 80. Cervical traction. \"C\" short external arm; \"M\" medium external arm; \"L\" long external arm. \"A\" high angulation (30\" ); \"H\" horizontal angulation (O\" ); \"B\" low angulation (-30\").", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Fig. 79. Lengths of the external arm.", "bbox": [156.0, 319.0, 319.0, 335.0]}], "type": "Caption", "position": 2}, {"raw_context": [{"text": "In order to make the force optimal, we must determine the", "bbox": [81.0, 378.0, 396.0, 394.0]}, {"text": "length and angulation of the external arm, so the line of", "bbox": [80.0, 396.0, 396.0, 411.0]}, {"text": "action of the force passes through the center of resistance of", "bbox": [80.0, 412.0, 397.0, 429.0]}, {"text": "the molar. A molar inclination can accentuate the opening", "bbox": [80.0, 430.0, 396.0, 447.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Asymmetrical cervical face bow", "bbox": [418.0, 80.0, 659.0, 100.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "This type of force is used for unilateral traction or for", "bbox": [418.0, 116.0, 733.0, 133.0]}, {"text": "asymmetrical force. There are two simple ways to obtain", "bbox": [418.0, 134.0, 733.0, 151.0]}, {"text": "this force:", "bbox": [418.0, 151.0, 477.0, 168.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "1.", "bbox": [419.0, 189.0, 434.0, 203.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "2.", "bbox": [418.0, 221.0, 433.0, 237.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Bend the external arm away from the face of the", "bbox": [443.0, 186.0, 733.0, 204.0]}, {"text": "patient on the side where is needed more force.", "bbox": [445.0, 204.0, 706.0, 219.0]}, {"text": "Another way to obtain an asymmetrical force is", "bbox": [444.0, 221.0, 733.0, 237.0]}, {"text": "cutting a piece of wire of an external arm. This is", "bbox": [444.0, 239.0, 733.0, 254.0]}, {"text": "sectioned at the first molar level. On the side that has", "bbox": [444.0, 255.0, 733.0, 272.0]}, {"text": "been cut we will have less force, so the contra lateral", "bbox": [444.0, 273.0, 732.0, 290.0]}, {"text": "side (the side that has not been cut) will exert almost", "bbox": [444.0, 291.0, 732.0, 306.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "triple the force compared to the side in which wire of", "bbox": [444.0, 307.0, 733.0, 323.0]}, {"text": "the external arm was cut off. (17)", "bbox": [444.0, 325.0, 616.0, 341.0]}], "type": "List-item", "position": 9}, {"raw_context": [{"text": "Fig. 80. Cervical traction. \"C\" short external arm; \"M\" medium external arm; \"L\" long external arm. \"A\" high angulation (30\" );", "bbox": [80.0, 883.0, 629.0, 899.0]}, {"text": "\"H\" horizontal angulation (O\" ); \"B\" low angulation (-30\").", "bbox": [80.0, 899.0, 334.0, 916.0]}], "type": "Caption", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 144}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#4#7#序号和正文分离", "type3": "无关文本#0#0#非正文\n无关文本#7#7#Fig. 80. Cervical traction. “C” short external arm; “M” medium external arm; “L” long external arm. “A” high angulation (30\" ); “H” horizontal angulation (O\" ); “B” low angulation (-30\").非正文内容", "type4": "语义不完整#1#1#结尾不完整", "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:32:53"}
{"id": 1042006, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "47b0f372-6abc-4d66-9e21-c9b14078107e", "title": null, "text": "【0】页码:39\n Intrusion of the molar and the incisors.\n\n【1】4.\n\n【2】5.\n\n【3】Positive torque in molars and incisors.\n\n【4】6.\n\n【5】Distal inclination of the crown and mesial inclination of the roots.\n\n【6】7.\n\n【7】Increase in length in the lower dental arch.\n\n【8】## Correction Of A Bilateral Posterior Open Bite With Reverse Curves\n\n【9】\n For the correction of this problem we can also help our¬ selves with the use of reverse curves (Retranol, GAC). The action principle of the curves, in this case, is exactly the same one that we use for the leveling of a deep Spee curve.\n\n【10】The reactions that are produced at molar, premolar and incisor levels are the same in the upper and lower dental\n Fig. 57. Lower inverse curve and an upper curve.\n\n【11】 arches. We simply have to know how to place the reverse curves in order to have the desired effect, that in this case is the closure of the bilateral open bite. On the contrary, if we do not place the curves correctly, far from solving the problem we can complicate it even more.\n Fig. 58. The curves will provoke premolar extrusion in the upper and lower dental arches, and the intrusion of molars and incisors in both dental arches.\n inclination of the roots, and a positive torque at the incisor level in both\n dental arches.\n\n【12】## Action Taken\n\n【13】\n 1.\n\n【14】 Use of curves on both dental arches.\n\n【15】 Produced reaction Intrusion of upper and lower molars and incisors.\n\n【16】1.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Intrusion of the molar and the incisors.", "bbox": [94.0, 85.0, 311.0, 102.0]}, {"text": "4.", "bbox": [68.0, 86.0, 83.0, 102.0]}, {"text": "5.", "bbox": [68.0, 102.0, 83.0, 118.0]}, {"text": "Positive torque in molars and incisors.", "bbox": [94.0, 102.0, 307.0, 118.0]}, {"text": "6.", "bbox": [67.0, 120.0, 83.0, 136.0]}, {"text": "Distal inclination of the crown and mesial inclination", "bbox": [94.0, 120.0, 382.0, 136.0]}, {"text": "of the roots.", "bbox": [94.0, 136.0, 164.0, 153.0]}, {"text": "7.", "bbox": [68.0, 153.0, 82.0, 170.0]}, {"text": "Increase in length in the lower dental arch.", "bbox": [93.0, 154.0, 330.0, 171.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Correction of a bilateral posterior open", "bbox": [68.0, 240.0, 363.0, 257.0]}, {"text": "bite with reverse curves", "bbox": [68.0, 258.0, 250.0, 275.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "For the correction of this problem we can also help our¬", "bbox": [68.0, 292.0, 381.0, 309.0]}, {"text": "selves with the use of reverse curves (Retranol, GAC). The", "bbox": [68.0, 310.0, 382.0, 327.0]}, {"text": "action principle of the curves, in this case, is exactly the", "bbox": [68.0, 328.0, 382.0, 344.0]}, {"text": "same one that we use for the leveling of a deep Spee curve.", "bbox": [68.0, 345.0, 381.0, 362.0]}, {"text": "The reactions that are produced at molar, premolar and", "bbox": [68.0, 363.0, 382.0, 379.0]}, {"text": "incisor levels are the same in the upper and lower dental", "bbox": [67.0, 380.0, 382.0, 396.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Fig. 57. Lower inverse curve and an upper curve.", "bbox": [115.0, 959.0, 329.0, 975.0]}], "type": "Caption", "position": 6}, {"raw_context": [{"text": "arches. We simply have to know how to place the reverse", "bbox": [404.0, 86.0, 719.0, 103.0]}, {"text": "curves in order to have the desired effect, that in this case", "bbox": [404.0, 104.0, 719.0, 120.0]}, {"text": "is the closure of the bilateral open bite. On the contrary, if", "bbox": [404.0, 121.0, 720.0, 137.0]}, {"text": "we do not place the curves correctly, far from solving the", "bbox": [404.0, 139.0, 719.0, 155.0]}, {"text": "problem we can complicate it even more.", "bbox": [404.0, 157.0, 633.0, 172.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Fig. 58. The curves will provoke premolar extrusion in the upper and", "bbox": [403.0, 518.0, 718.0, 532.0]}, {"text": "lower dental arches, and the intrusion of molars and incisors in both", "bbox": [403.0, 531.0, 718.0, 545.0]}, {"text": "dental arches.", "bbox": [404.0, 544.0, 467.0, 560.0]}], "type": "Caption", "position": 9}, {"raw_context": [{"text": "inclination of the roots, and a positive torque at the incisor level in both", "bbox": [402.0, 831.0, 718.0, 845.0]}], "type": "Caption", "position": 11}, {"raw_context": [{"text": "dental arches.", "bbox": [402.0, 845.0, 466.0, 859.0]}], "type": "Caption", "position": 12}, {"raw_context": [{"text": "Action taken", "bbox": [402.0, 888.0, 486.0, 904.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "1.", "bbox": [403.0, 907.0, 418.0, 922.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "Use of curves on both dental arches.", "bbox": [428.0, 906.0, 631.0, 922.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Produced reaction", "bbox": [402.0, 940.0, 520.0, 957.0]}, {"text": "Intrusion of upper and lower molars and incisors.", "bbox": [429.0, 958.0, 705.0, 975.0]}, {"text": "1.", "bbox": [404.0, 960.0, 417.0, 974.0]}], "type": "Text", "position": 16}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 39}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#1#1#与上面0段Intrusion of the molar and the incisors.联接，是0段的序号\n多余换行#3#3#Positive torque in ...与上面2段5.联接，是2段的内容\n多余换行#5#5#Distal inclination of the crown...与上面4段联接，是4段的内容\n多余换行#7#7#Increase in length in the ...与上面6段联接，是6段的内容\n多余换行#11#11# arches. We simply have to know how...与上面10段联接\n多余换行#14#14#Use of curves on both...与上面13段联接，是13段的内容\n多余换行#16#16#与上面15段 Produced reaction Intrusion of...联接，是15段的序号", "type3": null, "type4": null, "type5": null, "type6": "有用性#10#10#Fig. 57. Lower inverse curve and an upper curve.图片的描述\n有用性#11#11#Fig. 58. The curves will provoke premolar extrusion in the upper ...dental arches.图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:01:23"}
{"id": 1042005, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "5126f380-ba7c-43a6-9fcb-9accdb082829", "title": null, "text": "【0】页码:83\n 7) We must take X-rays at 6-month intervals to see that everything is in order.\n Fig. 138. We must take X-rays every 6 months to verify that the implant is still in the original placement site.\n\n【1】## Advantages\n\n【2】\n i.\n\n【3】2.\n\n【4】3.\n\n【5】4.\n\n【6】5.\n\n【7】6.\n\n【8】 Mini implants offer the best anchorage.\n\n【9】They require minimal patient cooperation.\n\n【10】Less treatment time required for anterosuperior sector retraction.\n\n【11】Overall treatment time reduction.\n\n【12】Less surgical instruments needed. (21) Allows alignment and retraction of the anterior sector.\n\n【13】Helps the correction of shifts along the medial line.\n\n【14】Allows space closure of edentulous posterior spaces in order to avoid prosthetics. (21.22)\n\n【15】 7.\n\n【16】8.\n\n【17】## Disadvantages\n\n【18】\n 1.\n\n【19】 2.\n\n【20】 3,\n\n【21】 Represents an extra expense that the patient has to pay.\n\n【22】Its use has certain counter indications, such as: Acute infectious processes.\n\n【23】a) (b) Uncontrolled diabetic patients.\n\n【24】c) Patients who smoke, because nicotine inhibits osseointegration.\n\n【25】Persistent periodontal disease. (2.22) (hod) Not always accepted by the patient because of the surgery involved.\n\n【26】## Recommendations\n\n【27】\n 1.\n\n【28】 2.\n\n【29】 3.\n\n【30】 The use of mini implants is recommended only in patients that have excellent oral hygiene; those who do not are at risk of developing periimplantitis. 123 A complete medical history is essential. (2) Once the implant is removed, we must tell the patient to continue with the good oral hygiene program complemented with a Clorhexidine based mouthwash in order to prevent infection of the implant site.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "7)", "bbox": [66.0, 85.0, 82.0, 102.0]}, {"text": "We must take X-rays at 6-month intervals to see that", "bbox": [92.0, 86.0, 381.0, 102.0]}, {"text": "everything is in order.", "bbox": [92.0, 103.0, 215.0, 119.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Fig. 138. We must take X-rays every 6 months to verify that the", "bbox": [90.0, 366.0, 379.0, 384.0]}, {"text": "implant is still in the original placement site.", "bbox": [91.0, 382.0, 286.0, 397.0]}], "type": "Caption", "position": 3}, {"raw_context": [{"text": "Advantages", "bbox": [65.0, 422.0, 152.0, 438.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "i.", "bbox": [66.0, 458.0, 80.0, 473.0]}, {"text": "2.", "bbox": [65.0, 474.0, 78.0, 490.0]}, {"text": "3.", "bbox": [65.0, 491.0, 80.0, 507.0]}, {"text": "4.", "bbox": [64.0, 525.0, 78.0, 541.0]}, {"text": "5.", "bbox": [65.0, 543.0, 79.0, 559.0]}, {"text": "6.", "bbox": [64.0, 562.0, 79.0, 577.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Mini implants offer the best anchorage.", "bbox": [91.0, 456.0, 310.0, 473.0]}, {"text": "They require minimal patient cooperation.", "bbox": [92.0, 475.0, 327.0, 490.0]}, {"text": "Less treatment time required for anterosuperior", "bbox": [91.0, 492.0, 358.0, 508.0]}, {"text": "sector retraction.", "bbox": [93.0, 509.0, 192.0, 525.0]}, {"text": "Overall treatment time reduction.", "bbox": [91.0, 526.0, 281.0, 542.0]}, {"text": "Less surgical instruments needed. (21)", "bbox": [91.0, 543.0, 293.0, 560.0]}, {"text": "Allows alignment and retraction of the anterior", "bbox": [91.0, 561.0, 357.0, 577.0]}, {"text": "sector.", "bbox": [91.0, 579.0, 132.0, 594.0]}, {"text": "Helps the correction of shifts along the medial line.", "bbox": [91.0, 595.0, 374.0, 612.0]}, {"text": "Allows space closure of edentulous posterior spaces", "bbox": [91.0, 613.0, 380.0, 629.0]}, {"text": "in order to avoid prosthetics. (21.22)", "bbox": [91.0, 630.0, 275.0, 646.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "7.", "bbox": [64.0, 595.0, 80.0, 611.0]}, {"text": "8.", "bbox": [65.0, 614.0, 79.0, 627.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Disadvantages", "bbox": [64.0, 663.0, 170.0, 680.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "1.", "bbox": [66.0, 700.0, 80.0, 715.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "2.", "bbox": [64.0, 733.0, 79.0, 749.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "3,", "bbox": [64.0, 837.0, 79.0, 853.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Represents an extra expense that the patient has to", "bbox": [91.0, 700.0, 380.0, 715.0]}, {"text": "pay.", "bbox": [91.0, 718.0, 117.0, 732.0]}, {"text": "Its use has certain counter indications, such as:", "bbox": [91.0, 734.0, 352.0, 750.0]}, {"text": "Acute infectious processes.", "bbox": [112.0, 752.0, 265.0, 767.0]}, {"text": "a)", "bbox": [91.0, 754.0, 107.0, 766.0]}, {"text": "(b)", "bbox": [90.0, 769.0, 108.0, 784.0]}, {"text": "Uncontrolled diabetic patients.", "bbox": [113.0, 769.0, 286.0, 785.0]}, {"text": "c)", "bbox": [90.0, 787.0, 107.0, 802.0]}, {"text": "Patients who smoke, because nicotine inhibits", "bbox": [114.0, 787.0, 367.0, 802.0]}, {"text": "osseointegration.", "bbox": [114.0, 803.0, 210.0, 818.0]}, {"text": "Persistent periodontal disease. (2.22)", "bbox": [111.0, 820.0, 301.0, 837.0]}, {"text": "(hod)", "bbox": [91.0, 821.0, 109.0, 835.0]}, {"text": "Not always accepted by the patient because of the", "bbox": [91.0, 838.0, 379.0, 854.0]}, {"text": "surgery involved.", "bbox": [91.0, 855.0, 188.0, 871.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Recommendations", "bbox": [402.0, 87.0, 533.0, 103.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "1.", "bbox": [402.0, 122.0, 416.0, 137.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "2.", "bbox": [402.0, 174.0, 416.0, 189.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "3.", "bbox": [402.0, 191.0, 416.0, 207.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "The use of mini implants is recommended only in", "bbox": [428.0, 122.0, 716.0, 138.0]}, {"text": "patients that have excellent oral hygiene; those who", "bbox": [428.0, 139.0, 716.0, 156.0]}, {"text": "do not are at risk of developing periimplantitis. 123", "bbox": [428.0, 157.0, 698.0, 174.0]}, {"text": "A complete medical history is essential. (2)", "bbox": [429.0, 175.0, 655.0, 189.0]}, {"text": "Once the implant is removed, we must tell the patient", "bbox": [428.0, 191.0, 716.0, 207.0]}, {"text": "to continue with the good oral hygiene program", "bbox": [428.0, 209.0, 716.0, 224.0]}, {"text": "complemented with a Clorhexidine based mouthwash", "bbox": [428.0, 226.0, 716.0, 242.0]}, {"text": "in order to prevent infection of the implant site.", "bbox": [428.0, 243.0, 692.0, 260.0]}], "type": "Text", "position": 17}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 83}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#2#2#i.应是1.\n", "type2": "多余换行#2#16#序号和正文分离1.和Mini implants offer the best anchorage.是一句话，以此类推\n 缺少换行#12#12#Allows alignment and另起一行\n多余换行#18#25#序号和正文分离1.和Represents an extra expense是一句话，以此类推\n 缺少换行#22#22#Acute infectious ling'qi'yi'hangprocesses.另起一行，接a)后面\n 缺少换行#23#23# (b) Uncontrolled diabetic patients.另起一行\n缺少序号#25#25#句首缺少d) \n缺少换行#25#25#Not always accepted by the另起一行\n多余换行#27#30#序号和正文分离1.和The use of mini implants is是一句话，以此类推\n 缺少换行#30#30#A complete medical history另起一行\nOnce the implant is removed,另起一行", "type3": "无关文本#0#30#instruments needed. (21)出现在句末的无关数字引用，应用全文", "type6": "有用性#0#0#Fig. 138. We must take X-rays every 6 months to verify that the implant is still in the original placement site.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:49:43"}
{"id": 1042004, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "5e86dd4f-d0f2-46d5-aef5-772da3ef6044", "title": null, "text": "【0】页码:43\n# Part 4: Cpr Overview 2010 American Heart Association Guidelines For Cardiopulmonary Resuscitation And Emergency Cardiovascular Care\n\n【1】\n Andrew H. Travers, Co-Chair*; Thomas D. Rea, Co-Chair*; Bentley J. Bobrow; Dana P. Edelson; Robert A. Berg; Michael R. Sayre; Marc D. Berg; Leon Chameides; Robert E. O'Connor; Robert A. Swor\n\n【2】 T ardiopulmonary resuscitation (CPR) is a series of lifefollowing cardiac arrest. 1 Although the optimal approach to CPR may vary, depending on the rescuer, the victim, and the available resources, the fundamental challenge remains: how to achieve early and effective CPR. Given this challenge, recognition of arrest and prompt action by the rescuer continue to be priorities for the 2010 AHA Guidelines for CPR and ECC . This chapter provides an overview of cardiac arrest epidemiology, the principles behind each link in the Chain of Survival, an overview of the core components of CPR (see Table 1), and the approaches of the 2010 AHA Guidelines for CPR and ECC to improving the quality of CPR.  The goal of this chapter is to integrate resuscitation science with real-world practice in order to improve the outcomes of CPR.\n\n【3】## Epidemiology\n\n【4】\n Despite important advances in prevention, cardiac arrest remains a substantial public health problem and a leading cause of death in many parts of the world. 2 Cardiac arrest occurs both in and out of the hospital. In the US and Canada, approximately 350 000 people/year (approximately half of them in-hospital) suffer a cardiac arrest and receive attempted resuscitation. 3–7 This estimate does not include the substantial number of victims who suffer an arrest without attempted resuscitation. While attempted resuscitation is not always appropriate, there are many lives and life-years lost because appropriate resuscitation is not attempted.\n\n【5】The estimated incidence of EMS-treated out-of-hospital cardiac arrest in the US and Canada is about 50 to 55/100 000 persons/year and approximately 25% of these present with pulseless ventricular arrhythmias. 3 . 8 The estimated incidence of in-hospital cardiac arrest is 3 to 6/1000 admissions 4–6 and similarly, approximately 25% of these present with pulseless ventricular arrhythmias. 7 Cardiac arrest victims who present with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) have a substantially better outcome com-\n\n【6】 pared with those who present with asystole or pulseless electric activity. 1 . 7 . 9 The vast majority of cardiac arrest victims are adults, but thousands of infants and children suffer either an in-hospital or out-of-hospital cardiac arrest each year in the US and Canada. 7,10\n\n【7】 Cardiac arrest continues to be an all-too-common cause of premature death, and small incremental improvements in survival can translate into thousands of lives saved every year.\n\n【8】## Key Principles In Resuscitation: Strengthening The Links In The Chain Of Survival\n\n【9】\n Successful resuscitation following cardiac arrest requires an integrated set of coordinated actions represented by the links in the Chain of Survival (see Figure 1).\n\n【10】The links include the following:\n\n【11】 • Immediate recognition of cardiac arrest and activation of the emergency response system • Early CPR with an emphasis on chest compressions • Rapid defibrillation\n\n【12】## • Effective Advanced Life Support • Integrated Post–Cardiac Arrest Care\n\n【13】\n Emergency systems that can effectively implement these links can achieve witnessed VF cardiac arrest survival of almost 50%. 11 -14 In most emergency systems, however, survival is lower, indicating that there is an opportunity for improvement by carefully examining the links and strengthening those that are weak. 3 The individual links are interdependent, and the success of each link is dependent on the effectiveness of those that precede it.\n\n【14】Rescuers have a wide variety of training, experience, and skills. The cardiac arrest victim's status and response to CPR maneuvers, as well as the settings in which the arrests occur, can also be heterogeneous. The challenge is how to encourage early, effective CPR for as many victims as possible, taking\n The American Heart Association requests that this document be cited as follows: Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR, Berg MD, Chameides L, O'Connor RE, Swor RA. Part 4: CPR overview: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S676–S684.\n\n【15】°Co-chairs and equal first co-authors.\n\n【16】( Circulation . 2010;122[suppl 3]:S676–S684.) © 2010 American Heart Association, Inc.\n\n【17】Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.110.970913", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Part 4: CPR Overview", "bbox": [265.0, 106.0, 515.0, 133.0]}, {"text": "2010 American Heart Association Guidelines for Cardiopulmonary", "bbox": [96.0, 137.0, 685.0, 160.0]}, {"text": "Resuscitation and Emergency Cardiovascular Care", "bbox": [167.0, 160.0, 615.0, 181.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "Andrew H. Travers, Co-Chair*; Thomas D. Rea, Co-Chair*; Bentley J. Bobrow;", "bbox": [135.0, 195.0, 646.0, 213.0]}, {"text": "Dana P. Edelson; Robert A. Berg; Michael R. Sayre; Marc D. Berg;", "bbox": [164.0, 214.0, 617.0, 229.0]}, {"text": "Leon Chameides; Robert E. O'Connor; Robert A. Swor", "bbox": [202.0, 232.0, 572.0, 247.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "T ardiopulmonary resuscitation (CPR) is a series of life-", "bbox": [60.0, 272.0, 377.0, 304.0]}, {"text": "following cardiac arrest. 1 Although the optimal approach to", "bbox": [60.0, 305.0, 376.0, 319.0]}, {"text": "CPR may vary, depending on the rescuer, the victim, and the", "bbox": [60.0, 321.0, 376.0, 334.0]}, {"text": "available resources, the fundamental challenge remains: how", "bbox": [60.0, 336.0, 375.0, 350.0]}, {"text": "to achieve early and effective CPR. Given this challenge,", "bbox": [60.0, 352.0, 375.0, 366.0]}, {"text": "recognition of arrest and prompt action by the rescuer", "bbox": [60.0, 368.0, 376.0, 381.0]}, {"text": "continue to be priorities for the 2010 AHA Guidelines for", "bbox": [60.0, 383.0, 375.0, 397.0]}, {"text": "CPR and ECC . This chapter provides an overview of cardiac", "bbox": [60.0, 399.0, 375.0, 413.0]}, {"text": "arrest epidemiology, the principles behind each link in the", "bbox": [60.0, 414.0, 376.0, 428.0]}, {"text": "Chain of Survival, an overview of the core components of", "bbox": [60.0, 430.0, 376.0, 444.0]}, {"text": "CPR (see Table 1), and the approaches of the 2010 AHA", "bbox": [60.0, 446.0, 376.0, 460.0]}, {"text": "Guidelines for CPR and ECC to improving the quality of", "bbox": [60.0, 461.0, 376.0, 475.0]}, {"text": "CPR.  The goal of this chapter is to integrate resuscitation", "bbox": [60.0, 477.0, 376.0, 491.0]}, {"text": "science with real-world practice in order to improve the", "bbox": [60.0, 493.0, 375.0, 507.0]}, {"text": "outcomes of CPR.", "bbox": [60.0, 508.0, 157.0, 522.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Epidemiology", "bbox": [171.0, 538.0, 263.0, 553.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Despite important advances in prevention, cardiac arrest", "bbox": [60.0, 554.0, 376.0, 568.0]}, {"text": "remains a substantial public health problem and a leading", "bbox": [60.0, 570.0, 375.0, 583.0]}, {"text": "cause of death in many parts of the world. 2 Cardiac arrest", "bbox": [60.0, 585.0, 377.0, 600.0]}, {"text": "occurs both in and out of the hospital. In the US and Canada,", "bbox": [60.0, 601.0, 375.0, 615.0]}, {"text": "approximately 350 000 people/year (approximately half of", "bbox": [60.0, 616.0, 376.0, 630.0]}, {"text": "them in-hospital) suffer a cardiac arrest and receive attempted", "bbox": [60.0, 632.0, 376.0, 646.0]}, {"text": "resuscitation. 3–7 This estimate does not include the substantial", "bbox": [60.0, 648.0, 376.0, 662.0]}, {"text": "number of victims who suffer an arrest without attempted", "bbox": [60.0, 663.0, 377.0, 677.0]}, {"text": "resuscitation. While attempted resuscitation is not always", "bbox": [60.0, 678.0, 377.0, 692.0]}, {"text": "appropriate, there are many lives and life-years lost because", "bbox": [60.0, 694.0, 375.0, 708.0]}, {"text": "appropriate resuscitation is not attempted.", "bbox": [60.0, 710.0, 280.0, 723.0]}, {"text": "The estimated incidence of EMS-treated out-of-hospital", "bbox": [74.0, 725.0, 376.0, 739.0]}, {"text": "cardiac arrest in the US and Canada is about 50 to 55/100 000", "bbox": [60.0, 741.0, 376.0, 755.0]}, {"text": "persons/year and approximately 25% of these present with", "bbox": [60.0, 757.0, 376.0, 770.0]}, {"text": "pulseless ventricular arrhythmias. 3 . 8 The estimated incidence", "bbox": [60.0, 772.0, 376.0, 786.0]}, {"text": "of in-hospital cardiac arrest is 3 to 6/1000 admissions 4–6 and", "bbox": [60.0, 788.0, 377.0, 802.0]}, {"text": "similarly, approximately 25% of these present with pulseless", "bbox": [60.0, 803.0, 376.0, 817.0]}, {"text": "ventricular arrhythmias. 7 Cardiac arrest victims who present", "bbox": [60.0, 819.0, 377.0, 833.0]}, {"text": "with ventricular fibrillation (VF) or pulseless ventricular", "bbox": [60.0, 835.0, 376.0, 849.0]}, {"text": "tachycardia (VT) have a substantially better outcome com-", "bbox": [60.0, 850.0, 375.0, 864.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "pared with those who present with asystole or pulseless", "bbox": [403.0, 273.0, 721.0, 287.0]}, {"text": "electric activity. 1 . 7 . 9", "bbox": [403.0, 289.0, 508.0, 303.0]}, {"text": "The vast majority of cardiac arrest victims are adults, but", "bbox": [417.0, 305.0, 721.0, 319.0]}, {"text": "thousands of infants and children suffer either an in-hospital", "bbox": [403.0, 321.0, 720.0, 334.0]}, {"text": "or out-of-hospital cardiac arrest each year in the US and", "bbox": [403.0, 336.0, 720.0, 350.0]}, {"text": "Canada. 7,10", "bbox": [404.0, 353.0, 464.0, 365.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Cardiac arrest continues to be an all-too-common cause", "bbox": [416.0, 367.0, 720.0, 381.0]}, {"text": "of premature death, and small incremental improvements", "bbox": [403.0, 383.0, 720.0, 397.0]}, {"text": "in survival can translate into thousands of lives saved", "bbox": [404.0, 399.0, 720.0, 413.0]}, {"text": "every year.", "bbox": [403.0, 414.0, 467.0, 429.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Key Principles in Resuscitation: Strengthening", "bbox": [404.0, 449.0, 721.0, 466.0]}, {"text": "the Links in the Chain of Survival", "bbox": [445.0, 468.0, 679.0, 482.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Successful resuscitation following cardiac arrest requires an", "bbox": [404.0, 484.0, 721.0, 498.0]}, {"text": "integrated set of coordinated actions represented by the links", "bbox": [403.0, 501.0, 720.0, 514.0]}, {"text": "in the Chain of Survival (see Figure 1).", "bbox": [404.0, 515.0, 613.0, 529.0]}, {"text": "The links include the following:", "bbox": [417.0, 531.0, 586.0, 545.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "• Immediate recognition of cardiac arrest and activation of", "bbox": [404.0, 557.0, 721.0, 571.0]}, {"text": "the emergency response system", "bbox": [416.0, 574.0, 584.0, 587.0]}, {"text": "• Early CPR with an emphasis on chest compressions", "bbox": [403.0, 588.0, 692.0, 603.0]}, {"text": "• Rapid defibrillation", "bbox": [403.0, 604.0, 525.0, 618.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "• Effective advanced life support", "bbox": [403.0, 620.0, 589.0, 635.0]}, {"text": "• Integrated post–cardiac arrest care", "bbox": [404.0, 636.0, 609.0, 649.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Emergency systems that can effectively implement these", "bbox": [403.0, 662.0, 720.0, 676.0]}, {"text": "links can achieve witnessed VF cardiac arrest survival of", "bbox": [403.0, 678.0, 721.0, 691.0]}, {"text": "almost 50%. 11 -14 In most emergency systems, however,", "bbox": [403.0, 693.0, 720.0, 708.0]}, {"text": "survival is lower, indicating that there is an opportunity for", "bbox": [404.0, 709.0, 720.0, 722.0]}, {"text": "improvement by carefully examining the links and", "bbox": [403.0, 724.0, 721.0, 739.0]}, {"text": "strengthening those that are weak. 3 The individual links are", "bbox": [404.0, 741.0, 720.0, 754.0]}, {"text": "interdependent, and the success of each link is dependent", "bbox": [403.0, 756.0, 720.0, 770.0]}, {"text": "on the effectiveness of those that precede it.", "bbox": [403.0, 772.0, 649.0, 785.0]}, {"text": "Rescuers have a wide variety of training, experience, and", "bbox": [416.0, 788.0, 720.0, 802.0]}, {"text": "skills. The cardiac arrest victim's status and response to CPR", "bbox": [404.0, 803.0, 720.0, 816.0]}, {"text": "maneuvers, as well as the settings in which the arrests occur,", "bbox": [403.0, 819.0, 720.0, 833.0]}, {"text": "can also be heterogeneous. The challenge is how to encourage", "bbox": [403.0, 835.0, 720.0, 848.0]}, {"text": "early, effective CPR for as many victims as possible, taking", "bbox": [403.0, 849.0, 720.0, 864.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "The American Heart Association requests that this document be cited as follows: Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR,", "bbox": [71.0, 902.0, 719.0, 913.0]}, {"text": "Berg MD, Chameides L, O'Connor RE, Swor RA. Part 4: CPR overview: 2010 American Heart Association Guidelines for Cardiopulmonary", "bbox": [61.0, 913.0, 719.0, 925.0]}, {"text": "Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S676–S684.", "bbox": [61.0, 926.0, 481.0, 937.0]}, {"text": "°Co-chairs and equal first co-authors.", "bbox": [72.0, 937.0, 239.0, 949.0]}, {"text": "( Circulation . 2010;122[suppl 3]:S676–S684.)", "bbox": [71.0, 949.0, 276.0, 962.0]}, {"text": "© 2010 American Heart Association, Inc.", "bbox": [71.0, 962.0, 254.0, 973.0]}, {"text": "Circulation is available at http://circ.ahajournals.org", "bbox": [70.0, 977.0, 317.0, 990.0]}, {"text": "DOI: 10.1161/CIRCULATIONAHA.110.970913", "bbox": [497.0, 977.0, 720.0, 991.0]}], "type": "Footnote", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 43}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#2#2#T ardiopulmonary 应为cardiopulmonary ", "type2": "多余换行#5#6#为同段内容\n缺少换行#6#6#The vast majority of 这里开始应与前面分行\n缺少换行#11#11#• Early CPR with        • Rapid defibrillation这两处开始应与前面换行\n缺少换行#12#12# • Integrated Post–Cardiac Arrest Care这个应和前面换行", "type3": "无关文本#0#14#全文存在多处数字引用转变成的无关数字\n", "type6": "信息有用性#0#1#无关内容\n信息有用性#14#14#The American Heart Association requests that this document be cited as follows: Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR, Berg MD, Chameides L, O’Connor RE, Swor RA. Part 4: CPR overview: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S676–S684.无关内容\n信息有用性#15#17#无关内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 19:56:33"}
{"id": 1042003, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "64ac2cae-3319-4e4c-9ab3-252a56661882", "title": null, "text": "【0】页码:82\n of having a peculiar scale. Yet we were also skeptical of studying self-esteem alone. The hypothesis of threatened egotism suggested that aggressive behavior would tend to occur among only a subset of people with high self-esteem. In the hope of identifying this subset, we tested for narcissism.\n\n【1】As defined by clinical psychologists, narcissism is a mental illness characterized by inflated or grandiose views of self, the quest for excessive admiration, an unreasonable or exaggerated sense of entitlement, a lack of empathy (that is, being unable to identify with the feelings of others), an exploitative attitude toward others, a proneness to envy or wish to be envied, frequent fantasies of greatness, and arrogance. The construct has been extended beyond the realm of mental illness by Robert Raskin of the Tulsa Institute of Behavioral Sciences in Oklahoma and several of his colleagues, who have constructed a scale for measuring narcissistic tendencies.\n\n【2】We included that measure alongside the self-esteem scales, because the two traits are not the same, although they are correlated. Individuals with high self-esteem need not be narcissistic. They can be good at things and recognize that fact without being conceited or regarding themselves as superior beings. The converse— high narcissism but low self-esteem—is quite rare, however.\n\n【3】The next problem was how to measure aggression in the laboratory. The procedure we favored involved having pairs of volunteers deliver blasts of loud noise to each other. The noise is unpleasant and people wish to avoid it, so it provides a good analogue to physical aggression. The famous social psychology experiments of the 1960s [see \"The Effects of Observing Violence,\" by Leonard Berkowitz; S cientific A merican , February 1964] used electric shock, but safety concerns have largely removed that as an option.\n\n【4】The noise was presented as part of a competition. Each par-\n\n【5】 other's work. Each participant then received his or her own essay back with the comments and ratings that the other person had (supposedly) given it.\n\n【6】In reality, the essays that people graded were fakes. We took the real essays aside and randomly marked them good or bad.\n\n【7】The good evaluation included very positive ratings on all counts and the handwritten comment, \"No suggestions, great essay!\" The bad evaluation contained low marks and the additional comment, \"This is one of the worst essays I have read!\" After handing back the essays and evaluations, we gave out instructions for the reaction-time test and the subjects began to compete. The measure of aggression was the level of noise with which they blasted each other.\n\n【8】The results supported the threatened-egotism theory rather than the low self-esteem theory. Aggression was highest among narcissists who had received the insulting criticism. Nonnarcissists (with either high or low self-esteem) were significantly less aggressive, as were narcissists who had been praised.\n\n【9】In a second study, we replicated these findings and added a new twist. Some participants were told that they would be playing the reaction-time game against a new person—someone different from the person who had praised or insulted them. We were curious about displaced aggression: Would people angered by their evaluation lash out at just anybody? As it happened, no. Narcissists blasted people who had insulted them but did not attack an innocent third party. This result agrees with a large body of evidence that violence against innocent bystanders is, despite conventional wisdom, quite rare.\n\n【10】A revealing incident illuminates the attitudes of the narcissists.\n\n【11】When a television news program did a feature on this experiment, we administered the test to several additional participants for the benefit of the cameras. One of them scored in the 98th percentile\n\n【12】## Narcissists Blasted People Who\nHad Insulted Them But Did Not\n\n【13】\n## Attack An Innocent Third Party.\n\n【14】\n ticipant vied with somebody else in a test of reaction time. Whoever responded more slowly received a blast of noise, with the volume and duration of the noise set by his or her opponent. This procedure differed from that of earlier studies, in which the subject played the role of a \"teacher\" who administered noise or shock to a \"learner\" whenever the learner made a mistake. Critics had suggested that such a method would yield ambiguous results, because a teacher might deliver strong shocks or loud noise out of a sincere belief that it was an effective way to teach.\n\n【15】## “One Of The Worst”\n\n【16】\n TO STUDY THE \"THREAT\" part of threatened egotism, we asked participants to write a brief essay expressing their opinion on abortion. We collected the essays and then (ostensibly) redistributed them, so the two contestants could evaluate each\n\n【17】 on narcissism and was quite aggressive during the study. Afterward he was shown the film and given the opportunity to refuse to let it be aired. He said to put it on—he thought he looked great.\n\n【18】Bushman then took him aside and explained that he might not want to be seen by a national audience as a highly aggressive narcissist. After all, the footage showed him using severe profanity when receiving his evaluation, then laughing while administering the highest permitted levels of aggression. The man shrugged this off with a smile and said he wanted to be on television. When Bushman proposed that the television station at least digitize his face to disguise his identity, the man responded with an incredulous no. In fact, he said, he wished the program could include his name and phone number.\n\n【19】Would our laboratory findings correspond to the outside world? Real-life violent offenders are not the easiest group of people to study, but we gained access to two sets of violent crim-", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "of having a peculiar scale. Yet we were also skeptical of study-", "bbox": [45.0, 86.0, 375.0, 101.0]}, {"text": "ing self-esteem alone. The hypothesis of threatened egotism sug-", "bbox": [44.0, 103.0, 375.0, 117.0]}, {"text": "gested that aggressive behavior would tend to occur among on-", "bbox": [44.0, 119.0, 375.0, 133.0]}, {"text": "ly a subset of people with high self-esteem. In the hope of", "bbox": [44.0, 135.0, 375.0, 149.0]}, {"text": "identifying this subset, we tested for narcissism.", "bbox": [45.0, 151.0, 299.0, 165.0]}, {"text": "As defined by clinical psychologists, narcissism is a mental", "bbox": [65.0, 167.0, 375.0, 181.0]}, {"text": "illness characterized by inflated or grandiose views of self, the", "bbox": [44.0, 183.0, 375.0, 197.0]}, {"text": "quest for excessive admiration, an unreasonable or exaggerat-", "bbox": [44.0, 199.0, 374.0, 213.0]}, {"text": "ed sense of entitlement, a lack of empathy (that is, being unable", "bbox": [44.0, 215.0, 375.0, 229.0]}, {"text": "to identify with the feelings of others), an exploitative attitude", "bbox": [44.0, 231.0, 375.0, 245.0]}, {"text": "toward others, a proneness to envy or wish to be envied, fre-", "bbox": [44.0, 247.0, 375.0, 261.0]}, {"text": "quent fantasies of greatness, and arrogance. The construct has", "bbox": [45.0, 263.0, 375.0, 277.0]}, {"text": "been extended beyond the realm of mental illness by Robert", "bbox": [44.0, 279.0, 375.0, 294.0]}, {"text": "Raskin of the Tulsa Institute of Behavioral Sciences in Okla-", "bbox": [45.0, 295.0, 375.0, 309.0]}, {"text": "homa and several of his colleagues, who have constructed a", "bbox": [44.0, 311.0, 375.0, 325.0]}, {"text": "scale for measuring narcissistic tendencies.", "bbox": [45.0, 327.0, 271.0, 342.0]}, {"text": "We included that measure alongside the self-esteem scales, be-", "bbox": [65.0, 344.0, 375.0, 357.0]}, {"text": "cause the two traits are not the same, although they are correlat-", "bbox": [44.0, 359.0, 375.0, 374.0]}, {"text": "ed. Individuals with high self-esteem need not be narcissistic. They", "bbox": [44.0, 375.0, 375.0, 389.0]}, {"text": "can be good at things and recognize that fact without being con-", "bbox": [44.0, 391.0, 375.0, 405.0]}, {"text": "ceited or regarding themselves as superior beings. The converse—", "bbox": [44.0, 407.0, 373.0, 422.0]}, {"text": "high narcissism but low self-esteem—is quite rare, however.", "bbox": [44.0, 423.0, 351.0, 437.0]}, {"text": "The next problem was how to measure aggression in the", "bbox": [65.0, 439.0, 375.0, 453.0]}, {"text": "laboratory. The procedure we favored involved having pairs of", "bbox": [44.0, 454.0, 375.0, 469.0]}, {"text": "volunteers deliver blasts of loud noise to each other. The noise", "bbox": [44.0, 471.0, 375.0, 485.0]}, {"text": "is unpleasant and people wish to avoid it, so it provides a good", "bbox": [44.0, 487.0, 375.0, 501.0]}, {"text": "analogue to physical aggression. The famous social psycholo-", "bbox": [44.0, 503.0, 375.0, 517.0]}, {"text": "gy experiments of the 1960s [see \"The Effects of Observing Vi-", "bbox": [44.0, 519.0, 375.0, 534.0]}, {"text": "olence,\" by Leonard Berkowitz; S cientific A merican , Feb-", "bbox": [44.0, 534.0, 375.0, 549.0]}, {"text": "ruary 1964] used electric shock, but safety concerns have", "bbox": [44.0, 551.0, 375.0, 565.0]}, {"text": "largely removed that as an option.", "bbox": [44.0, 567.0, 230.0, 581.0]}, {"text": "The noise was presented as part of a competition. Each par-", "bbox": [65.0, 583.0, 375.0, 597.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "other's work. Each participant then received his or her own es-", "bbox": [388.0, 86.0, 716.0, 101.0]}, {"text": "say back with the comments and ratings that the other person", "bbox": [388.0, 103.0, 718.0, 117.0]}, {"text": "had (supposedly) given it.", "bbox": [388.0, 119.0, 526.0, 133.0]}, {"text": "In reality, the essays that people graded were fakes. We took", "bbox": [406.0, 135.0, 717.0, 149.0]}, {"text": "the real essays aside and randomly marked them good or bad.", "bbox": [388.0, 151.0, 718.0, 165.0]}, {"text": "The good evaluation included very positive ratings on all counts", "bbox": [388.0, 167.0, 718.0, 181.0]}, {"text": "and the handwritten comment, \"No suggestions, great essay!\"", "bbox": [388.0, 183.0, 715.0, 197.0]}, {"text": "The bad evaluation contained low marks and the additional", "bbox": [388.0, 198.0, 718.0, 213.0]}, {"text": "comment, \"This is one of the worst essays I have read!\" After", "bbox": [388.0, 215.0, 718.0, 229.0]}, {"text": "handing back the essays and evaluations, we gave out instruc-", "bbox": [388.0, 231.0, 716.0, 245.0]}, {"text": "tions for the reaction-time test and the subjects began to com-", "bbox": [388.0, 247.0, 716.0, 261.0]}, {"text": "pete. The measure of aggression was the level of noise with", "bbox": [388.0, 264.0, 718.0, 277.0]}, {"text": "which they blasted each other.", "bbox": [388.0, 279.0, 551.0, 294.0]}, {"text": "The results supported the threatened-egotism theory rather", "bbox": [407.0, 294.0, 718.0, 309.0]}, {"text": "than the low self-esteem theory. Aggression was highest among", "bbox": [388.0, 311.0, 718.0, 325.0]}, {"text": "narcissists who had received the insulting criticism. Nonnar-", "bbox": [388.0, 327.0, 716.0, 342.0]}, {"text": "cissists (with either high or low self-esteem) were significantly", "bbox": [388.0, 344.0, 718.0, 357.0]}, {"text": "less aggressive, as were narcissists who had been praised.", "bbox": [388.0, 359.0, 690.0, 374.0]}, {"text": "In a second study, we replicated these findings and added a", "bbox": [406.0, 375.0, 718.0, 389.0]}, {"text": "new twist. Some participants were told that they would be play-", "bbox": [388.0, 392.0, 716.0, 405.0]}, {"text": "ing the reaction-time game against a new person—someone dif-", "bbox": [388.0, 407.0, 717.0, 421.0]}, {"text": "ferent from the person who had praised or insulted them. We", "bbox": [388.0, 423.0, 718.0, 437.0]}, {"text": "were curious about displaced aggression: Would people an-", "bbox": [388.0, 439.0, 717.0, 453.0]}, {"text": "gered by their evaluation lash out at just anybody? As it hap-", "bbox": [388.0, 454.0, 716.0, 469.0]}, {"text": "pened, no. Narcissists blasted people who had insulted them", "bbox": [388.0, 471.0, 718.0, 485.0]}, {"text": "but did not attack an innocent third party. This result agrees", "bbox": [388.0, 487.0, 718.0, 501.0]}, {"text": "with a large body of evidence that violence against innocent by-", "bbox": [388.0, 503.0, 716.0, 517.0]}, {"text": "standers is, despite conventional wisdom, quite rare.", "bbox": [388.0, 519.0, 666.0, 534.0]}, {"text": "A revealing incident illuminates the attitudes of the narcissists.", "bbox": [406.0, 535.0, 717.0, 549.0]}, {"text": "When a television news program did a feature on this experiment,", "bbox": [388.0, 551.0, 718.0, 565.0]}, {"text": "we administered the test to several additional participants for the", "bbox": [388.0, 567.0, 718.0, 581.0]}, {"text": "benefit of the cameras. One of them scored in the 98th percentile", "bbox": [387.0, 583.0, 718.0, 597.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "     Narcissists blasted people who\nhad insulted them but did not", "bbox": [91.0, 611.0, 616.0, 674.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "attack an innocent third party.", "bbox": [293.0, 669.0, 697.0, 700.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "ticipant vied with somebody else in a test of reaction time. Who-", "bbox": [44.0, 711.0, 375.0, 724.0]}, {"text": "ever responded more slowly received a blast of noise, with the", "bbox": [44.0, 727.0, 375.0, 741.0]}, {"text": "volume and duration of the noise set by his or her opponent. This", "bbox": [44.0, 743.0, 376.0, 757.0]}, {"text": "procedure differed from that of earlier studies, in which the sub-", "bbox": [44.0, 759.0, 375.0, 773.0]}, {"text": "ject played the role of a \"teacher\" who administered noise or", "bbox": [44.0, 774.0, 375.0, 790.0]}, {"text": "shock to a \"learner\" whenever the learner made a mistake. Crit-", "bbox": [44.0, 791.0, 375.0, 806.0]}, {"text": "ics had suggested that such a method would yield ambiguous re-", "bbox": [44.0, 807.0, 375.0, 821.0]}, {"text": "sults, because a teacher might deliver strong shocks or loud noise", "bbox": [44.0, 823.0, 375.0, 837.0]}, {"text": "out of a sincere belief that it was an effective way to teach.", "bbox": [44.0, 839.0, 348.0, 853.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "“One of the Worst”", "bbox": [44.0, 872.0, 230.0, 898.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "TO STUDY THE \"THREAT\" part of threatened egotism, we", "bbox": [45.0, 903.0, 375.0, 917.0]}, {"text": "asked participants to write a brief essay expressing their opin-", "bbox": [45.0, 918.0, 375.0, 933.0]}, {"text": "ion on abortion. We collected the essays and then (ostensibly)", "bbox": [45.0, 935.0, 376.0, 949.0]}, {"text": "redistributed them, so the two contestants could evaluate each", "bbox": [45.0, 952.0, 376.0, 965.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "on narcissism and was quite aggressive during the study. After-", "bbox": [388.0, 710.0, 716.0, 726.0]}, {"text": "ward he was shown the film and given the opportunity to refuse", "bbox": [388.0, 727.0, 718.0, 742.0]}, {"text": "to let it be aired. He said to put it on—he thought he looked great.", "bbox": [388.0, 743.0, 718.0, 757.0]}, {"text": "Bushman then took him aside and explained that he might not", "bbox": [388.0, 759.0, 718.0, 773.0]}, {"text": "want to be seen by a national audience as a highly aggressive nar-", "bbox": [388.0, 775.0, 716.0, 789.0]}, {"text": "cissist. After all, the footage showed him using severe profanity", "bbox": [387.0, 791.0, 717.0, 805.0]}, {"text": "when receiving his evaluation, then laughing while administer-", "bbox": [388.0, 807.0, 716.0, 821.0]}, {"text": "ing the highest permitted levels of aggression. The man shrugged", "bbox": [388.0, 823.0, 718.0, 837.0]}, {"text": "this off with a smile and said he wanted to be on television. When", "bbox": [388.0, 839.0, 718.0, 853.0]}, {"text": "Bushman proposed that the television station at least digitize his", "bbox": [388.0, 855.0, 718.0, 869.0]}, {"text": "face to disguise his identity, the man responded with an in-", "bbox": [388.0, 871.0, 717.0, 885.0]}, {"text": "credulous no. In fact, he said, he wished the program could in-", "bbox": [388.0, 887.0, 717.0, 902.0]}, {"text": "clude his name and phone number.", "bbox": [386.0, 903.0, 573.0, 917.0]}, {"text": "Would our laboratory findings correspond to the outside", "bbox": [406.0, 919.0, 718.0, 933.0]}, {"text": "world? Real-life violent offenders are not the easiest group of", "bbox": [388.0, 935.0, 718.0, 949.0]}, {"text": "people to study, but we gained access to two sets of violent crim-", "bbox": [388.0, 952.0, 716.0, 965.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 82}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "\n多余换行#13#14# Narcissists Blasted People...Attack An Innocent Third Party.与12段联接都是标题\n多余换行#17#17# on narcissism and was quite...与上面16段相连接", "type3": null, "type4": "栏目混乱#5#5#内容位置不对，排序错误\n栏目混乱#11#18#内容互相穿插，没有顺序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:09:42"}
{"id": 1042002, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "540e3abc-f64c-4b09-9197-fbd499ae9e7e", "title": null, "text": "【0】页码:163\n# Part 10: Acute Coronary Syndromes 2010 American Heart Association Guidelines For Cardiopulmonary Resuscitation And Emergency Cardiovascular Care\n\n【1】\n Robert E. O'Connor, Chair; William Brady; Steven C. Brooks; Deborah Diercks; Jonathan Egan; Chris Ghaemmaghami; Venu Menon; Brian J. O'Neil; Andrew H. Travers; Demetris Yannopoulos\n\n【2】 1 he 2010 AHA Guidelines for CPR and ECC for the 1 evaluation and management of acute coronary syndromes (ACS) are intended to define the scope of training for healthcare providers who treat patients with suspected or definite ACS within the first hours after onset of symptoms.\n\n【3】These guidelines summarize key out-of-hospital, emergency department (ED), and related initial critical-care topics that are relevant to diagnosis and initial stabilization and are not intended to guide treatment beyond the ED.  Emergency providers should use these contents to supplement other recommendations from the ACC/AHA Guidelines, which are used throughout the United States and Canada. 1–3 As with any guidelines, these general recommendations must be considered within the context of local resources and their application to individual patients by knowledgeable healthcare providers. The healthcare providers managing the individual patients are best suited to determine the most appropriate treatment strategy.\n\n【4】The primary goals of therapy for patients with ACS are to • Reduce the amount of myocardial necrosis that occurs in\n\n【5】 patients with acute myocardial infarction (AMI), thus preserving left ventricular (LV) function, preventing heart failure, and limiting other cardiovascular complications • Prevent major adverse cardiac events (MACE): death, nonfatal MI, and need for urgent revascularization • Treat acute, life-threatening complications of ACS, such as ventricular fibrillation (VF), pulseless ventricular tachycardia (VT), unstable tachycardias, symptomatic bradycardias (See Part 8: \"Advanced Cardiovascular Life Support''), pulmonary edema, cardiogenic shock and mechanical complications of AMI • An overview of recommended care for the ACS patient is illustrated in Figure 1, the Acute Coronary Syndromes Algorithm. Part 10 provides details of the care highlighted in the numbered algorithm boxes; box numbers in the text correspond to the numbered boxes in the algorithm. In this part, the abbreviation \"AMI\" refers to acute myocardial infarction, whether associated with ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial\n\n【6】 infarction (NSTEMI). The diagnosis and treatment of AMI, however, will often differ for patients with STEMI versus NSTEMI. Please note carefully which AMI type is being discussed.\n\n【7】## Prehospital Management\n\n【8】\n## Patient And Healthcare Provider Recognition Of Acs (Figure 1, Box 1)\n\n【9】\n Prompt diagnosis and treatment offers the greatest potential benefit for myocardial salvage in the first hours of STEMI; and early, focused management of unstable angina and NSTEMI reduces adverse events and improves outcome. 4 Thus, it is imperative that healthcare providers recognize patients with potential ACS in order to initiate the evaluation, appropriate triage, and management as expeditiously as possible; in the case of STEMI, this recognition also allows for prompt notification of the receiving hospital and preparation for emergent reperfusion therapy. Potential delays to therapy occur during 3 intervals: from onset of symptoms to patient recognition, during prehospital transport, and during emergency department (ED) evaluation.\n\n【10】Patient-based delay in recognition of ACS and activation of the emergency medical services (EMS) system often constitutes the longest period of delay to treatment. 5 With respect to the prehospital recognition of ACS, numerous issues have been identified as independent factors for prehospital treatment delay (ie, symptom-to-door time), including older age, 6 racial and ethnic minorities, 7.8 female gender, 9 lower socioeconomic status, 10 , 11 and solitary living arrangements. 7,12 Hospital-based delays in ACS recognition range from nonclassical patient presentations and other confounding diagnostic issues to provider misinterpretation of patient data and inefficient in-hospital system of care. 9 , 13 –16 Symptoms of ACS may be used in combination with other important information (biomarkers, risk factors, ECG, and other diagnostic tests) in making triage and some treatment decisions in the out-of-hospital and ED settings. The symptoms of AMI may be more intense than angina and most often\n The American Heart Association requests that this document be cited as follows: O'Connor RE, Brady W, Brooks SC, Diercks D, Egan J, Ghaemmaghami C, Menon V, O'Neil BJ, Travers AH, Yannopoulos D. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S787–S817.\n\n【11】( Circulation . 2010;122[suppl 3]:S787–S817.) © 2010 American Heart Association, Inc.\n\n【12】Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.110.971028", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Part 10: Acute Coronary Syndromes", "bbox": [189.0, 106.0, 591.0, 134.0]}, {"text": "2010 American Heart Association Guidelines for Cardiopulmonary", "bbox": [96.0, 139.0, 685.0, 160.0]}, {"text": "Resuscitation and Emergency Cardiovascular Care", "bbox": [167.0, 160.0, 615.0, 180.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "Robert E. O'Connor, Chair; William Brady; Steven C. Brooks; Deborah Diercks; Jonathan Egan;", "bbox": [81.0, 195.0, 699.0, 212.0]}, {"text": "Chris Ghaemmaghami; Venu Menon; Brian J. O'Neil; Andrew H. Travers; Demetris Yannopoulos", "bbox": [78.0, 214.0, 702.0, 230.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "1 he 2010 AHA Guidelines for CPR and ECC for the", "bbox": [60.0, 254.0, 377.0, 271.0]}, {"text": "1 evaluation and management of acute coronary syn-", "bbox": [65.0, 272.0, 376.0, 286.0]}, {"text": "dromes (ACS) are intended to define the scope of training for", "bbox": [60.0, 287.0, 377.0, 301.0]}, {"text": "healthcare providers who treat patients with suspected or", "bbox": [60.0, 303.0, 377.0, 317.0]}, {"text": "definite ACS within the first hours after onset of symptoms.", "bbox": [60.0, 319.0, 375.0, 333.0]}, {"text": "These guidelines summarize key out-of-hospital, emergency", "bbox": [61.0, 334.0, 376.0, 348.0]}, {"text": "department (ED), and related initial critical-care topics that", "bbox": [60.0, 350.0, 376.0, 364.0]}, {"text": "are relevant to diagnosis and initial stabilization and are not", "bbox": [60.0, 366.0, 376.0, 380.0]}, {"text": "intended to guide treatment beyond the ED.  Emergency", "bbox": [60.0, 382.0, 375.0, 395.0]}, {"text": "providers should use these contents to supplement other", "bbox": [60.0, 397.0, 376.0, 411.0]}, {"text": "recommendations from the ACC/AHA Guidelines, which are", "bbox": [60.0, 413.0, 376.0, 427.0]}, {"text": "used throughout the United States and Canada. 1–3 As with any", "bbox": [60.0, 428.0, 375.0, 442.0]}, {"text": "guidelines, these general recommendations must be consid-", "bbox": [60.0, 444.0, 375.0, 458.0]}, {"text": "ered within the context of local resources and their applica-", "bbox": [60.0, 460.0, 375.0, 475.0]}, {"text": "tion to individual patients by knowledgeable healthcare pro-", "bbox": [60.0, 476.0, 375.0, 489.0]}, {"text": "viders. The healthcare providers managing the individual", "bbox": [60.0, 491.0, 376.0, 505.0]}, {"text": "patients are best suited to determine the most appropriate", "bbox": [60.0, 508.0, 375.0, 521.0]}, {"text": "treatment strategy.", "bbox": [60.0, 522.0, 159.0, 536.0]}, {"text": "The primary goals of therapy for patients with ACS are to", "bbox": [74.0, 538.0, 377.0, 552.0]}, {"text": "• Reduce the amount of myocardial necrosis that occurs in", "bbox": [60.0, 564.0, 377.0, 579.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "patients with acute myocardial infarction (AMI), thus", "bbox": [72.0, 581.0, 376.0, 594.0]}, {"text": "preserving left ventricular (LV) function, preventing heart", "bbox": [72.0, 595.0, 377.0, 610.0]}, {"text": "failure, and limiting other cardiovascular complications", "bbox": [72.0, 612.0, 364.0, 625.0]}, {"text": "• Prevent major adverse cardiac events (MACE): death,", "bbox": [60.0, 627.0, 376.0, 642.0]}, {"text": "nonfatal MI, and need for urgent revascularization", "bbox": [71.0, 643.0, 338.0, 656.0]}, {"text": "• Treat acute, life-threatening complications of ACS, such as", "bbox": [60.0, 658.0, 377.0, 673.0]}, {"text": "ventricular fibrillation (VF), pulseless ventricular", "bbox": [72.0, 675.0, 376.0, 688.0]}, {"text": "tachycardia (VT), unstable tachycardias, symptomatic bra-", "bbox": [72.0, 689.0, 375.0, 704.0]}, {"text": "dycardias (See Part 8: \"Advanced Cardiovascular Life", "bbox": [71.0, 706.0, 376.0, 719.0]}, {"text": "Support''), pulmonary edema, cardiogenic shock and me-", "bbox": [72.0, 721.0, 375.0, 736.0]}, {"text": "chanical complications of AMI", "bbox": [71.0, 737.0, 237.0, 750.0]}, {"text": "• An overview of recommended care for the ACS patient is", "bbox": [60.0, 752.0, 376.0, 767.0]}, {"text": "illustrated in Figure 1, the Acute Coronary Syndromes", "bbox": [72.0, 769.0, 376.0, 782.0]}, {"text": "Algorithm. Part 10 provides details of the care highlighted", "bbox": [73.0, 783.0, 377.0, 798.0]}, {"text": "in the numbered algorithm boxes; box numbers in the text", "bbox": [72.0, 800.0, 376.0, 813.0]}, {"text": "correspond to the numbered boxes in the algorithm. In this", "bbox": [71.0, 815.0, 376.0, 829.0]}, {"text": "part, the abbreviation \"AMI\" refers to acute myocardial", "bbox": [72.0, 831.0, 377.0, 844.0]}, {"text": "infarction, whether associated with ST-elevation myocar-", "bbox": [72.0, 846.0, 375.0, 861.0]}, {"text": "dial infarction (STEMI) or non-ST-elevation myocardial", "bbox": [72.0, 863.0, 377.0, 876.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "infarction (NSTEMI). The diagnosis and treatment of AMI,", "bbox": [416.0, 255.0, 720.0, 270.0]}, {"text": "however, will often differ for patients with STEMI versus", "bbox": [416.0, 272.0, 721.0, 286.0]}, {"text": "NSTEMI. Please note carefully which AMI type is being", "bbox": [416.0, 287.0, 721.0, 301.0]}, {"text": "discussed.", "bbox": [416.0, 303.0, 471.0, 317.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Prehospital Management", "bbox": [477.0, 336.0, 649.0, 354.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Patient and Healthcare Provider Recognition of", "bbox": [404.0, 360.0, 700.0, 375.0]}, {"text": "ACS (Figure 1, Box 1)", "bbox": [404.0, 377.0, 545.0, 391.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Prompt diagnosis and treatment offers the greatest potential", "bbox": [404.0, 392.0, 720.0, 406.0]}, {"text": "benefit for myocardial salvage in the first hours of STEMI;", "bbox": [403.0, 408.0, 720.0, 422.0]}, {"text": "and early, focused management of unstable angina and", "bbox": [404.0, 424.0, 720.0, 437.0]}, {"text": "NSTEMI reduces adverse events and improves outcome. 4", "bbox": [404.0, 439.0, 720.0, 454.0]}, {"text": "Thus, it is imperative that healthcare providers recognize", "bbox": [404.0, 455.0, 721.0, 468.0]}, {"text": "patients with potential ACS in order to initiate the evaluation,", "bbox": [403.0, 470.0, 720.0, 485.0]}, {"text": "appropriate triage, and management as expeditiously as", "bbox": [403.0, 487.0, 720.0, 500.0]}, {"text": "possible; in the case of STEMI, this recognition also allows", "bbox": [404.0, 501.0, 721.0, 516.0]}, {"text": "for prompt notification of the receiving hospital and prepa-", "bbox": [404.0, 518.0, 720.0, 531.0]}, {"text": "ration for emergent reperfusion therapy. Potential delays to", "bbox": [403.0, 533.0, 722.0, 548.0]}, {"text": "therapy occur during 3 intervals: from onset of symptoms to", "bbox": [403.0, 549.0, 721.0, 562.0]}, {"text": "patient recognition, during prehospital transport, and during", "bbox": [404.0, 564.0, 721.0, 579.0]}, {"text": "emergency department (ED) evaluation.", "bbox": [403.0, 581.0, 613.0, 594.0]}, {"text": "Patient-based delay in recognition of ACS and activation", "bbox": [416.0, 595.0, 721.0, 610.0]}, {"text": "of the emergency medical services (EMS) system often", "bbox": [403.0, 612.0, 720.0, 625.0]}, {"text": "constitutes the longest period of delay to treatment. 5 With", "bbox": [403.0, 627.0, 721.0, 642.0]}, {"text": "respect to the prehospital recognition of ACS, numerous", "bbox": [403.0, 643.0, 720.0, 656.0]}, {"text": "issues have been identified as independent factors for", "bbox": [403.0, 658.0, 720.0, 673.0]}, {"text": "prehospital treatment delay (ie, symptom-to-door time),", "bbox": [404.0, 675.0, 721.0, 688.0]}, {"text": "including older age, 6 racial and ethnic minorities, 7.8 female", "bbox": [403.0, 689.0, 720.0, 704.0]}, {"text": "gender, 9 lower socioeconomic status, 10 , 11 and solitary liv-", "bbox": [404.0, 705.0, 720.0, 719.0]}, {"text": "ing arrangements. 7,12", "bbox": [403.0, 721.0, 519.0, 736.0]}, {"text": "Hospital-based delays in ACS recognition range from", "bbox": [416.0, 737.0, 721.0, 750.0]}, {"text": "nonclassical patient presentations and other confounding", "bbox": [403.0, 752.0, 720.0, 767.0]}, {"text": "diagnostic issues to provider misinterpretation of patient data", "bbox": [403.0, 769.0, 721.0, 782.0]}, {"text": "and inefficient in-hospital system of care. 9 , 13 –16", "bbox": [404.0, 783.0, 651.0, 798.0]}, {"text": "Symptoms of ACS may be used in combination with other", "bbox": [416.0, 799.0, 721.0, 813.0]}, {"text": "important information (biomarkers, risk factors, ECG, and", "bbox": [403.0, 815.0, 721.0, 829.0]}, {"text": "other diagnostic tests) in making triage and some treatment", "bbox": [403.0, 831.0, 721.0, 844.0]}, {"text": "decisions in the out-of-hospital and ED settings. The symp-", "bbox": [403.0, 846.0, 719.0, 861.0]}, {"text": "toms of AMI may be more intense than angina and most often", "bbox": [403.0, 863.0, 721.0, 876.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "The American Heart Association requests that this document be cited as follows: O'Connor RE, Brady W, Brooks SC, Diercks D, Egan J,", "bbox": [72.0, 913.0, 720.0, 925.0]}, {"text": "Ghaemmaghami C, Menon V, O'Neil BJ, Travers AH, Yannopoulos D. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines", "bbox": [61.0, 926.0, 720.0, 937.0]}, {"text": "for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S787–S817.", "bbox": [61.0, 937.0, 575.0, 950.0]}, {"text": "( Circulation . 2010;122[suppl 3]:S787–S817.)", "bbox": [71.0, 949.0, 277.0, 962.0]}, {"text": "© 2010 American Heart Association, Inc.", "bbox": [71.0, 962.0, 255.0, 973.0]}, {"text": "Circulation is available at http://circ.ahajournals.org", "bbox": [70.0, 977.0, 317.0, 990.0]}, {"text": "DOI: 10.1161/CIRCULATIONAHA.110.971028", "bbox": [497.0, 977.0, 720.0, 991.0]}], "type": "Footnote", "position": 8}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 163}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": "错别字#2#2# 1 he应该是The", "type2": "缺少换行#4#4# • Reduce the amount of myocardial necrosis that occurs in另起一行\n多余换行#5#5# patients with acute myocardial infarction ....与上面4段后面联接\n缺少换行#5#5#• Treat acute, life-threatening...\n • An overview of recommended care for ...都另起一行\n多余换行#6#6# infarction (NSTEMI). 与上面5段后面联接\n缺少换行#10#10#Hospital-based delays in ACS...\nSymptoms of ACS may be used...都另起一行", "type3": "无关文本#9#10#4 Thus, it is imperative...像这样在.号或，号的开头或结尾出现的数字都是无关引用", "type4": null, "type5": null, "type6": "有用性#10#10#The American Heart Association requests...2010;122(suppl 3):S787–S817.文件的补充说明\n有用性#11#12#文件的补充说明"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:43:31"}
{"id": 1042001, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "4525ed96-1283-4bc9-962f-d41e37d2c509", "title": null, "text": "【0】页码:28\n\n【1】## Questions You Can Ask Your Doctor\n\n【2】\n 1. Are there any other symptoms I should look out for?\n\n【3】 2. What tests will be involved in diagnosing my condition?\n\n【4】 3. What will these tests tell me?\n\n【5】 4. Are diagnostic tests painful?\n\n【6】 5. How long will the tests take?\n\n【7】 6. When will I know the test's results?\n\n【8】 7. Will I need more tests?\n\n【9】 8. What are my treatment options?\n\n【10】 9.  Do I need to come for a follow-up visit and if so, when?\n\n【11】 10. Do I need to take any precautions?\n\n【12】## Further Diagnostic Testing\n\n【13】\n In case your doctor is still uncertain, you may be referred to an ear, nose and throat (ENT) specialist and a neurologist for further testing. You may have to get electromyography and imaging scans to check for facial nerve damage and complications.\n\n【14】 Your doctor may also suggest the following lab tests:\n\n【15】 1. Hearing test if you have problems hearing\n\n【16】 2. Computed tomography scan of the head if your medical history and condition show signs of a stroke or tumor\n\n【17】## Electromyography\n\n【18】\n During electromyography (EMG), a very thin needle will be inserted to pass a mild electric current through the skin and into your facial muscle. A machine called an oscilloscope then measures the electrical activity in your muscles and", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Questions You Can Ask Your Doctor", "bbox": [93.0, 139.0, 403.0, 158.0]}], "type": "Section-header", "position": 1}, {"raw_context": [{"text": "1. Are there any other symptoms I should look out for?", "bbox": [106.0, 195.0, 541.0, 214.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "2. What tests will be involved in diagnosing my condition?", "bbox": [106.0, 228.0, 571.0, 250.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "3. What will these tests tell me?", "bbox": [106.0, 265.0, 362.0, 284.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "4. Are diagnostic tests painful?", "bbox": [106.0, 300.0, 356.0, 319.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "5. How long will the tests take?", "bbox": [106.0, 334.0, 359.0, 353.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "6. When will I know the test's results?", "bbox": [106.0, 370.0, 413.0, 388.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "7. Will I need more tests?", "bbox": [106.0, 403.0, 314.0, 424.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "8. What are my treatment options?", "bbox": [106.0, 439.0, 382.0, 458.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "9.  Do I need to come for a follow-up visit and if so, when?", "bbox": [106.0, 474.0, 567.0, 494.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "10. Do I need to take any precautions?", "bbox": [98.0, 509.0, 402.0, 528.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Further Diagnostic Testing", "bbox": [93.0, 550.0, 320.0, 569.0]}], "type": "Section-header", "position": 12}, {"raw_context": [{"text": "In case your doctor is still uncertain, you may be referred to an ear, nose and", "bbox": [93.0, 587.0, 722.0, 608.0]}, {"text": "throat (ENT) specialist and a neurologist for further testing. You may have to get", "bbox": [93.0, 610.0, 722.0, 629.0]}, {"text": "electromyography and imaging scans to check for facial nerve damage and", "bbox": [93.0, 632.0, 722.0, 652.0]}, {"text": "complications.", "bbox": [93.0, 654.0, 210.0, 674.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Your doctor may also suggest the following lab tests:", "bbox": [95.0, 689.0, 507.0, 708.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "1. Hearing test if you have problems hearing", "bbox": [107.0, 743.0, 460.0, 762.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "2. Computed tomography scan of the head if your medical history and", "bbox": [106.0, 777.0, 723.0, 798.0]}, {"text": "condition show signs of a stroke or tumor", "bbox": [131.0, 800.0, 456.0, 819.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Electromyography", "bbox": [93.0, 840.0, 251.0, 861.0]}], "type": "Section-header", "position": 17}, {"raw_context": [{"text": "During electromyography (EMG), a very thin needle will be inserted to pass a", "bbox": [93.0, 879.0, 722.0, 898.0]}, {"text": "mild electric current through the skin and into your facial muscle. A machine", "bbox": [93.0, 901.0, 722.0, 920.0]}, {"text": "called an oscilloscope then measures the electrical activity in your muscles and", "bbox": [93.0, 923.0, 722.0, 942.0]}], "type": "Text", "position": 18}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 28}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:42:00"}
{"id": 1042000, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "e8d10b25-a1eb-4dd0-91d9-75ccbbbf4bb8", "title": null, "text": "【0】页码:93\n 2.\n\n【1】3.\n\n【2】4.\n\n【3】5.\n\n【4】 Be cautious placing molar to molar chain in deep bite patients.\n\n【5】Use molar anchorage, especially in cases that require a facial change.\n\n【6】Do not apply too much pressure during chain place¬ ment, because we may debond some braces.\n\n【7】Replace the chain every 21 days.\n\n【8】## Iii. Space Closure With Open Coil And Chains\n\n【9】\n We can close extraction sites or diastemas combining two forces: a traction force and a pushing force; for example, a chain in combination with a NiTi open coil. By adding these forces, dental movement is quicker.\n Figs. 26 and 27. Chain and open coil.\n Figs. 28 and 29. Chain and coils two months later.\n\n【10】## Advantages\n\n【11】\n 1.\n\n【12】2.\n\n【13】 Space closure is at about 1.5 to 2 mm per month.\n\n【14】Being a greater force for dental movement, treatment time shortens.\n\n【15】## Disadvantages\n\n【16】\n 1.\n\n【17】2.\n\n【18】 Undesired crown tip.\n\n【19】Being a fast movement, it can cause more root resorp¬ tion.\n\n【20】Chain loses elasticity over time.\n\n【21】 3.\n\n【22】## Recommendations\n\n【23】\n Use heavy arch wires during space closure.\n\n【24】1.\n\n【25】Anchor teeth on which the coil is going to lean on.\n\n【26】2.\n\n【27】This will diminish their distal or mesial movement.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "2.", "bbox": [58.0, 85.0, 74.0, 102.0]}, {"text": "3.", "bbox": [58.0, 120.0, 74.0, 136.0]}, {"text": "4.", "bbox": [58.0, 155.0, 74.0, 171.0]}, {"text": "5.", "bbox": [58.0, 189.0, 73.0, 204.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Be cautious placing molar to molar chain in deep", "bbox": [85.0, 85.0, 374.0, 102.0]}, {"text": "bite patients.", "bbox": [85.0, 102.0, 160.0, 118.0]}, {"text": "Use molar anchorage, especially in cases that require", "bbox": [85.0, 120.0, 373.0, 136.0]}, {"text": "a facial change.", "bbox": [85.0, 138.0, 175.0, 153.0]}, {"text": "Do not apply too much pressure during chain place¬", "bbox": [85.0, 154.0, 372.0, 171.0]}, {"text": "ment, because we may debond some braces.", "bbox": [85.0, 172.0, 330.0, 189.0]}, {"text": "Replace the chain every 21 days.", "bbox": [85.0, 189.0, 273.0, 205.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "III. Space closure with open coil and chains", "bbox": [58.0, 256.0, 365.0, 276.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "We can close extraction sites or diastemas combining two", "bbox": [59.0, 306.0, 373.0, 323.0]}, {"text": "forces: a traction force and a pushing force; for example,", "bbox": [58.0, 324.0, 373.0, 340.0]}, {"text": "a chain in combination with a NiTi open coil. By adding", "bbox": [58.0, 341.0, 373.0, 358.0]}, {"text": "these forces, dental movement is quicker.", "bbox": [58.0, 359.0, 287.0, 375.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Figs. 26 and 27. Chain and open coil.", "bbox": [302.0, 658.0, 465.0, 673.0]}], "type": "Caption", "position": 6}, {"raw_context": [{"text": "Figs. 28 and 29. Chain and coils two months later.", "bbox": [273.0, 949.0, 492.0, 964.0]}], "type": "Caption", "position": 8}, {"raw_context": [{"text": "Advantages", "bbox": [395.0, 85.0, 482.0, 102.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "1.", "bbox": [397.0, 105.0, 410.0, 118.0]}, {"text": "2.", "bbox": [395.0, 122.0, 410.0, 136.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Space closure is at about 1.5 to 2 mm per month.", "bbox": [421.0, 102.0, 692.0, 119.0]}, {"text": "Being a greater force for dental movement, treatment", "bbox": [421.0, 120.0, 710.0, 137.0]}, {"text": "time shortens.", "bbox": [421.0, 138.0, 503.0, 154.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Disadvantages", "bbox": [395.0, 172.0, 501.0, 189.0]}], "type": "Section-header", "position": 12}, {"raw_context": [{"text": "1.", "bbox": [396.0, 208.0, 410.0, 223.0]}, {"text": "2.", "bbox": [395.0, 224.0, 409.0, 240.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Undesired crown tip.", "bbox": [421.0, 207.0, 541.0, 223.0]}, {"text": "Being a fast movement, it can cause more root resorp¬", "bbox": [421.0, 224.0, 709.0, 241.0]}, {"text": "tion.", "bbox": [421.0, 243.0, 450.0, 257.0]}, {"text": "Chain loses elasticity over time.", "bbox": [420.0, 259.0, 597.0, 276.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "3.", "bbox": [395.0, 259.0, 410.0, 275.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Recommendations", "bbox": [395.0, 292.0, 526.0, 309.0]}], "type": "Section-header", "position": 16}, {"raw_context": [{"text": "Use heavy arch wires during space closure.", "bbox": [421.0, 327.0, 658.0, 347.0]}, {"text": "1.", "bbox": [397.0, 330.0, 411.0, 344.0]}, {"text": "Anchor teeth on which the coil is going to lean on.", "bbox": [421.0, 345.0, 709.0, 362.0]}, {"text": "2.", "bbox": [395.0, 346.0, 410.0, 362.0]}, {"text": "This will diminish their distal or mesial movement.", "bbox": [422.0, 363.0, 703.0, 379.0]}], "type": "Text", "position": 17}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 93}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#0#7#序号与正文分离2.和 Be cautious placing molar是一句话，以此类推\n多余换行#11#14#序号与正文分离1.和 Space closure is at about 1.5 to 2 mm per month.是一句话，以此类推\n多余换行#16#21#序号与正文分离1.和 Undesired crown tip.是一句话，以此类推\n多余换行#23#27#序号与正文分离1.和 Use heavy arch wires during space closure.是一句话，2.和Anchor teeth on which the是一句话", "type3": null, "type6": "有用性#9#9#Figs. 26 and 27. Chain and open coil.\nFigs. 28 and 29. Chain and coils two months later.对图片的描述\n"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 01:19:01"}
{"id": 1041999, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "00d0665f-2f2f-474b-b664-b80bd08ae77b", "title": null, "text": "【0】页码:10\n# Chapter One: Introduction\n\n【1】# What Do We Know About Bell’S Palsy?\n\n【2】\n## The Science Behind The Name\n\n【3】\n The term Bell's palsy comes from Sir Charles Bell, a renowned 19th century Scottish anatomist and surgeon who discovered that the condition is caused by the dysfunction of the 7th facial nerve.\n\n【4】## Sir Charles Bell\n\n【5】\n Born in Scotland in 1774, Sir Charles Bell studied anatomy and medicine at the legendary University of Edinburgh. He and his brother left for London after being rejected by the Edinburgh Royal Infirmary.\n\n【6】 Sir Charles Bell returned to Scotland after living and working in London for almost 30 years. He ended his teaching career as a professor of surgery at the place he studied – University of Edinburgh. Bell also was an expert surgeon. In fact in 1815, he served in the British Army at the famous Battle of Waterloo.\n\n【7】He's also recognized for his medical illustration in neurology. The essays written by Sir Charles Bell on the anatomy of expression in painting are still considered a classic piece of art history.\n\n【8】## Is There A Difference Between Facial Paralysis And Bell’S Palsy?\n\n【9】\n People who lose the ability to move one side of their face are said to be victims of 'facial paralysis.' It is a general term and is frequently used when the facial muscles become paralyzed due to the facial nerve being injured. Facial paralysis", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Chapter One: Introduction", "bbox": [249.0, 121.0, 565.0, 146.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "What Do We Know about Bell’s Palsy?", "bbox": [94.0, 169.0, 418.0, 189.0]}], "type": "Title", "position": 1}, {"raw_context": [{"text": "The Science behind the Name", "bbox": [93.0, 207.0, 339.0, 227.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "The term Bell's palsy comes from Sir Charles Bell, a renowned 19th century", "bbox": [93.0, 246.0, 721.0, 266.0]}, {"text": "Scottish anatomist and surgeon who discovered that the condition is caused by", "bbox": [93.0, 269.0, 722.0, 288.0]}, {"text": "the dysfunction of the 7th facial nerve.", "bbox": [93.0, 291.0, 395.0, 310.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Sir Charles Bell", "bbox": [93.0, 560.0, 228.0, 580.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Born in Scotland in 1774, Sir Charles Bell studied anatomy and medicine at the", "bbox": [93.0, 597.0, 721.0, 617.0]}, {"text": "legendary University of Edinburgh. He and his brother left for London after", "bbox": [93.0, 620.0, 722.0, 639.0]}, {"text": "being rejected by the Edinburgh Royal Infirmary.", "bbox": [93.0, 643.0, 478.0, 661.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Sir Charles Bell returned to Scotland after living and working in London for", "bbox": [93.0, 676.0, 722.0, 696.0]}, {"text": "almost 30 years. He ended his teaching career as a professor of surgery at the", "bbox": [93.0, 699.0, 722.0, 718.0]}, {"text": "place he studied – University of Edinburgh. Bell also was an expert surgeon. In", "bbox": [93.0, 721.0, 723.0, 740.0]}, {"text": "fact in 1815, he served in the British Army at the famous Battle of Waterloo.", "bbox": [93.0, 743.0, 721.0, 762.0]}, {"text": "He's also recognized for his medical illustration in neurology. The essays written", "bbox": [93.0, 765.0, 722.0, 784.0]}, {"text": "by Sir Charles Bell on the anatomy of expression in painting are still considered", "bbox": [93.0, 788.0, 722.0, 806.0]}, {"text": "a classic piece of art history.", "bbox": [93.0, 810.0, 316.0, 829.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Is There a Difference between Facial Paralysis and Bell’s Palsy?", "bbox": [93.0, 850.0, 621.0, 870.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "People who lose the ability to move one side of their face are said to be victims", "bbox": [93.0, 887.0, 721.0, 908.0]}, {"text": "of 'facial paralysis.' It is a general term and is frequently used when the facial", "bbox": [93.0, 910.0, 722.0, 930.0]}, {"text": "muscles become paralyzed due to the facial nerve being injured. Facial paralysis", "bbox": [93.0, 932.0, 723.0, 952.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 10}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:15:22"}
{"id": 1041998, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "e3b79e0d-fc8f-496f-9802-57a53cbc5e98", "title": null, "text": "【0】页码:99\n Usually the prescribed force is obtained when the elastic is stretched three times its diameter. ( 20 )\n\n【1】 Retention is initiated after active treatment This is very important and we must keep in mind that selecting the wrong retainers, or if the patient does not fully cooperate, this can translate into total treatment failure.\n\n【2】 We can expect more rebound in the extraction sites in cases treated with extractions. This problem can be cor¬ rected with a thermoplastic retainer (mouth guard) in combination with intra-maxillary elastics. The guard is done with 0.060\" acetate and it is sectioned at the extrac¬ tion site level; then buttons are bonded for the use of space closure elastics.\n Fig. 48. Rebound in the premolar zone.\n Figs. 49-52. Sectioned acetate at the premolar level with buttons and space closure elastics.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Usually the prescribed force is obtained when the elastic", "bbox": [66.0, 83.0, 383.0, 106.0]}, {"text": "is stretched three times its diameter. ( 20 )", "bbox": [66.0, 103.0, 281.0, 119.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Retention is initiated after active treatment This is very", "bbox": [66.0, 137.0, 382.0, 156.0]}, {"text": "important and we must keep in mind that selecting the", "bbox": [66.0, 154.0, 381.0, 173.0]}, {"text": "wrong retainers, or if the patient does not fully cooperate,", "bbox": [66.0, 172.0, 382.0, 190.0]}, {"text": "this can translate into total treatment failure.", "bbox": [66.0, 189.0, 314.0, 206.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "We can expect more rebound in the extraction sites in", "bbox": [66.0, 224.0, 383.0, 243.0]}, {"text": "cases treated with extractions. This problem can be cor¬", "bbox": [66.0, 242.0, 380.0, 259.0]}, {"text": "rected with a thermoplastic retainer (mouth guard) in", "bbox": [66.0, 259.0, 382.0, 276.0]}, {"text": "combination with intra-maxillary elastics. The guard is", "bbox": [66.0, 277.0, 382.0, 293.0]}, {"text": "done with 0.060\" acetate and it is sectioned at the extrac¬", "bbox": [66.0, 292.0, 379.0, 312.0]}, {"text": "tion site level; then buttons are bonded for the use of space", "bbox": [66.0, 311.0, 381.0, 328.0]}, {"text": "closure elastics.", "bbox": [66.0, 328.0, 157.0, 344.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Fig. 48. Rebound in the premolar zone.", "bbox": [135.0, 653.0, 308.0, 670.0]}], "type": "Caption", "position": 5}, {"raw_context": [{"text": "Figs. 49-52. Sectioned acetate at the premolar level with buttons and space closure elastics.", "bbox": [189.0, 950.0, 588.0, 969.0]}], "type": "Caption", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 99}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#0#0#( 20 )\n", "type4": null, "type5": null, "type6": "有用性#2#2#Fig. 48. Rebound in the premolar zone.\nFigs. 49-52. Sectioned acetate at the premolar level with buttons and space closure elastics.对图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 19:16:12"}
{"id": 1041997, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "73ff7326-2a97-43e3-bae1-34d57f415d90", "title": null, "text": "【0】页码:22\n machine should be doubled. By moving the schedule, Intel has attempted to rally the industry around EUV and to eliminate electron projection lithography (EPL).\n\n【1】\"We fervently believe that there are not enough resources in the industry to develop both technologies,\" he says.\n\n【2】Silverman is also ready to blast ahead by placing an order with ASML for a $30- million EUV prototype machine, forcing the equipment manufacturer to commit to\n\n【3】 a delivery schedule. It behooves Intel to push. Although AMD, Motorola, Infineon and Micron are partners, Intel negotiated contract terms that let it get the first machines produced and, because it is the largest investor in the $250-million program, the greatest number of tools.\n\n【4】Suppliers have to implement fully two crushingly difficult generations of technology before they finish making an investment of perhaps $750 million to start producing EUV machines. Getting them to buy into the breakneck schedule set by Intel may be a bigger challenge than creating angstrom-smooth mirrors.\n\n【5】Even ASML, which dropped its involvement with EPL, is cautious, saying existing optical technologies may last longer than the industry expects. \"It's too early to decide whether EUV will happen in the time frame Intel is pushing,\" says Jos\n\n【6】 Benschop, research manager at ASML.\n\n【7】Intel would also like to bring Nikon  , its other main supplier, into the fold. But the industry's largest equipment manufacturer, which is researching EUV outside of the U.S. consortium, is not ready to commit to a single technology—and it continues work on EPL with IBM. Other chipmakers, such as Motorola and Texas Instruments, have voiced support for the EUV competitor. \"It's still a horse race between EPL and EUV,\" says Gilbert L. Varnell, president and chief operating officer of Nikon Research Corporation of America. \"Intel has taken the position that there's only one technology and they want to get rid of the competition. I'm not convinced that's the best approach for the industry. What if [EUV] fails? We're a toolmaker and they're a chipmaker, and there's a lot of other things we have to consider, such as manufacturability of the lithography equipment and profitability.\" Adds Lloyd R.\n\n【8】Harriott, a former Bell Labs employee who headed the EPL program and worked on\n\n【9】 sortium. Four years ago the only major American tool supplier in the consortium was SVG. Ultratech Stepper, an early U.S. partner in EUV research, had to settle grudgingly for a minor role when it was viewed as lacking the necessary financial resources to develop an EUV product line. ASML, moreover, has subsequently bought SVG, which would leave ASML as the primary beneficiary of this technology transfer. Intel has \"done everything in their power to give the technology on a silver platter to ASML,\" says David A. Markle, chief technology officer of Ultratech Stepper, adding that \"Intel has approached this situation with the attitude that what's good for Intel is good for America.\" Despite the trail of bruised egos, the EUV experience may serve as a case study for future research. It is one of the most successful collaborations between industry and national laboratories. More broadly, it constitutes a model for the creation of virtual laboratories that can undertake major projects on an as-needed basis\n\n【10】## The Collaborative Structure Of The Euv Program May Serve As A Model For How The Semiconductor Industry Conducts Future Research.\n\n【11】\n the early EUV program: \"I think a lot of progress has been made with EUV. But they've got a really long way to go. There's a lot of marketing hype about how this is a done deal.\" Varnell also believes that the current schedule—making commercial chips with EUV in 2005—is unrealistic, citing the nine years it took Nikon to develop the laser used in the current generation of lithography, a much less ambitious project. Says Varnell: \"You're going from an image to full-up production system by 2005, and it is going to come from the national labs. I've been around the toolmaking business for a long time. I don't believe that's going to happen.\" Along the way, another hurdle Intel and company have faced is convincing Washington to let a foreign company, the Dutch supplier ASML, enter the con-\n\n【12】 without the huge overhead of a central research facility.\n\n【13】Whether Intel's buy-it-when-you-needit strategy can work more generally remains to be seen. The real test may come in 15 years or so if EUV or EPL gives out and some wholly new substitute for silicon chips is needed. A paradigm shift— using molecules of DNA, nanotubes, quantum dots or other exotic materials to execute computations—may determine whether the virtual-research model can succeed. \"Intel did a magnificent job of picking up the technology, recognizing its worthiness and driving it home,\" Freeman says. \"But they're not putting the same effort into asking the questions about what to do when you get to 100 angstroms [10 nanometers].\" Maybe one of Moore's successors will have to lay down the law for quantum computing.\n\n【14】E", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "machine should be doubled. By moving", "bbox": [45.0, 134.0, 261.0, 149.0]}, {"text": "the schedule, Intel has attempted to rally", "bbox": [44.0, 151.0, 260.0, 165.0]}, {"text": "the industry around EUV and to elimi-", "bbox": [44.0, 167.0, 260.0, 181.0]}, {"text": "nate electron projection lithography (EPL).", "bbox": [44.0, 183.0, 260.0, 197.0]}, {"text": "\"We fervently believe that there are not", "bbox": [46.0, 199.0, 261.0, 213.0]}, {"text": "enough resources in the industry to de-", "bbox": [45.0, 215.0, 259.0, 229.0]}, {"text": "velop both technologies,\" he says.", "bbox": [45.0, 231.0, 228.0, 245.0]}, {"text": "Silverman is also ready to blast ahead", "bbox": [65.0, 247.0, 261.0, 261.0]}, {"text": "by placing an order with ASML for a $30-", "bbox": [44.0, 263.0, 260.0, 277.0]}, {"text": "million EUV prototype machine, forcing", "bbox": [44.0, 279.0, 261.0, 294.0]}, {"text": "the equipment manufacturer to commit to", "bbox": [45.0, 295.0, 261.0, 309.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "a delivery schedule. It behooves Intel to", "bbox": [44.0, 631.0, 261.0, 645.0]}, {"text": "push. Although AMD, Motorola, Infi-", "bbox": [44.0, 647.0, 260.0, 662.0]}, {"text": "neon and Micron are partners, Intel nego-", "bbox": [44.0, 663.0, 260.0, 677.0]}, {"text": "tiated contract terms that let it get the first", "bbox": [44.0, 679.0, 261.0, 694.0]}, {"text": "machines produced and, because it is the", "bbox": [45.0, 695.0, 261.0, 710.0]}, {"text": "largest investor in the $250-million pro-", "bbox": [45.0, 712.0, 259.0, 725.0]}, {"text": "gram, the greatest number of tools.", "bbox": [44.0, 727.0, 229.0, 742.0]}, {"text": "Suppliers have to implement fully", "bbox": [65.0, 743.0, 261.0, 757.0]}, {"text": "two crushingly difficult generations of", "bbox": [45.0, 759.0, 261.0, 773.0]}, {"text": "technology before they finish making an", "bbox": [44.0, 774.0, 261.0, 790.0]}, {"text": "investment of perhaps $750 million to", "bbox": [45.0, 791.0, 261.0, 805.0]}, {"text": "start producing EUV machines. Getting", "bbox": [45.0, 807.0, 261.0, 821.0]}, {"text": "them to buy into the breakneck schedule", "bbox": [44.0, 823.0, 261.0, 837.0]}, {"text": "set by Intel may be a bigger challenge", "bbox": [45.0, 839.0, 261.0, 853.0]}, {"text": "than creating angstrom-smooth mirrors.", "bbox": [44.0, 855.0, 260.0, 869.0]}, {"text": "Even ASML, which dropped its involve-", "bbox": [45.0, 871.0, 259.0, 885.0]}, {"text": "ment with EPL, is cautious, saying exist-", "bbox": [45.0, 887.0, 260.0, 901.0]}, {"text": "ing optical technologies may last longer", "bbox": [44.0, 903.0, 261.0, 917.0]}, {"text": "than the industry expects. \"It's too early", "bbox": [44.0, 919.0, 261.0, 933.0]}, {"text": "to decide whether EUV will happen in", "bbox": [44.0, 935.0, 261.0, 949.0]}, {"text": "the time frame Intel is pushing,\" says Jos", "bbox": [44.0, 951.0, 261.0, 965.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Benschop, research manager at ASML.", "bbox": [273.0, 135.0, 488.0, 149.0]}, {"text": "Intel would also like to bring Nikon  ,", "bbox": [292.0, 151.0, 489.0, 165.0]}, {"text": "its other main supplier, into the fold. But", "bbox": [274.0, 167.0, 489.0, 181.0]}, {"text": "the industry's largest equipment manu-", "bbox": [273.0, 183.0, 488.0, 197.0]}, {"text": "facturer, which is researching EUV out-", "bbox": [273.0, 199.0, 488.0, 214.0]}, {"text": "side of the U.S. consortium, is not ready", "bbox": [274.0, 215.0, 489.0, 229.0]}, {"text": "to commit to a single technology—and it", "bbox": [273.0, 231.0, 490.0, 245.0]}, {"text": "continues work on EPL with IBM. Oth-", "bbox": [273.0, 247.0, 488.0, 261.0]}, {"text": "er chipmakers, such as Motorola and", "bbox": [273.0, 263.0, 489.0, 277.0]}, {"text": "Texas Instruments, have voiced support", "bbox": [274.0, 279.0, 490.0, 294.0]}, {"text": "for the EUV competitor. \"It's still a horse", "bbox": [273.0, 295.0, 489.0, 309.0]}, {"text": "race between EPL and EUV,\" says Gil-", "bbox": [273.0, 311.0, 488.0, 325.0]}, {"text": "bert L. Varnell, president and chief op-", "bbox": [273.0, 327.0, 488.0, 341.0]}, {"text": "erating officer of Nikon Research Cor-", "bbox": [273.0, 343.0, 488.0, 357.0]}, {"text": "poration of America. \"Intel has taken the", "bbox": [273.0, 359.0, 490.0, 374.0]}, {"text": "position that there's only one technology", "bbox": [273.0, 374.0, 488.0, 389.0]}, {"text": "and they want to get rid of the competi-", "bbox": [273.0, 391.0, 488.0, 405.0]}, {"text": "tion. I'm not convinced that's the best ap-", "bbox": [273.0, 406.0, 488.0, 422.0]}, {"text": "proach for the industry. What if [EUV]", "bbox": [273.0, 423.0, 489.0, 437.0]}, {"text": "fails? We're a toolmaker and they're a", "bbox": [273.0, 439.0, 490.0, 453.0]}, {"text": "chipmaker, and there's a lot of other", "bbox": [273.0, 454.0, 489.0, 469.0]}, {"text": "things we have to consider, such as man-", "bbox": [273.0, 471.0, 488.0, 485.0]}, {"text": "ufacturability of the lithography equip-", "bbox": [273.0, 487.0, 487.0, 501.0]}, {"text": "ment and profitability.\" Adds Lloyd R.", "bbox": [273.0, 503.0, 488.0, 518.0]}, {"text": "Harriott, a former Bell Labs employee who", "bbox": [273.0, 519.0, 490.0, 534.0]}, {"text": "headed the EPL program and worked on", "bbox": [273.0, 535.0, 490.0, 550.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "sortium. Four years ago the only major", "bbox": [502.0, 135.0, 718.0, 149.0]}, {"text": "American tool supplier in the consortium", "bbox": [502.0, 151.0, 718.0, 165.0]}, {"text": "was SVG. Ultratech Stepper, an early", "bbox": [502.0, 167.0, 717.0, 181.0]}, {"text": "U.S. partner in EUV research, had to set-", "bbox": [502.0, 183.0, 716.0, 197.0]}, {"text": "tle grudgingly for a minor role when it", "bbox": [502.0, 199.0, 718.0, 214.0]}, {"text": "was viewed as lacking the necessary fi-", "bbox": [502.0, 215.0, 717.0, 229.0]}, {"text": "nancial resources to develop an EUV", "bbox": [502.0, 231.0, 717.0, 245.0]}, {"text": "product line. ASML, moreover, has sub-", "bbox": [502.0, 247.0, 716.0, 262.0]}, {"text": "sequently bought SVG, which would", "bbox": [502.0, 263.0, 718.0, 277.0]}, {"text": "leave ASML as the primary beneficiary of", "bbox": [502.0, 279.0, 718.0, 294.0]}, {"text": "this technology transfer. Intel has \"done", "bbox": [502.0, 295.0, 718.0, 309.0]}, {"text": "everything in their power to give the tech-", "bbox": [502.0, 311.0, 717.0, 325.0]}, {"text": "nology on a silver platter to ASML,\" says", "bbox": [502.0, 326.0, 718.0, 342.0]}, {"text": "David A. Markle, chief technology offi-", "bbox": [502.0, 344.0, 716.0, 357.0]}, {"text": "cer of Ultratech Stepper, adding that \"In-", "bbox": [501.0, 359.0, 716.0, 374.0]}, {"text": "tel has approached this situation with the", "bbox": [502.0, 374.0, 718.0, 391.0]}, {"text": "attitude that what's good for Intel is good", "bbox": [502.0, 390.0, 718.0, 406.0]}, {"text": "for America.\"", "bbox": [502.0, 407.0, 577.0, 421.0]}, {"text": "Despite the trail of bruised egos, the", "bbox": [520.0, 423.0, 718.0, 437.0]}, {"text": "EUV experience may serve as a case study", "bbox": [502.0, 439.0, 717.0, 453.0]}, {"text": "for future research. It is one of the most", "bbox": [502.0, 454.0, 718.0, 469.0]}, {"text": "successful collaborations between indus-", "bbox": [502.0, 471.0, 716.0, 485.0]}, {"text": "try and national laboratories. More broad-", "bbox": [502.0, 487.0, 716.0, 501.0]}, {"text": "ly, it constitutes a model for the creation", "bbox": [502.0, 503.0, 718.0, 517.0]}, {"text": "of virtual laboratories that can undertake", "bbox": [501.0, 519.0, 718.0, 534.0]}, {"text": "major projects on an as-needed basis", "bbox": [501.0, 535.0, 718.0, 549.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The collaborative structure of the EUV program", "bbox": [274.0, 560.0, 648.0, 581.0]}, {"text": "may serve as a model for how the ", "bbox": [273.0, 583.0, 552.0, 602.0]}, {"text": "semiconductor industry conducts future research.", "bbox": [273.0, 604.0, 686.0, 624.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "the early EUV program: \"I think a lot of", "bbox": [273.0, 630.0, 490.0, 645.0]}, {"text": "progress has been made with EUV. But", "bbox": [274.0, 647.0, 490.0, 662.0]}, {"text": "they've got a really long way to go. There's", "bbox": [273.0, 663.0, 489.0, 677.0]}, {"text": "a lot of marketing hype about how this is", "bbox": [273.0, 679.0, 490.0, 694.0]}, {"text": "a done deal.\"", "bbox": [274.0, 695.0, 345.0, 709.0]}, {"text": "Varnell also believes that the current", "bbox": [293.0, 711.0, 489.0, 724.0]}, {"text": "schedule—making commercial chips with", "bbox": [273.0, 725.0, 489.0, 743.0]}, {"text": "EUV in 2005—is unrealistic, citing the", "bbox": [273.0, 743.0, 490.0, 757.0]}, {"text": "nine years it took Nikon to develop the", "bbox": [273.0, 759.0, 489.0, 773.0]}, {"text": "laser used in the current generation of", "bbox": [273.0, 774.0, 489.0, 789.0]}, {"text": "lithography, a much less ambitious proj-", "bbox": [273.0, 791.0, 488.0, 805.0]}, {"text": "ect. Says Varnell: \"You're going from an", "bbox": [274.0, 807.0, 489.0, 821.0]}, {"text": "image to full-up production system by", "bbox": [273.0, 823.0, 489.0, 837.0]}, {"text": "2005, and it is going to come from the", "bbox": [274.0, 839.0, 490.0, 853.0]}, {"text": "national labs. I've been around the tool-", "bbox": [274.0, 855.0, 488.0, 869.0]}, {"text": "making business for a long time. I don't", "bbox": [273.0, 871.0, 490.0, 885.0]}, {"text": "believe that's going to happen.\"", "bbox": [273.0, 887.0, 442.0, 902.0]}, {"text": "Along the way, another hurdle Intel", "bbox": [293.0, 903.0, 489.0, 917.0]}, {"text": "and company have faced is convincing", "bbox": [274.0, 919.0, 490.0, 933.0]}, {"text": "Washington to let a foreign company,", "bbox": [274.0, 935.0, 490.0, 949.0]}, {"text": "the Dutch supplier ASML, enter the con-", "bbox": [273.0, 951.0, 488.0, 965.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "without the huge overhead of a central", "bbox": [502.0, 630.0, 718.0, 645.0]}, {"text": "research facility.", "bbox": [502.0, 647.0, 590.0, 662.0]}, {"text": "Whether Intel's buy-it-when-you-need-", "bbox": [521.0, 663.0, 716.0, 677.0]}, {"text": "it strategy can work more generally re-", "bbox": [501.0, 679.0, 716.0, 694.0]}, {"text": "mains to be seen. The real test may come", "bbox": [502.0, 694.0, 718.0, 710.0]}, {"text": "in 15 years or so if EUV or EPL gives out", "bbox": [502.0, 712.0, 718.0, 724.0]}, {"text": "and some wholly new substitute for sili-", "bbox": [502.0, 727.0, 717.0, 742.0]}, {"text": "con chips is needed. A paradigm shift—", "bbox": [501.0, 743.0, 716.0, 757.0]}, {"text": "using molecules of DNA, nanotubes,", "bbox": [502.0, 759.0, 717.0, 773.0]}, {"text": "quantum dots or other exotic materials", "bbox": [502.0, 774.0, 718.0, 789.0]}, {"text": "to execute computations—may deter-", "bbox": [502.0, 791.0, 716.0, 805.0]}, {"text": "mine whether the virtual-research mod-", "bbox": [502.0, 807.0, 717.0, 821.0]}, {"text": "el can succeed. \"Intel did a magnificent", "bbox": [501.0, 823.0, 718.0, 837.0]}, {"text": "job of picking up the technology, recog-", "bbox": [502.0, 839.0, 716.0, 853.0]}, {"text": "nizing its worthiness and driving it home,\"", "bbox": [502.0, 855.0, 716.0, 869.0]}, {"text": "Freeman says. \"But they're not putting the", "bbox": [502.0, 871.0, 718.0, 885.0]}, {"text": "same effort into asking the questions about", "bbox": [502.0, 887.0, 718.0, 901.0]}, {"text": "what to do when you get to 100 angstroms", "bbox": [502.0, 903.0, 718.0, 917.0]}, {"text": "[10 nanometers].\" Maybe one of Moore's", "bbox": [502.0, 919.0, 718.0, 933.0]}, {"text": "successors will have to lay down the law", "bbox": [502.0, 935.0, 718.0, 949.0]}, {"text": "for quantum computing.", "bbox": [502.0, 951.0, 634.0, 965.0]}, {"text": "E", "bbox": [706.0, 953.0, 720.0, 964.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 22}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": "多余换行#3#3#a delivery schedule.  ...与上面2是一段话\n多余换行#6#6#Suppliers have to implement...Benschop, research manager at ASML.与上面5是一段话\n缺少换行#9#9#” Despite the trail of bruised egos...应该另起一行\n缺少换行#11#11#Varnell also believes that the current schedule—making...应该另起一行", "type3": "无关文本#14#14#E无关内容", "type4": "栏目混乱#9#12#正文内容互相穿插，没有顺序"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:52:02"}
{"id": 1041996, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "3294ce63-3ad6-482b-923d-20367d70a075", "title": null, "text": "【0】页码:157\n 142. Marcusohn E, Roguin A, Sebbag A, Aronson D, Dragu R, Amikam S, Boulus M, Grenadier E, Kerner A, Nikolsky E, Markiewicz W, Hammerman H, Kapeliovich M. Primary percutaneous coronary intervention after out-of-hospital cardiac arrest: patients and outcomes. Isr Med Assoc J . 2007;9:257–259.\n\n【1】143. McCullough PA, Prakash R, Tobin KJ, O'Neill WW, Thompson RJ. Application of a cardiac arrest score in patients with sudden death and ST segment elevation for triage to angiography and intervention.\n\n【2】J Interv Cardiol . 2002;15:257–261.\n\n【3】144. Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K, Watanabe I.  Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol . 2000;36:776–783.\n\n【4】145. Peels HO, Jessurun GA, van der Horst IC, Arnold AE, Piers LH, Zijlstra F.  Outcome in transferred and nontransferred patients after primary percutaneous coronary intervention for ischaemic out-of-hospital cardiac arrest. Catheter Cardiovasc Interv. 2008;71:147–151.\n\n【5】146. Pleskot M, Babu A, Hazukova R, Stritecky J, Bis J, Matejka J, Cermakova E.  Out-of-hospital cardiac arrests in patients with acute ST elevation myocardial infarctions in the East Bohemian region over the period 2002–2004. Cardiology . 2008;109:41–51.\n\n【6】147. Quintero-Moran B, Moreno R, Villarreal S, Perez-Vizcayno MJ, Hernandez R, Conde C, Vazquez P, Alfonso F, Banuelos C, Escaned J, Fernandez-Ortiz A, Azcona L, Macaya C. Percutaneous coronary intervention for cardiac arrest secondary to ST-elevation acute myocardial infarction. Influence of immediate paramedical/medical assistance on clinical outcome. J Invasive Cardiol . 2006;18:269–272.\n\n【7】148.\n\n【8】Investigators A.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med . 1997;337:1576–1583.\n\n【9】149. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med . 1999;341:1882–1890.\n\n【10】150. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B.  Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation . 2000;101: 1297–1302.\n\n【11】151. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–754.\n\n【12】152. Wever EFD, Hauer RNW, Van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Wiesfeld ACP, Bakker PFA, Robles de Medina EO.  Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation .\n\n【13】1995;91:2195–2203.\n\n【14】153.\n\n【15】De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL.  Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med .\n\n【16】2010;362:779–789.\n\n【17】154. Kellum JA, Pinsky MR.  Use of vasopressor agents in critically ill patients. Curr Opin Crit Care . 2002;8:236–241.\n\n【18】155.\n\n【19】Zaritsky AL.  Catecholamines, inotropic medications, and vasopressor agents. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Ill ed. Baltimore, MD: Williams & Wilkins;1994: 387–404.\n\n【20】156. Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system. Crit Care Med . 1995;23:1061–1066.\n\n【21】Bonhomme L, Benhamou D, Comoy E, Preaux N. Stability of epineph- 157.\n\n【22】rine in alkalinized solutions. Ann Emerg Med . 1990;19:1242–1244.\n\n【23】Vasquez A, Kern KB, Hilwig RW, Heidenreich J, Berg RA, Ewy GA.\n\n【24】158.\n\n【25】Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction. Resuscitation . 2004;61:199–207.\n\n【26】159. Gisvold SE, Sterz F, Abramson NS, Bar-Joseph G, Ebmeyer U, Gervais H, Ginsberg M, Katz LM, Kochanek PM, Kuboyama K, Miller B, Obrist W, Roine RO, Safar P, Sim KM, Vandevelde K, White RJ, Xiao F.\n\n【27】Cerebral resuscitation from cardiac arrest: treatment potentials. Crit Care Med . 1996;24(2 Suppl):S69–80.\n\n【28】160.\n\n【29】del Zoppo GJ, Mabuchi T.  Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879–894.\n\n【30】 161. Zandbergen EG, de Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A.\n\n【31】Systematic review of early prediction of poor outcome in anoxicischaemic coma. Lancet . 1998;352(9143):1808–1812.\n\n【32】162. Rothstein TL. Recovery from near death following cerebral anoxia: A case report demonstrating superiority of median somatosensory evoked potentials over EEG in predicting a favorable outcome after cardiopulmonary resuscitation. Resuscitation. 2004;60:335–341.\n\n【33】163. Kaplan PW, Genoud D, Ho TW, Jallon P. Etiology, neurologic correlations, and prognosis in alpha coma. Clin Neurophysiol. 1999;110: 205–213.\n\n【34】164. Mullner M, Domanovits H, Sterz F, Herkner H, Gamper G, Kurkciyan I, Laggner AN. Measurement of myocardial contractility following successful resuscitation: quantitated left ventricular systolic function utilising non-invasive wall stress analysis. Resuscitation . 1998;39: 51–59.\n\n【35】165. Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation: a comparative trial using 175-J and 320-J shocks. N Engl J Med . 1982;307:1101–1106.\n\n【36】166. Mayr V, Luckner G, Jochberger S, Wenzel V, Ulmer H, Pajk W, Knotzer H, Friesenecker B, Lindner K, Hasibeder W, Dunser M.\n\n【37】Arginine vasopressin in advanced cardiovascular failure during the postresuscitation phase after cardiac arrest. Resuscitation . 2007;72:35–44.\n\n【38】167. Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004;110:975–981.\n\n【39】168.\n\n【40】Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.\n\n【41】Eur Heart J . 2005;26:1276–1283.\n\n【42】169. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW.  A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469 e461–e468.\n\n【43】170. Greenberg SB, Deshur M, Khavkin Y, Karaikovic E, Vender J.  Successful resuscitation of a patient who developed cardiac arrest from pulsed saline bacitracin lavage during thoracic laminectomy and fusion.\n\n【44】J Clin Anesth . 2008;20:294–296.\n\n【45】171.\n\n【46】Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52: 1584–1588.\n\n【47】172. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med . 2004;32:858–873.\n\n【48】173. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med . 2001;345: 1368–1377.\n\n【49】174. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K.\n\n【50】Outcome following admission to UK intensive care units after cardiac arrest: a secondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia. 2007;62:1207–1216.\n\n【51】175. Losert H, Sterz F, Roine RO, Holzer M, Martens P, Cerchiari E, Tiainen M, Mullner M, Laggner AN, Herkner H, Bischof MG. Strict normoglycaemic blood glucose levels in the therapeutic management of patients within 12h after cardiac arrest might not be necessary. Resuscitation .\n\n【52】2008;76:214–220.\n\n【53】176. Mullner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN.\n\n【54】Blood glucose concentration after cardiopulmonary resuscitation influences functional neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow Metab . 1997;17:430–436.\n\n【55】177. Oksanen T, Skrifvars MB, Varpula T, Kuitunen A, Pettila V, Nurmi J, Castren M.  Strict versus moderate glucose control after resuscitation from ventricular fibrillation. Intensive Care Med . 2007;33:2093–2100.\n\n【56】178. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R.\n\n【57】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "142. Marcusohn E, Roguin A, Sebbag A, Aronson D, Dragu R, Amikam S,", "bbox": [61.0, 85.0, 375.0, 98.0]}, {"text": "Boulus M, Grenadier E, Kerner A, Nikolsky E, Markiewicz W, Ham-", "bbox": [83.0, 98.0, 375.0, 109.0]}, {"text": "merman H, Kapeliovich M. Primary percutaneous coronary intervention", "bbox": [83.0, 109.0, 376.0, 120.0]}, {"text": "after out-of-hospital cardiac arrest: patients and outcomes. Isr Med", "bbox": [84.0, 122.0, 376.0, 133.0]}, {"text": "Assoc J . 2007;9:257–259.", "bbox": [83.0, 133.0, 190.0, 145.0]}, {"text": "143. McCullough PA, Prakash R, Tobin KJ, O'Neill WW, Thompson", "bbox": [61.0, 145.0, 375.0, 158.0]}, {"text": "RJ. Application of a cardiac arrest score in patients with sudden death", "bbox": [83.0, 158.0, 375.0, 169.0]}, {"text": "and ST segment elevation for triage to angiography and intervention.", "bbox": [84.0, 170.0, 375.0, 182.0]}, {"text": "J Interv Cardiol . 2002;15:257–261.", "bbox": [83.0, 182.0, 229.0, 194.0]}, {"text": "144. Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K,", "bbox": [61.0, 194.0, 375.0, 207.0]}, {"text": "Watanabe I.  Cardiopulmonary cerebral resuscitation using emergency", "bbox": [84.0, 207.0, 375.0, 218.0]}, {"text": "cardiopulmonary bypass, coronary reperfusion therapy and mild hypo-", "bbox": [83.0, 220.0, 375.0, 231.0]}, {"text": "thermia in patients with cardiac arrest outside the hospital. J Am Coll", "bbox": [83.0, 231.0, 375.0, 242.0]}, {"text": "Cardiol . 2000;36:776–783.", "bbox": [83.0, 242.0, 198.0, 254.0]}, {"text": "145. Peels HO, Jessurun GA, van der Horst IC, Arnold AE, Piers LH, Zijlstra", "bbox": [61.0, 254.0, 376.0, 267.0]}, {"text": "F.  Outcome in transferred and nontransferred patients after primary", "bbox": [83.0, 267.0, 375.0, 279.0]}, {"text": "percutaneous coronary intervention for ischaemic out-of-hospital", "bbox": [83.0, 279.0, 375.0, 290.0]}, {"text": "cardiac arrest. Catheter Cardiovasc Interv. 2008;71:147–151.", "bbox": [83.0, 290.0, 336.0, 301.0]}, {"text": "146. Pleskot M, Babu A, Hazukova R, Stritecky J, Bis J, Matejka J, Cer-", "bbox": [61.0, 303.0, 375.0, 314.0]}, {"text": "makova E.  Out-of-hospital cardiac arrests in patients with acute ST", "bbox": [83.0, 315.0, 375.0, 327.0]}, {"text": "elevation myocardial infarctions in the East Bohemian region over the", "bbox": [83.0, 327.0, 375.0, 340.0]}, {"text": "period 2002–2004. Cardiology . 2008;109:41–51.", "bbox": [83.0, 339.0, 286.0, 350.0]}, {"text": "147. Quintero-Moran B, Moreno R, Villarreal S, Perez-Vizcayno MJ, Her-", "bbox": [61.0, 352.0, 375.0, 363.0]}, {"text": "nandez R, Conde C, Vazquez P, Alfonso F, Banuelos C, Escaned J,", "bbox": [83.0, 363.0, 376.0, 374.0]}, {"text": "Fernandez-Ortiz A, Azcona L, Macaya C. Percutaneous coronary inter-", "bbox": [83.0, 376.0, 375.0, 388.0]}, {"text": "vention for cardiac arrest secondary to ST-elevation acute myocardial", "bbox": [84.0, 388.0, 376.0, 399.0]}, {"text": "infarction. Influence of immediate paramedical/medical assistance on", "bbox": [83.0, 401.0, 376.0, 412.0]}, {"text": "clinical outcome. J Invasive Cardiol . 2006;18:269–272.", "bbox": [83.0, 412.0, 313.0, 423.0]}, {"text": "148.", "bbox": [61.0, 423.0, 80.0, 434.0]}, {"text": "Investigators A.  A comparison of antiarrhythmic-drug therapy with", "bbox": [81.0, 424.0, 376.0, 435.0]}, {"text": "implantable defibrillators in patients resuscitated from near-fatal ven-", "bbox": [83.0, 435.0, 375.0, 448.0]}, {"text": "tricular arrhythmias. The Antiarrhythmics versus Implantable Defibril-", "bbox": [83.0, 448.0, 375.0, 459.0]}, {"text": "lators (AVID) Investigators. N Engl J Med . 1997;337:1576–1583.", "bbox": [84.0, 460.0, 355.0, 472.0]}, {"text": "149. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley", "bbox": [61.0, 471.0, 375.0, 486.0]}, {"text": "G. A randomized study of the prevention of sudden death in patients", "bbox": [83.0, 484.0, 375.0, 496.0]}, {"text": "with coronary artery disease. Multicenter Unsustained Tachycardia Trial", "bbox": [83.0, 497.0, 376.0, 508.0]}, {"text": "Investigators. N Engl J Med . 1999;341:1882–1890.", "bbox": [84.0, 509.0, 294.0, 520.0]}, {"text": "150. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS,", "bbox": [61.0, 519.0, 375.0, 532.0]}, {"text": "Mitchell LB, Green MS, Klein GJ, O'Brien B.  Canadian implantable", "bbox": [83.0, 533.0, 375.0, 544.0]}, {"text": "defibrillator study (CIDS): a randomized trial of the implantable cardio-", "bbox": [83.0, 544.0, 375.0, 555.0]}, {"text": "verter defibrillator against amiodarone. Circulation . 2000;101:", "bbox": [84.0, 557.0, 375.0, 568.0]}, {"text": "1297–1302.", "bbox": [84.0, 568.0, 133.0, 580.0]}, {"text": "151. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of", "bbox": [61.0, 581.0, 376.0, 593.0]}, {"text": "antiarrhythmic drug therapy with implantable defibrillators in patients", "bbox": [83.0, 592.0, 375.0, 604.0]}, {"text": "resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg", "bbox": [83.0, 605.0, 375.0, 616.0]}, {"text": "(CASH). Circulation. 2000;102:748–754.", "bbox": [83.0, 617.0, 255.0, 629.0]}, {"text": "152. Wever EFD, Hauer RNW, Van Capelle FJL, Tijssen JGP, Crijns HJGM,", "bbox": [61.0, 629.0, 375.0, 642.0]}, {"text": "Algra A, Wiesfeld ACP, Bakker PFA, Robles de Medina EO.  Ran-", "bbox": [84.0, 642.0, 375.0, 653.0]}, {"text": "domized study of implantable defibrillator as first-choice therapy versus", "bbox": [83.0, 654.0, 376.0, 665.0]}, {"text": "conventional strategy in postinfarct sudden death survivors. Circulation .", "bbox": [84.0, 665.0, 375.0, 677.0]}, {"text": "1995;91:2195–2203.", "bbox": [84.0, 677.0, 168.0, 689.0]}, {"text": "153.", "bbox": [61.0, 689.0, 80.0, 701.0]}, {"text": "De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C,", "bbox": [81.0, 689.0, 375.0, 702.0]}, {"text": "Brasseur A, Defrance P, Gottignies P, Vincent JL.  Comparison of", "bbox": [83.0, 702.0, 375.0, 713.0]}, {"text": "dopamine and norepinephrine in the treatment of shock. N Engl J Med .", "bbox": [84.0, 714.0, 375.0, 726.0]}, {"text": "2010;362:779–789.", "bbox": [84.0, 725.0, 165.0, 736.0]}, {"text": "154. Kellum JA, Pinsky MR.  Use of vasopressor agents in critically ill", "bbox": [61.0, 737.0, 377.0, 749.0]}, {"text": "patients. Curr Opin Crit Care . 2002;8:236–241.", "bbox": [84.0, 749.0, 283.0, 761.0]}, {"text": "155.", "bbox": [61.0, 762.0, 81.0, 773.0]}, {"text": "Zaritsky AL.  Catecholamines, inotropic medications, and vasopressor", "bbox": [81.0, 762.0, 375.0, 774.0]}, {"text": "agents. In: Chernow B, ed. The Pharmacologic Approach to the Crit-", "bbox": [83.0, 774.0, 375.0, 786.0]}, {"text": "ically Ill Patient. Ill ed. Baltimore, MD: Williams & Wilkins;1994:", "bbox": [84.0, 787.0, 375.0, 798.0]}, {"text": "387–404.", "bbox": [84.0, 798.0, 124.0, 809.0]}, {"text": "156. Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. Chemical", "bbox": [61.0, 810.0, 376.0, 823.0]}, {"text": "compatibility of inotropic and vasoactive agents delivered via a multiple", "bbox": [83.0, 823.0, 375.0, 834.0]}, {"text": "line infusion system. Crit Care Med . 1995;23:1061–1066.", "bbox": [84.0, 835.0, 323.0, 847.0]}, {"text": "Bonhomme L, Benhamou D, Comoy E, Preaux N. Stability of epineph-", "bbox": [81.0, 846.0, 374.0, 858.0]}, {"text": "157.", "bbox": [61.0, 847.0, 82.0, 857.0]}, {"text": "rine in alkalinized solutions. Ann Emerg Med . 1990;19:1242–1244.", "bbox": [83.0, 859.0, 362.0, 871.0]}, {"text": "Vasquez A, Kern KB, Hilwig RW, Heidenreich J, Berg RA, Ewy GA.", "bbox": [82.0, 870.0, 375.0, 883.0]}, {"text": "158.", "bbox": [61.0, 871.0, 79.0, 882.0]}, {"text": "Optimal dosing of dobutamine for treating post-resuscitation left ven-", "bbox": [83.0, 883.0, 375.0, 894.0]}, {"text": "tricular dysfunction. Resuscitation . 2004;61:199–207.", "bbox": [83.0, 895.0, 303.0, 906.0]}, {"text": "159. Gisvold SE, Sterz F, Abramson NS, Bar-Joseph G, Ebmeyer U, Gervais", "bbox": [61.0, 906.0, 376.0, 918.0]}, {"text": "H, Ginsberg M, Katz LM, Kochanek PM, Kuboyama K, Miller B, Obrist", "bbox": [83.0, 919.0, 376.0, 930.0]}, {"text": "W, Roine RO, Safar P, Sim KM, Vandevelde K, White RJ, Xiao F.", "bbox": [83.0, 931.0, 375.0, 943.0]}, {"text": "Cerebral resuscitation from cardiac arrest: treatment potentials. Crit", "bbox": [83.0, 943.0, 376.0, 956.0]}, {"text": "Care Med . 1996;24(2 Suppl):S69–80.", "bbox": [83.0, 956.0, 242.0, 967.0]}, {"text": "160.", "bbox": [61.0, 968.0, 81.0, 978.0]}, {"text": "del Zoppo GJ, Mabuchi T.  Cerebral microvessel responses to focal", "bbox": [81.0, 968.0, 377.0, 979.0]}, {"text": "ischemia. J Cereb Blood Flow Metab. 2003;23:879–894.", "bbox": [83.0, 980.0, 322.0, 990.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "161. Zandbergen EG, de Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A.", "bbox": [405.0, 85.0, 720.0, 97.0]}, {"text": "Systematic review of early prediction of poor outcome in anoxic-", "bbox": [427.0, 98.0, 719.0, 109.0]}, {"text": "ischaemic coma. Lancet . 1998;352(9143):1808–1812.", "bbox": [427.0, 109.0, 649.0, 120.0]}, {"text": "162. Rothstein TL. Recovery from near death following cerebral anoxia: A", "bbox": [405.0, 122.0, 720.0, 133.0]}, {"text": "case report demonstrating superiority of median somatosensory evoked", "bbox": [427.0, 133.0, 720.0, 145.0]}, {"text": "potentials over EEG in predicting a favorable outcome after cardiopul-", "bbox": [427.0, 147.0, 718.0, 158.0]}, {"text": "monary resuscitation. Resuscitation. 2004;60:335–341.", "bbox": [427.0, 157.0, 653.0, 169.0]}, {"text": "163. Kaplan PW, Genoud D, Ho TW, Jallon P. Etiology, neurologic corre-", "bbox": [405.0, 170.0, 718.0, 181.0]}, {"text": "lations, and prognosis in alpha coma. Clin Neurophysiol. 1999;110:", "bbox": [427.0, 182.0, 719.0, 194.0]}, {"text": "205–213.", "bbox": [428.0, 195.0, 468.0, 207.0]}, {"text": "164. Mullner M, Domanovits H, Sterz F, Herkner H, Gamper G, Kurkciyan", "bbox": [405.0, 206.0, 720.0, 218.0]}, {"text": "I, Laggner AN. Measurement of myocardial contractility following", "bbox": [427.0, 219.0, 720.0, 231.0]}, {"text": "successful resuscitation: quantitated left ventricular systolic function", "bbox": [427.0, 231.0, 719.0, 242.0]}, {"text": "utilising non-invasive wall stress analysis. Resuscitation . 1998;39:", "bbox": [427.0, 243.0, 719.0, 254.0]}, {"text": "51–59.", "bbox": [427.0, 255.0, 458.0, 266.0]}, {"text": "165. Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defi-", "bbox": [405.0, 266.0, 719.0, 279.0]}, {"text": "brillation: a comparative trial using 175-J and 320-J shocks. N Engl", "bbox": [427.0, 279.0, 720.0, 291.0]}, {"text": "J Med . 1982;307:1101–1106.", "bbox": [427.0, 290.0, 549.0, 301.0]}, {"text": "166. Mayr V, Luckner G, Jochberger S, Wenzel V, Ulmer H, Pajk W,", "bbox": [405.0, 303.0, 719.0, 315.0]}, {"text": "Knotzer H, Friesenecker B, Lindner K, Hasibeder W, Dunser M.", "bbox": [427.0, 314.0, 719.0, 327.0]}, {"text": "Arginine vasopressin in advanced cardiovascular failure during the post-", "bbox": [428.0, 327.0, 718.0, 340.0]}, {"text": "resuscitation phase after cardiac arrest. Resuscitation . 2007;72:35–44.", "bbox": [427.0, 340.0, 716.0, 350.0]}, {"text": "167. Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides", "bbox": [405.0, 352.0, 720.0, 363.0]}, {"text": "MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS,", "bbox": [427.0, 363.0, 720.0, 374.0]}, {"text": "Levitan RG, Mancini D. Left ventricular assist device as destination for", "bbox": [427.0, 376.0, 720.0, 388.0]}, {"text": "patients undergoing intravenous inotropic therapy: a subset analysis", "bbox": [427.0, 388.0, 720.0, 399.0]}, {"text": "from REMATCH (Randomized Evaluation of Mechanical Assistance in", "bbox": [427.0, 400.0, 720.0, 412.0]}, {"text": "Treatment of Chronic Heart Failure). Circulation. 2004;110:975–981.", "bbox": [429.0, 412.0, 715.0, 423.0]}, {"text": "168.", "bbox": [405.0, 423.0, 425.0, 434.0]}, {"text": "Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J,", "bbox": [425.0, 423.0, 719.0, 436.0]}, {"text": "Schuler G. Randomized comparison of intra-aortic balloon support with", "bbox": [427.0, 435.0, 720.0, 448.0]}, {"text": "a percutaneous left ventricular assist device in patients with revascu-", "bbox": [427.0, 449.0, 719.0, 460.0]}, {"text": "larized acute myocardial infarction complicated by cardiogenic shock.", "bbox": [427.0, 461.0, 719.0, 472.0]}, {"text": "Eur Heart J . 2005;26:1276–1283.", "bbox": [427.0, 473.0, 569.0, 484.0]}, {"text": "169. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW.  A randomized", "bbox": [406.0, 484.0, 720.0, 496.0]}, {"text": "multicenter clinical study to evaluate the safety and efficacy of the", "bbox": [427.0, 497.0, 720.0, 508.0]}, {"text": "TandemHeart percutaneous ventricular assist device versus conventional", "bbox": [428.0, 508.0, 719.0, 521.0]}, {"text": "therapy with intraaortic balloon pumping for treatment of cardiogenic", "bbox": [427.0, 519.0, 719.0, 533.0]}, {"text": "shock. Am Heart J. 2006;152:469 e461–e468.", "bbox": [428.0, 533.0, 617.0, 544.0]}, {"text": "170. Greenberg SB, Deshur M, Khavkin Y, Karaikovic E, Vender J.  Suc-", "bbox": [405.0, 544.0, 719.0, 555.0]}, {"text": "cessful resuscitation of a patient who developed cardiac arrest from", "bbox": [428.0, 557.0, 720.0, 568.0]}, {"text": "pulsed saline bacitracin lavage during thoracic laminectomy and fusion.", "bbox": [427.0, 568.0, 718.0, 580.0]}, {"text": "J Clin Anesth . 2008;20:294–296.", "bbox": [427.0, 580.0, 564.0, 593.0]}, {"text": "171.", "bbox": [405.0, 593.0, 425.0, 603.0]}, {"text": "Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R,", "bbox": [424.0, 592.0, 720.0, 604.0]}, {"text": "Dirschinger J, Kastrati A, Schomig A.  A randomized clinical trial to", "bbox": [427.0, 606.0, 721.0, 617.0]}, {"text": "evaluate the safety and efficacy of a percutaneous left ventricular assist", "bbox": [427.0, 617.0, 720.0, 629.0]}, {"text": "device versus intra-aortic balloon pumping for treatment of cardiogenic", "bbox": [427.0, 630.0, 719.0, 642.0]}, {"text": "shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:", "bbox": [427.0, 642.0, 719.0, 653.0]}, {"text": "1584–1588.", "bbox": [427.0, 654.0, 478.0, 665.0]}, {"text": "172. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J,", "bbox": [405.0, 665.0, 720.0, 677.0]}, {"text": "Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zim-", "bbox": [427.0, 677.0, 719.0, 690.0]}, {"text": "merman JL, Vincent JL, Levy MM.  Surviving Sepsis Campaign", "bbox": [427.0, 689.0, 720.0, 702.0]}, {"text": "guidelines for management of severe sepsis and septic shock. Crit Care", "bbox": [427.0, 702.0, 720.0, 714.0]}, {"text": "Med . 2004;32:858–873.", "bbox": [427.0, 714.0, 527.0, 725.0]}, {"text": "173. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B,", "bbox": [405.0, 725.0, 720.0, 736.0]}, {"text": "Peterson E, Tomlanovich M. Early goal-directed therapy in the", "bbox": [427.0, 738.0, 718.0, 749.0]}, {"text": "treatment of severe sepsis and septic shock. N Engl J Med . 2001;345:", "bbox": [427.0, 749.0, 719.0, 761.0]}, {"text": "1368–1377.", "bbox": [427.0, 762.0, 479.0, 773.0]}, {"text": "174. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K.", "bbox": [405.0, 774.0, 719.0, 786.0]}, {"text": "Outcome following admission to UK intensive care units after cardiac", "bbox": [427.0, 787.0, 719.0, 798.0]}, {"text": "arrest: a secondary analysis of the ICNARC Case Mix Programme", "bbox": [427.0, 798.0, 719.0, 809.0]}, {"text": "Database. Anaesthesia. 2007;62:1207–1216.", "bbox": [427.0, 811.0, 609.0, 823.0]}, {"text": "175. Losert H, Sterz F, Roine RO, Holzer M, Martens P, Cerchiari E, Tiainen", "bbox": [405.0, 823.0, 720.0, 834.0]}, {"text": "M, Mullner M, Laggner AN, Herkner H, Bischof MG. Strict normogly-", "bbox": [427.0, 836.0, 719.0, 847.0]}, {"text": "caemic blood glucose levels in the therapeutic management of patients", "bbox": [427.0, 846.0, 720.0, 858.0]}, {"text": "within 12h after cardiac arrest might not be necessary. Resuscitation .", "bbox": [427.0, 859.0, 719.0, 870.0]}, {"text": "2008;76:214–220.", "bbox": [428.0, 870.0, 503.0, 882.0]}, {"text": "176. Mullner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN.", "bbox": [405.0, 882.0, 719.0, 895.0]}, {"text": "Blood glucose concentration after cardiopulmonary resuscitation", "bbox": [427.0, 895.0, 720.0, 907.0]}, {"text": "influences functional neurological recovery in human cardiac arrest", "bbox": [427.0, 905.0, 720.0, 919.0]}, {"text": "survivors. J Cereb Blood Flow Metab . 1997;17:430–436.", "bbox": [428.0, 919.0, 666.0, 930.0]}, {"text": "177. Oksanen T, Skrifvars MB, Varpula T, Kuitunen A, Pettila V, Nurmi J,", "bbox": [405.0, 931.0, 720.0, 943.0]}, {"text": "Castren M.  Strict versus moderate glucose control after resuscitation", "bbox": [427.0, 943.0, 719.0, 956.0]}, {"text": "from ventricular fibrillation. Intensive Care Med . 2007;33:2093–2100.", "bbox": [427.0, 956.0, 718.0, 967.0]}, {"text": "178. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F,", "bbox": [405.0, 968.0, 718.0, 979.0]}, {"text": "Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R.", "bbox": [427.0, 980.0, 718.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 157}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#57#全文为参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:05:52"}
{"id": 1041995, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "b5ef1fe1-cf98-4d85-a381-d97a190efc13", "title": null, "text": "【0】页码:19\n tation: risks for patients not in cardiac arrest. Circulation. 2010;121: 91–97.\n\n【1】111. Cabrini L, Beccaria P, Landoni G, Biondi-Zoccai GG, Sheiban I, Cristofolini M, Fochi O, Maj G, Zangrillo A. Impact of impedance threshold devices on cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled studies. Crit Care Med. 2008; 36:1625–1632.\n\n【2】112. Hallstrom A, Rea TD, Sayre MR, Christenson J, Anton AR, Mosesso VN, Jr, Van Ottingham L, Olsufka M, Pennington S, White LJ, Yahn S, Husar J, Morris MF, Cobb LA. Manual chest compression vs use of an automated chest compression device during resuscitation following outof-hospital cardiac arrest: a randomized trial. JAMA . 2006;295: 2620–2628.\n\n【3】112a.Hallstrom A, Rea TD, Sayre MR, Christenson J, Cobb LA, Mosesso VN Jr, Anton AR. The ASPIRE trial investigators respond to inhomogenity and temporal effects assertion. Am J Emerg Med. August 16, 2010.\n\n【4】doi:10.1016/j.ajem.2010.07.001. Available at: http://www.ajemjournal.\n\n【5】com/article/S0735-6757(10)00307-4/fulltext.\n\n【6】113. Paradis N, Young G, Lemeshow S, Brewer J, Halperin H. Inhomogeneity and temporal effects in AutoPulse Assisted Prehospital International Resuscitation—an exception from consent trial terminated early.\n\n【7】Am J Emerg Med . 2010;28:391–398.\n\n【8】114. Tomte O, Sunde K, Lorem T, Auestad B, Souders C, Jensen J, Wik L.\n\n【9】Advanced life support performance with manual and mechanical chest compressions in a randomized, multicentre manikin study. Resuscitation .\n\n【10】2009;80:1152–1157.\n\n【11】115. Axelsson C, Nestin J, Svensson L, Axelsson AB, Herlitz J.  Clinical consequences of the introduction of mechanical chest compression in the EMS system for treatment of out-of-hospital cardiac arrest-a pilot study.\n\n【12】Resuscitation. 2006;71:47–55.\n\n【13】116. Larsen AI, Hjornevik AS, Ellingsen CL, Nilsen DW. Cardiac arrest with continuous mechanical chest compression during percutaneous coronary intervention. A report on the use of the LUCAS device. Resuscitation.\n\n【14】2007;75:454–459.\n\n【15】117. Deakin CD, O'Neill JF, Tabor T. Does compression-only cardiopulmonary resuscitation generate adequate passive ventilation during cardiac arrest? Resuscitation. 2007;75:53–59.\n\n【16】118. Bonnemeier H, Olivecrona G, Simonis G, Gotberg M, Weitz G, Iblher P, Gerling I, Schunkert H. Automated continuous chest compression for in-hospital cardiopulmonary resuscitation of patients with pulseless electrical activity: a report of five cases. Int J Cardiol . 2009;136: e39–e50.\n\n【17】119.\n\n【18】Wagner H, Terkelsen CJ, Friberg H, Harnek J, Kern K, Lassen JF, Olivecrona GK. Cardiac arrest in the catheterisation laboratory: a 5-year experience of using mechanical chest compressions to facilitate PCI during prolonged resuscitation efforts. Resuscitation. 2010;81:383–387.\n\n【19】120. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP.  Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med. 1993;22:1652–1658.\n\n【20】121. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. Circulation. 1997;96:3308–3313.\n\n【21】122. Swor RA, Jackson RE, Cynar M, Sadler E, Basse E, Boji B, Rivera- Rivera EJ, Maher A, Grubb W, Jacobson R, et  al. Bystander CPR, ventricular fibrillation, and survival in witnessed, unmonitored out-ofhospital cardiac arrest. Ann Emerg Med. 1995;25:780–784.\n\n【22】123. Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin M, Hallstrom AP.  Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.\n\n【23】JAMA . 1999;281:1182–1188.\n\n【24】124. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen PA. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. JAMA . 2003;289:1389–1395.\n\n【25】125. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ, Grantham H.  Defibrillation or cardiopulmonary resuscitation first for patients with out-of-hospital cardiac arrests found by paramedics to be in ventricular fibrillation? A randomised control trial. Resuscitation. 2008 ; 79:424–431.\n\n【26】126. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas .\n\n【27】2005;17:39–45.\n\n【28】127. Morrison LJ, Dorian P, Long J, Vermeulen M, Schwartz B, Sawadsky B, Frank J, Cameron B, Burgess R, Shield J, Bagley P, Mausz V, Brewer JE, Lerman BB.  Out-of-hospital cardiac arrest rectilinear biphasic to\n\n【29】 monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT). Resuscitation. 2005;66:149–157.\n\n【30】128. Schneider T, Martens PR, Paschen H, Kuisma M, Wolcke B, Gliner BE, Russell JK, Weaver WD, Bossaert L, Chamberlain D. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation. 2000;102:1780–1787.\n\n【31】129. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A prospective, randomised and blinded comparison of first shock success of monophasic and biphasic waveforms in out-of-hospital cardiac arrest.\n\n【32】Resuscitation . 2003;58:17–24.\n\n【33】130. Carpenter J, Rea TD, Murray JA, Kudenchuk PJ, Eisenberg MS. Defibrillation waveform and post-shock rhythm in out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation. 2003;59:189–196.\n\n【34】131. Freeman K, Hendey GW, Shalit M, Stroh G. Biphasic defibrillation does not improve outcomes compared to monophasic defibrillation in out-ofhospital cardiac arrest. Prehosp Emerg Care. 2008;12:152–156.\n\n【35】132. Gliner BE, White RD.  Electrocardiographic evaluation of defibrillation shocks delivered to out-of-hospital sudden cardiac arrest patients. Resuscitation. 1999;41:133–144.\n\n【36】133.\n\n【37】White RD, Hankins DG, Bugliosi TF. Seven years' experience with early defibrillation by police and paramedics in an emergency medical services system. Resuscitation. 1998;39:145–151.\n\n【38】134. Cummins RO, Eisenberg MS, Bergner L, Hallstrom A, Hearne T, Murray JA. Automatic external defibrillation: evaluations of its role in the home and in emergency medical services. Ann Emerg Med.\n\n【39】1984;13(pt 2):798–801.\n\n【40】135. White RD, Vukov LF, Bugliosi TF. Early defibrillation by police: initial experience with measurement of critical time intervals and patient outcome. Ann Emerg Med. 1994;23:1009–1013.\n\n【41】136. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation . 2000;101: 1282–1287.\n\n【42】137. Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, Olgin JE, Ricard P, Dalzell GW, Reddy R, Lazzara R, Lee K, Carlson M, Halperin B, Bardy GH.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol . 2002;39: 1956–1963.\n\n【43】138. Scholten M, Szili-Torok T, Klootwijk P, Jordaens L.  Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart. 2003;89:1032–1034.\n\n【44】139. Glover BM, Walsh SJ, McCann CJ, Moore MJ, Manoharan G, Dalzell GW, McAllister A, McClements B, McEneaney DJ, Trouton TG, Mathew TP, Adgey AA. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart . 2008;94: 884–887.\n\n【45】140. Reisinger J, Gstrein C, Winter T, Zeindlhofer E, Hollinger K, Mori M, Schiller A, Winter A, Geiger H, Siostrzonek P. Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med . 2010;28:159–165.\n\n【46】141. Kerber RE, Martins JB, Kienzle MG, Constantin L, Olshansky B, Hopson R, Charbonnier F. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation. 1988;77:1038–1046.\n\n【47】142. Hedges JR, Syverud SA, Dalsey WC, Feero S, Easter R, Shultz B.\n\n【48】Prehospital trial of emergency transcutaneous cardiac pacing. Circulation . 1987;76:1337–1343.\n\n【49】143. Barthell E, Troiano P, Olson D, Stueven HA, Hendley G. Prehospital external cardiac pacing: a prospective, controlled clinical trial. Ann Emerg Med . 1988;17:1221–1226.\n\n【50】144. Cummins RO, Graves JR, Larsen MP, Hallstrom AP, Hearne TR, Ciliberti J, Nicola RM, Horan S. Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. N Engl J Med . 1993;328:1377–1382.\n\n【51】145. Smith I, Monk TG, White PF.  Comparison of transesophageal atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia. Anesth Analg . 1994;78:245–252.\n\n【52】146. Morrison LJ, Long J, Vermeulen M, Schwartz B, Sawadsky B, Frank J, Cameron B, Burgess R, Shield J, Bagley P, Mausz V, Brewer JE, Dorian P. A randomized controlled feasibility trial comparing safety and effec-\n\n【53】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "tation: risks for patients not in cardiac arrest. Circulation. 2010;121:", "bbox": [83.0, 85.0, 376.0, 97.0]}, {"text": "91–97.", "bbox": [83.0, 98.0, 113.0, 108.0]}, {"text": "111. Cabrini L, Beccaria P, Landoni G, Biondi-Zoccai GG, Sheiban I, Cris-", "bbox": [61.0, 108.0, 375.0, 120.0]}, {"text": "tofolini M, Fochi O, Maj G, Zangrillo A. Impact of impedance threshold", "bbox": [83.0, 122.0, 376.0, 133.0]}, {"text": "devices on cardiopulmonary resuscitation: a systematic review and", "bbox": [83.0, 133.0, 375.0, 145.0]}, {"text": "meta-analysis of randomized controlled studies. Crit Care Med. 2008;", "bbox": [84.0, 147.0, 375.0, 158.0]}, {"text": "36:1625–1632.", "bbox": [84.0, 158.0, 146.0, 169.0]}, {"text": "112. Hallstrom A, Rea TD, Sayre MR, Christenson J, Anton AR, Mosesso", "bbox": [61.0, 169.0, 376.0, 182.0]}, {"text": "VN, Jr, Van Ottingham L, Olsufka M, Pennington S, White LJ, Yahn S,", "bbox": [84.0, 182.0, 375.0, 194.0]}, {"text": "Husar J, Morris MF, Cobb LA. Manual chest compression vs use of an", "bbox": [83.0, 195.0, 376.0, 207.0]}, {"text": "automated chest compression device during resuscitation following out-", "bbox": [84.0, 207.0, 375.0, 218.0]}, {"text": "of-hospital cardiac arrest: a randomized trial. JAMA . 2006;295:", "bbox": [83.0, 220.0, 375.0, 231.0]}, {"text": "2620–2628.", "bbox": [84.0, 231.0, 133.0, 242.0]}, {"text": "112a.Hallstrom A, Rea TD, Sayre MR, Christenson J, Cobb LA, Mosesso VN", "bbox": [61.0, 240.0, 376.0, 255.0]}, {"text": "Jr, Anton AR. The ASPIRE trial investigators respond to inhomogenity", "bbox": [82.0, 254.0, 375.0, 267.0]}, {"text": "and temporal effects assertion. Am J Emerg Med. August 16, 2010.", "bbox": [82.0, 267.0, 375.0, 278.0]}, {"text": "doi:10.1016/j.ajem.2010.07.001. Available at: http://www.ajemjournal.", "bbox": [82.0, 279.0, 375.0, 290.0]}, {"text": "com/article/S0735-6757(10)00307-4/fulltext.", "bbox": [82.0, 290.0, 267.0, 301.0]}, {"text": "113. Paradis N, Young G, Lemeshow S, Brewer J, Halperin H. Inhomo-", "bbox": [61.0, 302.0, 375.0, 315.0]}, {"text": "geneity and temporal effects in AutoPulse Assisted Prehospital Interna-", "bbox": [83.0, 315.0, 375.0, 326.0]}, {"text": "tional Resuscitation—an exception from consent trial terminated early.", "bbox": [84.0, 327.0, 375.0, 340.0]}, {"text": "Am J Emerg Med . 2010;28:391–398.", "bbox": [84.0, 340.0, 237.0, 350.0]}, {"text": "114. Tomte O, Sunde K, Lorem T, Auestad B, Souders C, Jensen J, Wik L.", "bbox": [61.0, 352.0, 374.0, 363.0]}, {"text": "Advanced life support performance with manual and mechanical chest", "bbox": [84.0, 364.0, 376.0, 374.0]}, {"text": "compressions in a randomized, multicentre manikin study. Resuscitation .", "bbox": [84.0, 376.0, 375.0, 388.0]}, {"text": "2009;80:1152–1157.", "bbox": [84.0, 388.0, 166.0, 399.0]}, {"text": "115. Axelsson C, Nestin J, Svensson L, Axelsson AB, Herlitz J.  Clinical", "bbox": [61.0, 400.0, 377.0, 412.0]}, {"text": "consequences of the introduction of mechanical chest compression in the", "bbox": [83.0, 411.0, 375.0, 423.0]}, {"text": "EMS system for treatment of out-of-hospital cardiac arrest-a pilot study.", "bbox": [84.0, 424.0, 375.0, 435.0]}, {"text": "Resuscitation. 2006;71:47–55.", "bbox": [84.0, 435.0, 207.0, 448.0]}, {"text": "116. Larsen AI, Hjornevik AS, Ellingsen CL, Nilsen DW. Cardiac arrest with", "bbox": [61.0, 447.0, 376.0, 460.0]}, {"text": "continuous mechanical chest compression during percutaneous coronary", "bbox": [83.0, 460.0, 375.0, 472.0]}, {"text": "intervention. A report on the use of the LUCAS device. Resuscitation.", "bbox": [84.0, 473.0, 375.0, 485.0]}, {"text": "2007;75:454–459.", "bbox": [84.0, 485.0, 160.0, 495.0]}, {"text": "117. Deakin CD, O'Neill JF, Tabor T. Does compression-only cardiopulmo-", "bbox": [61.0, 496.0, 375.0, 508.0]}, {"text": "nary resuscitation generate adequate passive ventilation during cardiac", "bbox": [83.0, 508.0, 375.0, 521.0]}, {"text": "arrest? Resuscitation. 2007;75:53–59.", "bbox": [83.0, 521.0, 240.0, 532.0]}, {"text": "118. Bonnemeier H, Olivecrona G, Simonis G, Gotberg M, Weitz G, Iblher", "bbox": [61.0, 533.0, 375.0, 544.0]}, {"text": "P, Gerling I, Schunkert H. Automated continuous chest compression for", "bbox": [83.0, 544.0, 376.0, 555.0]}, {"text": "in-hospital cardiopulmonary resuscitation of patients with pulseless", "bbox": [83.0, 557.0, 375.0, 568.0]}, {"text": "electrical activity: a report of five cases. Int J Cardiol . 2009;136:", "bbox": [83.0, 568.0, 375.0, 580.0]}, {"text": "e39–e50.", "bbox": [83.0, 582.0, 125.0, 592.0]}, {"text": "119.", "bbox": [61.0, 592.0, 81.0, 603.0]}, {"text": "Wagner H, Terkelsen CJ, Friberg H, Harnek J, Kern K, Lassen JF,", "bbox": [81.0, 592.0, 375.0, 604.0]}, {"text": "Olivecrona GK. Cardiac arrest in the catheterisation laboratory: a 5-year", "bbox": [83.0, 606.0, 375.0, 617.0]}, {"text": "experience of using mechanical chest compressions to facilitate PCI", "bbox": [83.0, 617.0, 375.0, 629.0]}, {"text": "during prolonged resuscitation efforts. Resuscitation. 2010;81:383–387.", "bbox": [83.0, 630.0, 375.0, 642.0]}, {"text": "120. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP.  Predicting", "bbox": [61.0, 642.0, 375.0, 653.0]}, {"text": "survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg", "bbox": [84.0, 655.0, 375.0, 666.0]}, {"text": "Med. 1993;22:1652–1658.", "bbox": [84.0, 664.0, 191.0, 678.0]}, {"text": "121. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating", "bbox": [61.0, 677.0, 376.0, 689.0]}, {"text": "effectiveness of cardiac arrest interventions: a logistic regression", "bbox": [83.0, 689.0, 375.0, 702.0]}, {"text": "survival model. Circulation. 1997;96:3308–3313.", "bbox": [83.0, 701.0, 290.0, 712.0]}, {"text": "122. Swor RA, Jackson RE, Cynar M, Sadler E, Basse E, Boji B, Rivera-", "bbox": [61.0, 713.0, 375.0, 725.0]}, {"text": "Rivera EJ, Maher A, Grubb W, Jacobson R, et  al. Bystander CPR,", "bbox": [83.0, 725.0, 375.0, 736.0]}, {"text": "ventricular fibrillation, and survival in witnessed, unmonitored out-of-", "bbox": [84.0, 738.0, 375.0, 749.0]}, {"text": "hospital cardiac arrest. Ann Emerg Med. 1995;25:780–784.", "bbox": [83.0, 749.0, 328.0, 761.0]}, {"text": "123. Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin", "bbox": [61.0, 762.0, 377.0, 774.0]}, {"text": "M, Hallstrom AP.  Influence of cardiopulmonary resuscitation prior to", "bbox": [83.0, 774.0, 376.0, 785.0]}, {"text": "defibrillation in patients with out-of-hospital ventricular fibrillation.", "bbox": [84.0, 787.0, 375.0, 798.0]}, {"text": "JAMA . 1999;281:1182–1188.", "bbox": [83.0, 798.0, 205.0, 809.0]}, {"text": "124. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen", "bbox": [61.0, 810.0, 376.0, 823.0]}, {"text": "PA. Delaying defibrillation to give basic cardiopulmonary resuscitation", "bbox": [83.0, 823.0, 376.0, 834.0]}, {"text": "to patients with out-of-hospital ventricular fibrillation: a randomized", "bbox": [83.0, 836.0, 376.0, 847.0]}, {"text": "trial. JAMA . 2003;289:1389–1395.", "bbox": [83.0, 846.0, 227.0, 858.0]}, {"text": "125. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ,", "bbox": [61.0, 858.0, 375.0, 871.0]}, {"text": "Grantham H.  Defibrillation or cardiopulmonary resuscitation first for", "bbox": [83.0, 870.0, 375.0, 883.0]}, {"text": "patients with out-of-hospital cardiac arrests found by paramedics to be in", "bbox": [83.0, 883.0, 376.0, 894.0]}, {"text": "ventricular fibrillation? A randomised control trial. Resuscitation. 2008 ;", "bbox": [84.0, 895.0, 375.0, 906.0]}, {"text": "79:424–431.", "bbox": [84.0, 906.0, 137.0, 917.0]}, {"text": "126. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in", "bbox": [61.0, 918.0, 376.0, 930.0]}, {"text": "out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas .", "bbox": [84.0, 931.0, 375.0, 943.0]}, {"text": "2005;17:39–45.", "bbox": [84.0, 943.0, 150.0, 955.0]}, {"text": "127. Morrison LJ, Dorian P, Long J, Vermeulen M, Schwartz B, Sawadsky B,", "bbox": [61.0, 955.0, 375.0, 968.0]}, {"text": "Frank J, Cameron B, Burgess R, Shield J, Bagley P, Mausz V, Brewer", "bbox": [83.0, 968.0, 375.0, 980.0]}, {"text": "JE, Lerman BB.  Out-of-hospital cardiac arrest rectilinear biphasic to", "bbox": [84.0, 980.0, 376.0, 991.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "monophasic damped sine defibrillation waveforms with advanced life", "bbox": [427.0, 85.0, 720.0, 96.0]}, {"text": "support intervention trial (ORBIT). Resuscitation. 2005;66:149–157.", "bbox": [428.0, 98.0, 711.0, 109.0]}, {"text": "128. Schneider T, Martens PR, Paschen H, Kuisma M, Wolcke B, Gliner BE,", "bbox": [405.0, 109.0, 719.0, 120.0]}, {"text": "Russell JK, Weaver WD, Bossaert L, Chamberlain D. Multicenter,", "bbox": [427.0, 122.0, 719.0, 134.0]}, {"text": "randomized, controlled trial of 150-J biphasic shocks compared with", "bbox": [427.0, 134.0, 720.0, 147.0]}, {"text": "200- to 360-J monophasic shocks in the resuscitation of out-of-hospital", "bbox": [428.0, 147.0, 720.0, 159.0]}, {"text": "cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA)", "bbox": [427.0, 159.0, 720.0, 170.0]}, {"text": "Investigators. Circulation. 2000;102:1780–1787.", "bbox": [427.0, 171.0, 627.0, 183.0]}, {"text": "129. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A pro-", "bbox": [405.0, 183.0, 719.0, 195.0]}, {"text": "spective, randomised and blinded comparison of first shock success of", "bbox": [427.0, 195.0, 720.0, 207.0]}, {"text": "monophasic and biphasic waveforms in out-of-hospital cardiac arrest.", "bbox": [427.0, 207.0, 719.0, 219.0]}, {"text": "Resuscitation . 2003;58:17–24.", "bbox": [427.0, 220.0, 551.0, 232.0]}, {"text": "130. Carpenter J, Rea TD, Murray JA, Kudenchuk PJ, Eisenberg MS. Defi-", "bbox": [405.0, 233.0, 720.0, 245.0]}, {"text": "brillation waveform and post-shock rhythm in out-of-hospital ventricu-", "bbox": [427.0, 245.0, 718.0, 256.0]}, {"text": "lar fibrillation cardiac arrest. Resuscitation. 2003;59:189–196.", "bbox": [427.0, 257.0, 685.0, 268.0]}, {"text": "131. Freeman K, Hendey GW, Shalit M, Stroh G. Biphasic defibrillation does", "bbox": [405.0, 269.0, 720.0, 281.0]}, {"text": "not improve outcomes compared to monophasic defibrillation in out-of-", "bbox": [427.0, 282.0, 718.0, 294.0]}, {"text": "hospital cardiac arrest. Prehosp Emerg Care. 2008;12:152–156.", "bbox": [427.0, 294.0, 689.0, 305.0]}, {"text": "132. Gliner BE, White RD.  Electrocardiographic evaluation of defibril-", "bbox": [405.0, 305.0, 719.0, 319.0]}, {"text": "lation shocks delivered to out-of-hospital sudden cardiac arrest", "bbox": [427.0, 318.0, 720.0, 329.0]}, {"text": "patients. Resuscitation. 1999;41:133–144.", "bbox": [427.0, 331.0, 607.0, 342.0]}, {"text": "133.", "bbox": [405.0, 342.0, 425.0, 353.0]}, {"text": "White RD, Hankins DG, Bugliosi TF. Seven years' experience with", "bbox": [426.0, 342.0, 720.0, 354.0]}, {"text": "early defibrillation by police and paramedics in an emergency medical", "bbox": [427.0, 355.0, 720.0, 367.0]}, {"text": "services system. Resuscitation. 1998;39:145–151.", "bbox": [427.0, 367.0, 632.0, 378.0]}, {"text": "134. Cummins RO, Eisenberg MS, Bergner L, Hallstrom A, Hearne T,", "bbox": [405.0, 380.0, 720.0, 392.0]}, {"text": "Murray JA. Automatic external defibrillation: evaluations of its role in", "bbox": [427.0, 391.0, 720.0, 402.0]}, {"text": "the home and in emergency medical services. Ann Emerg Med.", "bbox": [427.0, 404.0, 719.0, 415.0]}, {"text": "1984;13(pt 2):798–801.", "bbox": [427.0, 416.0, 527.0, 427.0]}, {"text": "135. White RD, Vukov LF, Bugliosi TF. Early defibrillation by police: initial", "bbox": [405.0, 428.0, 720.0, 441.0]}, {"text": "experience with measurement of critical time intervals and patient", "bbox": [427.0, 441.0, 720.0, 452.0]}, {"text": "outcome. Ann Emerg Med. 1994;23:1009–1013.", "bbox": [427.0, 453.0, 627.0, 464.0]}, {"text": "136. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ,", "bbox": [405.0, 465.0, 720.0, 477.0]}, {"text": "Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic", "bbox": [427.0, 477.0, 719.0, 489.0]}, {"text": "cardioversion of atrial fibrillation: comparison of rectilinear biphasic", "bbox": [427.0, 489.0, 719.0, 502.0]}, {"text": "versus damped sine wave monophasic shocks. Circulation . 2000;101:", "bbox": [428.0, 501.0, 719.0, 514.0]}, {"text": "1282–1287.", "bbox": [427.0, 515.0, 477.0, 526.0]}, {"text": "137. Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, Olgin", "bbox": [405.0, 526.0, 720.0, 538.0]}, {"text": "JE, Ricard P, Dalzell GW, Reddy R, Lazzara R, Lee K, Carlson M,", "bbox": [427.0, 539.0, 720.0, 551.0]}, {"text": "Halperin B, Bardy GH.  Biphasic versus monophasic shock waveform", "bbox": [427.0, 550.0, 720.0, 562.0]}, {"text": "for conversion of atrial fibrillation: the results of an international ran-", "bbox": [427.0, 564.0, 718.0, 575.0]}, {"text": "domized, double-blind multicenter trial. J Am Coll Cardiol . 2002;39:", "bbox": [427.0, 575.0, 719.0, 587.0]}, {"text": "1956–1963.", "bbox": [427.0, 588.0, 477.0, 598.0]}, {"text": "138. Scholten M, Szili-Torok T, Klootwijk P, Jordaens L.  Comparison of", "bbox": [406.0, 599.0, 720.0, 611.0]}, {"text": "monophasic and biphasic shocks for transthoracic cardioversion of atrial", "bbox": [428.0, 613.0, 720.0, 624.0]}, {"text": "fibrillation. Heart. 2003;89:1032–1034.", "bbox": [427.0, 624.0, 590.0, 635.0]}, {"text": "139. Glover BM, Walsh SJ, McCann CJ, Moore MJ, Manoharan G, Dalzell", "bbox": [405.0, 636.0, 720.0, 649.0]}, {"text": "GW, McAllister A, McClements B, McEneaney DJ, Trouton TG,", "bbox": [427.0, 649.0, 720.0, 660.0]}, {"text": "Mathew TP, Adgey AA. Biphasic energy selection for transthoracic", "bbox": [427.0, 662.0, 719.0, 673.0]}, {"text": "cardioversion of atrial fibrillation. The BEST AF Trial. Heart . 2008;94:", "bbox": [427.0, 673.0, 720.0, 684.0]}, {"text": "884–887.", "bbox": [427.0, 686.0, 469.0, 696.0]}, {"text": "140. Reisinger J, Gstrein C, Winter T, Zeindlhofer E, Hollinger K, Mori M,", "bbox": [405.0, 696.0, 719.0, 709.0]}, {"text": "Schiller A, Winter A, Geiger H, Siostrzonek P. Optimization of initial", "bbox": [427.0, 710.0, 720.0, 722.0]}, {"text": "energy for cardioversion of atrial tachyarrhythmias with biphasic", "bbox": [427.0, 721.0, 720.0, 734.0]}, {"text": "shocks. Am J Emerg Med . 2010;28:159–165.", "bbox": [428.0, 735.0, 614.0, 746.0]}, {"text": "141. Kerber RE, Martins JB, Kienzle MG, Constantin L, Olshansky B,", "bbox": [405.0, 746.0, 720.0, 758.0]}, {"text": "Hopson R, Charbonnier F. Energy, current, and success in defibrillation", "bbox": [427.0, 759.0, 720.0, 771.0]}, {"text": "and cardioversion: clinical studies using an automated impedance-based", "bbox": [427.0, 770.0, 720.0, 784.0]}, {"text": "method of energy adjustment. Circulation. 1988;77:1038–1046.", "bbox": [427.0, 783.0, 690.0, 796.0]}, {"text": "142. Hedges JR, Syverud SA, Dalsey WC, Feero S, Easter R, Shultz B.", "bbox": [405.0, 796.0, 719.0, 807.0]}, {"text": "Prehospital trial of emergency transcutaneous cardiac pacing. Circu-", "bbox": [427.0, 808.0, 718.0, 820.0]}, {"text": "lation . 1987;76:1337–1343.", "bbox": [427.0, 820.0, 542.0, 831.0]}, {"text": "143. Barthell E, Troiano P, Olson D, Stueven HA, Hendley G. Prehospital", "bbox": [405.0, 832.0, 720.0, 844.0]}, {"text": "external cardiac pacing: a prospective, controlled clinical trial. Ann", "bbox": [427.0, 845.0, 720.0, 856.0]}, {"text": "Emerg Med . 1988;17:1221–1226.", "bbox": [427.0, 856.0, 566.0, 869.0]}, {"text": "144. Cummins RO, Graves JR, Larsen MP, Hallstrom AP, Hearne TR,", "bbox": [405.0, 869.0, 719.0, 882.0]}, {"text": "Ciliberti J, Nicola RM, Horan S. Out-of-hospital transcutaneous pacing", "bbox": [427.0, 881.0, 719.0, 893.0]}, {"text": "by emergency medical technicians in patients with asystolic cardiac", "bbox": [427.0, 894.0, 719.0, 905.0]}, {"text": "arrest. N Engl J Med . 1993;328:1377–1382.", "bbox": [427.0, 905.0, 609.0, 917.0]}, {"text": "145. Smith I, Monk TG, White PF.  Comparison of transesophageal atrial", "bbox": [405.0, 918.0, 720.0, 930.0]}, {"text": "pacing with anticholinergic drugs for the treatment of intraoperative", "bbox": [427.0, 930.0, 720.0, 942.0]}, {"text": "bradycardia. Anesth Analg . 1994;78:245–252.", "bbox": [427.0, 943.0, 615.0, 955.0]}, {"text": "146. Morrison LJ, Long J, Vermeulen M, Schwartz B, Sawadsky B, Frank J,", "bbox": [405.0, 955.0, 720.0, 966.0]}, {"text": "Cameron B, Burgess R, Shield J, Bagley P, Mausz V, Brewer JE, Dorian", "bbox": [427.0, 968.0, 720.0, 979.0]}, {"text": "P. A randomized controlled feasibility trial comparing safety and effec-", "bbox": [427.0, 979.0, 718.0, 990.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 19}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "", "type4": null, "type5": null, "type6": "有用性#0#53#全篇都是摘要参考文献内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:33:18"}
{"id": 1041994, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "1d4798a4-a406-4c73-9092-5d1953da9e02", "title": null, "text": "【0】页码:78\n Figs. 114 and 115. Chromosome arch cemented, now we need to bond buttons on the palatine aspect of the teeth that are going to be pulled back, and this way we will have two parallel traction forces.\n Figs. 116-118. Chromosome arch with palatal plate for molar intrusion and bite closure.\n\n【1】 s\n\n【2】 , 2\n\n【3】 s f", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Figs. 114 and 115. Chromosome arch cemented, now we need to bond buttons on the palatine aspect of the teeth that are going to be pulled back, and", "bbox": [82.0, 588.0, 736.0, 606.0]}, {"text": "this way we will have two parallel traction forces.", "bbox": [82.0, 602.0, 304.0, 621.0]}], "type": "Caption", "position": 2}, {"raw_context": [{"text": "Figs. 116-118. Chromosome arch with palatal plate for molar intrusion and bite closure.", "bbox": [216.0, 941.0, 605.0, 958.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "s", "bbox": [135.0, 1081.0, 160.0, 1106.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": ", 2", "bbox": [385.0, 1081.0, 410.0, 1104.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "s f", "bbox": [635.0, 1081.0, 661.0, 1107.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 78}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type2": null, "type3": "", "type6": "有用性#0#3#全篇是对图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:48:16"}
{"id": 1041993, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "c990ca45-a23e-4edb-bdf8-ae0904d56b67", "title": null, "text": "【0】页码:70\n 2.\n\n【1】3.\n\n【2】4.\n\n【3】5.\n\n【4】6.\n\n【5】 The appliance can dislodge if it is removable.\n\n【6】Laboratory time consuming.\n\n【7】Not always well tolerated by the patient because of the food entrapment under the acrylic dab.\n\n【8】The bigger the dab, the greater the anchorage, but there will also be more food entrapment.\n\n【9】In cases where the button is directly bonded to the molars, it can loosen due to the force of the occlusion.\n\n【10】## Recommendations\n\n【11】\n 1.\n\n【12】2.\n\n【13】3.\n\n【14】 Short use periods in order to avoid ulcers.\n\n【15】Polish well both sides of the acrylic dab at the moment of fabrication. This will lessen food retention.\n\n【16】Not recommended for patients with bad oral hygiene.\n\n【17】In this case it is best to apply other anchorage appli¬ ances.\n\n【18】 4.\n\n【19】5.\n\n【20】 6.\n\n【21】7.\n\n【22】8.\n\n【23】 Leave the dab borders as rounded as possible so it will not impinge itself in the palate.\n\n【24】The bonded Nance button helps maintain periodontal integrity, more so in patients with periodontal prob¬ lems.\n\n【25】Remove the Nance button in a monthly basis if it is removable, this will enhance hygiene in the patient.\n\n【26】In case it is fixed, instruct the patients to use a syringe with a solution of water and Clorhexidine Gluconate under pressure to avoid gum irritation or ulcer forma¬ tion.\n\n【27】It may be placed at premolar level while upper molar distalization is taking place with NiTi open coils.\n\n【28】## B)\n\n【29】\n## Transpalatine Arch (Tpa).\n\n【30】\n Dr. Robert A. Goshgarian introduced this arch in 1972.\n\n【31】It crosses the palate joining as one unit both first mo¬ lars; it is effective as a moderate anchorage appliance forming an anchorage unit that resists mesial molar\n\n【32】 movement and mesial rotational lingual root tendency.\n\n【33】It is one of the most simple moderate anchorage ap¬ pliances to make and the most used by the majority of orthodontists. (12.17.24.29)\n Fig. 84. Transpalatine arch.\n\n【34】 We must take an impression with bands adapted on the first upper molars in order to fabricate one, then we pour plaster in the impression with the bands placed in it; then we can proceed to bend the 0.036\" stainless steel wire and form the transpalatine arch, leaving a 1 or 2 mm separation between the wire and the palatine mucosa. (29)\n Fig. 85. The transpalatine arch must be separated 1 or 2 mm from the palatine mucosa in order to avoid its impingement.\n\n【35】 The transpalatine arch can be fixed, soldered to the first molar bands or directly bonded on the palatine aspect of the molar. It can also be removable being inserted in lin¬ gual sheaths soldered on to the molar band itself. (1.14)", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "2.", "bbox": [73.0, 335.0, 86.0, 348.0]}, {"text": "3.", "bbox": [74.0, 353.0, 87.0, 365.0]}, {"text": "4.", "bbox": [74.0, 371.0, 87.0, 384.0]}, {"text": "5.", "bbox": [73.0, 405.0, 88.0, 419.0]}, {"text": "6.", "bbox": [73.0, 440.0, 87.0, 453.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "The appliance can dislodge if it is removable.", "bbox": [101.0, 334.0, 346.0, 350.0]}, {"text": "Laboratory time consuming.", "bbox": [101.0, 351.0, 260.0, 366.0]}, {"text": "Not always well tolerated by the patient because of", "bbox": [101.0, 368.0, 389.0, 384.0]}, {"text": "the food entrapment under the acrylic dab.", "bbox": [100.0, 386.0, 338.0, 402.0]}, {"text": "The bigger the dab, the greater the anchorage, but", "bbox": [101.0, 404.0, 388.0, 419.0]}, {"text": "there will also be more food entrapment.", "bbox": [100.0, 421.0, 326.0, 436.0]}, {"text": "In cases where the button is directly bonded to the mo-", "bbox": [100.0, 437.0, 385.0, 453.0]}, {"text": "lars, it can loosen due to the force of the occlusion.", "bbox": [100.0, 455.0, 374.0, 470.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Recommendations", "bbox": [74.0, 489.0, 204.0, 505.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "1.", "bbox": [75.0, 526.0, 89.0, 539.0]}, {"text": "2.", "bbox": [74.0, 543.0, 86.0, 556.0]}, {"text": "3.", "bbox": [73.0, 578.0, 88.0, 592.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Short use periods in order to avoid ulcers.", "bbox": [99.0, 524.0, 331.0, 539.0]}, {"text": "Polish well both sides of the acrylic dab at the moment", "bbox": [100.0, 542.0, 388.0, 556.0]}, {"text": "of fabrication. This will lessen food retention.", "bbox": [99.0, 559.0, 350.0, 575.0]}, {"text": "Not recommended for patients with bad oral hygiene.", "bbox": [100.0, 576.0, 387.0, 592.0]}, {"text": "In this case it is best to apply other anchorage appli¬", "bbox": [101.0, 594.0, 387.0, 609.0]}, {"text": "ances.", "bbox": [100.0, 612.0, 136.0, 627.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "4.", "bbox": [73.0, 630.0, 87.0, 643.0]}, {"text": "5.", "bbox": [72.0, 663.0, 86.0, 678.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "6.", "bbox": [72.0, 715.0, 87.0, 730.0]}, {"text": "7.", "bbox": [72.0, 749.0, 86.0, 764.0]}, {"text": "8.", "bbox": [72.0, 820.0, 86.0, 833.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Leave the dab borders as rounded as possible so it will", "bbox": [99.0, 627.0, 388.0, 643.0]}, {"text": "not impinge itself in the palate.", "bbox": [100.0, 645.0, 271.0, 661.0]}, {"text": "The bonded Nance button helps maintain periodontal", "bbox": [101.0, 663.0, 388.0, 678.0]}, {"text": "integrity, more so in patients with periodontal prob¬", "bbox": [100.0, 681.0, 386.0, 696.0]}, {"text": "lems.", "bbox": [99.0, 698.0, 131.0, 713.0]}, {"text": "Remove the Nance button in a monthly basis if it is", "bbox": [99.0, 714.0, 388.0, 730.0]}, {"text": "removable, this will enhance hygiene in the patient.", "bbox": [99.0, 732.0, 383.0, 747.0]}, {"text": "In case it is fixed, instruct the patients to use a syringe", "bbox": [99.0, 749.0, 387.0, 765.0]}, {"text": "with a solution of water and Clorhexidine Gluconate", "bbox": [99.0, 767.0, 388.0, 782.0]}, {"text": "under pressure to avoid gum irritation or ulcer forma¬", "bbox": [99.0, 784.0, 386.0, 800.0]}, {"text": "tion.", "bbox": [99.0, 802.0, 129.0, 816.0]}, {"text": "It may be placed at premolar level while upper molar", "bbox": [99.0, 818.0, 387.0, 833.0]}, {"text": "distalization is taking place with NiTi open coils.", "bbox": [99.0, 835.0, 368.0, 852.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "b)", "bbox": [72.0, 870.0, 90.0, 885.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Transpalatine Arch (TPA).", "bbox": [99.0, 869.0, 255.0, 886.0]}], "type": "Section-header", "position": 11}, {"raw_context": [{"text": "Dr. Robert A. Goshgarian introduced this arch in 1972.", "bbox": [72.0, 904.0, 387.0, 920.0]}, {"text": "It crosses the palate joining as one unit both first mo¬", "bbox": [72.0, 923.0, 387.0, 938.0]}, {"text": "lars; it is effective as a moderate anchorage appliance", "bbox": [72.0, 940.0, 388.0, 956.0]}, {"text": "forming an anchorage unit that resists mesial molar", "bbox": [72.0, 958.0, 387.0, 973.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "movement and mesial rotational lingual root tendency.", "bbox": [410.0, 85.0, 724.0, 100.0]}, {"text": "It is one of the most simple moderate anchorage ap¬", "bbox": [410.0, 102.0, 723.0, 117.0]}, {"text": "pliances to make and the most used by the majority of", "bbox": [410.0, 119.0, 725.0, 135.0]}, {"text": "orthodontists. (12.17.24.29)", "bbox": [410.0, 138.0, 540.0, 151.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Fig. 84. Transpalatine arch.", "bbox": [506.0, 419.0, 625.0, 432.0]}], "type": "Caption", "position": 15}, {"raw_context": [{"text": "We must take an impression with bands adapted on the", "bbox": [410.0, 468.0, 725.0, 484.0]}, {"text": "first upper molars in order to fabricate one, then we pour", "bbox": [410.0, 486.0, 724.0, 502.0]}, {"text": "plaster in the impression with the bands placed in it; then", "bbox": [410.0, 504.0, 724.0, 519.0]}, {"text": "we can proceed to bend the 0.036\" stainless steel wire and", "bbox": [410.0, 521.0, 725.0, 537.0]}, {"text": "form the transpalatine arch, leaving a 1 or 2 mm separation", "bbox": [410.0, 539.0, 724.0, 554.0]}, {"text": "between the wire and the palatine mucosa. (29)", "bbox": [410.0, 555.0, 658.0, 571.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Fig. 85. The transpalatine arch must be separated 1 or 2 mm from the", "bbox": [411.0, 828.0, 723.0, 841.0]}, {"text": "palatine mucosa in order to avoid its impingement.", "bbox": [411.0, 843.0, 633.0, 855.0]}], "type": "Caption", "position": 18}, {"raw_context": [{"text": "The transpalatine arch can be fixed, soldered to the first", "bbox": [410.0, 904.0, 725.0, 919.0]}, {"text": "molar bands or directly bonded on the palatine aspect of", "bbox": [410.0, 921.0, 725.0, 937.0]}, {"text": "the molar. It can also be removable being inserted in lin¬", "bbox": [410.0, 939.0, 722.0, 954.0]}, {"text": "gual sheaths soldered on to the molar band itself. (1.14)", "bbox": [410.0, 956.0, 713.0, 972.0]}], "type": "Text", "position": 19}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 70}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#0#9#0段序号2.联接5段 The appliance can dislodge...内容，1段序号3.联接6段Laboratory time consuming.内容，依次往下\n多余换行#11#16#11段序号1.联接14段 Short use periods in order...内容，12段序号2.联接15段Polish well both sides of...内容，依次往下\n标点错误#17#17#appli¬ 里面的¬去掉 \n多余换行#18#27#18段序号4.联接23段 Leave the dab borders ...内容，19段序号5.联接24段The bonded Nance button...内容，依次往下\n多余换行#29#29#Transpalatine Arch (Tpa).与上面28段联接\n标点错误#31#31#mo¬ 里面的¬去掉 \n多余换行#32#32#movement and mesial rotational...与上面31段联接\n标点错误#35#35# lin¬ 里面的¬去掉 ", "type3": "无关文本#33#33#(12.17.24.29)\n无关文本#34#34#(29)\n无关文本#35#35#(1.14)", "type4": null, "type5": null, "type6": "有用性#33#33#Fig. 84. Transpalatine arch.图片描述\n有用性#34#34#Fig. 85. The transpalatine arch must be separated 1 or 2 mm from the palatine mucosa in order to avoid its impingement.图片描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 01:25:03"}
{"id": 1041992, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "1d952aa1-0c62-4f17-9ab0-df1e032c5710", "title": null, "text": "【0】页码:172\n all patients with AMI, and in high-risk patients it reduced nonfatal AMI and vascular death. 177 Aspirin is also effective in patients with NSTEMI. The recommended dose is 160 to 325 mg. Chewable or soluble aspirin is absorbed more quickly than swallowed tablets. 178 , 179 Aspirin suppositories (300 mg) are safe and can be considered for patients with severe nausea, vomiting, or disorders of the upper gastrointestinal tract.\n\n【1】Other nonsteroidal anti-inflammatory medications (NSAIDS) are contraindicated and should be discontinued in patients who are taking these medications. NSAIDs (except for aspirin), both nonselective as well as COX-2 selective agents, should not be administered during hospitalization for STEMI because of the increased risk of mortality, reinfarction, hypertension, heart failure, and myocardial rupture associated with their use (Class III, LOE C). 180–182\n\n【2】## Nitroglycerin (Or Glyceryl Trinitrate)\n\n【3】\n Nitroglycerin has beneficial hemodynamic effects, including dilation of the coronary arteries (particularly in the region of plaque disruption), the peripheral arterial bed, and venous capacitance vessels. The treatment benefits of nitroglycerin are limited, however, and no conclusive evidence has been shown to support the routine use of IV, oral, or topical nitrate therapy in patients with AMI. 183 With this in mind, these agents should be carefully considered, especially in the patient with low blood pressure and when their use would preclude the use of other agents known to be beneficial, such as angiotensin-converting enzyme (ACE) inhibitors.\n\n【4】Patients with ischemic discomfort should receive up to 3 doses of sublingual or aerosol nitroglycerin at 3- to 5-minute intervals until pain is relieved or low blood pressure limits its use (Class I, LOE B). Topical nitrates are acceptable alternatives for patients who require anti-anginal therapy but who are hemodynamically stable and do not have ongoing refractory ischemic symptoms. Parenteral formulations, rather than long acting oral preparations, can be used acutely to enable titration in patients with obvious ACS, objective test abnormality, and ongoing discomfort. In patients with recurrent ischemia, nitrates are indicated in the first 24 to 48 hours.\n\n【5】The use of nitrates in patients with hypotension (SBP < 90 mm Hg or ≥ 30 mm Hg below baseline), extreme bradycardia (<50 bpm), or tachycardia in the absence of heart failure (> 100 bpm) and in patients with right ventricular infarction is contraindicated (Class III, LOE C). Caution is advised in patients with known inferior wall STEMI, and a right-sided ECG should be performed to evaluate RV infarction. Administer nitrates with extreme caution, if at all, to patients with inferior-wall MI and suspected right ventricular (RV) involvement because these patients require adequate RV preload. Nitroglycerin should not be administered to patients who had taken a phosphodiesterase inhibitor (eg, sildenafil) for erectile dysfunction within 24 hours (48 hours if tadalafil use).\n\n【6】Relief of chest discomfort with nitroglycerin is neither sensitive nor specific for ACS; gastrointestinal etiologies as well as other causes of chest discomfort can \"respond\" to nitroglycerin administration. 18, 184– 186\n\n【7】## Analgesia\n\n【8】\n Providers should administer analgesics, such as intravenous morphine, for chest discomfort unresponsive to nitrates.\n\n【9】Morphine is the preferred analgesic for patients with STEMI (Class I, LOE C). However, analysis of retrospective registry data raised a question about the potentially adverse effects of morphine in patients with UA/NSTEMI. 44 As a result, the ACC AHA UA/NSTEMI writing group reduced morphine use to a Class IIa recommendation for that patient population. 3\n\n【10】## Reperfusion Therapies (Figure 1, Box 7, 8) Acute Reperfusion Therapy Using Ppci Or Fibrinolytic Therapy\n\n【11】\n in patients with STEMI restores flow in the infarct-related artery, limits infarct size, and translates into early mortality benefit that is sustained over the next decade. 187 . 188 While optimal fibrinolysis restores normal coronary flow (TIMI 3) in 50% to 60% of subjects, PPCI is able to achieve restored flow in > 90% of subjects. The patency rates achieved with PPCI translates into reduced mortality and reinfarction rates as compared to fibrinolytic therapy. 189 This benefit is even greater in patients presenting with cardiogenic shock. PPCI also results in a decreased risk of intracranial hemorrhage and stroke, making it the reperfusion strategy of choice in the elderly and those at risk for bleeding complications.\n\n【12】## Fibrinolytics\n\n【13】\n Early fibrinolytic therapy is a well-established treatment modality for patients with STEMI who present within 12 hours of the onset of symptoms and who lack contraindications to its use. 188,190–193 Early reperfusion results in reduced mortality, and the shorter the time to reperfusion, the greater the benefit. A 47% reduction in mortality was noted when fibrinolytic therapy was provided within the first hour after onset of symptoms. 188 , 193 The major determinants of myocardial salvage and longterm prognosis are short time to reperfusion, 190 . 193 complete and sustained patency of the infarct-related artery with normal (TIMI grade 3) flow, 194, 195 and normal microvascular perfusion. 22, 196– 198 In the absence of contraindications, fibrinolytic therapy is recommended for STEMI if symptom onset has been within 12 hours of presentation and PCI is not available within 90 minutes of first medical contact (Class I, LOE A). Patients are evaluated for risk and benefit; for absolute and relative contraindications to therapy (see Table 5).\n\n【14】If fibrinolysis is chosen for reperfusion, the ED physician should administer fibrinolytics to eligible patients as early as possible according to a predetermined process of care developed by the ED and cardiology staff (Class I, LOE A). The goal is a door-to-needle time of less than 30 minutes with effort focused on shortening the time to therapy. Patients treated within the first 70 minutes of onset of symptoms have > 50% reduction in infarct size and 75% reduction in mortality rates. 199 For fibrinolytic therapy, it is estimated that 65 lives will be saved per 1000 patients treated if fibrinolytics are provided in the first hour, with a pooled total of 131 lives saved per 1000 patients treated if fibrinolytics are provided within the first 3 hours of onset of symptoms. 200 Although fibrinolytics may be beneficial if given within 12 hours after\n\n【15】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "all patients with AMI, and in high-risk patients it reduced", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "nonfatal AMI and vascular death. 177 Aspirin is also effective", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "in patients with NSTEMI. The recommended dose is 160 to", "bbox": [60.0, 114.0, 376.0, 130.0]}, {"text": "325 mg. Chewable or soluble aspirin is absorbed more", "bbox": [60.0, 131.0, 376.0, 145.0]}, {"text": "quickly than swallowed tablets. 178 , 179", "bbox": [60.0, 147.0, 253.0, 161.0]}, {"text": "Aspirin suppositories (300 mg) are safe and can be con-", "bbox": [73.0, 163.0, 375.0, 176.0]}, {"text": "sidered for patients with severe nausea, vomiting, or disorders", "bbox": [60.0, 178.0, 377.0, 193.0]}, {"text": "of the upper gastrointestinal tract.", "bbox": [60.0, 194.0, 237.0, 207.0]}, {"text": "Other nonsteroidal anti-inflammatory medications", "bbox": [72.0, 209.0, 376.0, 224.0]}, {"text": "(NSAIDS) are contraindicated and should be discontinued in", "bbox": [60.0, 226.0, 377.0, 239.0]}, {"text": "patients who are taking these medications. NSAIDs (except", "bbox": [60.0, 240.0, 376.0, 255.0]}, {"text": "for aspirin), both nonselective as well as COX-2 selective", "bbox": [60.0, 257.0, 376.0, 270.0]}, {"text": "agents, should not be administered during hospitalization for", "bbox": [60.0, 272.0, 376.0, 287.0]}, {"text": "STEMI because of the increased risk of mortality, reinfarc-", "bbox": [60.0, 288.0, 375.0, 301.0]}, {"text": "tion, hypertension, heart failure, and myocardial rupture", "bbox": [60.0, 303.0, 376.0, 318.0]}, {"text": "associated with their use (Class III, LOE C). 180–182", "bbox": [60.0, 320.0, 328.0, 333.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Nitroglycerin (or Glyceryl Trinitrate)", "bbox": [60.0, 351.0, 293.0, 365.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Nitroglycerin has beneficial hemodynamic effects, including", "bbox": [60.0, 367.0, 375.0, 381.0]}, {"text": "dilation of the coronary arteries (particularly in the region of", "bbox": [60.0, 382.0, 376.0, 395.0]}, {"text": "plaque disruption), the peripheral arterial bed, and venous", "bbox": [60.0, 397.0, 376.0, 412.0]}, {"text": "capacitance vessels. The treatment benefits of nitroglycerin", "bbox": [60.0, 414.0, 377.0, 427.0]}, {"text": "are limited, however, and no conclusive evidence has been", "bbox": [60.0, 428.0, 377.0, 443.0]}, {"text": "shown to support the routine use of IV, oral, or topical nitrate", "bbox": [60.0, 445.0, 375.0, 458.0]}, {"text": "therapy in patients with AMI. 183 With this in mind, these", "bbox": [60.0, 459.0, 376.0, 475.0]}, {"text": "agents should be carefully considered, especially in the", "bbox": [60.0, 475.0, 375.0, 489.0]}, {"text": "patient with low blood pressure and when their use would", "bbox": [60.0, 491.0, 377.0, 506.0]}, {"text": "preclude the use of other agents known to be beneficial, such", "bbox": [60.0, 508.0, 376.0, 521.0]}, {"text": "as angiotensin-converting enzyme (ACE) inhibitors.", "bbox": [60.0, 522.0, 332.0, 537.0]}, {"text": "Patients with ischemic discomfort should receive up to 3", "bbox": [72.0, 539.0, 377.0, 552.0]}, {"text": "doses of sublingual or aerosol nitroglycerin at 3- to 5-minute", "bbox": [60.0, 554.0, 376.0, 568.0]}, {"text": "intervals until pain is relieved or low blood pressure limits its", "bbox": [60.0, 570.0, 376.0, 583.0]}, {"text": "use (Class I, LOE B). Topical nitrates are acceptable alter-", "bbox": [60.0, 585.0, 375.0, 600.0]}, {"text": "natives for patients who require anti-anginal therapy but who", "bbox": [60.0, 602.0, 376.0, 615.0]}, {"text": "are hemodynamically stable and do not have ongoing refrac-", "bbox": [60.0, 616.0, 375.0, 631.0]}, {"text": "tory ischemic symptoms. Parenteral formulations, rather than", "bbox": [60.0, 633.0, 376.0, 646.0]}, {"text": "long acting oral preparations, can be used acutely to enable", "bbox": [60.0, 648.0, 376.0, 662.0]}, {"text": "titration in patients with obvious ACS, objective test abnor-", "bbox": [60.0, 664.0, 375.0, 677.0]}, {"text": "mality, and ongoing discomfort. In patients with recurrent", "bbox": [60.0, 679.0, 377.0, 694.0]}, {"text": "ischemia, nitrates are indicated in the first 24 to 48 hours.", "bbox": [60.0, 696.0, 365.0, 709.0]}, {"text": "The use of nitrates in patients with hypotension (SBP", "bbox": [73.0, 710.0, 375.0, 725.0]}, {"text": "< 90 mm Hg or ≥ 30 mm Hg below baseline), extreme", "bbox": [61.0, 727.0, 376.0, 740.0]}, {"text": "bradycardia (<50 bpm), or tachycardia in the absence of", "bbox": [60.0, 742.0, 377.0, 756.0]}, {"text": "heart failure (> 100 bpm) and in patients with right ventric-", "bbox": [60.0, 758.0, 375.0, 771.0]}, {"text": "ular infarction is contraindicated (Class III, LOE C). Caution", "bbox": [60.0, 773.0, 376.0, 788.0]}, {"text": "is advised in patients with known inferior wall STEMI, and a", "bbox": [60.0, 789.0, 377.0, 803.0]}, {"text": "right-sided ECG should be performed to evaluate RV infarc-", "bbox": [60.0, 804.0, 375.0, 819.0]}, {"text": "tion. Administer nitrates with extreme caution, if at all, to", "bbox": [60.0, 821.0, 376.0, 834.0]}, {"text": "patients with inferior-wall MI and suspected right ventricular", "bbox": [60.0, 836.0, 376.0, 850.0]}, {"text": "(RV) involvement because these patients require adequate", "bbox": [60.0, 852.0, 376.0, 865.0]}, {"text": "RV preload. Nitroglycerin should not be administered to", "bbox": [60.0, 867.0, 377.0, 882.0]}, {"text": "patients who had taken a phosphodiesterase inhibitor (eg,", "bbox": [60.0, 883.0, 376.0, 896.0]}, {"text": "sildenafil) for erectile dysfunction within 24 hours (48 hours", "bbox": [60.0, 898.0, 376.0, 913.0]}, {"text": "if tadalafil use).", "bbox": [60.0, 915.0, 145.0, 928.0]}, {"text": "Relief of chest discomfort with nitroglycerin is neither", "bbox": [72.0, 930.0, 377.0, 944.0]}, {"text": "sensitive nor specific for ACS; gastrointestinal etiologies as", "bbox": [60.0, 946.0, 376.0, 959.0]}, {"text": "well as other causes of chest discomfort can \"respond\" to", "bbox": [60.0, 961.0, 376.0, 976.0]}, {"text": "nitroglycerin administration. 18, 184– 186", "bbox": [60.0, 977.0, 252.0, 991.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Analgesia", "bbox": [404.0, 85.0, 466.0, 99.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Providers should administer analgesics, such as intravenous", "bbox": [404.0, 100.0, 720.0, 113.0]}, {"text": "morphine, for chest discomfort unresponsive to nitrates.", "bbox": [403.0, 115.0, 719.0, 130.0]}, {"text": "Morphine is the preferred analgesic for patients with STEMI", "bbox": [404.0, 132.0, 720.0, 145.0]}, {"text": "(Class I, LOE C). However, analysis of retrospective registry", "bbox": [403.0, 147.0, 719.0, 160.0]}, {"text": "data raised a question about the potentially adverse effects of", "bbox": [403.0, 162.0, 720.0, 176.0]}, {"text": "morphine in patients with UA/NSTEMI. 44 As a result, the ACC", "bbox": [404.0, 177.0, 720.0, 191.0]}, {"text": "AHA UA/NSTEMI writing group reduced morphine use to a", "bbox": [404.0, 192.0, 721.0, 207.0]}, {"text": "Class IIa recommendation for that patient population. 3", "bbox": [403.0, 208.0, 676.0, 222.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Reperfusion Therapies (Figure 1, Box 7, 8)", "bbox": [417.0, 238.0, 709.0, 253.0]}, {"text": "Acute reperfusion therapy using PPCI or fibrinolytic therapy", "bbox": [404.0, 254.0, 719.0, 267.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "in patients with STEMI restores flow in the infarct-related", "bbox": [403.0, 268.0, 720.0, 283.0]}, {"text": "artery, limits infarct size, and translates into early mortality", "bbox": [403.0, 285.0, 720.0, 298.0]}, {"text": "benefit that is sustained over the next decade. 187 . 188 While", "bbox": [403.0, 300.0, 720.0, 314.0]}, {"text": "optimal fibrinolysis restores normal coronary flow (TIMI 3)", "bbox": [403.0, 316.0, 721.0, 329.0]}, {"text": "in 50% to 60% of subjects, PPCI is able to achieve restored", "bbox": [403.0, 331.0, 720.0, 345.0]}, {"text": "flow in > 90% of subjects. The patency rates achieved with", "bbox": [403.0, 347.0, 720.0, 361.0]}, {"text": "PPCI translates into reduced mortality and reinfarction rates", "bbox": [404.0, 361.0, 720.0, 375.0]}, {"text": "as compared to fibrinolytic therapy. 189 This benefit is even", "bbox": [404.0, 377.0, 720.0, 391.0]}, {"text": "greater in patients presenting with cardiogenic shock. PPCI", "bbox": [404.0, 393.0, 720.0, 407.0]}, {"text": "also results in a decreased risk of intracranial hemorrhage and", "bbox": [403.0, 408.0, 720.0, 422.0]}, {"text": "stroke, making it the reperfusion strategy of choice in the", "bbox": [404.0, 424.0, 720.0, 437.0]}, {"text": "elderly and those at risk for bleeding complications.", "bbox": [403.0, 439.0, 677.0, 454.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Fibrinolytics", "bbox": [404.0, 468.0, 484.0, 481.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "Early fibrinolytic therapy is a well-established treatment", "bbox": [403.0, 483.0, 721.0, 497.0]}, {"text": "modality for patients with STEMI who present within 12", "bbox": [403.0, 498.0, 720.0, 513.0]}, {"text": "hours of the onset of symptoms and who lack contraindica-", "bbox": [403.0, 515.0, 719.0, 528.0]}, {"text": "tions to its use. 188,190–193 Early reperfusion results in reduced", "bbox": [403.0, 528.0, 721.0, 545.0]}, {"text": "mortality, and the shorter the time to reperfusion, the greater", "bbox": [403.0, 545.0, 721.0, 559.0]}, {"text": "the benefit. A 47% reduction in mortality was noted when", "bbox": [403.0, 561.0, 721.0, 575.0]}, {"text": "fibrinolytic therapy was provided within the first hour after", "bbox": [403.0, 575.0, 720.0, 589.0]}, {"text": "onset of symptoms. 188 , 193", "bbox": [404.0, 592.0, 536.0, 605.0]}, {"text": "The major determinants of myocardial salvage and long-", "bbox": [417.0, 606.0, 719.0, 621.0]}, {"text": "term prognosis are short time to reperfusion, 190 . 193 complete", "bbox": [404.0, 622.0, 720.0, 635.0]}, {"text": "and sustained patency of the infarct-related artery with", "bbox": [404.0, 637.0, 720.0, 652.0]}, {"text": "normal (TIMI grade 3) flow, 194, 195 and normal microvascular", "bbox": [403.0, 651.0, 720.0, 667.0]}, {"text": "perfusion. 22, 196– 198", "bbox": [404.0, 669.0, 499.0, 682.0]}, {"text": "In the absence of contraindications, fibrinolytic therapy is", "bbox": [416.0, 683.0, 721.0, 697.0]}, {"text": "recommended for STEMI if symptom onset has been within", "bbox": [404.0, 699.0, 721.0, 713.0]}, {"text": "12 hours of presentation and PCI is not available within 90", "bbox": [405.0, 714.0, 721.0, 729.0]}, {"text": "minutes of first medical contact (Class I, LOE A). Patients are", "bbox": [403.0, 730.0, 720.0, 744.0]}, {"text": "evaluated for risk and benefit; for absolute and relative", "bbox": [403.0, 745.0, 720.0, 760.0]}, {"text": "contraindications to therapy (see Table 5).", "bbox": [403.0, 762.0, 625.0, 775.0]}, {"text": "If fibrinolysis is chosen for reperfusion, the ED physician", "bbox": [416.0, 776.0, 721.0, 791.0]}, {"text": "should administer fibrinolytics to eligible patients as early as", "bbox": [404.0, 792.0, 720.0, 806.0]}, {"text": "possible according to a predetermined process of care devel-", "bbox": [404.0, 808.0, 720.0, 822.0]}, {"text": "oped by the ED and cardiology staff (Class I, LOE A). The", "bbox": [403.0, 824.0, 720.0, 837.0]}, {"text": "goal is a door-to-needle time of less than 30 minutes with", "bbox": [404.0, 838.0, 721.0, 852.0]}, {"text": "effort focused on shortening the time to therapy. Patients", "bbox": [403.0, 853.0, 720.0, 868.0]}, {"text": "treated within the first 70 minutes of onset of symptoms have", "bbox": [403.0, 870.0, 720.0, 883.0]}, {"text": "> 50% reduction in infarct size and 75% reduction in mor-", "bbox": [404.0, 884.0, 719.0, 899.0]}, {"text": "tality rates. 199 For fibrinolytic therapy, it is estimated that 65", "bbox": [403.0, 901.0, 720.0, 914.0]}, {"text": "lives will be saved per 1000 patients treated if fibrinolytics", "bbox": [403.0, 916.0, 720.0, 930.0]}, {"text": "are provided in the first hour, with a pooled total of 131 lives", "bbox": [404.0, 931.0, 720.0, 945.0]}, {"text": "saved per 1000 patients treated if fibrinolytics are provided", "bbox": [403.0, 947.0, 720.0, 961.0]}, {"text": "within the first 3 hours of onset of symptoms. 200 Although", "bbox": [404.0, 962.0, 721.0, 976.0]}, {"text": "fibrinolytics may be beneficial if given within 12 hours after", "bbox": [404.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 172}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#0#0#Aspirin suppositories (300 mg) are ...应该另起一行\n缺少换行#10#10#Acute Reperfusion Therapy Using Ppci Or Fibrinolytic Therapy属于下文正文内容，应该另起一行\n多余换行#11#11#in patients with STEMI restores flow...与上面10段后面联接\n缺少换行#13#13# The major determinants of myocardial...\nIn the absence of contraindications, ...都要另起一行", "type3": "无关文本#0#2#66 immediate referral to ...像这样在.号的开头或结尾出现的数字都是无关引用\n无关文本#15#15#属于页脚的内容，和正文无关", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:36:51"}
{"id": 1041991, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "e80a2ee0-d60d-4d05-bb39-e62946ac5a4f", "title": null, "text": "【0】页码:56\n\n【1】## What Will You Experience?\n\n【2】\n Wondering what happens in this rehabilitation therapy? Here are a few things that you can expect from a specialized therapist:\n\n【3】 1. Initial sessions with the therapist will involve the assessment of symptoms and condition. Patients may be asked about their existing symptoms, and they will also be asked what improves or worsens their condition.\n\n【4】 2. Medical history can also be reviewed to help the therapist evaluate the patient's condition. From these assessment results, the specialist will be able to develop an individualized plan for therapy.\n\n【5】 3. Typically, facial electromyography (EMG) is an essential part in the diagnosis of patients with Bell's palsy. It helps detect the presence of the condition and evaluates the extent of damage to the facial nerve. This also helps the therapist get an idea of the rate of recovery. There is no need to worry about this test. It is a simple, painless procedure and will not take much time.\n\n【6】 4. If the therapist doesn't have access to an EMG machine, he or she can evaluate the condition through careful inspection of facial features including the cheeks, lips, brows, etc. The therapist might ask patients to raise their eyebrows, close their eyes or smile widely. Through these actions, the therapist will be able to observe the symmetry and movement of the face. This will also help evaluate nerve functions.\n\n【7】 5. After this, the therapist will be able to judge the extent of weakness of the facial muscles. Subsequently, patients will be guided as to how they can protect their face and eyes. Therapists will perform the role of a coach and educate patients about how they can perform their daily life functions with this condition.\n\n【8】 6. If patients have severe problems, such as extremely dry eyes or slurred speech, the therapist may refer them to a specialist. An ophthalmologist (a physician who specializes in the surgical or medical care of the eyes) or language therapist would then be able to manage the specific symptoms.\n\n【9】## Guidance And Useful Advice\n\n【10】\n Patients may receive various wellness advice regarding treatment and care.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "What Will You Experience?", "bbox": [94.0, 96.0, 328.0, 116.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "Wondering what happens in this rehabilitation therapy? Here are a few things", "bbox": [93.0, 134.0, 722.0, 154.0]}, {"text": "that you can expect from a specialized therapist:", "bbox": [93.0, 157.0, 469.0, 176.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "1. Initial sessions with the therapist will involve the assessment of symptoms", "bbox": [106.0, 211.0, 722.0, 230.0]}, {"text": "and condition. Patients may be asked about their existing symptoms, and", "bbox": [131.0, 233.0, 723.0, 252.0]}, {"text": "they will also be asked what improves or worsens their condition.", "bbox": [131.0, 255.0, 641.0, 274.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "2. Medical history can also be reviewed to help the therapist evaluate the", "bbox": [106.0, 290.0, 722.0, 309.0]}, {"text": "patient's condition. From these assessment results, the specialist will be", "bbox": [131.0, 312.0, 723.0, 331.0]}, {"text": "able to develop an individualized plan for therapy.", "bbox": [131.0, 334.0, 523.0, 353.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "3. Typically, facial electromyography (EMG) is an essential part in the", "bbox": [106.0, 368.0, 722.0, 388.0]}, {"text": "diagnosis of patients with Bell's palsy. It helps detect the presence of the", "bbox": [131.0, 391.0, 722.0, 410.0]}, {"text": "condition and evaluates the extent of damage to the facial nerve. This also", "bbox": [131.0, 413.0, 723.0, 432.0]}, {"text": "helps the therapist get an idea of the rate of recovery. There is no need to", "bbox": [131.0, 435.0, 724.0, 454.0]}, {"text": "worry about this test. It is a simple, painless procedure and will not take", "bbox": [131.0, 457.0, 723.0, 476.0]}, {"text": "much time.", "bbox": [131.0, 479.0, 223.0, 498.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "4. If the therapist doesn't have access to an EMG machine, he or she can", "bbox": [106.0, 513.0, 722.0, 533.0]}, {"text": "evaluate the condition through careful inspection of facial features", "bbox": [131.0, 536.0, 723.0, 556.0]}, {"text": "including the cheeks, lips, brows, etc. The therapist might ask patients to", "bbox": [131.0, 559.0, 723.0, 577.0]}, {"text": "raise their eyebrows, close their eyes or smile widely. Through these", "bbox": [131.0, 579.0, 723.0, 600.0]}, {"text": "actions, the therapist will be able to observe the symmetry and movement", "bbox": [131.0, 602.0, 724.0, 621.0]}, {"text": "of the face. This will also help evaluate nerve functions.", "bbox": [131.0, 624.0, 567.0, 643.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "5. After this, the therapist will be able to judge the extent of weakness of the", "bbox": [106.0, 660.0, 722.0, 679.0]}, {"text": "facial muscles. Subsequently, patients will be guided as to how they can", "bbox": [131.0, 682.0, 723.0, 701.0]}, {"text": "protect their face and eyes. Therapists will perform the role of a coach and", "bbox": [131.0, 704.0, 723.0, 723.0]}, {"text": "educate patients about how they can perform their daily life functions with", "bbox": [131.0, 726.0, 723.0, 745.0]}, {"text": "this condition.", "bbox": [131.0, 748.0, 247.0, 767.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "6. If patients have severe problems, such as extremely dry eyes or slurred", "bbox": [106.0, 783.0, 722.0, 802.0]}, {"text": "speech, the therapist may refer them to a specialist. An ophthalmologist (a", "bbox": [131.0, 805.0, 723.0, 824.0]}, {"text": "physician who specializes in the surgical or medical care of the eyes) or", "bbox": [131.0, 827.0, 722.0, 846.0]}, {"text": "language therapist would then be able to manage the specific symptoms.", "bbox": [131.0, 849.0, 693.0, 868.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Guidance and Useful Advice", "bbox": [93.0, 889.0, 331.0, 909.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Patients may receive various wellness advice regarding treatment and care.", "bbox": [93.0, 928.0, 722.0, 947.0]}], "type": "Text", "position": 9}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 56}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:02:50"}
{"id": 1041990, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "a71fe6d6-6db3-4de4-8831-576e89b4d628", "title": null, "text": "【0】页码:201\n That said, it has long been observed that many children appear to \"grow out\" of their asthma. Contemporary medical thinking views the phenomenon of \"disappearing\" asthma as a state of prolonged asthma remission. Typically, adults in their late 20s or 30s who develops asthmatic symptoms will recall having had mild asthma as a child and are surprised that they continue to have asthma in adulthood.\n\n【1】## 96. Should My Child Be Excused From Physical Education Classes Since He’S Been Diagnosed With Asthma?\n\n【2】\n No, absolutely not. Your child's asthma should be brought under good control, and then he should be encouraged to participate fully in all aspects of school life, including fitness and sports. A diagnosis of asthma should never automatically lead to curtailed physical activity. Participation in physical education and in team sports is an important component of the healthy lifestyle advocated for all persons with asthma.\n\n【3】Having your child excused from physical education class not only robs him of the benefits associated with exercise, but also stigmatizes him, and sends the message that asthma is a physical impairment rather than a lung disease.\n\n【4】## 97. Should My Child Use A Peak-Flow Meter?\n\n【5】\n A peak-flow meter is a tool that you and your child can use to help assess the degree of asthma control at any given time. Even though some might erroneously view self-monitoring as a \"bother\" or a \"nuisance,\" it should be neither. Regular home peak-flow monitoring has", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "That said, it has long been observed that many chil-", "bbox": [150.0, 68.0, 505.0, 87.0]}, {"text": "dren appear to \"grow out\" of their asthma. Contempo-", "bbox": [149.0, 89.0, 506.0, 108.0]}, {"text": "rary medical thinking views the phenomenon of", "bbox": [150.0, 108.0, 509.0, 128.0]}, {"text": "\"disappearing\" asthma as a state of prolonged asthma", "bbox": [150.0, 128.0, 508.0, 147.0]}, {"text": "remission. Typically, adults in their late 20s or 30s who", "bbox": [149.0, 149.0, 507.0, 167.0]}, {"text": "develops asthmatic symptoms will recall having had", "bbox": [149.0, 168.0, 508.0, 188.0]}, {"text": "mild asthma as a child and are surprised that they con-", "bbox": [150.0, 189.0, 505.0, 208.0]}, {"text": "tinue to have asthma in adulthood.", "bbox": [149.0, 209.0, 378.0, 228.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "96. Should my child be excused from", "bbox": [151.0, 252.0, 461.0, 277.0]}, {"text": "physical education classes since he’s been", "bbox": [150.0, 279.0, 492.0, 301.0]}, {"text": "diagnosed with asthma?", "bbox": [149.0, 303.0, 366.0, 326.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "No, absolutely not. Your child's asthma should be", "bbox": [150.0, 328.0, 506.0, 350.0]}, {"text": "brought under good control, and then he should be", "bbox": [149.0, 351.0, 506.0, 370.0]}, {"text": "encouraged to participate fully in all aspects of school", "bbox": [149.0, 371.0, 507.0, 390.0]}, {"text": "life, including fitness and sports. A diagnosis of", "bbox": [149.0, 390.0, 508.0, 409.0]}, {"text": "asthma should never automatically lead to curtailed", "bbox": [149.0, 411.0, 507.0, 429.0]}, {"text": "physical activity. Participation in physical education", "bbox": [150.0, 431.0, 506.0, 449.0]}, {"text": "and in team sports is an important component of the", "bbox": [149.0, 451.0, 507.0, 470.0]}, {"text": "healthy lifestyle advocated for all persons with asthma.", "bbox": [149.0, 471.0, 507.0, 489.0]}, {"text": "Having your child excused from physical education", "bbox": [150.0, 491.0, 507.0, 509.0]}, {"text": "class not only robs him of the benefits associated with", "bbox": [149.0, 511.0, 507.0, 529.0]}, {"text": "exercise, but also stigmatizes him, and sends the mes-", "bbox": [150.0, 531.0, 506.0, 550.0]}, {"text": "sage that asthma is a physical impairment rather than a", "bbox": [150.0, 551.0, 507.0, 570.0]}, {"text": "lung disease.", "bbox": [149.0, 570.0, 235.0, 590.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "97. Should my child use a peak-flow", "bbox": [151.0, 614.0, 464.0, 639.0]}, {"text": "meter?", "bbox": [149.0, 644.0, 213.0, 662.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "A peak-flow meter is a tool that you and your child can", "bbox": [150.0, 668.0, 507.0, 687.0]}, {"text": "use to help assess the degree of asthma control at any", "bbox": [149.0, 689.0, 507.0, 707.0]}, {"text": "given time. Even though some might erroneously view", "bbox": [150.0, 709.0, 506.0, 727.0]}, {"text": "self-monitoring as a \"bother\" or a \"nuisance,\" it should", "bbox": [149.0, 729.0, 507.0, 748.0]}, {"text": "be neither. Regular home peak-flow monitoring has", "bbox": [149.0, 748.0, 507.0, 768.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 201}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "", "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:56:33"}
{"id": 1041989, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "62c14b4d-8c92-4168-9367-0b09b140003e", "title": null, "text": "页码:224\n VIESSO|D\n\n【1】 Internist: A physician specialized in the non-surgical medical care of adults.\n\n【2】 Larynx: The voice box. Two vocal cords allow for speech as inhaled air passes between them, and sets up vibrations within the larynx located in the mid-neck.\n\n【3】 Leptin: Leptin is a human protein identified in 1994, and named after leptos the Greek word for \"thin.\" Leptin seems to play a role in the regulation of fat accumulation. In humans, increasing body fat appears to correlate with increased leptin levels.\n\n【4】 Leukotriene:      Leukotrienes are inflammatory molecules. There are two families of leukotrienes. One in particular, called the cysteinyl-leukotriene, is important in asthma and allergy. Cysteinyl-leukotrienes are released in increased number during asthma exacerbations. Drugs, known as \"leukotriene modifiers,\" have been developed based on current knowledge of leukotrienes. The leukotriene modifiers include: (1) receptor antagonists or blockers, and (2) synthesis inhibitors. The first class blocks the effects of leukotrienes (blockers), while the second interferes with their formation (synthesis inhibitors).\n\n【5】Medicines in the first category are very safe and widely used in the maintenance treatment of allergic rhinitis and asthma.\n\n【6】 MDI: Stands for metered dose inhaler. MDIs are devices that allow\n\n【7】 the delivery of a precise and accurate dose of medicine to the lungs by inhalation. MDIs are reliable, portable, and very convenient. Many different types of respiratory medicines come in MDI form, including short-acting \"rescue\" bronchodilators, inhaled steroids, and antiinflammatory medicines, as well as inhaled anticholinergics. Medicines in MDI form are used in the treatment of asthma and COPD. The newer MDIs use a CFC-free propellant, usually HFA.\n\n【8】 Methacholine challenge test: The methacholine challenge test is a type of bronchoprovocation test. It is a specialized PFT used in the evaluation of suspected asthma, when the diagnosis is otherwise uncertain.\n\n【9】 Morbidity: A measure of illness in a given population. The yearly morbidity rate from a disease is defined as the proportion of people affected by that disease per year, per given unit of population.\n\n【10】 Mortality: A measure of illness; the rate of death from a disease in a given community or population at a precise point in time. The yearly mortality rate from a disease is defined as the ratio of deaths due to that disease, to the total number of persons in that community or population.\n\n【11】 Mucus: Mucus is a mixture composed of water, salt, and proteins produced by specialized cells in the nose  , sinuses, and lung passages. Mucus", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "VIESSO|D", "bbox": [547.0, 59.0, 568.0, 120.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Internist: A physician specialized in", "bbox": [70.0, 69.0, 277.0, 84.0]}, {"text": "the non-surgical medical care of adults.", "bbox": [70.0, 87.0, 276.0, 102.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Larynx: The voice box. Two vocal", "bbox": [70.0, 108.0, 277.0, 124.0]}, {"text": "cords allow for speech as inhaled air", "bbox": [70.0, 126.0, 277.0, 141.0]}, {"text": "passes between them, and sets up", "bbox": [70.0, 144.0, 276.0, 159.0]}, {"text": "vibrations within the larynx located", "bbox": [70.0, 161.0, 277.0, 176.0]}, {"text": "in the mid-neck.", "bbox": [70.0, 178.0, 163.0, 194.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Leptin: Leptin is a human protein", "bbox": [70.0, 200.0, 276.0, 216.0]}, {"text": "identified in 1994, and named after", "bbox": [70.0, 218.0, 276.0, 233.0]}, {"text": "leptos the Greek word for \"thin.\"", "bbox": [70.0, 235.0, 276.0, 251.0]}, {"text": "Leptin seems to play a role in the", "bbox": [70.0, 253.0, 277.0, 268.0]}, {"text": "regulation of fat accumulation. In", "bbox": [70.0, 270.0, 277.0, 285.0]}, {"text": "humans, increasing body fat", "bbox": [69.0, 288.0, 276.0, 303.0]}, {"text": "appears to correlate with increased", "bbox": [70.0, 305.0, 276.0, 320.0]}, {"text": "leptin levels.", "bbox": [69.0, 322.0, 143.0, 338.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Leukotriene:      Leukotrienes", "bbox": [70.0, 344.0, 251.0, 360.0]}, {"text": "are", "bbox": [254.0, 346.0, 275.0, 359.0]}, {"text": "inflammatory molecules. There are", "bbox": [70.0, 362.0, 276.0, 378.0]}, {"text": "two families of leukotrienes. One in", "bbox": [70.0, 379.0, 277.0, 395.0]}, {"text": "particular, called the cysteinyl-leuko-", "bbox": [70.0, 396.0, 275.0, 412.0]}, {"text": "triene, is important in asthma and", "bbox": [70.0, 413.0, 277.0, 429.0]}, {"text": "allergy. Cysteinyl-leukotrienes are", "bbox": [70.0, 431.0, 276.0, 447.0]}, {"text": "released in increased number during", "bbox": [70.0, 448.0, 276.0, 464.0]}, {"text": "asthma exacerbations. Drugs, known", "bbox": [70.0, 466.0, 277.0, 481.0]}, {"text": "as \"leukotriene modifiers,\" have been", "bbox": [70.0, 483.0, 277.0, 499.0]}, {"text": "developed based on current knowl-", "bbox": [70.0, 501.0, 275.0, 516.0]}, {"text": "edge of leukotrienes. The leukotriene", "bbox": [70.0, 518.0, 276.0, 534.0]}, {"text": "modifiers include: (1) receptor antag-", "bbox": [70.0, 535.0, 275.0, 551.0]}, {"text": "onists or blockers, and (2) synthesis", "bbox": [70.0, 552.0, 276.0, 568.0]}, {"text": "inhibitors. The first class blocks the", "bbox": [70.0, 570.0, 276.0, 586.0]}, {"text": "effects of leukotrienes (blockers),", "bbox": [70.0, 587.0, 277.0, 603.0]}, {"text": "while the second interferes with their", "bbox": [70.0, 604.0, 276.0, 620.0]}, {"text": "formation (synthesis inhibitors).", "bbox": [70.0, 622.0, 276.0, 637.0]}, {"text": "Medicines in the first category are", "bbox": [70.0, 640.0, 276.0, 655.0]}, {"text": "very safe and widely used in the", "bbox": [70.0, 657.0, 276.0, 672.0]}, {"text": "maintenance treatment of allergic", "bbox": [70.0, 674.0, 276.0, 690.0]}, {"text": "rhinitis and asthma.", "bbox": [70.0, 691.0, 180.0, 707.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "MDI: Stands for metered dose", "bbox": [70.0, 714.0, 276.0, 730.0]}, {"text": "inhaler. MDIs are devices that allow", "bbox": [70.0, 731.0, 276.0, 747.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "the delivery of a precise and accurate", "bbox": [300.0, 69.0, 506.0, 84.0]}, {"text": "dose of medicine to the lungs by", "bbox": [300.0, 86.0, 506.0, 102.0]}, {"text": "inhalation. MDIs are reliable,", "bbox": [300.0, 103.0, 507.0, 119.0]}, {"text": "portable, and very convenient. Many", "bbox": [300.0, 120.0, 507.0, 136.0]}, {"text": "different types of respiratory medi-", "bbox": [300.0, 138.0, 506.0, 154.0]}, {"text": "cines come in MDI form, including", "bbox": [300.0, 155.0, 507.0, 171.0]}, {"text": "short-acting \"rescue\" bronchodila-", "bbox": [300.0, 173.0, 506.0, 188.0]}, {"text": "tors, inhaled steroids, and anti-", "bbox": [301.0, 190.0, 506.0, 205.0]}, {"text": "inflammatory medicines, as well as", "bbox": [300.0, 208.0, 507.0, 223.0]}, {"text": "inhaled anticholinergics. Medicines", "bbox": [300.0, 225.0, 507.0, 241.0]}, {"text": "in MDI form are used in the treat-", "bbox": [300.0, 242.0, 506.0, 258.0]}, {"text": "ment of asthma and COPD. The", "bbox": [301.0, 259.0, 507.0, 275.0]}, {"text": "newer MDIs use a CFC-free propel-", "bbox": [300.0, 277.0, 506.0, 293.0]}, {"text": "lant, usually HFA.", "bbox": [300.0, 294.0, 404.0, 310.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Methacholine challenge test: The", "bbox": [300.0, 316.0, 507.0, 332.0]}, {"text": "methacholine challenge test is a type", "bbox": [300.0, 334.0, 507.0, 349.0]}, {"text": "of bronchoprovocation test. It is a", "bbox": [300.0, 352.0, 507.0, 367.0]}, {"text": "specialized PFT used in the evalua-", "bbox": [300.0, 368.0, 506.0, 384.0]}, {"text": "tion of suspected asthma, when the", "bbox": [300.0, 386.0, 507.0, 401.0]}, {"text": "diagnosis is otherwise uncertain.", "bbox": [300.0, 403.0, 478.0, 419.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Morbidity: A measure of illness in a", "bbox": [300.0, 426.0, 507.0, 442.0]}, {"text": "given population. The yearly morbid-", "bbox": [300.0, 443.0, 506.0, 459.0]}, {"text": "ity rate from a disease is defined as", "bbox": [300.0, 460.0, 507.0, 476.0]}, {"text": "the proportion of people affected by", "bbox": [300.0, 478.0, 507.0, 493.0]}, {"text": "that disease per year, per given unit", "bbox": [300.0, 496.0, 507.0, 511.0]}, {"text": "of population.", "bbox": [300.0, 513.0, 380.0, 528.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Mortality: A measure of illness; the", "bbox": [300.0, 535.0, 507.0, 551.0]}, {"text": "rate of death from a disease in a given", "bbox": [300.0, 552.0, 508.0, 568.0]}, {"text": "community or population at a precise", "bbox": [300.0, 570.0, 507.0, 586.0]}, {"text": "point in time. The yearly mortality", "bbox": [300.0, 587.0, 507.0, 603.0]}, {"text": "rate from a disease is defined as the", "bbox": [300.0, 604.0, 507.0, 620.0]}, {"text": "ratio of deaths due to that disease, to", "bbox": [300.0, 622.0, 508.0, 637.0]}, {"text": "the total number of persons in that", "bbox": [300.0, 640.0, 507.0, 655.0]}, {"text": "community or population.", "bbox": [300.0, 657.0, 445.0, 673.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Mucus: Mucus is a mixture com-", "bbox": [300.0, 679.0, 505.0, 694.0]}, {"text": "posed of water, salt, and proteins pro-", "bbox": [300.0, 696.0, 505.0, 712.0]}, {"text": "duced by specialized cells in the nose  ,", "bbox": [300.0, 714.0, 507.0, 730.0]}, {"text": "sinuses, and lung passages. Mucus", "bbox": [300.0, 731.0, 507.0, 748.0]}], "type": "Text", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 224}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#6#7#MDI: Stands for metered到propellant, usually HFA.是一句话\n", "type3": "无关文本#0#0#VIESSO|D\n", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:53:50"}
{"id": 1041988, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "37b7415a-5ba7-4fe3-b68b-16262a4c7a8e", "title": null, "text": "【0】页码:44\n sisoupeiq pue swozdw/s\n\n【1】## Table 8 Control Of Factors Affecting Asthma Severity\n\n【2】\n Any of the nine factors described below may contribute to making your asthma more difficult to control.\n\n【3】 Control Measure Factor Correctly identify specific allergens and address Allergens appropriately: avoidance, antihistamine therapy, immunotherapy injections. Epinephrine autoinjectors for emergency use might be prescribed.\n\n【4】Tobacco smoke Smoking cessation, smoke-free home and work environments.\n\n【5】Rhinitis Directed therapy: nasal sprays (cromolyn, nasal steroids), nasal washes, antihistamines, leukotriene antagonists, decongestants.\n\n【6】Sinusitis Correct diagnosis is important; drainage measures, washes, nasal steroids, antihistamines, and/or decongestants may be prescribed. Antibiotic therapy is reserved for acute bacterial infections.\n\n【7】Gastro-esophageal reflux, also Dietary manipulations; small, frequent meals; known as GERD prescription antacid medication. Elevation of the head of the bed may be advised.\n\n【8】Sulfite-sensitive asthmatics should avoid all sulfite- Sensitivity to sulfite additives containing foods. Common examples are red wine, beer, shrimp, dried fruits.\n\n【9】Selected medications Beta-blockers in any form: eye drops (used in glaucoma treatment), as will as pills (used in high blood pressure and heart disease treatment), can cause bronchospasm. \"Aspirin-sensitive\" asthmatics must avoid aspirin and the nonsteroidal, anti-inflammatory class of medicines.\n\n【10】Viral respiratory infections Yearly influenza vaccination should be recommended (unless contraindicated).\n\n【11】Importance of a safe workplace environment: proper Occupational exposures ventilation, avoidance, and when appropriate, personal protective respirators.\n", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "sisoupeiq pue swozdw/s", "bbox": [547.0, 90.0, 571.0, 257.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "Table 8", "bbox": [71.0, 69.0, 108.0, 82.0]}, {"text": "Control of Factors Affecting Asthma Severity", "bbox": [115.0, 69.0, 323.0, 83.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "Any of the nine factors described below may contribute to making your asthma more", "bbox": [74.0, 94.0, 484.0, 110.0]}, {"text": "difficult to control.", "bbox": [73.0, 110.0, 168.0, 122.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Control Measure", "bbox": [244.0, 143.0, 323.0, 158.0]}, {"text": "Factor", "bbox": [73.0, 144.0, 106.0, 157.0]}, {"text": "Correctly identify specific allergens and address", "bbox": [243.0, 176.0, 474.0, 190.0]}, {"text": "Allergens", "bbox": [74.0, 177.0, 122.0, 190.0]}, {"text": "appropriately: avoidance, antihistamine therapy,", "bbox": [243.0, 190.0, 477.0, 203.0]}, {"text": "immunotherapy injections. Epinephrine auto-", "bbox": [243.0, 204.0, 466.0, 217.0]}, {"text": "injectors for emergency use might be prescribed.", "bbox": [243.0, 218.0, 478.0, 230.0]}, {"text": "Tobacco smoke", "bbox": [74.0, 250.0, 152.0, 263.0]}, {"text": "Smoking cessation, smoke-free home and work", "bbox": [244.0, 250.0, 475.0, 263.0]}, {"text": "environments.", "bbox": [243.0, 264.0, 315.0, 277.0]}, {"text": "Rhinitis", "bbox": [74.0, 297.0, 115.0, 310.0]}, {"text": "Directed therapy: nasal sprays (cromolyn, nasal", "bbox": [244.0, 297.0, 472.0, 310.0]}, {"text": "steroids), nasal washes, antihistamines, leukotriene", "bbox": [244.0, 311.0, 490.0, 324.0]}, {"text": "antagonists, decongestants.", "bbox": [244.0, 324.0, 377.0, 336.0]}, {"text": "Sinusitis", "bbox": [74.0, 357.0, 118.0, 370.0]}, {"text": "Correct diagnosis is important; drainage measures,", "bbox": [243.0, 357.0, 489.0, 370.0]}, {"text": "washes, nasal steroids, antihistamines, and/or decon-", "bbox": [244.0, 371.0, 499.0, 383.0]}, {"text": "gestants may be prescribed. Antibiotic therapy is", "bbox": [244.0, 384.0, 480.0, 396.0]}, {"text": "reserved for acute bacterial infections.", "bbox": [243.0, 397.0, 427.0, 410.0]}, {"text": "Gastro-esophageal reflux, also", "bbox": [73.0, 429.0, 222.0, 443.0]}, {"text": "Dietary manipulations; small, frequent meals;", "bbox": [244.0, 429.0, 465.0, 444.0]}, {"text": "known as GERD", "bbox": [74.0, 444.0, 162.0, 457.0]}, {"text": "prescription antacid medication. Elevation of the", "bbox": [244.0, 444.0, 482.0, 457.0]}, {"text": "head of the bed may be advised.", "bbox": [244.0, 457.0, 399.0, 470.0]}, {"text": "Sulfite-sensitive asthmatics should avoid all sulfite-", "bbox": [244.0, 489.0, 491.0, 504.0]}, {"text": "Sensitivity to sulfite additives", "bbox": [74.0, 490.0, 218.0, 503.0]}, {"text": "containing foods. Common examples are red wine,", "bbox": [244.0, 504.0, 491.0, 516.0]}, {"text": "beer, shrimp, dried fruits.", "bbox": [243.0, 518.0, 369.0, 530.0]}, {"text": "Selected medications", "bbox": [74.0, 550.0, 178.0, 563.0]}, {"text": "Beta-blockers in any form: eye drops (used in glau-", "bbox": [244.0, 550.0, 491.0, 563.0]}, {"text": "coma treatment), as will as pills (used in high blood", "bbox": [243.0, 564.0, 494.0, 577.0]}, {"text": "pressure and heart disease treatment), can cause", "bbox": [244.0, 578.0, 475.0, 590.0]}, {"text": "bronchospasm. \"Aspirin-sensitive\" asthmatics must", "bbox": [243.0, 591.0, 492.0, 604.0]}, {"text": "avoid aspirin and the nonsteroidal, anti-inflamma-", "bbox": [244.0, 604.0, 488.0, 617.0]}, {"text": "tory class of medicines.", "bbox": [244.0, 617.0, 356.0, 630.0]}, {"text": "Viral respiratory infections", "bbox": [75.0, 650.0, 205.0, 664.0]}, {"text": "Yearly influenza vaccination should be recom-", "bbox": [244.0, 650.0, 468.0, 664.0]}, {"text": "mended (unless contraindicated).", "bbox": [244.0, 664.0, 405.0, 677.0]}, {"text": "Importance of a safe workplace environment: proper", "bbox": [244.0, 696.0, 498.0, 710.0]}, {"text": "Occupational exposures", "bbox": [73.0, 697.0, 191.0, 710.0]}, {"text": "ventilation, avoidance, and when appropriate, per-", "bbox": [244.0, 711.0, 486.0, 723.0]}, {"text": "sonal protective respirators.", "bbox": [244.0, 724.0, 377.0, 737.0]}], "type": "Table", "position": 4}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 44}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type3": "无关文本#0#0#sisoupeiq pue swozdw/s\n", "type4": "", "type6": "信息准确性#3#3#Control Measure Factor顺序前后颠倒，Allergens穿插在正文之间\n信息准确性#7#7#known as GERD在Gastro-esophageal reflux, also后面\n信息准确性#8#8#Sensitivity to sulfite additives应该在句首\n信息准确性#11#11#Occupational exposures应该在句首"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:07:25"}
{"id": 1041987, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "8bfea651-18a8-45d4-838d-6c5557d303c9", "title": null, "text": "【0】页码:20\n ography program, championed by IBM for decades, that used x-ray radiation.\n\n【1】The program consumed hundreds of millions of dollars in expenditures by both IBM and the Defense Advanced Research Projects Agency—and some industry observers estimate that the sum exceeded $1 billion. Moreover, in recent months two major semiconductor equipment manufacturers—ASML and Applied Materials—dropped plans to develop electron projection lithography, which uses parallel beams of electrons to print circuit patterns, another contender for the nextgeneration lithography that had been under development for years inside AT&T Bell Laboratories.\n\n【2】Despite its role as lead sponsor for EUV, Intel cannot claim credit for inventing it. In the late 1980s AT&T Bell Laboratories (now part of Lucent Technologies) and NTT Communications published separate papers on soft x-ray projection lithography. Two national laboratories—Sandia and Lawrence Livermore—expanded on this work using technologies from the Strategic Defense Initiative. Sandia fashioned an early lithography prototype using radiation from a laser-generated plasma, which had been involved before in testing the response of different materials to the high-energy pulses that satellites might sustain in scenarios postulated by \"Star Wars\" planners.\n\n【3】It has been understood for decades that the billion-dollar expense and overwhelming difficulties of producing chips with nanoscale circuitry would require that chipmakers such as IBM, Intel or (at one time) AT&T fund the early research of their equipment manufacturers. Bell Labs, which oversaw parallel efforts in five separate lithography technologies during the early 1990s, was enticed by the idea of short-wavelength radiation that did not require a synchrotron, the giant x-ray generators found in high-energy physics laboratories. The technical difficulties that beset x-ray lithography at the time led the Bell Labs researchers to change the name from soft x-rays to extreme ultraviolet lithography. Intel had\n\n【4】 joined AT&T and others in a cooperative research program with the national laboratories. But the actual day-to-day research was concentrated at Lawrence Livermore, Sandia and Bell Laboratories.\n\n【5】When Congress eliminated the program in 1996, pegging it as a form of corporate welfare, AT&T decided to get out. Intel then stepped in to salvage and carry on the work. \"Intel came to the realization [that] if they didn't put money into a couple of key technologies that would come into play in the 2000s, they were going to be in big trouble,\" says Richard R. Freeman, a professor of applied science at the University of Califor-\n\n【6】 nia at Davis, who headed lithography development at AT&T Bell Labs and later the EUV program at the national laboratories during the mid-1990s.\n\n【7】On paper, EUV was attractive. With a wavelength of 13 nanometers—almost one twentieth the wavelength being readied for use in commercial chipmaking five years ago—EUV could be extended until the physical challenges of making atomicscale chips rendered existing semiconductor technologies unworkable. And the technology used a machine tool that bears some resemblance to those deployed in existing fabrication facilities. Insiders at Intel were suspicious, though. \"People start-\n\n【8】## Extreme Ultraviolet Lithography\n\n【9】\n LUSTRATION BY SAMUEL VELAS", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "ography program, championed by IBM", "bbox": [45.0, 135.0, 261.0, 149.0]}, {"text": "for decades, that used x-ray radiation.", "bbox": [45.0, 151.0, 261.0, 164.0]}, {"text": "The program consumed hundreds of mil-", "bbox": [45.0, 166.0, 260.0, 181.0]}, {"text": "lions of dollars in expenditures by both", "bbox": [44.0, 183.0, 261.0, 197.0]}, {"text": "IBM and the Defense Advanced Research", "bbox": [45.0, 199.0, 261.0, 213.0]}, {"text": "Projects Agency—and some industry ob-", "bbox": [45.0, 215.0, 260.0, 229.0]}, {"text": "servers estimate that the sum exceeded $1", "bbox": [44.0, 231.0, 260.0, 245.0]}, {"text": "billion. Moreover, in recent months two", "bbox": [44.0, 247.0, 261.0, 261.0]}, {"text": "major semiconductor equipment manu-", "bbox": [44.0, 263.0, 260.0, 277.0]}, {"text": "facturers—ASML and Applied Materi-", "bbox": [44.0, 279.0, 260.0, 294.0]}, {"text": "als—dropped plans to develop electron", "bbox": [44.0, 295.0, 261.0, 309.0]}, {"text": "projection lithography, which uses par-", "bbox": [44.0, 311.0, 260.0, 325.0]}, {"text": "allel beams of electrons to print circuit", "bbox": [44.0, 327.0, 261.0, 342.0]}, {"text": "patterns, another contender for the next-", "bbox": [44.0, 344.0, 260.0, 356.0]}, {"text": "generation lithography that had been un-", "bbox": [44.0, 359.0, 261.0, 374.0]}, {"text": "der development for years inside AT&T", "bbox": [44.0, 374.0, 260.0, 389.0]}, {"text": "Bell Laboratories.", "bbox": [44.0, 392.0, 143.0, 405.0]}, {"text": "Despite its role as lead sponsor for", "bbox": [64.0, 407.0, 261.0, 421.0]}, {"text": "EUV, Intel cannot claim credit for in-", "bbox": [44.0, 423.0, 261.0, 437.0]}, {"text": "venting it. In the late 1980s AT&T Bell", "bbox": [44.0, 439.0, 261.0, 453.0]}, {"text": "Laboratories (now part of Lucent Tech-", "bbox": [44.0, 454.0, 261.0, 470.0]}, {"text": "nologies) and NTT Communications", "bbox": [44.0, 471.0, 261.0, 485.0]}, {"text": "published separate papers on soft x-ray", "bbox": [44.0, 487.0, 261.0, 501.0]}, {"text": "projection lithography. Two national", "bbox": [45.0, 503.0, 261.0, 517.0]}, {"text": "laboratories—Sandia and Lawrence Liv-", "bbox": [44.0, 519.0, 261.0, 534.0]}, {"text": "ermore—expanded on this work using", "bbox": [44.0, 535.0, 261.0, 549.0]}, {"text": "technologies from the Strategic Defense", "bbox": [44.0, 551.0, 261.0, 565.0]}, {"text": "Initiative. Sandia fashioned an early lith-", "bbox": [45.0, 567.0, 261.0, 581.0]}, {"text": "ography prototype using radiation from", "bbox": [44.0, 583.0, 261.0, 597.0]}, {"text": "a laser-generated plasma, which had been", "bbox": [45.0, 599.0, 261.0, 614.0]}, {"text": "involved before in testing the response of", "bbox": [45.0, 615.0, 261.0, 629.0]}, {"text": "different materials to the high-energy puls-", "bbox": [44.0, 631.0, 261.0, 645.0]}, {"text": "es that satellites might sustain in scenarios", "bbox": [44.0, 647.0, 261.0, 662.0]}, {"text": "postulated by \"Star Wars\" planners.", "bbox": [45.0, 662.0, 234.0, 677.0]}, {"text": "It has been understood for decades", "bbox": [64.0, 678.0, 262.0, 694.0]}, {"text": "that the billion-dollar expense and over-", "bbox": [44.0, 695.0, 261.0, 709.0]}, {"text": "whelming difficulties of producing chips", "bbox": [44.0, 711.0, 261.0, 724.0]}, {"text": "with nanoscale circuitry would require", "bbox": [44.0, 726.0, 261.0, 741.0]}, {"text": "that chipmakers such as IBM, Intel or (at", "bbox": [44.0, 743.0, 261.0, 757.0]}, {"text": "one time) AT&T fund the early research", "bbox": [44.0, 759.0, 261.0, 773.0]}, {"text": "of their equipment manufacturers. Bell", "bbox": [44.0, 775.0, 261.0, 789.0]}, {"text": "Labs, which oversaw parallel efforts in", "bbox": [45.0, 791.0, 261.0, 805.0]}, {"text": "five separate lithography technologies", "bbox": [44.0, 807.0, 261.0, 821.0]}, {"text": "during the early 1990s, was enticed by", "bbox": [44.0, 823.0, 261.0, 837.0]}, {"text": "the idea of short-wavelength radiation", "bbox": [44.0, 839.0, 261.0, 853.0]}, {"text": "that did not require a synchrotron, the gi-", "bbox": [44.0, 855.0, 261.0, 869.0]}, {"text": "ant x-ray generators found in high-ener-", "bbox": [45.0, 871.0, 260.0, 885.0]}, {"text": "gy physics laboratories. The technical dif-", "bbox": [45.0, 887.0, 261.0, 902.0]}, {"text": "ficulties that beset x-ray lithography at", "bbox": [45.0, 903.0, 261.0, 917.0]}, {"text": "the time led the Bell Labs researchers to", "bbox": [44.0, 919.0, 261.0, 933.0]}, {"text": "change the name from soft x-rays to ex-", "bbox": [44.0, 935.0, 261.0, 949.0]}, {"text": "treme ultraviolet lithography. Intel had", "bbox": [44.0, 951.0, 261.0, 965.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "joined AT&T and others in a cooperative", "bbox": [273.0, 134.0, 490.0, 149.0]}, {"text": "research program with the national lab-", "bbox": [273.0, 151.0, 488.0, 165.0]}, {"text": "oratories. But the actual day-to-day re-", "bbox": [274.0, 166.0, 488.0, 181.0]}, {"text": "search was concentrated at Lawrence Liv-", "bbox": [273.0, 183.0, 488.0, 197.0]}, {"text": "ermore, Sandia and Bell Laboratories.", "bbox": [273.0, 199.0, 477.0, 214.0]}, {"text": "When Congress eliminated the pro-", "bbox": [293.0, 215.0, 488.0, 229.0]}, {"text": "gram in 1996, pegging it as a form of cor-", "bbox": [273.0, 231.0, 488.0, 245.0]}, {"text": "porate welfare, AT&T decided to get", "bbox": [273.0, 247.0, 490.0, 261.0]}, {"text": "out. Intel then stepped in to salvage and", "bbox": [273.0, 263.0, 490.0, 277.0]}, {"text": "carry on the work. \"Intel came to the re-", "bbox": [273.0, 279.0, 488.0, 294.0]}, {"text": "alization [that] if they didn't put money", "bbox": [274.0, 295.0, 488.0, 309.0]}, {"text": "into a couple of key technologies that", "bbox": [273.0, 311.0, 490.0, 325.0]}, {"text": "would come into play in the 2000s, they", "bbox": [273.0, 326.0, 489.0, 342.0]}, {"text": "were going to be in big trouble,\" says", "bbox": [273.0, 344.0, 490.0, 358.0]}, {"text": "Richard R. Freeman, a professor of ap-", "bbox": [273.0, 359.0, 488.0, 374.0]}, {"text": "plied science at the University of Califor-", "bbox": [274.0, 374.0, 488.0, 389.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "nia at Davis, who headed lithography de-", "bbox": [501.0, 134.0, 716.0, 149.0]}, {"text": "velopment at AT&T Bell Labs and later", "bbox": [502.0, 151.0, 718.0, 165.0]}, {"text": "the EUV program at the national labora-", "bbox": [502.0, 166.0, 716.0, 181.0]}, {"text": "tories during the mid-1990s.", "bbox": [502.0, 183.0, 655.0, 197.0]}, {"text": "On paper, EUV was attractive. With", "bbox": [520.0, 199.0, 717.0, 214.0]}, {"text": "a wavelength of 13 nanometers—almost", "bbox": [502.0, 215.0, 717.0, 229.0]}, {"text": "one twentieth the wavelength being read-", "bbox": [502.0, 231.0, 716.0, 245.0]}, {"text": "ied for use in commercial chipmaking five", "bbox": [502.0, 247.0, 718.0, 261.0]}, {"text": "years ago—EUV could be extended until", "bbox": [502.0, 263.0, 718.0, 277.0]}, {"text": "the physical challenges of making atomic-", "bbox": [502.0, 279.0, 716.0, 294.0]}, {"text": "scale chips rendered existing semiconduc-", "bbox": [502.0, 295.0, 716.0, 308.0]}, {"text": "tor technologies unworkable. And the", "bbox": [502.0, 311.0, 718.0, 325.0]}, {"text": "technology used a machine tool that bears", "bbox": [502.0, 327.0, 718.0, 342.0]}, {"text": "some resemblance to those deployed in ex-", "bbox": [502.0, 344.0, 716.0, 356.0]}, {"text": "isting fabrication facilities. Insiders at In-", "bbox": [502.0, 359.0, 716.0, 374.0]}, {"text": "tel were suspicious, though. \"People start-", "bbox": [501.0, 374.0, 716.0, 389.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "EXTREME ULTRAVIOLET LITHOGRAPHY", "bbox": [287.0, 407.0, 586.0, 429.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "LUSTRATION BY SAMUEL VELAS", "bbox": [746.0, 847.0, 759.0, 954.0]}], "type": "Text", "position": 6}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 20}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#3#4#为同段\n多余换行#5#6#为同段", "type3": null, "type4": null, "type5": null, "type6": "信息有用性#8#9#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:35:59"}
{"id": 1041986, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "a1b53473-1a09-44eb-8b40-6f289baa08b0", "title": null, "text": "【0】页码:202\n uə:plid) pue emitsA :piqoT leipadc\n\n【1】 been shown to improve a child's asthma control, reduce exacerbations, and decrease school absences. Using a peak-flow monitor may also increase your child's confidence as it will help him or her learn how to optimize asthma control and achieve greater mastery over his or her asthma. Most children can accurately measure their peak flow under adult guidance starting at about 6 years of age. Measurement of peak flow is an assessment of lung function, more precisely, of airflow through larger airways (discussed in Question 28). Peak-flow monitoring also allows for objective decisions about modifying your child's asthma regimen if appropriate, based on information contained in the written asthma action plan your physician has provided.\n\n【2】 When your child is given a prescription for home peakflow monitoring, you will be asked to determine his or her \"personal best\" value based on measurements obtained when your child feels well and is symptomfree. An asthma action plan provides instructions on what asthma medication to take as the peak-flow value falls into one of three zones labeled \"green,\" \"yellow,\" or \"red.\" The green zone includes peak-flow measurements in the range of 80% to 100% of a child's personal best. Yellow corresponds to peak-flow measurements in the range of 60% to 80% of the personal best value. The red zone includes all peak flow values below 60% of a child's personal best. Peak-flow measurements in the red zone indicate that the child's asthma is poorly controlled, and that you will need to either contact your physician, proceed to the emergency room, or both. So, if your 10-year-old child with asthma is scheduled to play in a soccer match on Saturday morning and he wakes up feeling apprehensive about the important game, how will a peak-flow measurement be of help?", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "uə:plid) pue emitsA :piqoT leipadc", "bbox": [546.0, 60.0, 569.0, 288.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "been shown to improve a child's asthma control, reduce", "bbox": [69.0, 68.0, 427.0, 87.0]}, {"text": "exacerbations, and decrease school absences. Using a", "bbox": [70.0, 88.0, 427.0, 108.0]}, {"text": "peak-flow monitor may also increase your child's confi-", "bbox": [69.0, 108.0, 425.0, 128.0]}, {"text": "dence as it will help him or her learn how to optimize", "bbox": [69.0, 128.0, 427.0, 148.0]}, {"text": "asthma control and achieve greater mastery over his or", "bbox": [69.0, 149.0, 427.0, 168.0]}, {"text": "her asthma. Most children can accurately measure their", "bbox": [69.0, 169.0, 427.0, 187.0]}, {"text": "peak flow under adult guidance starting at about 6 years", "bbox": [69.0, 189.0, 427.0, 207.0]}, {"text": "of age. Measurement of peak flow is an assessment of", "bbox": [69.0, 209.0, 429.0, 228.0]}, {"text": "lung function, more precisely, of airflow through larger", "bbox": [69.0, 228.0, 427.0, 248.0]}, {"text": "airways (discussed in Question 28). Peak-flow monitor-", "bbox": [69.0, 248.0, 426.0, 268.0]}, {"text": "ing also allows for objective decisions about modifying", "bbox": [69.0, 267.0, 427.0, 289.0]}, {"text": "your child's asthma regimen if appropriate, based on", "bbox": [69.0, 288.0, 427.0, 308.0]}, {"text": "information contained in the written asthma action plan", "bbox": [69.0, 308.0, 427.0, 328.0]}, {"text": "your physician has provided.", "bbox": [69.0, 329.0, 252.0, 347.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "When your child is given a prescription for home peak-", "bbox": [70.0, 368.0, 425.0, 388.0]}, {"text": "flow monitoring, you will be asked to determine his or", "bbox": [69.0, 388.0, 427.0, 408.0]}, {"text": "her \"personal best\" value based on measurements", "bbox": [69.0, 408.0, 427.0, 429.0]}, {"text": "obtained when your child feels well and is symptom-", "bbox": [69.0, 428.0, 426.0, 447.0]}, {"text": "free. An asthma action plan provides instructions on", "bbox": [69.0, 448.0, 428.0, 467.0]}, {"text": "what asthma medication to take as the peak-flow value", "bbox": [70.0, 468.0, 427.0, 488.0]}, {"text": "falls into one of three zones labeled \"green,\" \"yellow,\" or", "bbox": [69.0, 488.0, 427.0, 509.0]}, {"text": "\"red.\" The green zone includes peak-flow measure-", "bbox": [70.0, 509.0, 425.0, 527.0]}, {"text": "ments in the range of 80% to 100% of a child's personal", "bbox": [70.0, 529.0, 428.0, 547.0]}, {"text": "best. Yellow corresponds to peak-flow measurements in", "bbox": [69.0, 548.0, 427.0, 568.0]}, {"text": "the range of 60% to 80% of the personal best value. The", "bbox": [70.0, 568.0, 426.0, 588.0]}, {"text": "red zone includes all peak flow values below 60% of a", "bbox": [69.0, 588.0, 427.0, 608.0]}, {"text": "child's personal best. Peak-flow measurements in the", "bbox": [69.0, 608.0, 427.0, 627.0]}, {"text": "red zone indicate that the child's asthma is poorly con-", "bbox": [70.0, 629.0, 426.0, 648.0]}, {"text": "trolled, and that you will need to either contact your", "bbox": [70.0, 648.0, 427.0, 668.0]}, {"text": "physician, proceed to the emergency room, or both. So,", "bbox": [70.0, 668.0, 427.0, 688.0]}, {"text": "if your 10-year-old child with asthma is scheduled to", "bbox": [69.0, 689.0, 427.0, 708.0]}, {"text": "play in a soccer match on Saturday morning and he", "bbox": [69.0, 709.0, 427.0, 728.0]}, {"text": "wakes up feeling apprehensive about the important", "bbox": [69.0, 729.0, 427.0, 748.0]}, {"text": "game, how will a peak-flow measurement be of help?", "bbox": [69.0, 748.0, 426.0, 768.0]}], "type": "Text", "position": 3}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 202}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": "无关文本#0#0#正文并没出现的内容，可能是页眉的内容没有识别出来", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:04:42"}
{"id": 1041985, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "3538f3df-d69f-4ff0-9775-0d5029f61a55", "title": null, "text": "【0】页码:159\n excess weight on your frame, it literally \"feels\" as if you are transporting additional pounds as you walk around.\n\n【1】How can you tell whether you or your child are obese?\n\n【2】An obese adult is, by definition, a person who weighs 30% or more above their predicted or ideal body weight. One useful and handy formula for calculating an adult's ideal body weight requires knowledge of your height. Females are allowed 100 pounds for the first 5 feet of height, and 5 more pounds for each additional inch above 5 feet. A few additional pounds are added or subtracted for persons with large or small frames. So, a 5'3\" woman should ideally weigh about 115 pounds. The formula for men is similar: A man is allowed 106 pounds for \"the first\" 5 feet of height, and 6 additional pounds are added for every additional inch over 5 feet. A 6-foot tall man of average build would thus be expected to weigh 178 pounds. As for women, there is a correction for individuals with small and large frames.\n\n【3】 Ideal body weight for children is best determined by computation of the body mass index (BMI). BMI is a measure that can also be used in adults. Assessment of BMI requires accurate measurement of height and weight, ideally in meters and kilograms. The BMI is the weight (in kilograms) divided by the square of the height (in meters). You will need to obtain a table of predicted BMI for any age to compare your child's BMI to the standard. A child with a BMI greater or equal to the 95th percentile for his or her age is considered obese. If you prefer not to do the math, there are several clever Web sites that ask you to enter data such as your weight, height, and age, and then calculate your ideal body weight and BMI for you. Simply go to your preferred search engine, and type a phrase such as: \"ideal body weight cal-", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "excess weight on your frame, it literally \"feels\" as if you", "bbox": [150.0, 69.0, 507.0, 87.0]}, {"text": "are transporting additional pounds as you walk around.", "bbox": [150.0, 89.0, 507.0, 108.0]}, {"text": "How can you tell whether you or your child are obese?", "bbox": [150.0, 109.0, 507.0, 128.0]}, {"text": "An obese adult is, by definition, a person who weighs", "bbox": [150.0, 129.0, 508.0, 148.0]}, {"text": "30% or more above their predicted or ideal body", "bbox": [150.0, 149.0, 507.0, 167.0]}, {"text": "weight. One useful and handy formula for calculating", "bbox": [150.0, 169.0, 507.0, 187.0]}, {"text": "an adult's ideal body weight requires knowledge of", "bbox": [150.0, 189.0, 508.0, 208.0]}, {"text": "your height. Females are allowed 100 pounds for the", "bbox": [150.0, 209.0, 507.0, 228.0]}, {"text": "first 5 feet of height, and 5 more pounds for each addi-", "bbox": [149.0, 229.0, 506.0, 248.0]}, {"text": "tional inch above 5 feet. A few additional pounds are", "bbox": [150.0, 249.0, 507.0, 267.0]}, {"text": "added or subtracted for persons with large or small", "bbox": [150.0, 269.0, 507.0, 288.0]}, {"text": "frames. So, a 5'3\" woman should ideally weigh about", "bbox": [150.0, 289.0, 507.0, 308.0]}, {"text": "115 pounds. The formula for men is similar: A man is", "bbox": [151.0, 308.0, 507.0, 329.0]}, {"text": "allowed 106 pounds for \"the first\" 5 feet of height, and", "bbox": [150.0, 329.0, 507.0, 348.0]}, {"text": "6 additional pounds are added for every additional", "bbox": [150.0, 349.0, 507.0, 367.0]}, {"text": "inch over 5 feet. A 6-foot tall man of average build", "bbox": [149.0, 369.0, 507.0, 388.0]}, {"text": "would thus be expected to weigh 178 pounds. As for", "bbox": [150.0, 389.0, 507.0, 408.0]}, {"text": "women, there is a correction for individuals with small", "bbox": [150.0, 409.0, 507.0, 427.0]}, {"text": "and large frames.", "bbox": [150.0, 429.0, 264.0, 448.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Ideal body weight for children is best determined by", "bbox": [150.0, 469.0, 506.0, 488.0]}, {"text": "computation of the body mass index (BMI). BMI is a", "bbox": [150.0, 489.0, 507.0, 508.0]}, {"text": "measure that can also be used in adults. Assessment of", "bbox": [150.0, 509.0, 509.0, 527.0]}, {"text": "BMI requires accurate measurement of height and", "bbox": [150.0, 529.0, 507.0, 547.0]}, {"text": "weight, ideally in meters and kilograms. The BMI is the", "bbox": [150.0, 549.0, 507.0, 568.0]}, {"text": "weight (in kilograms) divided by the square of the height", "bbox": [150.0, 569.0, 507.0, 588.0]}, {"text": "(in meters). You will need to obtain a table of predicted", "bbox": [149.0, 589.0, 507.0, 608.0]}, {"text": "BMI for any age to compare your child's BMI to the", "bbox": [150.0, 609.0, 506.0, 627.0]}, {"text": "standard. A child with a BMI greater or equal to the 95th", "bbox": [150.0, 629.0, 507.0, 648.0]}, {"text": "percentile for his or her age is considered obese. If you", "bbox": [150.0, 649.0, 507.0, 668.0]}, {"text": "prefer not to do the math, there are several clever Web", "bbox": [150.0, 669.0, 507.0, 688.0]}, {"text": "sites that ask you to enter data such as your weight,", "bbox": [150.0, 689.0, 507.0, 707.0]}, {"text": "height, and age, and then calculate your ideal body weight", "bbox": [150.0, 709.0, 507.0, 727.0]}, {"text": "and BMI for you. Simply go to your preferred search", "bbox": [150.0, 729.0, 507.0, 748.0]}, {"text": "engine, and type a phrase such as: \"ideal body weight cal-", "bbox": [150.0, 749.0, 505.0, 768.0]}], "type": "Text", "position": 2}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 159}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:49:07"}
{"id": 1041984, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "841bd086-8be6-4c26-80b6-529d32d6b356", "title": null, "text": "【0】页码:226\n and the mesial stop is closed, then the distal stop is closed against the brace of the first premolar; the first premolars must be anchored with a transpalatine arch or a Nance button. This is going to act as anchorage reinforcement. In occasions this button is going to extend all the way to the palatine aspects of the inci¬ sors like an anterior bite plane. (25.32.47)\n Fig. 20. Bio force arch with two kwik stops (mesial and distal).\n Figs. 21 and 22. Active super elastic NiTi arch that is going to distalize the first upper left molar.\n Figs. 23 and 24. Anchorage with a direct bond transpalatine arch laced with steel wire ligature from the molar to the second premolar.\n\n【1】 \n\n【2】 r\n\n【3】 state", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "and the mesial stop is closed, then the distal stop is", "bbox": [91.0, 84.0, 381.0, 102.0]}, {"text": "closed against the brace of the first premolar; the first", "bbox": [90.0, 102.0, 381.0, 119.0]}, {"text": "premolars must be anchored with a transpalatine arch", "bbox": [91.0, 119.0, 381.0, 137.0]}, {"text": "or a Nance button. This is going to act as anchorage", "bbox": [90.0, 137.0, 380.0, 154.0]}, {"text": "reinforcement. In occasions this button is going to", "bbox": [91.0, 156.0, 381.0, 171.0]}, {"text": "extend all the way to the palatine aspects of the inci¬", "bbox": [91.0, 173.0, 380.0, 191.0]}, {"text": "sors like an anterior bite plane. (25.32.47)", "bbox": [91.0, 193.0, 297.0, 209.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Fig. 20. Bio force arch with two kwik stops (mesial and distal).", "bbox": [88.0, 524.0, 361.0, 539.0]}], "type": "Caption", "position": 5}, {"raw_context": [{"text": "Figs. 21 and 22. Active super elastic NiTi arch that is going", "bbox": [405.0, 579.0, 666.0, 596.0]}, {"text": "to distalize the first upper left molar.", "bbox": [405.0, 595.0, 568.0, 610.0]}], "type": "Caption", "position": 7}, {"raw_context": [{"text": "Figs. 23 and 24. Anchorage with a direct bond transpalatine arch laced with steel wire", "bbox": [91.0, 943.0, 469.0, 957.0]}, {"text": "ligature from the molar to the second premolar.", "bbox": [256.0, 956.0, 469.0, 972.0]}], "type": "Caption", "position": 9}, {"raw_context": [{"text": "", "bbox": [226.0, 1083.0, 236.0, 1096.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "r", "bbox": [725.0, 1084.0, 735.0, 1095.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "state", "bbox": [730.0, 1093.0, 745.0, 1104.0]}], "type": "Text", "position": 13}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 226}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "标点错误#0#0#inci¬ 应该去掉¬ ", "type3": "无关文本#0#0#(25.32.47)\n无关文本#2#3#都是原文找不到的内容 r  state", "type4": null, "type5": null, "type6": "有用性#0#0#Fig. 20. Bio force arch with two kwik...ligature from the molar to the second premolar.关于图片的描述"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:33:20"}
{"id": 1041983, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "84a03125-79c0-4a01-8e66-9734dadbdc55", "title": null, "text": "【0】页码:261\n airway obstruction, poor lung compliance, or the rescuer has difficulty in creating a tight mask-to-face seal. 57. 58 One rescuer uses both hands to maintain an open airway with a jaw thrust and a tight mask-to-face seal while the other compresses the ventilation bag. Both rescuers should observe the victim's chest to ensure chest rise.\n\n【1】## Gastric Inflation\n\n【2】\n Gastric inflation may interfere with effective ventilation 59 and cause regurgitation, aspiration of stomach contents, and further ventilatory compromise. The risk of gastric inflation can be decreased by\n • Avoiding excessive peak inspiratory pressures by ventilating slowly and giving only enough tidal volume to just achieve visible chest rise. 45 • Applying cricoid pressure in an unresponsive victim to reduce air entry into the stomach (Class IIa, LOE B). 60–62 This may require a third rescuer if cricoid pressure cannot be applied by the rescuer who is securing the bag to the face. Avoid excessive cricoid pressure so as not to obstruct the trachea (Class III, LOE B). 63 • Passing a nasogastric or orogastric tube to relieve gastric inflation, especially if oxygenation and ventilation are\n\n【3】 compromised. Pass the tube after intubation because a gastric tube interferes with gastroesophageal sphincter function, allowing regurgitation during intubation. If a gastrostomy tube is present, vent it during bag-mask ventilation to allow gastric decompression.\n\n【4】## Ventilation With An Endotracheal Tube\n\n【5】\n Endotracheal intubation in infants and children requires special training because the pediatric airway anatomy differs from that of the adult. The likelihood of successful endotracheal tube placement with minimal complications is related to the length of training, supervised experience in the operating room and in the field, 64.65 adequate ongoing experience, 66 and use of rapid sequence intubation (RSI). 67.68\n\n【6】## Rapid Sequence Intubation (Rsi)\n\n【7】\n To facilitate emergency intubation and reduce the incidence of complications, skilled, experienced providers may use sedatives, neuromuscular blocking agents, and other medications to rapidly sedate and neuromuscularly block the pediatric patient. 69 Use RSI only if you are trained, and have experience using these medications and are proficient in the evaluation and management of the pediatric airway. If you use RSI you must have a secondary plan to manage the airway in the event that you cannot achieve intubation.\n\n【8】Actual body weight, rather than ideal body weight, should be used for some non-resuscitation medications (eg, succinylcholine). 70–85\n\n【9】## Cricoid Pressure During Intubation\n\n【10】\n There is insufficient evidence to recommend routine cricoid pressure application to prevent aspiration during endotracheal intubation in children. Do not continue cricoid pressure if it interferes with ventilation or the speed or ease of intubation (Class III, LOE C).86,87\n\n【11】## Cuffed Versus Uncuffed Endotracheal Tubes\n\n【12】\n Both cuffed and uncuffed endotracheal tubes are acceptable for intubating infants and children (Class IIa, LOE C). In the operating room, cuffed endotracheal tubes are associated with a higher likelihood of correct selection of tube size, thus achieving a lower reintubation rate with no increased risk of perioperative complications. 88– 90 In intensive care settings the risk of complications in infants and in children is no greater with cuffed tubes than with noncuffed tubes. 91–93 Cuffed endotracheal tubes may decrease the risk of aspiration. 94 If cuffed endotracheal tubes are used, cuff inflating pressure should be monitored and limited according to manufacturer's instruction (usually less than 20 to 25 cm H 2 O).\n\n【13】In certain circumstances (eg, poor lung compliance, high airway resistance, or a large glottic air leak) a cuffed endotracheal tube may be preferable to an uncuffed tube, provided that attention is paid to endotracheal tube size, position, and cuff inflation pressure (Class IIa, LOE B).88,91,92\n\n【14】## Endotracheal Tube Size\n\n【15】\n Length-based resuscitation tapes are helpful and more accurate than age-based formula estimates of endotracheal tube size for children up to approximately 35 kg, 77 . 95 . 96 even for children with short stature. 97 In preparation for intubation with either a cuffed or an uncuffed endotracheal tube, confirm that tubes with an internal diameter (ID) 0.5  mm smaller and 0.5  mm larger than the estimated size are available. During intubation, if the endotracheal tube meets resistance, place a tube 0.5 mm smaller instead.\n\n【16】Following intubation, if there is a large glottic air leak that interferes with oxygenation or ventilation, consider replacing the tube with one that is 0.5 mm larger, or place a cuffed tube of the same size if an uncuffed tube was used originally. Note that replacement of a functional endotracheal tube is associated with risk; the procedure should be undertaken in an appropriate setting by experienced personnel.\n\n【17】If an uncuffed endotracheal tube is used for emergency intubation, it is reasonable to select a 3.5-mm ID tube for infants up to one year of age and a 4.0-mm ID tube for patients between 1 and 2 years of age. After age 2, uncuffed endotracheal tube size can be estimated by the following formula:\n\n【18】## Uncuffed Endotracheal Tube Id (Mm)=4+(Age/4)\n\n【19】\n If a cuffed tube is used for emergency intubation of an infant less than 1 year of age, it is reasonable to select a 3.0 mm ID tube. For children between 1 and 2 years of age, it is reasonable to use a cuffed endotracheal tube with an internal diameter of 3.5 mm (Class IIa, LOE B). 89.98–100 After age 2 it is reasonable to estimate tube size with the following formula (Class IIa, LOE B: 89,98–101 ):\n\n【20】 Cuffed endotracheal tube ID (mm)=3.5+(age/4)\n\n【21】## Verification Of Endotracheal Tube Placement\n\n【22】\n There is a risk of endotracheal tube misplacement (ie, in the esophagus, the pharynx above the vocal cords, or a mainstem bronchus) and an ongoing risk of displacement or obstruction, 45 . 102 especially during patient transport. 103 Since no single confirmation technique, including clinical signs104 or\n\n【23】 Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "airway obstruction, poor lung compliance, or the rescuer has", "bbox": [60.0, 84.0, 376.0, 99.0]}, {"text": "difficulty in creating a tight mask-to-face seal. 57. 58 One", "bbox": [60.0, 100.0, 376.0, 113.0]}, {"text": "rescuer uses both hands to maintain an open airway with a", "bbox": [60.0, 115.0, 376.0, 129.0]}, {"text": "jaw thrust and a tight mask-to-face seal while the other", "bbox": [60.0, 131.0, 376.0, 145.0]}, {"text": "compresses the ventilation bag. Both rescuers should observe", "bbox": [60.0, 146.0, 376.0, 160.0]}, {"text": "the victim's chest to ensure chest rise.", "bbox": [60.0, 161.0, 261.0, 175.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Gastric Inflation", "bbox": [60.0, 190.0, 165.0, 204.0]}], "type": "Section-header", "position": 4}, {"raw_context": [{"text": "Gastric inflation may interfere with effective ventilation 59 and", "bbox": [60.0, 205.0, 377.0, 219.0]}, {"text": "cause regurgitation, aspiration of stomach contents, and", "bbox": [60.0, 220.0, 377.0, 234.0]}, {"text": "further ventilatory compromise. The risk of gastric inflation", "bbox": [60.0, 236.0, 376.0, 250.0]}, {"text": "can be decreased by", "bbox": [60.0, 251.0, 168.0, 266.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "• Avoiding excessive peak inspiratory pressures by ventilat-", "bbox": [60.0, 277.0, 375.0, 291.0]}, {"text": "ing slowly and giving only enough tidal volume to just", "bbox": [71.0, 293.0, 377.0, 307.0]}, {"text": "achieve visible chest rise. 45", "bbox": [72.0, 308.0, 216.0, 321.0]}, {"text": "• Applying cricoid pressure in an unresponsive victim to", "bbox": [60.0, 323.0, 376.0, 337.0]}, {"text": "reduce air entry into the stomach (Class IIa, LOE B). 60–62", "bbox": [71.0, 338.0, 375.0, 353.0]}, {"text": "This may require a third rescuer if cricoid pressure cannot", "bbox": [73.0, 354.0, 376.0, 368.0]}, {"text": "be applied by the rescuer who is securing the bag to the", "bbox": [71.0, 369.0, 376.0, 383.0]}, {"text": "face. Avoid excessive cricoid pressure so as not to obstruct", "bbox": [72.0, 385.0, 376.0, 399.0]}, {"text": "the trachea (Class III, LOE B). 63", "bbox": [71.0, 400.0, 245.0, 414.0]}, {"text": "• Passing a nasogastric or orogastric tube to relieve gastric", "bbox": [60.0, 415.0, 376.0, 429.0]}, {"text": "inflation, especially if oxygenation and ventilation are", "bbox": [72.0, 431.0, 375.0, 444.0]}], "type": "List-item", "position": 6}, {"raw_context": [{"text": "compromised. Pass the tube after intubation because a", "bbox": [71.0, 446.0, 377.0, 461.0]}, {"text": "gastric tube interferes with gastroesophageal sphincter", "bbox": [72.0, 462.0, 376.0, 475.0]}, {"text": "function, allowing regurgitation during intubation. If a", "bbox": [72.0, 477.0, 377.0, 491.0]}, {"text": "gastrostomy tube is present, vent it during bag-mask", "bbox": [72.0, 493.0, 375.0, 507.0]}, {"text": "ventilation to allow gastric decompression.", "bbox": [73.0, 508.0, 297.0, 522.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Ventilation With an Endotracheal Tube", "bbox": [60.0, 536.0, 307.0, 551.0]}], "type": "Section-header", "position": 8}, {"raw_context": [{"text": "Endotracheal intubation in infants and children requires", "bbox": [60.0, 552.0, 376.0, 566.0]}, {"text": "special training because the pediatric airway anatomy differs", "bbox": [60.0, 567.0, 376.0, 581.0]}, {"text": "from that of the adult. The likelihood of successful endotra-", "bbox": [60.0, 582.0, 375.0, 596.0]}, {"text": "cheal tube placement with minimal complications is related to", "bbox": [60.0, 598.0, 376.0, 611.0]}, {"text": "the length of training, supervised experience in the operating", "bbox": [60.0, 613.0, 375.0, 628.0]}, {"text": "room and in the field, 64.65 adequate ongoing experience, 66 and", "bbox": [60.0, 629.0, 376.0, 642.0]}, {"text": "use of rapid sequence intubation (RSI). 67.68", "bbox": [60.0, 643.0, 287.0, 657.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Rapid Sequence Intubation (RSI)", "bbox": [60.0, 672.0, 267.0, 687.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "To facilitate emergency intubation and reduce the incidence", "bbox": [61.0, 688.0, 376.0, 702.0]}, {"text": "of complications, skilled, experienced providers may use", "bbox": [60.0, 703.0, 376.0, 717.0]}, {"text": "sedatives, neuromuscular blocking agents, and other medica-", "bbox": [60.0, 718.0, 375.0, 732.0]}, {"text": "tions to rapidly sedate and neuromuscularly block the pedi-", "bbox": [60.0, 734.0, 375.0, 748.0]}, {"text": "atric patient. 69", "bbox": [60.0, 749.0, 135.0, 763.0]}, {"text": "Use RSI only if you are trained, and have experience using", "bbox": [72.0, 764.0, 375.0, 778.0]}, {"text": "these medications and are proficient in the evaluation and", "bbox": [60.0, 780.0, 376.0, 794.0]}, {"text": "management of the pediatric airway. If you use RSI you must", "bbox": [60.0, 796.0, 376.0, 809.0]}, {"text": "have a secondary plan to manage the airway in the event that", "bbox": [60.0, 810.0, 376.0, 824.0]}, {"text": "you cannot achieve intubation.", "bbox": [60.0, 825.0, 222.0, 840.0]}, {"text": "Actual body weight, rather than ideal body weight,", "bbox": [73.0, 841.0, 376.0, 855.0]}, {"text": "should be used for some non-resuscitation medications (eg,", "bbox": [60.0, 856.0, 376.0, 870.0]}, {"text": "succinylcholine). 70–85", "bbox": [60.0, 871.0, 179.0, 885.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Cricoid Pressure During Intubation", "bbox": [60.0, 901.0, 282.0, 915.0]}], "type": "Section-header", "position": 12}, {"raw_context": [{"text": "There is insufficient evidence to recommend routine cricoid", "bbox": [61.0, 916.0, 377.0, 930.0]}, {"text": "pressure application to prevent aspiration during endotracheal", "bbox": [60.0, 931.0, 377.0, 945.0]}, {"text": "intubation in children. Do not continue cricoid pressure if it", "bbox": [60.0, 946.0, 376.0, 960.0]}, {"text": "interferes with ventilation or the speed or ease of intubation", "bbox": [60.0, 962.0, 376.0, 976.0]}, {"text": "(Class III, LOE C).86,87", "bbox": [60.0, 977.0, 183.0, 991.0]}], "type": "Text", "position": 13}, {"raw_context": [{"text": "Cuffed Versus Uncuffed Endotracheal Tubes", "bbox": [403.0, 84.0, 683.0, 99.0]}], "type": "Section-header", "position": 14}, {"raw_context": [{"text": "Both cuffed and uncuffed endotracheal tubes are acceptable", "bbox": [404.0, 100.0, 720.0, 113.0]}, {"text": "for intubating infants and children (Class IIa, LOE C). In the", "bbox": [403.0, 115.0, 720.0, 129.0]}, {"text": "operating room, cuffed endotracheal tubes are associated with", "bbox": [403.0, 132.0, 720.0, 145.0]}, {"text": "a higher likelihood of correct selection of tube size, thus", "bbox": [403.0, 147.0, 720.0, 160.0]}, {"text": "achieving a lower reintubation rate with no increased risk of", "bbox": [404.0, 162.0, 721.0, 176.0]}, {"text": "perioperative complications. 88– 90 In intensive care settings the", "bbox": [403.0, 178.0, 720.0, 191.0]}, {"text": "risk of complications in infants and in children is no greater", "bbox": [403.0, 193.0, 720.0, 207.0]}, {"text": "with cuffed tubes than with noncuffed tubes. 91–93 Cuffed", "bbox": [403.0, 209.0, 720.0, 223.0]}, {"text": "endotracheal tubes may decrease the risk of aspiration. 94 If", "bbox": [403.0, 225.0, 721.0, 239.0]}, {"text": "cuffed endotracheal tubes are used, cuff inflating pressure", "bbox": [403.0, 240.0, 720.0, 254.0]}, {"text": "should be monitored and limited according to manufacturer's", "bbox": [403.0, 255.0, 720.0, 269.0]}, {"text": "instruction (usually less than 20 to 25 cm H 2 O).", "bbox": [403.0, 271.0, 657.0, 285.0]}, {"text": "In certain circumstances (eg, poor lung compliance, high", "bbox": [416.0, 287.0, 721.0, 301.0]}, {"text": "airway resistance, or a large glottic air leak) a cuffed", "bbox": [404.0, 302.0, 721.0, 315.0]}, {"text": "endotracheal tube may be preferable to an uncuffed tube,", "bbox": [403.0, 317.0, 720.0, 332.0]}, {"text": "provided that attention is paid to endotracheal tube size,", "bbox": [404.0, 334.0, 720.0, 347.0]}, {"text": "position, and cuff inflation pressure (Class IIa, LOE B).88,91,92", "bbox": [403.0, 348.0, 720.0, 363.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "Endotracheal Tube Size", "bbox": [404.0, 377.0, 553.0, 392.0]}], "type": "Section-header", "position": 16}, {"raw_context": [{"text": "Length-based resuscitation tapes are helpful and more accu-", "bbox": [403.0, 393.0, 719.0, 407.0]}, {"text": "rate than age-based formula estimates of endotracheal tube", "bbox": [403.0, 408.0, 720.0, 422.0]}, {"text": "size for children up to approximately 35 kg, 77 . 95 . 96 even for", "bbox": [403.0, 424.0, 720.0, 438.0]}, {"text": "children with short stature. 97", "bbox": [403.0, 439.0, 555.0, 454.0]}, {"text": "In preparation for intubation with either a cuffed or an", "bbox": [416.0, 455.0, 721.0, 468.0]}, {"text": "uncuffed endotracheal tube, confirm that tubes with an internal", "bbox": [404.0, 470.0, 720.0, 485.0]}, {"text": "diameter (ID) 0.5  mm smaller and 0.5  mm larger than the", "bbox": [403.0, 487.0, 720.0, 500.0]}, {"text": "estimated size are available. During intubation, if the endotra-", "bbox": [403.0, 501.0, 719.0, 515.0]}, {"text": "cheal tube meets resistance, place a tube 0.5 mm smaller instead.", "bbox": [403.0, 517.0, 719.0, 531.0]}, {"text": "Following intubation, if there is a large glottic air leak that", "bbox": [403.0, 533.0, 720.0, 547.0]}, {"text": "interferes with oxygenation or ventilation, consider replacing the", "bbox": [403.0, 548.0, 720.0, 562.0]}, {"text": "tube with one that is 0.5 mm larger, or place a cuffed tube of the", "bbox": [403.0, 564.0, 720.0, 578.0]}, {"text": "same size if an uncuffed tube was used originally. Note that", "bbox": [404.0, 580.0, 720.0, 594.0]}, {"text": "replacement of a functional endotracheal tube is associated with", "bbox": [403.0, 595.0, 720.0, 608.0]}, {"text": "risk; the procedure should be undertaken in an appropriate", "bbox": [403.0, 610.0, 720.0, 624.0]}, {"text": "setting by experienced personnel.", "bbox": [403.0, 626.0, 572.0, 640.0]}, {"text": "If an uncuffed endotracheal tube is used for emergency", "bbox": [416.0, 642.0, 720.0, 655.0]}, {"text": "intubation, it is reasonable to select a 3.5-mm ID tube for infants", "bbox": [404.0, 657.0, 720.0, 670.0]}, {"text": "up to one year of age and a 4.0-mm ID tube for patients between", "bbox": [403.0, 672.0, 720.0, 687.0]}, {"text": "1 and 2 years of age. After age 2, uncuffed endotracheal tube", "bbox": [404.0, 689.0, 720.0, 702.0]}, {"text": "size can be estimated by the following formula:", "bbox": [403.0, 703.0, 644.0, 717.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Uncuffed endotracheal tube ID (mm)=4+(age/4)", "bbox": [429.0, 728.0, 696.0, 742.0]}], "type": "Section-header", "position": 18}, {"raw_context": [{"text": "If a cuffed tube is used for emergency intubation of an infant", "bbox": [403.0, 752.0, 721.0, 767.0]}, {"text": "less than 1 year of age, it is reasonable to select a 3.0 mm ID", "bbox": [403.0, 768.0, 721.0, 782.0]}, {"text": "tube. For children between 1 and 2 years of age, it is", "bbox": [403.0, 783.0, 721.0, 796.0]}, {"text": "reasonable to use a cuffed endotracheal tube with an internal", "bbox": [403.0, 798.0, 720.0, 812.0]}, {"text": "diameter of 3.5 mm (Class IIa, LOE B). 89.98–100 After age 2 it", "bbox": [403.0, 814.0, 721.0, 827.0]}, {"text": "is reasonable to estimate tube size with the following formula", "bbox": [403.0, 829.0, 721.0, 843.0]}, {"text": "(Class IIa, LOE B: 89,98–101 ):", "bbox": [403.0, 845.0, 551.0, 858.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "Cuffed endotracheal tube ID (mm)=3.5+(age/4)", "bbox": [429.0, 869.0, 695.0, 883.0]}], "type": "Text", "position": 20}, {"raw_context": [{"text": "Verification of Endotracheal Tube Placement", "bbox": [404.0, 900.0, 685.0, 914.0]}], "type": "Section-header", "position": 21}, {"raw_context": [{"text": "There is a risk of endotracheal tube misplacement (ie, in the", "bbox": [404.0, 916.0, 720.0, 929.0]}, {"text": "esophagus, the pharynx above the vocal cords, or a mainstem", "bbox": [403.0, 930.0, 721.0, 944.0]}, {"text": "bronchus) and an ongoing risk of displacement or obstruc-", "bbox": [403.0, 946.0, 719.0, 960.0]}, {"text": "tion, 45 . 102 especially during patient transport. 103 Since no", "bbox": [403.0, 962.0, 721.0, 976.0]}, {"text": "single confirmation technique, including clinical signs104 or", "bbox": [404.0, 977.0, 720.0, 991.0]}], "type": "Text", "position": 22}, {"raw_context": [{"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [202.0, 1002.0, 575.0, 1016.0]}], "type": "Text", "position": 23}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 261}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#2#2# • Applying cricoid pressure...\n• Passing a nasogastric or orogastric ...都另起一行\n多余换行#3#3# compromised. Pass the tube after intubation because...与上面第二段最后内容联接\n缺少换行#7#7#Use RSI only if you are trained, ...另起一行\n缺少换行#15#15#In preparation for intubation with either...另起一行", "type3": "无关文本#2#22#60–62 This may require a third ...\n...trachea (Class III, LOE B). 63像这样在.号或，号的开头或结尾出现的数字都是无关引用\n无关文本#23#23#属于页脚的内容，和正文无关", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 00:01:29"}
{"id": 1041982, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "4073cbf7-01cf-422e-a233-0ecad4240871", "title": null, "text": "【0】页码:325\n Fig. 61. Spring aligner in mouth.\n\n【1】## Advantages\n\n【2】\n## 1.\n\n【3】\n 2.\n\n【4】3.\n\n【5】4.\n\n【6】 Hygienic.\n\n【7】It allows the use of dental floss.\n\n【8】Does not cause caries or periodontal problems.\n\n【9】Well made retainers can correct rebound in 2 to 3 months.\n\n【10】It allows syndesmothomy.\n\n【11】It is lasting. (4,11,26)\n\n【12】 5.\n\n【13】6.\n\n【14】## Disadvantages\n\n【15】\n 1.\n\n【16】2.\n\n【17】3, 4.\n\n【18】5.\n\n【19】 Not very esthetic.\n\n【20】We depend upon patient cooperation.\n\n【21】It can absorb foul odors and change color.\n\n【22】We must invest laboratory time.\n\n【23】The wires that pass over the incisal edges can interfere with the occlusion and not allow settlement of the posterior teeth.\n\n【24】## Recommendations\n\n【25】\n 1.\n\n【26】 2.\n\n【27】 3.\n\n【28】4.\n\n【29】5.\n\n【30】 Must be worn all day and night during the first two or three weeks. Later it may be worn only at night.\n\n【31】At the moment of insertion of the spring aligner, it will move toward the incisal edge. This is the reason why the patient must bite down on the retainer the first two or three weeks.\n\n【32】Perform stripping in the anterior segment to acceler¬ ate dental movement.\n\n【33】Take off the retainer by pulling the loops on the canines.\n\n【34】Put the spring aligner in a glass of water or mouth wash during meal time. This will diminish foul odor absorption.\n Figs. 59 and 60. Spring aligner.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Fig. 61. Spring aligner in mouth.", "bbox": [489.0, 323.0, 632.0, 338.0]}], "type": "Caption", "position": 4}, {"raw_context": [{"text": "Advantages", "bbox": [404.0, 374.0, 490.0, 391.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "1.", "bbox": [405.0, 409.0, 418.0, 424.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "2.", "bbox": [404.0, 426.0, 417.0, 442.0]}, {"text": "3.", "bbox": [404.0, 443.0, 417.0, 459.0]}, {"text": "4.", "bbox": [404.0, 461.0, 418.0, 477.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Hygienic.", "bbox": [430.0, 408.0, 485.0, 424.0]}, {"text": "It allows the use of dental floss.", "bbox": [430.0, 426.0, 604.0, 442.0]}, {"text": "Does not cause caries or periodontal problems.", "bbox": [430.0, 444.0, 692.0, 460.0]}, {"text": "Well made retainers can correct rebound in 2 to 3", "bbox": [431.0, 461.0, 719.0, 478.0]}, {"text": "months.", "bbox": [431.0, 479.0, 477.0, 494.0]}, {"text": "It allows syndesmothomy.", "bbox": [430.0, 495.0, 574.0, 511.0]}, {"text": "It is lasting. (4,11,26)", "bbox": [430.0, 512.0, 525.0, 529.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "5.", "bbox": [404.0, 495.0, 417.0, 511.0]}, {"text": "6.", "bbox": [403.0, 513.0, 417.0, 529.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Disadvantages", "bbox": [404.0, 545.0, 510.0, 565.0]}], "type": "Section-header", "position": 10}, {"raw_context": [{"text": "1.", "bbox": [404.0, 582.0, 417.0, 597.0]}, {"text": "2.", "bbox": [403.0, 598.0, 417.0, 615.0]}, {"text": "3,", "bbox": [404.0, 616.0, 417.0, 632.0]}, {"text": "4.", "bbox": [403.0, 633.0, 416.0, 650.0]}, {"text": "5.", "bbox": [403.0, 651.0, 417.0, 668.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "Not very esthetic.", "bbox": [430.0, 582.0, 530.0, 597.0]}, {"text": "We depend upon patient cooperation.", "bbox": [430.0, 599.0, 641.0, 616.0]}, {"text": "It can absorb foul odors and change color.", "bbox": [430.0, 617.0, 662.0, 633.0]}, {"text": "We must invest laboratory time.", "bbox": [430.0, 634.0, 609.0, 650.0]}, {"text": "The wires that pass over the incisal edges can interfere", "bbox": [430.0, 651.0, 719.0, 668.0]}, {"text": "with the occlusion and not allow settlement of the", "bbox": [430.0, 669.0, 718.0, 685.0]}, {"text": "posterior teeth.", "bbox": [430.0, 685.0, 518.0, 701.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Recommendations", "bbox": [403.0, 719.0, 534.0, 736.0]}], "type": "Section-header", "position": 13}, {"raw_context": [{"text": "1.", "bbox": [404.0, 757.0, 418.0, 772.0]}], "type": "Text", "position": 14}, {"raw_context": [{"text": "2.", "bbox": [402.0, 789.0, 417.0, 805.0]}], "type": "Text", "position": 15}, {"raw_context": [{"text": "3.", "bbox": [402.0, 859.0, 417.0, 875.0]}, {"text": "4.", "bbox": [402.0, 893.0, 416.0, 909.0]}, {"text": "5.", "bbox": [402.0, 910.0, 416.0, 927.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Must be worn all day and night during the first two", "bbox": [429.0, 755.0, 719.0, 772.0]}, {"text": "or three weeks. Later it may be worn only at night.", "bbox": [429.0, 772.0, 709.0, 788.0]}, {"text": "At the moment of insertion of the spring aligner, it", "bbox": [429.0, 789.0, 719.0, 806.0]}, {"text": "will move toward the incisal edge. This is the reason", "bbox": [429.0, 807.0, 718.0, 823.0]}, {"text": "why the patient must bite down on the retainer the", "bbox": [429.0, 824.0, 718.0, 841.0]}, {"text": "first two or three weeks.", "bbox": [429.0, 842.0, 565.0, 858.0]}, {"text": "Perform stripping in the anterior segment to acceler¬", "bbox": [429.0, 860.0, 716.0, 875.0]}, {"text": "ate dental movement.", "bbox": [429.0, 876.0, 552.0, 892.0]}, {"text": "Take off the retainer by pulling the loops on the canines.", "bbox": [430.0, 894.0, 710.0, 910.0]}, {"text": "Put the spring aligner in a glass of water or mouth", "bbox": [429.0, 911.0, 718.0, 927.0]}, {"text": "wash during meal time. This will diminish foul odor", "bbox": [429.0, 928.0, 717.0, 945.0]}, {"text": "absorption.", "bbox": [429.0, 944.0, 495.0, 963.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "Figs. 59 and 60. Spring aligner.", "bbox": [156.0, 931.0, 291.0, 946.0]}], "type": "Caption", "position": 20}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 325}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#2#13#序号和正文分离\n多余换行#15#23#序号和正文分离\n多余换行#25#34#序号和正文分离", "type3": "无关文本#0#0#Fig. 61. Spring aligner in mouth.\n无关文本#34#34#Figs. 59 and 60. Spring aligner.", "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-29 01:14:07"}
{"id": 1041981, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "d5cf12a5-b28c-43f2-806e-57074ac346d8", "title": null, "text": "【0】页码:101\n# Part 8: Adult Advanced Cardiovascular Life Support 2010 American Heart Association Guidelines For Cardiopulmonary Resuscitation And Emergency Cardiovascular Care\n\n【1】\n Robert W. Neumar, Chair; Charles W. Otto; Mark S. Link; Steven L. Kronick; Michael Shuster; Clifton W. Callaway; Peter J. Kudenchuk; Joseph P. Ornato; Bryan McNally; Scott M. Silvers; Rod S. Passman; Roger D. White; Erik P. Hess; Wanchun Tang; Daniel Davis; Elizabeth Sinz; Laurie J. Morrison\n\n【2】 A tiple key links in the chain of survival that include interventions to prevent cardiac arrest, treat cardiac arrest, and improve outcomes of patients who achieve return of spontaneous circulation (ROSC) after cardiac arrest. ACLS interventions aimed at preventing cardiac arrest include airway management, ventilation support, and treatment of bradyarrhythmias and tachyarrhythmias. For the treatment of cardiac arrest, ACLS interventions build on the basic life support (BLS) foundation of immediate recognition and activation of the emergency response system, early CPR, and rapid defibrillation to further increase the likelihood of ROSC with drug therapy, advanced airway management, and physiologic monitoring. Following ROSC, survival and neurologic outcome can be improved with integrated post–cardiac arrest care.\n\n【3】Part 8 presents the 2010 Adult ACLS Guidelines: 8.1: \"Adjuncts for Airway Control and Ventilation\"; 8.2: \"Management of Cardiac Arrest''; and 8.3: \"Management of Symptomatic Bradycardia and Tachycardia.\" Post–cardiac arrest interventions are addressed in Part 9: \"Post–Cardiac Arrest Care.\" Key changes from the 2005 ACLS Guidelines include\n\n【4】 • Continuous quantitative waveform capnography is recommended for confirmation and monitoring of endotracheal tube placement.\n\n【5】• Cardiac arrest algorithms are simplified and redesigned to emphasize the importance of high-quality CPR (including chest compressions of adequate rate and depth, allowing complete chest recoil after each compression, minimizing interruptions in chest compressions and avoiding excessive ventilation).\n\n【6】• Atropine is no longer recommended for routine use in the management of pulseless electrical activity (PEA)/asystole.\n\n【7】• There is an increased emphasis on physiologic monitoring to optimize CPR quality and detect ROSC.\n\n【8】• Chronotropic drug infusions are recommended as an alternative to pacing in symptomatic and unstable bradycardia.\n\n【9】 • Adenosine is recommended as a safe and potentially effective therapy in the initial management of stable undifferentiated regular monomorphic wide-complex\n tachycardia.\n\n【10】## Part 8.1: Adjuncts For Airway Control And Ventilation\n\n【11】\n## Overview Of Airway Management\n\n【12】\n This section highlights recommendations for the support of ventilation and oxygenation during CPR and the peri-arrest period. The purpose of ventilation during CPR is to maintain adequate oxygenation and sufficient elimination of carbon dioxide. However, research has not identified the optimal tidal volume, respiratory rate, and inspired oxygen concentration required during resuscitation from cardiac arrest.\n\n【13】Both ventilation and chest compressions are thought to be important for victims of prolonged ventricular fibrillation (VF) cardiac arrest and for all victims with other presenting rhythms. Because both systemic and pulmonary perfusion are substantially reduced during CPR, normal ventilationperfusion relationships can be maintained with a minute ventilation that is much lower than normal. During CPR with an advanced airway in place, a lower rate of rescue breathing is needed to avoid hyperventilation.\n\n【14】## Ventilation And Oxygen Administration During Cpr\n\n【15】\n During low blood flow states such as CPR, oxygen delivery to the heart and brain is limited by blood flow rather than by arterial oxygen content. 1.2 Therefore, rescue breaths are less important than chest compressions during the first few minutes of resuscitation from witnessed VF cardiac arrest and could reduce CPR efficacy due to interruption in chest compressions and the increase in intrathoracic pressure that accompanies positivepressure ventilation. Thus, during the first few minutes of witnessed cardiac arrest a lone rescuer should not interrupt chest\n The American Heart Association requests that this document be cited as follows: Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\n\n【16】Circulation. 2010;122(suppl 3):S729–S767.\n\n【17】( Circulation . 2010;122[suppl 3]:S729–S767.) © 2010 American Heart Association, Inc.\n\n【18】Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.110.970988", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Part 8: Adult Advanced Cardiovascular Life Support", "bbox": [100.0, 107.0, 683.0, 133.0]}, {"text": "2010 American Heart Association Guidelines for Cardiopulmonary", "bbox": [96.0, 138.0, 685.0, 160.0]}, {"text": "Resuscitation and Emergency Cardiovascular Care", "bbox": [167.0, 160.0, 615.0, 180.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "Robert W. Neumar, Chair; Charles W. Otto; Mark S. Link; Steven L. Kronick;", "bbox": [139.0, 196.0, 642.0, 213.0]}, {"text": "Michael Shuster; Clifton W. Callaway; Peter J. Kudenchuk; Joseph P. Ornato; Bryan McNally;", "bbox": [89.0, 213.0, 692.0, 231.0]}, {"text": "Scott M. Silvers; Rod S. Passman; Roger D. White; Erik P. Hess; Wanchun Tang;", "bbox": [128.0, 232.0, 653.0, 247.0]}, {"text": "Daniel Davis; Elizabeth Sinz; Laurie J. Morrison", "bbox": [234.0, 249.0, 546.0, 264.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "A tiple key links in the chain of survival that include", "bbox": [61.0, 290.0, 376.0, 321.0]}, {"text": "interventions to prevent cardiac arrest, treat cardiac arrest, and", "bbox": [60.0, 322.0, 376.0, 336.0]}, {"text": "improve outcomes of patients who achieve return of spontane-", "bbox": [60.0, 338.0, 375.0, 352.0]}, {"text": "ous circulation (ROSC) after cardiac arrest. ACLS interventions", "bbox": [60.0, 354.0, 375.0, 368.0]}, {"text": "aimed at preventing cardiac arrest include airway management,", "bbox": [60.0, 369.0, 375.0, 383.0]}, {"text": "ventilation support, and treatment of bradyarrhythmias and", "bbox": [60.0, 385.0, 376.0, 399.0]}, {"text": "tachyarrhythmias. For the treatment of cardiac arrest, ACLS", "bbox": [60.0, 401.0, 376.0, 414.0]}, {"text": "interventions build on the basic life support (BLS) foundation of", "bbox": [60.0, 415.0, 376.0, 429.0]}, {"text": "immediate recognition and activation of the emergency response", "bbox": [60.0, 431.0, 375.0, 444.0]}, {"text": "system, early CPR, and rapid defibrillation to further increase the", "bbox": [60.0, 447.0, 376.0, 461.0]}, {"text": "likelihood of ROSC with drug therapy, advanced airway man-", "bbox": [60.0, 462.0, 375.0, 476.0]}, {"text": "agement, and physiologic monitoring. Following ROSC, sur-", "bbox": [60.0, 478.0, 375.0, 492.0]}, {"text": "vival and neurologic outcome can be improved with integrated", "bbox": [60.0, 494.0, 376.0, 507.0]}, {"text": "post–cardiac arrest care.", "bbox": [60.0, 509.0, 182.0, 523.0]}, {"text": "Part 8 presents the 2010 Adult ACLS Guidelines: 8.1:", "bbox": [72.0, 524.0, 375.0, 538.0]}, {"text": "\"Adjuncts for Airway Control and Ventilation\"; 8.2: \"Manage-", "bbox": [61.0, 540.0, 375.0, 555.0]}, {"text": "ment of Cardiac Arrest''; and 8.3: \"Management of Symptomatic", "bbox": [60.0, 555.0, 375.0, 569.0]}, {"text": "Bradycardia and Tachycardia.\" Post–cardiac arrest interventions", "bbox": [60.0, 571.0, 376.0, 586.0]}, {"text": "are addressed in Part 9: \"Post–Cardiac Arrest Care.\"", "bbox": [60.0, 587.0, 322.0, 601.0]}, {"text": "Key changes from the 2005 ACLS Guidelines include", "bbox": [73.0, 602.0, 358.0, 616.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "• Continuous quantitative waveform capnography is rec-", "bbox": [60.0, 629.0, 375.0, 642.0]}, {"text": "ommended for confirmation and monitoring of endotra-", "bbox": [71.0, 644.0, 375.0, 658.0]}, {"text": "cheal tube placement.", "bbox": [71.0, 660.0, 192.0, 674.0]}, {"text": "• Cardiac arrest algorithms are simplified and redesigned", "bbox": [60.0, 675.0, 377.0, 689.0]}, {"text": "to emphasize the importance of high-quality CPR (in-", "bbox": [71.0, 691.0, 375.0, 705.0]}, {"text": "cluding chest compressions of adequate rate and depth,", "bbox": [71.0, 707.0, 375.0, 721.0]}, {"text": "allowing complete chest recoil after each compression,", "bbox": [71.0, 722.0, 375.0, 736.0]}, {"text": "minimizing interruptions in chest compressions and", "bbox": [72.0, 737.0, 376.0, 751.0]}, {"text": "avoiding excessive ventilation).", "bbox": [72.0, 753.0, 245.0, 767.0]}, {"text": "• Atropine is no longer recommended for routine use in the", "bbox": [60.0, 769.0, 375.0, 782.0]}, {"text": "management of pulseless electrical activity (PEA)/asystole.", "bbox": [71.0, 784.0, 375.0, 798.0]}, {"text": "• There is an increased emphasis on physiologic monitoring", "bbox": [60.0, 800.0, 375.0, 813.0]}, {"text": "to optimize CPR quality and detect ROSC.", "bbox": [71.0, 815.0, 298.0, 829.0]}, {"text": "• Chronotropic drug infusions are recommended as an alter-", "bbox": [60.0, 831.0, 375.0, 844.0]}, {"text": "native to pacing in symptomatic and unstable bradycardia.", "bbox": [72.0, 846.0, 375.0, 861.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "• Adenosine is recommended as a safe and potentially", "bbox": [404.0, 291.0, 720.0, 305.0]}, {"text": "effective therapy in the initial management of stable", "bbox": [416.0, 307.0, 720.0, 321.0]}, {"text": "undifferentiated regular monomorphic wide-complex", "bbox": [416.0, 322.0, 720.0, 336.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "tachycardia.", "bbox": [416.0, 338.0, 481.0, 353.0]}], "type": "List-item", "position": 5}, {"raw_context": [{"text": "Part 8.1: Adjuncts for Airway Control", "bbox": [431.0, 369.0, 694.0, 385.0]}, {"text": "and Ventilation", "bbox": [509.0, 387.0, 615.0, 402.0]}], "type": "Section-header", "position": 6}, {"raw_context": [{"text": "Overview of Airway Management", "bbox": [404.0, 409.0, 614.0, 424.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "This section highlights recommendations for the support of", "bbox": [404.0, 425.0, 721.0, 440.0]}, {"text": "ventilation and oxygenation during CPR and the peri-arrest", "bbox": [404.0, 441.0, 720.0, 455.0]}, {"text": "period. The purpose of ventilation during CPR is to maintain", "bbox": [404.0, 456.0, 720.0, 470.0]}, {"text": "adequate oxygenation and sufficient elimination of carbon", "bbox": [404.0, 473.0, 720.0, 486.0]}, {"text": "dioxide. However, research has not identified the optimal", "bbox": [403.0, 488.0, 720.0, 501.0]}, {"text": "tidal volume, respiratory rate, and inspired oxygen concen-", "bbox": [403.0, 504.0, 720.0, 517.0]}, {"text": "tration required during resuscitation from cardiac arrest.", "bbox": [403.0, 519.0, 698.0, 534.0]}, {"text": "Both ventilation and chest compressions are thought to be", "bbox": [416.0, 535.0, 720.0, 548.0]}, {"text": "important for victims of prolonged ventricular fibrillation", "bbox": [403.0, 550.0, 721.0, 565.0]}, {"text": "(VF) cardiac arrest and for all victims with other presenting", "bbox": [403.0, 566.0, 720.0, 580.0]}, {"text": "rhythms. Because both systemic and pulmonary perfusion are", "bbox": [403.0, 582.0, 720.0, 595.0]}, {"text": "substantially reduced during CPR, normal ventilation-", "bbox": [404.0, 597.0, 719.0, 611.0]}, {"text": "perfusion relationships can be maintained with a minute", "bbox": [404.0, 613.0, 720.0, 628.0]}, {"text": "ventilation that is much lower than normal. During CPR with", "bbox": [404.0, 629.0, 720.0, 642.0]}, {"text": "an advanced airway in place, a lower rate of rescue breathing", "bbox": [404.0, 644.0, 720.0, 658.0]}, {"text": "is needed to avoid hyperventilation.", "bbox": [403.0, 661.0, 592.0, 674.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Ventilation and Oxygen Administration", "bbox": [404.0, 689.0, 649.0, 705.0]}, {"text": "During CPR", "bbox": [404.0, 706.0, 484.0, 719.0]}], "type": "Section-header", "position": 9}, {"raw_context": [{"text": "During low blood flow states such as CPR, oxygen delivery to", "bbox": [403.0, 721.0, 721.0, 736.0]}, {"text": "the heart and brain is limited by blood flow rather than by arterial", "bbox": [403.0, 736.0, 720.0, 750.0]}, {"text": "oxygen content. 1.2 Therefore, rescue breaths are less important", "bbox": [403.0, 752.0, 720.0, 766.0]}, {"text": "than chest compressions during the first few minutes of resus-", "bbox": [403.0, 769.0, 718.0, 782.0]}, {"text": "citation from witnessed VF cardiac arrest and could reduce CPR", "bbox": [403.0, 783.0, 720.0, 798.0]}, {"text": "efficacy due to interruption in chest compressions and the", "bbox": [403.0, 800.0, 720.0, 813.0]}, {"text": "increase in intrathoracic pressure that accompanies positive-", "bbox": [404.0, 815.0, 719.0, 829.0]}, {"text": "pressure ventilation. Thus, during the first few minutes of", "bbox": [404.0, 831.0, 721.0, 844.0]}, {"text": "witnessed cardiac arrest a lone rescuer should not interrupt chest", "bbox": [404.0, 846.0, 721.0, 861.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "The American Heart Association requests that this document be cited as follows: Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway", "bbox": [71.0, 901.0, 720.0, 914.0]}, {"text": "CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced", "bbox": [61.0, 913.0, 720.0, 925.0]}, {"text": "cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.", "bbox": [61.0, 926.0, 719.0, 937.0]}, {"text": "Circulation. 2010;122(suppl 3):S729–S767.", "bbox": [61.0, 936.0, 254.0, 949.0]}, {"text": "( Circulation . 2010;122[suppl 3]:S729–S767.)", "bbox": [71.0, 950.0, 276.0, 962.0]}, {"text": "© 2010 American Heart Association, Inc.", "bbox": [71.0, 962.0, 254.0, 974.0]}, {"text": "Circulation is available at http://circ.ahajournals.org", "bbox": [70.0, 977.0, 317.0, 990.0]}, {"text": "DOI: 10.1161/CIRCULATIONAHA.110.970988", "bbox": [497.0, 977.0, 720.0, 991.0]}], "type": "Footnote", "position": 11}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 101}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "缺少换行#3#3#Key changes from the 2005 ACLS Guidelines include应与前面分行\n多余换行#9#9#9 tachycardia.应跟前面接上", "type3": null, "type4": "语义不完整#2#2#开头缺少内容", "type5": null, "type6": "信息有用性#0#1#无用内容\n信息有用性#15#15#The American Heart Association requests that this document be cited as follows: Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.无用内容\n信息有用性#16#18#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:55:12"}
{"id": 1041980, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "a58105be-d417-4b54-85ba-4b8cbae16890", "title": null, "text": "【0】页码:154\n  əlvis\t971] Vd1169H A :\t6md15A\n\n【1】 the store are synthesized in a pharmaceutical laboratory, \"copied\" in a sense from the vitamins extracted from food and found in nature. Supplements should never replace good eating habits and healthful food selections.\n\n【2】Many foods in the American diet are, in fact, further fortified with vitamins and nutrients. Vitamin deficiencies in our society are usually due to an illness (often of the intestinal tract) that interferes with the body's ability to absorb the vitamins present in food, rather than a vitamin deficiency in the diet or food itself.\n\n【3】 A closer review of vitamins reveals that there are two categories of vitamins: fat-soluble vitamins and watersoluble vitamins. Fat-soluble vitamins include Vitamins A, D, E, and K. If taken in amounts exceeding the body's immediate requirements, the \"extra\" fat-soluble vitamins are stored in the body's fatty tissues. If still more fat-soluble vitamins are ingested, vitamin toxicity can develop.\n\n【4】Water-soluble vitamins, on the other hand, are not stored by the human body. The B vitamins and Vitamin C are examples of water-soluble vitamins. If you take a tablet of Vitamin C, for example, most of it is eliminated in your urine. Your body absorbs what is requires and the kidneys excrete the rest. Since the majority of the dose of the water-soluble vitamins people add to their diet in pill form ends up in their urine, many nutritionists joke that Americans have the \"healthiest\" and most expensive toilet water in the world!\n\n【5】 The U.S. National Academy of Science's National Research Council has established guidelines on the amount of various nutrients men and women should eat at different ages. The guidelines constitute the \"Recommended Dietary Allowances,\" or RDAs— often referred to as Recommended Daily [sic]", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": " əlvis\t971] Vd1169H A :\t6md15A", "bbox": [546.0, 83.0, 570.0, 270.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "the store are synthesized in a pharmaceutical laboratory,", "bbox": [70.0, 69.0, 426.0, 87.0]}, {"text": "\"copied\" in a sense from the vitamins extracted from", "bbox": [70.0, 88.0, 427.0, 107.0]}, {"text": "food and found in nature. Supplements should never", "bbox": [70.0, 108.0, 427.0, 127.0]}, {"text": "replace good eating habits and healthful food selections.", "bbox": [70.0, 128.0, 426.0, 147.0]}, {"text": "Many foods in the American diet are, in fact, further", "bbox": [70.0, 149.0, 427.0, 167.0]}, {"text": "fortified with vitamins and nutrients. Vitamin deficien-", "bbox": [69.0, 169.0, 426.0, 187.0]}, {"text": "cies in our society are usually due to an illness (often of", "bbox": [70.0, 188.0, 428.0, 207.0]}, {"text": "the intestinal tract) that interferes with the body's abil-", "bbox": [69.0, 208.0, 426.0, 227.0]}, {"text": "ity to absorb the vitamins present in food, rather than a", "bbox": [69.0, 228.0, 427.0, 247.0]}, {"text": "vitamin deficiency in the diet or food itself.", "bbox": [69.0, 248.0, 346.0, 267.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "A closer review of vitamins reveals that there are two", "bbox": [70.0, 288.0, 426.0, 307.0]}, {"text": "categories of vitamins: fat-soluble vitamins and water-", "bbox": [70.0, 308.0, 426.0, 327.0]}, {"text": "soluble vitamins. Fat-soluble vitamins include Vitamins", "bbox": [70.0, 329.0, 427.0, 346.0]}, {"text": "A, D, E, and K. If taken in amounts exceeding the body's", "bbox": [70.0, 348.0, 427.0, 367.0]}, {"text": "immediate requirements, the \"extra\" fat-soluble vitamins", "bbox": [69.0, 368.0, 427.0, 388.0]}, {"text": "are stored in the body's fatty tissues. If still more fat-solu-", "bbox": [70.0, 388.0, 426.0, 407.0]}, {"text": "ble vitamins are ingested, vitamin toxicity can develop.", "bbox": [69.0, 408.0, 426.0, 427.0]}, {"text": "Water-soluble vitamins, on the other hand, are not", "bbox": [70.0, 429.0, 427.0, 447.0]}, {"text": "stored by the human body. The B vitamins and Vitamin", "bbox": [70.0, 448.0, 428.0, 468.0]}, {"text": "C are examples of water-soluble vitamins. If you take a", "bbox": [69.0, 468.0, 427.0, 487.0]}, {"text": "tablet of Vitamin C, for example, most of it is eliminated", "bbox": [70.0, 488.0, 427.0, 507.0]}, {"text": "in your urine. Your body absorbs what is requires and the", "bbox": [69.0, 509.0, 427.0, 527.0]}, {"text": "kidneys excrete the rest. Since the majority of the dose of", "bbox": [69.0, 528.0, 428.0, 547.0]}, {"text": "the water-soluble vitamins people add to their diet in pill", "bbox": [70.0, 548.0, 427.0, 567.0]}, {"text": "form ends up in their urine, many nutritionists joke that", "bbox": [70.0, 568.0, 427.0, 587.0]}, {"text": "Americans have the \"healthiest\" and most expensive toi-", "bbox": [70.0, 588.0, 425.0, 608.0]}, {"text": "let water in the world!", "bbox": [69.0, 609.0, 211.0, 627.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "The U.S. National Academy of Science's National", "bbox": [70.0, 648.0, 427.0, 667.0]}, {"text": "Research Council has established guidelines on the", "bbox": [70.0, 668.0, 426.0, 687.0]}, {"text": "amount of various nutrients men and women should", "bbox": [70.0, 689.0, 427.0, 707.0]}, {"text": "eat at different ages. The guidelines constitute the", "bbox": [69.0, 708.0, 427.0, 727.0]}, {"text": "\"Recommended Dietary Allowances,\" or RDAs—", "bbox": [70.0, 728.0, 425.0, 748.0]}, {"text": "often referred to as Recommended Daily [sic]", "bbox": [69.0, 748.0, 425.0, 768.0]}], "type": "Text", "position": 4}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf", "page_num": 154}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "信息有用性#0#0#əlvis\t971] Vd1169H A :\t6md15A无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:02:12"}
{"id": 1041979, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "a6ea0f57-e3bd-4bc8-8bae-719856e89767", "title": null, "text": "【0】页码:50\n\n【1】## References\n\n【2】\n 1. Sasson C, Rogers MA, Dahl J, Kellermann AL.  Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.\n\n【3】1. 2.\n\n【4】Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone Circulation . 2008;118:2550–2554.\n\n【5】G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mus- Ann Emerg Med . 2003;42:731–737.\n\n【6】solino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford 10. 22.\n\n【7】R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215.\n\n【8】877–883.\n\n【9】3. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I.\n\n【10】Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA . 2008;300:1423–1431.\n\n【11】4. Hodgetts TJ, Kenward G, Vlackonikolis I, Payne S, Castle N, Crouch R, Ineson N, Shaikh L. Incidence, location and reasons for avoidable in-hospital cardiac arrest in a district general hospital. Resuscitation .\n\n【12】2002;54:115–123.\n\n【13】10. 5.\n\n【14】Jones-Crawford JL, Parish DC, Smith BE, Dane FC. Resuscitation in the hospital: circadian variation of cardiopulmonary arrest. Am J Med . 2007; 120:158–164.\n\n【15】6. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C.  Rapid response teams: a systematic review and meta-analysis. Arch Intern Med . 2010; 179–187.\n\n【16】170:18–26.\n\n【17】7. Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W, Mancini ME, Nichol G, Lane-Truitt T, Potts J, Ornato JP, Berg RA. First documented rhythm and clinical outcome from in-hospital cardiac arrest 11:878–880.\n\n【18】among children and adults. JAMA . 2006;295:50–57.\n\n【19】8. Rea TD, Eisenberg MS, Sinibaldi G, White RD.  Incidence of EMS- treated out-of-hospital cardiac arrest in the United States. Resuscitation .\n\n【20】2001;104:2513–2516.\n\n【21】2004;63:17–24.\n\n【22】9. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA.\n\n【23】Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med .\n\n【24】2010;38:101–108.\n\n【25】10. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, Berg RA. Epidemiology and outcomes from out-of-hospital cardiac 358:9–17.\n\n【26】arrest in children: the Resuscitation Outcomes Consortium Epistry- Cardiac Arrest. Circulation. 2009;119:1484–1491.\n\n【27】11. Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg M. Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest: survival implications of guideline changes.\n\n【28】Circulation . 2006;114:2760–2765.\n\n【29】2004;351:637–646.\n\n【30】12. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation in Rochester, Minnesota: experience over 18 years. Resuscitation . 2009;80: 1253–1258.\n\n【31】13. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK. Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med . 2009;169:1265–1273.\n\n【32】14. Hinchey PR, Myers JB, Lewis R, De Maio VJ, Reyer E, Licatese D, Zalkin J, Snyder G. Improved out-of-hospital cardiac arrest survival after the sequential implementation of 2005 AHA guidelines for compressions, ventilations, and induced hypothermia: the Wake County experience. Ann Emerg Med . 2010.[epub ahead of print].\n\n【33】15. 2005 American Heart Association Guidelines for Cardiopulmonary 2008;299:1158–1165.\n\n【34】Resuscitation and Emergency Cardiovascular Care. Part 1: Introduction.\n\n【35】Circulation . 2005;112(24 suppl):IV-1–5.\n\n【36】16. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L, 2008;52:244–252.\n\n【37】Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. Ann Emerg Med . 2010; 55:249–257.\n\n【38】17. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Nadkarni VM, Berg RA, Hiraide A. Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-ofhospital cardiac arrests: a prospective, nationwide, population-based cohort study. Lancet. 2010;375:1347–1354.\n\n【39】Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW.\n\n【40】18.\n\n【41】Importance of the first link: description and recognition of an out-ofhospital cardiac arrest in an emergency call. Circulation . 2009;119: 2096–2102.\n\n【42】19. Clawson J, Olola C, Scott G, Heward A, Patterson B. Effect of a Medical Priority Dispatch System key question addition in the seizure/convulsion/ Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011\n\n【43】 fitting protocol to improve recognition of ineffective (agonal) breathing.\n\n【44】Resuscitation. 2008;79:257–264.\n\n【45】20. Bobrow BJ, Zuercher M, Ewy GA, Clark L, Chikani V, Donahue D, Sanders AB, Hilwig RW, Berg RA, Kern KB.  Gasping during cardiac arrest in humans is frequent and associated with improved survival.\n\n【46】Circulation . 2008;118:2550–2554.\n\n【47】21. Hauff SR, Rea TD, Culley LL, Kerry F, Becker L, Eisenberg MS. Factors impeding dispatcher-assisted telephone cardiopulmonary resuscitation.\n\n【48】Ann Emerg Med . 2003;42:731–737.\n\n【49】10. 22.\n\n【50】Vaillancourt C, Verma A, Trickett J, Crete D, Beaudoin T, Nesbitt L, Wells GA, Stiell IG.  Evaluating the effectiveness of dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg Med . 2007;14: 877–883.\n\n【51】23. Bohm K, Rosenqvist M, Hollenberg J, Biber B, Engerstrom L, Svensson L. Dispatcher-assisted telephone-guided cardiopulmonary resuscitation: an underused lifesaving system. Eur J Emerg Med . 2007;14:256–259.\n\n【52】24. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I.\n\n【53】Checking the carotid pulse check: diagnostic accuracy of first responders in patients with and without a pulse. Resuscitation . 1996;33:107–116.\n\n【54】25. Tibballs J, Russell P.  Reliability of pulse palpation by healthcare personnel to diagnose pediatric cardiac arrest. Resuscitation . 2009;80:61–64.\n\n【55】26. Chamberlain D, Smith A, Woollard M, Colquhoun M, Handley AJ, Leaves S, Kern KB. Trials of teaching methods in basic life support (3): comparison of simulated CPR performance after first training and at 6 months, with a note on the value of re-training. Resuscitation . 2002;53: 179–187.\n\n【56】27. Lapostolle F, Le Toumelin P, Agostinucci JM, Catineau J, Adnet F. Basic cardiac life support providers checking the carotid pulse: performance, degree of conviction, and influencing factors. Acad Emerg Med . 2004; 11:878–880.\n\n【57】28. Rea TD, Eisenberg MS, Culley LL, Becker L. Dispatcher-assisted cardiopulmonary resuscitation and survival in cardiac arrest. Circulation .\n\n【58】2001;104:2513–2516.\n\n【59】29. Roppolo LP, Westfall A, Pepe PE, Nobel LL, Cowan J, Kay JJ, Idris AH.\n\n【60】Dispatcher assessments for agonal breathing improve detection of cardiac arrest. Resuscitation. 2009;80:769–772.\n\n【61】30. Chan PS, Krumholz HM, Nichol G, Nallamothu BK.  Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med . 2008; 358:9–17.\n\n【62】31. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.\n\n【63】Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med . 2000;343:1206–1209.\n\n【64】32. The Public Access Defibrillation Trial Investigators. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med .\n\n【65】2004;351:637–646.\n\n【66】33. Christenson J, Andrusiek D, Everson-Stewart S, Kudenchuk P, Hostler D, Powell J, Callaway CW, Bishop D, Vaillancourt C, Davis D, Aufderheide TP, Idris A, Stouffer JA, Stiell I, Berg R.  Chest compression fraction determines survival in patients with out-of-hospital ventricular fibrillation. Circulation . 2009;120:1241–1247.\n\n【67】34. Garza AG, Gratton MC, Salomone JA, Lindholm D, McElroy J, Archer R. Improved patient survival using a modified resuscitation protocol for out-of-hospital cardiac arrest. Circulation. 2009;119:2597–2605.\n\n【68】35. Bobrow BJ, Clark LL, Ewy GA, Chikani V, Sanders AB, Berg RA, Richman PB, Kern KB. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest. JAMA .\n\n【69】2008;299:1158–1165.\n\n【70】36. Kellum MJ, Kennedy KW, Barney R, Keilhauer FA, Bellino M, Zuercher M, Ewy GA. Cardiocerebral resuscitation improves neurologically intact survival of patients with out-of-hospital cardiac arrest. Ann Emerg Med .\n\n【71】2008;52:244–252.\n\n【72】37. Sayre MR, Cantrell SA, White LJ, Hiestand BC, Keseg DP, Koser S.\n\n【73】Impact of the 2005 American Heart Association cardiopulmonary resuscitation and emergency cardiovascular care guidelines on out-of-hospital cardiac arrest survival. Prehosp Emerg Care . 2009;13:469–477.\n\n【74】38. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol Scand . 2008;52:908–913.\n\n【75】39. Aufderheide TP, Yannopoulos D, Lick CJ, Myers B, Romig LA, Stothert JC, Barnard J, Vartanian L, Pilgrim AJ, Benditt DG. Implementing the 2005 American Heart Association guidelines improves outcomes after out-of-hospital cardiac arrest. Heart Rhythm . 2010.[epub ahead of print].\n\n【76】40. Rea TD, Page RL. Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. Circulation . 2010;121:1134–1140.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "References", "bbox": [180.0, 87.0, 256.0, 100.0]}], "type": "Section-header", "position": 0}, {"raw_context": [{"text": "1. Sasson C, Rogers MA, Dahl J, Kellermann AL.  Predictors of survival", "bbox": [66.0, 102.0, 377.0, 113.0]}, {"text": "from out-of-hospital cardiac arrest: a systematic review and meta-analy-", "bbox": [78.0, 115.0, 375.0, 127.0]}, {"text": "sis. Circ Cardiovasc Qual Outcomes . 2010;3:63–81.", "bbox": [79.0, 127.0, 293.0, 138.0]}, {"text": "1. 2.", "bbox": [66.0, 138.0, 76.0, 148.0]}, {"text": "Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone", "bbox": [76.0, 139.0, 375.0, 150.0]}, {"text": "Circulation . 2008;118:2550–2554.", "bbox": [423.0, 147.0, 566.0, 158.0]}, {"text": "G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase", "bbox": [78.0, 150.0, 375.0, 162.0]}, {"text": "N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D,", "bbox": [78.0, 163.0, 376.0, 174.0]}, {"text": "Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mus-", "bbox": [78.0, 174.0, 375.0, 187.0]}, {"text": "Ann Emerg Med . 2003;42:731–737.", "bbox": [423.0, 184.0, 570.0, 195.0]}, {"text": "solino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford", "bbox": [79.0, 186.0, 376.0, 198.0]}, {"text": "10. 22.", "bbox": [405.0, 195.0, 421.0, 207.0]}, {"text": "R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American", "bbox": [78.0, 199.0, 376.0, 211.0]}, {"text": "Heart Association Statistics Committee and Stroke Statistics Subcom-", "bbox": [78.0, 210.0, 375.0, 221.0]}, {"text": "mittee. Heart disease and stroke statistics–2010 update: a report from the", "bbox": [79.0, 223.0, 376.0, 234.0]}, {"text": "American Heart Association. Circulation. 2010;121:e46–e215.", "bbox": [79.0, 234.0, 339.0, 246.0]}, {"text": "877–883.", "bbox": [422.0, 234.0, 464.0, 244.0]}, {"text": "3. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide", "bbox": [66.0, 247.0, 375.0, 259.0]}, {"text": "TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I.", "bbox": [79.0, 259.0, 375.0, 270.0]}, {"text": "Regional variation in out-of-hospital cardiac arrest incidence and", "bbox": [79.0, 270.0, 376.0, 283.0]}, {"text": "outcome. JAMA . 2008;300:1423–1431.", "bbox": [79.0, 283.0, 239.0, 294.0]}, {"text": "4. Hodgetts TJ, Kenward G, Vlackonikolis I, Payne S, Castle N, Crouch R,", "bbox": [66.0, 294.0, 375.0, 307.0]}, {"text": "Ineson N, Shaikh L. Incidence, location and reasons for avoidable", "bbox": [79.0, 307.0, 375.0, 318.0]}, {"text": "in-hospital cardiac arrest in a district general hospital. Resuscitation .", "bbox": [79.0, 318.0, 375.0, 330.0]}, {"text": "2002;54:115–123.", "bbox": [79.0, 331.0, 154.0, 342.0]}, {"text": "10. 5.", "bbox": [66.0, 342.0, 76.0, 352.0]}, {"text": "Jones-Crawford JL, Parish DC, Smith BE, Dane FC. Resuscitation in the", "bbox": [76.0, 342.0, 375.0, 354.0]}, {"text": "hospital: circadian variation of cardiopulmonary arrest. Am J Med . 2007;", "bbox": [78.0, 355.0, 375.0, 367.0]}, {"text": "120:158–164.", "bbox": [79.0, 367.0, 138.0, 378.0]}, {"text": "6. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C.  Rapid response", "bbox": [65.0, 379.0, 375.0, 391.0]}, {"text": "teams: a systematic review and meta-analysis. Arch Intern Med . 2010;", "bbox": [79.0, 391.0, 375.0, 402.0]}, {"text": "179–187.", "bbox": [423.0, 392.0, 462.0, 402.0]}, {"text": "170:18–26.", "bbox": [79.0, 403.0, 127.0, 413.0]}, {"text": "7. Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W, Mancini", "bbox": [66.0, 414.0, 376.0, 427.0]}, {"text": "ME, Nichol G, Lane-Truitt T, Potts J, Ornato JP, Berg RA. First docu-", "bbox": [78.0, 427.0, 375.0, 439.0]}, {"text": "mented rhythm and clinical outcome from in-hospital cardiac arrest", "bbox": [79.0, 439.0, 376.0, 450.0]}, {"text": "11:878–880.", "bbox": [422.0, 441.0, 478.0, 451.0]}, {"text": "among children and adults. JAMA . 2006;295:50–57.", "bbox": [79.0, 450.0, 295.0, 461.0]}, {"text": "8. Rea TD, Eisenberg MS, Sinibaldi G, White RD.  Incidence of EMS-", "bbox": [65.0, 463.0, 375.0, 475.0]}, {"text": "treated out-of-hospital cardiac arrest in the United States. Resuscitation .", "bbox": [79.0, 475.0, 375.0, 486.0]}, {"text": "2001;104:2513–2516.", "bbox": [423.0, 477.0, 512.0, 488.0]}, {"text": "2004;63:17–24.", "bbox": [79.0, 487.0, 144.0, 497.0]}, {"text": "9. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA.", "bbox": [65.0, 498.0, 375.0, 510.0]}, {"text": "Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med .", "bbox": [79.0, 511.0, 375.0, 522.0]}, {"text": "2010;38:101–108.", "bbox": [79.0, 523.0, 154.0, 534.0]}, {"text": "10. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden", "bbox": [61.0, 534.0, 376.0, 547.0]}, {"text": "CR, Berg RA. Epidemiology and outcomes from out-of-hospital cardiac", "bbox": [78.0, 547.0, 375.0, 559.0]}, {"text": "358:9–17.", "bbox": [423.0, 551.0, 466.0, 562.0]}, {"text": "arrest in children: the Resuscitation Outcomes Consortium Epistry-", "bbox": [79.0, 558.0, 375.0, 569.0]}, {"text": "Cardiac Arrest. Circulation. 2009;119:1484–1491.", "bbox": [78.0, 571.0, 287.0, 582.0]}, {"text": "11. Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg", "bbox": [61.0, 582.0, 376.0, 594.0]}, {"text": "M. Increasing use of cardiopulmonary resuscitation during out-of-hospital", "bbox": [79.0, 595.0, 376.0, 607.0]}, {"text": "ventricular fibrillation arrest: survival implications of guideline changes.", "bbox": [79.0, 607.0, 375.0, 618.0]}, {"text": "Circulation . 2006;114:2760–2765.", "bbox": [79.0, 619.0, 222.0, 629.0]}, {"text": "2004;351:637–646.", "bbox": [423.0, 624.0, 505.0, 635.0]}, {"text": "12. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrillation in", "bbox": [61.0, 630.0, 376.0, 642.0]}, {"text": "Rochester, Minnesota: experience over 18 years. Resuscitation . 2009;80:", "bbox": [79.0, 643.0, 375.0, 654.0]}, {"text": "1253–1258.", "bbox": [79.0, 655.0, 126.0, 666.0]}, {"text": "13. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK. Hospital", "bbox": [61.0, 666.0, 377.0, 678.0]}, {"text": "variation in time to defibrillation after in-hospital cardiac arrest. Arch", "bbox": [79.0, 679.0, 376.0, 690.0]}, {"text": "Intern Med . 2009;169:1265–1273.", "bbox": [79.0, 690.0, 219.0, 702.0]}, {"text": "14. Hinchey PR, Myers JB, Lewis R, De Maio VJ, Reyer E, Licatese D,", "bbox": [61.0, 702.0, 375.0, 715.0]}, {"text": "Zalkin J, Snyder G. Improved out-of-hospital cardiac arrest survival after", "bbox": [78.0, 715.0, 375.0, 726.0]}, {"text": "the sequential implementation of 2005 AHA guidelines for compressions,", "bbox": [78.0, 727.0, 375.0, 739.0]}, {"text": "ventilations, and induced hypothermia: the Wake County experience. Ann", "bbox": [79.0, 739.0, 376.0, 750.0]}, {"text": "Emerg Med . 2010.[epub ahead of print].", "bbox": [79.0, 752.0, 245.0, 763.0]}, {"text": "15. 2005 American Heart Association Guidelines for Cardiopulmonary", "bbox": [61.0, 763.0, 375.0, 775.0]}, {"text": "2008;299:1158–1165.", "bbox": [423.0, 771.0, 515.0, 782.0]}, {"text": "Resuscitation and Emergency Cardiovascular Care. Part 1: Introduction.", "bbox": [79.0, 776.0, 375.0, 788.0]}, {"text": "Circulation . 2005;112(24 suppl):IV-1–5.", "bbox": [79.0, 788.0, 245.0, 799.0]}, {"text": "16. Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh", "bbox": [61.0, 799.0, 376.0, 811.0]}, {"text": "S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L,", "bbox": [78.0, 811.0, 375.0, 823.0]}, {"text": "2008;52:244–252.", "bbox": [423.0, 820.0, 499.0, 831.0]}, {"text": "Davis D, Idris A, Nichol G.  Predicting survival after out-of-hospital", "bbox": [78.0, 822.0, 376.0, 837.0]}, {"text": "cardiac arrest: role of the Utstein data elements. Ann Emerg Med . 2010;", "bbox": [79.0, 836.0, 375.0, 848.0]}, {"text": "55:249–257.", "bbox": [79.0, 847.0, 133.0, 858.0]}, {"text": "17. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Nadkarni VM,", "bbox": [61.0, 860.0, 375.0, 871.0]}, {"text": "Berg RA, Hiraide A. Conventional and chest-compression-only cardio-", "bbox": [79.0, 871.0, 375.0, 883.0]}, {"text": "pulmonary resuscitation by bystanders for children who have out-of-", "bbox": [79.0, 884.0, 375.0, 896.0]}, {"text": "hospital cardiac arrests: a prospective, nationwide, population-based", "bbox": [79.0, 896.0, 376.0, 907.0]}, {"text": "cohort study. Lancet. 2010;375:1347–1354.", "bbox": [78.0, 908.0, 258.0, 919.0]}, {"text": "Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW.", "bbox": [76.0, 919.0, 375.0, 931.0]}, {"text": "18.", "bbox": [61.0, 920.0, 76.0, 930.0]}, {"text": "Importance of the first link: description and recognition of an out-of-", "bbox": [79.0, 932.0, 375.0, 943.0]}, {"text": "hospital cardiac arrest in an emergency call. Circulation . 2009;119:", "bbox": [79.0, 943.0, 375.0, 956.0]}, {"text": "2096–2102.", "bbox": [79.0, 956.0, 130.0, 967.0]}, {"text": "19. Clawson J, Olola C, Scott G, Heward A, Patterson B. Effect of a Medical", "bbox": [61.0, 967.0, 376.0, 979.0]}, {"text": "Priority Dispatch System key question addition in the seizure/convulsion/", "bbox": [78.0, 980.0, 376.0, 990.0]}, {"text": "Downloaded from http://circ.ahajournals.org/ by guest on September 4, 2011", "bbox": [203.0, 1003.0, 575.0, 1017.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "fitting protocol to improve recognition of ineffective (agonal) breathing.", "bbox": [422.0, 85.0, 718.0, 97.0]}, {"text": "Resuscitation. 2008;79:257–264.", "bbox": [423.0, 98.0, 557.0, 109.0]}, {"text": "20. Bobrow BJ, Zuercher M, Ewy GA, Clark L, Chikani V, Donahue D,", "bbox": [405.0, 109.0, 720.0, 121.0]}, {"text": "Sanders AB, Hilwig RW, Berg RA, Kern KB.  Gasping during cardiac", "bbox": [422.0, 122.0, 719.0, 134.0]}, {"text": "arrest in humans is frequent and associated with improved survival.", "bbox": [422.0, 135.0, 720.0, 147.0]}, {"text": "Circulation . 2008;118:2550–2554.", "bbox": [423.0, 147.0, 566.0, 158.0]}, {"text": "21. Hauff SR, Rea TD, Culley LL, Kerry F, Becker L, Eisenberg MS. Factors", "bbox": [404.0, 159.0, 721.0, 170.0]}, {"text": "impeding dispatcher-assisted telephone cardiopulmonary resuscitation.", "bbox": [422.0, 171.0, 718.0, 183.0]}, {"text": "Ann Emerg Med . 2003;42:731–737.", "bbox": [423.0, 184.0, 570.0, 195.0]}, {"text": "10. 22.", "bbox": [405.0, 195.0, 421.0, 207.0]}, {"text": "Vaillancourt C, Verma A, Trickett J, Crete D, Beaudoin T, Nesbitt L,", "bbox": [419.0, 195.0, 719.0, 207.0]}, {"text": "Wells GA, Stiell IG.  Evaluating the effectiveness of dispatch-assisted", "bbox": [423.0, 207.0, 720.0, 221.0]}, {"text": "cardiopulmonary resuscitation instructions. Acad Emerg Med . 2007;14:", "bbox": [422.0, 220.0, 720.0, 232.0]}, {"text": "877–883.", "bbox": [422.0, 234.0, 464.0, 244.0]}, {"text": "23. Bohm K, Rosenqvist M, Hollenberg J, Biber B, Engerstrom L, Svensson", "bbox": [405.0, 244.0, 720.0, 256.0]}, {"text": "L. Dispatcher-assisted telephone-guided cardiopulmonary resuscitation:", "bbox": [422.0, 258.0, 720.0, 269.0]}, {"text": "an underused lifesaving system. Eur J Emerg Med . 2007;14:256–259.", "bbox": [422.0, 269.0, 714.0, 281.0]}, {"text": "24. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I.", "bbox": [405.0, 281.0, 719.0, 294.0]}, {"text": "Checking the carotid pulse check: diagnostic accuracy of first responders", "bbox": [422.0, 294.0, 721.0, 305.0]}, {"text": "in patients with and without a pulse. Resuscitation . 1996;33:107–116.", "bbox": [422.0, 307.0, 713.0, 317.0]}, {"text": "25. Tibballs J, Russell P.  Reliability of pulse palpation by healthcare per-", "bbox": [404.0, 318.0, 719.0, 329.0]}, {"text": "sonnel to diagnose pediatric cardiac arrest. Resuscitation . 2009;80:61–64.", "bbox": [422.0, 331.0, 720.0, 342.0]}, {"text": "26. Chamberlain D, Smith A, Woollard M, Colquhoun M, Handley AJ,", "bbox": [405.0, 342.0, 720.0, 354.0]}, {"text": "Leaves S, Kern KB. Trials of teaching methods in basic life support (3):", "bbox": [422.0, 355.0, 720.0, 367.0]}, {"text": "comparison of simulated CPR performance after first training and at 6", "bbox": [422.0, 366.0, 720.0, 380.0]}, {"text": "months, with a note on the value of re-training. Resuscitation . 2002;53:", "bbox": [423.0, 380.0, 720.0, 391.0]}, {"text": "179–187.", "bbox": [423.0, 392.0, 462.0, 402.0]}, {"text": "27. Lapostolle F, Le Toumelin P, Agostinucci JM, Catineau J, Adnet F. Basic", "bbox": [404.0, 403.0, 719.0, 417.0]}, {"text": "cardiac life support providers checking the carotid pulse: performance,", "bbox": [423.0, 416.0, 719.0, 428.0]}, {"text": "degree of conviction, and influencing factors. Acad Emerg Med . 2004;", "bbox": [423.0, 428.0, 720.0, 441.0]}, {"text": "11:878–880.", "bbox": [422.0, 441.0, 478.0, 451.0]}, {"text": "28. Rea TD, Eisenberg MS, Culley LL, Becker L. Dispatcher-assisted car-", "bbox": [405.0, 452.0, 719.0, 465.0]}, {"text": "diopulmonary resuscitation and survival in cardiac arrest. Circulation .", "bbox": [422.0, 466.0, 719.0, 478.0]}, {"text": "2001;104:2513–2516.", "bbox": [423.0, 477.0, 512.0, 488.0]}, {"text": "29. Roppolo LP, Westfall A, Pepe PE, Nobel LL, Cowan J, Kay JJ, Idris AH.", "bbox": [405.0, 489.0, 719.0, 502.0]}, {"text": "Dispatcher assessments for agonal breathing improve detection of cardiac", "bbox": [422.0, 501.0, 719.0, 514.0]}, {"text": "arrest. Resuscitation. 2009;80:769–772.", "bbox": [423.0, 515.0, 585.0, 525.0]}, {"text": "30. Chan PS, Krumholz HM, Nichol G, Nallamothu BK.  Delayed time to", "bbox": [405.0, 526.0, 721.0, 538.0]}, {"text": "defibrillation after in-hospital cardiac arrest. N Engl J Med . 2008;", "bbox": [422.0, 539.0, 720.0, 551.0]}, {"text": "358:9–17.", "bbox": [423.0, 551.0, 466.0, 562.0]}, {"text": "31. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG.", "bbox": [405.0, 562.0, 719.0, 575.0]}, {"text": "Outcomes of rapid defibrillation by security officers after cardiac arrest in", "bbox": [422.0, 575.0, 721.0, 587.0]}, {"text": "casinos. N Engl J Med . 2000;343:1206–1209.", "bbox": [423.0, 589.0, 612.0, 599.0]}, {"text": "32. The Public Access Defibrillation Trial Investigators. Public-access defi-", "bbox": [405.0, 599.0, 719.0, 611.0]}, {"text": "brillation and survival after out-of-hospital cardiac arrest. N Engl J Med .", "bbox": [423.0, 613.0, 719.0, 624.0]}, {"text": "2004;351:637–646.", "bbox": [423.0, 624.0, 505.0, 635.0]}, {"text": "33. Christenson J, Andrusiek D, Everson-Stewart S, Kudenchuk P, Hostler D,", "bbox": [405.0, 636.0, 720.0, 649.0]}, {"text": "Powell J, Callaway CW, Bishop D, Vaillancourt C, Davis D, Aufderheide", "bbox": [422.0, 649.0, 720.0, 660.0]}, {"text": "TP, Idris A, Stouffer JA, Stiell I, Berg R.  Chest compression fraction", "bbox": [423.0, 662.0, 720.0, 673.0]}, {"text": "determines survival in patients with out-of-hospital ventricular fibril-", "bbox": [422.0, 674.0, 719.0, 684.0]}, {"text": "lation. Circulation . 2009;120:1241–1247.", "bbox": [422.0, 686.0, 592.0, 697.0]}, {"text": "34. Garza AG, Gratton MC, Salomone JA, Lindholm D, McElroy J, Archer", "bbox": [405.0, 697.0, 720.0, 709.0]}, {"text": "R. Improved patient survival using a modified resuscitation protocol for", "bbox": [422.0, 710.0, 720.0, 722.0]}, {"text": "out-of-hospital cardiac arrest. Circulation. 2009;119:2597–2605.", "bbox": [422.0, 722.0, 687.0, 733.0]}, {"text": "35. Bobrow BJ, Clark LL, Ewy GA, Chikani V, Sanders AB, Berg RA,", "bbox": [405.0, 735.0, 720.0, 746.0]}, {"text": "Richman PB, Kern KB. Minimally interrupted cardiac resuscitation by", "bbox": [422.0, 746.0, 719.0, 758.0]}, {"text": "emergency medical services for out-of-hospital cardiac arrest. JAMA .", "bbox": [423.0, 759.0, 719.0, 770.0]}, {"text": "2008;299:1158–1165.", "bbox": [423.0, 771.0, 515.0, 782.0]}, {"text": "36. Kellum MJ, Kennedy KW, Barney R, Keilhauer FA, Bellino M, Zuercher", "bbox": [405.0, 783.0, 720.0, 796.0]}, {"text": "M, Ewy GA. Cardiocerebral resuscitation improves neurologically intact", "bbox": [422.0, 796.0, 720.0, 807.0]}, {"text": "survival of patients with out-of-hospital cardiac arrest. Ann Emerg Med .", "bbox": [423.0, 808.0, 719.0, 819.0]}, {"text": "2008;52:244–252.", "bbox": [423.0, 820.0, 499.0, 831.0]}, {"text": "37. Sayre MR, Cantrell SA, White LJ, Hiestand BC, Keseg DP, Koser S.", "bbox": [405.0, 832.0, 719.0, 844.0]}, {"text": "Impact of the 2005 American Heart Association cardiopulmonary resus-", "bbox": [422.0, 845.0, 719.0, 856.0]}, {"text": "citation and emergency cardiovascular care guidelines on out-of-hospital", "bbox": [422.0, 856.0, 720.0, 869.0]}, {"text": "cardiac arrest survival. Prehosp Emerg Care . 2009;13:469–477.", "bbox": [423.0, 870.0, 689.0, 882.0]}, {"text": "38. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved", "bbox": [405.0, 882.0, 720.0, 893.0]}, {"text": "survival after an out-of-hospital cardiac arrest using new guidelines. Acta", "bbox": [422.0, 894.0, 720.0, 905.0]}, {"text": "Anaesthesiol Scand . 2008;52:908–913.", "bbox": [423.0, 905.0, 583.0, 917.0]}, {"text": "39. Aufderheide TP, Yannopoulos D, Lick CJ, Myers B, Romig LA, Stothert", "bbox": [405.0, 917.0, 720.0, 930.0]}, {"text": "JC, Barnard J, Vartanian L, Pilgrim AJ, Benditt DG. Implementing the", "bbox": [422.0, 930.0, 720.0, 942.0]}, {"text": "2005 American Heart Association guidelines improves outcomes after", "bbox": [423.0, 943.0, 720.0, 955.0]}, {"text": "out-of-hospital cardiac arrest. Heart Rhythm . 2010.[epub ahead of print].", "bbox": [422.0, 955.0, 719.0, 966.0]}, {"text": "40. Rea TD, Page RL. Community approaches to improve resuscitation after", "bbox": [405.0, 968.0, 719.0, 979.0]}, {"text": "out-of-hospital sudden cardiac arrest. Circulation . 2010;121:1134–1140.", "bbox": [422.0, 979.0, 719.0, 990.0]}], "type": "Text", "position": 5}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 50}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#76#全篇为参考文献内容\n"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:43:31"}
{"id": 1041978, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "326d285a-1cd8-4718-9ca6-1a6199d9b06c", "title": null, "text": "【0】页码:19\n Brilliant bassist and member of the renowned metal band Def Leppard, Rick Savage is another celebrity who dealt with Bell's palsy. Popularly known as 'Sav,' Rick was extremely popular among female fans largely because of his good looks. He was also called the pretty boy of this English band.\n\n【1】 In 1994, Rick Savage was diagnosed with Bell’s palsy. The condition 'froze’ one side of his face and his facial muscles weakened. According to Savage, his face felt as if it had melted. His reputation as a sex symbol received a serious blow.\n\n【2】He resorted to various treatments including steroids, but he believes it was acupuncture that helped him recover rapidly.\n\n【3】 Rick Savage has managed to recover from this condition, but some symptoms are still visible. These effects can be observed clearly when he seems fatigued and weary. Rick once commented that it was difficult to not be able to do everyday things such as eat properly and not sleep without covering his eye with an eye patch. However, Rick also had to witness the tragedy that his fellow band member Rick Allen went through when he lost his arm. This helped Savage deal with his condition.\n\n【4】## Alexis Denisof\n\n【5】\n Alexis Denisof is a famous American actor who has worked extensively in theater, television productions as well as movies.  However, he is largely recognized for his great role in 'Buffy the Vampire Slayer', a television series.\n\n【6】 In 1999, three weeks before the filming of 'Angel' Season Five, Alexis was affected by Bell's palsy. According to Joss Whedon, who was directing the series, Denisof found it hard to speak and move the left side of his face, which was paralyzed due to the condition.\n\n【7】 The actor was concerned that he would not be able to shoot the first episode properly. However, he began to recover by that time, but considering the immobility problem with his left side, the director chose to do things differently.\n\n【8】Most of Denisof's shots were kept on his right side during the filming of the episode.\n\n【9】## Ralph Nader\n\n【10】\n Included in Time Magazine's list of 100 Most Influential Americans in the Twentieth Century, Ralph Nader is not just a political activist. He is one of the top consumer advocates, an author and a lawyer.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Brilliant bassist and member of the renowned metal band Def Leppard, Rick", "bbox": [93.0, 96.0, 724.0, 116.0]}, {"text": "Savage is another celebrity who dealt with Bell's palsy. Popularly known as", "bbox": [93.0, 118.0, 723.0, 138.0]}, {"text": "'Sav,' Rick was extremely popular among female fans largely because of his", "bbox": [95.0, 140.0, 722.0, 161.0]}, {"text": "good looks. He was also called the pretty boy of this English band.", "bbox": [93.0, 163.0, 612.0, 183.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "In 1994, Rick Savage was diagnosed with Bell’s palsy. The condition 'froze’ one", "bbox": [93.0, 197.0, 722.0, 217.0]}, {"text": "side of his face and his facial muscles weakened. According to Savage, his face", "bbox": [93.0, 220.0, 723.0, 239.0]}, {"text": "felt as if it had melted. His reputation as a sex symbol received a serious blow.", "bbox": [93.0, 242.0, 723.0, 261.0]}, {"text": "He resorted to various treatments including steroids, but he believes it was", "bbox": [93.0, 264.0, 723.0, 284.0]}, {"text": "acupuncture that helped him recover rapidly.", "bbox": [93.0, 286.0, 443.0, 305.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Rick Savage has managed to recover from this condition, but some symptoms", "bbox": [93.0, 322.0, 724.0, 341.0]}, {"text": "are still visible. These effects can be observed clearly when he seems fatigued", "bbox": [93.0, 344.0, 724.0, 363.0]}, {"text": "and weary. Rick once commented that it was difficult to not be able to do", "bbox": [93.0, 366.0, 723.0, 385.0]}, {"text": "everyday things such as eat properly and not sleep without covering his eye with", "bbox": [93.0, 388.0, 724.0, 407.0]}, {"text": "an eye patch. However, Rick also had to witness the tragedy that his fellow band", "bbox": [93.0, 410.0, 723.0, 429.0]}, {"text": "member Rick Allen went through when he lost his arm. This helped Savage deal", "bbox": [93.0, 432.0, 723.0, 451.0]}, {"text": "with his condition.", "bbox": [93.0, 454.0, 242.0, 473.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": "Alexis Denisof", "bbox": [93.0, 488.0, 216.0, 508.0]}], "type": "Section-header", "position": 3}, {"raw_context": [{"text": "Alexis Denisof is a famous American actor who has worked extensively in", "bbox": [93.0, 525.0, 724.0, 545.0]}, {"text": "theater, television productions as well as movies.  However, he is largely", "bbox": [93.0, 548.0, 723.0, 567.0]}, {"text": "recognized for his great role in 'Buffy the Vampire Slayer', a television series.", "bbox": [93.0, 570.0, 703.0, 590.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "In 1999, three weeks before the filming of 'Angel' Season Five, Alexis was", "bbox": [93.0, 603.0, 723.0, 623.0]}, {"text": "affected by Bell's palsy. According to Joss Whedon, who was directing the", "bbox": [93.0, 627.0, 722.0, 646.0]}, {"text": "series, Denisof found it hard to speak and move the left side of his face, which", "bbox": [93.0, 649.0, 724.0, 668.0]}, {"text": "was paralyzed due to the condition.", "bbox": [93.0, 671.0, 371.0, 690.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "The actor was concerned that he would not be able to shoot the first episode", "bbox": [93.0, 706.0, 723.0, 726.0]}, {"text": "properly. However, he began to recover by that time, but considering the", "bbox": [93.0, 729.0, 723.0, 748.0]}, {"text": "immobility problem with his left side, the director chose to do things differently.", "bbox": [93.0, 750.0, 723.0, 770.0]}, {"text": "Most of Denisof's shots were kept on his right side during the filming of the", "bbox": [93.0, 773.0, 723.0, 792.0]}, {"text": "episode.", "bbox": [93.0, 795.0, 161.0, 814.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Ralph Nader", "bbox": [93.0, 829.0, 205.0, 849.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "Included in Time Magazine's list of 100 Most Influential Americans in the", "bbox": [93.0, 866.0, 723.0, 886.0]}, {"text": "Twentieth Century, Ralph Nader is not just a political activist. He is one of the", "bbox": [93.0, 888.0, 723.0, 909.0]}, {"text": "top consumer advocates, an author and a lawyer.", "bbox": [93.0, 911.0, 472.0, 930.0]}], "type": "Text", "position": 8}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/Bells Palsy Handbook Facial Nerve Palsy or Bells Palsy facial paralysis causes, symptoms, treatment, face exercises ... (Alan Mc Donald  Dr Alexa Smith) (Z-Library).pdf", "page_num": 19}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 23:51:44"}
{"id": 1041977, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "fde97e19-f33b-4200-bd30-0610ad040c59", "title": null, "text": "【0】页码:19\n# Innovations\n\n【1】# The Company’S Company Venture Capitalism Becomes A New Mission For The Nation’S Spymasters   By Daniel G. Dupont\n\n【2】\n In 1998 Ruth A. David, then the Central Intelligence Agency's top science and technology official, came away impressed from a trip to the Massachusetts Institute of Technology's Media Lab. On the flight back to Washington, she remarked to her deputy, Joanne Isham, that the agency could benefit from a high-powered, in-house technology incubator.\n\n【3】The CIA was having a tough time tapping into the information technology revolution, yet it had a pressing need to implement more advanced software tools for tasks such as Internet security to prevent hacker incursions. The agency could no longer rely solely on its traditional contractor base and government labs for the cutting-edge information technologies that would allow it to keep spying on the world. It had unsuccessfully tried a number of internal efforts to take advantage of new technologies. But it often had trouble reaching out beyond the confines of the agency. Security concerns frequently hindered it from detailing its needs to outside suppliers.\n\n【4】 George J. Tenet, the agency's director, convinced of the importance of adopting new information technology, gave the green light to David and other agency employees who wanted to try a wholly new approach. Using outside consultants and legal experts, the team began putting together an infrastructure for linking the CIA with the network of investment bankers, venture capitalists and information technology entrepreneurs who turn new ideas into useful products. After much refinement, the CIA created In-Q-Tel, a private not-for-profit venture-capital firm whose funding comes from taxpayer dollars.\n\n【5】The CIA has set up companies before, but they have\n\n【6】 been primarily undisclosed fronts for secret agency operations, such as Air America, the airline the CIA ran for many years in Southeast Asia. In-Q-Tel is different: the agency acknowledges and promotes its relationship with In-Q-Tel. Company officials like to call the publicly funded CIA creation a \"venture catalyst\" because it does more than seed start-ups and new technologies.\n\n【7】It does, of course, shell out much needed funding. \"No one comes to us not looking for our money,\" says Christopher Tucker, the company's chief strategist. But In-Q-Tel also acts as a buffer between the agency and the information technology community. It offers the expertise of a group of people who have spent a great deal of time thinking through the particular problems the agency confronts.\n\n【8】The CIA requires a series of target technologies: software for Internet security—threat detection and eradication of hackers who pry into its databases—as well as information management, network security access, and the searching and indexing of open-source documents, just to name a few. But the agency's insular culture keeps it from acknowledging that existing systems may be deficient. And security is always paramount. Just getting a list of technology-related needs on paper was difficult. Doing so, Tucker says, \"was a real watershed event, and then having it articulated at\n\n【9】 TOM DRAPER DESIGN", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Innovations", "bbox": [306.0, 42.0, 481.0, 70.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": "The Company’s Company", "bbox": [44.0, 226.0, 518.0, 270.0]}, {"text": "Venture capitalism becomes a new mission for the nation’s spymasters   By DANIEL G. DUPONT", "bbox": [45.0, 277.0, 676.0, 296.0]}], "type": "Title", "position": 2}, {"raw_context": [{"text": "In 1998 Ruth A. David, then the Central Intelligence", "bbox": [130.0, 343.0, 417.0, 357.0]}, {"text": "Agency's top science and technology official, came", "bbox": [131.0, 359.0, 417.0, 374.0]}, {"text": "away impressed from a trip to the Massachusetts In-", "bbox": [130.0, 375.0, 417.0, 389.0]}, {"text": "stitute of Technology's Media Lab. On the flight back", "bbox": [130.0, 392.0, 417.0, 405.0]}, {"text": "to Washington, she remarked to her deputy, Joanne", "bbox": [130.0, 407.0, 417.0, 421.0]}, {"text": "Isham, that the agency could benefit from a high-pow-", "bbox": [130.0, 423.0, 416.0, 437.0]}, {"text": "ered, in-house technology incubator.", "bbox": [130.0, 440.0, 327.0, 453.0]}, {"text": "The CIA was having a tough time tapping into the", "bbox": [151.0, 454.0, 417.0, 469.0]}, {"text": "information technology revolution, yet it had a press-", "bbox": [130.0, 471.0, 416.0, 485.0]}, {"text": "ing need to implement more advanced software tools", "bbox": [130.0, 488.0, 417.0, 501.0]}, {"text": "for tasks such as Internet security to prevent hacker in-", "bbox": [130.0, 503.0, 417.0, 517.0]}, {"text": "cursions. The agency could no longer rely solely on its tra-", "bbox": [130.0, 519.0, 417.0, 534.0]}, {"text": "ditional contractor base and government labs for the cut-", "bbox": [130.0, 535.0, 416.0, 549.0]}, {"text": "ting-edge information technologies that would allow it to", "bbox": [130.0, 551.0, 418.0, 565.0]}, {"text": "keep spying on the world. It had unsuccessfully tried a", "bbox": [130.0, 567.0, 417.0, 581.0]}, {"text": "number of internal efforts to take advantage of new tech-", "bbox": [130.0, 583.0, 417.0, 597.0]}, {"text": "nologies. But it often had trouble reaching out beyond", "bbox": [130.0, 599.0, 417.0, 614.0]}, {"text": "the confines of the agency. Security concerns frequently", "bbox": [130.0, 615.0, 417.0, 629.0]}, {"text": "hindered it from detailing its needs to outside suppliers.", "bbox": [130.0, 631.0, 416.0, 645.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "George J. Tenet, the agency's director, convinced of", "bbox": [449.0, 343.0, 718.0, 357.0]}, {"text": "the importance of adopting new information technolo-", "bbox": [430.0, 359.0, 716.0, 374.0]}, {"text": "gy, gave the green light to David and other agency em-", "bbox": [430.0, 375.0, 716.0, 389.0]}, {"text": "ployees who wanted to try a wholly new approach. Us-", "bbox": [430.0, 392.0, 716.0, 405.0]}, {"text": "ing outside consultants and legal experts, the team be-", "bbox": [430.0, 406.0, 716.0, 421.0]}, {"text": "gan putting together an infrastructure for linking the CIA", "bbox": [430.0, 423.0, 718.0, 437.0]}, {"text": "with the network of investment bankers, venture capi-", "bbox": [430.0, 440.0, 716.0, 453.0]}, {"text": "talists and information technology entrepreneurs who", "bbox": [430.0, 454.0, 718.0, 469.0]}, {"text": "turn new ideas into useful products. After much refine-", "bbox": [430.0, 471.0, 716.0, 485.0]}, {"text": "ment, the CIA created In-Q-Tel, a private not-for-profit", "bbox": [430.0, 487.0, 717.0, 501.0]}, {"text": "venture-capital firm whose funding comes from taxpay-", "bbox": [430.0, 502.0, 716.0, 519.0]}, {"text": "er dollars.", "bbox": [430.0, 519.0, 484.0, 534.0]}, {"text": "The CIA has set up companies before, but they have", "bbox": [450.0, 535.0, 718.0, 549.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "been primarily undisclosed fronts for secret agency op-", "bbox": [429.0, 551.0, 716.0, 565.0]}, {"text": "erations, such as Air America, the airline the CIA ran", "bbox": [429.0, 567.0, 718.0, 581.0]}, {"text": "for many years in Southeast Asia. In-Q-Tel is different:", "bbox": [429.0, 583.0, 717.0, 597.0]}, {"text": "the agency acknowledges and promotes its relationship", "bbox": [429.0, 599.0, 718.0, 614.0]}, {"text": "with In-Q-Tel. Company officials like to call the pub-", "bbox": [429.0, 615.0, 716.0, 629.0]}, {"text": "licly funded CIA creation a \"venture catalyst\" because", "bbox": [429.0, 632.0, 718.0, 645.0]}, {"text": "it does more than seed start-ups and new technologies.", "bbox": [429.0, 647.0, 717.0, 662.0]}, {"text": "It does, of course, shell out much needed funding. \"No", "bbox": [429.0, 663.0, 718.0, 677.0]}, {"text": "one comes to us not looking for our money,\" says", "bbox": [429.0, 679.0, 718.0, 694.0]}, {"text": "Christopher Tucker, the company's chief strategist. But", "bbox": [429.0, 695.0, 718.0, 710.0]}, {"text": "In-Q-Tel also acts as a buffer between the agency and", "bbox": [429.0, 712.0, 718.0, 725.0]}, {"text": "the information technology community. It offers the", "bbox": [429.0, 727.0, 718.0, 741.0]}, {"text": "expertise of a group of people who have spent a great", "bbox": [429.0, 743.0, 718.0, 758.0]}, {"text": "deal of time thinking through the particular problems", "bbox": [429.0, 759.0, 718.0, 774.0]}, {"text": "the agency confronts.", "bbox": [429.0, 775.0, 546.0, 789.0]}, {"text": "The CIA requires a series of target technologies:", "bbox": [450.0, 791.0, 718.0, 805.0]}, {"text": "software for Internet security—threat detection and", "bbox": [430.0, 808.0, 718.0, 821.0]}, {"text": "eradication of hackers who pry into its databases—as", "bbox": [429.0, 823.0, 718.0, 837.0]}, {"text": "well as information management, network security ac-", "bbox": [430.0, 839.0, 716.0, 853.0]}, {"text": "cess, and the searching and indexing of open-source", "bbox": [430.0, 855.0, 718.0, 869.0]}, {"text": "documents, just to name a few. But the agency's insu-", "bbox": [430.0, 871.0, 716.0, 885.0]}, {"text": "lar culture keeps it from acknowledging that existing", "bbox": [430.0, 887.0, 718.0, 902.0]}, {"text": "systems may be deficient. And security is always para-", "bbox": [430.0, 903.0, 716.0, 917.0]}, {"text": "mount. Just getting a list of technology-related needs", "bbox": [430.0, 919.0, 718.0, 933.0]}, {"text": "on paper was difficult. Doing so, Tucker says, \"was a", "bbox": [430.0, 935.0, 718.0, 950.0]}, {"text": "real watershed event, and then having it articulated at", "bbox": [430.0, 952.0, 717.0, 965.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "TOM DRAPER DESIGN", "bbox": [746.0, 890.0, 759.0, 962.0]}], "type": "Text", "position": 7}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-08) Cyber Cells (Scientific American) (Z-Library).pdf", "page_num": 19}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#5#6#The CIA has set up到and new technologies.是一句话", "type3": "无关文本#9#9# TOM DRAPER DESIGN", "type4": "", "type5": null, "type6": null}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 18:30:37"}
{"id": 1041976, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "8d9262da-8e26-40fa-b7e0-b78ae3f61838", "title": null, "text": "【0】页码:291\n# American Heart Association Learn And Liver\n\n【1】\n Part 15: Neonatal Resuscitation : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care John Kattwinkel, Jeffrey M. Perlman, Khalid Aziz, Christopher Colby, Karen Fairchild, John Gallagher, Mary Fran Hazinski, Louis P. Halamek, Praveen Kumar, George Little, Jane E. McGowan, Barbara Nightengale, Mildred M. Ramirez, Steven Ringer, Wendy M. Simon, Gary M. Weiner, Myra Wyckoff and Jeanette Zaichkin\n\n【2】 Circulation 2010, 122:S909-S919 doi: 10.1161/CIRCULATIONAHA.110.971119 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514 Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539\n\n【3】 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circ.ahajournals.org/content/122/18_suppl_3/S909\n\n【4】 Subscriptions: Information about subscribing to Circulation is online at http://circ.ahajournals.org//subscriptions/\n\n【5】 Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax: 410-528-8550. E-mail: journalpermissions@lww.com\n\n【6】 Reprints: Information about reprints can be found online at http://www.lww.com/reprints", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "American Heart", "bbox": [520.0, 126.0, 678.0, 148.0]}, {"text": "Association", "bbox": [562.0, 153.0, 675.0, 172.0]}, {"text": "Learn and Liver", "bbox": [570.0, 190.0, 711.0, 207.0]}], "type": "Title", "position": 2}, {"raw_context": [{"text": "Part 15: Neonatal Resuscitation : 2010 American Heart Association Guidelines", "bbox": [119.0, 267.0, 660.0, 284.0]}, {"text": "for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care", "bbox": [133.0, 283.0, 640.0, 299.0]}, {"text": "John Kattwinkel, Jeffrey M. Perlman, Khalid Aziz, Christopher Colby, Karen", "bbox": [139.0, 299.0, 640.0, 315.0]}, {"text": "Fairchild, John Gallagher, Mary Fran Hazinski, Louis P. Halamek, Praveen Kumar,", "bbox": [120.0, 315.0, 659.0, 331.0]}, {"text": "George Little, Jane E. McGowan, Barbara Nightengale, Mildred M. Ramirez, Steven", "bbox": [115.0, 331.0, 663.0, 347.0]}, {"text": "Ringer, Wendy M. Simon, Gary M. Weiner, Myra Wyckoff and Jeanette Zaichkin", "bbox": [122.0, 348.0, 653.0, 363.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Circulation 2010, 122:S909-S919", "bbox": [278.0, 397.0, 500.0, 414.0]}, {"text": "doi: 10.1161/CIRCULATIONAHA.110.971119", "bbox": [232.0, 414.0, 544.0, 429.0]}, {"text": "Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX", "bbox": [125.0, 427.0, 652.0, 445.0]}, {"text": "72514", "bbox": [369.0, 442.0, 406.0, 456.0]}, {"text": "Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online", "bbox": [122.0, 455.0, 656.0, 470.0]}, {"text": "ISSN: 1524-4539", "bbox": [339.0, 469.0, 437.0, 482.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "The online version of this article, along with updated information and services, is", "bbox": [128.0, 585.0, 651.0, 601.0]}, {"text": "located on the World Wide Web at:", "bbox": [271.0, 602.0, 503.0, 617.0]}, {"text": "http://circ.ahajournals.org/content/122/18_suppl_3/S909", "bbox": [206.0, 617.0, 572.0, 633.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Subscriptions: Information about subscribing to Circulation is online at", "bbox": [123.0, 806.0, 506.0, 823.0]}, {"text": "http://circ.ahajournals.org//subscriptions/", "bbox": [122.0, 822.0, 343.0, 836.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters", "bbox": [123.0, 847.0, 637.0, 861.0]}, {"text": "Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax:", "bbox": [123.0, 860.0, 653.0, 876.0]}, {"text": "410-528-8550. E-mail:", "bbox": [122.0, 874.0, 248.0, 889.0]}, {"text": "journalpermissions@lww.com", "bbox": [122.0, 889.0, 289.0, 903.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "Reprints: Information about reprints can be found online at", "bbox": [122.0, 915.0, 441.0, 930.0]}, {"text": "http://www.lww.com/reprints", "bbox": [123.0, 930.0, 284.0, 942.0]}], "type": "Text", "position": 10}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (Mary Fran Hazinski, John M. Field) (Z-Library).pdf", "page_num": 291}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "", "type3": null, "type4": null, "type5": null, "type6": "有用性#0#6#全文为封面内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 19:00:14"}
{"id": 1041975, "user_id": "65dea7050c9e908864e3bcde", "user_name": "焦瀚远", "task_id": 715, "source_info": {"seq_id": "ea5a23d6-d7de-41fe-9563-65f5ab0304bf", "title": null, "text": "【0】页码:11\n groups have used such a system to bring light, in effect, to a complete halt and then controllably release it back on its way. The process could have applications ranging from extremely precise measurements of properties of atoms to quantum computing.\n\n【1】Lene V. Hau's group at the Rowland Institute for Science in Cambridge, Mass., and at Harvard University carries out these tricks in a tiny cloud of sodium atoms chilled to less than a microkelvin above absolute zero. The other group, led by Ronald L.\n\n【2】Walsworth and Mikhail D. Lukin of the Harvard-Smithsonian Center for Astrophysics, also in Cambridge, achieves much the same results in a four-centimeter-long cell of rubidium vapor almost as hot as boiling water. Both use the same two-step process to freeze the light.\n\n【3】First a laser sends a carefully tuned pulse of light into the gas.\n\n【4】Usually the gas would be as opaque as a brick wall to this \"signal\" light and would completely absorb it. In these slow-light experiments, however, a second \"control\" laser beam is irradiating the gas, making it transparent to the signal pulse. This effect, called electromagnetically induced transparency, was pioneered in the early 1990s by Stephen E.\n\n【5】Harris of Stanford University and others. The control light interacts with the atoms and by a process of quantum interference eliminates their ability to absorb photons of the signal pulse. The changes to the gas's optical properties also greatly slow down the speed of the signal pulse. Such slow light was demonstrated a couple of years ago by Hau and Harris and their colleagues.\n\n【6】Traveling through the gas in unison with the slow pulse is a pattern in the alignment of the atoms' tiny magnetic fields, which exactly mimics the form of the light pulse. The combination of atomic polarizations and light is called a polariton. Stopping this polariton—the second step of the process—is achieved by turning off the control beam while the polariton is still traversing the gas. As the control beam's intensity ebbs, the remaining signal light is absorbed, and the increasingly atomic polariton slows even more. At zero intensity, the last glimmer of the light vanishes into the atoms, and the polariton comes to a dead stop.\n\n【7】 All the properties of the light pulse remain encoded in this motionless entity. The experimenters demonstrated this by waiting for a while—only a fraction of a second but aeons on the timescale of the original light pulse— and then turning the control beam back on again. The polariton is converted back into a pulse that now crawls onward to the far end of the gas and then speeds away through the air.\n\n【8】Of course, the storage and regeneration of the light is not perfect; the longer the pause,\n\n【9】 ( orange ), is compressed and slowed in the artificially transparent\n\n【10】 atomic gas ( blue ). The pulse can be frozen in place as a magnetic\n\n【11】 pattern in the atoms and then regenerated.\n\n【12】 the more degraded the output pulse becomes.\n\n【13】The atoms that carry the polarizations are not, after all, frozen in place. Diffusion and collisions steadily disperse and destroy the polariton—more rapidly in the hot gas.\n\n【14】The process achieves a key function needed for large-scale quantum-information processing, as would occur in quantum computers: reliable interconversion of fast-moving quantum states (light pulses) and robust stationary ones (polaritons). Quantum-computing expert David P. DiVincenzo of IBM cautions, however, that other aspects of the slow-light system are not so well suited for quantum computation. \"It doesn't produce a straight shot to a quantum computer,\" he says. Nevertheless, he calls it \"beautiful research\" that is \"a very positive step forward in the manipulation of quantum systems.\"\n\n【15】 A 10-microsecond pulse of light is three kilometers long in air but is crammed into 0.3 millimeter inside the cold gas used in the experiment.\n\n【16】 The light pulse can be regenerated in compressed or stretched form—or in multiple copies—by varying how the \"read-out\" laser beam is applied.\n\n【17】 The cold gas experiment stores and revives entire pulses; the hot gas stores only parts of pulses.\n\n【18】 Longer storage times are achieved in the cold gas. Slightly coldergas—a Bose-Einstein condensate — should preserve pulses for even longer times.\n\n【19】 AGES BY LENEV. HAUAND CHIEN LIU Rawland Institute for Science", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "groups have used such a system to bring light,", "bbox": [61.0, 55.0, 297.0, 69.0]}, {"text": "in effect, to a complete halt and then control-", "bbox": [61.0, 71.0, 297.0, 85.0]}, {"text": "lably release it back on its way. The process", "bbox": [61.0, 87.0, 299.0, 101.0]}, {"text": "could have applications ranging from ex-", "bbox": [60.0, 103.0, 297.0, 117.0]}, {"text": "tremely precise measurements of properties of", "bbox": [61.0, 119.0, 299.0, 133.0]}, {"text": "atoms to quantum computing.", "bbox": [61.0, 135.0, 222.0, 149.0]}, {"text": "Lene V. Hau's group at the Rowland In-", "bbox": [81.0, 151.0, 297.0, 165.0]}, {"text": "stitute for Science in Cambridge, Mass., and at", "bbox": [61.0, 167.0, 298.0, 181.0]}, {"text": "Harvard University carries out these tricks in", "bbox": [61.0, 183.0, 299.0, 197.0]}, {"text": "a tiny cloud of sodium atoms chilled to less", "bbox": [61.0, 199.0, 299.0, 213.0]}, {"text": "than a microkelvin above absolute zero. The", "bbox": [61.0, 215.0, 299.0, 229.0]}, {"text": "other group, led by Ronald L.", "bbox": [61.0, 231.0, 236.0, 245.0]}, {"text": "Walsworth and Mikhail D. Lukin", "bbox": [62.0, 247.0, 238.0, 261.0]}, {"text": "of the Harvard-Smithsonian Cen-", "bbox": [61.0, 264.0, 237.0, 277.0]}, {"text": "ter for Astrophysics, also in Cam-", "bbox": [61.0, 279.0, 237.0, 294.0]}, {"text": "bridge, achieves much the same re-", "bbox": [61.0, 295.0, 237.0, 309.0]}, {"text": "sults in a four-centimeter-long cell", "bbox": [61.0, 312.0, 238.0, 325.0]}, {"text": "of rubidium vapor almost as hot as", "bbox": [61.0, 327.0, 238.0, 342.0]}, {"text": "boiling water. Both use the same", "bbox": [61.0, 344.0, 237.0, 356.0]}, {"text": "two-step process to freeze the light.", "bbox": [61.0, 359.0, 237.0, 374.0]}, {"text": "First a laser sends a carefully", "bbox": [80.0, 375.0, 237.0, 390.0]}, {"text": "tuned pulse of light into the gas.", "bbox": [61.0, 392.0, 238.0, 405.0]}, {"text": "Usually the gas would be as", "bbox": [61.0, 407.0, 238.0, 422.0]}, {"text": "opaque as a brick wall to this \"sig-", "bbox": [61.0, 423.0, 236.0, 437.0]}, {"text": "nal\" light and would completely", "bbox": [61.0, 440.0, 237.0, 453.0]}, {"text": "absorb it. In these slow-light ex-", "bbox": [61.0, 455.0, 237.0, 469.0]}, {"text": "periments, however, a second", "bbox": [61.0, 471.0, 238.0, 485.0]}, {"text": "\"control\" laser beam is irradiat-", "bbox": [63.0, 487.0, 236.0, 501.0]}, {"text": "ing the gas, making it transparent", "bbox": [61.0, 503.0, 238.0, 517.0]}, {"text": "to the signal pulse. This effect,", "bbox": [61.0, 519.0, 237.0, 534.0]}, {"text": "called electromagnetically induced", "bbox": [61.0, 535.0, 238.0, 549.0]}, {"text": "transparency, was pioneered in", "bbox": [61.0, 551.0, 238.0, 565.0]}, {"text": "the early 1990s by Stephen E.", "bbox": [61.0, 567.0, 237.0, 581.0]}, {"text": "Harris of Stanford University and", "bbox": [61.0, 583.0, 239.0, 597.0]}, {"text": "others. The control light interacts", "bbox": [61.0, 599.0, 240.0, 614.0]}, {"text": "with the atoms and by a process", "bbox": [61.0, 615.0, 240.0, 629.0]}, {"text": "of quantum interference elimi-", "bbox": [61.0, 632.0, 239.0, 645.0]}, {"text": "nates their ability to absorb pho-", "bbox": [61.0, 647.0, 237.0, 662.0]}, {"text": "tons of the signal pulse. The changes to the", "bbox": [61.0, 663.0, 300.0, 677.0]}, {"text": "gas's optical properties also greatly slow", "bbox": [61.0, 679.0, 298.0, 694.0]}, {"text": "down the speed of the signal pulse. Such slow", "bbox": [61.0, 695.0, 298.0, 710.0]}, {"text": "light was demonstrated a couple of years ago", "bbox": [61.0, 712.0, 299.0, 725.0]}, {"text": "by Hau and Harris and their colleagues.", "bbox": [61.0, 727.0, 276.0, 742.0]}, {"text": "Traveling through the gas in unison with", "bbox": [81.0, 743.0, 299.0, 758.0]}, {"text": "the slow pulse is a pattern in the alignment of", "bbox": [61.0, 760.0, 299.0, 773.0]}, {"text": "the atoms' tiny magnetic fields, which exactly", "bbox": [61.0, 775.0, 298.0, 790.0]}, {"text": "mimics the form of the light pulse. The com-", "bbox": [61.0, 791.0, 297.0, 805.0]}, {"text": "bination of atomic polarizations and light is", "bbox": [61.0, 807.0, 299.0, 821.0]}, {"text": "called a polariton. Stopping this polariton—the", "bbox": [61.0, 823.0, 299.0, 837.0]}, {"text": "second step of the process—is achieved by", "bbox": [61.0, 839.0, 298.0, 853.0]}, {"text": "turning off the control beam while the polari-", "bbox": [61.0, 855.0, 297.0, 869.0]}, {"text": "ton is still traversing the gas. As the control", "bbox": [61.0, 871.0, 299.0, 885.0]}, {"text": "beam's intensity ebbs, the remaining signal", "bbox": [61.0, 887.0, 298.0, 902.0]}, {"text": "light is absorbed, and the increasingly atomic", "bbox": [61.0, 903.0, 299.0, 917.0]}, {"text": "polariton slows even more. At zero intensity,", "bbox": [61.0, 919.0, 298.0, 933.0]}, {"text": "the last glimmer of the light vanishes into the", "bbox": [61.0, 935.0, 299.0, 950.0]}, {"text": "atoms, and the polariton comes to a dead stop.", "bbox": [62.0, 952.0, 298.0, 965.0]}], "type": "Text", "position": 0}, {"raw_context": [{"text": "All the properties of the light pulse remain", "bbox": [330.0, 55.0, 548.0, 69.0]}, {"text": "encoded in this motionless entity. The exper-", "bbox": [310.0, 71.0, 547.0, 85.0]}, {"text": "imenters demonstrated this by waiting for a", "bbox": [310.0, 86.0, 549.0, 101.0]}, {"text": "while—only a fraction of a second but aeons", "bbox": [310.0, 103.0, 549.0, 117.0]}, {"text": "on the timescale of the original light pulse—", "bbox": [310.0, 119.0, 545.0, 133.0]}, {"text": "and then turning the control beam back on", "bbox": [311.0, 135.0, 549.0, 149.0]}, {"text": "again. The polariton is converted back into a", "bbox": [310.0, 151.0, 548.0, 165.0]}, {"text": "pulse that now crawls onward to the far end of", "bbox": [310.0, 167.0, 549.0, 181.0]}, {"text": "the gas and then speeds away through the air.", "bbox": [310.0, 183.0, 547.0, 197.0]}, {"text": "Of course, the storage and regeneration of", "bbox": [330.0, 199.0, 548.0, 214.0]}, {"text": "the light is not perfect; the longer the pause,", "bbox": [310.0, 215.0, 547.0, 229.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "( orange ), is compressed and slowed in the artificially transparent", "bbox": [252.0, 598.0, 531.0, 611.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "atomic gas ( blue ). The pulse can be frozen in place as a magnetic", "bbox": [253.0, 613.0, 524.0, 625.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "pattern in the atoms and then regenerated.", "bbox": [253.0, 626.0, 434.0, 638.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "the more degraded the output pulse becomes.", "bbox": [310.0, 663.0, 547.0, 677.0]}, {"text": "The atoms that carry the polarizations are", "bbox": [312.0, 679.0, 547.0, 694.0]}, {"text": "not, after all, frozen in place. Diffusion and", "bbox": [310.0, 695.0, 548.0, 710.0]}, {"text": "collisions steadily disperse and destroy the po-", "bbox": [310.0, 712.0, 547.0, 725.0]}, {"text": "lariton—more rapidly in the hot gas.", "bbox": [310.0, 727.0, 503.0, 742.0]}, {"text": "The process achieves a key function need-", "bbox": [330.0, 743.0, 547.0, 757.0]}, {"text": "ed for large-scale quantum-information pro-", "bbox": [310.0, 760.0, 547.0, 773.0]}, {"text": "cessing, as would occur in quantum comput-", "bbox": [310.0, 775.0, 547.0, 790.0]}, {"text": "ers: reliable interconversion of fast-moving", "bbox": [310.0, 791.0, 549.0, 805.0]}, {"text": "quantum states (light pulses) and robust sta-", "bbox": [310.0, 807.0, 547.0, 821.0]}, {"text": "tionary ones (polaritons). Quantum-com-", "bbox": [310.0, 823.0, 547.0, 837.0]}, {"text": "puting expert David P. DiVincenzo of IBM", "bbox": [310.0, 839.0, 548.0, 853.0]}, {"text": "cautions, however, that other aspects of the", "bbox": [310.0, 855.0, 548.0, 869.0]}, {"text": "slow-light system are not so well suited for", "bbox": [310.0, 871.0, 547.0, 885.0]}, {"text": "quantum computation. \"It doesn't produce a", "bbox": [310.0, 887.0, 549.0, 902.0]}, {"text": "straight shot to a quantum computer,\" he", "bbox": [311.0, 903.0, 548.0, 917.0]}, {"text": "says. Nevertheless, he calls it \"beautiful re-", "bbox": [310.0, 919.0, 547.0, 933.0]}, {"text": "search\" that is \"a very positive step forward", "bbox": [310.0, 935.0, 548.0, 950.0]}, {"text": "in the manipulation of quantum systems.\"", "bbox": [310.0, 952.0, 534.0, 965.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "A 10-microsecond pulse of", "bbox": [575.0, 686.0, 690.0, 700.0]}, {"text": "light is three kilometers long", "bbox": [575.0, 699.0, 711.0, 712.0]}, {"text": "in air but is crammed into", "bbox": [575.0, 713.0, 686.0, 724.0]}, {"text": "0.3 millimeter inside the cold", "bbox": [575.0, 727.0, 707.0, 738.0]}, {"text": "gas used in the experiment.", "bbox": [575.0, 740.0, 692.0, 752.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "The light pulse can be", "bbox": [575.0, 767.0, 669.0, 780.0]}, {"text": "regenerated in compressed or", "bbox": [575.0, 780.0, 711.0, 792.0]}, {"text": "stretched form—or in multiple", "bbox": [575.0, 793.0, 712.0, 804.0]}, {"text": "copies—by varying how the", "bbox": [575.0, 806.0, 694.0, 820.0]}, {"text": "\"read-out\" laser beam is applied.", "bbox": [577.0, 820.0, 715.0, 832.0]}], "type": "Text", "position": 9}, {"raw_context": [{"text": "The cold gas experiment stores", "bbox": [576.0, 847.0, 709.0, 859.0]}, {"text": "and revives entire pulses; the hot", "bbox": [576.0, 860.0, 724.0, 872.0]}, {"text": "gas stores only parts of pulses.", "bbox": [576.0, 874.0, 717.0, 885.0]}], "type": "Text", "position": 10}, {"raw_context": [{"text": "Longer storage times are", "bbox": [575.0, 900.0, 694.0, 911.0]}, {"text": "achieved in the cold gas. Slightly", "bbox": [576.0, 913.0, 715.0, 925.0]}, {"text": "coldergas—a Bose-Einstein ", "bbox": [575.0, 927.0, 707.0, 939.0]}, {"text": "condensate — should preserve", "bbox": [575.0, 940.0, 711.0, 952.0]}, {"text": "pulses for even longer times.", "bbox": [575.0, 952.0, 698.0, 965.0]}], "type": "Text", "position": 11}, {"raw_context": [{"text": "AGES BY LENEV. HAUAND CHIEN LIU Rawland Institute for Science", "bbox": [19.0, 716.0, 35.0, 953.0]}], "type": "Text", "position": 12}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/(2001-04) Whose Blood Is It, Anyway (Scientific American) (Z-Library).pdf", "page_num": 11}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "多余换行#8#12# 8和12为同段", "type3": null, "type4": null, "type5": null, "type6": "信息有用性#9#11#无用内容\n信息有用性#15#19#无用内容"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:37:38"}
{"id": 1041974, "user_id": "65e7dd234a08e7753ad36f9f", "user_name": " 黄艳玲", "task_id": 715, "source_info": {"seq_id": "6f0a2fb2-e754-468a-a142-1b2c01edb635", "title": null, "text": "【0】页码:11\n# Collaborators\n\n【1】\n .\n\n【2】 Burguera Pascu, Elias. Orthodontist.\n\n【3】Dentist, graduated at Universidad de los Andes, Merida state, Merida, Venezuela.\n\n【4】Masters Degree in Orthodontics and Maxillofacial Orthopedics at Centro de Estudios Superiores de Ortodoncia (CESO), Mexico, DF.\n\n【5】CONADES Award 1998.\n\n【6】CONABA Award 2000.\n\n【7】CONABA Award 2003.\n\n【8】Honorific Mention in Orthodontics and Maxillofacial Orthopedics at Centro de Estudios Superiores de Ortodoncia (CESO).\n\n【9】Author of the book \"Crecimiento y Desarrollo Craneo-Facial\".\n\n【10】Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\" edited and distributed by AMOLCA publications.\n\n【11】Head of the Orthodontic Department, Universidad de los Andes, Merida, Merida state, Venezuela.\n\n【12】National and Internacional dental publications.\n\n【13】 .\n\n【14】 Camacho Badillo, Mauricio. Orthodontist.\n\n【15】Dentist, graduated at Facultad de Estomatología en la Universidad Autonoma de San Luis Potosi, S.L.P. Mexico.\n\n【16】Articles published nationally and internationally.\n\n【17】Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\" edited and distributed by AMOLCA publications.\n\n【18】Specialist Degree in Orthodontics, Centro de Estudios de Ortodoncia del Bajio (CEOB), Irapuato, Guanajuato, Mexico.\n\n【19】 .\n\n【20】 Coutino Escobar, Carlos. Resident.\n\n【21】Dentist, graduated at Universidad Michoacana de San Nicolas de Hidalgo, Morelia, Michoacan, Mexico.\n\n【22】Articles published nationally and internationally.\n\n【23】Resident of the orthodontic specialty program at Centro de Estudios de Ortodoncia del Bajio (CEOB), Irapuato, Guanajuato, Mexico,\n\n【24】 .\n\n【25】 Del Pozo Moreno, Eduardo. Resident.\n\n【26】Dentist, graduated at Universidad Quetzalcoatl, Irapuato, Guanajuato, Mexico.\n\n【27】Articles published nationally and internationally.\n\n【28】Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\" edited and distributed by AMOLCA publications.\n\n【29】Resident of the orthodontic specialty program at Centro de Estudios de Ortodoncia del Bajio (CEOB), Irapuato, Guanajuato, Mexico.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Collaborators", "bbox": [226.0, 85.0, 433.0, 118.0]}], "type": "Title", "position": 0}, {"raw_context": [{"text": ".", "bbox": [228.0, 258.0, 239.0, 270.0]}], "type": "Text", "position": 1}, {"raw_context": [{"text": "Burguera Pascu, Elias. Orthodontist.", "bbox": [247.0, 256.0, 470.0, 272.0]}, {"text": "Dentist, graduated at Universidad de los Andes, Merida state, Merida,", "bbox": [249.0, 273.0, 633.0, 289.0]}, {"text": "Venezuela.", "bbox": [249.0, 291.0, 310.0, 306.0]}, {"text": "Masters Degree in Orthodontics and Maxillofacial Orthopedics at Centro de", "bbox": [249.0, 306.0, 671.0, 321.0]}, {"text": "Estudios Superiores de Ortodoncia (CESO), Mexico, DF.", "bbox": [249.0, 322.0, 561.0, 338.0]}, {"text": "CONADES Award 1998.", "bbox": [248.0, 340.0, 386.0, 355.0]}, {"text": "CONABA Award 2000.", "bbox": [249.0, 356.0, 380.0, 372.0]}, {"text": "CONABA Award 2003.", "bbox": [249.0, 374.0, 379.0, 388.0]}, {"text": "Honorific Mention in Orthodontics and Maxillofacial Orthopedics at Centro", "bbox": [249.0, 390.0, 673.0, 403.0]}, {"text": "de Estudios Superiores de Ortodoncia (CESO).", "bbox": [249.0, 407.0, 508.0, 422.0]}, {"text": "Author of the book \"Crecimiento y Desarrollo Craneo-Facial\".", "bbox": [249.0, 422.0, 590.0, 438.0]}, {"text": "Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\"", "bbox": [249.0, 439.0, 656.0, 455.0]}, {"text": "edited and distributed by AMOLCA publications.", "bbox": [249.0, 456.0, 525.0, 472.0]}, {"text": "Head of the Orthodontic Department, Universidad de los Andes, Merida,", "bbox": [249.0, 472.0, 655.0, 488.0]}, {"text": "Merida state, Venezuela.", "bbox": [250.0, 490.0, 385.0, 505.0]}, {"text": "National and Internacional dental publications.", "bbox": [250.0, 506.0, 510.0, 522.0]}], "type": "Text", "position": 2}, {"raw_context": [{"text": ".", "bbox": [229.0, 540.0, 240.0, 554.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "Camacho Badillo, Mauricio. Orthodontist.", "bbox": [249.0, 540.0, 506.0, 554.0]}, {"text": "Dentist, graduated at Facultad de Estomatología en la Universidad", "bbox": [250.0, 555.0, 617.0, 571.0]}, {"text": "Autonoma de San Luis Potosi, S.L.P. Mexico.", "bbox": [248.0, 573.0, 493.0, 588.0]}, {"text": "Articles published nationally and internationally.", "bbox": [248.0, 590.0, 516.0, 605.0]}, {"text": "Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\"", "bbox": [250.0, 606.0, 657.0, 621.0]}, {"text": "edited and distributed by AMOLCA publications.", "bbox": [250.0, 623.0, 526.0, 638.0]}, {"text": "Specialist Degree in Orthodontics, Centro de Estudios de Ortodoncia del Bajio", "bbox": [250.0, 640.0, 676.0, 654.0]}, {"text": "(CEOB), Irapuato, Guanajuato, Mexico.", "bbox": [250.0, 656.0, 469.0, 671.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": ".", "bbox": [230.0, 690.0, 240.0, 703.0]}], "type": "Text", "position": 5}, {"raw_context": [{"text": "Coutino Escobar, Carlos. Resident.", "bbox": [250.0, 689.0, 462.0, 705.0]}, {"text": "Dentist, graduated at Universidad Michoacana de San Nicolas de", "bbox": [252.0, 705.0, 609.0, 721.0]}, {"text": "Hidalgo, Morelia, Michoacan, Mexico.", "bbox": [252.0, 723.0, 463.0, 738.0]}, {"text": "Articles published nationally and internationally.", "bbox": [252.0, 740.0, 519.0, 755.0]}, {"text": "Resident of the orthodontic specialty program at Centro de Estudios de", "bbox": [252.0, 756.0, 644.0, 772.0]}, {"text": "Ortodoncia del Bajio (CEOB), Irapuato, Guanajuato, Mexico,", "bbox": [252.0, 772.0, 587.0, 788.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": ".", "bbox": [231.0, 807.0, 242.0, 820.0]}], "type": "Text", "position": 7}, {"raw_context": [{"text": "Del Pozo Moreno, Eduardo. Resident.", "bbox": [250.0, 805.0, 479.0, 821.0]}, {"text": "Dentist, graduated at Universidad Quetzalcoatl, Irapuato, Guanajuato,", "bbox": [252.0, 822.0, 637.0, 837.0]}, {"text": "Mexico.", "bbox": [252.0, 840.0, 299.0, 855.0]}, {"text": "Articles published nationally and internationally.", "bbox": [252.0, 856.0, 520.0, 871.0]}, {"text": "Collaborator of \"Ortodoncia Contemporanea. Diagnostico y Tratamiento\"", "bbox": [252.0, 872.0, 658.0, 888.0]}, {"text": "edited and distributed by AMOLCA publications.", "bbox": [252.0, 889.0, 528.0, 904.0]}, {"text": "Resident of the orthodontic specialty program at Centro de Estudios de", "bbox": [252.0, 905.0, 645.0, 921.0]}, {"text": "Ortodoncia del Bajio (CEOB), Irapuato, Guanajuato, Mexico.", "bbox": [252.0, 922.0, 588.0, 938.0]}], "type": "Text", "position": 8}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 11}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": null, "type3": null, "type4": null, "type5": null, "type6": "有用性#0#29#全篇都是合作者信息"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:32:07"}
{"id": 1041973, "user_id": "65e7dd68e6dc6a3a8618a668", "user_name": "王磊", "task_id": 715, "source_info": {"seq_id": "05f590d9-6299-4715-b1d7-e40ef0fd67ee", "title": null, "text": "【0】页码:38\n\n【1】## Action Taken\n\n【2】\n Apically directed Tip back.\n\n【3】 1.\n\n【4】## Produced Reaction\n\n【5】\n Molar extrusion.\n\n【6】1.\n\n【7】2.\n\n【8】Incisor intrusion.\n\n【9】3.\n\n【10】Distal inclination of the molar crowns.\n\n【11】Mesial inclination of the molar roots.\n\n【12】4.\n\n【13】5.\n\n【14】Buccal movement of the incisors.\n\n【15】Increase of dental arch length.\n\n【16】6, 6, 7.\n\n【17】Posterior anchorage.\n\n【18】## Spee Curve Leveling With Reverse Curves\n\n【19】\n When we use reverse curves to level a deep curve of Spee, we find that the intrusive forces exercised in the anterior and posterior sectors are balanced with the extrusive forces that are exercised in the premolar region. 69 Another effect is that the intrusive forces are going to provoke at the molar level a positive torque and a distal inclination of the crowns and a mesial movement of their roots; on the other hand the intrusive forces exercised at the incisor level will provoke a buccal movement of these (positive torque).\n Fig. 53. Inferior reverse curve.\n\n【20】 Fig. 54. The extrusive forces at the premolar level are going to be equilibrated by the intrusive forces exercised at the molar and incisor levels.\n Fig. 55. The moments produced by the action of an inverse curve are evidenced at the molar level with a distal inclination of the crown and a mesial in the roots and at the incisor level with a buccal movement of them (positive torque).\n\n【21】## Action Taken\n\n【22】\n Use of an inverse curve in the inferior arch.\n\n【23】1.\n\n【24】 Produced reaction\n\n【25】 2.\n\n【26】 Leveling of the deep Spee curve.\n\n【27】i.\n\n【28】2.\n\n【29】Overbite reduction.\n\n【30】3.\n\n【31】Extrusion of the premolar sector.\n\n【32】 3.", "tags": {}, "lang": "en", "attr": {"raw_info": [{"raw_context": [{"text": "Action taken", "bbox": [70.0, 83.0, 154.0, 100.0]}], "type": "Section-header", "position": 2}, {"raw_context": [{"text": "Apically directed Tip back.", "bbox": [96.0, 101.0, 247.0, 117.0]}], "type": "Text", "position": 3}, {"raw_context": [{"text": "1.", "bbox": [72.0, 102.0, 85.0, 116.0]}], "type": "Text", "position": 4}, {"raw_context": [{"text": "Produced reaction", "bbox": [69.0, 135.0, 187.0, 151.0]}], "type": "Section-header", "position": 5}, {"raw_context": [{"text": "Molar extrusion.", "bbox": [96.0, 153.0, 191.0, 169.0]}, {"text": "1.", "bbox": [70.0, 155.0, 84.0, 169.0]}, {"text": "2.", "bbox": [69.0, 170.0, 84.0, 186.0]}, {"text": "Incisor intrusion.", "bbox": [96.0, 171.0, 194.0, 186.0]}, {"text": "3.", "bbox": [69.0, 188.0, 84.0, 204.0]}, {"text": "Distal inclination of the molar crowns.", "bbox": [95.0, 188.0, 310.0, 204.0]}, {"text": "Mesial inclination of the molar roots.", "bbox": [95.0, 205.0, 303.0, 220.0]}, {"text": "4.", "bbox": [70.0, 206.0, 84.0, 220.0]}, {"text": "5.", "bbox": [69.0, 222.0, 84.0, 237.0]}, {"text": "Buccal movement of the incisors.", "bbox": [95.0, 223.0, 281.0, 238.0]}, {"text": "Increase of dental arch length.", "bbox": [95.0, 240.0, 265.0, 256.0]}, {"text": "6, 6,", "bbox": [69.0, 241.0, 84.0, 255.0]}, {"text": "7.", "bbox": [69.0, 257.0, 84.0, 272.0]}, {"text": "Posterior anchorage.", "bbox": [95.0, 257.0, 213.0, 273.0]}], "type": "Text", "position": 6}, {"raw_context": [{"text": "Spee curve leveling with reverse curves", "bbox": [69.0, 342.0, 368.0, 359.0]}], "type": "Section-header", "position": 7}, {"raw_context": [{"text": "When we use reverse curves to level a deep curve of Spee,", "bbox": [69.0, 379.0, 383.0, 394.0]}, {"text": "we find that the intrusive forces exercised in the anterior", "bbox": [69.0, 396.0, 383.0, 411.0]}, {"text": "and posterior sectors are balanced with the extrusive forces", "bbox": [69.0, 412.0, 383.0, 429.0]}, {"text": "that are exercised in the premolar region. 69 Another effect", "bbox": [68.0, 430.0, 383.0, 447.0]}, {"text": "is that the intrusive forces are going to provoke at the molar", "bbox": [68.0, 448.0, 383.0, 464.0]}, {"text": "level a positive torque and a distal inclination of the crowns", "bbox": [68.0, 465.0, 383.0, 481.0]}, {"text": "and a mesial movement of their roots; on the other hand the", "bbox": [68.0, 482.0, 383.0, 498.0]}, {"text": "intrusive forces exercised at the incisor level will provoke a", "bbox": [68.0, 499.0, 383.0, 515.0]}, {"text": "buccal movement of these (positive torque).", "bbox": [68.0, 517.0, 307.0, 533.0]}], "type": "Text", "position": 8}, {"raw_context": [{"text": "Fig. 53. Inferior reverse curve.", "bbox": [156.0, 958.0, 291.0, 972.0]}], "type": "Caption", "position": 10}, {"raw_context": [{"text": "Fig. 54. The extrusive forces at the premolar level are going to be", "bbox": [405.0, 415.0, 719.0, 430.0]}, {"text": "equilibrated by the intrusive forces exercised at the molar and incisor", "bbox": [406.0, 430.0, 719.0, 445.0]}, {"text": "levels.", "bbox": [405.0, 443.0, 436.0, 456.0]}], "type": "Text", "position": 12}, {"raw_context": [{"text": "Fig. 55. The moments produced by the action of an inverse curve are", "bbox": [403.0, 743.0, 718.0, 758.0]}, {"text": "evidenced at the molar level with a distal inclination of the crown and", "bbox": [403.0, 757.0, 718.0, 770.0]}, {"text": "a mesial in the roots and at the incisor level with a buccal movement of", "bbox": [403.0, 772.0, 719.0, 784.0]}, {"text": "them (positive torque).", "bbox": [403.0, 784.0, 508.0, 797.0]}], "type": "Caption", "position": 14}, {"raw_context": [{"text": "Action taken", "bbox": [403.0, 851.0, 487.0, 867.0]}], "type": "Section-header", "position": 15}, {"raw_context": [{"text": "Use of an inverse curve in the inferior arch.", "bbox": [428.0, 870.0, 669.0, 886.0]}, {"text": "1.", "bbox": [404.0, 871.0, 420.0, 885.0]}], "type": "Text", "position": 16}, {"raw_context": [{"text": "Produced reaction", "bbox": [402.0, 904.0, 520.0, 919.0]}], "type": "Text", "position": 17}, {"raw_context": [{"text": "2.", "bbox": [402.0, 939.0, 417.0, 954.0]}], "type": "Text", "position": 18}, {"raw_context": [{"text": "Leveling of the deep Spee curve.", "bbox": [429.0, 921.0, 610.0, 937.0]}, {"text": "i.", "bbox": [404.0, 923.0, 417.0, 937.0]}, {"text": "2.", "bbox": [402.0, 939.0, 417.0, 954.0]}, {"text": "Overbite reduction.", "bbox": [429.0, 939.0, 541.0, 954.0]}, {"text": "3.", "bbox": [402.0, 956.0, 417.0, 972.0]}, {"text": "Extrusion of the premolar sector.", "bbox": [429.0, 956.0, 614.0, 972.0]}], "type": "Text", "position": 19}, {"raw_context": [{"text": "3.", "bbox": [402.0, 956.0, 417.0, 972.0]}], "type": "Text", "position": 20}], "obj_key": "oss://inf-beta/datasets/medical_books_v1130/1001 tips for orthodontics and its secrets (Esequiel E. Rodriguez Yanez  Coauthors etc.) (Z-Library).pdf", "page_num": 38}, "ext": null, "dataset": "medical_stage4_surya", "batch_name": "20240429", "version": "version0"}, "result_info": {"type1": null, "type2": "序号格式不一致#27#27#i.应该是1.", "type3": "无关文本#16#16#6, \n无关文本#25#25#2.多余的序号\n无关文本#32#32#3.多余的序号", "type4": "栏目混乱#2#17#序号和正文内容分离，相互交错\n栏目混乱#22#31#序号和正文内容分离，相互交错", "type5": null, "type6": "有用性#19#19#Fig. 53. Inferior reverse curve.图片信息\n有用性#20#20# Fig. 54. The extrusive forces at the premolar level are going......图片信息"}, "finished": true, "dropped": false, "create_time": "2024-04-28 18:10:52", "update_time": "2024-04-28 22:54:34"}